[{"comparisonGroups":["Control_0h","Wounding_72h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 72h wounding treatment response","group_a_title":"Control group at time point 0h. Serves as the reference point for all subsequent time points and treatments","group_b_title":"Wounding treatment group at time point 72h. Captures response to wounding treatment at 72h","id":"MTBLS10_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS10","studyUrl":"http://integmet.org/study/MTBLS10","title":"Control_0h_vs_Wounding_72h","topHits":[{"chebi_id":"67236","direction":"down","inn_name":"","iupac_name":"(2<i>Z</i>,6<i>E</i>,10<i>E</i>,14<i>S</i>)-14-{[4-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraen-1-yl 2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"CWAXZXSFUDEMIX-ZIKBFGBNSA-N","pvalue":0.0001254792416871,"ratio":0.3380945512651232,"synonym_name":""},{"chebi_id":"138000","direction":"down","inn_name":"","iupac_name":"3-(1-methylpyrrolidin-2-yl)pyridine","metabolite_id":"SNICXCGAKADSCV-UHFFFAOYSA-N","pvalue":2.540100536108432e-05,"ratio":0.6227839403747736,"synonym_name":""}],"totalFeatures":7},{"comparisonGroups":["Control","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HIAE condition comparison","group_a_title":"Control group with no HIAE condition. Provides baseline metabolic profile for comparison with HIAE and treated groups.","group_b_title":"Group with HIAE condition. Represents the metabolic state associated with HIAE, crucial for understanding disease-related changes.","id":"MTBLS103_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS103","studyUrl":"http://integmet.org/study/MTBLS103","title":"Control_vs_HIAE","topHits":[{"chebi_id":"49033","direction":"down","inn_name":"","iupac_name":"2-amino-4-(methylsulfinyl)butanoic acid","metabolite_id":"QEFRNWWLZKMPFJ-UHFFFAOYSA-N","pvalue":3.688633546137796e-06,"ratio":0.374326878601751,"synonym_name":"methionine sulfoxide"},{"chebi_id":"73505","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamylglycine","metabolite_id":"LSPKYLAFTPBWIL-BYPYZUCNSA-N","pvalue":1.2336650934500191e-06,"ratio":0.5059886077616765,"synonym_name":"glutamylglycine"},{"chebi_id":"75011","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-glutamic acid","metabolite_id":"UPJONISHZRADBH-XPUUQOCRSA-N","pvalue":4.21027745554106e-05,"ratio":0.4509154111428206,"synonym_name":"Valyl-Glutamate"},{"chebi_id":"57932","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-SCSAIBSYSA-N","pvalue":5.647755765099944e-05,"ratio":1.987065458077588,"synonym_name":"(2<i>R</i>)-2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"29985","direction":"down","inn_name":"","iupac_name":"hydrogen <small>L</small>-glutamate","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-M","pvalue":3.738333922196682e-05,"ratio":0.6220202963141719,"synonym_name":"L-glutamate"},{"chebi_id":"172511","direction":"down","inn_name":"","iupac_name":"2-[(2-azaniumyl-4-carboxylatobutanoyl)amino]pentanedioate","metabolite_id":"KOSRFJWDECSPRO-UHFFFAOYSA-L","pvalue":0.0061964550582653,"ratio":0.5483724333491508,"synonym_name":""}],"totalFeatures":9},{"comparisonGroups":["Control","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HIAE condition comparison","group_a_title":"Control group with no HIAE condition. Provides baseline metabolic profile for comparison with HIAE and treated groups.","group_b_title":"Group with HIAE condition. Represents the metabolic state associated with HIAE, crucial for understanding disease-related changes.","id":"MTBLS103_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS103","studyUrl":"http://integmet.org/study/MTBLS103","title":"Control_vs_HIAE","topHits":[{"chebi_id":"57932","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-SCSAIBSYSA-N","pvalue":1.0581079676406257e-07,"ratio":3.652638720556937,"synonym_name":"(2<i>R</i>)-2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"17515","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteine","metabolite_id":"RITKHVBHSGLULN-WHFBIAKZSA-N","pvalue":1.0581745372788613e-05,"ratio":0.5943733321065947,"synonym_name":"Glu(-Cys)"},{"chebi_id":"18183","direction":"down","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0002059412133548,"ratio":0.5988821579059442,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"29985","direction":"down","inn_name":"","iupac_name":"hydrogen <small>L</small>-glutamate","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-M","pvalue":0.0001801303838502,"ratio":0.652442418589414,"synonym_name":"L-glutamate"},{"chebi_id":"49033","direction":"down","inn_name":"","iupac_name":"2-amino-4-(methylsulfinyl)butanoic acid","metabolite_id":"QEFRNWWLZKMPFJ-UHFFFAOYSA-N","pvalue":0.0023244105798985,"ratio":0.6073972457782709,"synonym_name":"methionine sulfoxide"},{"chebi_id":"5390","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"KOSRFJWDECSPRO-WDSKDSINSA-N","pvalue":0.0064981521456281,"ratio":0.6624032096336191,"synonym_name":"<small>L</small>-Glu-<small>L</small>-Glu"}],"totalFeatures":8},{"comparisonGroups":["Control","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HIAE condition comparison","group_a_title":"Control group with no HIAE condition. Provides baseline metabolic profile for comparison with HIAE and treated groups.","group_b_title":"Group with HIAE condition. Represents the metabolic state associated with HIAE, crucial for understanding disease-related changes.","id":"MTBLS103_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS103","studyUrl":"http://integmet.org/study/MTBLS103","title":"Control_vs_HIAE","topHits":[{"chebi_id":"49033","direction":"down","inn_name":"","iupac_name":"2-amino-4-(methylsulfinyl)butanoic acid","metabolite_id":"QEFRNWWLZKMPFJ-UHFFFAOYSA-N","pvalue":3.688633546137796e-06,"ratio":0.374326878601751,"synonym_name":"methionine sulfoxide"},{"chebi_id":"73505","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamylglycine","metabolite_id":"LSPKYLAFTPBWIL-BYPYZUCNSA-N","pvalue":1.2336650934500191e-06,"ratio":0.5059886077616765,"synonym_name":"glutamylglycine"},{"chebi_id":"57932","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-SCSAIBSYSA-N","pvalue":5.647755765099944e-05,"ratio":1.987065458077588,"synonym_name":"(2<i>R</i>)-2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"29985","direction":"down","inn_name":"","iupac_name":"hydrogen <small>L</small>-glutamate","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-M","pvalue":3.738333922196682e-05,"ratio":0.6220202963141719,"synonym_name":"L-glutamate"},{"chebi_id":"5390","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"KOSRFJWDECSPRO-WDSKDSINSA-N","pvalue":0.0061964550582653,"ratio":0.5483724333491508,"synonym_name":"<small>L</small>-Glu-<small>L</small>-Glu"}],"totalFeatures":8},{"comparisonGroups":["Control","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HIAE condition comparison","group_a_title":"Control group with no HIAE condition. Provides baseline metabolic profile for comparison with HIAE and treated groups.","group_b_title":"Group with HIAE condition. Represents the metabolic state associated with HIAE, crucial for understanding disease-related changes.","id":"MTBLS103_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS103","studyUrl":"http://integmet.org/study/MTBLS103","title":"Control_vs_HIAE","topHits":[{"chebi_id":"57932","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-SCSAIBSYSA-N","pvalue":1.0581079676406257e-07,"ratio":3.652638720556937,"synonym_name":"(2<i>R</i>)-2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"17515","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteine","metabolite_id":"RITKHVBHSGLULN-WHFBIAKZSA-N","pvalue":1.0581745372788613e-05,"ratio":0.5943733321065947,"synonym_name":"Glu(-Cys)"},{"chebi_id":"18183","direction":"down","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0002059412133548,"ratio":0.5988821579059442,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"29985","direction":"down","inn_name":"","iupac_name":"hydrogen <small>L</small>-glutamate","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-M","pvalue":0.0001801303838502,"ratio":0.652442418589414,"synonym_name":"L-glutamate"},{"chebi_id":"49033","direction":"down","inn_name":"","iupac_name":"2-amino-4-(methylsulfinyl)butanoic acid","metabolite_id":"QEFRNWWLZKMPFJ-UHFFFAOYSA-N","pvalue":0.0023244105798985,"ratio":0.6073972457782709,"synonym_name":"methionine sulfoxide"},{"chebi_id":"172511","direction":"down","inn_name":"","iupac_name":"2-[(2-azaniumyl-4-carboxylatobutanoyl)amino]pentanedioate","metabolite_id":"KOSRFJWDECSPRO-UHFFFAOYSA-L","pvalue":0.0064981521456281,"ratio":0.6624032096336191,"synonym_name":""}],"totalFeatures":8},{"comparisonGroups":["Control","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HIAE condition comparison","group_a_title":"Control group with no HIAE condition. Provides baseline metabolic profile for comparison with HIAE and treated groups.","group_b_title":"Group with HIAE condition. Represents the metabolic state associated with HIAE, crucial for understanding disease-related changes.","id":"MTBLS103_0005_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS103","studyUrl":"http://integmet.org/study/MTBLS103","title":"Control_vs_HIAE","topHits":[{"chebi_id":"49033","direction":"down","inn_name":"","iupac_name":"2-amino-4-(methylsulfinyl)butanoic acid","metabolite_id":"QEFRNWWLZKMPFJ-UHFFFAOYSA-N","pvalue":3.688633546137796e-06,"ratio":0.374326878601751,"synonym_name":"methionine sulfoxide"},{"chebi_id":"73505","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamylglycine","metabolite_id":"LSPKYLAFTPBWIL-BYPYZUCNSA-N","pvalue":1.2336650934500191e-06,"ratio":0.5059886077616765,"synonym_name":"glutamylglycine"},{"chebi_id":"75011","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-glutamic acid","metabolite_id":"UPJONISHZRADBH-XPUUQOCRSA-N","pvalue":4.21027745554106e-05,"ratio":0.4509154111428206,"synonym_name":"Valyl-Glutamate"},{"chebi_id":"57932","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-SCSAIBSYSA-N","pvalue":5.647755765099944e-05,"ratio":1.987065458077588,"synonym_name":"(2<i>R</i>)-2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"29985","direction":"down","inn_name":"","iupac_name":"hydrogen <small>L</small>-glutamate","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-M","pvalue":3.738333922196682e-05,"ratio":0.6220202963141719,"synonym_name":"L-glutamate"},{"chebi_id":"172511","direction":"down","inn_name":"","iupac_name":"2-[(2-azaniumyl-4-carboxylatobutanoyl)amino]pentanedioate","metabolite_id":"KOSRFJWDECSPRO-UHFFFAOYSA-L","pvalue":0.0061964550582653,"ratio":0.5483724333491508,"synonym_name":""}],"totalFeatures":9},{"comparisonGroups":["rps2-wildtype","rps2-A226Y"],"dateCreated":"2025-09-26 00:00:00","display_title":"HEK-293 cells: RPS2 A226Y mutant vs wild-type","group_a_title":"Wild-type HEK-293 cells expressing normal RPS2 protein.. Serves as the reference group to assess the effects of the A226Y mutation.","group_b_title":"HEK-293 cells expressing mutant RPS2 protein with A226Y mutation.. Allows for the investigation of the effects of the A226Y mutation on cellular processes.","id":"MTBLS106_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS106","studyUrl":"http://integmet.org/study/MTBLS106","title":"rps2_wildtype_vs_rps2_A226Y","topHits":[{"chebi_id":"16908","direction":"up","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BOPGDPNILDQYTO-NNYOXOHSSA-N","pvalue":0.0001825579071201,"ratio":1000000.0,"synonym_name":"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE"},{"chebi_id":"57345","direction":"up","inn_name":"","iupac_name":"3'-phosphonatoadenosine 5'-{3-[(3<i>R</i>)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(3-methylbutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl] diphosphate}","metabolite_id":"UYVZIWWBJMYRCD-ZMHDXICWSA-J","pvalue":0.0038087790483092,"ratio":1000000.0,"synonym_name":"isovaleryl-coenzyme A(4\u2212)"},{"chebi_id":"27468","direction":"down","inn_name":"","iupac_name":"5-methyldihydropyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"NBAKTGXDIBVZOO-UHFFFAOYSA-N","pvalue":0.0053058109761219,"ratio":1e-06,"synonym_name":"5,6-Dihydro-5-methyluracil"},{"chebi_id":"73034","direction":"down","inn_name":"","iupac_name":"3-[(3-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"HAEVNYBCYZZDFL-UHFFFAOYSA-N","pvalue":0.0003522922796663,"ratio":0.152226415731978,"synonym_name":"3-[(3-carboxypropanoyl)oxy]-4-(trimethylammonio)butanoate"},{"chebi_id":"141429","direction":"down","inn_name":"","iupac_name":"<small>L</small>-glutaminyl-<small>L</small>-leucine","metabolite_id":"ARPVSMCNIDAQBO-YUMQZZPRSA-N","pvalue":0.0176587530760571,"ratio":0.1602030599518698,"synonym_name":"<em>N</em>-<small>L</small>-glutaminyl-<small>L</small>-leucine"},{"chebi_id":"73527","direction":"down","inn_name":"","iupac_name":"<small>L</small>-leucyl-<small>L</small>-alanine","metabolite_id":"HSQGMTRYSIHDAC-BQBZGAKWSA-N","pvalue":0.0456296021805877,"ratio":0.1007149735456482,"synonym_name":"L-A"},{"chebi_id":"73025","direction":"down","inn_name":"","iupac_name":"3-[(3-methylbutanoyl)oxy]-4-(trimethylammonio)butanoate","metabolite_id":"IGQBPDJNUXPEMT-UHFFFAOYSA-N","pvalue":0.0022210164669398,"ratio":0.3218649711324433,"synonym_name":"3-methylbutyrylcarnitine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AWUHAZDZHNWQAG-GFCCVEGCSA-O","pvalue":0.0065648388474586,"ratio":0.3168046940616629,"synonym_name":""},{"chebi_id":"32392","direction":"down","inn_name":"","iupac_name":"(15<i>Z</i>)-tetracos-15-enoate","metabolite_id":"GWHCXVQVJPWHRF-KTKRTIGZSA-M","pvalue":0.0079390357074142,"ratio":0.3030554003435982,"synonym_name":"(<i>Z</i>)-tetracos-15-enoate"},{"chebi_id":"68561","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetyltyrosine","metabolite_id":"CAHKINHBCWCHCF-UHFFFAOYSA-N","pvalue":0.0145365035776582,"ratio":3.589118639256744,"synonym_name":"<em>N</em>-acetyl-<small>D</small><small>L</small>-tyrosine"}],"totalFeatures":482},{"comparisonGroups":["Root","Young Leaf"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. wilfordii: root vs young leaf tissue","group_a_title":"Samples from the root of Tripterygium wilfordii. Provides insights into the metabolite profile of the root tissue.","group_b_title":"Samples from the young leaf of Tripterygium wilfordii. Provides insights into the metabolite profile of the young leaf tissue.","id":"MTBLS1080_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1080","studyUrl":"http://integmet.org/study/MTBLS1080","title":"Root_vs_Young_Leaf","topHits":[],"totalFeatures":2},{"comparisonGroups":["Root","Young Leaf"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. wilfordii: root vs young leaf tissue","group_a_title":"Samples from the root of Tripterygium wilfordii. Provides insights into the metabolite profile of the root tissue.","group_b_title":"Samples from the young leaf of Tripterygium wilfordii. Provides insights into the metabolite profile of the young leaf tissue.","id":"MTBLS1080_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1080","studyUrl":"http://integmet.org/study/MTBLS1080","title":"Root_vs_Young_Leaf","topHits":[],"totalFeatures":1},{"comparisonGroups":["Root","Young Leaf"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. wilfordii: root vs young leaf tissue","group_a_title":"Samples from the root of Tripterygium wilfordii. Provides insights into the metabolite profile of the root tissue.","group_b_title":"Samples from the young leaf of Tripterygium wilfordii. Provides insights into the metabolite profile of the young leaf tissue.","id":"MTBLS1080_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1080","studyUrl":"http://integmet.org/study/MTBLS1080","title":"Root_vs_Young_Leaf","topHits":[],"totalFeatures":1},{"comparisonGroups":["mennormal","menLCCstage1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Male colon: healthy vs stage I descending cancer","group_a_title":"Healthy male controls. Provides baseline metabolic profile for comparison with disease states","group_b_title":"Male patients with descending colon cancer at stage I. Understanding early-stage disease metabolism in males","id":"MTBLS1122_0001_00000017","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1122","studyUrl":"http://integmet.org/study/MTBLS1122","title":"mennormal_vs_menLCCstage1","topHits":[{"chebi_id":"57947","direction":"down","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.000656727871835,"ratio":0.4132774867292785,"synonym_name":""},{"chebi_id":"17929","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(dimethylamino)(imino)methyl]amino}pentanoic acid","metabolite_id":"YDGMGEXADBMOMJ-LURJTMIESA-N","pvalue":0.0309231660126519,"ratio":4.618758210442253,"synonym_name":"NG,NG-Dimethyl-L-arginine"},{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0014232070751865,"ratio":1.989346351883022,"synonym_name":"colamine phosphate"},{"chebi_id":"16960","direction":"up","inn_name":"","iupac_name":"adenosine 5'-[3-(<small>D</small>-ribofuranos-5-<em>O</em>-yl) dihydrogen diphosphate]","metabolite_id":"SRNWOUGRCWSEMX-TYASJMOZSA-N","pvalue":0.0151454966805948,"ratio":1.6797472455898406,"synonym_name":"ribose adenosinediphosphate"}],"totalFeatures":10},{"comparisonGroups":["Wild_Type","AmBRAcl1"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. mexicana: AmB-resistant vs wild-type","group_a_title":"Wild type Leishmania mexicana samples. Baseline group for comparison with resistant samples to understand resistance mechanisms.","group_b_title":"AmB-resistant L. mexicana line AmBRAcl1. Helps in understanding the resistance mechanisms in AmBRAcl1 line.","id":"MTBLS1167_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS1167","studyUrl":"http://integmet.org/study/MTBLS1167","title":"G1_Wild_Type_vs_G2_AmBRAcl1","topHits":[{"chebi_id":"35243","direction":"up","inn_name":"","iupac_name":"2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-UHFFFAOYSA-N","pvalue":0.0001496862917381,"ratio":2.207693610594611,"synonym_name":"serine zwitterion"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BYSGBSNPRWKUQH-UJDJLXLFSA-N","pvalue":0.0018578767130545,"ratio":2.3279280079833544,"synonym_name":""},{"chebi_id":"17306","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":0.0001812678277421,"ratio":0.5638576569062868,"synonym_name":"Malzzucker"},{"chebi_id":"27931","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"FYGDTMLNYKFZSV-PXXRMHSHSA-N","pvalue":0.00290925184244,"ratio":2.3232488502090622,"synonym_name":"Amylotriose"},{"chebi_id":"42111","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-UWTATZPHSA-N","pvalue":0.0013714104390392,"ratio":0.5845742498228093,"synonym_name":"(\u2212)-lactic acid"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0011022037993808,"ratio":0.634265314838554,"synonym_name":"E363"},{"chebi_id":"48928","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0027441470162705,"ratio":1.601494490246296,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"15820","direction":"up","inn_name":"","iupac_name":"guanosine 5'-[3-(\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-GDJBGNAASA-N","pvalue":0.0138741445435777,"ratio":1.5354735003305904,"synonym_name":"Guanosine diphosphomannose"},{"chebi_id":"62976","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-D-glucopyranose","metabolite_id":"FTNIPWXXIGNQQF-XHCCAYEESA-N","pvalue":0.0411716935439844,"ratio":1.5528682577596922,"synonym_name":"\u03b2-<small>D</small>-Glc<em>p</em>-(1\u21924)-\u03b2-<small>D</small>-Glc<em>p</em>-(1\u21924)-\u03b2-<small>D</small>-Glc<em>p</em>-(1\u21924)-\u03b2-<small>D</small>-Glc<em>p</em>-(1\u21924)-<small>D</small>-Glc<em>p</em>"}],"totalFeatures":14},{"comparisonGroups":["Wild_Type","AmBRAcl1"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. mexicana: AmB-resistant vs wild-type","group_a_title":"Wild type Leishmania mexicana samples. Baseline group for comparison with resistant samples to understand resistance mechanisms.","group_b_title":"AmB-resistant L. mexicana line AmBRAcl1. Helps in understanding the resistance mechanisms in AmBRAcl1 line.","id":"MTBLS1167_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS1167","studyUrl":"http://integmet.org/study/MTBLS1167","title":"G1_Wild_Type_vs_G2_AmBRAcl1","topHits":[{"chebi_id":"17842","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,7<i>R</i>,26<i>R</i>,31<i>S</i>)-2,31-diamino-5,8,11,22,25,28-hexaoxo-7,26-bis(sulfanylmethyl)-6,9,12,16,21,24,27-heptaazadotriacontane-1,32-dioic acid","metabolite_id":"PHDOXVGRXXAYEB-VJANTYMQSA-N","pvalue":4.567417446987709e-05,"ratio":0.0519700602056749,"synonym_name":"N1,N8-Bis(glutathionyl)spermidine"},{"chebi_id":"57912","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":5.481659575800375e-06,"ratio":0.3688243483552018,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0012757668426368,"ratio":0.4094774703076336,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":0.0009225495281619,"ratio":1.7190826215959505,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"15729","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2,5-diaminopentanoic acid","metabolite_id":"AHLPHDHHMVZTML-BYPYZUCNSA-N","pvalue":0.0021265604989255,"ratio":1.7660000210372233,"synonym_name":"(<i>S</i>)-\u03b1,\u03b4-diaminovaleric acid"},{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0113761365496396,"ratio":1.5503293052265827,"synonym_name":""}],"totalFeatures":16},{"comparisonGroups":["Wild_Type","tmRNA_Deletion"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aeromonas veronii: tmRNA deletion vs wild-type","group_a_title":"Wild type group representing the normal state of Aeromonas veronii.. Serves as the reference group to assess the impact of tmRNA deletion.","group_b_title":"Group with tmRNA deletion to study its effects on persistence and metabolism.. Key group for understanding the role of tmRNA in bacterial persistence and metabolism.","id":"MTBLS1182_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS1182","studyUrl":"http://integmet.org/study/MTBLS1182","title":"Wild_Type_vs_tmRNA_Deletion","topHits":[{"chebi_id":"16020","direction":"down","inn_name":"","iupac_name":"1-methyladenosine","metabolite_id":"GFYLSDSUCHVORB-IOSLPCCCSA-N","pvalue":1.4761669980167771e-05,"ratio":0.2753813191269799,"synonym_name":"m1a"},{"chebi_id":"62462","direction":"down","inn_name":"","iupac_name":"6-amino-3,7-dihydro-2<em>H</em>-purin-2-one","metabolite_id":"DRAVOWXCEBXPTN-UHFFFAOYSA-N","pvalue":4.1028971402106905e-06,"ratio":0.3500459149850132,"synonym_name":"6-amino-3,7-dihydro-purin-2-one"},{"chebi_id":"27407","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(furan-2-ylmethyl)-7<em>H</em>-purin-6-amine","metabolite_id":"QANMHLXAZMSUEX-UHFFFAOYSA-N","pvalue":3.025638488304936e-05,"ratio":0.3566370980599397,"synonym_name":"6-(furfurylamino)purine"},{"chebi_id":"15760","direction":"down","inn_name":"","iupac_name":"4-(2-aminoethyl)phenol","metabolite_id":"DZGWFCGJZKJUFP-UHFFFAOYSA-N","pvalue":2.3146009249465185e-05,"ratio":0.3881580224281801,"synonym_name":"Tyramin"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.000338144542804,"ratio":0.3652112107649169,"synonym_name":"u"},{"chebi_id":"16750","direction":"down","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.000210661200797,"ratio":0.3889639083862273,"synonym_name":"G"},{"chebi_id":"17568","direction":"down","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":0.0004862190727268,"ratio":0.3713532121537224,"synonym_name":"Urazil"},{"chebi_id":"75012","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-isoleucine","metabolite_id":"PNVLWFYAPWAQMU-CIUDSAMLSA-N","pvalue":0.0010818727526738,"ratio":0.3677945371716859,"synonym_name":"<small>L</small>-Val-<small>L</small>-Ile"},{"chebi_id":"16584","direction":"down","inn_name":"","iupac_name":"3-methylbut-3-en-1-yl trihydrogen diphosphate","metabolite_id":"NUHSROFQTUXZQQ-UHFFFAOYSA-N","pvalue":0.0002267596228338,"ratio":0.4437954808364412,"synonym_name":"3-Methyl-3-butenyl pyrophosphate"},{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":6.469979767982436e-05,"ratio":0.4972901379330135,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"}],"totalFeatures":231},{"comparisonGroups":["IFN_responder_Pre-infection","IFN_responder_Diagnosis"],"dateCreated":"2025-09-26 00:00:00","display_title":"IFN responders: pre-infection vs diagnosis timepoints","group_a_title":"IFN responders at pre-infection time point. Provides baseline data for IFN responders before infection.","group_b_title":"IFN responders at diagnosis time point. Provides data on IFN responders at the time of clinical diagnosis.","id":"MTBLS1188_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS1188","studyUrl":"http://integmet.org/study/MTBLS1188","title":"IFN_responder_Pre-infection_vs_Diagnosis","topHits":[{"chebi_id":"34018","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UUDAMDVQRQNNHZ-UHFFFAOYSA-N","pvalue":0.0007085395460843,"ratio":6.974511307014182,"synonym_name":"(S)-AMPA"},{"chebi_id":"30923","direction":"up","inn_name":"","iupac_name":"2-hydroxy-4-oxopentanedioic acid","metabolite_id":"WXSKVKPSMAHCSG-UHFFFAOYSA-N","pvalue":0.0158289186828115,"ratio":25.153934300993125,"synonym_name":"4-Hydroxy-2-oxoglutaric acid"},{"chebi_id":"16870","direction":"up","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0180551367061889,"ratio":5.250225036284708,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0139728055225389,"ratio":0.2106556200716011,"synonym_name":"Adenosin"},{"chebi_id":"15354","direction":"up","inn_name":"","iupac_name":"2-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","pvalue":0.0021038487326914,"ratio":2.600420659043396,"synonym_name":"Choline"},{"chebi_id":"73858","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IHNKQIMGVNPMTC-RUZDIDTESA-N","pvalue":0.0057989802062287,"ratio":2.7981578664658917,"synonym_name":"Lysophosphatidylcholine(18:0)"},{"chebi_id":"35491","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":0.0073226572250124,"ratio":0.4389022507676478,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"16002","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>S</i>)-2,3,4,5-tetrahydroxyhexanedioic acid","metabolite_id":"DSLZVSRJTYRBFB-LLEIAEIESA-N","pvalue":0.008662346315119,"ratio":2.1100696999870125,"synonym_name":"saccharic acid"},{"chebi_id":"89930","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZHRLECIZINSPKL-AKGZTFGVSA-N","pvalue":0.0360709435989683,"ratio":0.6235439736533829,"synonym_name":"Cystinyl-GLY"}],"totalFeatures":10},{"comparisonGroups":["IFN_responder_Pre-infection","IFN_responder_Diagnosis"],"dateCreated":"2025-09-26 00:00:00","display_title":"IFN responders: pre-infection vs diagnosis timepoints","group_a_title":"IFN responders at pre-infection time point. Provides baseline data for IFN responders before infection.","group_b_title":"IFN responders at diagnosis time point. Provides data on IFN responders at the time of clinical diagnosis.","id":"MTBLS1188_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS1188","studyUrl":"http://integmet.org/study/MTBLS1188","title":"IFN_responder_Pre-infection_vs_Diagnosis","topHits":[{"chebi_id":"34018","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UUDAMDVQRQNNHZ-UHFFFAOYSA-N","pvalue":0.0007085395460843,"ratio":6.974511307014182,"synonym_name":"(S)-AMPA"},{"chebi_id":"30923","direction":"up","inn_name":"","iupac_name":"2-hydroxy-4-oxopentanedioic acid","metabolite_id":"WXSKVKPSMAHCSG-UHFFFAOYSA-N","pvalue":0.0158289186828115,"ratio":25.153934300993125,"synonym_name":"4-Hydroxy-2-oxoglutaric acid"},{"chebi_id":"16870","direction":"up","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0180551367061889,"ratio":5.250225036284708,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0139728055225389,"ratio":0.2106556200716011,"synonym_name":"Adenosin"},{"chebi_id":"15354","direction":"up","inn_name":"","iupac_name":"2-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","pvalue":0.0021038487326914,"ratio":2.600420659043396,"synonym_name":"Choline"},{"chebi_id":"73858","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IHNKQIMGVNPMTC-RUZDIDTESA-N","pvalue":0.0057989802062287,"ratio":2.7981578664658917,"synonym_name":"Lysophosphatidylcholine(18:0)"},{"chebi_id":"35491","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":0.0073226572250124,"ratio":0.4389022507676478,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"16002","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>S</i>)-2,3,4,5-tetrahydroxyhexanedioic acid","metabolite_id":"DSLZVSRJTYRBFB-LLEIAEIESA-N","pvalue":0.008662346315119,"ratio":2.1100696999870125,"synonym_name":"saccharic acid"},{"chebi_id":"89930","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZHRLECIZINSPKL-AKGZTFGVSA-N","pvalue":0.0360709435989683,"ratio":0.6235439736533829,"synonym_name":"Cystinyl-GLY"}],"totalFeatures":10},{"comparisonGroups":["Wild Type","tmRNA Knockout"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aeromonas veronii: tmRNA knockout vs wild-type","group_a_title":"Wild type Aeromonas veronii samples. Serves as the reference group for comparing the effects of tmRNA knockout.","group_b_title":"Aeromonas veronii samples with tmRNA knockout. Key group for understanding the role of tmRNA in bacterial persistence.","id":"MTBLS1191_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":47,"studyId":"MTBLS1191","studyUrl":"http://integmet.org/study/MTBLS1191","title":"Wild_Type_vs_tmRNA_Knockout","topHits":[{"chebi_id":"194379","direction":"down","inn_name":"","iupac_name":"(11E,14E)-icosa-11,14-dienoic acid","metabolite_id":"XSXIVVZCUAHUJO-AVQMFFATSA-N","pvalue":1.2233547288464622e-06,"ratio":0.2672718051595582,"synonym_name":""},{"chebi_id":"18425","direction":"down","inn_name":"","iupac_name":"(6<i>S</i>,7<i>R</i>)-6-(hydroxymethyl)-6-methyl-1,3,5,2,4-trioxadiphosphocane-2,4,7-triol 2,4-dioxide","metabolite_id":"SFRQRNJMIIUYDI-UHNVWZDZSA-N","pvalue":0.0004976939589824,"ratio":0.1421346245407545,"synonym_name":"MEcPP"},{"chebi_id":"16118","direction":"up","inn_name":"","iupac_name":"9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-<em>g</em>]isoquino[3,2-<em>a</em>]isoquinolin-7-ium","metabolite_id":"YBHILYKTIRIUTE-UHFFFAOYSA-N","pvalue":0.0002657232687444,"ratio":5.35015674223903,"synonym_name":"5,6-dihydro-9,10-dimethoxy-1,3-benzodioxolo[5,6-<em>a</em>]benzo[<em>g</em>]quinolizinium"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SHZGCJCMOBCMKK-UHFFFAOYSA-N","pvalue":0.0002436182756416,"ratio":4.644693974848461,"synonym_name":""},{"chebi_id":"48928","direction":"down","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":2.08039584663472e-05,"ratio":0.370624786211118,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"18107","direction":"down","inn_name":"","iupac_name":"xanthosine","metabolite_id":"UBORTCNDUKBEOP-UUOKFMHZSA-N","pvalue":7.3118833256791246e-06,"ratio":0.4206233829605701,"synonym_name":"9-\u03b2-<small>D</small>-ribofuranosyl-3,9-dihydro-1<em>H</em>-purine-2,6-dione"},{"chebi_id":"63581","direction":"down","inn_name":"stavudine","iupac_name":"1-[(2<i>R</i>,5<i>S</i>)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"XNKLLVCARDGLGL-JGVFFNPUSA-N","pvalue":6.279109712356357e-05,"ratio":0.373671921289079,"synonym_name":"1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine"},{"chebi_id":"4170","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":0.001423691951359,"ratio":0.2390053735644668,"synonym_name":"Glc6P"},{"chebi_id":"194527","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VPVOXUSPXFPWBN-VKHMYHEASA-N","pvalue":9.279673673057431e-06,"ratio":0.4499442517241797,"synonym_name":""},{"chebi_id":"16750","direction":"down","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.0001392243625379,"ratio":0.3565185466169063,"synonym_name":"G"}],"totalFeatures":171},{"comparisonGroups":["Wild Type","tmRNA Knockout"],"dateCreated":"2025-09-26 00:00:00","display_title":"A. veronii: tmRNA knockout vs wild-type","group_a_title":"Wild type Aeromonas veronii samples. Serves as the reference group for comparing the effects of tmRNA knockout.","group_b_title":"Aeromonas veronii samples with tmRNA knockout. Key group for understanding the role of tmRNA in bacterial persistence.","id":"MTBLS1191_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":59,"studyId":"MTBLS1191","studyUrl":"http://integmet.org/study/MTBLS1191","title":"Wild_Type_vs_tmRNA_Knockout","topHits":[{"chebi_id":"16020","direction":"down","inn_name":"","iupac_name":"1-methyladenosine","metabolite_id":"GFYLSDSUCHVORB-IOSLPCCCSA-N","pvalue":1.562879013935578e-05,"ratio":0.2737364443760103,"synonym_name":"m1a"},{"chebi_id":"62462","direction":"down","inn_name":"","iupac_name":"6-amino-3,7-dihydro-2<em>H</em>-purin-2-one","metabolite_id":"DRAVOWXCEBXPTN-UHFFFAOYSA-N","pvalue":7.698617654665103e-06,"ratio":0.3378984469528187,"synonym_name":"6-amino-3,7-dihydro-purin-2-one"},{"chebi_id":"16899","direction":"up","inn_name":"","iupac_name":"<small>D</small>-mannitol","metabolite_id":"FBPFZTCFMRRESA-KVTDHHQDSA-N","pvalue":0.0006283276468834,"ratio":5.40094222183858,"synonym_name":"E-421"},{"chebi_id":"17924","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucitol","metabolite_id":"FBPFZTCFMRRESA-JGWLITMVSA-N","pvalue":0.0011976606130168,"ratio":5.546786961253907,"synonym_name":"D-SORBITOL"},{"chebi_id":"27407","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(furan-2-ylmethyl)-7<em>H</em>-purin-6-amine","metabolite_id":"QANMHLXAZMSUEX-UHFFFAOYSA-N","pvalue":1.239363839574229e-05,"ratio":0.3760534588993333,"synonym_name":"6-(furfurylamino)purine"},{"chebi_id":"15584","direction":"down","inn_name":"","iupac_name":"2-hydroxy-2-methylbutanedioic acid","metabolite_id":"XFTRTWQBIOMVPK-UHFFFAOYSA-N","pvalue":1.235835859177262e-05,"ratio":0.4065916743493808,"synonym_name":"2-methylmalic acid"},{"chebi_id":"19062","direction":"down","inn_name":"","iupac_name":"1-methylguanosine","metabolite_id":"UTAIYTHAJQNQDW-KQYNXXCUSA-N","pvalue":3.565681931963058e-05,"ratio":0.3720513765298209,"synonym_name":"N1-Methylguanosine"},{"chebi_id":"15760","direction":"down","inn_name":"","iupac_name":"4-(2-aminoethyl)phenol","metabolite_id":"DZGWFCGJZKJUFP-UHFFFAOYSA-N","pvalue":2.4312636056368643e-05,"ratio":0.3983069328324695,"synonym_name":"Tyramin"},{"chebi_id":"177258","direction":"down","inn_name":"","iupac_name":"1-[(3aR,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-oxo-3a,4,6,6a-tetrahydrouro[3,4-d][1,3,2]dioxaphosphol-4-yl]-4-aminopyrimidin-2-one","metabolite_id":"NMPZCCZXCOMSDQ-ZRTZXPPTSA-N","pvalue":6.0436447686423864e-05,"ratio":0.3840716850188999,"synonym_name":""},{"chebi_id":"19068","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>)-1,4-anhydro-1-(1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-<small>D</small>-ribitol","metabolite_id":"UVBYMVOUBXYSFV-XUTVFYLZSA-N","pvalue":2.779565443057051e-05,"ratio":0.4140396842531786,"synonym_name":"m<small><sup>1</small></sup>f"}],"totalFeatures":229},{"comparisonGroups":["Low Contamination","High Contamination"],"dateCreated":"2025-09-26 00:00:00","display_title":"Soil microbes: low vs high PAH contamination","group_a_title":"Control group with low PAH contamination.. Provides a reference point for assessing the impact of high PAH contamination.","group_b_title":"Treatment group with high PAH contamination.. Allows for the assessment of the impact of high PAH contamination on soil microbial activity and metabolism.","id":"MTBLS1196_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS1196","studyUrl":"http://integmet.org/study/MTBLS1196","title":"Low_Contamination_vs_High_Contamination","topHits":[{"chebi_id":"20067","direction":"up","inn_name":"","iupac_name":"3-hydroxybutanoic acid","metabolite_id":"WHBMMWSBFZVSSR-UHFFFAOYSA-N","pvalue":5.996371493252862e-05,"ratio":7.686578004550454,"synonym_name":"\u03b2-hydroxy-<em>n</em>-butyric acid"},{"chebi_id":"17981","direction":"down","inn_name":"","iupac_name":"<em>O</em>-acetyl-<small>L</small>-serine","metabolite_id":"VZXPDPZARILFQX-BYPYZUCNSA-N","pvalue":0.0001070989102098,"ratio":0.2433087067234824,"synonym_name":"O-acetyl-L-serine"},{"chebi_id":"15753","direction":"up","inn_name":"","iupac_name":"2-oxohexanedioic acid","metabolite_id":"FGSBNBBHOZHUBO-UHFFFAOYSA-N","pvalue":0.0004428790091202,"ratio":4.595879930587183,"synonym_name":"2-Oxoadipic acid"},{"chebi_id":"32154","direction":"down","inn_name":"","iupac_name":"octadecan-1-ol","metabolite_id":"GLDOVTGHNKAZLK-UHFFFAOYSA-N","pvalue":0.0008122586372464,"ratio":0.2045516235595494,"synonym_name":"1-hydroxyoctadecane"},{"chebi_id":"30763","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":0.0027876858605502,"ratio":3.745904106836393,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"40813","direction":"up","inn_name":"","iupac_name":"4-methoxybenzoic acid","metabolite_id":"ZEYHEAKUIGZSGI-UHFFFAOYSA-N","pvalue":0.0038687393979563,"ratio":3.700323507469072,"synonym_name":"4-Anisic acid"},{"chebi_id":"45296","direction":"down","inn_name":"","iupac_name":"hexadecane","metabolite_id":"DCAYPVUWAIABOU-UHFFFAOYSA-N","pvalue":0.0026927921285029,"ratio":0.2995006020045145,"synonym_name":"<em>n</em>-cetane"},{"chebi_id":"16667","direction":"down","inn_name":"","iupac_name":"(4-hydroxyphenyl)acetonitrile","metabolite_id":"AYKYOOPFBCOXSL-UHFFFAOYSA-N","pvalue":9.844131364532922e-05,"ratio":0.5192023641505846,"synonym_name":"4-Hydroxybenzylcyanide"},{"chebi_id":"26836","direction":"down","inn_name":"","iupac_name":"tetraoxosulfuric acid","metabolite_id":"QAOWNCQODCNURD-UHFFFAOYSA-N","pvalue":0.001791998403954,"ratio":0.4714261333305245,"synonym_name":"sulphuric acid"},{"chebi_id":"16235","direction":"down","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":0.0216141797822539,"ratio":0.2948755011769833,"synonym_name":"GUANINE"}],"totalFeatures":178},{"comparisonGroups":["Homo sapiens_Fibroblast_Drug Vehicle_HT01 wild type","Homo sapiens_Fibroblast_Nicotinamide Riboside_HT01 wild type"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fibroblasts: Nicotinamide Riboside vs vehicle control","group_a_title":"Wild type fibroblasts treated with drug vehicle.. Provides baseline for comparison with treated wild type samples.","group_b_title":"Wild type fibroblasts treated with Nicotinamide Riboside.. Evaluates the effect of Nicotinamide Riboside on wild type fibroblasts.","id":"MTBLS1223_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1223","studyUrl":"http://integmet.org/study/MTBLS1223","title":"Wild_Type_Control_vs_Treatment","topHits":[{"chebi_id":"18304","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carboxypyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"SENPVEZBRZQVST-HISDBWNOSA-O","pvalue":0.003468158312426,"ratio":1e-06,"synonym_name":"Deamido-NAD+"}],"totalFeatures":4},{"comparisonGroups":["Control_Oral_Blood","RESV_Oral_Blood"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: Control vs RESV oral treatment","group_a_title":"Control group for oral administration in blood samples. Provides baseline for comparison with RESV oral treatment in blood","group_b_title":"RESV treatment group for oral administration in blood samples. Evaluates the effect of RESV oral treatment in blood","id":"MTBLS125_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS125","studyUrl":"http://integmet.org/study/MTBLS125","title":"Control_Oral_Blood_vs_RESV_Oral_Blood","topHits":[],"totalFeatures":107},{"comparisonGroups":["Control_Oral_Blood","RESV_Oral_Blood"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: oral RESV treatment vs control","group_a_title":"Control group for oral administration in blood samples. Provides baseline for comparison with RESV oral treatment in blood","group_b_title":"RESV treatment group for oral administration in blood samples. Evaluates the effect of RESV oral treatment in blood","id":"MTBLS125_0002_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS125","studyUrl":"http://integmet.org/study/MTBLS125","title":"Control_Oral_Blood_vs_RESV_Oral_Blood","topHits":[{"chebi_id":"43355","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-indol-3-yl hydrogen sulfate","metabolite_id":"BXFFHSIDQOFMLE-UHFFFAOYSA-N","pvalue":0.039413681369028,"ratio":1.9745448730985715,"synonym_name":"3-indolyl sulfate"}],"totalFeatures":116},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs untreated control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0001_00000027","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":38,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"8198","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>E</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"HSTZMXCBWJGKHG-CUYWLFDKSA-N","pvalue":2.3678177320993565e-06,"ratio":1e-06,"synonym_name":"<i>trans</i>-resveratrol 3-<em>O</em>-\u03b2-<small>D</small>-glucoside"},{"chebi_id":"86971","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>Z</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"QWSAYEBSTMCFKY-BMPGWQKJSA-N","pvalue":0.000197414241481,"ratio":1e-06,"synonym_name":""},{"chebi_id":"27881","direction":"down","inn_name":"","iupac_name":"5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-UHFFFAOYSA-N","pvalue":0.0140712828301073,"ratio":7.923720979371913e-05,"synonym_name":"Resveratrol"},{"chebi_id":"17568","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":1.4449880234429372e-06,"ratio":10.740740740740742,"synonym_name":"Urazil"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":9.679103704755736e-06,"ratio":0.0666666666666666,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0004998023252493,"ratio":0.1533546325878594,"synonym_name":"GMP"},{"chebi_id":"28907","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-N","pvalue":1.7486914127775083e-06,"ratio":2.911111111111111,"synonym_name":""},{"chebi_id":"18089","direction":"down","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":1.5197525763357734e-05,"ratio":0.3243243243243244,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"15820","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-GDJBGNAASA-N","pvalue":5.15957807642896e-05,"ratio":0.2911764705882353,"synonym_name":"Guanosine diphosphomannose"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0001042503648962,"ratio":3.2458100558659218,"synonym_name":"UDP-alpha-D-glucuronate"}],"totalFeatures":81},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs untreated control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0002_00000027","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":38,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":2.781904613015557e-64,"ratio":1000000.0,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"73025","direction":"up","inn_name":"","iupac_name":"3-[(3-methylbutanoyl)oxy]-4-(trimethylammonio)butanoate","metabolite_id":"IGQBPDJNUXPEMT-UHFFFAOYSA-N","pvalue":1.73869038313471e-65,"ratio":2.999999999999999,"synonym_name":"3-methylbutyrylcarnitine"},{"chebi_id":"43997","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>,<em>N</em><small><sup>6</small></sup>-dimethyl-<small>L</small>-lysine","metabolite_id":"XXEWFEBMSGLYBY-ZETCQYMHSA-N","pvalue":6.95476153253893e-63,"ratio":0.5,"synonym_name":"Lys(Me<small><sub>2</sub></small>)"},{"chebi_id":"28907","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-N","pvalue":6.95476153253893e-63,"ratio":2.0,"synonym_name":""},{"chebi_id":"17533","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidopentanedioic acid","metabolite_id":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","pvalue":0.0021921298066929,"ratio":1000000.0,"synonym_name":"(S)-2-(acetylamino)pentanedioic acid"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":2.3038073815066424e-05,"ratio":0.0714285714285714,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"19289","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>-dimethylguanosine","metabolite_id":"RSPURTUNRHNVGF-IOSLPCCCSA-N","pvalue":0.0001510114022218,"ratio":0.0666666666666666,"synonym_name":"2-(dimethylamino)-9-(\u03b2-<small>D</small>-ribofuranosyl)-1,9-dihydro-6<em>H</em>-purin-6-one"},{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0003627099994935,"ratio":0.1265822784810126,"synonym_name":"GMP"},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":4.189825064054016e-06,"ratio":0.3462821734985701,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"15820","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-GDJBGNAASA-N","pvalue":0.0001567654807496,"ratio":0.2307692307692307,"synonym_name":"Guanosine diphosphomannose"}],"totalFeatures":79},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs untreated control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":39,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":2.781904613015557e-64,"ratio":1000000.0,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"73025","direction":"up","inn_name":"","iupac_name":"3-[(3-methylbutanoyl)oxy]-4-(trimethylammonio)butanoate","metabolite_id":"IGQBPDJNUXPEMT-UHFFFAOYSA-N","pvalue":1.73869038313471e-65,"ratio":2.999999999999999,"synonym_name":"3-methylbutyrylcarnitine"},{"chebi_id":"43997","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>,<em>N</em><small><sup>6</small></sup>-dimethyl-<small>L</small>-lysine","metabolite_id":"XXEWFEBMSGLYBY-ZETCQYMHSA-N","pvalue":6.95476153253893e-63,"ratio":0.5,"synonym_name":"Lys(Me<small><sub>2</sub></small>)"},{"chebi_id":"28907","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-N","pvalue":6.95476153253893e-63,"ratio":2.0,"synonym_name":""},{"chebi_id":"17533","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidopentanedioic acid","metabolite_id":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","pvalue":0.0021921298066929,"ratio":1000000.0,"synonym_name":"(S)-2-(acetylamino)pentanedioic acid"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":2.3038073815066424e-05,"ratio":0.0714285714285714,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"19289","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>-dimethylguanosine","metabolite_id":"RSPURTUNRHNVGF-IOSLPCCCSA-N","pvalue":0.0001510114022218,"ratio":0.0666666666666666,"synonym_name":"2-(dimethylamino)-9-(\u03b2-<small>D</small>-ribofuranosyl)-1,9-dihydro-6<em>H</em>-purin-6-one"},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":4.189825064054016e-06,"ratio":0.3462821734985701,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"15820","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-GDJBGNAASA-N","pvalue":0.0001567654807496,"ratio":0.2307692307692307,"synonym_name":"Guanosine diphosphomannose"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0003815326359015,"ratio":4.2857142857142865,"synonym_name":"UDP-alpha-D-glucuronate"}],"totalFeatures":79},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0004_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"86971","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>Z</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"QWSAYEBSTMCFKY-BMPGWQKJSA-N","pvalue":4.271172949299647e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"27881","direction":"down","inn_name":"","iupac_name":"5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-UHFFFAOYSA-N","pvalue":0.0009312509273679,"ratio":1e-06,"synonym_name":"Resveratrol"},{"chebi_id":"8198","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>E</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"HSTZMXCBWJGKHG-CUYWLFDKSA-N","pvalue":0.0016312206432558,"ratio":1e-06,"synonym_name":"<i>trans</i>-resveratrol 3-<em>O</em>-\u03b2-<small>D</small>-glucoside"},{"chebi_id":"17568","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":1.4449880234429372e-06,"ratio":10.740740740740742,"synonym_name":"Urazil"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":9.679103704755736e-06,"ratio":0.0666666666666666,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"28907","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-N","pvalue":1.7486914127775083e-06,"ratio":2.911111111111111,"synonym_name":""},{"chebi_id":"18089","direction":"down","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":1.5197525763357734e-05,"ratio":0.3243243243243244,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"15820","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-GDJBGNAASA-N","pvalue":5.15957807642896e-05,"ratio":0.2911764705882353,"synonym_name":"Guanosine diphosphomannose"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0001042503648962,"ratio":3.2458100558659218,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":5.172122841699666e-05,"ratio":0.3452088452088452,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"}],"totalFeatures":81},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0005_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"86971","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>Z</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"QWSAYEBSTMCFKY-BMPGWQKJSA-N","pvalue":4.271172949299647e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"45713","direction":"down","inn_name":"","iupac_name":"5-[(1<i>E</i>)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-OWOJBTEDSA-N","pvalue":0.0009312509273679,"ratio":1e-06,"synonym_name":"RESVERATROL"},{"chebi_id":"175990","direction":"down","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxane-2-carboxylic acid","metabolite_id":"QWSAYEBSTMCFKY-OTPOQTMVSA-N","pvalue":0.0016312206432558,"ratio":1e-06,"synonym_name":""},{"chebi_id":"17568","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":1.4449880234429372e-06,"ratio":10.740740740740742,"synonym_name":"Urazil"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":9.679103704755736e-06,"ratio":0.0666666666666666,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"17720","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UWTATZPHSA-N","pvalue":1.7486914127775083e-06,"ratio":2.911111111111111,"synonym_name":"2,3-Disphospho-D-glycerate"},{"chebi_id":"18089","direction":"down","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":1.5197525763357734e-05,"ratio":0.3243243243243244,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"17383","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-ZQVROCHNSA-N","pvalue":5.15957807642896e-05,"ratio":0.2911764705882353,"synonym_name":"GDP-glucose"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0001042503648962,"ratio":3.2458100558659218,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":5.172122841699666e-05,"ratio":0.3452088452088452,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"}],"totalFeatures":81},{"comparisonGroups":["HepG2_0uM","HepG2_200uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"HepG2 cells: 200\u03bcM resveratrol vs untreated control","group_a_title":"HepG2 cells with 0 \u00b5M Resveratrol. Baseline group for comparison with treated HepG2 samples.","group_b_title":"HepG2 cells with 200 \u00b5M Resveratrol. Represents high concentration treatment effect in HepG2 cells.","id":"MTBLS127_0005_00000027","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":38,"studyId":"MTBLS127","studyUrl":"http://integmet.org/study/MTBLS127","title":"HepG2_0uM_vs_HepG2_200uM","topHits":[{"chebi_id":"175990","direction":"down","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxane-2-carboxylic acid","metabolite_id":"QWSAYEBSTMCFKY-OTPOQTMVSA-N","pvalue":2.3678177320993565e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"86971","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>Z</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"QWSAYEBSTMCFKY-BMPGWQKJSA-N","pvalue":0.000197414241481,"ratio":1e-06,"synonym_name":""},{"chebi_id":"45713","direction":"down","inn_name":"","iupac_name":"5-[(1<i>E</i>)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-OWOJBTEDSA-N","pvalue":0.0140712828301073,"ratio":7.923720979371913e-05,"synonym_name":"RESVERATROL"},{"chebi_id":"17568","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":1.4449880234429372e-06,"ratio":10.740740740740742,"synonym_name":"Urazil"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":9.679103704755736e-06,"ratio":0.0666666666666666,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0004998023252493,"ratio":0.1533546325878594,"synonym_name":"GMP"},{"chebi_id":"17720","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UWTATZPHSA-N","pvalue":1.7486914127775083e-06,"ratio":2.911111111111111,"synonym_name":"2,3-Disphospho-D-glycerate"},{"chebi_id":"18089","direction":"down","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":1.5197525763357734e-05,"ratio":0.3243243243243244,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"17383","direction":"down","inn_name":"","iupac_name":"guanosine 5'-[3-(<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"MVMSCBBUIHUTGJ-ZQVROCHNSA-N","pvalue":5.15957807642896e-05,"ratio":0.2911764705882353,"synonym_name":"GDP-glucose"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0001042503648962,"ratio":3.2458100558659218,"synonym_name":"UDP-alpha-D-glucuronate"}],"totalFeatures":81},{"comparisonGroups":["Non-challenged Control","Challenged Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Broiler chickens: Salmonella Pullorum challenge vs control","group_a_title":"Samples from broilers not exposed to Salmonella Pullorum challenge.. Provides a reference point for evaluating the effects of Salmonella challenge and OA treatment.","group_b_title":"Samples from broilers exposed to Salmonella Pullorum challenge without any treatment.. Helps in understanding the baseline effects of Salmonella challenge without any treatment.","id":"MTBLS1274_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS1274","studyUrl":"http://integmet.org/study/MTBLS1274","title":"Non-challenged_Control_vs_Challenged_Control","topHits":[{"chebi_id":"29461","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,7<i>R</i>,9<i>E</i>,11<i>R</i>,12<i>R</i>)-12-ethyl-4-hydroxy-3,5,7,11-tetramethyloxacyclododec-9-ene-2,8-dione","metabolite_id":"NZUJVBSYQXETNF-PQWITYJESA-N","pvalue":0.0404083749943462,"ratio":0.207552365521781,"synonym_name":""},{"chebi_id":"18145","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,5,7,8-tetramethyl-2-[(4<i>R</i>,8<i>R</i>)-4,8,12-trimethyltridecyl]-3,4-dihydro-2<em>H</em>-chromen-6-ol","metabolite_id":"GVJHHUAWPYXKBD-IEOSBIPESA-N","pvalue":0.0170619342382248,"ratio":2.2307692082928767,"synonym_name":"<i>R</i><i>R</i><i>R</i>-\u03b1-tocopherol"},{"chebi_id":"17515","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteine","metabolite_id":"RITKHVBHSGLULN-WHFBIAKZSA-N","pvalue":0.0064152731496278,"ratio":1.6711812810301387,"synonym_name":"Glu(-Cys)"},{"chebi_id":"58066","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-5-oxopentanoate","metabolite_id":"KABXUUFDPUOJMW-BYPYZUCNSA-N","pvalue":0.0107866415647783,"ratio":1.6421072087066235,"synonym_name":"(2<i>S</i>)-2-ammonio-5-oxopentanoate"},{"chebi_id":"17759","direction":"up","inn_name":"","iupac_name":"cholesta-5,7-dien-3\u03b2-ol","metabolite_id":"UCTLRSWJYQTBFZ-DDPQNLDTSA-N","pvalue":0.0249549125903845,"ratio":1.5579943726325896,"synonym_name":"Cholesta-5,7-dien-3beta-ol"},{"chebi_id":"81407","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KDOSWTYNZQCOFJ-NRPADANISA-N","pvalue":0.0476800614095627,"ratio":0.6325863763994568,"synonym_name":"N-Acetylphosphinothricin tripeptide"},{"chebi_id":"33276","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,8-dimethyl-2-[(3<i>E</i>,7<i>E</i>)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2<em>H</em>-chromen-6-ol","metabolite_id":"ODADKLYLWWCHNB-LDYBVBFYSA-N","pvalue":0.0490709113469793,"ratio":1.562901311880012,"synonym_name":"(2<i>R</i>)-2,8-dimethyl-2-[(3<i>E</i>,7<i>E</i>)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2<em>H</em>-1-benzopyran-6-ol"}],"totalFeatures":46},{"comparisonGroups":["Non-challenged Control","Challenged Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Broiler chickens: Salmonella Pullorum challenge vs control","group_a_title":"Samples from broilers not exposed to Salmonella Pullorum challenge.. Provides a reference point for evaluating the effects of Salmonella challenge and OA treatment.","group_b_title":"Samples from broilers exposed to Salmonella Pullorum challenge without any treatment.. Helps in understanding the baseline effects of Salmonella challenge without any treatment.","id":"MTBLS1274_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1274","studyUrl":"http://integmet.org/study/MTBLS1274","title":"Non-challenged_Control_vs_Challenged_Control","topHits":[{"chebi_id":"32802","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-hydroxy(4-hydroxyphenyl)acetic acid","metabolite_id":"YHXHKYRQLYQUIH-ZETCQYMHSA-N","pvalue":0.0047029182544793,"ratio":0.469608179727183,"synonym_name":"(S)-4-Hydroxymandelate"},{"chebi_id":"50707","direction":"up","inn_name":"","iupac_name":"5-(methylsulfanyl)norvaline","metabolite_id":"SFSJZXMDTNDWIX-UHFFFAOYSA-N","pvalue":0.0035279116855265,"ratio":1.9217142197163468,"synonym_name":""},{"chebi_id":"17622","direction":"down","inn_name":"","iupac_name":"2'-deoxy-5'-uridylic acid","metabolite_id":"JSRLJPSBLDHEIO-SHYZEUOFSA-N","pvalue":0.0251766008217731,"ratio":0.4402124816054159,"synonym_name":"dUMP"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BYSGBSNPRWKUQH-UJDJLXLFSA-N","pvalue":0.0187951498931493,"ratio":1.6347141494181778,"synonym_name":""}],"totalFeatures":5},{"comparisonGroups":["ATCC 21831","ATCC 13032"],"dateCreated":"2025-09-26 00:00:00","display_title":"Canavanine-resistant vs wild-type strain comparison","group_a_title":"Mutant strain resistant to canavanine, used for L-arginine production.. Key group for identifying potential bottlenecks in the biosynthetic pathway.","group_b_title":"Type strain used as a reference for comparison.. Serves as the reference point for identifying differences in metabolite abundances.","id":"MTBLS128_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS128","studyUrl":"http://integmet.org/study/MTBLS128","title":"ATCC_21831_vs_ATCC_13032","topHits":[{"chebi_id":"15682","direction":"up","inn_name":"","iupac_name":"2-(<em>N</em><small><sup>\u03c9</small></sup>-<small>L</small>-arginino)butanedioic acid","metabolite_id":"KDZOASGQNOPSCU-ZBHICJROSA-N","pvalue":0.0005185555058286,"ratio":45.3950839188075,"synonym_name":"L-arginosuccinic acid"},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":1.8773163735737037e-05,"ratio":12.26059169884374,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"16015","direction":"down","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":1.6084026363630086e-06,"ratio":0.2304771417878555,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0009493199923702,"ratio":0.4612930476140951,"synonym_name":"L-Lysine"},{"chebi_id":"57743","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RHGKLRLOHDJJDR-BYPYZUCNSA-N","pvalue":0.0107529606830625,"ratio":1.931633149286667,"synonym_name":"(2<i>S</i>)-2-azaniumyl-5-(carbamoylamino)pentanoate"}],"totalFeatures":5},{"comparisonGroups":["ATCC 21831","ATCC 13032"],"dateCreated":"2025-09-26 00:00:00","display_title":"Canavanine-resistant vs wild-type strain comparison","group_a_title":"Mutant strain resistant to canavanine, used for L-arginine production.. Key group for identifying potential bottlenecks in the biosynthetic pathway.","group_b_title":"Type strain used as a reference for comparison.. Serves as the reference point for identifying differences in metabolite abundances.","id":"MTBLS128_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS128","studyUrl":"http://integmet.org/study/MTBLS128","title":"ATCC_21831_vs_ATCC_13032","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KDZOASGQNOPSCU-WDSKDSINSA-O","pvalue":0.0005185555058286,"ratio":45.3950839188075,"synonym_name":""},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":1.8773163735737037e-05,"ratio":12.26059169884374,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"16015","direction":"down","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":1.6084026363630086e-06,"ratio":0.2304771417878555,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0009493199923702,"ratio":0.4612930476140951,"synonym_name":"L-Lysine"},{"chebi_id":"57743","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RHGKLRLOHDJJDR-BYPYZUCNSA-N","pvalue":0.0107529606830625,"ratio":1.931633149286667,"synonym_name":"(2<i>S</i>)-2-azaniumyl-5-(carbamoylamino)pentanoate"}],"totalFeatures":5},{"comparisonGroups":["Healthy","Cholestasis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Gut microbiota: healthy vs cholestasis bile metabolism","group_a_title":"Samples from healthy individuals.. Provides a baseline for understanding changes in gut microbiota and bile acid metabolism in disease conditions.","group_b_title":"Samples from individuals with cholestasis.. Understanding the gut microbiota and bile acid metabolism in cholestasis.","id":"MTBLS1295_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS1295","studyUrl":"http://integmet.org/study/MTBLS1295","title":"Healthy_vs_Cholestasis","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DXOCDBGWDZAYRQ-QPVZPPSOSA-N","pvalue":5.3792490394265034e-05,"ratio":0.0638432572012697,"synonym_name":""},{"chebi_id":"81298","direction":"down","inn_name":"","iupac_name":"3\u03b1,6\u03b2,7\u03b2-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DKPMWHFRUGMUKF-CRKPLTDNSA-N","pvalue":0.000256819693458,"ratio":0.0526789636218919,"synonym_name":"3,6,7-trihydroxy-5\u03b2-cholan-24-oic acid"},{"chebi_id":"16359","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"BHQCQFFYRZLCQQ-OELDTZBJSA-N","pvalue":8.595433076368723e-05,"ratio":0.1149917603929607,"synonym_name":"Cholic acid"},{"chebi_id":"88108","direction":"down","inn_name":"","iupac_name":"7\u03b1,12\u03b1-dihydroxy-3-oxo-5\u03b2-cholan-24-oic acid","metabolite_id":"OEKUSRBIIZNLHZ-DJDNIQJZSA-N","pvalue":0.0014588678030063,"ratio":0.0633228150654584,"synonym_name":"3-ketocholic acid"},{"chebi_id":"16755","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-BSWAIDMHSA-N","pvalue":3.327190196775595e-05,"ratio":0.2809584227245884,"synonym_name":"anthropodesoxycholic acid"},{"chebi_id":"81308","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b1-cholan-24-oic acid","metabolite_id":"BHQCQFFYRZLCQQ-PGHAKIONSA-N","pvalue":0.0367606786219227,"ratio":0.0351045011709992,"synonym_name":"5\u03b1-cholic acid"},{"chebi_id":"81244","direction":"down","inn_name":"","iupac_name":"3\u03b1,6\u03b1,7\u03b1-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DKPMWHFRUGMUKF-KWXDGCAGSA-N","pvalue":0.0041138092915355,"ratio":0.1345046970362044,"synonym_name":"\u03b3-muricholic acid"},{"chebi_id":"36259","direction":"down","inn_name":"","iupac_name":"2-[(3\u03b1-hydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"QBYUNVOYXHFVKC-GBURMNQMSA-N","pvalue":0.0264349849681495,"ratio":0.1000579400098052,"synonym_name":"Taurolithocholic acid"},{"chebi_id":"81299","direction":"down","inn_name":"","iupac_name":"3\u03b1,6\u03b1,7\u03b2-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DKPMWHFRUGMUKF-NTPBNISXSA-N","pvalue":0.0302240157174342,"ratio":0.2624158055848274,"synonym_name":"(3\u03b1,5\u03b2,6\u03b1,7\u03b2)-3,6,7-trihydroxycholan-24-oic acid"},{"chebi_id":"28834","direction":"down","inn_name":"","iupac_name":"3\u03b1,12\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"KXGVEGMKQFWNSR-LLQZFEROSA-N","pvalue":0.0306756131435783,"ratio":0.351879249097921,"synonym_name":"Desoxychols\u00e4ure"}],"totalFeatures":31},{"comparisonGroups":["Wild Type 0h AN11736","Wild Type 6h AN11736"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. congolense: AN11736 treatment 0h vs 6h","group_a_title":"Wild type Trypanosoma congolense at 0h treated with AN11736.. Serves as the reference point for evaluating the effects of AN11736 treatment and resistance development.","group_b_title":"Wild type Trypanosoma congolense at 6h treated with AN11736.. Provides insight into the effects of AN11736 treatment over time.","id":"MTBLS1309_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1309","studyUrl":"http://integmet.org/study/MTBLS1309","title":"G1_Wild_Type_0h_AN11736_vs_G2_Wild_Type_6h_AN11736","topHits":[{"chebi_id":"157672","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AMXPURQVAMENCC-UHFFFAOYSA-N","pvalue":0.0017672349896882,"ratio":0.2652811983672,"synonym_name":""}],"totalFeatures":1},{"comparisonGroups":["Unstimulated_Pellet","Thrombin_1U/ml_Pellet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood platelets: baseline vs 1U/ml thrombin treatment","group_a_title":"Unstimulated blood platelet pellet samples. Baseline group for comparison with treated samples in the pellet fraction.","group_b_title":"Blood platelet pellet samples treated with 1 U/ml Thrombin. Represents the effect of high concentration Thrombin on the pellet fraction.","id":"MTBLS1381_0001_00000025","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1381","studyUrl":"http://integmet.org/study/MTBLS1381","title":"Unstimulated_Pellet_vs_Thrombin_1U/ml_Pellet","topHits":[],"totalFeatures":1},{"comparisonGroups":["WT_0min","WT_30min"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild-type seedlings: 0min vs 30min time course","group_a_title":"Wild-type seedlings at time point 0 minutes.. Baseline group for comparison with mutant samples at the same time point.","group_b_title":"Wild-type seedlings at time point 30 minutes.. Represents the wild-type response over time.","id":"MTBLS1383_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS1383","studyUrl":"http://integmet.org/study/MTBLS1383","title":"WT_0min_vs_WT_30min","topHits":[{"chebi_id":"145996","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IEVWTBIZULGLHA-XKYBNXMZSA-N","pvalue":2.7549954080077592e-08,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"80988","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SJHVRBSHKTUXLG-LFHLZQBKSA-N","pvalue":7.652684729837795e-08,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"145995","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CGAALQATDWOQFD-DLRNHMSSSA-N","pvalue":9.861021684346029e-08,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"29028","direction":"up","inn_name":"","iupac_name":"1-<em>S</em>-[2-(1<em>H</em>-indol-3-yl)-<em>N</em>-(sulfooxy)ethanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"DNDNWOWHUWNBCK-JZYAIQKZSA-N","pvalue":1.655956563478315e-07,"ratio":1000000.0,"synonym_name":"3-Indolylmethylglucosinolate"},{"chebi_id":"79324","direction":"up","inn_name":"","iupac_name":"1-S-[(1<i>Z</i>)-6-(methylsulfanyl)-N-(sulfooxy)hexanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"MEFPHTVXBPLRLX-CBEPRAPJSA-N","pvalue":3.298640709412287e-07,"ratio":1000000.0,"synonym_name":"5-Methylthiopentyl glucosinolate"},{"chebi_id":"145997","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LGEQIQASZQVYEB-CLHCNKLFSA-N","pvalue":3.81445876166943e-07,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"80987","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZAKICGFSIJSCSF-LPUQOGTASA-N","pvalue":9.308669879232544e-07,"ratio":1000000.0,"synonym_name":"6-Methylthiohexyl glucosinolate"},{"chebi_id":"79347","direction":"up","inn_name":"","iupac_name":"1-<i>S</i>-[(1<i>Z</i>)-3-phenyl-<em>N</em>-(sulfooxy)propanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"CKIJIGYDFNXSET-OOMJLXHVSA-N","pvalue":1.2798951301181974e-06,"ratio":1000000.0,"synonym_name":"2-Phenylethyl glucosinolate"},{"chebi_id":"5395","direction":"up","inn_name":"","iupac_name":"1-<em>S</em>-[(1<i>Z</i>)-6-(methylsulfinyl)-<em>N</em>-(sulfonatooxy)hexanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"HUCGRJSHMZWRQQ-PWGYDFSISA-N","pvalue":1.8889569195711248e-06,"ratio":1000000.0,"synonym_name":"Glucoalyssin"},{"chebi_id":"132553","direction":"up","inn_name":"","iupac_name":"1-<em>S</em>-[8-(methanesulfinyl)-<em>N</em>-(sulfooxy)octanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"LQZALQLZOQQFGM-MMLSCURJSA-N","pvalue":1.9778684780806756e-06,"ratio":1000000.0,"synonym_name":"7-(Methylsulfinyl)heptyl glucosinolate"}],"totalFeatures":13},{"comparisonGroups":["Non-Induced_0_Day","Induced_8_Day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Non-induced baseline vs 8-day induced response","group_a_title":"Non-induced samples at 0 day. Baseline group for comparison with induced samples at various time points.","group_b_title":"Induced samples at 8 days. Represents extended response to induction.","id":"MTBLS1390_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS1390","studyUrl":"http://integmet.org/study/MTBLS1390","title":"Non_Induced_0_Day_vs_Induced_8_Day","topHits":[{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0004465267884736,"ratio":178.57866114204325,"synonym_name":""},{"chebi_id":"58027","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-oxopropyl phosphate","metabolite_id":"LXJXRIRHZLFYRP-UHFFFAOYSA-L","pvalue":4.607385102176546e-05,"ratio":6.887403951005503,"synonym_name":"glyceraldehyde 3-phosphate dianion"},{"chebi_id":"60377","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatocytidine","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-L","pvalue":0.0001835728961043,"ratio":9.026503834450857,"synonym_name":"CMP dianion"},{"chebi_id":"37574","direction":"down","inn_name":"","iupac_name":"2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethyl hydrogen phosphate","metabolite_id":"HZSAJDVWZRBGIF-UHFFFAOYSA-N","pvalue":0.0006583421913175,"ratio":0.0869746101179155,"synonym_name":"THIAMIN PHOSPHATE"},{"chebi_id":"58315","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":1.550881459924368e-05,"ratio":0.2479025926687161,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"16908","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BOPGDPNILDQYTO-NNYOXOHSSA-N","pvalue":0.0007558775095275,"ratio":0.1197069487816608,"synonym_name":"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE"},{"chebi_id":"17368","direction":"down","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":6.18222913924317e-05,"ratio":0.2124974283008606,"synonym_name":"Purine-6-ol"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":7.547510187921289e-05,"ratio":3.8851059416655938,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"16977","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":3.821559199589496e-06,"ratio":0.3584077446721673,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0120387782421864,"ratio":0.0919023731930402,"synonym_name":"Citronens\u00e4ure"}],"totalFeatures":34},{"comparisonGroups":["Non-Induced_0_Day","Induced_8_Day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline vs 8-day induced samples","group_a_title":"Non-induced samples at 0 day. Baseline group for comparison with induced samples at various time points.","group_b_title":"Induced samples at 8 days. Represents extended response to induction.","id":"MTBLS1390_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS1390","studyUrl":"http://integmet.org/study/MTBLS1390","title":"Non_Induced_0_Day_vs_Induced_8_Day","topHits":[{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0004465267884736,"ratio":178.57866114204325,"synonym_name":""},{"chebi_id":"58027","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-oxopropyl phosphate","metabolite_id":"LXJXRIRHZLFYRP-UHFFFAOYSA-L","pvalue":4.607385102176546e-05,"ratio":6.887403951005503,"synonym_name":"glyceraldehyde 3-phosphate dianion"},{"chebi_id":"60377","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatocytidine","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-L","pvalue":0.0001835728961043,"ratio":9.026503834450857,"synonym_name":"CMP dianion"},{"chebi_id":"37574","direction":"down","inn_name":"","iupac_name":"2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethyl hydrogen phosphate","metabolite_id":"HZSAJDVWZRBGIF-UHFFFAOYSA-N","pvalue":0.0006583421913175,"ratio":0.0869746101179155,"synonym_name":"THIAMIN PHOSPHATE"},{"chebi_id":"58315","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":1.550881459924368e-05,"ratio":0.2479025926687161,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"16908","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BOPGDPNILDQYTO-NNYOXOHSSA-N","pvalue":0.0007558775095275,"ratio":0.1197069487816608,"synonym_name":"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE"},{"chebi_id":"17368","direction":"down","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":6.18222913924317e-05,"ratio":0.2124974283008606,"synonym_name":"Purine-6-ol"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":7.547510187921289e-05,"ratio":3.8851059416655938,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"16977","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":3.821559199589496e-06,"ratio":0.3584077446721673,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0120387782421864,"ratio":0.0919023731930402,"synonym_name":"Citronens\u00e4ure"}],"totalFeatures":34},{"comparisonGroups":["Lotus_japonicus_MG20_Control","Lotus_japonicus_MG20_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Lotus japonicus MG20: salt stress vs control","group_a_title":"Control group of Lotus japonicus MG20 with 0 Mole per Liter salt concentration. Provides baseline data for comparison with treated samples.","group_b_title":"Treatment group of Lotus japonicus MG20 with increasing salt concentration. Allows assessment of salt treatment effects on Lotus japonicus MG20.","id":"MTBLS14_0001_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS14","studyUrl":"http://integmet.org/study/MTBLS14","title":"Lotus_japonicus_MG20_Control_vs_Treatment","topHits":[{"chebi_id":"61185","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-piperidinium-2-carboxylate","metabolite_id":"HXEACLLIILLPRG-YFKPBYRVSA-N","pvalue":6.3289493661878166e-09,"ratio":0.0564877008868164,"synonym_name":"(<i>S</i>)-2-carboxypiperidinium betaine"},{"chebi_id":"4167","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-GASJEMHNSA-N","pvalue":8.574310376737395e-08,"ratio":0.2821947266546209,"synonym_name":"Dextrose"},{"chebi_id":"28645","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":7.139480882081394e-07,"ratio":0.2836365139146624,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"33384","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":0.0003833975175531,"ratio":0.1602919763141059,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"18266","direction":"down","inn_name":"","iupac_name":"1<small>D</small>-4-<em>O</em>-methyl-<em>myo</em>-inositol","metabolite_id":"DSCFFEYYQKSRSV-GESKJZQWSA-N","pvalue":2.281970610246965e-05,"ratio":0.42072289522159,"synonym_name":"1D-4-O-Methyl-myo-inositol"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0075833601564447,"ratio":0.1794817369754086,"synonym_name":""},{"chebi_id":"5457","direction":"down","inn_name":"","iupac_name":"bis(2,3-dihydroxypropyl) hydrogen phosphate","metabolite_id":"LLCSXHMJULHSJN-UHFFFAOYSA-N","pvalue":0.0040133958013481,"ratio":0.2356460334558442,"synonym_name":""},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0002643009183469,"ratio":0.4856824000839267,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"16977","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.0006961727540131,"ratio":0.5565392163637748,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"16995","direction":"down","inn_name":"","iupac_name":"oxalic acid","metabolite_id":"MUBZPKHOEPUJKR-UHFFFAOYSA-N","pvalue":0.041483416004346,"ratio":0.3083292419842268,"synonym_name":"OXALIC ACID"}],"totalFeatures":54},{"comparisonGroups":["Control_1_day","High_14_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control 1-day vs high-dose 14-day treatment","group_a_title":"Control group at 1 day. Provides baseline data for comparison with treated samples at 1 day","group_b_title":"High dose group at 14 days. Represents the effect of high dose treatment at 14 days","id":"MTBLS140_0001_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS140","studyUrl":"http://integmet.org/study/MTBLS140","title":"Control_1_day_vs_High_14_day","topHits":[{"chebi_id":"16761","direction":"down","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":0.0405140286570041,"ratio":0.1868361374532183,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.0195020096639017,"ratio":2.5863102092157155,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"}],"totalFeatures":9},{"comparisonGroups":["Control_1_day","High_14_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control 1 day vs high dose 14 days","group_a_title":"Control group at 1 day. Provides baseline data for comparison with treated samples at 1 day","group_b_title":"High dose group at 14 days. Represents the effect of high dose treatment at 14 days","id":"MTBLS140_0002_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS140","studyUrl":"http://integmet.org/study/MTBLS140","title":"Control_1_day_vs_High_14_day","topHits":[{"chebi_id":"16761","direction":"down","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":0.0405140286570041,"ratio":0.1868361374532183,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.0195020096639017,"ratio":2.5863102092157155,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":0.0450597895925202,"ratio":2.771061258345188,"synonym_name":"L-Aspartic acid"}],"totalFeatures":20},{"comparisonGroups":["Control_1_day","High_14_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control 1 day vs high dose 14 day treatment","group_a_title":"Control group at 1 day. Provides baseline data for comparison with treated samples at 1 day","group_b_title":"High dose group at 14 days. Represents the effect of high dose treatment at 14 days","id":"MTBLS140_0003_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS140","studyUrl":"http://integmet.org/study/MTBLS140","title":"Control_1_day_vs_High_14_day","topHits":[{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":0.0450597895925202,"ratio":2.771061258345188,"synonym_name":"L-Aspartic acid"}],"totalFeatures":11},{"comparisonGroups":["Wild type","hfq"],"dateCreated":"2025-09-26 00:00:00","display_title":"hfq deletion vs wild-type (antibiotic resistance study)","group_a_title":"Wild type control group. Provides baseline data for comparison with experimental groups.","group_b_title":"hfq deletion experimental group. Key group for understanding the role of hfq in antibiotic resistance.","id":"MTBLS1411_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":806,"studyId":"MTBLS1411","studyUrl":"http://integmet.org/study/MTBLS1411","title":"Wild_type_vs_hfq","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QEMSHYYBCNAAQA-AVQMFFATSA-N","pvalue":3.026903128888046e-09,"ratio":0.1381688933119146,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MVJPWTFBRAZGDC-UHFFFAOYSA-N","pvalue":3.026903128888046e-09,"ratio":0.1381688933119146,"synonym_name":""},{"chebi_id":"168589","direction":"down","inn_name":"","iupac_name":"2-amino-3-[5-oxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-1,2-oxazol-4-yl]propanoic acid","metabolite_id":"OURYTICKCZBKFC-UHFFFAOYSA-N","pvalue":1.5630700706211065e-07,"ratio":0.1089365695667369,"synonym_name":""},{"chebi_id":"80656","direction":"down","inn_name":"","iupac_name":"4-oxoretinoic acid","metabolite_id":"GGCUJPCCTQNTJF-FRCNGJHJSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":"4-oxo-<i>all</i>-<i>trans</i>-retinoic acid"},{"chebi_id":"18272","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(<em>N</em>-formylglycyl)-5-<em>O</em>-phosphono-<small>D</small>-ribofuranosylamine","metabolite_id":"VDXLUNDMVKSKHO-ZRTZXPPTSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":"5'-Phosphoribosyl-N-formylglycinamide"},{"chebi_id":"6085","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"TYBGBKQPLBAYQG-CJIMKZOCSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":"Jatrophatrione"},{"chebi_id":"9419","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FNNZMRSRVYUVQT-AZUAARDMSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":"Taxodione"},{"chebi_id":"79455","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AUFJJDNCJZQOKS-ZESOOZHZSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":""},{"chebi_id":"79522","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GFPFWODQGPZXMQ-VYJAJWGXSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":""},{"chebi_id":"49191","direction":"down","inn_name":"","iupac_name":"6\u03b2,18-epoxy-9\u03b2-pimara-7,15-diene-3,18-dione","metabolite_id":"MPHXYQVSOFGNEN-JGHPTVLTSA-N","pvalue":1.8371133696774843e-08,"ratio":0.1556061169540968,"synonym_name":"Momilacton A"}],"totalFeatures":2711},{"comparisonGroups":["Wild type","hfq"],"dateCreated":"2025-09-26 00:00:00","display_title":"hfq deletion vs wild-type (antibiotic resistance study)","group_a_title":"Wild type control group. Provides baseline data for comparison with experimental groups.","group_b_title":"hfq deletion experimental group. Key group for understanding the role of hfq in antibiotic resistance.","id":"MTBLS1411_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":415,"studyId":"MTBLS1411","studyUrl":"http://integmet.org/study/MTBLS1411","title":"Wild_type_vs_hfq","topHits":[{"chebi_id":"75012","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-isoleucine","metabolite_id":"PNVLWFYAPWAQMU-CIUDSAMLSA-N","pvalue":1.5278065702506317e-08,"ratio":0.1266294811087691,"synonym_name":"<small>L</small>-Val-<small>L</small>-Ile"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QEMSHYYBCNAAQA-AVQMFFATSA-N","pvalue":2.6521641079350985e-08,"ratio":0.1465091598710724,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MVJPWTFBRAZGDC-UHFFFAOYSA-N","pvalue":2.6521641079350985e-08,"ratio":0.1465091598710724,"synonym_name":""},{"chebi_id":"73704","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-valine","metabolite_id":"KRNYOVHEKOBTEF-YUMQZZPRSA-N","pvalue":2.154541675017343e-09,"ratio":0.1962184150423638,"synonym_name":"valylvaline"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YOJXOIWMUVWNAB-DAFODLJHSA-N","pvalue":1.689913537953921e-07,"ratio":0.1286296806117379,"synonym_name":""},{"chebi_id":"50662","direction":"down","inn_name":"marimastat","iupac_name":"(2<i>S</i>,3<i>R</i>)-<em>N</em><small><sup>4</small></sup>-[(2<i>S</i>)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-<em>N</em><small><sup>1</small></sup>,2-dihydroxy-3-(2-methylpropyl)butanediamide","metabolite_id":"OCSMOTCMPXTDND-OUAUKWLOSA-N","pvalue":3.735171642667145e-08,"ratio":0.177986519047047,"synonym_name":""},{"chebi_id":"6721","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PONWUQDRLFXKSM-GSNPUYSQSA-N","pvalue":3.735171642667145e-08,"ratio":0.177986519047047,"synonym_name":"Megastachine"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":1.5030578735016466e-07,"ratio":0.1653269469535865,"synonym_name":"u"},{"chebi_id":"17568","direction":"down","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":2.575028586197659e-07,"ratio":0.1674928782051885,"synonym_name":"Urazil"},{"chebi_id":"9453","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GUGOEEXESWIERI-UHFFFAOYSA-N","pvalue":0.000132949583031,"ratio":0.0495343315474052,"synonym_name":"ternadin"}],"totalFeatures":1818},{"comparisonGroups":["Sangiovese_Tuscany","Sangiovese_Romagna"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sangiovese wine: Tuscany vs Romagna regions","group_a_title":"Sangiovese cultivar from Tuscany region.. Provides insight into the metabolomic profile of Sangiovese wines from Tuscany.","group_b_title":"Sangiovese cultivar from Romagna region.. Provides insight into the metabolomic profile of Sangiovese wines from Romagna.","id":"MTBLS1443_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS1443","studyUrl":"http://integmet.org/study/MTBLS1443","title":"G1_Sangiovese_Tuscany_vs_G2_Sangiovese_Romagna","topHits":[{"chebi_id":"147413","direction":"up","inn_name":"","iupac_name":"3-(2-hydroxyethyl)-1<em>H</em>-indole-2-sulfonic acid","metabolite_id":"ZYURVYKNOZACDY-UHFFFAOYSA-N","pvalue":1.951765180366834e-05,"ratio":4.229788690511489,"synonym_name":"TOL-SO<small><sub>3</sub></small>H"},{"chebi_id":"28499","direction":"down","inn_name":"","iupac_name":"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"IYRMWMYZSQPJKC-UHFFFAOYSA-N","pvalue":0.0021457838132857,"ratio":0.1533593087440544,"synonym_name":"Kampherol"},{"chebi_id":"75813","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4<em>H</em>-chromen-3-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"FOHXFLPXBUAOJM-LIBJPBHASA-N","pvalue":0.0004992251233116,"ratio":0.3758309384215186,"synonym_name":""},{"chebi_id":"70255","direction":"down","inn_name":"","iupac_name":"[(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate","metabolite_id":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","pvalue":0.0178558073486989,"ratio":0.2994178716686583,"synonym_name":"3-gallate(\u2212)-epicatechol"},{"chebi_id":"36281","direction":"down","inn_name":"","iupac_name":"3-(3,4-dihydroxyphenyl)prop-2-enoic acid","metabolite_id":"QAIPRVGONGVQAS-UHFFFAOYSA-N","pvalue":0.0210284433548409,"ratio":0.2962506360638918,"synonym_name":""},{"chebi_id":"30200","direction":"down","inn_name":"","iupac_name":"3-(\u03b2-<small>D</small>-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"JPUKWEQWGBDDQB-QSOFNFLRSA-N","pvalue":0.0273669693029126,"ratio":0.2868734140305132,"synonym_name":"Astragalin"},{"chebi_id":"28937","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>,4<i>E</i>)-5-[(1<i>R</i>)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid","metabolite_id":"JLIDBLDQVAYHNE-QHFMCZIYSA-N","pvalue":0.0003160537930668,"ratio":1.6553393914467305,"synonym_name":"(-)-ABA"},{"chebi_id":"147434","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XZYZGXXLESEEBE-UHFFFAOYSA-N","pvalue":0.0037773597098809,"ratio":1.9539133605496648,"synonym_name":""},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.0021347838406602,"ratio":0.5910538259379847,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"28472","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>,8<i>S</i>,14<i>R</i>,15<i>R</i>)-2,8-bis(3,4-dihydroxyphenyl)-3,4-dihydro-2<em>H</em>,14<em>H</em>-8,14-methanochromeno[7,8-<em>d</em>][1,3]benzodioxocine-3,5,11,13,15-pentol","metabolite_id":"NSEWTSAADLNHNH-LSBOWGMISA-N","pvalue":0.0054415548172108,"ratio":0.59075692624627,"synonym_name":"Proanthocyanidin A2"}],"totalFeatures":48},{"comparisonGroups":["Sangiovese_Tuscany","Sangiovese_Romagna"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sangiovese wine: Tuscany vs Romagna regions","group_a_title":"Sangiovese cultivar from Tuscany region.. Provides insight into the metabolomic profile of Sangiovese wines from Tuscany.","group_b_title":"Sangiovese cultivar from Romagna region.. Provides insight into the metabolomic profile of Sangiovese wines from Romagna.","id":"MTBLS1443_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1443","studyUrl":"http://integmet.org/study/MTBLS1443","title":"G1_Sangiovese_Tuscany_vs_G2_Sangiovese_Romagna","topHits":[{"chebi_id":"75678","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium-3-yl 6-<em>O</em>-acetyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"QPXIWIXIRHZIMM-OXUVVOBNSA-O","pvalue":0.0355088947232728,"ratio":0.234355383198951,"synonym_name":"Delphinidin 3-(6''-acetylglucoside)"},{"chebi_id":"75707","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenium-3-yl 6-<em>O</em>-[(2<i>E</i>)-3-(4-hydroxyphenyl)prop-2-enoyl]-\u03b2-<small>D</small>-glucoside-glucopyranoside","metabolite_id":"MFHMTMFSFNMTFQ-GVFKUQRYSA-O","pvalue":0.0255968742432614,"ratio":2.1514720946370156,"synonym_name":"peonidin-3-<em>O</em>-(6-<em>O</em>-<em>trans</em>-<em>p</em>-coumaryl-\u03b2-<small>D</small>-glucoside)"},{"chebi_id":"18186","direction":"up","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0158473051135126,"ratio":1.684669080984622,"synonym_name":"Tyrosin"},{"chebi_id":"147433","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GYXGDEQYOIGEEQ-DAFODLJHSA-N","pvalue":0.0297826211549593,"ratio":0.6499807075364683,"synonym_name":""}],"totalFeatures":32},{"comparisonGroups":["T0","T3"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline vs 25-day drought recovery phase","group_a_title":"Baseline group at time point 0 days. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Group at time point 25 days. Captures the recovery phase after drought stress.","id":"MTBLS1463_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS1463","studyUrl":"http://integmet.org/study/MTBLS1463","title":"T0_vs_T3","topHits":[{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0340274043647957,"ratio":1e-06,"synonym_name":"Glutaminic acid"},{"chebi_id":"16634","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-glucopyranoside","metabolite_id":"MUPFEKGTMRGPLJ-ZQSKZDJDSA-N","pvalue":0.0036419594074996,"ratio":0.030984998826093,"synonym_name":"Gossypose"},{"chebi_id":"22660","direction":"down","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0274074538003177,"ratio":0.0337580199811465,"synonym_name":"Aspartic acid"},{"chebi_id":"137501","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CZDNLUMNELLDDD-JAIJEDJZSA-N","pvalue":0.0033861360697717,"ratio":0.2110179910476508,"synonym_name":""},{"chebi_id":"137508","direction":"down","inn_name":"","iupac_name":"[2-(\u03b2-<small>D</small>-glucopyranosyloxy)-5-hydroxyphenyl]methyl benzoate","metabolite_id":"UQCOPGRRWQCCFR-BFMVXSJESA-N","pvalue":0.002491575342789,"ratio":0.2603471543112073,"synonym_name":""},{"chebi_id":"9687","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QJWRHLSORLOREK-BFMVXSJESA-N","pvalue":0.0038636731019316,"ratio":0.2605254519144502,"synonym_name":"Trichocarpin"},{"chebi_id":"155896","direction":"down","inn_name":"","iupac_name":"benzyl 2,5-dihydroxybenzoate","metabolite_id":"LRYANVPYFCKCCR-UHFFFAOYSA-N","pvalue":0.000415629750863,"ratio":0.3830019564493631,"synonym_name":"2,5-dihydroxybenzoic acid benzyl ester"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VBSPBYNZPRRGSB-UHFFFAOYSA-N","pvalue":0.0033139463499738,"ratio":0.3028587431814052,"synonym_name":""},{"chebi_id":"17268","direction":"down","inn_name":"","iupac_name":"<i>myo</i>-inositol","metabolite_id":"CDAISMWEOUEBRE-GPIVLXJGSA-N","pvalue":0.0038278577644541,"ratio":0.309089244176569,"synonym_name":"D-myo-Inositol"},{"chebi_id":"137977","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YHBIHSCTXBGAIK-NUABRCLCSA-N","pvalue":0.0167671235810002,"ratio":0.2706885881355835,"synonym_name":"2-<em>O</em>-salicyloylsalicin"}],"totalFeatures":41},{"comparisonGroups":["Wild type, DMSO, 6h","Wild type, AN11736, 6h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type: AN11736 vs DMSO treatment (6h)","group_a_title":"Wild type treated with DMSO for 6 hours. Serves as a control group to assess the effect of DMSO on wild type.","group_b_title":"Wild type treated with AN11736 for 6 hours. Assesses the effect of AN11736 on wild type after 6 hours.","id":"MTBLS1474_0001_00000054","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1474","studyUrl":"http://integmet.org/study/MTBLS1474","title":"Wild type, DMSO, 6h_vs_Wild type, AN11736, 6h","topHits":[{"chebi_id":"157671","direction":"down","inn_name":"","iupac_name":"(4-fluorophenyl)methyl (2S)-2-[(1-hydroxy-7-methyl-3H-2,1-benzoxaborole-6-carbonyl)amino]-3-methylbutanoate","metabolite_id":"AUDHLQWLNVOGDC-IBGZPJMESA-N","pvalue":0.0012261999715413,"ratio":1e-06,"synonym_name":""}],"totalFeatures":1},{"comparisonGroups":["Wild type, DMSO, 6h","Wild type, AN11736, 6h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type: AN11736 vs DMSO control at 6h","group_a_title":"Wild type treated with DMSO for 6 hours. Serves as a control group to assess the effect of DMSO on wild type.","group_b_title":"Wild type treated with AN11736 for 6 hours. Assesses the effect of AN11736 on wild type after 6 hours.","id":"MTBLS1474_0002_00000054","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1474","studyUrl":"http://integmet.org/study/MTBLS1474","title":"Wild type, DMSO, 6h_vs_Wild type, AN11736, 6h","topHits":[{"chebi_id":"157671","direction":"down","inn_name":"","iupac_name":"(4-fluorophenyl)methyl (2S)-2-[(1-hydroxy-7-methyl-3H-2,1-benzoxaborole-6-carbonyl)amino]-3-methylbutanoate","metabolite_id":"AUDHLQWLNVOGDC-IBGZPJMESA-N","pvalue":0.0012261999715413,"ratio":1e-06,"synonym_name":""}],"totalFeatures":1},{"comparisonGroups":["Wild type, DMSO, 6h","Wild type, AN11736, 6h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type: AN11736 vs DMSO treatment (6h)","group_a_title":"Wild type treated with DMSO for 6 hours. Serves as a control group to assess the effect of DMSO on wild type.","group_b_title":"Wild type treated with AN11736 for 6 hours. Assesses the effect of AN11736 on wild type after 6 hours.","id":"MTBLS1474_0003_00000054","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1474","studyUrl":"http://integmet.org/study/MTBLS1474","title":"Wild type, DMSO, 6h_vs_Wild type, AN11736, 6h","topHits":[{"chebi_id":"157671","direction":"down","inn_name":"","iupac_name":"(4-fluorophenyl)methyl (2S)-2-[(1-hydroxy-7-methyl-3H-2,1-benzoxaborole-6-carbonyl)amino]-3-methylbutanoate","metabolite_id":"AUDHLQWLNVOGDC-IBGZPJMESA-N","pvalue":0.0012261999715413,"ratio":1e-06,"synonym_name":""}],"totalFeatures":1},{"comparisonGroups":["Crown_root_peel","Crown_root_with_no_peel"],"dateCreated":"2025-09-26 00:00:00","display_title":"Piper methysticum crown root: peel vs no peel","group_a_title":"Samples from the crown root peel of Piper methysticum. Provides insight into the metabolomic profile of the crown root peel.","group_b_title":"Samples from the crown root with no peel of Piper methysticum. Provides insight into the metabolomic profile of the crown root without peel.","id":"MTBLS1485_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS1485","studyUrl":"http://integmet.org/study/MTBLS1485","title":"Crown_root_peel_vs_Crown_root_with_no_peel","topHits":[{"chebi_id":"157726","direction":"up","inn_name":"","iupac_name":"[6-oxo-1-(3-phenylpropanoyl)-2,3-dihydropyridin-3-yl] acetate","metabolite_id":"JLNNQCUATONMIT-UHFFFAOYSA-N","pvalue":1.912755982737867e-05,"ratio":10.091985150644206,"synonym_name":""},{"chebi_id":"157707","direction":"up","inn_name":"","iupac_name":"(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl) (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate","metabolite_id":"PKAIECBWQZFYRP-SOFGYWHQSA-N","pvalue":0.0146705412754564,"ratio":2.163422548681859,"synonym_name":""},{"chebi_id":"81482","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QFQYZMGOKIROEC-DUXPYHPUSA-N","pvalue":0.0142892341352948,"ratio":1.5590273266559829,"synonym_name":"MDCA"}],"totalFeatures":27},{"comparisonGroups":["Crown_root_peel","Crown_root_with_no_peel"],"dateCreated":"2025-09-26 00:00:00","display_title":"Piper methysticum crown root: peel vs no peel","group_a_title":"Samples from the crown root peel of Piper methysticum. Provides insight into the metabolomic profile of the crown root peel.","group_b_title":"Samples from the crown root with no peel of Piper methysticum. Provides insight into the metabolomic profile of the crown root without peel.","id":"MTBLS1485_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS1485","studyUrl":"http://integmet.org/study/MTBLS1485","title":"Crown_root_peel_vs_Crown_root_with_no_peel","topHits":[{"chebi_id":"157718","direction":"up","inn_name":"","iupac_name":"(E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one","metabolite_id":"UXUFMIJZNYXWDX-VMPITWQZSA-N","pvalue":0.0263742983130787,"ratio":1.8884826858159711,"synonym_name":""},{"chebi_id":"80491","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-4<em>H</em>-1-benzopyran-4-one","metabolite_id":"ORJDDOBAOGKRJV-AWEZNQCLSA-N","pvalue":0.0263742983130787,"ratio":1.8884826858159711,"synonym_name":"dihydrotectochrysin"},{"chebi_id":"15440","direction":"down","inn_name":"","iupac_name":"(6<i>E</i>,10<i>E</i>,14<i>E</i>,18<i>E</i>)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene","metabolite_id":"YYGNTYWPHWGJRM-AAJYLUCBSA-N","pvalue":0.0487176806567992,"ratio":0.4878638930443318,"synonym_name":"Squalene"}],"totalFeatures":29},{"comparisonGroups":["Control_16.6_months","Treatment_16.6_months"],"dateCreated":"2025-09-26 00:00:00","display_title":"Treatment vs control at 16.6 months","group_a_title":"Control group with 16.6 months age. Provides baseline for comparison with treated samples at the same age.","group_b_title":"Treated group with 16.6 months age. Represents the effect of treatment at 16.6 months age.","id":"MTBLS1490_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":70,"studyId":"MTBLS1490","studyUrl":"http://integmet.org/study/MTBLS1490","title":"Control_16.6_months_vs_Treatment_16.6_months","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JOMHSQGEWSNUKU-UHFFFAOYSA-N","pvalue":5.535976899186015e-05,"ratio":31.93181818181818,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AWTJQBOUKQEACS-MXEPGKFPSA-N","pvalue":0.0001086469933045,"ratio":19.6,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OGOHSCJKRSLFLO-UHFFFAOYSA-N","pvalue":0.0008824370012899,"ratio":25.4,"synonym_name":""},{"chebi_id":"18381","direction":"up","inn_name":"","iupac_name":"1-(4-carbamoyl-5-formamido-1<em>H</em>-imidazol-1-yl)-1-deoxy-<small>D</small>-ribofuranose 5-(dihydrogen phosphate)","metabolite_id":"ABCOOORLYAOBOZ-KQYNXXCUSA-N","pvalue":0.0003626487303634,"ratio":8.044776119402986,"synonym_name":"5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide"},{"chebi_id":"191980","direction":"down","inn_name":"","iupac_name":"3-[3,4-dihydroxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-phenylchromen-4-one","metabolite_id":"OUUQNKHDCPSYJE-UHFFFAOYSA-N","pvalue":0.0074344295036917,"ratio":0.0497287522603978,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LMVFAFXAMGAFOO-SRQIZXRXSA-N","pvalue":0.0032714414794454,"ratio":8.392857142857144,"synonym_name":""},{"chebi_id":"184939","direction":"up","inn_name":"","iupac_name":"1-chloro-4-(5-thiophen-2-ylthiophen-2-yl)but-3-yn-2-ol","metabolite_id":"GFYWABYZRGXGNU-UHFFFAOYSA-N","pvalue":0.0394541906497843,"ratio":42.63333333333333,"synonym_name":""},{"chebi_id":"16414","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":0.0260186570844956,"ratio":26.46666666666667,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"},{"chebi_id":"3110","direction":"up","inn_name":"","iupac_name":"5'-O-[hydroxy({5-[(3a<i>S</i>,4<i>S</i>,6a<i>R</i>)-2-oxohexahydro-1<em>H</em>-thieno[3,4-<em>d</em>]imidazol-4-yl]pentanoyl}oxy)phosphoryl]adenosine","metabolite_id":"UTQCSTJVMLODHM-RHCAYAJFSA-N","pvalue":0.0046026230360705,"ratio":8.767441860465116,"synonym_name":"Biotinyl-5'-AMP"},{"chebi_id":"37024","direction":"up","inn_name":"","iupac_name":"2-aminohexanedioic acid","metabolite_id":"OYIFNHCXNCRBQI-UHFFFAOYSA-N","pvalue":0.0451924491094995,"ratio":29.67391304347826,"synonym_name":"2-aminoadipic acid"}],"totalFeatures":613},{"comparisonGroups":["Control_16.6_months","Treatment_16.6_months"],"dateCreated":"2025-09-26 00:00:00","display_title":"Treatment vs control at 16.6 months age","group_a_title":"Control group with 16.6 months age. Provides baseline for comparison with treated samples at the same age.","group_b_title":"Treated group with 16.6 months age. Represents the effect of treatment at 16.6 months age.","id":"MTBLS1490_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS1490","studyUrl":"http://integmet.org/study/MTBLS1490","title":"Control_16.6_months_vs_Treatment_16.6_months","topHits":[{"chebi_id":"75697","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenium-3-yl 6-<em>O</em>-acetyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"MBSKDCPWFSMEFD-WKKMNAASSA-O","pvalue":0.0132871950490878,"ratio":1e-06,"synonym_name":"Peonidin 3-(6''-acetylglucoside)"},{"chebi_id":"196669","direction":"down","inn_name":"","iupac_name":"[(2R)-3-dodecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"PXSRIASFTWIQOT-QYZSMWKLSA-N","pvalue":0.0251015164720653,"ratio":1e-06,"synonym_name":""},{"chebi_id":"186133","direction":"up","inn_name":"","iupac_name":"[(2R)-1-icosanoyloxy-3-phosphonooxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate","metabolite_id":"AVPZPEHDIWHRRN-MTFJKWJPSA-N","pvalue":0.0426699460933197,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"16954","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4<em>H</em>-chromen-8-yl]-<small>D</small>-glucitol","metabolite_id":"SGEWCQFRYRRZDC-VPRICQMDSA-N","pvalue":0.0015473930815553,"ratio":0.0887392501429537,"synonym_name":"Apigenin 8-C-glucoside"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AUINKJITOILUGW-QBISYZCESA-N","pvalue":0.0054523534022355,"ratio":0.1447801830608083,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CWTCSQCPFXJPDL-SZQIBGDISA-N","pvalue":0.0092914369562855,"ratio":0.1172288773622583,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CJHLOIVYCZZNBR-DODNOZFWSA-N","pvalue":0.016346443352681,"ratio":0.0940997200723114,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IBUKXRINTKQBRQ-NBURIUCMSA-N","pvalue":0.0094047079585073,"ratio":0.1440121343153381,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VQWOKPHLVOSHNB-JXVUEMGPSA-N","pvalue":0.0426050706933516,"ratio":0.0806168437578181,"synonym_name":""},{"chebi_id":"191036","direction":"down","inn_name":"","iupac_name":"1,3,8,9-tetrahydroxy-[1]benzouro[3,2-c]chromen-6-one","metabolite_id":"LUTYTNLPIUCKBJ-UHFFFAOYSA-N","pvalue":0.0252178131710824,"ratio":0.1810766813883862,"synonym_name":""}],"totalFeatures":904},{"comparisonGroups":["Mus_musculus_enriched","Mus_musculus_control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: enriched environment vs control","group_a_title":"Mice exposed to an enriched environment. This group is crucial for understanding the effects of environmental enrichment on synaptic function","group_b_title":"Control group of mice. Provides a reference point for evaluating the effects of environmental enrichment","id":"MTBLS1531_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1531","studyUrl":"http://integmet.org/study/MTBLS1531","title":"Mus_musculus_enriched_vs_control","topHits":[],"totalFeatures":40},{"comparisonGroups":["Mus_musculus_enriched","Mus_musculus_control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse brain: enriched environment vs control","group_a_title":"Mice exposed to an enriched environment. This group is crucial for understanding the effects of environmental enrichment on synaptic function","group_b_title":"Control group of mice. Provides a reference point for evaluating the effects of environmental enrichment","id":"MTBLS1531_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1531","studyUrl":"http://integmet.org/study/MTBLS1531","title":"Mus_musculus_enriched_vs_control","topHits":[{"chebi_id":"84438","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-1-hydroxy-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propan-2-yl (7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoate","metabolite_id":"XLFXOFMAQPNCDB-IATQTFTGSA-N","pvalue":0.0229396218344684,"ratio":2.545871647253431,"synonym_name":"DG(18:1n9/22:4n6)"}],"totalFeatures":13},{"comparisonGroups":["Local_Leaf_Control","Local_Leaf_Avr"],"dateCreated":"2025-09-26 00:00:00","display_title":"Leaf: control vs Avr antibiotic treatment","group_a_title":"Local leaf samples under mock-control conditions.. Provides baseline data for evaluating the effects of treatments on local leaves.","group_b_title":"Local leaf samples treated with Avr (streptomycin and tetracycline).. Allows assessment of Avr treatment effects on local leaves.","id":"MTBLS1550_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":180,"studyId":"MTBLS1550","studyUrl":"http://integmet.org/study/MTBLS1550","title":"Local_Leaf_Control_vs_Local_Leaf_Avr","topHits":[{"chebi_id":"190313","direction":"down","inn_name":"","iupac_name":"(8S,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","metabolite_id":"OXHNQTSIKGHVBH-ANULTFPQSA-N","pvalue":8.038408188609477e-12,"ratio":0.0498845863859044,"synonym_name":""},{"chebi_id":"177821","direction":"down","inn_name":"","iupac_name":"3-(3-hydroxytridecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"DOFFCMLMRQLXPK-UHFFFAOYSA-N","pvalue":4.60724559364834e-16,"ratio":0.121501343249626,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZVFDPYZBJGKPII-UHFFFAOYSA-N","pvalue":3.517107519669686e-13,"ratio":0.0815740047454084,"synonym_name":""},{"chebi_id":"89234","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HIAJCGFYHIANNA-QIZZZRFXSA-N","pvalue":7.741327416292326e-12,"ratio":0.0660174515449503,"synonym_name":"D5-Cholenic acid"},{"chebi_id":"28865","direction":"down","inn_name":"","iupac_name":"2-[(3\u03b1,7\u03b1,12\u03b1-trihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"WBWWGRHZICKQGZ-HZAMXZRMSA-N","pvalue":1.3852552169481857e-17,"ratio":0.1781663861363967,"synonym_name":"cholic acid taurine conjugate"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":5.136776600144878e-11,"ratio":0.0664693283259607,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CXWVLACISIBSHX-PSQQFKKASA-N","pvalue":6.109114850917083e-14,"ratio":0.1254149173078386,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UZNYMWWMHBZMLI-IOLBBIBUSA-N","pvalue":3.5803193494821055e-11,"ratio":0.0775380867217258,"synonym_name":""},{"chebi_id":"88842","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VQRMNXBTDRJEKI-UHFFFAOYSA-N","pvalue":1.6277671114236193e-11,"ratio":0.0964087643736393,"synonym_name":"Methyl-N,N-diethylthiocarbamic acid"},{"chebi_id":"157725","direction":"down","inn_name":"","iupac_name":"(E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one","metabolite_id":"CGIBCVBDFUTMPT-RMKNXTFCSA-N","pvalue":1.1456075675942345e-15,"ratio":0.1942951639668931,"synonym_name":""}],"totalFeatures":382},{"comparisonGroups":["Water","HNG"],"dateCreated":"2025-09-26 00:00:00","display_title":"HNG peptide treatment vs water control","group_a_title":"Vehicle control group treated with water.. Serves as the reference group for evaluating the effects of peptide treatments.","group_b_title":"Group treated with humanin analog S14G (HNG).. Evaluates the metabolic impact of HNG treatment.","id":"MTBLS159_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS159","studyUrl":"http://integmet.org/study/MTBLS159","title":"Water_vs_HNG","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HJORCZCMNWLHMB-UHFFFAOYSA-N","pvalue":0.0074661516153282,"ratio":0.4243908160697453,"synonym_name":""},{"chebi_id":"86507","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"BSVHAXJKBCWVDA-SNVBAGLBSA-N","pvalue":0.0083454832247331,"ratio":1.95352945597905,"synonym_name":""},{"chebi_id":"74359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumylbutanoate","metabolite_id":"QWCKQJZIFLGMSD-VKHMYHEASA-N","pvalue":0.0179466919534964,"ratio":2.0706686356552506,"synonym_name":"(2<i>S</i>)-2-ammoniobutanoate"},{"chebi_id":"70984","direction":"down","inn_name":"","iupac_name":"[(3-methylbutanoyl)amino]acetic acid","metabolite_id":"ZRQXMKMBBMNNQC-UHFFFAOYSA-N","pvalue":0.0126907898981382,"ratio":0.5748305518139598,"synonym_name":"isopentanoylglycine"},{"chebi_id":"141472","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<em>S</em>-methyl-<small>L</small>-cysteinylglycine","metabolite_id":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","pvalue":0.0231014862768695,"ratio":1.7369145966752582,"synonym_name":"S-Methyl GSH"},{"chebi_id":"16552","direction":"down","inn_name":"","iupac_name":"<em>N</em>-formyl-<small>L</small>-methionine","metabolite_id":"PYUSHNKNPOHWEZ-YFKPBYRVSA-N","pvalue":0.0230385703357976,"ratio":0.6074708206183298,"synonym_name":"N-formylmethionine"},{"chebi_id":"133622","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[(4<i>S</i>)-4-azaniumyl-4-carboxylatobutanoyl]amino}pentanedioate","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-L","pvalue":0.0145559274966178,"ratio":1.5084961425019352,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Glu(2\u2212)"},{"chebi_id":"16566","direction":"up","inn_name":"","iupac_name":"sphinganine","metabolite_id":"OTKJDMGTUTTYMP-ZWKOTPCHSA-N","pvalue":0.0259069654930206,"ratio":1.5859377837913455,"synonym_name":"C<small><sub>18</sub></small>-sphinganine"},{"chebi_id":"91315","direction":"up","inn_name":"","iupac_name":"2-methylbutanedioic acid","metabolite_id":"WXUAQHNMJWJLTG-UHFFFAOYSA-N","pvalue":0.0187534748624465,"ratio":1.516822068811249,"synonym_name":""},{"chebi_id":"131434","direction":"down","inn_name":"","iupac_name":"5-hydroxyhexanoic acid","metabolite_id":"YDCRNMJQROAWFT-UHFFFAOYSA-N","pvalue":0.0346873248869714,"ratio":0.6482756725495364,"synonym_name":"5-hydroxy caproic acid"}],"totalFeatures":371},{"comparisonGroups":["Water","HNG"],"dateCreated":"2025-09-26 00:00:00","display_title":"HNG (humanin analog S14G) treatment vs water control","group_a_title":"Vehicle control group treated with water.. Serves as the reference group for evaluating the effects of peptide treatments.","group_b_title":"Group treated with humanin analog S14G (HNG).. Evaluates the metabolic impact of HNG treatment.","id":"MTBLS159_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS159","studyUrl":"http://integmet.org/study/MTBLS159","title":"Water_vs_HNG","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HJORCZCMNWLHMB-UHFFFAOYSA-N","pvalue":0.0074661516153282,"ratio":0.4243908160697453,"synonym_name":""},{"chebi_id":"86507","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"BSVHAXJKBCWVDA-SNVBAGLBSA-N","pvalue":0.0083454832247331,"ratio":1.95352945597905,"synonym_name":""},{"chebi_id":"74359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumylbutanoate","metabolite_id":"QWCKQJZIFLGMSD-VKHMYHEASA-N","pvalue":0.0179466919534964,"ratio":2.0706686356552506,"synonym_name":"(2<i>S</i>)-2-ammoniobutanoate"},{"chebi_id":"70984","direction":"down","inn_name":"","iupac_name":"[(3-methylbutanoyl)amino]acetic acid","metabolite_id":"ZRQXMKMBBMNNQC-UHFFFAOYSA-N","pvalue":0.0126907898981382,"ratio":0.5748305518139598,"synonym_name":"isopentanoylglycine"},{"chebi_id":"141472","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<em>S</em>-methyl-<small>L</small>-cysteinylglycine","metabolite_id":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","pvalue":0.0231014862768695,"ratio":1.7369145966752582,"synonym_name":"S-Methyl GSH"},{"chebi_id":"16552","direction":"down","inn_name":"","iupac_name":"<em>N</em>-formyl-<small>L</small>-methionine","metabolite_id":"PYUSHNKNPOHWEZ-YFKPBYRVSA-N","pvalue":0.0230385703357976,"ratio":0.6074708206183298,"synonym_name":"N-formylmethionine"},{"chebi_id":"133622","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[(4<i>S</i>)-4-azaniumyl-4-carboxylatobutanoyl]amino}pentanedioate","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-L","pvalue":0.0145559274966178,"ratio":1.5084961425019352,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Glu(2\u2212)"},{"chebi_id":"16566","direction":"up","inn_name":"","iupac_name":"sphinganine","metabolite_id":"OTKJDMGTUTTYMP-ZWKOTPCHSA-N","pvalue":0.0259069654930206,"ratio":1.5859377837913455,"synonym_name":"C<small><sub>18</sub></small>-sphinganine"},{"chebi_id":"91315","direction":"up","inn_name":"","iupac_name":"2-methylbutanedioic acid","metabolite_id":"WXUAQHNMJWJLTG-UHFFFAOYSA-N","pvalue":0.0187534748624465,"ratio":1.516822068811249,"synonym_name":""},{"chebi_id":"131434","direction":"down","inn_name":"","iupac_name":"5-hydroxyhexanoic acid","metabolite_id":"YDCRNMJQROAWFT-UHFFFAOYSA-N","pvalue":0.0346873248869714,"ratio":0.6482756725495364,"synonym_name":"5-hydroxy caproic acid"}],"totalFeatures":371},{"comparisonGroups":["Water","HNG"],"dateCreated":"2025-09-26 00:00:00","display_title":"Water control vs HNG (humanin analog S14G) treatment","group_a_title":"Vehicle control group treated with water.. Serves as the reference group for evaluating the effects of peptide treatments.","group_b_title":"Group treated with humanin analog S14G (HNG).. Evaluates the metabolic impact of HNG treatment.","id":"MTBLS159_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS159","studyUrl":"http://integmet.org/study/MTBLS159","title":"Water_vs_HNG","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HJORCZCMNWLHMB-UHFFFAOYSA-N","pvalue":0.0074661516153282,"ratio":0.4243908160697453,"synonym_name":""},{"chebi_id":"86507","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"BSVHAXJKBCWVDA-SNVBAGLBSA-N","pvalue":0.0083454832247331,"ratio":1.95352945597905,"synonym_name":""},{"chebi_id":"74359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumylbutanoate","metabolite_id":"QWCKQJZIFLGMSD-VKHMYHEASA-N","pvalue":0.0179466919534964,"ratio":2.0706686356552506,"synonym_name":"(2<i>S</i>)-2-ammoniobutanoate"},{"chebi_id":"70984","direction":"down","inn_name":"","iupac_name":"[(3-methylbutanoyl)amino]acetic acid","metabolite_id":"ZRQXMKMBBMNNQC-UHFFFAOYSA-N","pvalue":0.0126907898981382,"ratio":0.5748305518139598,"synonym_name":"isopentanoylglycine"},{"chebi_id":"141472","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<em>S</em>-methyl-<small>L</small>-cysteinylglycine","metabolite_id":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","pvalue":0.0231014862768695,"ratio":1.7369145966752582,"synonym_name":"S-Methyl GSH"},{"chebi_id":"16552","direction":"down","inn_name":"","iupac_name":"<em>N</em>-formyl-<small>L</small>-methionine","metabolite_id":"PYUSHNKNPOHWEZ-YFKPBYRVSA-N","pvalue":0.0230385703357976,"ratio":0.6074708206183298,"synonym_name":"N-formylmethionine"},{"chebi_id":"133622","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[(4<i>S</i>)-4-azaniumyl-4-carboxylatobutanoyl]amino}pentanedioate","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-L","pvalue":0.0145559274966178,"ratio":1.5084961425019352,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Glu(2\u2212)"},{"chebi_id":"16566","direction":"up","inn_name":"","iupac_name":"sphinganine","metabolite_id":"OTKJDMGTUTTYMP-ZWKOTPCHSA-N","pvalue":0.0259069654930206,"ratio":1.5859377837913455,"synonym_name":"C<small><sub>18</sub></small>-sphinganine"},{"chebi_id":"91315","direction":"up","inn_name":"","iupac_name":"2-methylbutanedioic acid","metabolite_id":"WXUAQHNMJWJLTG-UHFFFAOYSA-N","pvalue":0.0187534748624465,"ratio":1.516822068811249,"synonym_name":""},{"chebi_id":"131434","direction":"down","inn_name":"","iupac_name":"5-hydroxyhexanoic acid","metabolite_id":"YDCRNMJQROAWFT-UHFFFAOYSA-N","pvalue":0.0346873248869714,"ratio":0.6482756725495364,"synonym_name":"5-hydroxy caproic acid"}],"totalFeatures":371},{"comparisonGroups":["Water","HNG"],"dateCreated":"2025-09-26 00:00:00","display_title":"Water control vs HNG (humanin analog S14G) treatment","group_a_title":"Vehicle control group treated with water.. Serves as the reference group for evaluating the effects of peptide treatments.","group_b_title":"Group treated with humanin analog S14G (HNG).. Evaluates the metabolic impact of HNG treatment.","id":"MTBLS159_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS159","studyUrl":"http://integmet.org/study/MTBLS159","title":"Water_vs_HNG","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HJORCZCMNWLHMB-UHFFFAOYSA-N","pvalue":0.0074661516153282,"ratio":0.4243908160697453,"synonym_name":""},{"chebi_id":"86507","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"BSVHAXJKBCWVDA-SNVBAGLBSA-N","pvalue":0.0083454832247331,"ratio":1.95352945597905,"synonym_name":""},{"chebi_id":"74359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumylbutanoate","metabolite_id":"QWCKQJZIFLGMSD-VKHMYHEASA-N","pvalue":0.0179466919534964,"ratio":2.0706686356552506,"synonym_name":"(2<i>S</i>)-2-ammoniobutanoate"},{"chebi_id":"70984","direction":"down","inn_name":"","iupac_name":"[(3-methylbutanoyl)amino]acetic acid","metabolite_id":"ZRQXMKMBBMNNQC-UHFFFAOYSA-N","pvalue":0.0126907898981382,"ratio":0.5748305518139598,"synonym_name":"isopentanoylglycine"},{"chebi_id":"141472","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<em>S</em>-methyl-<small>L</small>-cysteinylglycine","metabolite_id":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","pvalue":0.0231014862768695,"ratio":1.7369145966752582,"synonym_name":"S-Methyl GSH"},{"chebi_id":"16552","direction":"down","inn_name":"","iupac_name":"<em>N</em>-formyl-<small>L</small>-methionine","metabolite_id":"PYUSHNKNPOHWEZ-YFKPBYRVSA-N","pvalue":0.0230385703357976,"ratio":0.6074708206183298,"synonym_name":"N-formylmethionine"},{"chebi_id":"133622","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[(4<i>S</i>)-4-azaniumyl-4-carboxylatobutanoyl]amino}pentanedioate","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-L","pvalue":0.0145559274966178,"ratio":1.5084961425019352,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Glu(2\u2212)"},{"chebi_id":"16566","direction":"up","inn_name":"","iupac_name":"sphinganine","metabolite_id":"OTKJDMGTUTTYMP-ZWKOTPCHSA-N","pvalue":0.0259069654930206,"ratio":1.5859377837913455,"synonym_name":"C<small><sub>18</sub></small>-sphinganine"},{"chebi_id":"91315","direction":"up","inn_name":"","iupac_name":"2-methylbutanedioic acid","metabolite_id":"WXUAQHNMJWJLTG-UHFFFAOYSA-N","pvalue":0.0187534748624465,"ratio":1.516822068811249,"synonym_name":""},{"chebi_id":"131434","direction":"down","inn_name":"","iupac_name":"5-hydroxyhexanoic acid","metabolite_id":"YDCRNMJQROAWFT-UHFFFAOYSA-N","pvalue":0.0346873248869714,"ratio":0.6482756725495364,"synonym_name":"5-hydroxy caproic acid"}],"totalFeatures":371},{"comparisonGroups":["Lotus japonicus var. MG20 Control","Lotus japonicus var. MG20 Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Lotus japonicus: control vs salt treatment","group_a_title":"Control group for Lotus japonicus var. MG20 with 0 Mole per Liter salt concentration. Provides baseline data for comparison with treatment groups.","group_b_title":"Treatment group for Lotus japonicus var. MG20 with increasing salt concentrations. Allows assessment of salt concentration effects on Lotus japonicus var. MG20.","id":"MTBLS16_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS16","studyUrl":"http://integmet.org/study/MTBLS16","title":"G1_Lotus_japonicus_var_MG20_Control_vs_G2_Lotus_japonicus_var_MG20_Treatment","topHits":[{"chebi_id":"18266","direction":"down","inn_name":"","iupac_name":"1<small>D</small>-4-<em>O</em>-methyl-<em>myo</em>-inositol","metabolite_id":"DSCFFEYYQKSRSV-GESKJZQWSA-N","pvalue":3.254165421108685e-07,"ratio":0.1463167830038096,"synonym_name":"1D-4-O-Methyl-myo-inositol"},{"chebi_id":"28645","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":0.000284056279298,"ratio":0.1553803583345905,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"39244","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"HDTRYLNUVZCQOY-BTLHAWITSA-N","pvalue":3.830856943002083e-05,"ratio":0.2504992561348667,"synonym_name":"\u03b1-<small>D</small>-glucopyranosyl \u03b2-<small>D</small>-glucopyranoside"},{"chebi_id":"30794","direction":"up","inn_name":"","iupac_name":"propanedioic acid","metabolite_id":"OFOBLEOULBTSOW-UHFFFAOYSA-N","pvalue":3.650029581140301e-05,"ratio":3.071522658606337,"synonym_name":"Propanedioic acid"},{"chebi_id":"4167","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-GASJEMHNSA-N","pvalue":0.0001825589360538,"ratio":0.2662894511553382,"synonym_name":"Dextrose"},{"chebi_id":"22653","direction":"down","inn_name":"","iupac_name":"asparagine","metabolite_id":"DCXYFEDJOCDNAF-UHFFFAOYSA-N","pvalue":0.0013168286700675,"ratio":0.2081241217538733,"synonym_name":"Asparagin"},{"chebi_id":"33384","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":0.0007224065699619,"ratio":0.2656799845215939,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"15741","direction":"up","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0003649756306451,"ratio":3.247294399281831,"synonym_name":"E363"},{"chebi_id":"15429","direction":"up","inn_name":"","iupac_name":"hydroxylamine","metabolite_id":"AVXURJPOCDRRFD-UHFFFAOYSA-N","pvalue":0.0014322024377362,"ratio":4.0845098058070395,"synonym_name":"H<small><sub>2</sub></small>NHO"},{"chebi_id":"17053","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":0.0039119504047102,"ratio":0.1899903065280211,"synonym_name":"L-Aspartic acid"}],"totalFeatures":50},{"comparisonGroups":["Nepalese_BPK173","Nepalese_BPK178"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. donovani: BPK173 vs BPK178 strains (aneuploidy)","group_a_title":"Samples from Nepalese BPK173 strain of Leishmania donovani.. Represents one of the strains used to study aneuploidy effects.","group_b_title":"Samples from Nepalese BPK178 strain of Leishmania donovani.. Represents one of the strains used to study aneuploidy effects.","id":"MTBLS1612_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS1612","studyUrl":"http://integmet.org/study/MTBLS1612","title":"Nepalese_BPK173_vs_Nepalese_BPK178","topHits":[{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":0.034289708930312,"ratio":3.026281981277221,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"15978","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-N","pvalue":0.0364462064350965,"ratio":2.874216679921089,"synonym_name":"Phosphors\u00e4ure-mono-((<i>R</i>)-2,3-dihydroxy-propylester)"},{"chebi_id":"16870","direction":"up","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0284784762284138,"ratio":2.5325223843235385,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0133428533619679,"ratio":2.0599504175133925,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"17345","direction":"up","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0069818576528688,"ratio":1.856083184674705,"synonym_name":"GMP"},{"chebi_id":"58066","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-5-oxopentanoate","metabolite_id":"KABXUUFDPUOJMW-BYPYZUCNSA-N","pvalue":0.0045935746733039,"ratio":1.6567922995509894,"synonym_name":"(2<i>S</i>)-2-ammonio-5-oxopentanoate"},{"chebi_id":"49268","direction":"up","inn_name":"","iupac_name":"5-amino-2-oxopentanoic acid","metabolite_id":"BWHGMFYTDQEALD-UHFFFAOYSA-N","pvalue":0.0045935746733039,"ratio":1.6567922995509894,"synonym_name":"5-amino-2-oxovaleric acid"},{"chebi_id":"22660","direction":"up","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0144091886055359,"ratio":1.6633672214334447,"synonym_name":"Aspartic acid"},{"chebi_id":"17562","direction":"up","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":0.0363646877114521,"ratio":1.845970586893675,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0174470128940196,"ratio":1.6023792436079385,"synonym_name":"colamine phosphate"}],"totalFeatures":83},{"comparisonGroups":["36_week","104_week"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: 36-week vs 104-week aging comparison","group_a_title":"Samples from 36-week-old mice.. Provides baseline data for comparison with older age group.","group_b_title":"Samples from 104-week-old mice.. Allows for comparison with younger age group to study aging effects.","id":"MTBLS1622_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":893,"studyId":"MTBLS1622","studyUrl":"http://integmet.org/study/MTBLS1622","title":"36_week_vs_104_week","topHits":[{"chebi_id":"81961","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YQVMVCCFZCMYQB-SNVBAGLBSA-N","pvalue":1.4777335112419026e-10,"ratio":25751481.999999993,"synonym_name":""},{"chebi_id":"82179","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YQVMVCCFZCMYQB-UHFFFAOYSA-N","pvalue":1.4777335112419026e-10,"ratio":25751481.999999993,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DZPMBJHSZPWWDS-ZIBCJSCZSA-N","pvalue":6.766006488684931e-06,"ratio":48916099.99999999,"synonym_name":""},{"chebi_id":"797","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XDGRXQNYJMQLPU-VFZBCNBRSA-N","pvalue":6.766006488684931e-06,"ratio":48916099.99999999,"synonym_name":"19-Hydroxytabersonine"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YJKNDUBIWGQYFI-NWRWZVFGSA-N","pvalue":6.766006488684931e-06,"ratio":48916099.99999999,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OVEMZEHFRQWSFP-KTMIOCPHSA-N","pvalue":7.025392635907673e-06,"ratio":8769347.199999997,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OVEMZEHFRQWSFP-LNSUZNPRSA-N","pvalue":7.025392635907673e-06,"ratio":8769347.199999997,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AHCZVAORYHARLA-XTGROYTHSA-N","pvalue":7.025392635907673e-06,"ratio":8769347.199999997,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JXOONFORBFAKIN-AFYJWTTESA-N","pvalue":7.025392635907673e-06,"ratio":8769347.199999997,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YYZXYYHUGHQGHI-DVTGEIKXSA-N","pvalue":7.025392635907673e-06,"ratio":8769347.199999997,"synonym_name":""}],"totalFeatures":2604},{"comparisonGroups":["Supplementary_feeding","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Piglets: supplementary feeding vs sow's milk","group_a_title":"Piglets receiving supplementary feeding. This group is crucial for understanding the effects of supplementary feeding on gut microbiota and barrier function.","group_b_title":"Piglets receiving sow's milk. This group serves as the reference point for evaluating the effects of supplementary feeding.","id":"MTBLS1698_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS1698","studyUrl":"http://integmet.org/study/MTBLS1698","title":"Supplementary_feeding_vs_Control","topHits":[{"chebi_id":"89644","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SBKADJXSGGTEPN-UHFFFAOYSA-N","pvalue":3.436965084977079e-05,"ratio":0.286414247649344,"synonym_name":"3-Methoxy-4-Hydroxyphenylglycol Sulfate"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MSFSPUZXLOGKHJ-LEISLEKSSA-N","pvalue":4.0132880190456e-05,"ratio":0.389236719783495,"synonym_name":""},{"chebi_id":"17821","direction":"up","inn_name":"","iupac_name":"thymine","metabolite_id":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","pvalue":0.000355813052751,"ratio":3.2514169362671255,"synonym_name":"5-Methyluracil"},{"chebi_id":"28088","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-3-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"TZBJGXHYKVUXJN-UHFFFAOYSA-N","pvalue":0.0162940589366946,"ratio":6.827230090540021,"synonym_name":"4',5,7-trihydroxyisoflavone"},{"chebi_id":"153573","direction":"up","inn_name":"","iupac_name":"(8\u03be,9\u03be,14\u03be)-3-oxoandrost-4-en-17\u03b2-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"NIKZPECGCSUSBV-FWDQRILVSA-N","pvalue":0.0310413988871931,"ratio":5.464841718771026,"synonym_name":"(17\u03b2)-3-oxoandrost-4-en-17-yl \u03b2-<small>D</small>-glucopyranosiduronic acid"},{"chebi_id":"16755","direction":"up","inn_name":"","iupac_name":"3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-BSWAIDMHSA-N","pvalue":0.0300603276737911,"ratio":4.07182461176613,"synonym_name":"anthropodesoxycholic acid"},{"chebi_id":"28729","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-mannopyranose","metabolite_id":"WQZGKKKJIJFFOK-PQMKYFCFSA-N","pvalue":0.0175925011778552,"ratio":0.4524033241676949,"synonym_name":"ALPHA-D-MANNOSE"},{"chebi_id":"28661","direction":"down","inn_name":"","iupac_name":"(6<i>Z</i>,9<i>Z</i>,12<i>Z</i>)-octadeca-6,9,12-trienoic acid","metabolite_id":"VZCCETWTMQHEPK-QNEBEIHSSA-N","pvalue":0.0004868696339947,"ratio":0.6615562907147419,"synonym_name":"(6Z,9Z,12Z)-Octadecatrienoic acid"},{"chebi_id":"17925","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-DVKNGEFBSA-N","pvalue":0.0143505142080376,"ratio":0.510031884190384,"synonym_name":"alpha-D-Glucose"},{"chebi_id":"16450","direction":"up","inn_name":"","iupac_name":"1-(2-deoxy-\u03b2-<small>D</small>-<i>erythro</i>-pentofuranosyl)uracil","metabolite_id":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","pvalue":0.0072713491773593,"ratio":1.6823972037436483,"synonym_name":"Deoxyuridine"}],"totalFeatures":17},{"comparisonGroups":["Supplementary_feeding","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Piglets: supplementary feeding vs sow's milk control","group_a_title":"Piglets receiving supplementary feeding. This group is crucial for understanding the effects of supplementary feeding on gut microbiota and barrier function.","group_b_title":"Piglets receiving sow's milk. This group serves as the reference point for evaluating the effects of supplementary feeding.","id":"MTBLS1698_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS1698","studyUrl":"http://integmet.org/study/MTBLS1698","title":"Supplementary_feeding_vs_Control","topHits":[{"chebi_id":"74669","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis[(9<i>Z</i>)-octadec-9-enoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"SNKAWJBJQDLSFF-NVKMUCNASA-N","pvalue":0.0022185522414457,"ratio":4.715257658647791,"synonym_name":"Dioleoyl phosphatidylcholine"},{"chebi_id":"34778","direction":"up","inn_name":"","iupac_name":"7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4<em>H</em>-one","metabolite_id":"DXYUAIFZCFRPTH-UHFFFAOYSA-N","pvalue":0.0065423594272154,"ratio":5.696615577717668,"synonym_name":"7,4'-Dihydroxy-6-methoxyisoflavone"},{"chebi_id":"28197","direction":"up","inn_name":"","iupac_name":"7-hydroxy-3-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"ZQSIJRDFPHDXIC-UHFFFAOYSA-N","pvalue":0.0102734091930269,"ratio":4.979756308432069,"synonym_name":"daidzeol"},{"chebi_id":"16359","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"BHQCQFFYRZLCQQ-OELDTZBJSA-N","pvalue":0.025672512525574,"ratio":0.2030291020249553,"synonym_name":"Cholic acid"},{"chebi_id":"16040","direction":"up","inn_name":"","iupac_name":"4-aminopyrimidin-2(1<em>H</em>)-one","metabolite_id":"OPTASPLRGRRNAP-UHFFFAOYSA-N","pvalue":0.0061205843461905,"ratio":2.9331107228619784,"synonym_name":"Zytosin"},{"chebi_id":"74762","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QLROSWPKSBORFJ-BQBZGAKWSA-N","pvalue":0.0017878165288045,"ratio":0.43880894354459,"synonym_name":"Prolyl-Glutamate"},{"chebi_id":"16199","direction":"down","inn_name":"carbamide","iupac_name":"urea","metabolite_id":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","pvalue":4.1815421697505696e-05,"ratio":0.6011538282477152,"synonym_name":"H<small><sub>2</sub></small>NC(O)NH<small><sub>2</sub></small>"},{"chebi_id":"74753","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-alanine","metabolite_id":"FELJDCNGZFDUNR-WDSKDSINSA-N","pvalue":0.0041743013145524,"ratio":0.3973978788459632,"synonym_name":"<small>L</small>-Pro-<small>L</small>-Ala"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0041294813183285,"ratio":0.4127636833242274,"synonym_name":"u"},{"chebi_id":"17750","direction":"up","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0013410121540195,"ratio":2.0590099221646225,"synonym_name":"Bet"}],"totalFeatures":41},{"comparisonGroups":["Uninjured_limb","Late_digits_limb_growth"],"dateCreated":"2025-09-26 00:00:00","display_title":"Limb: uninjured vs late regeneration (56 days)","group_a_title":"Samples from uninjured limb at time point 0 day.. Serves as the reference point for all subsequent regeneration stages.","group_b_title":"Samples from late digits-limb growth stage at time point 56 days.. Represents the culmination of the regenerative process.","id":"MTBLS1708_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS1708","studyUrl":"http://integmet.org/study/MTBLS1708","title":"Uninjured_limb_vs_Late_digits_limb_growth","topHits":[{"chebi_id":"44992","direction":"up","inn_name":"","iupac_name":"2-aminopteridin-4(3<em>H</em>)-one","metabolite_id":"HNXQXTQTPAJEJL-UHFFFAOYSA-N","pvalue":6.228152750156991e-06,"ratio":11.774171129407948,"synonym_name":"Pterin"},{"chebi_id":"173771","direction":"down","inn_name":"","iupac_name":"5-amino-2-[(2-amino-3-sulanylpropanoyl)amino]-5-oxopentanoic acid","metabolite_id":"YHDXIZKDOIWPBW-UHFFFAOYSA-N","pvalue":0.0088044045806778,"ratio":0.5141212510437854,"synonym_name":""},{"chebi_id":"43474","direction":"up","inn_name":"","iupac_name":"hydrogentetraoxophosphate(V)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-L","pvalue":0.004762777968387,"ratio":1.794461868641107,"synonym_name":"hydrogen phosphate"},{"chebi_id":"17015","direction":"up","inn_name":"riboflavine","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUNGANRZJHBGPY-SCRDCRAPSA-N","pvalue":0.0379459431231054,"ratio":2.5982242087382947,"synonym_name":"E101"},{"chebi_id":"74802","direction":"down","inn_name":"","iupac_name":"<small>L</small>-seryl-<small>L</small>-asparagine","metabolite_id":"LTFSLKWFMWZEBD-IMJSIDKUSA-N","pvalue":0.005906747574262,"ratio":0.5889257401810122,"synonym_name":"serylasparagine"},{"chebi_id":"73851","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(9<i>Z</i>)-hexadec-9-enoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LFUDDCMNKWEORN-ZXEGGCGDSA-N","pvalue":0.0262781723016554,"ratio":1.863661917549253,"synonym_name":"GPC(16:1)"},{"chebi_id":"76942","direction":"down","inn_name":"","iupac_name":"3-{[(1<i>S</i>)-1,3-dicarboxylatopropyl]carbamoyl}-3-hydroxypentanedioate","metabolite_id":"GAQNUGISBQJMKO-YFKPBYRVSA-J","pvalue":0.0104433913511245,"ratio":0.6232544578887121,"synonym_name":""},{"chebi_id":"145284","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QJHRNPQXCMXOOH-XBJNFHHOSA-N","pvalue":0.040103719957772,"ratio":0.5148496037690725,"synonym_name":"LPE 20:2(11Z,14Z)/0:0"},{"chebi_id":"17368","direction":"down","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":0.0167311342150581,"ratio":0.6319745625642159,"synonym_name":"Purine-6-ol"},{"chebi_id":"47876","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5-methylcytidine","metabolite_id":"LUCHPKXVUGJYGU-XLPZGREQSA-N","pvalue":0.0300129973306208,"ratio":1.5538032660693926,"synonym_name":"5-Methyl-2'-deoxycytidine"}],"totalFeatures":64},{"comparisonGroups":["BSTFA_Control_manual","BSTFA_Automated_batch"],"dateCreated":"2025-09-26 00:00:00","display_title":"BSTFA derivatization: manual vs automated batch protocol","group_a_title":"Control samples derivatized with BSTFA using manual protocol. Serves as the baseline for comparison with automated BSTFA protocols","group_b_title":"Samples derivatized with BSTFA using automated batch protocol. Represents the automated batch processing condition for BSTFA","id":"MTBLS171_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS171","studyUrl":"http://integmet.org/study/MTBLS171","title":"BSTFA_Control_manual_vs_Automated_batch","topHits":[{"chebi_id":"47962","direction":"up","inn_name":"","iupac_name":"<em>aldehydo</em>-<small>D</small>-galacturonic acid","metabolite_id":"IAJILQKETJEXLJ-RSJOWCBRSA-N","pvalue":2.313944007615789e-11,"ratio":1000000.0,"synonym_name":"(2<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid"},{"chebi_id":"16977","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":3.2021000090851875e-11,"ratio":1e-06,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"57966","direction":"down","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":2.261413227060947e-09,"ratio":1e-06,"synonym_name":"3-ammoniopropanoate"},{"chebi_id":"87988","direction":"up","inn_name":"","iupac_name":"tetradecamethylcycloheptasiloxane","metabolite_id":"GSANOGQCVHBHIF-UHFFFAOYSA-N","pvalue":8.499182739721575e-08,"ratio":1000000.0,"synonym_name":"Cyclomethicone 7"},{"chebi_id":"17306","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":0.0240448253069067,"ratio":1e-06,"synonym_name":"Malzzucker"},{"chebi_id":"87984","direction":"up","inn_name":"","iupac_name":"hexadecamethylcyclooctasiloxane","metabolite_id":"XKJMJYZFAWYREL-UHFFFAOYSA-N","pvalue":0.0248393042489509,"ratio":1000000.0,"synonym_name":""}],"totalFeatures":54},{"comparisonGroups":["FeInt_T1","FeLim_T3"],"dateCreated":"2025-09-26 00:00:00","display_title":"Iron sufficient T1 vs iron limited T3 comparison","group_a_title":"Iron sufficient condition at timepoint 1. Provides a reference for understanding the effects of iron limitation.","group_b_title":"Iron limited condition at timepoint 3. Provides insight into the long-term response to iron limitation.","id":"MTBLS1715_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS1715","studyUrl":"http://integmet.org/study/MTBLS1715","title":"FeInt_T1_vs_FeLim_T3","topHits":[{"chebi_id":"48928","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0122587953467357,"ratio":17.861855108833275,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"30915","direction":"up","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0034020226089695,"ratio":6.226010668271604,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0122025606633655,"ratio":8.24277626934328,"synonym_name":"PEP"},{"chebi_id":"16108","direction":"up","inn_name":"","iupac_name":"3-hydroxy-2-oxopropyl dihydrogen phosphate","metabolite_id":"GNGACRATGGDKBX-UHFFFAOYSA-N","pvalue":0.0470705523221502,"ratio":11.260335661614176,"synonym_name":"2-Propanone, 1-hydroxy-3-(phosphonooxy)-"},{"chebi_id":"17050","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":0.0435923999821239,"ratio":3.792643660835565,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"15741","direction":"up","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0069892447213446,"ratio":1.6442597710458975,"synonym_name":"E363"}],"totalFeatures":14},{"comparisonGroups":["WT_RCD_2m","ObOb_RCD_14m"],"dateCreated":"2025-09-26 00:00:00","display_title":"Young WT vs old ObOb mice on regular chow diet","group_a_title":"Wild-type mice on regular chow diet at 2 months. Provides baseline data for wild-type mice on a regular chow diet at an early age.","group_b_title":"ObOb mice on regular chow diet at 14 months. Provides data for ob/ob mice on a regular chow diet at an advanced age.","id":"MTBLS173_0001_00000040","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS173","studyUrl":"http://integmet.org/study/MTBLS173","title":"WT_RCD_2m_vs_ObOb_RCD_14m","topHits":[],"totalFeatures":0},{"comparisonGroups":["WT_RCD_2m","ObOb_RCD_14m"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice: 2m wild-type vs 14m ObOb on regular chow diet","group_a_title":"Wild-type mice on regular chow diet at 2 months. Provides baseline data for wild-type mice on a regular chow diet at an early age.","group_b_title":"ObOb mice on regular chow diet at 14 months. Provides data for ob/ob mice on a regular chow diet at an advanced age.","id":"MTBLS173_0002_00000040","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS173","studyUrl":"http://integmet.org/study/MTBLS173","title":"WT_RCD_2m_vs_ObOb_RCD_14m","topHits":[],"totalFeatures":0},{"comparisonGroups":["Control","COX10 Knockout"],"dateCreated":"2025-09-26 00:00:00","display_title":"Endothelial cells: COX10 knockout vs wild-type","group_a_title":"Control group with genotype cox10fl/fl. Baseline group for comparison with COX10 knockout samples to assess the impact of gene deletion.","group_b_title":"COX10 knockout group with genotype cox10ECKO. Key group for understanding the effects of COX10 gene deletion on endothelial cells.","id":"MTBLS1764_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS1764","studyUrl":"http://integmet.org/study/MTBLS1764","title":"Control_vs_COX10_Knockout","topHits":[{"chebi_id":"17239","direction":"up","inn_name":"","iupac_name":"cytidine 5'-(trihydrogen diphosphate)","metabolite_id":"ZWIADYZPOWUWEW-XVFCMESISA-N","pvalue":0.0065740806882865,"ratio":15.349478485450666,"synonym_name":"Cytidine, 5'-(trihydrogen pyrophosphate)"},{"chebi_id":"4170","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":0.0099688544017313,"ratio":8.90778274043258,"synonym_name":"Glc6P"},{"chebi_id":"15946","direction":"up","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.0147238804155512,"ratio":7.603272926350464,"synonym_name":"D-Fructose 6-phosphate"},{"chebi_id":"17659","direction":"up","inn_name":"","iupac_name":"uridine 5'-(trihydrogen diphosphate)","metabolite_id":"XCCTYIAWTASOJW-XVFCMESISA-N","pvalue":0.0319433610601669,"ratio":11.409094192005623,"synonym_name":"Uridine 5'-diphosphate"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":0.0303903843339367,"ratio":3.2681339611430915,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"57865","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatouridine","metabolite_id":"DJJCXFVJDGTHFX-XVFCMESISA-L","pvalue":0.0397074700314554,"ratio":3.3285791068076147,"synonym_name":"uridine 5'-phosphate"},{"chebi_id":"60377","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatocytidine","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-L","pvalue":0.0305615786750341,"ratio":2.920444042224743,"synonym_name":"CMP dianion"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0165299024024692,"ratio":0.4314499733713955,"synonym_name":"E363"}],"totalFeatures":18},{"comparisonGroups":["Eubacterium rectale_DMSO_30","Eubacterium rectale_Duloxetine_47"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. rectale: 47\u03bcM duloxetine vs 30\u03bcM DMSO control","group_a_title":"Eubacterium rectale treated with 30 micromolar DMSO. Serves as a baseline to compare the effects of duloxetine.","group_b_title":"Eubacterium rectale treated with 47 micromolar duloxetine. Helps in understanding the effect of duloxetine at the highest concentration.","id":"MTBLS1792_0001_00000018","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS1792","studyUrl":"http://integmet.org/study/MTBLS1792","title":"G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47","topHits":[{"chebi_id":"17076","direction":"up","inn_name":"streptomycin","iupac_name":"<em>N</em>,<em>N</em>'''-[(1<i>R</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-4-{5-deoxy-2-<em>O</em>-[2-deoxy-2-(methylamino)-\u03b1-<small>L</small>-glucopyranosyl]-3-<em>C</em>-formyl-\u03b1-<small>L</small>-lyxofuranosyloxy}-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine","metabolite_id":"UCSJYZPVAKXKNQ-HZYVHMACSA-N","pvalue":0.010180477668515,"ratio":1000000.0,"synonym_name":"streomycin"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YUXKTUVIOWXKPA-UHFFFAOYSA-N","pvalue":0.0493348012525454,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"168691","direction":"up","inn_name":"","iupac_name":"N-[(2R,3S,4R)-4-hydroxy-2-(hydroxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-yl]acetamide","metabolite_id":"MIDRXTGJGROJRO-JFXDCXPESA-N","pvalue":0.0493619742470216,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"169233","direction":"up","inn_name":"","iupac_name":"N-[(2R,3S,4R)-3-hydroxy-2-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-yl]acetamide","metabolite_id":"SXLFMZWGFIBWMJ-QTGWYDPFSA-N","pvalue":0.0493619742470216,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZFHPYBQKHVEFHO-LECUDPRGSA-N","pvalue":0.0494014093035974,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RJCPXHXLCWWGHO-APFRPCTBSA-N","pvalue":0.0494014093035974,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XUKIKVBUXFVHNV-MFAQWRDPSA-N","pvalue":0.0494014093035974,"ratio":1e-06,"synonym_name":""},{"chebi_id":"189038","direction":"down","inn_name":"","iupac_name":"(Z)-7-[(1S,2E)-5-[(2R)-2-[[(4R)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulanyl-2-[(3S)-3-hydroxyoctylidene]-3-oxocyclopentyl]hept-5-enoic acid","metabolite_id":"RPHLHZIDWIFTII-RJQMMLODSA-N","pvalue":0.0494014093035974,"ratio":1e-06,"synonym_name":""},{"chebi_id":"84634","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-LJQANCHMSA-N","pvalue":0.0495367315010359,"ratio":1e-06,"synonym_name":"(<i>R</i>)-myristoylcarnitine"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":0.049886681800415,"ratio":1000000.0,"synonym_name":"Purine-6-ol"}],"totalFeatures":2786},{"comparisonGroups":["Phloem","Cambium"],"dateCreated":"2025-09-26 00:00:00","display_title":"Plant tissue: phloem vs cambium comparison","group_a_title":"Samples from the phloem tissue. Represents the phloem tissue, which is crucial for understanding the transport of nutrients and signals in plants.","group_b_title":"Samples from the cambium tissue. Represents the cambium tissue, which is crucial for understanding the growth and development of secondary xylem.","id":"MTBLS1796_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS1796","studyUrl":"http://integmet.org/study/MTBLS1796","title":"Phloem_vs_Cambium","topHits":[{"chebi_id":"18297","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl dihydrogen phosphate","metabolite_id":"INAPMGSXUVUWAF-UOTPTPDRSA-N","pvalue":2.6444153136033604e-11,"ratio":2.010267319357729,"synonym_name":"I1P"},{"chebi_id":"137501","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CZDNLUMNELLDDD-JAIJEDJZSA-N","pvalue":0.0010683612985189,"ratio":7.347581091506711,"synonym_name":""},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":7.863204441817319e-06,"ratio":2.112736737771531,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"17814","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"NGFMICBWJRZIBI-UJPOAAIJSA-N","pvalue":0.0019308373635089,"ratio":3.721108842884964,"synonym_name":"Salicin"},{"chebi_id":"137977","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YHBIHSCTXBGAIK-NUABRCLCSA-N","pvalue":0.0057259712808079,"ratio":4.292087180055952,"synonym_name":"2-<em>O</em>-salicyloylsalicin"},{"chebi_id":"16634","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-glucopyranoside","metabolite_id":"MUPFEKGTMRGPLJ-ZQSKZDJDSA-N","pvalue":0.0025560070261294,"ratio":2.893176350818815,"synonym_name":"Gossypose"},{"chebi_id":"30763","direction":"down","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":0.0010330236559439,"ratio":0.4470105045421138,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"17964","direction":"up","inn_name":"","iupac_name":"piperidine-2-carboxylic acid","metabolite_id":"HXEACLLIILLPRG-UHFFFAOYSA-N","pvalue":1.7401148850539264e-05,"ratio":1.5798705533333102,"synonym_name":"homoproline"},{"chebi_id":"155892","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)phenyl 2-<em>O</em>-benzoyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"FWPNCAYVELBDRB-BFMVXSJESA-N","pvalue":0.0098963512608147,"ratio":2.9202660462881056,"synonym_name":"2'-benzoylsalicin"},{"chebi_id":"30915","direction":"up","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0030736514046973,"ratio":2.336998447414776,"synonym_name":"\u03b1-ketoglutaric acid"}],"totalFeatures":89},{"comparisonGroups":["Phloem","Cambium"],"dateCreated":"2025-09-26 00:00:00","display_title":"Populus tremula: phloem vs cambium tissue","group_a_title":"Samples from the phloem tissue of Populus tremula.. Understanding the metabolic profile of phloem tissue.","group_b_title":"Samples from the cambium tissue of Populus tremula.. Understanding the metabolic profile of cambium tissue.","id":"MTBLS1797_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS1797","studyUrl":"http://integmet.org/study/MTBLS1797","title":"Phloem_vs_Cambium","topHits":[{"chebi_id":"17814","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"NGFMICBWJRZIBI-UJPOAAIJSA-N","pvalue":0.0078730755833928,"ratio":333.04391778376015,"synonym_name":"Salicin"},{"chebi_id":"15834","direction":"up","inn_name":"","iupac_name":"1-<em>O</em>-(3,4,5-trihydroxybenzoyl)-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"GDVRUDXLQBVIKP-HQHREHCSSA-N","pvalue":0.0033191529153398,"ratio":67.62319177088413,"synonym_name":"1-O-galloyl-beta-D-glucose"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GVECSFFLZYNEBO-UHFFFAOYSA-N","pvalue":0.0033979679574811,"ratio":41.526508280344245,"synonym_name":""},{"chebi_id":"28230","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4<em>H</em>-chromen-4-one","metabolite_id":"AIONOLUJZLIMTK-AWEZNQCLSA-N","pvalue":0.0316263975630727,"ratio":454.1463564539927,"synonym_name":"3',5,7-Trihydroxy-4'-methoxyflavanone"},{"chebi_id":"15413","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one","metabolite_id":"YQHMWTPYORBCMF-ZZXKWVIFSA-N","pvalue":0.0372882428519742,"ratio":539.3886858456685,"synonym_name":"Chalconaringenin"},{"chebi_id":"90","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":8.053474043108848e-05,"ratio":0.2107570582092869,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VBSPBYNZPRRGSB-UHFFFAOYSA-N","pvalue":0.0079880518963127,"ratio":8.880269029173876,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JPFCOVZKLAXXOE-UHFFFAOYSA-N","pvalue":0.0019747768340901,"ratio":4.013757746051129,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CZDNLUMNELLDDD-QZFWYPLZSA-N","pvalue":0.0226247195366122,"ratio":8.372548667585454,"synonym_name":""},{"chebi_id":"5679","direction":"up","inn_name":"","iupac_name":"7-(methyloxy)-2<em>H</em>-chromen-2-one","metabolite_id":"LIIALPBMIOVAHH-UHFFFAOYSA-N","pvalue":0.0006817213397578,"ratio":2.885521136733259,"synonym_name":"7-Methoxycoumarin"}],"totalFeatures":22},{"comparisonGroups":["Phloem","Cambium"],"dateCreated":"2025-09-26 00:00:00","display_title":"Populus tremula: phloem vs cambium tissue","group_a_title":"Samples from the phloem tissue of Populus tremula.. Understanding the metabolic profile of phloem tissue.","group_b_title":"Samples from the cambium tissue of Populus tremula.. Understanding the metabolic profile of cambium tissue.","id":"MTBLS1797_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS1797","studyUrl":"http://integmet.org/study/MTBLS1797","title":"Phloem_vs_Cambium","topHits":[{"chebi_id":"176884","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"TZPBMNKOLMSJPF-UHFFFAOYSA-N","pvalue":8.650143219466147e-11,"ratio":5.742795548790941,"synonym_name":""},{"chebi_id":"167538","direction":"down","inn_name":"","iupac_name":"3,5-dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid","metabolite_id":"BLKMDORKRDACEI-UHFFFAOYSA-N","pvalue":1.004433721074609e-06,"ratio":0.1252355147385308,"synonym_name":""},{"chebi_id":"5679","direction":"up","inn_name":"","iupac_name":"7-(methyloxy)-2<em>H</em>-chromen-2-one","metabolite_id":"LIIALPBMIOVAHH-UHFFFAOYSA-N","pvalue":0.0021220348026562,"ratio":10.171799162541229,"synonym_name":"7-Methoxycoumarin"},{"chebi_id":"9657","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RCKCYCDBDYUIGM-LFMHJWGUSA-N","pvalue":2.9679120489476965e-05,"ratio":3.4809188181649677,"synonym_name":"Tremulacin"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CZDNLUMNELLDDD-QZFWYPLZSA-N","pvalue":8.194872928741344e-06,"ratio":2.1441883157123565,"synonym_name":""},{"chebi_id":"18305","direction":"down","inn_name":"","iupac_name":"4-hydroxyphenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"BJRNKVDFDLYUGJ-RMPHRYRLSA-N","pvalue":3.697119093873954e-05,"ratio":0.4594889487188606,"synonym_name":"Ursin"},{"chebi_id":"155892","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)phenyl 2-<em>O</em>-benzoyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"FWPNCAYVELBDRB-BFMVXSJESA-N","pvalue":0.0028183432140032,"ratio":3.365276215634686,"synonym_name":"2'-benzoylsalicin"},{"chebi_id":"139241","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NPNFZOGKIFFKGT-UJPOAAIJSA-N","pvalue":0.0009605841556095,"ratio":0.3706604777055008,"synonym_name":""},{"chebi_id":"90","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":0.0289862694226672,"ratio":3.9997128554839527,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":0.0234434879937939,"ratio":0.2869039593987579,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"}],"totalFeatures":13},{"comparisonGroups":["Benedetta_2016","Carlotta_2016"],"dateCreated":"2025-09-26 00:00:00","display_title":"Benedetta vs Carlotta variety comparison (2016)","group_a_title":"Samples from Benedetta variety harvested in 2016. Represents the Benedetta variety for the year 2016","group_b_title":"Samples from Carlotta variety harvested in 2016. Represents the Carlotta variety for the year 2016","id":"MTBLS1803_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1803","studyUrl":"http://integmet.org/study/MTBLS1803","title":"Benedetta_2016_vs_Carlotta_2016","topHits":[{"chebi_id":"16243","direction":"up","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4<em>H</em>-chromen-4-one","metabolite_id":"REFJWTPEDVJJIY-UHFFFAOYSA-N","pvalue":0.0017315573730294,"ratio":4.756097777594831,"synonym_name":"3,5,7,3',4'-PENTAHYDROXYFLAVONE"},{"chebi_id":"90","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":9.29723786630916e-05,"ratio":2.5567935147732044,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"183094","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KUODBSWFMJMVJV-UHFFFAOYSA-N","pvalue":0.0009414384625998,"ratio":0.392967440698682,"synonym_name":""},{"chebi_id":"23053","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PFTAWBLQPZVEMU-UHFFFAOYSA-N","pvalue":0.0004662779904721,"ratio":2.3086280269447697,"synonym_name":"catechins"}],"totalFeatures":6},{"comparisonGroups":["Benedetta_2016","Carlotta_2016"],"dateCreated":"2025-09-26 00:00:00","display_title":"Benedetta vs Carlotta variety comparison (2016)","group_a_title":"Samples from Benedetta variety harvested in 2016. Represents the Benedetta variety for the year 2016","group_b_title":"Samples from Carlotta variety harvested in 2016. Represents the Carlotta variety for the year 2016","id":"MTBLS1803_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1803","studyUrl":"http://integmet.org/study/MTBLS1803","title":"Benedetta_2016_vs_Carlotta_2016","topHits":[{"chebi_id":"16243","direction":"up","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4<em>H</em>-chromen-4-one","metabolite_id":"REFJWTPEDVJJIY-UHFFFAOYSA-N","pvalue":0.0017315573730294,"ratio":4.756097777594831,"synonym_name":"3,5,7,3',4'-PENTAHYDROXYFLAVONE"},{"chebi_id":"90","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":9.29723786630916e-05,"ratio":2.5567935147732044,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"183094","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KUODBSWFMJMVJV-UHFFFAOYSA-N","pvalue":0.0009414384625998,"ratio":0.392967440698682,"synonym_name":""},{"chebi_id":"23053","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PFTAWBLQPZVEMU-UHFFFAOYSA-N","pvalue":0.0004662779904721,"ratio":2.3086280269447697,"synonym_name":"catechins"}],"totalFeatures":6},{"comparisonGroups":["Dry_Seed","8h_Imbibed_Seed"],"dateCreated":"2025-09-26 00:00:00","display_title":"Seeds: dry vs 8h imbibition","group_a_title":"Dry seeds at 0h imbibition time point. Baseline group for comparison with imbibed seeds at different time points.","group_b_title":"Seeds imbibed for 8 hours. Represents later response to imbibition.","id":"MTBLS181_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":166,"studyId":"MTBLS181","studyUrl":"http://integmet.org/study/MTBLS181","title":"Dry_Seed_vs_8h_Imbibed_Seed","topHits":[{"chebi_id":"69438","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XPCTZQVDEJYUGT-UHFFFAOYSA-N","pvalue":1.980255409033174e-05,"ratio":14.43763946508504,"synonym_name":"Palatone"},{"chebi_id":"17957","direction":"up","inn_name":"","iupac_name":"2-(4-methyl-1,3-thiazol-5-yl)ethanol","metabolite_id":"BKAWJIRCKVUVED-UHFFFAOYSA-N","pvalue":1.8866934126798535e-05,"ratio":8.414575480984595,"synonym_name":"4-methyl-5-(2'-hydroxyethyl)-thiazole"},{"chebi_id":"64564","direction":"up","inn_name":"timonacicum","iupac_name":"1,3-thiazolidine-4-carboxylic acid","metabolite_id":"DZLNHFMRPBPULJ-UHFFFAOYSA-N","pvalue":6.753598331382241e-05,"ratio":8.93949012954303,"synonym_name":"Thiazolidine-4-carboxylic acid"},{"chebi_id":"15940","direction":"up","inn_name":"acide nicotinique","iupac_name":"pyridine-3-carboxylic acid","metabolite_id":"PVNIIMVLHYAWGP-UHFFFAOYSA-N","pvalue":1.4184159259847834e-05,"ratio":6.33706928160177,"synonym_name":"anti-pellagra vitamin"},{"chebi_id":"30763","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":5.999319995443207e-06,"ratio":5.45109502145973,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"15908","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonic acid","metabolite_id":"JPIJQSOTBSSVTP-STHAYSLISA-N","pvalue":4.968695821356976e-05,"ratio":6.1226689179367515,"synonym_name":""},{"chebi_id":"16010","direction":"up","inn_name":"","iupac_name":"5-oxopyrrolidine-2-carboxylic acid","metabolite_id":"ODHCTXKNWHHXJC-UHFFFAOYSA-N","pvalue":4.210277505532102e-06,"ratio":4.240988007285216,"synonym_name":"2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"138368","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ISXAJCKCTSMILF-UHFFFAOYSA-N","pvalue":5.100153379244675e-05,"ratio":5.093068199458738,"synonym_name":""},{"chebi_id":"27652","direction":"up","inn_name":"cifostodina","iupac_name":"cytidine 2',3'-(hydrogen phosphate)","metabolite_id":"NMPZCCZXCOMSDQ-XVFCMESISA-N","pvalue":2.1492465003523717e-05,"ratio":4.209752605707589,"synonym_name":"cCMP"},{"chebi_id":"71466","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-<em>N</em>-(2-hydroxyethyl)octadec-9-enamide","metabolite_id":"BOWVQLFMWHZBEF-KTKRTIGZSA-N","pvalue":2.954489865536872e-05,"ratio":4.381126795667739,"synonym_name":"oleoylethanolamide"}],"totalFeatures":256},{"comparisonGroups":["wild_type","UGT91T1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type vs UGT91T1 silenced comparison","group_a_title":"Wild type control group. Provides a reference point for evaluating the effects of genetic modifications.","group_b_title":"UGT91T1 silenced group. Helps in understanding the role of UGT91T1 in the biosynthetic pathway.","id":"MTBLS1819_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS1819","studyUrl":"http://integmet.org/study/MTBLS1819","title":"G1_wild_type_vs_G2_UGT91T1","topHits":[{"chebi_id":"133834","direction":"down","inn_name":"","iupac_name":"(3<i>S</i>,6<i>E</i>,10<i>E</i>,14<i>Z</i>)-16-[(2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranosyl)oxy]-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"QAUYGCMOBFCRSP-ZEBUDOFZSA-N","pvalue":3.1293269862703615e-05,"ratio":0.0408752774159357,"synonym_name":"3-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-20-hydroxygeranyllinalool-20-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-(1\u21922)-\u03b2-<small>D</small>-glucopyranoside"},{"chebi_id":"167212","direction":"down","inn_name":"","iupac_name":"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2Z,6E,10E,14S)-2,6,10,14-tetramethyl-14-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-2,6,10,15-tetraenoxy]oxane-3,4,5-triol","metabolite_id":"HQUVEBJUUSKUCJ-VLUPPCEVSA-N","pvalue":1.521909520989407e-05,"ratio":0.0523645440966732,"synonym_name":""},{"chebi_id":"67240","direction":"up","inn_name":"","iupac_name":"(3<i>S</i>,6<i>E</i>,10<i>E</i>,14<i>Z</i>)-16-(\u03b2-<small>D</small>-glucopyranosyloxy)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-yl 4-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"OEOWMDSFDQHCFJ-JUMADDCISA-N","pvalue":6.801444562713807e-05,"ratio":9.292198122202487,"synonym_name":""},{"chebi_id":"67236","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>,6<i>E</i>,10<i>E</i>,14<i>S</i>)-14-{[4-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraen-1-yl 2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"CWAXZXSFUDEMIX-ZIKBFGBNSA-N","pvalue":0.0007883148371263,"ratio":8.800922306739052,"synonym_name":""}],"totalFeatures":5},{"comparisonGroups":["Control_T1","Continuous_Drought_T1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wheat: Control vs continuous drought at T1","group_a_title":"Control samples at time point T1. Provides a baseline for comparison with drought conditions at T1","group_b_title":"Samples under continuous drought conditions at time point T1. Helps in understanding the impact of continuous drought on wheat at an early stage","id":"MTBLS1821_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1821","studyUrl":"http://integmet.org/study/MTBLS1821","title":"Control_T1_vs_Continuous_Drought_T1","topHits":[{"chebi_id":"176884","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"TZPBMNKOLMSJPF-UHFFFAOYSA-N","pvalue":0.0044998974856915,"ratio":0.2572303274097734,"synonym_name":""}],"totalFeatures":4},{"comparisonGroups":["Wild Type Fourth Instar Larval Stage","Gene Knockout Fourth Instar Larval Stage"],"dateCreated":"2025-09-26 00:00:00","display_title":"Bombyx mori larvae: gene knockout vs wild-type","group_a_title":"Wild type Bombyx mori at the fourth instar larval stage. Serves as the control group to assess the impact of gene knockout.","group_b_title":"Gene knockout Bombyx mori at the fourth instar larval stage. Allows assessment of the impact of gene knockout on the organism.","id":"MTBLS1825_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS1825","studyUrl":"http://integmet.org/study/MTBLS1825","title":"Wild_Type_Fourth_Instar_Larval_Stage_vs_Gene_Knockout_Fourth_Instar_Larval_Stage","topHits":[{"chebi_id":"57702","direction":"down","inn_name":"","iupac_name":"<em>N</em>-acetyl-<small>L</small>-phenylalaninate","metabolite_id":"CBQJSKKFNMDLON-JTQLQIEISA-M","pvalue":0.0004540074621752,"ratio":0.1743448228028586,"synonym_name":"(2<i>S</i>)-2-acetamido-3-phenylpropanoate"},{"chebi_id":"40721","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-O","pvalue":5.0622059951892345e-05,"ratio":2.274237192574296,"synonym_name":"N1-PROTONATED ADENOSINE-5'-MONOPHOSPHATE"},{"chebi_id":"20891","direction":"up","inn_name":"","iupac_name":"3-[(2<i>R</i>)-2-hydroxy-4-[(hydroxyphosphinato)oxy]-3,3-dimethylbutanamido]propanoate","metabolite_id":"XHFVGHPGDLDEQO-ZETCQYMHSA-L","pvalue":0.007352486001368,"ratio":4.8704365964504275,"synonym_name":""}],"totalFeatures":4},{"comparisonGroups":["Milk_0h","Whey_72h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Milk at 0h vs whey after 72h fermentation","group_a_title":"Milk samples collected at 0h. Serves as the reference point for all subsequent fermentation and treatment comparisons.","group_b_title":"Whey samples collected after 72h of primary fermentation. Provides insight into the changes occurring in whey after extended fermentation.","id":"MTBLS1830_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS1830","studyUrl":"http://integmet.org/study/MTBLS1830","title":"Milk_0h_vs_Whey_72h","topHits":[{"chebi_id":"422","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-REOHCLBHSA-N","pvalue":5.56164211939415e-08,"ratio":0.0031912350301784,"synonym_name":"L-Lactic acid"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":1.666777508256065e-05,"ratio":1380.92721780826,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"16113","direction":"up","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":3.37854545852809e-05,"ratio":222.09161325052585,"synonym_name":"CHOLESTEROL"},{"chebi_id":"16610","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)butane-1,4-diamine","metabolite_id":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","pvalue":0.0003803272256543,"ratio":743.658841160501,"synonym_name":"N-(3-Aminopropyl)-1,4-butane-diamine"},{"chebi_id":"16865","direction":"down","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":6.80186474201857e-07,"ratio":0.0398037593065163,"synonym_name":"GABA"},{"chebi_id":"17568","direction":"down","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":4.471898869510147e-07,"ratio":0.0441597262195518,"synonym_name":"Urazil"},{"chebi_id":"15903","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":4.412995502335648e-05,"ratio":64.54671362152192,"synonym_name":"beta-D-Glucose"},{"chebi_id":"28645","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":1.5517852531874218e-06,"ratio":0.1030837250898021,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":1.388176403825346e-06,"ratio":0.1066519935369201,"synonym_name":"Acetylformic acid"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":3.2181857352621867e-06,"ratio":0.1760361332846414,"synonym_name":""}],"totalFeatures":41},{"comparisonGroups":["Fiber","Ray"],"dateCreated":"2025-09-26 00:00:00","display_title":"Populus tremula wood: fiber vs ray cells","group_a_title":"Samples from fiber cells in the wood-forming zone of Populus tremula. Understanding the metabolic processes specific to fiber cells during wood formation","group_b_title":"Samples from ray cells in the wood-forming zone of Populus tremula. Understanding the metabolic processes specific to ray cells during wood formation","id":"MTBLS1831_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS1831","studyUrl":"http://integmet.org/study/MTBLS1831","title":"Fiber_vs_Ray","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JPFCOVZKLAXXOE-UHFFFAOYSA-N","pvalue":0.0430140458480141,"ratio":10.949978492996392,"synonym_name":""},{"chebi_id":"17094","direction":"down","inn_name":"","iupac_name":"4-hydroxy-3,3-dimethyl-2-oxobutanoic acid","metabolite_id":"PKVVTUWHANFMQC-UHFFFAOYSA-N","pvalue":0.0041135995735211,"ratio":0.3473578043164356,"synonym_name":"2-Dehydropantoate"},{"chebi_id":"27681","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-ethyl-2-hydroxy-3-oxobutanoic acid","metabolite_id":"VUQLHQFKACOHNZ-LURJTMIESA-N","pvalue":0.0041135995735211,"ratio":0.3473578043164356,"synonym_name":"(<i>S</i>)-2-acetyl-2-hydroxybutyric acid"},{"chebi_id":"37011","direction":"down","inn_name":"","iupac_name":"4-oxopyrrolidine-2-carboxylic acid","metabolite_id":"HFXAFXVXPMUQCQ-UHFFFAOYSA-N","pvalue":0.0144167405795026,"ratio":0.2583328271691856,"synonym_name":"4-Oxoproline"},{"chebi_id":"32303","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XTFOFYSQUZTRGJ-SAZLWWCESA-N","pvalue":0.0032808698296893,"ratio":0.384658612497287,"synonym_name":"Xanthoxic acid"},{"chebi_id":"27849","direction":"down","inn_name":"","iupac_name":"4-methylbenzenesulfonic acid","metabolite_id":"JOXIMZWYDAKGHI-UHFFFAOYSA-N","pvalue":0.011871884094055,"ratio":0.3497159356862646,"synonym_name":"toluene-4-sulfonic acid"},{"chebi_id":"149468","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GUAHPAJOXVYFON-ZETCQYMHSA-N","pvalue":0.0130855737273116,"ratio":0.3512448636089372,"synonym_name":""},{"chebi_id":"9300","direction":"down","inn_name":"","iupac_name":"octanedioic acid","metabolite_id":"TYFQFVWCELRYAO-UHFFFAOYSA-N","pvalue":0.0094277393688262,"ratio":0.4963957871931562,"synonym_name":"Cork acid"},{"chebi_id":"73718","direction":"down","inn_name":"","iupac_name":"tridecanedioic acid","metabolite_id":"DXNCZXXFRKPEPY-UHFFFAOYSA-N","pvalue":0.0051409635393862,"ratio":0.5669523003489588,"synonym_name":"Undecane-1,11-dicarboxylic acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LVYMIYJFCKIBMR-UHFFFAOYSA-N","pvalue":0.025858341227239,"ratio":1.9473949137942663,"synonym_name":""}],"totalFeatures":72},{"comparisonGroups":["NM-control","NM-Pb"],"dateCreated":"2025-09-26 00:00:00","display_title":"Non-mycorrhizal: lead treatment vs control","group_a_title":"Non-mycorrhizal control group. Provides a reference point for comparison with Pb-treated groups","group_b_title":"Non-mycorrhizal Pb-treated group. Allows assessment of Pb effects in non-mycorrhizal conditions","id":"MTBLS1847_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS1847","studyUrl":"http://integmet.org/study/MTBLS1847","title":"NM-control_vs_NM-Pb","topHits":[{"chebi_id":"30794","direction":"up","inn_name":"","iupac_name":"propanedioic acid","metabolite_id":"OFOBLEOULBTSOW-UHFFFAOYSA-N","pvalue":0.01887426375259,"ratio":1000000.0,"synonym_name":"Propanedioic acid"},{"chebi_id":"17716","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QKKXKWKRSA-N","pvalue":0.0340659880418381,"ratio":0.1682139677124497,"synonym_name":"milk sugar"},{"chebi_id":"21405","direction":"down","inn_name":"","iupac_name":"<small>L</small>-<i>threo</i>-tetrose","metabolite_id":"YTBSYETUWUMLBZ-IMJSIDKUSA-N","pvalue":0.0401859435374134,"ratio":0.1746926363089387,"synonym_name":"L-Threose"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0102615909424891,"ratio":0.4885123499299851,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"17351","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":0.0233302362769116,"ratio":1.7811205450916112,"synonym_name":"Linoleic acid"}],"totalFeatures":94},{"comparisonGroups":["slyA","wild_type"],"dateCreated":"2025-09-26 00:00:00","display_title":"slyA deletion vs wild-type comparison","group_a_title":"Samples with slyA deletion. Key group for understanding the metabolic changes due to slyA deletion.","group_b_title":"Wild type samples. Provides a baseline for comparison to assess the impact of slyA deletion.","id":"MTBLS1858_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS1858","studyUrl":"http://integmet.org/study/MTBLS1858","title":"slyA_vs_wild_type","topHits":[{"chebi_id":"28716","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>)-hexadec-9-enoic acid","metabolite_id":"SECPZKHBENQXJG-FPLPWBNLSA-N","pvalue":0.0001999328383786,"ratio":0.4232314121701887,"synonym_name":"16:1\u03949"},{"chebi_id":"17568","direction":"down","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":0.0052467955761963,"ratio":0.2840435885937836,"synonym_name":"Urazil"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.003623209557525,"ratio":0.3862326823083377,"synonym_name":"Adenosin"},{"chebi_id":"58045","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":0.0188612520220034,"ratio":0.4566164188026446,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"},{"chebi_id":"15940","direction":"down","inn_name":"acide nicotinique","iupac_name":"pyridine-3-carboxylic acid","metabolite_id":"PVNIIMVLHYAWGP-UHFFFAOYSA-N","pvalue":0.0468085019733712,"ratio":0.3756565039539897,"synonym_name":"anti-pellagra vitamin"},{"chebi_id":"18257","direction":"down","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":0.0385366026356677,"ratio":0.4874813525890529,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"27266","direction":"down","inn_name":"","iupac_name":"valine","metabolite_id":"KZSNJWFQEVHDMF-UHFFFAOYSA-N","pvalue":0.0272992209647298,"ratio":0.5414178831292196,"synonym_name":"2-amino-3-methylbutanoic acid"},{"chebi_id":"25017","direction":"down","inn_name":"","iupac_name":"leucine","metabolite_id":"ROHFNLRQFUQHCH-UHFFFAOYSA-N","pvalue":0.038412887268711,"ratio":0.5100678523464027,"synonym_name":"DL-Leucine"},{"chebi_id":"57597","direction":"down","inn_name":"","iupac_name":"<em>sn</em>-glycerol 3-phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-L","pvalue":0.0399258859594689,"ratio":0.5074574840087838,"synonym_name":"(2<i>R</i>)-3-(phosphonatooxy)propane-1,2-diol"},{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0343368527667002,"ratio":0.5390673587645765,"synonym_name":"colamine phosphate"}],"totalFeatures":67},{"comparisonGroups":["non-COVID-19 healthy","non-critical COVID-19"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs non-critical COVID-19 patients","group_a_title":"Samples from healthy individuals without COVID-19.. Provides a baseline for identifying metabolic changes due to COVID-19.","group_b_title":"Samples from non-critical COVID-19 patients.. Understanding the metabolic profile of non-critical COVID-19 patients helps in identifying potential biomarkers and therapeutic targets.","id":"MTBLS1866_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":84,"studyId":"MTBLS1866","studyUrl":"http://integmet.org/study/MTBLS1866","title":"non_COVID_19_healthy_vs_non_critical_COVID_19","topHits":[{"chebi_id":"74475","direction":"up","inn_name":"","iupac_name":"hexadecanamide","metabolite_id":"HSEMFIZWXHQJAE-UHFFFAOYSA-N","pvalue":3.759750345921669e-06,"ratio":1000000.0,"synonym_name":"Cetyl amide"},{"chebi_id":"165244","direction":"up","inn_name":"","iupac_name":"pentane-1,2,3,4-tetrol","metabolite_id":"FJGNTEKSQVNVTJ-UHFFFAOYSA-N","pvalue":1.7039829761734492e-09,"ratio":24.53031009670804,"synonym_name":""},{"chebi_id":"143770","direction":"up","inn_name":"","iupac_name":"(13<i>E</i>)-octadec-13-enoic acid","metabolite_id":"BDLLSHRIFPDGQB-AATRIKPKSA-N","pvalue":1.2465772916435032e-06,"ratio":82.84910540712228,"synonym_name":"(<i>E</i>)-octadec-13-enoic acid"},{"chebi_id":"183278","direction":"up","inn_name":"","iupac_name":"1-(3,5-ditert-butyl-4-hydroxyphenyl)ethanone","metabolite_id":"WGJPGMJLARWHRK-UHFFFAOYSA-N","pvalue":9.288393006324758e-07,"ratio":61.801633397384485,"synonym_name":""},{"chebi_id":"75455","direction":"down","inn_name":"","iupac_name":"1,3-dihydroxypropan-2-yl hexadecanoate","metabolite_id":"BBNYCLAREVXOSG-UHFFFAOYSA-N","pvalue":3.40498063489845e-08,"ratio":0.0647852808597734,"synonym_name":"2-monopalmitoylglycerol"},{"chebi_id":"28300","direction":"up","inn_name":"","iupac_name":"glutamine","metabolite_id":"ZDXPYRJPNDTMRX-UHFFFAOYSA-N","pvalue":6.754418492991989e-08,"ratio":12.623654244742756,"synonym_name":"Glutamine"},{"chebi_id":"60645","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-methylbutanoic acid","metabolite_id":"NGEWQZIDQIYUNV-UHFFFAOYSA-N","pvalue":5.816862979869742e-10,"ratio":6.8627943263543445,"synonym_name":"3-Methyl-2-hydroxybutyric acid"},{"chebi_id":"16196","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":6.262821473824169e-06,"ratio":14.805008641748383,"synonym_name":"Oleate"},{"chebi_id":"20067","direction":"up","inn_name":"","iupac_name":"3-hydroxybutanoic acid","metabolite_id":"WHBMMWSBFZVSSR-UHFFFAOYSA-N","pvalue":2.1731393307799525e-08,"ratio":5.7874665158831595,"synonym_name":"\u03b2-hydroxy-<em>n</em>-butyric acid"},{"chebi_id":"18237","direction":"up","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":1.6572367571522458e-05,"ratio":15.270730484711803,"synonym_name":"Glutaminic acid"}],"totalFeatures":224},{"comparisonGroups":["non-COVID-19 healthy","non-critical COVID-19"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs non-critical COVID-19 patients","group_a_title":"Samples from healthy individuals without COVID-19.. Provides a baseline for identifying metabolic changes due to COVID-19.","group_b_title":"Samples from non-critical COVID-19 patients.. Understanding the metabolic profile of non-critical COVID-19 patients helps in identifying potential biomarkers and therapeutic targets.","id":"MTBLS1866_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS1866","studyUrl":"http://integmet.org/study/MTBLS1866","title":"non_COVID_19_healthy_vs_non_critical_COVID_19","topHits":[{"chebi_id":"28733","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"SPJFYYJXNPEZDW-FTJOPAKQSA-N","pvalue":5.361211187454665e-17,"ratio":0.3307354031193818,"synonym_name":"1-Linoleoylglycerophosphocholine"},{"chebi_id":"72749","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"TWBVHOYVCUOMJY-PAUXXPOVSA-N","pvalue":1.1296357969080807e-06,"ratio":2.062847178063248,"synonym_name":"LPE 0:0/22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)"},{"chebi_id":"76233","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"SVRBKLJIDJHADS-USWSLJGRSA-N","pvalue":4.306352293887002e-06,"ratio":0.5183507546849434,"synonym_name":"LPE(18:2)"},{"chebi_id":"138523","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZMHRXVSSWJALGN-GOGKNFEWSA-N","pvalue":0.0003220795944249,"ratio":2.010755243309666,"synonym_name":"LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z))"},{"chebi_id":"133144","direction":"up","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-hydroxy-2-(octadecanoyloxy)propyl phosphate","metabolite_id":"KIHAGWUUUHJRMS-JOCHJYFZSA-N","pvalue":9.92139053732874e-06,"ratio":1.5489733073035212,"synonym_name":"phosphatidylethanolamine zwitterion (18:0)"},{"chebi_id":"145268","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VLFJNHPNIOTOOA-YMIVKDKMSA-N","pvalue":0.0127066878336629,"ratio":1.865807113300714,"synonym_name":"LysoPE(0:0/22:4(7Z,10Z,13Z,16Z))"}],"totalFeatures":22},{"comparisonGroups":["non-COVID-19 healthy","non-critical COVID-19"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs non-critical COVID-19 patients","group_a_title":"Samples from healthy individuals without COVID-19.. Provides a baseline for identifying metabolic changes due to COVID-19.","group_b_title":"Samples from non-critical COVID-19 patients.. Understanding the metabolic profile of non-critical COVID-19 patients helps in identifying potential biomarkers and therapeutic targets.","id":"MTBLS1866_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":91,"studyId":"MTBLS1866","studyUrl":"http://integmet.org/study/MTBLS1866","title":"non_COVID_19_healthy_vs_non_critical_COVID_19","topHits":[{"chebi_id":"137295","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MIEYBHWKRILIAE-JUUZHAOZSA-N","pvalue":1.955971273540093e-15,"ratio":8.813782272334173,"synonym_name":"1-(11<i>Z</i>-octadecenoyl)-2-(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>-docosahexaenoyl)-<em>sn</em>-glycero-3-phosphoethanolamine"},{"chebi_id":"86031","direction":"up","inn_name":"","iupac_name":"3-{[(2<i>E</i>)-hexadec-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate","metabolite_id":"SOYNLLDADLOGAM-ISLYRVAYSA-N","pvalue":2.0106314207864019e-16,"ratio":3.8928751177116734,"synonym_name":"trans-2-Hexadecenoyl-carnitine"},{"chebi_id":"86344","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyl]oxy}-3-(pentadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"ZSWHHKKYMMYPPD-MSZSINMWSA-N","pvalue":1.5540561175462926e-14,"ratio":3.684477625280546,"synonym_name":"GPCho(15:0/20:4w6)"},{"chebi_id":"73118","direction":"up","inn_name":"","iupac_name":"3-[(11<i>Z</i>)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"PVOQPLSKYNZHOT-SEYXRHQNSA-N","pvalue":6.642176422146603e-11,"ratio":5.3909408431219745,"synonym_name":"(11<i>Z</i>)-icoseneoylcarnitine"},{"chebi_id":"170882","direction":"down","inn_name":"","iupac_name":"[(2S)-1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"IYZLSPKVBGVQGT-KDMZTRHFSA-N","pvalue":2.938801349020778e-07,"ratio":0.0836367753540136,"synonym_name":""},{"chebi_id":"88796","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YGOMWJXISJKIPY-CJZWHCSYSA-N","pvalue":1.3685346206418864e-10,"ratio":4.933812313973164,"synonym_name":"1-Myristoyl-2-eicosadienoyl-sn-glycerol"},{"chebi_id":"84634","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-LJQANCHMSA-N","pvalue":4.19627874145353e-14,"ratio":2.7146849787676786,"synonym_name":"(<i>R</i>)-myristoylcarnitine"},{"chebi_id":"72689","direction":"up","inn_name":"","iupac_name":"3-[(9<i>Z</i>)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"IPOLTUVFXFHAHI-SEYXRHQNSA-N","pvalue":2.0500092017245005e-11,"ratio":3.4500792784982184,"synonym_name":"3-[(9<i>Z</i>)-octadec-9-enoyloxy]-4-(trimethylammonio)butanoate"},{"chebi_id":"176732","direction":"up","inn_name":"","iupac_name":"[3-carboxy-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyl]oxypropyl]-trimethylazanium","metabolite_id":"DBCKADUSYJAPII-LJURNQLPSA-O","pvalue":3.028272004387732e-07,"ratio":6.732293106309046,"synonym_name":""},{"chebi_id":"73082","direction":"up","inn_name":"","iupac_name":"3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"RBFQHRALHSUPIA-SNPVRQPZSA-N","pvalue":3.495441224740133e-08,"ratio":5.161768066641872,"synonym_name":"3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylammonio)butanoate"}],"totalFeatures":201},{"comparisonGroups":["Phosphate Buffered Saline_7_days","Toxoplasma gondii PRU_7_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: T. gondii PRU infection vs PBS control (7 days)","group_a_title":"Control samples treated with phosphate buffered saline for 7 days.. Provides a baseline for comparison with the 7-day Toxoplasma gondii PRU treatment group.","group_b_title":"Samples from mice infected with Toxoplasma gondii PRU for 7 days.. Provides insight into the initial metabolic changes due to Toxoplasma gondii infection.","id":"MTBLS1890_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS1890","studyUrl":"http://integmet.org/study/MTBLS1890","title":"G5_Phosphate_Buffered_Saline_7_days_vs_G2_Toxoplasma_gondii_PRU_7_days","topHits":[],"totalFeatures":11},{"comparisonGroups":["Phosphate Buffered Saline_7_days","Toxoplasma gondii PRU_7_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: 7-day T. gondii PRU infection vs PBS control","group_a_title":"Control samples treated with phosphate buffered saline for 7 days.. Provides a baseline for comparison with the 7-day Toxoplasma gondii PRU treatment group.","group_b_title":"Samples from mice infected with Toxoplasma gondii PRU for 7 days.. Provides insight into the initial metabolic changes due to Toxoplasma gondii infection.","id":"MTBLS1890_0002_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS1890","studyUrl":"http://integmet.org/study/MTBLS1890","title":"G5_Phosphate_Buffered_Saline_7_days_vs_G2_Toxoplasma_gondii_PRU_7_days","topHits":[{"chebi_id":"72999","direction":"up","inn_name":"colfoscerili palmitas","iupac_name":"(2<i>R</i>)-2,3-bis(hexadecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"KILNVBDSWZSGLL-KXQOOQHDSA-N","pvalue":0.0100112085231261,"ratio":6.4858635033464145,"synonym_name":"GPC(16:0/16:0)"}],"totalFeatures":32},{"comparisonGroups":["Wild_Type_Day_-2_Pollination_0","Wild_Type_Day_2_Pollination_1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type: pre-pollination vs 2-day post-pollination","group_a_title":"Wild type samples at day -2 with no pollination. Serves as a reference point for all subsequent time points and pollination conditions in wild type.","group_b_title":"Wild type samples at day 2 with pollination. Highlights the metabolic changes following pollination in wild type.","id":"MTBLS1892_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":36,"studyId":"MTBLS1892","studyUrl":"http://integmet.org/study/MTBLS1892","title":"G1_Wild_Type_Day_-2_Pollination_0_vs_G3_Wild_Type_Day_2_Pollination_1","topHits":[{"chebi_id":"17964","direction":"down","inn_name":"","iupac_name":"piperidine-2-carboxylic acid","metabolite_id":"HXEACLLIILLPRG-UHFFFAOYSA-N","pvalue":9.43661519809734e-06,"ratio":0.057209533389556,"synonym_name":"homoproline"},{"chebi_id":"22653","direction":"up","inn_name":"","iupac_name":"asparagine","metabolite_id":"DCXYFEDJOCDNAF-UHFFFAOYSA-N","pvalue":2.550156976029805e-06,"ratio":5.074290506766946,"synonym_name":"Asparagin"},{"chebi_id":"64558","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-UHFFFAOYSA-N","pvalue":1.4459410440065264e-05,"ratio":0.1586429376187804,"synonym_name":"2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"15978","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-N","pvalue":3.2534919445072394e-07,"ratio":0.2587500917652311,"synonym_name":"Phosphors\u00e4ure-mono-((<i>R</i>)-2,3-dihydroxy-propylester)"},{"chebi_id":"26271","direction":"down","inn_name":"","iupac_name":"proline","metabolite_id":"ONIBWKKTOPOVIA-UHFFFAOYSA-N","pvalue":0.0033273241727529,"ratio":0.0386341190594988,"synonym_name":"DL-Proline"},{"chebi_id":"15676","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(2,5-dioxoimidazolidin-4-yl)urea","metabolite_id":"POJWUDADGALRAB-UHFFFAOYSA-N","pvalue":6.066204301365765e-07,"ratio":3.3246572008366524,"synonym_name":"(2,5-Dioxo-4-imidazolidinyl)urea"},{"chebi_id":"16002","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>S</i>)-2,3,4,5-tetrahydroxyhexanedioic acid","metabolite_id":"DSLZVSRJTYRBFB-LLEIAEIESA-N","pvalue":1.3909703633082322e-06,"ratio":3.54594320993855,"synonym_name":"saccharic acid"},{"chebi_id":"30653","direction":"down","inn_name":"","iupac_name":"homoserine","metabolite_id":"UKAUYVFTDYCKQA-UHFFFAOYSA-N","pvalue":0.0002929093126979,"ratio":0.1353779030274353,"synonym_name":"Hse"},{"chebi_id":"17781","direction":"up","inn_name":"","iupac_name":"7,8-dimethylbenzo[<em>g</em>]pteridine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ZJTJUVIJVLLGSP-UHFFFAOYSA-N","pvalue":1.1391073746958254e-06,"ratio":3.2399998019885303,"synonym_name":"LUMICHROME"},{"chebi_id":"28824","direction":"up","inn_name":"","iupac_name":"(22<i>E</i>)-stigmasta-5,22-dien-3\u03b2-ol","metabolite_id":"HCXVJBMSMIARIN-PHZDYDNGSA-N","pvalue":0.0014122882051479,"ratio":9.085724066124232,"synonym_name":"Stigmasterol"}],"totalFeatures":75},{"comparisonGroups":["Wild_Type_Day_-2_Pollination_0","Wild_Type_Day_2_Pollination_1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type: pre-pollination day -2 vs post-pollination day 2","group_a_title":"Wild type samples at day -2 with no pollination. Serves as a reference point for all subsequent time points and pollination conditions in wild type.","group_b_title":"Wild type samples at day 2 with pollination. Highlights the metabolic changes following pollination in wild type.","id":"MTBLS1892_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS1892","studyUrl":"http://integmet.org/study/MTBLS1892","title":"G1_Wild_Type_Day_-2_Pollination_0_vs_G3_Wild_Type_Day_2_Pollination_1","topHits":[{"chebi_id":"17579","direction":"up","inn_name":"","iupac_name":"\u03b2,\u03b2-carotene","metabolite_id":"OENHQHLEOONYIE-JLTXGRSLSA-N","pvalue":5.845280252821465e-10,"ratio":2.341463414634146,"synonym_name":"1,1'-[(1<i>E</i>,3<i>E</i>,5<i>E</i>,7<i>E</i>,9<i>E</i>,11<i>E</i>,13<i>E</i>,15<i>E</i>,17<i>E</i>)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl]bis(2,6,6-trimethylcyclohexene)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SYHZSPMCAROBPW-AENOIHSZSA-M","pvalue":2.2727897885634942e-09,"ratio":2.432809773123909,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MSLKMRUEVOYOOZ-VBYMZDBQSA-M","pvalue":1.1169347046574372e-08,"ratio":2.425675675675675,"synonym_name":""},{"chebi_id":"28838","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,3'<i>R</i>,6'<i>R</i>)-\u03b2,\u03b5-carotene-3,3'-diol","metabolite_id":"KBPHJBAIARWVSC-RGZFRNHPSA-N","pvalue":1.3542281775745028e-08,"ratio":2.293650793650794,"synonym_name":"Bo-Xan"},{"chebi_id":"35288","direction":"up","inn_name":"","iupac_name":"(3<i>S</i>,3'<i>S</i>,5<i>R</i>,5'<i>R</i>,6<i>S</i>,6'<i>S</i>)-5,5',6,6'-tetrahydro-5,6:5',6'-diepoxy-\u03b2,\u03b2-carotene-3,3'-diol","metabolite_id":"SZCBXWMUOPQSOX-WVJDLNGLSA-N","pvalue":2.691817666723621e-06,"ratio":1.7368421052631575,"synonym_name":"(3<i>S</i>,3'<i>S</i>,5<i>R</i>,5'<i>R</i>,6<i>S</i>,6'<i>S</i>)-5,6:5',6'-diepoxy-5,5',6,6'-tetrahydro-\u03b2,\u03b2-carotene-3,3'-diol"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PGYAYSRVSAJXTE-HPJQNRMISA-N","pvalue":0.0001437918012805,"ratio":1.7083333333333337,"synonym_name":""}],"totalFeatures":6},{"comparisonGroups":["n-3 PUFA sufficient","n-3 PUFA deficient"],"dateCreated":"2025-09-26 00:00:00","display_title":"n-3 PUFA sufficient vs deficient diet effects","group_a_title":"Group of samples with sufficient n-3 PUFA diet.. Serves as the reference group to assess the impact of n-3 PUFA deficiency.","group_b_title":"Group of samples with deficient n-3 PUFA diet.. Critical for understanding the effects of n-3 PUFA deficiency on brain development.","id":"MTBLS1952_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS1952","studyUrl":"http://integmet.org/study/MTBLS1952","title":"n-3_PUFA_sufficient_vs_n-3_PUFA_deficient","topHits":[{"chebi_id":"131889","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,12<i>E</i>,14<i>Z</i>,17<i>Z</i>)-11-hydroxyicosa-5,8,12,14,17-pentaenoic acid","metabolite_id":"IDEHSDHMEMMYIR-WSAGHCNZSA-N","pvalue":0.0106346797308551,"ratio":1000000.0,"synonym_name":"(5<i>Z</i>,8<i>Z</i>,12<i>E</i>,14<i>Z</i>,17<i>Z</i>)-11-hydroxyicosapentaenoic acid"},{"chebi_id":"88347","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,13<i>E</i>,15<i>S</i>,17<i>Z</i>)-15-hydroxyicosa-5,8,11,13,17-pentaenoic acid","metabolite_id":"WLKCSMCLEKGITB-DBVSHIMFSA-N","pvalue":0.0240081967557308,"ratio":1000000.0,"synonym_name":"15S-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid"},{"chebi_id":"88493","direction":"up","inn_name":"","iupac_name":"(5<i>S</i>,6<i>Z</i>,8<i>E</i>,10<i>E</i>,12<i>R</i>,14<i>Z</i>,17<i>Z</i>)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoic acid","metabolite_id":"BISQPGCQOHLHQK-HDNPQISLSA-N","pvalue":0.0240081967557308,"ratio":1000000.0,"synonym_name":"LTB5"},{"chebi_id":"35032","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>S</i>,12<i>R</i>,14<i>Z</i>)-10,11,12-trihydroxyicosa-5,8,14-trienoic acid","metabolite_id":"GOHNIXDAQODZKP-OZPSOFALSA-N","pvalue":0.0285538894711065,"ratio":1e-06,"synonym_name":"(5Z,8Z,14Z)-(11S,12R)-10,11,12-Trihydroxyeicosa-5,8,14-trienoic acid"},{"chebi_id":"28364","direction":"up","inn_name":"icosapentum","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoic acid","metabolite_id":"JAZBEHYOTPTENJ-JLNKQSITSA-N","pvalue":0.0008690189068609,"ratio":3.332566168009206,"synonym_name":"5,8,11,14,17-EICOSAPENTAENOIC ACID"},{"chebi_id":"72643","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-8-hydroxyicosa-5,9,11,14-tetraenoic acid","metabolite_id":"NLUNAYAEIJYXRB-HEJOTXCHSA-N","pvalue":0.0231496676610223,"ratio":0.332046332046332,"synonym_name":"8-hydroxy-5<i>Z</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid"},{"chebi_id":"36203","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,9<i>E</i>,11<i>R</i>,12<i>S</i>,14<i>Z</i>)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid","metabolite_id":"WPLPEZUSILBTGP-CIQDQOFUSA-N","pvalue":0.0359014153533387,"ratio":0.3184565318456532,"synonym_name":"Trioxilin A3"},{"chebi_id":"19138","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZNHVWPKMFKADKW-UHFFFAOYSA-N","pvalue":0.027838812101073,"ratio":0.3601593625498008,"synonym_name":"12-hydroxy-5,8,10,14-eicosatetraenoic acid"},{"chebi_id":"15843","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoic acid","metabolite_id":"YZXBAPSDXZZRGB-DOFZRALJSA-N","pvalue":0.0240012562733748,"ratio":0.5665665665665665,"synonym_name":"Arachidonate"}],"totalFeatures":53},{"comparisonGroups":["Control_Root","Wild_Type_Root"],"dateCreated":"2025-09-26 00:00:00","display_title":"Zea mays roots: control vs Trichoderma virens colonized","group_a_title":"Control group of Zea mays roots. Provides baseline metabolic profile for comparison with treated root samples","group_b_title":"Wild type Trichoderma virens colonized Zea mays roots. Allows assessment of metabolic changes due to wild type fungal colonization","id":"MTBLS1964_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS1964","studyUrl":"http://integmet.org/study/MTBLS1964","title":"Control_Root_vs_Wild_Type_Root","topHits":[{"chebi_id":"18388","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"KZNIFHPLKGYRTM-UHFFFAOYSA-N","pvalue":0.0001385187934879,"ratio":1e-06,"synonym_name":"Apigenin"},{"chebi_id":"10043","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-8-methoxy-2-phenyl-4<em>H</em>-chromen-4-one","metabolite_id":"XLTFNNCXVBYBSX-UHFFFAOYSA-N","pvalue":0.0001764008223161,"ratio":1e-06,"synonym_name":"Norwogonin 8-methyl ether"},{"chebi_id":"50202","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4<em>H</em>-chromen-4-one","metabolite_id":"FTVWIRXFELQLPI-UHFFFAOYSA-N","pvalue":0.0002339405720219,"ratio":1e-06,"synonym_name":""},{"chebi_id":"17295","direction":"up","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":0.0001631731997189,"ratio":2.212709966098558,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"173103","direction":"down","inn_name":"","iupac_name":"4,7,8-trimethoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4-benzoxazin-3-one","metabolite_id":"AJLYPYKZKJKHKI-FPUYRSMXSA-N","pvalue":0.0002538516339829,"ratio":0.5522611980235771,"synonym_name":""},{"chebi_id":"59979","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"HRGUSFBJBOKSML-UHFFFAOYSA-N","pvalue":0.0073746154894376,"ratio":0.4377270775734908,"synonym_name":"3',5'-O-Dimethyltricetin"},{"chebi_id":"63670","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-4-hydroxy-3-oxo-3,4-dihydro-2<em>H</em>-1,4-benzoxazin-2-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"OUSLYTBGQGKTME-TWTZXXGESA-N","pvalue":0.0084782661543958,"ratio":1.6069494698521778,"synonym_name":"(<i>R</i>)-DIBOA \u03b2-<small>D</small>-glucoside"}],"totalFeatures":13},{"comparisonGroups":["U251_WT_ER","U251_RC_ER"],"dateCreated":"2025-09-26 00:00:00","display_title":"U251 cells ER: IDH1 R132C mutant vs wild-type","group_a_title":"Wild type U251 cell line samples from the Endoplasmic Reticulum.. Provides baseline for comparison with IDH1 mutant samples.","group_b_title":"IDH1 mutant (R132C) U251 cell line samples from the Endoplasmic Reticulum.. Allows assessment of IDH1 R132C mutation impact on ER morphology.","id":"MTBLS1967_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS1967","studyUrl":"http://integmet.org/study/MTBLS1967","title":"U251_WT_ER_vs_U251_RC_ER","topHits":[{"chebi_id":"39567","direction":"up","inn_name":"","iupac_name":"12-hydroxydodecanoic acid","metabolite_id":"ZDHCZVWCTKTBRY-UHFFFAOYSA-N","pvalue":0.0087831887320879,"ratio":1.57703960678816,"synonym_name":"12-HYDROXYDODECANOIC ACID"},{"chebi_id":"43197","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-hydroxydodecanoic acid","metabolite_id":"MUCMKTPAZLSKTL-LLVKDONJSA-N","pvalue":0.0431628312994888,"ratio":1.5309326601203006,"synonym_name":"(3R)-3-hydroxydodecanoic acid"}],"totalFeatures":28},{"comparisonGroups":["IDH1WT_U251_ER_Untreated","IDH1R132C_U251_ER_Untreated"],"dateCreated":"2025-09-26 00:00:00","display_title":"U251 cells: IDH1 wild-type vs IDH1R132C mutation in ER","group_a_title":"U251 cells with wild-type IDH1 in the endoplasmic reticulum, untreated.. Provides baseline data for comparison with IDH1 mutant samples.","group_b_title":"U251 cells with IDH1R132C mutation in the endoplasmic reticulum, untreated.. Helps in understanding the morphological changes in the ER due to IDH1R132C mutation.","id":"MTBLS1973_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS1973","studyUrl":"http://integmet.org/study/MTBLS1973","title":"G3_IDH1WT_U251_ER_Untreated_vs_G1_IDH1R132C_U251_ER_Untreated","topHits":[{"chebi_id":"17023","direction":"down","inn_name":"","iupac_name":"2-hydroxyhexanedioic acid","metabolite_id":"OTTXIFWBPRRYOG-UHFFFAOYSA-N","pvalue":0.0010068454395509,"ratio":0.3094551430723196,"synonym_name":"2-Hydroxyadipate"},{"chebi_id":"28364","direction":"down","inn_name":"icosapentum","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoic acid","metabolite_id":"JAZBEHYOTPTENJ-JLNKQSITSA-N","pvalue":0.0126736286475917,"ratio":0.6619401183747539,"synonym_name":"5,8,11,14,17-EICOSAPENTAENOIC ACID"}],"totalFeatures":7},{"comparisonGroups":["IDH1R132C_U251_ER_Untreated","IDH1WT_U251_ER_Untreated"],"dateCreated":"2025-09-26 00:00:00","display_title":"U251 cells: IDH1 R132C mutation vs wild-type (ER)","group_a_title":"IDH1R132C mutation in U251 cells, untreated, Endoplasmic Reticulum. Helps in understanding the mutation effect on ER morphology without treatment","group_b_title":"IDH1 Wild type in U251 cells, untreated, Endoplasmic Reticulum. Provides baseline for comparison with mutated samples","id":"MTBLS1974_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS1974","studyUrl":"http://integmet.org/study/MTBLS1974","title":"IDH1R132C_U251_ER_Untreated_vs_IDH1WT_U251_ER_Untreated","topHits":[{"chebi_id":"74344","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LAXQYRRMGGEGOH-JXRLJXCWSA-N","pvalue":0.0007061544737823,"ratio":0.49116059285741,"synonym_name":"PC(20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)/0:0)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QCEZSXZDLSGARX-JTDYEGOHSA-N","pvalue":0.0012838010536886,"ratio":0.4810248722843858,"synonym_name":""},{"chebi_id":"133657","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoyl]oxy}-2-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"ZOJBSSVHFSBHMP-JJJSWPRASA-N","pvalue":0.001976417832979,"ratio":0.5652390725411301,"synonym_name":"LysoPC(22:4)"},{"chebi_id":"86422","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(6<i>Z</i>,9<i>Z</i>,12<i>Z</i>)-octadeca-6,9,12-trienoyl]oxy}-2-{[(15<i>Z</i>)-tetracos-15-enoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"LQQRQYIGEYFSIG-UWESVXFQSA-N","pvalue":0.0077026972753075,"ratio":0.4893716578491997,"synonym_name":"PC(18:3(6Z,9Z,12Z)/24:1(15Z))"},{"chebi_id":"131690","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl icosanoate","metabolite_id":"HEQMDGOBDIGJOC-XMMPIXPASA-N","pvalue":0.0012330994543376,"ratio":1.5585660808089614,"synonym_name":"lyso-PE(20:0/0:0)"},{"chebi_id":"84565","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoyloxy]-3-(octadecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"AXZGUCXCTZMPTR-UVGACIQRSA-N","pvalue":0.0053463827411233,"ratio":0.6179200425608913,"synonym_name":"PC(18:0/22:4(7Z,10Z,13Z,16Z))"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ALJUYAAJNSNTHU-PVPDQLFYSA-N","pvalue":0.0045873561531526,"ratio":0.6483605675547872,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XLKQWAMTMYIQMG-SVUPRYTISA-N","pvalue":0.0099753709727239,"ratio":0.6081312451693072,"synonym_name":""}],"totalFeatures":28},{"comparisonGroups":["Alexandrium","Amphidinium"],"dateCreated":"2025-09-26 00:00:00","display_title":"Alexandrium vs Amphidinium phytoplankton species","group_a_title":"Samples from the organism Alexandrium. Represents one of the phytoplankton species used in the study.","group_b_title":"Samples from the organism Amphidinium. Represents one of the phytoplankton species used in the study.","id":"MTBLS1980_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":41,"studyId":"MTBLS1980","studyUrl":"http://integmet.org/study/MTBLS1980","title":"Alexandrium_vs_Amphidinium","topHits":[{"chebi_id":"16899","direction":"up","inn_name":"","iupac_name":"<small>D</small>-mannitol","metabolite_id":"FBPFZTCFMRRESA-KVTDHHQDSA-N","pvalue":3.1561473923730114e-07,"ratio":1000000.0,"synonym_name":"E-421"},{"chebi_id":"17505","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactosyl-(1\u21923)-1<small>D</small>-<em>myo</em>-inositol","metabolite_id":"VCWMRQDBPZKXKG-DXNLKLAMSA-N","pvalue":0.0001476153755462,"ratio":1e-06,"synonym_name":"3-O-alpha-D-Galactosyl-1D-myo-inositol"},{"chebi_id":"17270","direction":"down","inn_name":"","iupac_name":"glycerol 2-(dihydrogen phosphate)","metabolite_id":"DHCLVCXQIBBOPH-UHFFFAOYSA-N","pvalue":0.0244062557972382,"ratio":1e-06,"synonym_name":"\u03b2-glycerophosphoric acid"},{"chebi_id":"16113","direction":"up","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":0.0002732716794446,"ratio":88.99904448651861,"synonym_name":"CHOLESTEROL"},{"chebi_id":"33198","direction":"down","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":0.0032765458456465,"ratio":0.0124359598626734,"synonym_name":"Hexonic acid"},{"chebi_id":"28061","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactopyranose","metabolite_id":"WQZGKKKJIJFFOK-PHYPRBDBSA-N","pvalue":0.0002217940278028,"ratio":0.0562270131460898,"synonym_name":"ALPHA D-GALACTOSE"},{"chebi_id":"42111","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-UWTATZPHSA-N","pvalue":0.0003617345081637,"ratio":0.0647523628962559,"synonym_name":"(\u2212)-lactic acid"},{"chebi_id":"47013","direction":"down","inn_name":"","iupac_name":"<small>D</small>-ribofuranose","metabolite_id":"HMFHBZSHGGEWLO-SOOFDHNKSA-N","pvalue":0.0015007572310632,"ratio":0.0381551412674649,"synonym_name":"D-Ribose"},{"chebi_id":"24848","direction":"down","inn_name":"","iupac_name":"inositols","metabolite_id":"CDAISMWEOUEBRE-UHFFFAOYSA-N","pvalue":1.5166754212788266e-06,"ratio":0.2086650516223708,"synonym_name":"inositol"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QZXMUPATKGLZAP-UHFFFAOYSA-N","pvalue":0.0016155979504628,"ratio":0.0382209352331137,"synonym_name":""}],"totalFeatures":91},{"comparisonGroups":["Healthy","Patient_SARS-CoV-2_Positive"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs SARS-CoV-2 positive patients","group_a_title":"Samples from healthy individuals.. Serves as the baseline for identifying metabolic changes associated with SARS-CoV-2 infection.","group_b_title":"Samples from patients who tested positive for SARS-CoV-2.. Key to understanding the metabolic effects of SARS-CoV-2 infection.","id":"MTBLS2014_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS2014","studyUrl":"http://integmet.org/study/MTBLS2014","title":"Healthy_vs_Patient_SARS-CoV-2_Positive","topHits":[{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":8.695658946062973e-08,"ratio":0.3357180726648994,"synonym_name":"Glutaminic acid"},{"chebi_id":"22660","direction":"down","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0006692898629074,"ratio":0.1893462831527829,"synonym_name":"Aspartic acid"},{"chebi_id":"507393","direction":"down","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":9.891626512951782e-06,"ratio":0.5294959599846095,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"28683","direction":"down","inn_name":"","iupac_name":"2-amino-4-(2-aminophenyl)-4-oxobutanoic acid","metabolite_id":"YGPSJZOEDVAXAB-UHFFFAOYSA-N","pvalue":8.33442522942538e-05,"ratio":0.5665216532467314,"synonym_name":"Kynurenine"},{"chebi_id":"16000","direction":"down","inn_name":"","iupac_name":"2-aminoethanol","metabolite_id":"HZAXFHJVJLSVMW-UHFFFAOYSA-N","pvalue":0.0001632688269895,"ratio":0.5870906200317966,"synonym_name":"2-Amino-ethanol"},{"chebi_id":"28044","direction":"down","inn_name":"","iupac_name":"2-amino-3-phenylpropanoic acid","metabolite_id":"COLNVLDHVKWLRT-UHFFFAOYSA-N","pvalue":0.0025668373977456,"ratio":0.636273121717287,"synonym_name":"alpha-Amino-beta-phenylpropionic acid"},{"chebi_id":"57966","direction":"down","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":0.0136914768892229,"ratio":0.6420000000000001,"synonym_name":"3-ammoniopropanoate"}],"totalFeatures":31},{"comparisonGroups":["RPMI_B36","Pooled_Sera_B36"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. coli B36: RPMI media vs pooled sera growth","group_a_title":"Samples of Escherichia coli B36 grown in RPMI media. This group helps in understanding the metabolic profile of Escherichia coli B36 in RPMI media","group_b_title":"Samples of Escherichia coli B36 grown in pooled sera. This group helps in understanding the metabolic profile of Escherichia coli B36 in pooled sera","id":"MTBLS2015_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS2015","studyUrl":"http://integmet.org/study/MTBLS2015","title":"RPMI_B36_vs_Pooled_Sera_B36","topHits":[{"chebi_id":"17113","direction":"up","inn_name":"","iupac_name":"<i>meso</i>-erythritol","metabolite_id":"UNXHWFMMPAWVPI-ZXZARUISSA-N","pvalue":2.387365224154622e-05,"ratio":5.659499328062006,"synonym_name":"Erythrol"},{"chebi_id":"30753","direction":"up","inn_name":"","iupac_name":"4-aminobenzoic acid","metabolite_id":"ALYNCZNDIQEVRV-UHFFFAOYSA-N","pvalue":0.001200736846522,"ratio":12.668046586079372,"synonym_name":"4-Amino-benzoic acid"},{"chebi_id":"63154","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-\u03b2-<small>D</small>-mannopyranose","metabolite_id":"OVRNDRQMDRJTHS-OZRXBMAMSA-N","pvalue":0.0007164968492318,"ratio":10.531715600103034,"synonym_name":"<em>N</em>-acetyl-\u03b2-mannosamine"},{"chebi_id":"60645","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-methylbutanoic acid","metabolite_id":"NGEWQZIDQIYUNV-UHFFFAOYSA-N","pvalue":0.0004558822064686,"ratio":8.585668707424334,"synonym_name":"3-Methyl-2-hydroxybutyric acid"},{"chebi_id":"30763","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":1.0912375332647412e-05,"ratio":4.183899502900963,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"30745","direction":"up","inn_name":"","iupac_name":"phenylacetic acid","metabolite_id":"WLJVXDMOQOGPHL-UHFFFAOYSA-N","pvalue":0.0008348549436383,"ratio":5.091465989006791,"synonym_name":"benzeneacetic acid"},{"chebi_id":"15674","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxybutanedioic acid","metabolite_id":"FEWJPZIEWOKRBE-UHFFFAOYSA-N","pvalue":0.01006939741534,"ratio":0.0871863333734753,"synonym_name":"2,3-dihydroxysuccinic acid"},{"chebi_id":"18333","direction":"up","inn_name":"","iupac_name":"<small>D</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-QWWZWVQMSA-N","pvalue":2.888242256164645e-05,"ratio":2.5721604783313174,"synonym_name":"D-Arabinitol"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0012088303851149,"ratio":3.482180127531559,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":0.000381346566578,"ratio":2.615744967056503,"synonym_name":"2-Hydroxysuccinic acid"}],"totalFeatures":113},{"comparisonGroups":["RPMI_B36","Pooled_Sera_B36"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. coli B36: RPMI media vs pooled sera growth","group_a_title":"Samples of Escherichia coli B36 grown in RPMI media. This group helps in understanding the metabolic profile of Escherichia coli B36 in RPMI media","group_b_title":"Samples of Escherichia coli B36 grown in pooled sera. This group helps in understanding the metabolic profile of Escherichia coli B36 in pooled sera","id":"MTBLS2015_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":52,"studyId":"MTBLS2015","studyUrl":"http://integmet.org/study/MTBLS2015","title":"RPMI_B36_vs_Pooled_Sera_B36","topHits":[{"chebi_id":"25722","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FKCRAVPPBFWEJD-XVFCMESISA-N","pvalue":1.8401498463598896e-07,"ratio":8.972454311256204,"synonym_name":"6-Carboxyuridine"},{"chebi_id":"33033","direction":"up","inn_name":"","iupac_name":"2-oxopentanoic acid","metabolite_id":"KDVFRMMRZOCFLS-UHFFFAOYSA-N","pvalue":0.0042380873710166,"ratio":19.516251961443626,"synonym_name":"2-oxovaleric acid"},{"chebi_id":"57595","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-imidazol-4-yl)propanoate","metabolite_id":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","pvalue":4.195981814917454e-05,"ratio":0.2005929567501073,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"15908","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonic acid","metabolite_id":"JPIJQSOTBSSVTP-STHAYSLISA-N","pvalue":0.0211121225073343,"ratio":0.0172326602282704,"synonym_name":""},{"chebi_id":"15674","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxybutanedioic acid","metabolite_id":"FEWJPZIEWOKRBE-UHFFFAOYSA-N","pvalue":0.0092203742409375,"ratio":0.0371287554950213,"synonym_name":"2,3-dihydroxysuccinic acid"},{"chebi_id":"16414","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":0.0002103701269823,"ratio":4.7205335252385945,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"},{"chebi_id":"17012","direction":"down","inn_name":"aceneuramic acid","iupac_name":"5-acetamido-3,5-dideoxy-<small>D</small>-<i>glycero</i>-<small>D</small>-<i>galacto</i>-non-2-ulopyranosonic acid","metabolite_id":"SQVRNKJHWKZAKO-LUWBGTNYSA-N","pvalue":0.0193782124339394,"ratio":0.0395253566330996,"synonym_name":"Aceneuramic acid"},{"chebi_id":"15570","direction":"up","inn_name":"","iupac_name":"<small>D</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-UWTATZPHSA-N","pvalue":0.0008200339318937,"ratio":5.682681811065333,"synonym_name":"(<i>R</i>)-alanine"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.0010605850351843,"ratio":5.31263353460288,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"30772","direction":"up","inn_name":"","iupac_name":"butanoic acid","metabolite_id":"FERIUCNNQQJTOY-UHFFFAOYSA-N","pvalue":0.0020002138238346,"ratio":6.15793318722189,"synonym_name":"butyric acid"}],"totalFeatures":164},{"comparisonGroups":["0h","24h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Nitrogen deprivation: 0h baseline vs 24h treatment","group_a_title":"Baseline control group at time point 0h. Serves as the reference point for all subsequent time points.","group_b_title":"Group at time point 24 hours after nitrogen deprivation. Provides insight into the progression of cellular responses.","id":"MTBLS208_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS208","studyUrl":"http://integmet.org/study/MTBLS208","title":"0h_vs_24h","topHits":[{"chebi_id":"16235","direction":"down","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":0.0001320228438026,"ratio":0.0201730553744189,"synonym_name":"GUANINE"},{"chebi_id":"48430","direction":"down","inn_name":"","iupac_name":"4-methyl-2-oxopentanoic acid","metabolite_id":"BKAJNAXTPSGJCU-UHFFFAOYSA-N","pvalue":2.1438659199275397e-06,"ratio":0.099742516434356,"synonym_name":"2-Oxoisocaproate"},{"chebi_id":"16914","direction":"down","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":0.00010335075338,"ratio":0.1702679638163509,"synonym_name":"o-Hydroxybenzoic acid"},{"chebi_id":"17151","direction":"down","inn_name":"","iupac_name":"<i>meso</i>-xylitol","metabolite_id":"HEBKCHPVOIAQTA-SCDXWVJYSA-N","pvalue":0.0001395515681444,"ratio":0.2125628332599734,"synonym_name":"Xylit"},{"chebi_id":"28635","direction":"up","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":0.0008730509908199,"ratio":5.674666666666666,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"},{"chebi_id":"16196","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":2.5807833546187045e-05,"ratio":0.4649543927028324,"synonym_name":"Oleate"},{"chebi_id":"42090","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-butane-1,2,3,4-tetrol","metabolite_id":"UNXHWFMMPAWVPI-IMJSIDKUSA-N","pvalue":0.000324971940419,"ratio":0.4073701433986809,"synonym_name":"<small>L</small>-<i>threo</i>-tetritol"},{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0173784385028321,"ratio":5.35335174789866,"synonym_name":""},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":0.015896007373683,"ratio":4.889510210195217,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"47962","direction":"down","inn_name":"","iupac_name":"<em>aldehydo</em>-<small>D</small>-galacturonic acid","metabolite_id":"IAJILQKETJEXLJ-RSJOWCBRSA-N","pvalue":0.0076481250814093,"ratio":0.2923640462102,"synonym_name":"(2<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid"}],"totalFeatures":99},{"comparisonGroups":["Control_Baseline","Control_Post-Exercise"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control group: baseline vs post-exercise","group_a_title":"Control group at baseline. Serves as the reference point for all post-exercise comparisons","group_b_title":"Control group post-exercise. Provides insight into the effects of exercise on the control group","id":"MTBLS2104_0001_00000028","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2104","studyUrl":"http://integmet.org/study/MTBLS2104","title":"Control_Baseline_vs_Control_Post-Exercise","topHits":[],"totalFeatures":80},{"comparisonGroups":["Control_Baseline","Control_Post-Exercise"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control group: baseline vs post-exercise","group_a_title":"Control group at baseline. Serves as the reference point for all post-exercise comparisons","group_b_title":"Control group post-exercise. Provides insight into the effects of exercise on the control group","id":"MTBLS2104_0002_00000028","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS2104","studyUrl":"http://integmet.org/study/MTBLS2104","title":"Control_Baseline_vs_Control_Post-Exercise","topHits":[{"chebi_id":"16449","direction":"down","inn_name":"","iupac_name":"alanine","metabolite_id":"QNAYBMKLOCPYGJ-UHFFFAOYSA-N","pvalue":0.0005259620866424,"ratio":0.6330603889457523,"synonym_name":"2-Aminopropanoic acid"}],"totalFeatures":39},{"comparisonGroups":["Old","Young"],"dateCreated":"2025-09-26 00:00:00","display_title":"Elderly (76\u00b14y) vs young adults (30\u00b13y) comparison","group_a_title":"Elderly group with an average age of 76 \u00b1 4 years. Represents the elderly population to study age-related metabolic changes.","group_b_title":"Young group with an average age of 30 \u00b1 3 years. Serves as the baseline control group for comparison with the elderly group.","id":"MTBLS2108_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS2108","studyUrl":"http://integmet.org/study/MTBLS2108","title":"Old_vs_Young","topHits":[{"chebi_id":"15721","direction":"down","inn_name":"","iupac_name":"<small>D</small>-<i>altro</i>-hept-2-ulose 7-phosphate","metabolite_id":"JDTUMPKOJBQPKX-GBNDHIKLSA-N","pvalue":0.0009168434727928,"ratio":0.4710652345485112,"synonym_name":"D-Sedoheptulose 7-phosphate"},{"chebi_id":"44897","direction":"down","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0092184694955321,"ratio":0.3868057766645019,"synonym_name":"PEP"},{"chebi_id":"15946","direction":"down","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.0039828946689766,"ratio":0.4791168891365885,"synonym_name":"D-Fructose 6-phosphate"},{"chebi_id":"24344","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":0.0215312192073063,"ratio":0.4097059684323993,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"4170","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":0.0190025420013031,"ratio":0.5783745884663558,"synonym_name":"Glc6P"},{"chebi_id":"16737","direction":"down","inn_name":"","iupac_name":"2-imino-1-methylimidazolidin-4-one","metabolite_id":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","pvalue":0.020756662291397,"ratio":0.6533491958152494,"synonym_name":"cr\u00e9atinine"}],"totalFeatures":41},{"comparisonGroups":["Old","Young"],"dateCreated":"2025-09-26 00:00:00","display_title":"Elderly (76\u00b14y) vs young (30\u00b13y) age comparison","group_a_title":"Elderly group with an average age of 76 \u00b1 4 years. Represents the elderly population to study age-related metabolic changes.","group_b_title":"Young group with an average age of 30 \u00b1 3 years. Serves as the baseline control group for comparison with the elderly group.","id":"MTBLS2108_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS2108","studyUrl":"http://integmet.org/study/MTBLS2108","title":"Old_vs_Young","topHits":[{"chebi_id":"17858","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":0.0126744024620947,"ratio":0.3886223015206234,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0027654969426174,"ratio":0.5053914453358748,"synonym_name":"Glutaminic acid"},{"chebi_id":"64558","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-UHFFFAOYSA-N","pvalue":0.0322274535175621,"ratio":0.3191200605214637,"synonym_name":"2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0099913185035991,"ratio":0.4623811576806552,"synonym_name":"Adenosin"},{"chebi_id":"17154","direction":"down","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0103811167612559,"ratio":0.4784127011600704,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"19702","direction":"down","inn_name":"","iupac_name":"9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-(methylamino)-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"SLEHROROQDYRAW-KQYNXXCUSA-N","pvalue":0.0189422676955452,"ratio":0.4683266470634312,"synonym_name":"m2g"},{"chebi_id":"17126","direction":"down","inn_name":"","iupac_name":"3-hydroxy-4-(trimethylammonio)butanoate","metabolite_id":"PHIQHXFUZVPYII-UHFFFAOYSA-N","pvalue":0.010795324797828,"ratio":0.5300666578377417,"synonym_name":"<small>D</small>,<small>L</small>-carnitine"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0252140553447048,"ratio":0.55128799598558,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":0.0213064765077943,"ratio":1.7617768734383308,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"18211","direction":"down","inn_name":"","iupac_name":"citrulline","metabolite_id":"RHGKLRLOHDJJDR-UHFFFAOYSA-N","pvalue":0.0128651372614425,"ratio":0.6184468336430267,"synonym_name":"2-Amino-5-uredovaleric acid"}],"totalFeatures":54},{"comparisonGroups":["5mM_12C","25mM_12C"],"dateCreated":"2025-09-26 00:00:00","display_title":"5mM vs 25mM D-glucose treatment comparison","group_a_title":"Samples with 5mM D-glucose and 12C label. Provides baseline for comparison with higher glucose concentrations and isotopic labeling.","group_b_title":"Samples with 25mM D-glucose and 12C label. Allows assessment of high glucose concentration effects compared to baseline.","id":"MTBLS213_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS213","studyUrl":"http://integmet.org/study/MTBLS213","title":"G1_5mM_12C_vs_G2_25mM_12C","topHits":[],"totalFeatures":10},{"comparisonGroups":["Control_Plasma","WY-14,643_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Plasma: WY-14,643 treatment vs control","group_a_title":"Control group for plasma samples. Provides baseline for comparison with treated plasma samples","group_b_title":"Plasma samples treated with WY-14,643. Evaluates the effect of WY-14,643 on plasma","id":"MTBLS2131_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2131","studyUrl":"http://integmet.org/study/MTBLS2131","title":"Control_Plasma_vs_WY-14,643_Plasma","topHits":[],"totalFeatures":109},{"comparisonGroups":["280 mOsm","480 mOsm"],"dateCreated":"2025-09-26 00:00:00","display_title":"Hyperosmotic stress: 280 vs 480 mOsm osmolarity","group_a_title":"Control group at 280 mOsm osmolarity.. Serves as the reference point for comparing hyperosmotic stress conditions.","group_b_title":"Treatment group at 480 mOsm osmolarity.. Allows for the assessment of severe hyperosmotic stress effects.","id":"MTBLS214_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS214","studyUrl":"http://integmet.org/study/MTBLS214","title":"280_mOsm_vs_480_mOsm","topHits":[{"chebi_id":"16870","direction":"down","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0012266096797883,"ratio":0.088700216449221,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"73685","direction":"down","inn_name":"","iupac_name":"2-(acetylamino)-5-amino-5-oxopentanoic acid","metabolite_id":"KSMRODHGGIIXDV-UHFFFAOYSA-N","pvalue":0.0001854007326868,"ratio":0.397904077067725,"synonym_name":"GlcNAc"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-P","pvalue":6.78941378334093e-05,"ratio":0.5364102941065549,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MSWKATKSSLJVEX-UHFFFAOYSA-J","pvalue":0.0015019905205071,"ratio":0.4120493625101421,"synonym_name":""},{"chebi_id":"48517","direction":"down","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":0.0013928780055901,"ratio":0.4944895097887723,"synonym_name":"Xanthine"},{"chebi_id":"58359","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0020858261653049,"ratio":0.473993842805907,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"17154","direction":"down","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0047012384326902,"ratio":0.4477410159290856,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HXWKMJZFIJNGES-YZVFIFBQSA-L","pvalue":0.0118417456566866,"ratio":0.5229107964014502,"synonym_name":""},{"chebi_id":"7916","direction":"up","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.0377508356652782,"ratio":2.3793848782236666,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"16296","direction":"down","inn_name":"","iupac_name":"<small>D</small>-tryptophan","metabolite_id":"QIVBCDIJIAJPQS-SECBINFHSA-N","pvalue":0.0342167491074201,"ratio":0.4328691859645898,"synonym_name":"D-Tryptophan"}],"totalFeatures":19},{"comparisonGroups":["280 mOsm","480 mOsm"],"dateCreated":"2025-09-26 00:00:00","display_title":"Hyperosmotic stress: 280 vs 480 mOsm conditions","group_a_title":"Control group at 280 mOsm osmolarity.. Serves as the reference point for comparing hyperosmotic stress conditions.","group_b_title":"Treatment group at 480 mOsm osmolarity.. Allows for the assessment of severe hyperosmotic stress effects.","id":"MTBLS214_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS214","studyUrl":"http://integmet.org/study/MTBLS214","title":"280_mOsm_vs_480_mOsm","topHits":[{"chebi_id":"73685","direction":"down","inn_name":"","iupac_name":"2-(acetylamino)-5-amino-5-oxopentanoic acid","metabolite_id":"KSMRODHGGIIXDV-UHFFFAOYSA-N","pvalue":0.0001854007326868,"ratio":0.397904077067725,"synonym_name":"GlcNAc"},{"chebi_id":"48517","direction":"down","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":0.0013928780055901,"ratio":0.4944895097887723,"synonym_name":"Xanthine"},{"chebi_id":"28300","direction":"down","inn_name":"","iupac_name":"glutamine","metabolite_id":"ZDXPYRJPNDTMRX-UHFFFAOYSA-N","pvalue":0.0020858261653049,"ratio":0.473993842805907,"synonym_name":"Glutamine"},{"chebi_id":"64558","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-UHFFFAOYSA-N","pvalue":0.0010267007810361,"ratio":0.5147062143351397,"synonym_name":"2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"18186","direction":"down","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0056754890179153,"ratio":0.5393476867736243,"synonym_name":"Tyrosin"},{"chebi_id":"16264","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":0.0118417456566866,"ratio":0.5229107964014502,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"7916","direction":"up","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.0377508356652782,"ratio":2.3793848782236666,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0129323037327128,"ratio":0.5534377330807746,"synonym_name":"Glutaminic acid"}],"totalFeatures":8},{"comparisonGroups":["280 mOsm","480 mOsm"],"dateCreated":"2025-09-26 00:00:00","display_title":"Hyperosmotic stress: 280 vs 480 mOsm osmolarity","group_a_title":"Control group at 280 mOsm osmolarity.. Serves as the reference point for comparing hyperosmotic stress conditions.","group_b_title":"Treatment group at 480 mOsm osmolarity.. Allows for the assessment of severe hyperosmotic stress effects.","id":"MTBLS214_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS214","studyUrl":"http://integmet.org/study/MTBLS214","title":"280_mOsm_vs_480_mOsm","topHits":[{"chebi_id":"16870","direction":"down","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0012266096797883,"ratio":0.088700216449221,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"64558","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-UHFFFAOYSA-N","pvalue":0.0008703967022877,"ratio":0.3610150582211412,"synonym_name":"2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"59789","direction":"down","inn_name":"","iupac_name":"[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-O","pvalue":6.78941378334093e-05,"ratio":0.5364102941065549,"synonym_name":"S-adenosyl-L-methionine"},{"chebi_id":"73506","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamyl-<small>L</small>-leucine","metabolite_id":"YBAFDPFAUTYYRW-YUMQZZPRSA-N","pvalue":0.0015019905205071,"ratio":0.4120493625101421,"synonym_name":"EL"},{"chebi_id":"18186","direction":"down","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0026034891311899,"ratio":0.4221180468981505,"synonym_name":"Tyrosin"},{"chebi_id":"17154","direction":"down","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0047012384326902,"ratio":0.4477410159290856,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"64554","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-UHFFFAOYSA-N","pvalue":0.0342167491074201,"ratio":0.4328691859645898,"synonym_name":"2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"27266","direction":"down","inn_name":"","iupac_name":"valine","metabolite_id":"KZSNJWFQEVHDMF-UHFFFAOYSA-N","pvalue":0.0189298514772706,"ratio":0.5227261309530318,"synonym_name":"2-amino-3-methylbutanoic acid"},{"chebi_id":"28044","direction":"down","inn_name":"","iupac_name":"2-amino-3-phenylpropanoic acid","metabolite_id":"COLNVLDHVKWLRT-UHFFFAOYSA-N","pvalue":0.0414365308716535,"ratio":0.4759613588288926,"synonym_name":"alpha-Amino-beta-phenylpropionic acid"},{"chebi_id":"25017","direction":"down","inn_name":"","iupac_name":"leucine","metabolite_id":"ROHFNLRQFUQHCH-UHFFFAOYSA-N","pvalue":0.0331551752712651,"ratio":0.5158237435519998,"synonym_name":"DL-Leucine"}],"totalFeatures":18},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental samples: 0h vs 96h treatment response","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0001_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1623,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"25312","direction":"down","inn_name":"","iupac_name":"2-hydroxy-3-methylbutanedioic acid","metabolite_id":"NPYQJIHHTGFBLN-UHFFFAOYSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":"\u03b2-methylmalate"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"88950","direction":"down","inn_name":"","iupac_name":"3-oxopentanedioic acid","metabolite_id":"OXTNCQMOKLOUAM-UHFFFAOYSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":"b-Ketoglutaric Acid"},{"chebi_id":"4488","direction":"down","inn_name":"","iupac_name":"3-(prop-2-en-1-yldisulfanyl)prop-1-ene","metabolite_id":"PFRGXCVKLLPLIP-UHFFFAOYSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":"3,3'-dithiobis(prop-1-ene)"},{"chebi_id":"173607","direction":"down","inn_name":"","iupac_name":"(Z)-1-[[(Z)-prop-1-enyl]disulanyl]prop-1-ene","metabolite_id":"FHSDVOJKLYJNCQ-GLIMQPGKSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":""},{"chebi_id":"173609","direction":"down","inn_name":"","iupac_name":"(Z)-1-(prop-2-enyldisulanyl)prop-1-ene","metabolite_id":"KBXOGESWPIVMNJ-XQRVVYSFSA-N","pvalue":2.7902186069762236e-07,"ratio":0.0251130085384229,"synonym_name":""},{"chebi_id":"17432","direction":"down","inn_name":"","iupac_name":"4-[(8-amino-8-oxo-3-sulfanyloctyl)sulfanyl]-4-oxobutanoic acid","metabolite_id":"KWKBJWYJJBQOAE-UHFFFAOYSA-N","pvalue":1.5225135008616723e-06,"ratio":0.0336664054336468,"synonym_name":"S-Succinyldihydrolipoamide"},{"chebi_id":"174938","direction":"down","inn_name":"","iupac_name":"15-hydroxy-16-methoxy-10-methyl-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2,4,6,8,13,15-heptaene-11,12-dione","metabolite_id":"JGDZUWXHWYXMSD-UHFFFAOYSA-N","pvalue":1.5225135008616723e-06,"ratio":0.0336664054336468,"synonym_name":""},{"chebi_id":"170087","direction":"down","inn_name":"","iupac_name":"2-acetyl-5-hydroxy-11-methyluro[2,3-c]acridin-6-one","metabolite_id":"GZVRDNACRGJZNW-UHFFFAOYSA-N","pvalue":1.5225135008616723e-06,"ratio":0.0336664054336468,"synonym_name":""},{"chebi_id":"57853","direction":"down","inn_name":"","iupac_name":"2-azaniumylethanesulfinate","metabolite_id":"VVIUBCNYACGLLV-UHFFFAOYSA-N","pvalue":7.312491654247791e-07,"ratio":0.0421679118652652,"synonym_name":"2-mmonioethane-1-sulfinate"}],"totalFeatures":4803},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental samples: 0h vs 96h time course","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0002_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2007,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"64348","direction":"down","inn_name":"","iupac_name":"<em>N</em>-methylvaline","metabolite_id":"AKCRVYNORCOYQT-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"MeVal"},{"chebi_id":"67144","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KKFDCBRMNNSAAW-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"4-(2-hydroxyethyl)morpholine"},{"chebi_id":"172323","direction":"down","inn_name":"","iupac_name":"2-methylpiperidine-3,4-diol","metabolite_id":"RMJCALHKIHCSMY-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":""},{"chebi_id":"173525","direction":"down","inn_name":"","iupac_name":"3-aminohexanoic acid","metabolite_id":"YIJFIIXHVSHQEN-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":""},{"chebi_id":"58045","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"},{"chebi_id":"43433","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alloisoleucine","metabolite_id":"AGPKZVBTJJNPAG-UHNVWZDZSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"allo-<small>L</small>-isoleucine"},{"chebi_id":"18347","direction":"down","inn_name":"","iupac_name":"<small>L</small>-norleucine","metabolite_id":"LRQKBLKVPFOOQJ-YFKPBYRVSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"\u03b1-aminocaproic acid"},{"chebi_id":"16586","direction":"down","inn_name":"acide aminocaproque","iupac_name":"6-aminohexanoic acid","metabolite_id":"SLXKOJJOQWFEFD-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"6-Aminocaproic acid"},{"chebi_id":"72772","direction":"down","inn_name":"","iupac_name":"3-amino-4-methylpentanoic acid","metabolite_id":"GLUJNGJDHCTUJY-UHFFFAOYSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":""},{"chebi_id":"28225","direction":"down","inn_name":"","iupac_name":"<small>D</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-RXMQYKEDSA-N","pvalue":6.220676141581361e-06,"ratio":0.0002440647881073,"synonym_name":"DLE"}],"totalFeatures":5087},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental samples: 0h vs 96h time course","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0003_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"28013","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":0.0007390160054052,"ratio":1e-06,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"27891","direction":"up","inn_name":"","iupac_name":"3-(sulfosulfanyl)-<small>L</small>-alanine","metabolite_id":"NOKPBJYHPHHWAN-REOHCLBHSA-N","pvalue":0.0325318580909914,"ratio":1000000.0,"synonym_name":"S-Sulfo-L-cysteine"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":0.0492577860402024,"ratio":1e-06,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"16345","direction":"up","inn_name":"","iupac_name":"3-sulfino-<small>L</small>-alanine","metabolite_id":"ADVPTQAUNPRNPO-REOHCLBHSA-N","pvalue":0.0042863641687902,"ratio":50.7008547008547,"synonym_name":"3-SULFINOALANINE"},{"chebi_id":"132958","direction":"down","inn_name":"","iupac_name":"<em>N</em>-acetylmethionine","metabolite_id":"XUYPXLNMDZIRQH-UHFFFAOYSA-N","pvalue":0.0029540464918207,"ratio":0.0588066551921973,"synonym_name":"Ac-Met"},{"chebi_id":"22660","direction":"up","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0005881789253619,"ratio":4.781560364464693,"synonym_name":"Aspartic acid"},{"chebi_id":"15908","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonic acid","metabolite_id":"JPIJQSOTBSSVTP-STHAYSLISA-N","pvalue":0.0006819360357468,"ratio":3.967729877896835,"synonym_name":""},{"chebi_id":"42111","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-UWTATZPHSA-N","pvalue":0.000869187199675,"ratio":0.2889626935535305,"synonym_name":"(\u2212)-lactic acid"},{"chebi_id":"173469","direction":"up","inn_name":"","iupac_name":"4-propan-2-ylbenzenesulonic acid","metabolite_id":"CVLHGLWXLDOELD-UHFFFAOYSA-N","pvalue":0.0230531062636199,"ratio":8.63076923076923,"synonym_name":""},{"chebi_id":"41321","direction":"up","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-yl hydrogen sulfate","metabolite_id":"BHYOQNUELFTYRT-DPAQBDIFSA-N","pvalue":0.0007255628587292,"ratio":2.818150289017341,"synonym_name":"CHOLEST-5-EN-3-YL HYDROGEN SULFATE"}],"totalFeatures":108},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental condition: 0h baseline vs 96h treatment","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0004_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"73234","direction":"down","inn_name":"","iupac_name":"(19<i>R</i>,25<i>S</i>)-22,25,26-trihydroxy-22-oxido-16-oxo-17,21,23-trioxa-22\u03bb<small><sup>5</small></sup>-phosphahexacosan-19-yl (9<i>Z</i>)-octadec-9-enoate","metabolite_id":"PAZGBAOHGQRCBP-HGWHEPCSSA-N","pvalue":0.0009260520421532,"ratio":0.0704515706806282,"synonym_name":"16:0/18:1 PG"},{"chebi_id":"85037","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(11<i>Z</i>)-octadec-11-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"AEPVLLKGEBHLEJ-KWNHIAGJSA-N","pvalue":0.0020909946396532,"ratio":0.2273086029992107,"synonym_name":"1-Palmitoyl-2-vaccenoyl-sn-glycero-3-phosphocholine"},{"chebi_id":"73205","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-({[(2<i>S</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-(hexadecanoyloxy)propyl hexadecanoate","metabolite_id":"BIABMEZBCHDPBV-MPQUPPDSSA-N","pvalue":0.000714820519804,"ratio":0.3197781885397412,"synonym_name":"dihexadecanoylphosphatidylglycerol"},{"chebi_id":"89071","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VWDLPQNBLHJJIU-OILVUHFKSA-N","pvalue":0.045187813600112,"ratio":1.548141086749285,"synonym_name":"Phosphatidylglycerol(16:1n7/20:3n9)"}],"totalFeatures":15},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental samples: 0h vs 96h treatment response","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0005_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HOKXMLLDKJYHPU-VXPUYCOJSA-N","pvalue":1.6311104086727695e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UIOGVZKAOSZDAK-VXPUYCOJSA-N","pvalue":8.685542889552743e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"16113","direction":"down","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":3.240050257882085e-06,"ratio":0.0046749290592082,"synonym_name":"CHOLESTEROL"},{"chebi_id":"86437","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecyloxy)-2-{[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"YHSSHPWVFALMBA-IARQOZKNSA-N","pvalue":7.234657633044884e-07,"ratio":0.0122539768131571,"synonym_name":"PC(O-16:0/20:5(5Z,8Z,11Z,14Z,17Z))"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KCWGBXXAJHVZNN-JLNKQSITSA-N","pvalue":2.632628915195077e-07,"ratio":0.0291148705486494,"synonym_name":""},{"chebi_id":"188162","direction":"down","inn_name":"","iupac_name":"[(2R)-2-heptadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"MJWAVUYQCBFFHQ-WESJWMGVSA-N","pvalue":3.896235529127964e-08,"ratio":0.0531421186236247,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GDJAIASCRXEGBE-JRQMLGJJSA-N","pvalue":1.260805395786894e-07,"ratio":0.0597349329458377,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IIOOVJGBEQXRHD-VXPUYCOJSA-N","pvalue":0.0001428338159323,"ratio":0.0083079557096144,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OFRWLQSOUIZELQ-VEAYGOGPSA-N","pvalue":5.658124886608373e-06,"ratio":0.0854380385905012,"synonym_name":""},{"chebi_id":"83055","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(11<i>Z</i>,14<i>Z</i>)-icosa-11,14-dienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YYQVCMMXPIJVHY-ZOIJLGJPSA-N","pvalue":3.6559177495092544e-05,"ratio":13.989432703003336,"synonym_name":"LPC(20:2w6/0:0)"}],"totalFeatures":45},{"comparisonGroups":["Experimental_Sample_0h","Experimental_Sample_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Experimental samples: 0h baseline vs 96h treatment","group_a_title":"Experimental samples collected at 0 hours.. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Experimental samples collected at 96 hours.. Captures the full extent of cellular responses to the experimental condition.","id":"MTBLS2145_0006_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS2145","studyUrl":"http://integmet.org/study/MTBLS2145","title":"G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h","topHits":[{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0010428286744244,"ratio":1000000.0,"synonym_name":"colamine phosphate"},{"chebi_id":"5623","direction":"up","inn_name":"","iupac_name":"1-methyl-9<em>H</em>-pyrido[3,4-<em>b</em>]indole","metabolite_id":"PSFDQSOCUJVVGF-UHFFFAOYSA-N","pvalue":0.0159664314368064,"ratio":1000000.0,"synonym_name":"Harman"},{"chebi_id":"34698","direction":"down","inn_name":"","iupac_name":"diethyl benzene-1,2-dicarboxylate","metabolite_id":"FLKPEMZONWLCSK-UHFFFAOYSA-N","pvalue":7.56904671781135e-05,"ratio":0.0289417109479576,"synonym_name":"1,2-Benzenedicarboxylic acid diethyl ester"},{"chebi_id":"184023","direction":"down","inn_name":"","iupac_name":"(2S)-2-[[N'-[(4S)-4-amino-4-carboxybutyl]carbamimidoyl]amino]butanedioic acid","metabolite_id":"KDZOASGQNOPSCU-WDSKDSINSA-N","pvalue":0.0021262656672558,"ratio":0.0431537962362102,"synonym_name":""},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0069853220067212,"ratio":0.0285870085241448,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"16695","direction":"down","inn_name":"","iupac_name":"5'-uridylic acid","metabolite_id":"DJJCXFVJDGTHFX-XVFCMESISA-N","pvalue":0.0001137345690765,"ratio":0.1761204481792717,"synonym_name":"pU"},{"chebi_id":"16610","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)butane-1,4-diamine","metabolite_id":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","pvalue":0.0001989799123429,"ratio":0.1654509392818137,"synonym_name":"N-(3-Aminopropyl)-1,4-butane-diamine"},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0001625361586385,"ratio":0.1789158928932754,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"17509","direction":"down","inn_name":"","iupac_name":"5'-deoxy-5'-(methylsulfanyl)adenosine","metabolite_id":"WUUGFSXJNOTRMR-IOSLPCCCSA-N","pvalue":0.0024830310215477,"ratio":0.1028552530040789,"synonym_name":"5'-Deoxy-5'-(methylthio)adenosine"},{"chebi_id":"7676","direction":"down","inn_name":"","iupac_name":"3-(butanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"QWYFHHGCZUCMBN-UHFFFAOYSA-N","pvalue":0.0001963343064243,"ratio":0.2264828624204693,"synonym_name":"Butyrylcarnitine"}],"totalFeatures":85},{"comparisonGroups":["Control","75mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 75mM salt stress","group_a_title":"Control group with 0 millimolar salt concentration.. Baseline group for comparison with treated samples at various salt concentrations.","group_b_title":"Group with 75 millimolar salt concentration.. Represents maximum response to salt stress.","id":"MTBLS22_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS22","studyUrl":"http://integmet.org/study/MTBLS22","title":"Control_vs_75mM","topHits":[{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":5.543628316179771e-06,"ratio":0.0334898999938753,"synonym_name":""},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":2.8757184795652677e-05,"ratio":14.5422214481544,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":1.9061761262793786e-05,"ratio":0.1252428085392299,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"15741","direction":"up","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":2.244998539926845e-07,"ratio":4.165091554917735,"synonym_name":"E363"},{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":2.350993603799556e-05,"ratio":0.2456395341170327,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"26078","direction":"up","inn_name":"","iupac_name":"trihydrogen tetraoxophosphate(3\u2212)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","pvalue":0.0002237236296503,"ratio":4.644626326058512,"synonym_name":"phosphoric acid"},{"chebi_id":"17505","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactosyl-(1\u21923)-1<small>D</small>-<em>myo</em>-inositol","metabolite_id":"VCWMRQDBPZKXKG-DXNLKLAMSA-N","pvalue":3.85054712582595e-06,"ratio":0.3569507093247882,"synonym_name":"3-O-alpha-D-Galactosyl-1D-myo-inositol"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0003403690198899,"ratio":0.2834951593763972,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"15428","direction":"down","inn_name":"","iupac_name":"glycine","metabolite_id":"DHMQDGOQFOQNFH-UHFFFAOYSA-N","pvalue":0.0020706123233816,"ratio":0.2196318267276892,"synonym_name":"aminoethanoic acid"},{"chebi_id":"16414","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":0.0001361085803479,"ratio":0.3575902378096282,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"}],"totalFeatures":62},{"comparisonGroups":["Jurkat_Negative_Control_0h","Jurkat_Menaquinone_72h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Jurkat cells: menaquinone 72h vs untreated control","group_a_title":"Jurkat cells with no treatment at 0 hours. Provides baseline data for comparison with treated Jurkat cells.","group_b_title":"Jurkat cells treated with menaquinone at 72 hours. Evaluates the effect of menaquinone on Jurkat cells at 72 hours.","id":"MTBLS226_0001_00000024","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS226","studyUrl":"http://integmet.org/study/MTBLS226","title":"G1_Jurkat_Negative_Control_0h_vs_G7_Jurkat_Menaquinone_72h","topHits":[{"chebi_id":"36632","direction":"up","inn_name":"","iupac_name":"2-methylbenzoic acid","metabolite_id":"ZWLPBLYKEWSWPD-UHFFFAOYSA-N","pvalue":0.0018370381731292,"ratio":584.0646753467789,"synonym_name":"2-toluic acid"},{"chebi_id":"87440","direction":"down","inn_name":"","iupac_name":"pyridin-3-ol","metabolite_id":"GRFNBEZIAWKNCO-UHFFFAOYSA-N","pvalue":0.0117350601276469,"ratio":0.0002279735199988,"synonym_name":"<em>m</em>-hydroxypyridine"},{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":2.0648787862244204e-05,"ratio":0.2424740626878429,"synonym_name":"colamine phosphate"},{"chebi_id":"57966","direction":"down","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":0.0014185628953762,"ratio":0.3562940827479827,"synonym_name":"3-ammoniopropanoate"},{"chebi_id":"57853","direction":"down","inn_name":"","iupac_name":"2-azaniumylethanesulfinate","metabolite_id":"VVIUBCNYACGLLV-UHFFFAOYSA-N","pvalue":0.0012961742149433,"ratio":0.3874122097546993,"synonym_name":"2-mmonioethane-1-sulfinate"},{"chebi_id":"58375","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidinium-2-carboxylate","metabolite_id":"PMMYEEVYMWASQN-DMTCNVIQSA-N","pvalue":0.0040881228387628,"ratio":0.4470154982728724,"synonym_name":"hydroxyproline zwitterion"},{"chebi_id":"69441","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"NWVVVBRKAWDGAB-UHFFFAOYSA-N","pvalue":0.0211244169623867,"ratio":2.185357884033751,"synonym_name":"1-Hydroxy-4-methoxybenzene"},{"chebi_id":"84272","direction":"down","inn_name":"","iupac_name":"dodecamethylpentasiloxane","metabolite_id":"FBZANXDWQAVSTQ-UHFFFAOYSA-N","pvalue":0.0067047953786501,"ratio":0.5505200154983492,"synonym_name":""},{"chebi_id":"84273","direction":"up","inn_name":"","iupac_name":"(2,3-diphenylcyclopropyl)methyl phenyl sulfoxide","metabolite_id":"MVULGCSHGFLUBH-UHFFFAOYSA-N","pvalue":0.0034855495566292,"ratio":1.5265612806375466,"synonym_name":"1,1'-{3-[(phenylsulfinyl)methyl]cyclopropane-1,2-diyl}dibenzene"},{"chebi_id":"17151","direction":"down","inn_name":"","iupac_name":"<i>meso</i>-xylitol","metabolite_id":"HEBKCHPVOIAQTA-SCDXWVJYSA-N","pvalue":0.0303267399807116,"ratio":0.5313291949768264,"synonym_name":"Xylit"}],"totalFeatures":68},{"comparisonGroups":["Control","AONFH_Stage_III_IV"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs alcohol-induced ONFH stages III/IV","group_a_title":"Healthy control samples. Provides baseline lipidome profile for comparison with ONFH samples.","group_b_title":"Alcohol-induced ONFH at stages III/IV. Helps in understanding advanced lipidome changes in alcohol-induced ONFH.","id":"MTBLS2262_0001_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS2262","studyUrl":"http://integmet.org/study/MTBLS2262","title":"Control_vs_AONFH_Stage_III_IV","topHits":[{"chebi_id":"55328","direction":"up","inn_name":"","iupac_name":"16-hydroxyhexadecanoic acid","metabolite_id":"UGAGPNKCDRTDHP-UHFFFAOYSA-N","pvalue":0.0001305059390768,"ratio":2.594788705795622,"synonym_name":"16-OH 16:0"},{"chebi_id":"89348","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KBDCFYFMQOAHAN-WUQMUQDBSA-N","pvalue":6.611103013759505e-05,"ratio":2.3267737745176524,"synonym_name":"PG(18:2/18:1)"},{"chebi_id":"15674","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxybutanedioic acid","metabolite_id":"FEWJPZIEWOKRBE-UHFFFAOYSA-N","pvalue":0.0001704662244457,"ratio":2.443257413213501,"synonym_name":"2,3-dihydroxysuccinic acid"},{"chebi_id":"176739","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"SGQIECCWAOPTNL-LEFPGAKQSA-N","pvalue":0.0002916522473264,"ratio":0.4206400368443084,"synonym_name":""},{"chebi_id":"18346","direction":"down","inn_name":"","iupac_name":"4-hydroxy-3-methoxybenzaldehyde","metabolite_id":"MWOOGOJBHIARFG-UHFFFAOYSA-N","pvalue":7.370483782663996e-06,"ratio":0.5528768913556974,"synonym_name":"4-Hydroxy-3-methoxy-benzaldehyde"},{"chebi_id":"78668","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-10-hydroxydec-2-enoic acid","metabolite_id":"QHBZHVUGQROELI-SOFGYWHQSA-N","pvalue":9.980659539695869e-06,"ratio":0.5531217149676582,"synonym_name":"<i>trans</i>-10-hydroxydec-2-enoic acid"},{"chebi_id":"138531","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DAZYZDVAACSMFA-DYFSFZQGSA-N","pvalue":3.879180045056782e-05,"ratio":1.7797175295923322,"synonym_name":"PE(15:0/20:1(11Z))"},{"chebi_id":"170675","direction":"down","inn_name":"","iupac_name":"[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] icosanoate","metabolite_id":"CLPMAPXZURYSNH-CNBLIUODSA-N","pvalue":4.625451479904594e-05,"ratio":0.5605841720997418,"synonym_name":""},{"chebi_id":"89929","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b2-dihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"GHCZAUBVMUEKKP-XROMFQGDSA-N","pvalue":0.0005564771697086,"ratio":0.5212133953586171,"synonym_name":"GUDCA"},{"chebi_id":"4893","direction":"down","inn_name":"","iupac_name":"ethyl 3-oxobutanoate","metabolite_id":"XYIBRDXRRQCHLP-UHFFFAOYSA-N","pvalue":0.0024279618228697,"ratio":0.4446261700082292,"synonym_name":"ethyl acetyl acetate"}],"totalFeatures":269},{"comparisonGroups":["Control","AONFH_Stage_III_IV"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs advanced alcohol-induced ONFH","group_a_title":"Healthy control samples. Provides baseline lipidome profile for comparison with ONFH samples.","group_b_title":"Alcohol-induced ONFH at stages III/IV. Helps in understanding advanced lipidome changes in alcohol-induced ONFH.","id":"MTBLS2262_0002_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS2262","studyUrl":"http://integmet.org/study/MTBLS2262","title":"Control_vs_AONFH_Stage_III_IV","topHits":[{"chebi_id":"17278","direction":"down","inn_name":"","iupac_name":"5\u03b2-cholestane-3\u03b1,7\u03b1,12\u03b1,26-tetrol","metabolite_id":"XJZGNVBLVFOSKJ-XZULNKEGSA-N","pvalue":1.163831737712789e-08,"ratio":0.5068997656483182,"synonym_name":"5beta-Cholestane-3alpha,7alpha,12alpha,26-tetraol"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RMIVRCBSQPCSCQ-BDANYOJNSA-N","pvalue":0.0004275584977031,"ratio":2.862627775555817,"synonym_name":""},{"chebi_id":"90048","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YBWITEZBUYUNFC-GUIYCBLGSA-N","pvalue":0.0001247662727891,"ratio":0.4648191759753788,"synonym_name":"TAG(16:1n7/18:1n9/18:1n9)"},{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0001397355095664,"ratio":1.9429504969826452,"synonym_name":""},{"chebi_id":"176723","direction":"down","inn_name":"","iupac_name":"[3-carboxy-2-[(Z)-hexadec-7-enoyl]oxypropyl]-trimethylazanium","metabolite_id":"NRCCZFJHTDUMBS-SEYXRHQNSA-O","pvalue":1.9310670728899735e-05,"ratio":0.6086674834282982,"synonym_name":""},{"chebi_id":"155847","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-1-[(2<i>S</i>)-2-azaniumyl-4-methylpentanoyl]pyrrolidine-2-carboxylate","metabolite_id":"VTJUNIYRYIAIHF-IUCAKERBSA-N","pvalue":6.861808536908661e-05,"ratio":1.738616822047419,"synonym_name":"<small>L</small>-leucyl-<small>L</small>-proline zwitterion"},{"chebi_id":"87117","direction":"down","inn_name":"","iupac_name":"2-(2,4,5,7-tetraiodo-6-oxido-3-oxo-8a,10a-dihydro-3<em>H</em>-xanthen-9-yl)benzoic acid","metabolite_id":"WTOSNONTQZJEBC-UHFFFAOYSA-N","pvalue":0.0004772491236091,"ratio":0.5012690745152835,"synonym_name":"acid red 51 (free acid form)"},{"chebi_id":"84439","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-1-hydroxy-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propan-2-yl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"ZILMKERHGSKQBG-PNCFOYGISA-N","pvalue":0.0013129135642881,"ratio":1.9169935875416488,"synonym_name":"DAG(40:7)"},{"chebi_id":"57947","direction":"down","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.0002352235507656,"ratio":0.5988908782877391,"synonym_name":""},{"chebi_id":"89751","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(hexadecanoyloxy)propyl octadecanoate","metabolite_id":"DQKMNCLZNGAXNX-VCZQVZGSSA-N","pvalue":0.0011728451561039,"ratio":1.8665964636090335,"synonym_name":"1,2-dipalmitoyl-3-stearoyl-<em>sn</em>-glycerol"}],"totalFeatures":300},{"comparisonGroups":["Control_Day_8","Lactoferrin_Day_8"],"dateCreated":"2025-09-26 00:00:00","display_title":"Liver: lactoferrin treatment vs control at day 8","group_a_title":"Control group at day 8. Provides baseline data for comparison with lactoferrin-treated samples at day 8.","group_b_title":"Lactoferrin-treated group at day 8. Allows assessment of lactoferrin's effects on liver metabolism at day 8.","id":"MTBLS2279_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":30,"studyId":"MTBLS2279","studyUrl":"http://integmet.org/study/MTBLS2279","title":"Control_Day_8_vs_Lactoferrin_Day_8","topHits":[{"chebi_id":"79285","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21925)-<small>D</small>-fructopyranose","metabolite_id":"JPFGFRMPGVDDGE-PUVWEJBASA-N","pvalue":0.0002468124161479,"ratio":1e-06,"synonym_name":"5-<em>O</em>-\u03b1-<small>D</small>-glucopyranosyl-<small>D</small>-fructopyranose"},{"chebi_id":"48430","direction":"up","inn_name":"","iupac_name":"4-methyl-2-oxopentanoic acid","metabolite_id":"BKAJNAXTPSGJCU-UHFFFAOYSA-N","pvalue":0.0017418643567204,"ratio":1000000.0,"synonym_name":"2-Oxoisocaproate"},{"chebi_id":"16831","direction":"up","inn_name":"meglutol","iupac_name":"3-hydroxy-3-methylpentanedioic acid","metabolite_id":"NPOAOTPXWNWTSH-UHFFFAOYSA-N","pvalue":0.0045134996257984,"ratio":1000000.0,"synonym_name":"3-HYDROXY-3-METHYL-GLUTARIC ACID"},{"chebi_id":"16450","direction":"up","inn_name":"","iupac_name":"1-(2-deoxy-\u03b2-<small>D</small>-<i>erythro</i>-pentofuranosyl)uracil","metabolite_id":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","pvalue":0.0102734514020585,"ratio":1000000.0,"synonym_name":"Deoxyuridine"},{"chebi_id":"15551","direction":"down","inn_name":"dinoprostona","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-11\u03b1,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"XEYBRNLFEZDVAW-ARSRFYASSA-N","pvalue":0.0104116595712957,"ratio":1e-06,"synonym_name":"PGE2"},{"chebi_id":"27543","direction":"down","inn_name":"","iupac_name":"9<em>H</em>-carbazole","metabolite_id":"UJOBWOGCFQCDNV-UHFFFAOYSA-N","pvalue":0.0112376145129992,"ratio":1e-06,"synonym_name":"dibenzopyrrole"},{"chebi_id":"50235","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>,2<i>S</i>,4<i>S</i>)-<em>p</em>-menth-8-en-2-ol","metabolite_id":"KRCZYMFUWVJCLI-GUBZILKMSA-N","pvalue":0.0145708692370249,"ratio":1e-06,"synonym_name":"(1S,2S,4S)-Dihydrocarveol"},{"chebi_id":"40823","direction":"down","inn_name":"","iupac_name":"(aminooxy)acetic acid","metabolite_id":"NQRKYASMKDDGHT-UHFFFAOYSA-N","pvalue":9.458130621832885e-05,"ratio":0.1226865065089798,"synonym_name":"aminooxyacetic acid"},{"chebi_id":"35114","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-(propan-2-yl)butanedioic acid","metabolite_id":"RNQHMTFBUSSBJQ-UHFFFAOYSA-N","pvalue":0.0476799112244962,"ratio":23.2780375618598,"synonym_name":"3-carboxy-2-hydroxy-4-methylpentanoic acid"},{"chebi_id":"16204","direction":"down","inn_name":"","iupac_name":"benzene-1,3,5-triol","metabolite_id":"QCDYQQDYXPDABM-UHFFFAOYSA-N","pvalue":0.0092691804968243,"ratio":0.1363344412583052,"synonym_name":"benzene-1,3,5-triol"}],"totalFeatures":400},{"comparisonGroups":["Control","Lipopolysaccharide stimulated"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs lipopolysaccharide stimulation","group_a_title":"Control group with no treatment applied. Provides baseline metabolic state for comparison with treated samples","group_b_title":"Group treated with lipopolysaccharide to stimulate activation. Represents the metabolic response to lipopolysaccharide stimulation","id":"MTBLS23_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":59,"studyId":"MTBLS23","studyUrl":"http://integmet.org/study/MTBLS23","title":"Control_vs_Lipopolysaccharide_stimulated","topHits":[{"chebi_id":"17626","direction":"down","inn_name":"","iupac_name":"(2<i>Z</i>)-2-methylbut-2-enedioic acid","metabolite_id":"HNEGQIOMVPPMNR-IHWYPQMZSA-N","pvalue":7.279961305112375e-10,"ratio":1e-06,"synonym_name":"2-Methyl-2-butenedioic acid"},{"chebi_id":"30915","direction":"up","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":1.3370105353974426e-09,"ratio":1000000.0,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"18333","direction":"down","inn_name":"","iupac_name":"<small>D</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-QWWZWVQMSA-N","pvalue":1.974923136453342e-09,"ratio":1e-06,"synonym_name":"D-Arabinitol"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":1.7818673155840904e-08,"ratio":1000000.0,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"16750","direction":"up","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":2.099174656502387e-07,"ratio":1000000.0,"synonym_name":"G"},{"chebi_id":"33198","direction":"down","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":2.213229854782692e-07,"ratio":1e-06,"synonym_name":"Hexonic acid"},{"chebi_id":"74168","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3<em>H</em>)-one","metabolite_id":"CUOKHACJLGPRHD-BXXZVTAOSA-N","pvalue":3.40596105542725e-07,"ratio":1000000.0,"synonym_name":"D-Ribono-gamma-lactone"},{"chebi_id":"4139","direction":"up","inn_name":"","iupac_name":"<small>D</small>-galactopyranose","metabolite_id":"WQZGKKKJIJFFOK-SVZMEOIVSA-N","pvalue":9.860017493929655e-07,"ratio":1000000.0,"synonym_name":"<small>D</small>-galactose"},{"chebi_id":"58315","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":1.7356946855002024e-06,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"29888","direction":"down","inn_name":"","iupac_name":"\u03bc-oxido-bis(dihydroxidooxidophosphorus)","metabolite_id":"XPPKVPWEQAFLFU-UHFFFAOYSA-N","pvalue":3.43969740668739e-05,"ratio":1e-06,"synonym_name":"PYROPHOSPHATE"}],"totalFeatures":68},{"comparisonGroups":["Ammonium_Low","Ammonium_High"],"dateCreated":"2025-09-26 00:00:00","display_title":"Poplar: low vs high ammonium treatment","group_a_title":"Poplar samples treated with low concentration of ammonium. Represents the baseline ammonium treatment condition for comparison with higher concentrations.","group_b_title":"Poplar samples treated with high concentration of ammonium. Represents the maximum ammonium treatment condition for comparison with lower concentrations.","id":"MTBLS2305_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS2305","studyUrl":"http://integmet.org/study/MTBLS2305","title":"Ammonium_Low_vs_Ammonium_High","topHits":[{"chebi_id":"139294","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OJKSPAPMILKAPV-UHFFFAOYSA-N","pvalue":1.4756186942782629e-05,"ratio":60.452412906185806,"synonym_name":""},{"chebi_id":"16464","direction":"down","inn_name":"","iupac_name":"2-(hydroxymethyl)phenol","metabolite_id":"CQRYARSYNCAZFO-UHFFFAOYSA-N","pvalue":2.284509664371492e-06,"ratio":0.1060185077809573,"synonym_name":"2-Hydroxybenzyl alcohol"},{"chebi_id":"8333","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HHSKNLJWHGXWPK-BFMVXSJESA-N","pvalue":2.4893875939241375e-05,"ratio":14.133030104181492,"synonym_name":"Populin"},{"chebi_id":"91172","direction":"up","inn_name":"","iupac_name":"1-(4-hydroxy-3-methoxyphenyl)-2-{4-[(1<i>E</i>)-3-hydroxy-1-propen-1-yl]-2-methoxyphenoxy}-1,3-propanediol","metabolite_id":"FYEZJIXULOZDRT-ONEGZZNKSA-N","pvalue":1.3391099131679347e-06,"ratio":4.528114416362201,"synonym_name":"G(8-O-4)G"},{"chebi_id":"16220","direction":"up","inn_name":"","iupac_name":"4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"SFLMUHDGSQZDOW-FAOXUISGSA-N","pvalue":0.000162240996576,"ratio":6.916965943037234,"synonym_name":"Coniferin"},{"chebi_id":"137481","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)phenyl 2-<em>O</em>-acetyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"RRRGZNGWWIEOLB-UXXRCYHCSA-N","pvalue":1.652382226916662e-05,"ratio":4.456068856861105,"synonym_name":""},{"chebi_id":"183515","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HITLEOURIXKLBL-DRATVDAASA-N","pvalue":4.2385166293820126e-05,"ratio":3.957347921810157,"synonym_name":""},{"chebi_id":"3293","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-[3-(\u03b2-<small>D</small>-glucopyranosyloxy)-4-hydroxyphenyl]prop-2-enoic acid","metabolite_id":"QOPSZFXPZWQLOG-VHCZEJTMSA-N","pvalue":0.0038738672998955,"ratio":8.525895438430638,"synonym_name":"<i>trans</i>-caffeic acid 3-<em>O</em>-\u03b2-<small>D</small>-glucoside"},{"chebi_id":"176098","direction":"up","inn_name":"","iupac_name":"[3,4,5-trihydroxy-6-[2-(hydroxymethyl)phenoxy]oxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"ODOVSOIHEQVVMZ-JXMROGBWSA-N","pvalue":0.0022383890123924,"ratio":4.640953736831571,"synonym_name":""},{"chebi_id":"59015","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2<em>H</em>-chromen-7-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"ADSYMQORONDIDD-ZJHVPRRPSA-N","pvalue":0.0069103415301272,"ratio":5.183994506921997,"synonym_name":"Hesperetin 7-O-glucoside"}],"totalFeatures":25},{"comparisonGroups":["Ammonium_Low","Ammonium_High"],"dateCreated":"2025-09-26 00:00:00","display_title":"Poplar: low vs high ammonium treatment","group_a_title":"Poplar samples treated with low concentration of ammonium. Represents the baseline ammonium treatment condition for comparison with higher concentrations.","group_b_title":"Poplar samples treated with high concentration of ammonium. Represents the maximum ammonium treatment condition for comparison with lower concentrations.","id":"MTBLS2305_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS2305","studyUrl":"http://integmet.org/study/MTBLS2305","title":"Ammonium_Low_vs_Ammonium_High","topHits":[{"chebi_id":"36635","direction":"up","inn_name":"","iupac_name":"4-methylbenzoic acid","metabolite_id":"LPNBBFKOUUSUDB-UHFFFAOYSA-N","pvalue":1.5532517520629442e-07,"ratio":6.505103719742789,"synonym_name":"para-Toluic acid"},{"chebi_id":"32374","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxyphenyl)prop-2-enoic acid","metabolite_id":"NGSWKAQJJWESNS-ZZXKWVIFSA-N","pvalue":1.0439590065616825e-08,"ratio":0.2062606849099931,"synonym_name":"4'-HYDROXYCINNAMIC ACID"},{"chebi_id":"16235","direction":"down","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":8.264286653849595e-08,"ratio":0.1937804511096238,"synonym_name":"GUANINE"},{"chebi_id":"61508","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-5-oxo-5-[(4-oxobutyl)amino]pentanoate","metabolite_id":"JZNLEPLZUABCSQ-ZETCQYMHSA-N","pvalue":2.935160031357113e-05,"ratio":0.100313499329639,"synonym_name":"(2<i>S</i>)-2-ammonio-5-oxo-5-[(4-oxobutyl)amino]pentanoate"},{"chebi_id":"136772","direction":"up","inn_name":"","iupac_name":"5-(\u03b2-<small>D</small>-glucopyranosyloxy)-2-hydroxybenzoic acid","metabolite_id":"CBTFERBMQQAROP-BZNQNGANSA-N","pvalue":0.0002013443798567,"ratio":10.48222594603037,"synonym_name":"2,5-dihydroxybenzoic acid 5-<em>O</em>-\u03b2-glucoside"},{"chebi_id":"17964","direction":"down","inn_name":"","iupac_name":"piperidine-2-carboxylic acid","metabolite_id":"HXEACLLIILLPRG-UHFFFAOYSA-N","pvalue":1.6039448762429409e-06,"ratio":0.2852640261039003,"synonym_name":"homoproline"},{"chebi_id":"16673","direction":"up","inn_name":"","iupac_name":"{3-[(21<i>R</i>)-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3,4-didehydrophorbin-3-yl-\u03ba<small><sup>4</small></sup><em>N</em><small><sup>23</small></sup>,<em>N</em><small><sup>24</small></sup>,<em>N</em><small><sup>25</small></sup>,<em>N</em><small><sup>26</small></sup>]propanoato(2\u2212)}magnesium","metabolite_id":"QBPCOMNNISRCTC-KKNVGXODSA-L","pvalue":0.0002074611970785,"ratio":4.804204783346901,"synonym_name":"{3-[(21<i>R</i>)-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinyl-3,4-didehydrophorbin-3-yl-\u03ba<small><sup>4</small></sup><em>N</em><small><sup>23</small></sup>,<em>N</em><small><sup>24</small></sup>,<em>N</em><small><sup>25</small></sup>,<em>N</em><small><sup>26</small></sup>]propanoato(2\u2212)}magnesium"},{"chebi_id":"167538","direction":"up","inn_name":"","iupac_name":"3,5-dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid","metabolite_id":"BLKMDORKRDACEI-UHFFFAOYSA-N","pvalue":0.0005650951430146,"ratio":3.790083270217105,"synonym_name":""},{"chebi_id":"10565","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(1<i>S</i>)-1-carboxy-2-cyanoethyl]-<small>L</small>-glutamine","metabolite_id":"QUAADUAOVLZBJM-WDSKDSINSA-N","pvalue":0.0032086180645252,"ratio":4.362892978287179,"synonym_name":""},{"chebi_id":"74075","direction":"down","inn_name":"","iupac_name":"<small>L</small>-isoleucyl-<small>L</small>-phenylalanine","metabolite_id":"WMDZARSFSMZOQO-DRZSPHRISA-N","pvalue":0.0003346536689816,"ratio":0.3971168793534942,"synonym_name":"isoleucylphenylalanine"}],"totalFeatures":17},{"comparisonGroups":["Good_Responder_Discovery","Poor_Responder_Discovery"],"dateCreated":"2025-09-26 00:00:00","display_title":"Propofol response: good vs poor responders (discovery)","group_a_title":"Good responders in the discovery set. Helps identify metabolic markers associated with good response to propofol.","group_b_title":"Poor responders in the discovery set. Helps identify metabolic markers associated with poor response to propofol.","id":"MTBLS2311_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS2311","studyUrl":"http://integmet.org/study/MTBLS2311","title":"Good_vs_Poor_Responder_Discovery","topHits":[{"chebi_id":"32173","direction":"down","inn_name":"suxibuzone","iupac_name":"4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid","metabolite_id":"ONWXNHPOAGOMTG-UHFFFAOYSA-N","pvalue":0.0010569095483847,"ratio":0.1243850289422913,"synonym_name":"4-Hydroxymethylbutazolidine hemisuccinate"},{"chebi_id":"177942","direction":"down","inn_name":"","iupac_name":"[(2R)-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate","metabolite_id":"MLBWOYIGPAJIRN-FUAZWUEQSA-N","pvalue":0.0010659722983081,"ratio":0.1274975544510895,"synonym_name":""},{"chebi_id":"174842","direction":"down","inn_name":"","iupac_name":"4-hydroxy-3-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)methyl]-1-methylquinolin-2-one","metabolite_id":"JCLGYGPWVWEPSU-UHFFFAOYSA-N","pvalue":0.0017529459487335,"ratio":0.1387351913182975,"synonym_name":""},{"chebi_id":"133086","direction":"up","inn_name":"","iupac_name":"octadecanedioic acid","metabolite_id":"BNJOQKFENDDGSC-UHFFFAOYSA-N","pvalue":3.168513886868434e-05,"ratio":3.235816672475324,"synonym_name":"1,18-octadecanedioic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CAPHXUZAFHNJAV-SZDWCIKQSA-N","pvalue":0.0019718066371508,"ratio":0.1447700071483089,"synonym_name":""},{"chebi_id":"17823","direction":"up","inn_name":"calcitriol","iupac_name":"(1<i>S</i>,3<i>R</i>,5<i>Z</i>,7<i>E</i>)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol","metabolite_id":"GMRQFYUYWCNGIN-NKMMMXOESA-N","pvalue":0.0024426641038959,"ratio":1.766065776250905,"synonym_name":"1-alpha-25-Dihydroxyvitamin D3"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SAHCQBPGXQFTRA-FPKLTXOWSA-N","pvalue":0.0068412759588109,"ratio":1.9861865319775855,"synonym_name":""},{"chebi_id":"180632","direction":"up","inn_name":"","iupac_name":"17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,5,6-triol","metabolite_id":"VGSSUFQMXBFFTM-UHFFFAOYSA-N","pvalue":0.0048637166241926,"ratio":1.8807106211316689,"synonym_name":""},{"chebi_id":"165451","direction":"up","inn_name":"","iupac_name":"pentacosa-12,14-diynoic acid","metabolite_id":"WGUBUTPKAGTFAB-UHFFFAOYSA-N","pvalue":0.0038583201543083,"ratio":1.7379984910777615,"synonym_name":""},{"chebi_id":"16496","direction":"up","inn_name":"","iupac_name":"5\u03b2-cholestane-3\u03b1,7\u03b1,12\u03b1-triol","metabolite_id":"RIVQQZVHIVNQFH-XJZYBRFWSA-N","pvalue":0.005558559387685,"ratio":1.6933720561273515,"synonym_name":"5beta-cholestane-3alpha,7alpha,12alpha-triol"}],"totalFeatures":10},{"comparisonGroups":["Good_Responder_Discovery","Poor_Responder_Discovery"],"dateCreated":"2025-09-26 00:00:00","display_title":"Propofol response: good vs poor responders (discovery)","group_a_title":"Good responders in the discovery set. Helps identify metabolic markers associated with good response to propofol.","group_b_title":"Poor responders in the discovery set. Helps identify metabolic markers associated with poor response to propofol.","id":"MTBLS2311_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS2311","studyUrl":"http://integmet.org/study/MTBLS2311","title":"Good_vs_Poor_Responder_Discovery","topHits":[{"chebi_id":"180635","direction":"down","inn_name":"","iupac_name":"[6-[3,16-dihydroxy-4,9,13,14-tetramethyl-11-oxo-2-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-7,8,12,15,16,17-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate","metabolite_id":"VZFXZQQZJZPIGO-UHFFFAOYSA-N","pvalue":0.0127100466923224,"ratio":0.0361423405253802,"synonym_name":""},{"chebi_id":"180636","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-3-icosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"QDCLIEMDHNMIGJ-NUZBEXIASA-N","pvalue":0.0001369680855485,"ratio":4.99993302951994,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CEAZRRDELHUEMR-UHFFFAOYSA-N","pvalue":0.0015399408390661,"ratio":0.1346368636950982,"synonym_name":""},{"chebi_id":"180640","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (Z)-nonadec-9-enoate","metabolite_id":"XEYMIBOUJRVPFY-GDAYGPEISA-N","pvalue":0.0001430241587391,"ratio":4.117081427216375,"synonym_name":""},{"chebi_id":"72952","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-({[(2<i>S</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropyl (9<i>Z</i>)-octadec-9-enoate","metabolite_id":"FQQQKGAFQIIGLQ-SNZQZGEVSA-N","pvalue":0.0001450011642996,"ratio":4.090504670717603,"synonym_name":"PG(18:1/0:0)"},{"chebi_id":"141500","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PCSYNZSWISKYPW-DOFZRALJSA-N","pvalue":0.0001342389654072,"ratio":4.035242109989397,"synonym_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-<em>N</em>-[2-(4-sulfamoylphenyl)ethyl]icosa-5,8,11,14-tetraenamide"},{"chebi_id":"168398","direction":"up","inn_name":"","iupac_name":"2-[4,5-diethoxy-2-(ethoxymethyl)-6-methoxyoxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol","metabolite_id":"ZZSNKZQZMQGXPY-UHFFFAOYSA-N","pvalue":0.0001502625469882,"ratio":4.063664941027713,"synonym_name":""},{"chebi_id":"89282","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BWWWIHHYPYDOJQ-BSGVGGAOSA-N","pvalue":0.0037212326323485,"ratio":0.1132602832272141,"synonym_name":"Glycocholic acid 3-glucuronide"},{"chebi_id":"180637","direction":"down","inn_name":"","iupac_name":"[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate","metabolite_id":"XPVPRBUMVPRRIJ-FWANEPEWSA-N","pvalue":0.0023927766330525,"ratio":0.13309397183156,"synonym_name":""},{"chebi_id":"180634","direction":"up","inn_name":"","iupac_name":"[(2R)-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] heptadecanoate","metabolite_id":"KNQQEDTUCAXLKN-MFVLMDSLSA-N","pvalue":0.0001740294324787,"ratio":3.9298236219610634,"synonym_name":""}],"totalFeatures":28},{"comparisonGroups":["Control_Head","Floret"],"dateCreated":"2025-09-26 00:00:00","display_title":"Floret tissue: control head vs wounded floret samples","group_a_title":"Control group with head samples. Provides baseline for comparison with wounded samples","group_b_title":"Floret samples subjected to wounding. Allows assessment of wounding effects on florets","id":"MTBLS2317_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS2317","studyUrl":"http://integmet.org/study/MTBLS2317","title":"Control_Head_vs_Floret","topHits":[{"chebi_id":"30744","direction":"up","inn_name":"","iupac_name":"2-oxobutanedioic acid","metabolite_id":"KHPXUQMNIQBQEV-UHFFFAOYSA-N","pvalue":0.0010133290434952,"ratio":1.5111864149052885,"synonym_name":"3-carboxy-3-oxopropanoic acid"}],"totalFeatures":3},{"comparisonGroups":["Control_Head","Floret"],"dateCreated":"2025-09-26 00:00:00","display_title":"Floret tissue: control head vs wounded floret samples","group_a_title":"Control group with head samples. Provides baseline for comparison with wounded samples","group_b_title":"Floret samples subjected to wounding. Allows assessment of wounding effects on florets","id":"MTBLS2317_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS2317","studyUrl":"http://integmet.org/study/MTBLS2317","title":"Control_Head_vs_Floret","topHits":[{"chebi_id":"16643","direction":"down","inn_name":"","iupac_name":"<small>L</small>-methionine","metabolite_id":"FFEARJCKVFRZRR-BYPYZUCNSA-N","pvalue":0.0121167914344304,"ratio":0.5904874572087415,"synonym_name":"L-Methionine"}],"totalFeatures":18},{"comparisonGroups":["Klebsiella_pneumoniae_AJ218_RPMI","Klebsiella_pneumoniae_AJ218_Pooled_sera"],"dateCreated":"2025-09-26 00:00:00","display_title":"K. pneumoniae AJ218: RPMI media vs pooled sera","group_a_title":"Samples of Klebsiella pneumoniae AJ218 grown in RPMI media.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in RPMI media.","group_b_title":"Samples of Klebsiella pneumoniae AJ218 grown in pooled sera.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in pooled sera.","id":"MTBLS2322_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":65,"studyId":"MTBLS2322","studyUrl":"http://integmet.org/study/MTBLS2322","title":"G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera","topHits":[{"chebi_id":"16113","direction":"down","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":0.001387789891055,"ratio":0.0188598652866765,"synonym_name":"CHOLESTEROL"},{"chebi_id":"40356","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-\u03b1-<small>D</small>-galactopyranose","metabolite_id":"OVRNDRQMDRJTHS-CBQIKETKSA-N","pvalue":0.0024428194103303,"ratio":14.5731070187466,"synonym_name":"TN antigen saccharide"},{"chebi_id":"17268","direction":"up","inn_name":"","iupac_name":"<i>myo</i>-inositol","metabolite_id":"CDAISMWEOUEBRE-GPIVLXJGSA-N","pvalue":0.0031900204619978,"ratio":14.449325191153076,"synonym_name":"D-myo-Inositol"},{"chebi_id":"58045","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":2.1093676228843757e-05,"ratio":3.5575601898182745,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"},{"chebi_id":"58199","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-4-sulfanylbutanoate","metabolite_id":"FFFHZYDWPBMWHY-VKHMYHEASA-N","pvalue":0.0027663721897688,"ratio":9.188535040626316,"synonym_name":""},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0030769991638688,"ratio":8.859642115353891,"synonym_name":"PEP"},{"chebi_id":"55534","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-4-methylpentanoic acid","metabolite_id":"LVRFTAZAXQPQHI-RXMQYKEDSA-N","pvalue":0.0002651443660767,"ratio":4.3770404100726585,"synonym_name":"<small>D</small>-2-hydroxy-4-methylvaleric acid"},{"chebi_id":"60645","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-methylbutanoic acid","metabolite_id":"NGEWQZIDQIYUNV-UHFFFAOYSA-N","pvalue":0.0006123307017922,"ratio":4.906235972204765,"synonym_name":"3-Methyl-2-hydroxybutyric acid"},{"chebi_id":"18101","direction":"up","inn_name":"","iupac_name":"(4-hydroxyphenyl)acetic acid","metabolite_id":"XQXPVVBIMDBYFF-UHFFFAOYSA-N","pvalue":0.0145969865500102,"ratio":15.939392164900156,"synonym_name":"4-Hydroxyphenylacetic acid"},{"chebi_id":"57966","direction":"up","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":0.0065477915003613,"ratio":9.57992036365505,"synonym_name":"3-ammoniopropanoate"}],"totalFeatures":126},{"comparisonGroups":["Klebsiella_pneumoniae_AJ218_RPMI","Klebsiella_pneumoniae_AJ218_Pooled_sera"],"dateCreated":"2025-09-26 00:00:00","display_title":"K. pneumoniae AJ218: RPMI media vs pooled sera","group_a_title":"Samples of Klebsiella pneumoniae AJ218 grown in RPMI media.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in RPMI media.","group_b_title":"Samples of Klebsiella pneumoniae AJ218 grown in pooled sera.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in pooled sera.","id":"MTBLS2322_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":118,"studyId":"MTBLS2322","studyUrl":"http://integmet.org/study/MTBLS2322","title":"G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera","topHits":[{"chebi_id":"507393","direction":"down","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":2.607510735371284e-06,"ratio":0.0148177539873429,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"73685","direction":"up","inn_name":"","iupac_name":"2-(acetylamino)-5-amino-5-oxopentanoic acid","metabolite_id":"KSMRODHGGIIXDV-UHFFFAOYSA-N","pvalue":8.339579686993275e-07,"ratio":12.577687012608123,"synonym_name":"GlcNAc"},{"chebi_id":"45931","direction":"up","inn_name":"","iupac_name":"2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethyl dihydrogen diphosphate","metabolite_id":"AYEKOFBPNLCAJY-UHFFFAOYSA-N","pvalue":4.6610516832374e-06,"ratio":17.461415286075013,"synonym_name":"thiamin diphosphate"},{"chebi_id":"18257","direction":"up","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":2.5796760403448343e-09,"ratio":5.103570207937441,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"20392","direction":"up","inn_name":"","iupac_name":"4-hydroxyproline","metabolite_id":"PMMYEEVYMWASQN-UHFFFAOYSA-N","pvalue":0.0002372546078495,"ratio":29.757065093386355,"synonym_name":"4Hyp"},{"chebi_id":"86542","direction":"up","inn_name":"","iupac_name":"2-hydroxyhexanoic acid","metabolite_id":"NYHNVHGFPZAZGA-UHFFFAOYSA-N","pvalue":1.5736920924135896e-05,"ratio":11.203843202901584,"synonym_name":"2-hydroxycaproic acid"},{"chebi_id":"10295","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>L</small>-sorbopyranose","metabolite_id":"LKDRXBCSQODPBY-BGPJRJDNSA-N","pvalue":0.0042441888756412,"ratio":65.91139703361748,"synonym_name":"alpha-L-Sorbopyranose"},{"chebi_id":"16411","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-indol-3-ylacetic acid","metabolite_id":"SEOVTRFCIGRIMH-UHFFFAOYSA-N","pvalue":7.055955219462835e-05,"ratio":10.351195143911012,"synonym_name":"heteroauxin"},{"chebi_id":"17268","direction":"up","inn_name":"","iupac_name":"<i>myo</i>-inositol","metabolite_id":"CDAISMWEOUEBRE-GPIVLXJGSA-N","pvalue":7.180903031027339e-05,"ratio":9.734921516329395,"synonym_name":"D-myo-Inositol"},{"chebi_id":"57791","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,6<i>S</i>)-2,6-diazaniumylheptanedioate","metabolite_id":"GMKMEZVLHJARHF-SYDPRGILSA-N","pvalue":0.0028230115899594,"ratio":40.40666631562319,"synonym_name":"<i>meso</i>-2,6-diaminopimelic acid zwitterion"}],"totalFeatures":243},{"comparisonGroups":["Pooled_Sera_Blood_4559","RPMI_Glucose_Blood_4559"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pneumoniae 4559 blood: pooled sera vs RPMI+glucose","group_a_title":"Samples from pooled sera in blood with serovar 14 and strain 4559.. Provides insight into the metabolic profile of Streptococcus pneumoniae strain 4559 in blood.","group_b_title":"Samples from RPMI with glucose in blood with serovar 14 and strain 4559.. Provides insight into the metabolic profile of Streptococcus pneumoniae strain 4559 in blood with glucose as a growth media.","id":"MTBLS2323_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":74,"studyId":"MTBLS2323","studyUrl":"http://integmet.org/study/MTBLS2323","title":"G1_Pooled_Sera_Blood_4559_vs_G2_RPMI_Glucose_Blood_4559","topHits":[{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":4.386284342766086e-07,"ratio":104.82014388489208,"synonym_name":"colamine phosphate"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":8.539369097306537e-10,"ratio":6.305814654920465,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":1.1523617184363083e-08,"ratio":6.692700130804346,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"28797","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-aminobutanoic acid","metabolite_id":"QWCKQJZIFLGMSD-GSVOUGTGSA-N","pvalue":7.237251865346589e-08,"ratio":6.427297633872977,"synonym_name":"(<i>R</i>)-2-aminobutyric acid"},{"chebi_id":"37712","direction":"up","inn_name":"","iupac_name":"<em>O</em>-phosphonoserine","metabolite_id":"BZQFBWGGLXLEPQ-UHFFFAOYSA-N","pvalue":0.0002010012786062,"ratio":35.741010650258595,"synonym_name":"<small>D</small><small>L</small>-serine, dihydrogen phosphate (ester)"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0113877954533014,"ratio":269.61415746814373,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"2089","direction":"up","inn_name":"","iupac_name":"2-(5-methoxy-1<em>H</em>-indol-3-yl)ethanamine","metabolite_id":"JTEJPPKMYBDEMY-UHFFFAOYSA-N","pvalue":0.0013932350532211,"ratio":41.56428811847862,"synonym_name":"5-MeOT"},{"chebi_id":"45441","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetylserine","metabolite_id":"JJIHLJJYMXLCOY-BYPYZUCNSA-N","pvalue":0.000110263960989,"ratio":13.18195588776579,"synonym_name":""},{"chebi_id":"16600","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-2-methylbut-2-enedioic acid","metabolite_id":"HNEGQIOMVPPMNR-NSCUHMNNSA-N","pvalue":3.1274569551830705e-05,"ratio":8.909472259810554,"synonym_name":"Mesaconic acid"},{"chebi_id":"16217","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one","metabolite_id":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","pvalue":3.0166161051056067e-06,"ratio":5.591386551495254,"synonym_name":"<small>D</small>-gluconic acid lactone"}],"totalFeatures":112},{"comparisonGroups":["Pooled_Sera_Blood_4559","RPMI_Glucose_Blood_4559"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pneumoniae blood: pooled sera vs RPMI+glucose media","group_a_title":"Samples from pooled sera in blood with serovar 14 and strain 4559.. Provides insight into the metabolic profile of Streptococcus pneumoniae strain 4559 in blood.","group_b_title":"Samples from RPMI with glucose in blood with serovar 14 and strain 4559.. Provides insight into the metabolic profile of Streptococcus pneumoniae strain 4559 in blood with glucose as a growth media.","id":"MTBLS2323_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":44,"studyId":"MTBLS2323","studyUrl":"http://integmet.org/study/MTBLS2323","title":"G1_Pooled_Sera_Blood_4559_vs_G2_RPMI_Glucose_Blood_4559","topHits":[{"chebi_id":"73685","direction":"up","inn_name":"","iupac_name":"2-(acetylamino)-5-amino-5-oxopentanoic acid","metabolite_id":"KSMRODHGGIIXDV-UHFFFAOYSA-N","pvalue":1.348226601007588e-05,"ratio":111.58097027204914,"synonym_name":"GlcNAc"},{"chebi_id":"28645","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":1.131465298097024e-05,"ratio":62.455739539783394,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":8.67776545428201e-05,"ratio":74.1486392128732,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"16865","direction":"up","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":7.646264959032529e-08,"ratio":6.122673555368195,"synonym_name":"GABA"},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":5.561944123595577e-07,"ratio":7.395656423548943,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":1.1862672416783806e-07,"ratio":5.391219659317252,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"57966","direction":"up","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":2.4738611108311328e-06,"ratio":6.854787532645041,"synonym_name":"3-ammoniopropanoate"},{"chebi_id":"30831","direction":"up","inn_name":"","iupac_name":"2-oxobutanoic acid","metabolite_id":"TYEYBOSBBBHJIV-UHFFFAOYSA-N","pvalue":7.898764356101184e-06,"ratio":6.978964502598135,"synonym_name":"\u03b1-ketobutyric acid"},{"chebi_id":"7916","direction":"up","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.0001435753406901,"ratio":11.452255755553496,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":2.418747273359857e-05,"ratio":5.782118515619084,"synonym_name":"L-Aspartic acid"}],"totalFeatures":74},{"comparisonGroups":["RPMI_modified_Blood_M1T1_5448","Pooled_sera_Blood_M1T1_5448"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pyogenes M1T1: RPMI modified vs pooled sera","group_a_title":"Samples from Streptococcus pyogenes M1T1 clone 5448 grown in RPMI modified media from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.","group_b_title":"Samples from Streptococcus pyogenes M1T1 clone 5448 grown in pooled sera from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.","id":"MTBLS2324_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":39,"studyId":"MTBLS2324","studyUrl":"http://integmet.org/study/MTBLS2324","title":"G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448","topHits":[{"chebi_id":"16113","direction":"down","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":0.0001236323408941,"ratio":0.0048650878825312,"synonym_name":"CHOLESTEROL"},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":2.5384974333953087e-05,"ratio":37.644019933554816,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":6.472221740636001e-05,"ratio":46.19466498992891,"synonym_name":"PEP"},{"chebi_id":"17050","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":2.256158693533574e-05,"ratio":29.737028627569103,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"17821","direction":"up","inn_name":"","iupac_name":"thymine","metabolite_id":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","pvalue":1.750946599250651e-07,"ratio":8.427723453246015,"synonym_name":"5-Methyluracil"},{"chebi_id":"18243","direction":"up","inn_name":"dopaminum","iupac_name":"4-(2-aminoethyl)benzene-1,2-diol","metabolite_id":"VYFYYTLLBUKUHU-UHFFFAOYSA-N","pvalue":0.0002403808075493,"ratio":11.413453736118518,"synonym_name":"2-(3,4-dihydroxyphenyl)ethylamine"},{"chebi_id":"7916","direction":"up","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.0008889956209888,"ratio":13.836177318267076,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"33508","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxypropanoic acid","metabolite_id":"RBNPOMFGQQGHHO-UHFFFAOYSA-N","pvalue":0.0001171455183248,"ratio":6.539955248291003,"synonym_name":"glyceric acid"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.003610349044498,"ratio":19.302226507161173,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"47013","direction":"up","inn_name":"","iupac_name":"<small>D</small>-ribofuranose","metabolite_id":"HMFHBZSHGGEWLO-SOOFDHNKSA-N","pvalue":0.0003859435452093,"ratio":5.967073574759805,"synonym_name":"D-Ribose"}],"totalFeatures":119},{"comparisonGroups":["RPMI_modified_Blood_M1T1_5448","Pooled_sera_Blood_M1T1_5448"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pyogenes M1T1: RPMI modified vs pooled sera media","group_a_title":"Samples from Streptococcus pyogenes M1T1 clone 5448 grown in RPMI modified media from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.","group_b_title":"Samples from Streptococcus pyogenes M1T1 clone 5448 grown in pooled sera from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.","id":"MTBLS2324_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":52,"studyId":"MTBLS2324","studyUrl":"http://integmet.org/study/MTBLS2324","title":"G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448","topHits":[{"chebi_id":"18307","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(<small>D</small>-galactopyranosyl) dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-LNYDKVEPSA-N","pvalue":5.912642870707808e-05,"ratio":1000000.0,"synonym_name":"UDP-D-galactopyranose"},{"chebi_id":"58000","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-GSVOUGTGSA-N","pvalue":8.913077550719368e-06,"ratio":132.97913596279295,"synonym_name":"(2<i>R</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"507393","direction":"down","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":1.1530070208321273e-07,"ratio":0.0454146229410731,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":2.576577837927519e-05,"ratio":58.80538784159302,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":4.8502082943459214e-05,"ratio":16.597255839933545,"synonym_name":"PEP"},{"chebi_id":"139123","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DQAKJEWZWDQURW-UHFFFAOYSA-N","pvalue":3.88441534474359e-06,"ratio":9.2009522397527,"synonym_name":""},{"chebi_id":"17050","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":0.003071876826669,"ratio":104.99216612104424,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"15603","direction":"up","inn_name":"","iupac_name":"<small>L</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","pvalue":3.925520132295636e-06,"ratio":8.223151838264405,"synonym_name":"<small>L</small>-Leuzin"},{"chebi_id":"17821","direction":"up","inn_name":"","iupac_name":"thymine","metabolite_id":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","pvalue":9.89762531360167e-06,"ratio":7.726096403938636,"synonym_name":"5-Methyluracil"},{"chebi_id":"7916","direction":"up","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.000131771838419,"ratio":13.413261872073155,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"}],"totalFeatures":121},{"comparisonGroups":["Merlot_Control_Free_2011","Merlot_Water_Deficit_Free_2011"],"dateCreated":"2025-09-26 00:00:00","display_title":"Merlot grapes: control vs water deficit (2011)","group_a_title":"Merlot control group with free volatile compounds in 2011. Provides baseline for comparison with water deficit treatment in Merlot for free volatile compounds in 2011","group_b_title":"Merlot water deficit group with free volatile compounds in 2011. Allows assessment of water deficit impact on Merlot free volatile compounds in 2011","id":"MTBLS2330_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS2330","studyUrl":"http://integmet.org/study/MTBLS2330","title":"G1_Merlot_Control_Free_2011_vs_G2_Merlot_Water_Deficit_Free_2011","topHits":[{"chebi_id":"16135","direction":"down","inn_name":"","iupac_name":"2-methylpropanoic acid","metabolite_id":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","pvalue":0.0003539481409349,"ratio":0.3879440885264997,"synonym_name":"2-METHYL-PROPIONIC ACID"},{"chebi_id":"28768","direction":"up","inn_name":"","iupac_name":"4-methyl-1-(propan-2-yl)benzene","metabolite_id":"HFPZCAJZSCWRBC-UHFFFAOYSA-N","pvalue":0.0067263031016972,"ratio":2.7898351648351656,"synonym_name":"<em>p</em>-cymol"},{"chebi_id":"169507","direction":"down","inn_name":"","iupac_name":"diethyl butanedioate","metabolite_id":"DKMROQRQHGEIOW-UHFFFAOYSA-N","pvalue":0.0377974908783897,"ratio":0.4305422104421469,"synonym_name":""},{"chebi_id":"2781","direction":"up","inn_name":"","iupac_name":"1-(4-hydroxy-3-methoxyphenyl)ethan-1-one","metabolite_id":"DFYRUELUNQRZTB-UHFFFAOYSA-N","pvalue":0.005118404329539,"ratio":1.5438553251794571,"synonym_name":"4-Hydroxy-3-methoxyphenyl methyl ketone"}],"totalFeatures":29},{"comparisonGroups":["Col-0_Control","Col-0_Pseudomonas"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis: control vs Pseudomonas infection","group_a_title":"Col-0 wild-type Arabidopsis thaliana under control conditions. Provides baseline data for comparison with infected Col-0 samples","group_b_title":"Col-0 wild-type Arabidopsis thaliana infected with Pseudomonas syringae. Allows assessment of infection response in Col-0 variant","id":"MTBLS2334_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS2334","studyUrl":"http://integmet.org/study/MTBLS2334","title":"Col-0_Control_vs_Col-0_Pseudomonas","topHits":[{"chebi_id":"145681","direction":"down","inn_name":"","iupac_name":"1-<em>O</em>-(2-hydroxybenzoyl)-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"XNHKMZHWRNMFCU-HMUNZLOLSA-N","pvalue":0.0016613011750339,"ratio":1e-06,"synonym_name":"salicylic acid \u03b2-<small>D</small>-glucopyranosyl ester"},{"chebi_id":"87766","direction":"down","inn_name":"","iupac_name":"2-{[(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid","metabolite_id":"TZPBMNKOLMSJPF-TWEVDUBQSA-N","pvalue":0.0020230449787416,"ratio":0.0304709685100605,"synonym_name":"salicylic acid glucopyranoside"},{"chebi_id":"16914","direction":"down","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":0.005175386019498,"ratio":0.093873886934267,"synonym_name":"o-Hydroxybenzoic acid"}],"totalFeatures":3},{"comparisonGroups":["Col-0_Control","Col-0_Pseudomonas"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis Col-0: Pseudomonas infection vs control","group_a_title":"Col-0 wild-type Arabidopsis thaliana under control conditions. Provides baseline data for comparison with infected Col-0 samples","group_b_title":"Col-0 wild-type Arabidopsis thaliana infected with Pseudomonas syringae. Allows assessment of infection response in Col-0 variant","id":"MTBLS2334_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS2334","studyUrl":"http://integmet.org/study/MTBLS2334","title":"Col-0_Control_vs_Col-0_Pseudomonas","topHits":[{"chebi_id":"17964","direction":"down","inn_name":"","iupac_name":"piperidine-2-carboxylic acid","metabolite_id":"HXEACLLIILLPRG-UHFFFAOYSA-N","pvalue":0.0004272939995233,"ratio":0.0175540188352818,"synonym_name":"homoproline"},{"chebi_id":"87766","direction":"down","inn_name":"","iupac_name":"2-{[(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid","metabolite_id":"TZPBMNKOLMSJPF-TWEVDUBQSA-N","pvalue":0.0001730311427245,"ratio":0.0682608770450909,"synonym_name":"salicylic acid glucopyranoside"},{"chebi_id":"141463","direction":"down","inn_name":"","iupac_name":"1-hydroxypiperidine-2-carboxylic acid","metabolite_id":"SEWARTPIJFHCRP-UHFFFAOYSA-N","pvalue":0.0002163061384627,"ratio":0.0689359144954286,"synonym_name":"1-hydroxy-2-piperidinecarboxylic acid"}],"totalFeatures":3},{"comparisonGroups":["Non_Bagged_Fruits","Bagged_Fruits_With_Browning"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fruits: non-bagged vs bagged with browning","group_a_title":"Fruits that have not been bagged.. Serves as a baseline to assess the impact of bagging on fruit browning.","group_b_title":"Bagged fruits that exhibit browning.. Helps in understanding the metabolic changes associated with browning in bagged fruits.","id":"MTBLS2384_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":784,"studyId":"MTBLS2384","studyUrl":"http://integmet.org/study/MTBLS2384","title":"Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning","topHits":[{"chebi_id":"169205","direction":"down","inn_name":"","iupac_name":"[6-[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"DHTPVCYNNWQRMN-UHFFFAOYSA-O","pvalue":1.6954975182903061e-07,"ratio":1.0754441953110796e-08,"synonym_name":""},{"chebi_id":"138779","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DEBINYRQIQKNDF-UHFFFAOYSA-N","pvalue":1.5989483822346244e-07,"ratio":84628596.4389336,"synonym_name":"2-methoxy-7,7,8b-trimethyloctahydrocyclopropa[4,5]indeno[5,6-c]furan-4a,5(4H)-diol"},{"chebi_id":"167925","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)-6-[(3-hydroxyphenyl)methoxy]oxane-3,4,5-triol","metabolite_id":"PNRKIXSZTUCIJN-UHFFFAOYSA-N","pvalue":3.248973361749048e-07,"ratio":36749844.87359362,"synonym_name":""},{"chebi_id":"168706","direction":"up","inn_name":"","iupac_name":"3-(2-methyluran-3-yl)sulanylbutan-2-one","metabolite_id":"AOEYNSLUBHRZPA-UHFFFAOYSA-N","pvalue":1.082790285073694e-05,"ratio":160857189.53733316,"synonym_name":""},{"chebi_id":"17275","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-2-(propan-2-yl)but-2-enedioic acid","metabolite_id":"NJMGRJLQRLFQQX-HYXAFXHYSA-N","pvalue":7.34485991450186e-06,"ratio":51229810.4461069,"synonym_name":"2-Isopropylmaleate"},{"chebi_id":"168712","direction":"down","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[4-(4-hydroxyphenyl)-8,8-dimethyl-6-(2-methylpropanoyl)-2-oxopyrano[2,3-h]chromen-5-yl]oxyoxane-2-carboxylic acid","metabolite_id":"VUHKDAJWNBVMIX-UHFFFAOYSA-N","pvalue":1.049428819226277e-05,"ratio":1.2910829845924877e-08,"synonym_name":""},{"chebi_id":"73787","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2<em>H</em>-chromen-7-yl 6-<em>O</em>-(3,4,5-trihydroxybenzoyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"UNTKZTADYPALEE-RKLFNRSMSA-N","pvalue":3.0280980762690177e-06,"ratio":8.02187401695607e-08,"synonym_name":"5,7,4'-trihydroxyflavanone 7-<em>O</em>-glucoside-6\"-<em>O</em>-gallate"},{"chebi_id":"17597","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzaldehyde","metabolite_id":"RGHHSNMVTDWUBI-UHFFFAOYSA-N","pvalue":3.749747675669952e-05,"ratio":267763890.14039952,"synonym_name":"p-Hydroxybenzaldehyde"},{"chebi_id":"168261","direction":"down","inn_name":"","iupac_name":"(2E)-2-[4-[8-[(5E)-5-[carboxy-(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxouran-3-yl]-5,6-dioxonaphthalen-2-yl]-3-hydroxy-5-oxouran-2-ylidene]-2-(4-hydroxyphenyl)acetic acid","metabolite_id":"DPDCZWLANAIGKX-HCTXVGCHSA-N","pvalue":4.2452158978319935e-05,"ratio":4.384562628529052e-09,"synonym_name":""},{"chebi_id":"167990","direction":"up","inn_name":"","iupac_name":"(E)-7-[(2R)-1-[[(2S)-2-amino-2-carboxyethoxy]-hydroxyphosphoryl]oxy-3-hexadecanoyloxypropan-2-yl]oxy-4,7-dioxohept-2-enoic acid","metabolite_id":"JLIOQNFUGAUGHJ-ZIHYZGTESA-N","pvalue":2.1566273787729348e-05,"ratio":57792722.54095294,"synonym_name":""}],"totalFeatures":1432},{"comparisonGroups":["Non_Bagged_Fruits","Bagged_Fruits_With_Browning"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fruits: non-bagged vs bagged with browning","group_a_title":"Fruits that have not been bagged.. Serves as a baseline to assess the impact of bagging on fruit browning.","group_b_title":"Bagged fruits that exhibit browning.. Helps in understanding the metabolic changes associated with browning in bagged fruits.","id":"MTBLS2384_0002_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1201,"studyId":"MTBLS2384","studyUrl":"http://integmet.org/study/MTBLS2384","title":"Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning","topHits":[{"chebi_id":"165478","direction":"down","inn_name":"","iupac_name":"(6E,9E,12E)-hexadeca-6,9,12-trienoic acid","metabolite_id":"SBEXLJDCZSJDLW-JSIPCRQOSA-N","pvalue":8.344984960257341e-09,"ratio":1.1597345005210825e-08,"synonym_name":""},{"chebi_id":"169357","direction":"down","inn_name":"","iupac_name":"[(2R)-2-hydroxy-3-[hydroxy-[(1R,4R,6R)-2,3,4,5-tetrahydroxy-6-[(2R,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl]oxyphosphoryl]oxypropyl] (9Z,12Z)-octadeca-9,12-dienoate","metabolite_id":"PIBNAUWISYGQJI-JOLMBGRLSA-N","pvalue":4.9030554113624455e-08,"ratio":1.1695053093856929e-08,"synonym_name":""},{"chebi_id":"169068","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LNDWPMYWLUFZEI-UHFFFAOYSA-N","pvalue":2.401396905568808e-08,"ratio":22096232.72843971,"synonym_name":""},{"chebi_id":"169906","direction":"down","inn_name":"","iupac_name":"[(3R,4S,6S)-3,5-dihydroxy-6-[5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-7-yl]oxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"YPLRCGKIMLXRLI-TVXZPBIFSA-N","pvalue":3.182211863109909e-07,"ratio":1.8343747042486422e-08,"synonym_name":""},{"chebi_id":"169534","direction":"down","inn_name":"","iupac_name":"(E)-4-ormyl-3-(2-oxoethyl)hex-4-enoic acid","metabolite_id":"DBMWDRVDXUPGBP-UQCOIBPSSA-N","pvalue":1.7891308674960244e-06,"ratio":2.6805801836614023e-08,"synonym_name":""},{"chebi_id":"2007","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NYCXYKOXLNBYID-UHFFFAOYSA-N","pvalue":1.4396104735516958e-06,"ratio":9.05302043456058e-08,"synonym_name":"5,7-Dihydroxychromone"},{"chebi_id":"169282","direction":"down","inn_name":"","iupac_name":"3-(1,3-benzodioxol-5-yl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one","metabolite_id":"GWACEFYEIOPAJV-MIUGBVLSSA-N","pvalue":7.3017697886160354e-06,"ratio":1.9983337271871817e-08,"synonym_name":""},{"chebi_id":"168768","direction":"down","inn_name":"","iupac_name":"[(2S,4S,5S)-4,5-dihydroxy-2-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-7-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-8-yl]-6-(hydroxymethyl)oxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"PXNSTKATGVBLJY-YLVQBOABSA-N","pvalue":7.465353017789994e-06,"ratio":2.4412532614090563e-08,"synonym_name":""},{"chebi_id":"18372","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl tetrahydrogen triphosphate","metabolite_id":"DGGUVLXVLHAAGT-XINAWCOVSA-N","pvalue":4.7207342963746785e-06,"ratio":9617651.868386382,"synonym_name":"6-[(1S,2R)-1,2-Dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"},{"chebi_id":"81077","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JAQZKPHHLRTVCY-ZHRKTGFNSA-N","pvalue":3.4253649086282124e-05,"ratio":8.61026650577531e-09,"synonym_name":""}],"totalFeatures":2169},{"comparisonGroups":["Control_Concord_Southeast","Treatment_Concord_Southeast"],"dateCreated":"2025-09-26 00:00:00","display_title":"Concord grapes: treatment vs control (Southeast region)","group_a_title":"Control group for Concord cultivar in Southeast region. Provides baseline for comparison with treated Concord samples in the Southeast region","group_b_title":"Treatment group for Concord cultivar in Southeast region. Allows assessment of treatment effects on Concord cultivar in the Southeast region","id":"MTBLS2401_0001_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS2401","studyUrl":"http://integmet.org/study/MTBLS2401","title":"G1_Control_Concord_Southeast_vs_G5_Treatment_Concord_Southeast","topHits":[{"chebi_id":"90","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":0.0025894655340319,"ratio":0.5631522390826438,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"23053","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PFTAWBLQPZVEMU-UHFFFAOYSA-N","pvalue":0.0021907619992709,"ratio":0.6199662670659545,"synonym_name":"catechins"},{"chebi_id":"30200","direction":"up","inn_name":"","iupac_name":"3-(\u03b2-<small>D</small>-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"JPUKWEQWGBDDQB-QSOFNFLRSA-N","pvalue":0.0346347687177124,"ratio":2.1426590396949208,"synonym_name":"Astragalin"},{"chebi_id":"36002","direction":"up","inn_name":"","iupac_name":"5-[(1<i>Z</i>)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-UPHRSURJSA-N","pvalue":0.0116862359967071,"ratio":1.5157384987893463,"synonym_name":"(<i>Z</i>)-resveratrol"}],"totalFeatures":19},{"comparisonGroups":["Control_Concord_Southeast","Treatment_Concord_Southeast"],"dateCreated":"2025-09-26 00:00:00","display_title":"Concord cultivar: treatment vs control in Southeast","group_a_title":"Control group for Concord cultivar in Southeast region. Provides baseline for comparison with treated Concord samples in the Southeast region","group_b_title":"Treatment group for Concord cultivar in Southeast region. Allows assessment of treatment effects on Concord cultivar in the Southeast region","id":"MTBLS2401_0002_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2401","studyUrl":"http://integmet.org/study/MTBLS2401","title":"G1_Control_Concord_Southeast_vs_G5_Treatment_Concord_Southeast","topHits":[],"totalFeatures":5},{"comparisonGroups":["Flufenacet","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Flufenacet exposure vs control samples","group_a_title":"Samples exposed to Flufenacet. Represents the effect of Flufenacet exposure","group_b_title":"Control samples with no pesticide exposure. Serves as the reference point for all pesticide exposure comparisons","id":"MTBLS2402_0001_00000023","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2402","studyUrl":"http://integmet.org/study/MTBLS2402","title":"G1_Flufenacet_vs_G23_Control","topHits":[],"totalFeatures":16},{"comparisonGroups":["Flufenacet","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Flufenacet exposure vs control samples","group_a_title":"Samples exposed to Flufenacet. Represents the effect of Flufenacet exposure","group_b_title":"Control samples with no pesticide exposure. Serves as the reference point for all pesticide exposure comparisons","id":"MTBLS2402_0002_00000023","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS2402","studyUrl":"http://integmet.org/study/MTBLS2402","title":"G1_Flufenacet_vs_G23_Control","topHits":[{"chebi_id":"136494","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SMINYPCTNJDYGK-UHFFFAOYSA-N","pvalue":9.606277727058526e-05,"ratio":16.094890510948904,"synonym_name":"chloroacetyl-2-ethyl-6-methylaniline"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MHTNLJYRURGLAC-UHFFFAOYSA-N","pvalue":0.0002376257479974,"ratio":5.712250712250712,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BUQMIGOVPVIUER-UHFFFAOYSA-N","pvalue":0.0054206901882953,"ratio":4.5598194130925505,"synonym_name":""},{"chebi_id":"83544","direction":"up","inn_name":"","iupac_name":"1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-one","metabolite_id":"ADWTYURAFSWNSU-UHFFFAOYSA-N","pvalue":0.0003746920879661,"ratio":1.9751626256652868,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"WWGFOVBITPNLNL-UHFFFAOYSA-N","pvalue":0.0435805155605788,"ratio":4.814520703346569,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PTBBMSMCUIPUSC-UHFFFAOYSA-N","pvalue":0.0063815420739427,"ratio":0.5933250927070457,"synonym_name":""}],"totalFeatures":35},{"comparisonGroups":["Control","nsPEF_7_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"nsPEF treatment vs control (7 days)","group_a_title":"Control group with no treatment. Serves as the reference point for all treatment comparisons","group_b_title":"Samples treated with nsPEF for 7 days. Represents long-term response to nsPEF treatment","id":"MTBLS2406_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":739,"studyId":"MTBLS2406","studyUrl":"http://integmet.org/study/MTBLS2406","title":"Control_vs_nsPEF_7_day","topHits":[{"chebi_id":"168327","direction":"down","inn_name":"","iupac_name":"(2S)-2-hydrazinyl-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid","metabolite_id":"CZEXQBQCMOVXGP-NSHDSACASA-N","pvalue":3.6455296591107875e-11,"ratio":1.3597720571537052e-10,"synonym_name":""},{"chebi_id":"175165","direction":"down","inn_name":"","iupac_name":"8,17-dihydroxy-6,19-dimethoxy-14,14-dimethyl-3,15-dioxapentacyclo[11.6.1.02,11.04,9.016,20]icosa-1(19),2(11),4,6,8,16(20),17-heptaen-10-one","metabolite_id":"LDQNIBPJKBVZEF-UHFFFAOYSA-N","pvalue":3.343576412077613e-12,"ratio":1.068671146306566e-09,"synonym_name":""},{"chebi_id":"167953","direction":"down","inn_name":"","iupac_name":"2-[4,5-dihydroxy-6-(hydroxymethyl)piperidin-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"CQLSQWAVFSEMIE-UHFFFAOYSA-N","pvalue":2.7447422427969545e-10,"ratio":2.409296897094288e-10,"synonym_name":""},{"chebi_id":"73646","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-proline","metabolite_id":"RWCOTTLHDJWHRS-YUMQZZPRSA-N","pvalue":1.956466595160193e-09,"ratio":2.2179927046137e-10,"synonym_name":"P-P"},{"chebi_id":"168958","direction":"down","inn_name":"","iupac_name":"6-[6-[(2-carboxyacetyl)oxymethyl]-2,4,5-trihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"NOLPUILTGZBYGW-UHFFFAOYSA-N","pvalue":5.557439396165735e-10,"ratio":2.439957053411744e-09,"synonym_name":""},{"chebi_id":"8674","direction":"down","inn_name":"","iupac_name":"4,6-dimethyl-<em>N</em>-phenylpyrimidin-2-amine","metabolite_id":"ZLIBICFPKPWGIZ-UHFFFAOYSA-N","pvalue":1.6176093378785748e-08,"ratio":1.3132216748755047e-10,"synonym_name":"4,6-Dimethyl-N-phenyl-2-pyrimidinamine"},{"chebi_id":"173621","direction":"down","inn_name":"","iupac_name":"1-(2-amino-3-hydroxybutanoyl)pyrrolidine-2-carboxylic acid","metabolite_id":"QOLYAJSZHIJCTO-UHFFFAOYSA-N","pvalue":3.2260929283082395e-08,"ratio":1.6823241909026099e-09,"synonym_name":""},{"chebi_id":"36791","direction":"down","inn_name":"escitalopram","iupac_name":"(1<i>S</i>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile","metabolite_id":"WSEQXVZVJXJVFP-FQEVSTJZSA-N","pvalue":5.816087911522803e-07,"ratio":2.2664320394124703e-10,"synonym_name":"<i>S</i>(+)-citalopram"},{"chebi_id":"168143","direction":"down","inn_name":"","iupac_name":"2-[2-[(E)-pent-2-enyl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid","metabolite_id":"GJZJZRWFRZFTEE-ONEGZZNKSA-N","pvalue":8.450745944824998e-07,"ratio":1.7409886010655998e-10,"synonym_name":""},{"chebi_id":"16353","direction":"down","inn_name":"","iupac_name":"2-[(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyloxy]-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"HUJXHFRXWWGYQH-UHFFFAOYSA-O","pvalue":3.5813788579449127e-06,"ratio":2.1590187438228136e-09,"synonym_name":"Sinapoylcholine"}],"totalFeatures":2383},{"comparisonGroups":["Control","nsPEF_7_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"7-day nsPEF treatment vs control","group_a_title":"Control group with no treatment. Serves as the reference point for all treatment comparisons","group_b_title":"Samples treated with nsPEF for 7 days. Represents long-term response to nsPEF treatment","id":"MTBLS2406_0002_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1229,"studyId":"MTBLS2406","studyUrl":"http://integmet.org/study/MTBLS2406","title":"Control_vs_nsPEF_7_day","topHits":[{"chebi_id":"179182","direction":"down","inn_name":"","iupac_name":"4,5-dimethyl-2-(2-methylpropyl)-2,5-dihydro-1,3-thiazole","metabolite_id":"FDOISHJOXPONIV-UHFFFAOYSA-N","pvalue":8.691378786469063e-11,"ratio":5.5859798933171137e-11,"synonym_name":""},{"chebi_id":"63971","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-ethanimidoyl-<small>L</small>-lysine","metabolite_id":"ONYFNWIHJBLQKE-ZETCQYMHSA-N","pvalue":6.215880234942887e-08,"ratio":4.104921789445534e-12,"synonym_name":"<em>N</em><small><sup>6</small></sup>-acetimidoyllysine"},{"chebi_id":"70811","direction":"down","inn_name":"","iupac_name":"5-amino-2-[(1<em>H</em>-indol-3-ylacetyl)amino]-5-oxopentanoic acid","metabolite_id":"DVJIJAYHBZALOJ-UHFFFAOYSA-N","pvalue":2.0829433605571637e-07,"ratio":1.374167997179067e-10,"synonym_name":"<em>N</em>-indoleacetylglutamine"},{"chebi_id":"133412","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>,2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-2,3,4,5-tetrahydroxy-6-methoxycyclohexyl \u03b1-<small>D</small>-galactopyranoside","metabolite_id":"RSYNCMYDVZFZBP-KEUHYNFLSA-N","pvalue":1.3701481660254306e-07,"ratio":1.2125590478894651e-09,"synonym_name":"<small>D</small>-galactosylononitol"},{"chebi_id":"17802","direction":"down","inn_name":"","iupac_name":"5-(\u03b2-<small>D</small>-ribofuranosyl)pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"PTJWIQPHWPFNBW-GBNDHIKLSA-N","pvalue":5.477221128479316e-06,"ratio":2.8122704828287033e-09,"synonym_name":"Pseudouridine"},{"chebi_id":"36219","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-XLOQQCSPSA-N","pvalue":6.660971347839482e-06,"ratio":2.3433930156154662e-09,"synonym_name":"LACTOSE"},{"chebi_id":"177774","direction":"down","inn_name":"","iupac_name":"3-(4-chloro-1H-indol-3-yl)-2-[(3-ethoxy-3-oxopropanoyl)amino]propanoic acid","metabolite_id":"DWVLUSJVGYOTDB-UHFFFAOYSA-N","pvalue":1.8972986435549957e-05,"ratio":3.7329203097985893e-10,"synonym_name":""},{"chebi_id":"63638","direction":"down","inn_name":"vigabatrinum","iupac_name":"4-aminohex-5-enoic acid","metabolite_id":"PJDFLNIOAUIZSL-UHFFFAOYSA-N","pvalue":7.567865436588897e-05,"ratio":9.148524186492951e-11,"synonym_name":"gamma-vinyl GABA"},{"chebi_id":"179839","direction":"down","inn_name":"","iupac_name":"(E)-3-(4-methoxy-3-sulooxyphenyl)prop-2-enoic acid","metabolite_id":"DCMKMHVTKFJMAU-HWKANZROSA-N","pvalue":5.2482145743695944e-05,"ratio":3.985009778314762e-10,"synonym_name":""},{"chebi_id":"176719","direction":"down","inn_name":"","iupac_name":"(2S)-6-amino-2-ormamidohexanamide","metabolite_id":"DKPYGQKMNSGPGT-LURJTMIESA-N","pvalue":2.105279081572843e-13,"ratio":0.0009467554849738,"synonym_name":""}],"totalFeatures":5138},{"comparisonGroups":["Control","CIA"],"dateCreated":"2025-09-26 00:00:00","display_title":"DBA/1J mice: collagen-induced arthritis vs control","group_a_title":"Healthy control group of DBA/1J male mice.. Serves as the reference group to assess the effects of collagen-induced arthritis.","group_b_title":"Collagen-induced arthritis group of DBA/1J male mice.. Represents the condition of interest to study the effects of collagen-induced arthritis.","id":"MTBLS243_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS243","studyUrl":"http://integmet.org/study/MTBLS243","title":"Control_vs_CIA","topHits":[],"totalFeatures":33},{"comparisonGroups":["Olfactory_Bulb_6w","Olfactory_Bulb_68w"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse olfactory bulb: 6-week vs 68-week old","group_a_title":"Samples from the olfactory bulb of 6-week-old mice.. Provides insight into sterol lipid metabolism in the olfactory bulb at an early age.","group_b_title":"Samples from the olfactory bulb of 68-week-old mice.. Provides insight into sterol lipid metabolism in the olfactory bulb at an older age.","id":"MTBLS2457_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS2457","studyUrl":"http://integmet.org/study/MTBLS2457","title":"Olfactory_Bulb_6w_vs_Olfactory_Bulb_68w","topHits":[{"chebi_id":"173045","direction":"up","inn_name":"","iupac_name":"(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol","metabolite_id":"ONQRKEUAIJMULO-SPBTXPORSA-N","pvalue":0.0272060034670456,"ratio":3.118368475670387,"synonym_name":""}],"totalFeatures":115},{"comparisonGroups":["WT","WT_Aco"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. brucei: Acoziborole treatment vs untreated control","group_a_title":"Wild-type Trypanosoma brucei samples without treatment.. Serves as the reference point for all treatment comparisons.","group_b_title":"Wild-type Trypanosoma brucei samples treated with Acoziborole.. Demonstrates the effect of Acoziborole on wild-type organisms.","id":"MTBLS2559_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":134,"studyId":"MTBLS2559","studyUrl":"http://integmet.org/study/MTBLS2559","title":"WT_vs_WT_Aco","topHits":[{"chebi_id":"183111","direction":"down","inn_name":"","iupac_name":"4-luoro-N-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-6-yl)-2-(triluoromethyl)benzamide","metabolite_id":"PTYGDEXEGLDNAZ-UHFFFAOYSA-N","pvalue":5.697897584459463e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"183113","direction":"down","inn_name":"","iupac_name":"2-(hydroxymethyl)-2H-uran-5-one","metabolite_id":"AWNLUIGMHSSXHB-UHFFFAOYSA-N","pvalue":1.912401758113135e-05,"ratio":0.1667889646340865,"synonym_name":""},{"chebi_id":"183212","direction":"up","inn_name":"","iupac_name":"2-[[2-[[1-(2,4-diamino-4-oxobutanoyl)pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoic acid","metabolite_id":"IIQIOFVDFOLCHP-UHFFFAOYSA-N","pvalue":0.0008266275146527,"ratio":12.333897755565983,"synonym_name":""},{"chebi_id":"57805","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamido-5-azaniumylpentanoate","metabolite_id":"JRLGPAXAGHMNOL-LURJTMIESA-N","pvalue":0.0001703965682384,"ratio":0.1859581458466765,"synonym_name":"(2<i>S</i>)-2-acetamido-5-ammoniopentanoate"},{"chebi_id":"61138","direction":"down","inn_name":"","iupac_name":"<em>N</em>-hydroxy-<small>L</small>-valine","metabolite_id":"PXEKBQAJOBYINU-BYPYZUCNSA-N","pvalue":0.0023541965907276,"ratio":0.1191948153738643,"synonym_name":"<em>N</em>-hydroxyvaline"},{"chebi_id":"73701","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-proline","metabolite_id":"GIAZPLMMQOERPN-YUMQZZPRSA-N","pvalue":0.0031550144275082,"ratio":7.81577318918232,"synonym_name":"valylproline"},{"chebi_id":"73209","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-1-[(hydroxy{[(1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]-3-(hexadecanoyloxy)propan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoate","metabolite_id":"KIQYUSYSJTUGFZ-LSLODQAYSA-N","pvalue":4.850706133674218e-05,"ratio":2.9155372380996596,"synonym_name":"Phosphatidylinositol(36:4)"},{"chebi_id":"57532","direction":"down","inn_name":"","iupac_name":"8-azaniumyl-7-oxononanoate","metabolite_id":"GUAHPAJOXVYFON-UHFFFAOYSA-N","pvalue":0.0005497201907673,"ratio":0.2437316964993687,"synonym_name":"8-ammonio-7-oxononanoate"},{"chebi_id":"137339","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-prolyl-<small>L</small>-serine","metabolite_id":"SSYBNWFXCFNRFN-GUBZILKMSA-N","pvalue":0.0014589270754077,"ratio":4.970554642478596,"synonym_name":"<small>L</small>-Val-<small>L</small>-Pro-<small>L</small>-Ser"},{"chebi_id":"162893","direction":"down","inn_name":"","iupac_name":"(2R)-1-[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid","metabolite_id":"KUTPGXNAAOQSPD-LPEHRKFASA-N","pvalue":0.0140763250978229,"ratio":0.095647741631698,"synonym_name":""}],"totalFeatures":739},{"comparisonGroups":["Wild_Type","Transgenic"],"dateCreated":"2025-09-26 00:00:00","display_title":"Switchgrass: wild-type vs PtLecRLK1 transgenic","group_a_title":"Wild type switchgrass samples. Serves as the baseline for evaluating the effects of genetic modification.","group_b_title":"Transgenic switchgrass samples with PtLecRLK1 gene. Key to understanding the effects of PtLecRLK1 gene introduction on root colonization by L. bicolor.","id":"MTBLS2597_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS2597","studyUrl":"http://integmet.org/study/MTBLS2597","title":"Wild_Type_vs_Transgenic","topHits":[{"chebi_id":"28044","direction":"down","inn_name":"","iupac_name":"2-amino-3-phenylpropanoic acid","metabolite_id":"COLNVLDHVKWLRT-UHFFFAOYSA-N","pvalue":0.0057231590862369,"ratio":1e-06,"synonym_name":"alpha-Amino-beta-phenylpropionic acid"},{"chebi_id":"16112","direction":"up","inn_name":"","iupac_name":"edit(1<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3-{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid","metabolite_id":"CWVRJTMFETXNAD-JUHZACGLSA-N","pvalue":8.551279493364826e-10,"ratio":30.19188149214038,"synonym_name":"5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid"},{"chebi_id":"28300","direction":"down","inn_name":"","iupac_name":"glutamine","metabolite_id":"ZDXPYRJPNDTMRX-UHFFFAOYSA-N","pvalue":0.0257839300645581,"ratio":1e-06,"synonym_name":"Glutamine"},{"chebi_id":"86348","direction":"down","inn_name":"","iupac_name":"2,4-dihydroxybutanoic acid","metabolite_id":"UFYGCFHQAXXBCF-UHFFFAOYSA-N","pvalue":2.1995517324805886e-06,"ratio":0.0244413522299141,"synonym_name":"2,4-dihydroxybutyric acid"},{"chebi_id":"17025","direction":"down","inn_name":"","iupac_name":"(4<i>S</i>)-2,6-dioxohexahydropyrimidine-4-carboxylic acid","metabolite_id":"UFIVEPVSAGBUSI-REOHCLBHSA-N","pvalue":0.0048415316799102,"ratio":0.0201605994210739,"synonym_name":"L-Dihydroorotic acid"},{"chebi_id":"68950","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JYFOSWJYZIVJPO-YGEZULPYSA-N","pvalue":1.1154055419621964e-06,"ratio":0.2602272090800092,"synonym_name":""},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":0.0015725583395942,"ratio":0.0688475150520013,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"15908","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonic acid","metabolite_id":"JPIJQSOTBSSVTP-STHAYSLISA-N","pvalue":2.6707423835018517e-08,"ratio":0.4200388114780174,"synonym_name":""},{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0028445750609074,"ratio":0.0782612550754305,"synonym_name":"Glutaminic acid"},{"chebi_id":"77860","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-cyanopropanoate","metabolite_id":"BXRLWGXPSRYJDZ-VKHMYHEASA-N","pvalue":0.048545658518783,"ratio":0.0087148386670398,"synonym_name":"(2<i>S</i>)-2-ammonio-3-cyanopropanoate"}],"totalFeatures":47},{"comparisonGroups":["Exp1_0_hours","Exp1_6_hours"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline (0h) vs 6-hour timepoint comparison","group_a_title":"Samples collected at 0 hours. Baseline group for comparison with samples at later time points.","group_b_title":"Samples collected at 6 hours. Represents later time point for observing changes over time.","id":"MTBLS2630_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS2630","studyUrl":"http://integmet.org/study/MTBLS2630","title":"G1_Exp1_0_hours_vs_G2_Exp1_6_hours","topHits":[{"chebi_id":"151125","direction":"down","inn_name":"","iupac_name":"methyl triacontanoate","metabolite_id":"BIRUBGLRQLAEFF-UHFFFAOYSA-N","pvalue":0.0133459761970904,"ratio":0.0466609011270581,"synonym_name":""},{"chebi_id":"17044","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-glucitol","metabolite_id":"GACTWZZMVMUKNG-SLPGGIOYSA-N","pvalue":0.0228953256698561,"ratio":10.736980292903755,"synonym_name":"D-Glucitol 6-phosphate"},{"chebi_id":"57966","direction":"up","inn_name":"","iupac_name":"3-azaniumylpropanoate","metabolite_id":"UCMIRNVEIXFBKS-UHFFFAOYSA-N","pvalue":0.0122151010350229,"ratio":5.251959012086625,"synonym_name":"3-ammoniopropanoate"},{"chebi_id":"16997","direction":"down","inn_name":"","iupac_name":"propane-1,2-diol","metabolite_id":"DNIAPMSPPWPWGF-UHFFFAOYSA-N","pvalue":0.0132424354181275,"ratio":-2.5227292003188175,"synonym_name":"Propane-1,2-diol"},{"chebi_id":"422","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-REOHCLBHSA-N","pvalue":0.0033667507754955,"ratio":-3.243082343711373,"synonym_name":"L-Lactic acid"},{"chebi_id":"20067","direction":"down","inn_name":"","iupac_name":"3-hydroxybutanoic acid","metabolite_id":"WHBMMWSBFZVSSR-UHFFFAOYSA-N","pvalue":0.0044737980843197,"ratio":-3.3157419666108288,"synonym_name":"\u03b2-hydroxy-<em>n</em>-butyric acid"},{"chebi_id":"340824","direction":"down","inn_name":"","iupac_name":"methyl dihydrogen phosphate","metabolite_id":"CAAULPUQFIIOTL-UHFFFAOYSA-N","pvalue":1.7305906130140598e-05,"ratio":-0.7469218038912161,"synonym_name":"monomethyl phosphate"},{"chebi_id":"30794","direction":"down","inn_name":"","iupac_name":"propanedioic acid","metabolite_id":"OFOBLEOULBTSOW-UHFFFAOYSA-N","pvalue":0.0001089298133347,"ratio":-2.634069543500445,"synonym_name":"Propanedioic acid"},{"chebi_id":"42383","direction":"down","inn_name":"","iupac_name":"ethyl dihydrogen phosphate","metabolite_id":"ZJXZSIYSNXKHEA-UHFFFAOYSA-N","pvalue":2.9814731933073737e-05,"ratio":-3.5172915918440077,"synonym_name":"Phosphoric acid monoethyl ester"},{"chebi_id":"16016","direction":"down","inn_name":"","iupac_name":"1,3-dihydroxypropan-2-one","metabolite_id":"RXKJFZQQPQGTFL-UHFFFAOYSA-N","pvalue":2.735794807779841e-06,"ratio":-4.681438106171484,"synonym_name":"DHA"}],"totalFeatures":62},{"comparisonGroups":["Alcohol_Treatment","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Rat serum: alcohol treatment vs control","group_a_title":"Rats subjected to alcohol treatment. Key group for assessing the impact of alcohol on gut microbiota and serum metabolic profile","group_b_title":"Control group of rats not subjected to alcohol treatment. Provides baseline data for comparison with alcohol-treated group","id":"MTBLS2688_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS2688","studyUrl":"http://integmet.org/study/MTBLS2688","title":"Alcohol_Treatment_vs_Control","topHits":[{"chebi_id":"82914","direction":"down","inn_name":"","iupac_name":"4-methylphenyl hydrogen sulfate","metabolite_id":"WGNAKZGUSRVWRH-UHFFFAOYSA-N","pvalue":0.0139829568132166,"ratio":0.1588619595026646,"synonym_name":"4-cresol sulfate"},{"chebi_id":"17859","direction":"up","inn_name":"","iupac_name":"pentanedioic acid","metabolite_id":"JFCQEDHGNNZCLN-UHFFFAOYSA-N","pvalue":0.0001082835418652,"ratio":1.6544709504318604,"synonym_name":"Glutaric acid"},{"chebi_id":"59270","direction":"down","inn_name":"","iupac_name":"2-hydroxytetradecanoic acid","metabolite_id":"JYZJYKOZGGEXSX-UHFFFAOYSA-N","pvalue":0.0013306915833057,"ratio":0.6375412570190067,"synonym_name":"\u03b1-hydroxy-<em>n</em>-tetradecylic acid"},{"chebi_id":"52649","direction":"down","inn_name":"","iupac_name":"<em>O</em>-[hydroxy({(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl}oxy)phosphoryl]-<small>L</small>-serine","metabolite_id":"JZWNYZVVZXZRRH-YFKVPUFHSA-N","pvalue":0.0239853735365034,"ratio":0.5731524644417753,"synonym_name":"1-oleoyl-<em>sn</em>-glycero-3-phosphoserine"}],"totalFeatures":53},{"comparisonGroups":["Alcohol_Treatment","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Rat serum: alcohol treatment vs control","group_a_title":"Rats subjected to alcohol treatment. Key group for assessing the impact of alcohol on gut microbiota and serum metabolic profile","group_b_title":"Control group of rats not subjected to alcohol treatment. Provides baseline data for comparison with alcohol-treated group","id":"MTBLS2688_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS2688","studyUrl":"http://integmet.org/study/MTBLS2688","title":"Alcohol_Treatment_vs_Control","topHits":[{"chebi_id":"27480","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(phenylacetyl)glycine","metabolite_id":"UTYVDVLMYQPLQB-UHFFFAOYSA-N","pvalue":4.311504841307681e-05,"ratio":0.5099871661369418,"synonym_name":"Phenaceturic acid"},{"chebi_id":"46966","direction":"down","inn_name":"","iupac_name":"2-amino-1-hydroxyoctadecan-3-one","metabolite_id":"KBUNOSOGGAARKZ-UHFFFAOYSA-N","pvalue":0.0246081106723087,"ratio":0.2117419537570515,"synonym_name":"2-amino-1-hydroxy-3-octadecanone"},{"chebi_id":"57947","direction":"down","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":3.7581975046479414e-05,"ratio":0.5806864839398932,"synonym_name":""},{"chebi_id":"73061","direction":"down","inn_name":"","iupac_name":"3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-UHFFFAOYSA-N","pvalue":0.0053832981134507,"ratio":0.50033446819063,"synonym_name":"myristoylcarnitine"},{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0006381061502483,"ratio":0.612325179529663,"synonym_name":"L-Lysine"},{"chebi_id":"16870","direction":"up","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":0.0017181857253325,"ratio":1.7491774484414124,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"17490","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-hexadecanoyloxy-4-(trimethylammonio)butanoate","metabolite_id":"XOMRRQXKHMYMOC-OAQYLSRUSA-N","pvalue":0.0065181912838219,"ratio":0.504211782230338,"synonym_name":"Hexadecenoyl carnitine"},{"chebi_id":"145277","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DSOWUEHXZJUNID-WHXUGTBJSA-N","pvalue":0.0076818169387156,"ratio":2.0024636664823907,"synonym_name":"LysoPE 16:1(9Z)/0:0"},{"chebi_id":"77086","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"FUJLYHJROOYKRA-QGZVFWFLSA-N","pvalue":0.0062682574677388,"ratio":0.5223622533044016,"synonym_name":"(3<i>R</i>)-3-(dodecanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"41254","direction":"down","inn_name":"","iupac_name":"2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid","metabolite_id":"WMCQWXZMVIETAO-UHFFFAOYSA-N","pvalue":0.0144676921384936,"ratio":0.4983298744525076,"synonym_name":"CMPF"}],"totalFeatures":73},{"comparisonGroups":["Cichorium intybus var. Symphonie_16C_2w","Cichorium intybus var. Symphonie_16C_3w"],"dateCreated":"2025-09-26 00:00:00","display_title":"Symphonie chicory: 16\u00b0C 2 weeks vs 3 weeks","group_a_title":"Samples of Cichorium intybus var. Symphonie at 16\u00b0C for 2 weeks. Represents a specific condition of temperature and duration for the Symphonie variety.","group_b_title":"Samples of Cichorium intybus var. Symphonie at 16\u00b0C for 3 weeks. Represents a specific condition of temperature and duration for the Symphonie variety.","id":"MTBLS270_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS270","studyUrl":"http://integmet.org/study/MTBLS270","title":"Symphonie_16C_2w_vs_3w","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SNIFBMIPCYBVSS-IOPVRHDVSA-N","pvalue":3.941104056421192e-07,"ratio":3.1725778753041065,"synonym_name":""},{"chebi_id":"520","direction":"down","inn_name":"","iupac_name":"(1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-1,3-bis{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexane-1-carboxylic acid","metabolite_id":"YDDUMTOHNYZQPO-RVXRWRFUSA-N","pvalue":0.0001353827611394,"ratio":0.158857821007305,"synonym_name":"1,5-Dicaffeoylquinic acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZHZZKRDEPZMPLJ-PCDSSTERSA-N","pvalue":3.080792879162727e-05,"ratio":2.7401358653161214,"synonym_name":""},{"chebi_id":"64554","direction":"up","inn_name":"","iupac_name":"2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-UHFFFAOYSA-N","pvalue":2.7759001121964434e-06,"ratio":2.0850943020059844,"synonym_name":"2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"3594","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2,3-bis{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid","metabolite_id":"YDDGKXBLOXEEMN-IABMMNSOSA-N","pvalue":0.0058390712636202,"ratio":4.321632187652714,"synonym_name":"Chicoric acid"},{"chebi_id":"36281","direction":"up","inn_name":"","iupac_name":"3-(3,4-dihydroxyphenyl)prop-2-enoic acid","metabolite_id":"QAIPRVGONGVQAS-UHFFFAOYSA-N","pvalue":0.0039170306279439,"ratio":3.853658536585366,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DLXJJCZRGOSZAZ-IOPVRHDVSA-N","pvalue":0.0115373122079667,"ratio":1.6719776761749623,"synonym_name":""}],"totalFeatures":22},{"comparisonGroups":["Control","CF_high"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose Zhuyu Pill treatment","group_a_title":"Control group with no treatment applied.. Provides baseline data for comparison with treated groups.","group_b_title":"High dose Zhuyu Pill treatment group.. Evaluates the effect of high dose Zhuyu Pill on cholestasis.","id":"MTBLS2721_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":46,"studyId":"MTBLS2721","studyUrl":"http://integmet.org/study/MTBLS2721","title":"Control_vs_CF_high","topHits":[{"chebi_id":"173128","direction":"down","inn_name":"","iupac_name":"6-(2-benzoyloxy-5-prop-2-enylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"RNHPWASTISTGIP-UHFFFAOYSA-N","pvalue":0.0006361963799051,"ratio":3.5468567606123903e-10,"synonym_name":""},{"chebi_id":"173184","direction":"down","inn_name":"","iupac_name":"3-[7-(uran-3-yl)-1,8,15,15-tetramethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.02,4.02,8.012,16]octadecan-12-yl]-3-hydroxypropanoic acid","metabolite_id":"SZSLZBYOLTYIOE-UHFFFAOYSA-N","pvalue":0.0061345840044748,"ratio":1.0771267269228312e-10,"synonym_name":""},{"chebi_id":"173131","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-[7-hydroxy-2-(hydroxymethyl)-2-(4-methylpent-3-enyl)chromen-6-yl]-2,3-dihydrochromen-4-one","metabolite_id":"ISLXOQLYOVJTQL-UHFFFAOYSA-N","pvalue":3.14751528686693e-05,"ratio":0.0004260401927851,"synonym_name":""},{"chebi_id":"173126","direction":"down","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[2-[9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl]propan-2-yloxy]oxane-2-carboxylic acid","metabolite_id":"UVISYWPYGSRGJF-UHFFFAOYSA-N","pvalue":6.2188809691309875e-06,"ratio":0.001401000669502,"synonym_name":""},{"chebi_id":"3506","direction":"down","inn_name":"cefprozilum","iupac_name":"(6<i>R</i>,7<i>R</i>)-7-{[(2<i>R</i>)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","metabolite_id":"WDLWHQDACQUCJR-PBFPGSCMSA-N","pvalue":0.0005675358926091,"ratio":0.0001621223352844,"synonym_name":"Cefprozil anhydrous"},{"chebi_id":"173129","direction":"down","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[2-(2-methoxy-4-prop-2-enylphenoxy)carbonylphenoxy]oxane-2-carboxylic acid","metabolite_id":"JFHIFUDPQDOKTR-UHFFFAOYSA-N","pvalue":0.0011402409521785,"ratio":0.0001591113570181,"synonym_name":""},{"chebi_id":"173144","direction":"down","inn_name":"","iupac_name":"[(3S,4S,6S)-3,4,5-trihydroxy-6-[3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl acetate","metabolite_id":"HZJBDSMAAFNHHL-HSQINTTRSA-N","pvalue":1.2824248392529745e-05,"ratio":0.0098764529438723,"synonym_name":""},{"chebi_id":"173158","direction":"down","inn_name":"","iupac_name":"(1R,2R,4S,7S,8S,11R,12R,18R)-7-(uran-3-yl)-13-hydroxy-1,8,12,17,17-pentamethyl-3,6,16-trioxapentacyclo[9.9.0.02,4.02,8.012,18]icosane-5,15,20-trione","metabolite_id":"HWAJASVMTDEFJN-MKBHYRRPSA-N","pvalue":0.0035804669347967,"ratio":0.0008272263519883,"synonym_name":""},{"chebi_id":"173182","direction":"down","inn_name":"","iupac_name":"2-[4,5-dihydroxy-6-(hydroxymethyl)-2-(2,4,5-trihydroxyoxan-3-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol","metabolite_id":"DPTWUYFOEZBIEX-UHFFFAOYSA-N","pvalue":0.0036053682493433,"ratio":0.0030583023306189,"synonym_name":""},{"chebi_id":"81555","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HVDGDHBAMCBBLR-PBHICJAKSA-N","pvalue":6.768459573581056e-08,"ratio":5.810124137665733,"synonym_name":"3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one"}],"totalFeatures":110},{"comparisonGroups":["Control","CF_high"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose Zhuyu Pill treatment","group_a_title":"Control group with no treatment applied.. Provides baseline data for comparison with treated groups.","group_b_title":"High dose Zhuyu Pill treatment group.. Evaluates the effect of high dose Zhuyu Pill on cholestasis.","id":"MTBLS2721_0002_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2721","studyUrl":"http://integmet.org/study/MTBLS2721","title":"Control_vs_CF_high","topHits":[],"totalFeatures":2},{"comparisonGroups":["Control","CF_high"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high-dose Zhuyu Pill treatment","group_a_title":"Control group with no treatment applied.. Provides baseline data for comparison with treated groups.","group_b_title":"High dose Zhuyu Pill treatment group.. Evaluates the effect of high dose Zhuyu Pill on cholestasis.","id":"MTBLS2721_0003_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":89,"studyId":"MTBLS2721","studyUrl":"http://integmet.org/study/MTBLS2721","title":"Control_vs_CF_high","topHits":[{"chebi_id":"169170","direction":"down","inn_name":"","iupac_name":"[butoxy(ethylsulanyl)phosphoryl]sulanylmethylbenzene","metabolite_id":"WRIYPTGFYKBSFU-UHFFFAOYSA-N","pvalue":2.2014687591729267e-05,"ratio":0.0020863158412297,"synonym_name":""},{"chebi_id":"141524","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(3<i>R</i>)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1<em>H</em>-2-benzopyran-7-carbonyl]-<small>L</small>-phenylalanine","metabolite_id":"DAEYIVCTQUFNTM-ABAIWWIYSA-N","pvalue":9.475737795211908e-05,"ratio":0.0010978661840634,"synonym_name":"<em>N</em>-{[(3<i>R</i>)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1<em>H</em>-isochromen-7-yl]carbonyl}-<small>L</small>-phenylalanine"},{"chebi_id":"16226","direction":"down","inn_name":"","iupac_name":"(4a<i>S</i>,6a<i>R</i>,8a<i>R</i>,8b<i>R</i>,9a<i>S</i>,12<i>R</i>,12a<i>S</i>,14a<i>R</i>,14b<i>R</i>)-12-(3-furyl)-6,6,8a,12a-tetramethyldecahydro-3<em>H</em>-oxireno[<em>d</em>]pyrano[4',3':3,3a][2]benzofuro[5,4-<em>f</em>]isochromene-3,8,10(6<em>H</em>,9a<em>H</em>)-trione","metabolite_id":"KBDSLGBFQAGHBE-MSGMIQHVSA-N","pvalue":0.0015011421792912,"ratio":0.0001128499150537,"synonym_name":"Evodin"},{"chebi_id":"166631","direction":"down","inn_name":"","iupac_name":"3-methoxy-2-phenyluro[2,3-h]chromen-4-one","metabolite_id":"LKPQNZRGGNOPPU-UHFFFAOYSA-N","pvalue":0.0011688030161545,"ratio":0.0003972143404229,"synonym_name":""},{"chebi_id":"48294","direction":"down","inn_name":"","iupac_name":"3-[2-(methylamino)ethyl]-1<em>H</em>-indol-5-ol","metabolite_id":"ASUSBMNYRHGZIG-UHFFFAOYSA-N","pvalue":1.8959117817694324e-05,"ratio":0.0117652841106992,"synonym_name":"N-Methylserotonin"},{"chebi_id":"173198","direction":"down","inn_name":"","iupac_name":"6-[[9,10-dihydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid","metabolite_id":"TWUOPSPDYDPTLF-UHFFFAOYSA-N","pvalue":0.0001657702688331,"ratio":0.0084972639584836,"synonym_name":""},{"chebi_id":"173207","direction":"down","inn_name":"","iupac_name":"6,11-dihydroxy-10-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one","metabolite_id":"AOYGNVHBYGMHGR-UHFFFAOYSA-N","pvalue":0.0049453960177628,"ratio":0.0019050636022936,"synonym_name":""},{"chebi_id":"173216","direction":"up","inn_name":"","iupac_name":"(4R)-4-[(3R,5R,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","metabolite_id":"MHMJDFLOHGJHIJ-UMNDTTGPSA-N","pvalue":0.0015333728345004,"ratio":119.85688489070333,"synonym_name":""},{"chebi_id":"16096","direction":"down","inn_name":"","iupac_name":"2,3,9,10-tetramethoxy-5,6-dihydroisoquino[3,2-<em>a</em>]isoquinolinium","metabolite_id":"QUCQEUCGKKTEBI-UHFFFAOYSA-N","pvalue":0.0085518972244862,"ratio":0.0019246642155618,"synonym_name":"5,6-Dihydro-2,3,9,10-tetramethoxydibenzo[a,g]quinolizinium"},{"chebi_id":"173150","direction":"down","inn_name":"","iupac_name":"6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1(12),2(9),10,14,16,18-hexaen-13-one","metabolite_id":"SWALXCKAJQTSAC-UHFFFAOYSA-N","pvalue":0.0230570587750496,"ratio":0.0003791475562085,"synonym_name":""}],"totalFeatures":216},{"comparisonGroups":["Male","Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Yak subcutaneous adipose: male vs female","group_a_title":"Male yaks with subcutaneous adipose tissue samples. Represents the male gender group for comparison with the female group.","group_b_title":"Female yaks with subcutaneous adipose tissue samples. Represents the female gender group for comparison with the male group.","id":"MTBLS2737_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":52,"studyId":"MTBLS2737","studyUrl":"http://integmet.org/study/MTBLS2737","title":"Male_vs_Female","topHits":[{"chebi_id":"177111","direction":"down","inn_name":"","iupac_name":"[(2R)-3-hexadecoxy-2-prop-2-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FZTHXYOLVRRAMJ-AREMUKBSSA-N","pvalue":0.0195143692876884,"ratio":0.0160345312641256,"synonym_name":""},{"chebi_id":"601027","direction":"down","inn_name":"aliskiren","iupac_name":"(2<i>S</i>,4<i>S</i>,5<i>S</i>,7<i>S</i>)-5-amino-<em>N</em>-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide","metabolite_id":"UXOWGYHJODZGMF-QORCZRPOSA-N","pvalue":0.0329848101805336,"ratio":0.0158569721886242,"synonym_name":"SPP 100"},{"chebi_id":"9907","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b2-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-UZVSRGJWSA-N","pvalue":0.0128012660278704,"ratio":0.0518913209726023,"synonym_name":"Ursodeoxycholic acid"},{"chebi_id":"166646","direction":"down","inn_name":"","iupac_name":"(1R,6S,13R)-16,17-dimethoxy-6-propan-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one","metabolite_id":"DTFARBHXORYQBF-ORYQWCPZSA-N","pvalue":0.0271900006428353,"ratio":0.0289190533557378,"synonym_name":""},{"chebi_id":"6650","direction":"down","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":5.927820439284894e-05,"ratio":0.2783045521901199,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"28683","direction":"down","inn_name":"","iupac_name":"2-amino-4-(2-aminophenyl)-4-oxobutanoic acid","metabolite_id":"YGPSJZOEDVAXAB-UHFFFAOYSA-N","pvalue":8.878115549242895e-05,"ratio":0.2852230838671634,"synonym_name":"Kynurenine"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PVOTVRVECJWYFR-GEMLJDPKSA-N","pvalue":0.007363723754125,"ratio":9.954232125454167,"synonym_name":""},{"chebi_id":"149582","direction":"down","inn_name":"","iupac_name":"3,3,14,14-tetramethylhexadecanedioic acid","metabolite_id":"HYSMCRNFENOHJH-UHFFFAOYSA-N","pvalue":0.0223370017557771,"ratio":0.0537758143258382,"synonym_name":"MEDIC-16"},{"chebi_id":"74757","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-glutamine","metabolite_id":"SHAQGFGGJSLLHE-BQBZGAKWSA-N","pvalue":0.0001682134733032,"ratio":0.2955062789873702,"synonym_name":"<small>L</small>-Pro-<small>L</small>-Gln"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0035076760933265,"ratio":0.1612523220999882,"synonym_name":"\u03b1-ketoglutaric acid"}],"totalFeatures":138},{"comparisonGroups":["Male","Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Yak subcutaneous adipose: male vs female","group_a_title":"Male yaks with subcutaneous adipose tissue samples. Represents the male gender group for comparison with the female group.","group_b_title":"Female yaks with subcutaneous adipose tissue samples. Represents the female gender group for comparison with the male group.","id":"MTBLS2737_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":30,"studyId":"MTBLS2737","studyUrl":"http://integmet.org/study/MTBLS2737","title":"Male_vs_Female","topHits":[{"chebi_id":"167961","direction":"down","inn_name":"","iupac_name":"9-oxo-11-(3-pentyloxiran-2-yl)undec-10-enoic acid","metabolite_id":"RCMABBHQYMBYKV-UHFFFAOYSA-N","pvalue":0.0246935923871052,"ratio":0.0005902716461395,"synonym_name":""},{"chebi_id":"165297","direction":"down","inn_name":"","iupac_name":"(6Z,15Z)-20-hydroxyicosa-6,15-dienoic acid","metabolite_id":"RYHYNNWEPYGEEH-WGEIWTTOSA-N","pvalue":0.0076267480368758,"ratio":0.0415875031451038,"synonym_name":""},{"chebi_id":"17687","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"RFDAIACWWDREDC-FRVQLJSFSA-N","pvalue":0.0019576358601396,"ratio":0.1145529302823477,"synonym_name":"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine"},{"chebi_id":"176415","direction":"down","inn_name":"","iupac_name":"(4R)-4-[(3R,5R,10S,13R,14R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","metabolite_id":"BCMBRGZVZCQHFO-GCIZHPIPSA-N","pvalue":0.0126673864446038,"ratio":0.0472442685162858,"synonym_name":""},{"chebi_id":"27910","direction":"down","inn_name":"","iupac_name":"(3\u03b2)-cholesta-5,7,24-trien-3-ol","metabolite_id":"RUSSPKPUXDSHNC-DDPQNLDTSA-N","pvalue":0.0316704923727564,"ratio":0.0332415346917021,"synonym_name":"cholesta-5,7,24-trien-3\u03b2-ol"},{"chebi_id":"27823","direction":"down","inn_name":"","iupac_name":"(5-hydroxy-1<em>H</em>-indol-3-yl)acetic acid","metabolite_id":"DUUGKQCEGZLZNO-UHFFFAOYSA-N","pvalue":2.214848408028573e-05,"ratio":0.3544946912449298,"synonym_name":"5-Hydroxyindoleacetic acid"},{"chebi_id":"143585","direction":"down","inn_name":"","iupac_name":"methyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"QWDCYFDDFPWISL-JEBPEJKESA-N","pvalue":0.0465969148169927,"ratio":0.0482089523448113,"synonym_name":""},{"chebi_id":"28238","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-indole-3-carbaldehyde","metabolite_id":"OLNJUISKUQQNIM-UHFFFAOYSA-N","pvalue":0.017095328605686,"ratio":0.1045666342590627,"synonym_name":"3-Indolecarboxaldehyde"},{"chebi_id":"169476","direction":"down","inn_name":"","iupac_name":"(3Z,6Z)-12-hydroxydodeca-3,6-dienoic acid","metabolite_id":"BSWDOBLGMLCOJP-NGNAIVRQSA-N","pvalue":0.0269229532839514,"ratio":0.1031507979629081,"synonym_name":""},{"chebi_id":"79177","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JHRQMZPLCYCFPI-UHFFFAOYSA-N","pvalue":0.0006968270916121,"ratio":2.8686566562792284,"synonym_name":"17-hydroxy-heptadecanoic acid"}],"totalFeatures":123},{"comparisonGroups":["Frt_Ctrl_Day_6","Rasv12_Scrib_Day_6"],"dateCreated":"2025-09-26 00:00:00","display_title":"Frt control vs Rasv12 Scrib genotype at day 6","group_a_title":"Control group with Frt genotype at day 6. Provides baseline data for comparison with other genotypes and conditions.","group_b_title":"Rasv12 Scrib genotype at day 6. Allows for comparison of Rasv12 Scrib genotype effects at day 6.","id":"MTBLS2771_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS2771","studyUrl":"http://integmet.org/study/MTBLS2771","title":"G1_Frt_Ctrl_Day_6_vs_G3_Rasv12_Scrib_Day_6","topHits":[{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0003252150376589,"ratio":0.0651848246693783,"synonym_name":"colamine phosphate"},{"chebi_id":"73685","direction":"up","inn_name":"","iupac_name":"2-(acetylamino)-5-amino-5-oxopentanoic acid","metabolite_id":"KSMRODHGGIIXDV-UHFFFAOYSA-N","pvalue":0.0012907100384909,"ratio":7.530949324474072,"synonym_name":"GlcNAc"},{"chebi_id":"44897","direction":"down","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":5.1906885913975575e-05,"ratio":0.3307036098067263,"synonym_name":"PEP"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0005626760697341,"ratio":0.2342733034044911,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"58375","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidinium-2-carboxylate","metabolite_id":"PMMYEEVYMWASQN-DMTCNVIQSA-N","pvalue":0.0018366443491313,"ratio":0.2243261525802815,"synonym_name":"hydroxyproline zwitterion"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":0.0018491722477094,"ratio":3.5275201400333422,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"18237","direction":"up","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0021522397263949,"ratio":3.501985313156411,"synonym_name":"Glutaminic acid"},{"chebi_id":"73061","direction":"up","inn_name":"","iupac_name":"3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-UHFFFAOYSA-N","pvalue":0.0317925925112148,"ratio":8.633322801371447,"synonym_name":"myristoylcarnitine"},{"chebi_id":"35492","direction":"down","inn_name":"","iupac_name":"3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-UHFFFAOYSA-N","pvalue":0.0004183827034363,"ratio":0.3886745194901802,"synonym_name":"3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"17202","direction":"up","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":0.0095051798807105,"ratio":4.62293894158343,"synonym_name":"Inosine 5'-phosphate"}],"totalFeatures":119},{"comparisonGroups":["Control","Busulfan_5_mg_kg_RAAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice: Control vs Busulfan + 5mg/kg RAAE treatment","group_a_title":"Control group with no RAAE treatment.. Serves as the baseline for comparison with RAAE-treated groups.","group_b_title":"Busulfan-treated group with 5 mg/kg RAAE.. Assesses the effect of high-dose RAAE on busulfan-treated mice.","id":"MTBLS2782_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS2782","studyUrl":"http://integmet.org/study/MTBLS2782","title":"Control_vs_Busulfan_5_mg_kg_RAAE","topHits":[{"chebi_id":"168243","direction":"up","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-propylpentanoyloxy)oxane-2-carboxylic acid","metabolite_id":"XXKSYIHWRBBHIC-JVWRJRKNSA-N","pvalue":0.0005947986072205,"ratio":3.6280231843044017,"synonym_name":""},{"chebi_id":"176385","direction":"up","inn_name":"","iupac_name":"2-amino-5-oxo-5-(pyrrolidine-2-carbonylamino)pentanoic acid","metabolite_id":"FSGFZJVYAZKWHO-UHFFFAOYSA-N","pvalue":0.0231983200779233,"ratio":10.585877243821194,"synonym_name":""},{"chebi_id":"176370","direction":"up","inn_name":"","iupac_name":"6-[3-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"DXVCSJFCGCMPOC-UHFFFAOYSA-N","pvalue":0.0024834602506866,"ratio":3.841541446426643,"synonym_name":""},{"chebi_id":"176379","direction":"up","inn_name":"","iupac_name":"[4-[1-oxo-1-(2,4,6-trihydroxyphenyl)propan-2-yl]phenyl] hydrogen sulate","metabolite_id":"QVJWMXFISOIERI-UHFFFAOYSA-N","pvalue":0.0016128011977707,"ratio":3.0124871685495314,"synonym_name":""},{"chebi_id":"68848","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(1<i>S</i>)-1-carboxy-2-methylpropyl]amino}-5-oxopentanoic acid","metabolite_id":"AQAKHZVPOOGUCK-XPUUQOCRSA-N","pvalue":0.0015756663382771,"ratio":2.9635703343381015,"synonym_name":"gamma-Glutamylvaline"},{"chebi_id":"176362","direction":"up","inn_name":"","iupac_name":"[4-(7-hydroxy-3,4-dihydro-2H-chromen-3-yl)phenyl] hydrogen sulate","metabolite_id":"UXOJWGSGKUYMIA-UHFFFAOYSA-N","pvalue":0.0002572708713868,"ratio":2.3288002182047904,"synonym_name":""},{"chebi_id":"73873","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LSOWKZULVQWMLY-APPDJCNMSA-N","pvalue":3.504896442409301e-07,"ratio":1.5416063981151684,"synonym_name":"Lyso(22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)/0:0)"},{"chebi_id":"87248","direction":"up","inn_name":"","iupac_name":"ethyl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"IWJBVMJWSPZNJH-UQGZVRACSA-N","pvalue":0.0039827673929358,"ratio":3.112014043546675,"synonym_name":""},{"chebi_id":"34151","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,10<i>E</i>,14<i>Z</i>)-12-oxoicosa-5,8,10,14-tetraenoic acid","metabolite_id":"GURBRQGDZZKITB-VXBMJZGYSA-N","pvalue":0.0105382150179758,"ratio":0.2820253864746194,"synonym_name":"(5<i>Z</i>,8<i>Z</i>,10<i>E</i>,14<i>Z</i>)-12-oxoeicosa-5,8,10,14-tetraenoic acid"},{"chebi_id":"74344","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LAXQYRRMGGEGOH-JXRLJXCWSA-N","pvalue":4.2152246910504245e-06,"ratio":1.569586518928286,"synonym_name":"PC(20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)/0:0)"}],"totalFeatures":121},{"comparisonGroups":["Control","Busulfan_5_mg_kg_RAAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice: Control vs Busulfan + 5mg/kg RAAE treatment","group_a_title":"Control group with no RAAE treatment.. Serves as the baseline for comparison with RAAE-treated groups.","group_b_title":"Busulfan-treated group with 5 mg/kg RAAE.. Assesses the effect of high-dose RAAE on busulfan-treated mice.","id":"MTBLS2782_0002_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS2782","studyUrl":"http://integmet.org/study/MTBLS2782","title":"Control_vs_Busulfan_5_mg_kg_RAAE","topHits":[{"chebi_id":"49260","direction":"up","inn_name":"","iupac_name":"4-(<small>L</small>-\u03b3-glutamylamino)butanoic acid","metabolite_id":"MKYPKZSGLSOGLL-LURJTMIESA-N","pvalue":0.0027006344431966,"ratio":4.035563960342009,"synonym_name":"Glutamylgaba"},{"chebi_id":"84058","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":0.0204561185593057,"ratio":7.438935028512755,"synonym_name":""},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.0011271810697123,"ratio":2.8319150358103555,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"136629","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KGTRBDVOUPALMB-PPNLDZOPSA-N","pvalue":4.797829712212598e-05,"ratio":1.971744894868854,"synonym_name":"1-[(1-Carboxy-3-methylbutyl)amino]-1-deoxyfructose, 9CI"},{"chebi_id":"136561","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FAVRCIXPIVJIPN-VJDSNFAGSA-N","pvalue":7.469008470620503e-05,"ratio":1.9648600367782616,"synonym_name":"<em>N</em>-(<small>D</small>-fructos-1-yl)phenylalanine"},{"chebi_id":"82969","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-tyrosine","metabolite_id":"VVLXCWVSSLFQDS-QWRGUYRKSA-N","pvalue":3.51798008961371e-05,"ratio":1.807678805786472,"synonym_name":"\u03b3-glutamyltyrosine"},{"chebi_id":"132958","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetylmethionine","metabolite_id":"XUYPXLNMDZIRQH-UHFFFAOYSA-N","pvalue":0.0009128060209789,"ratio":1.8969998974669695,"synonym_name":"Ac-Met"},{"chebi_id":"79190","direction":"up","inn_name":"","iupac_name":"20-hydroxyicosanoic acid","metabolite_id":"JLDIWYKSFMPIDW-UHFFFAOYSA-N","pvalue":5.744778238453195e-05,"ratio":1.5740767659901076,"synonym_name":"\u03c9-hydroxyarachidic acid"},{"chebi_id":"138490","direction":"down","inn_name":"","iupac_name":"4-{(2<i>S</i>,3<i>R</i>)-3-[(1<i>E</i>,3<i>E</i>,5<i>Z</i>,8<i>Z</i>,10<i>E</i>,12<i>S</i>)-12-hydroxytetradeca-1,3,5,8,10-pentaen-1-yl]oxiran-2-yl}butanoic acid","metabolite_id":"ZPAJZAMPZXISSE-RXTGXWMYSA-N","pvalue":0.0216465794081368,"ratio":0.3191346750760984,"synonym_name":"5<i>S</i>,6-epoxy,18<i>S</i>-hydroxy-7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>-eicosapentaenoic acid"},{"chebi_id":"18330","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4<em>H</em>-chromen-6-yl]-<small>D</small>-glucitol","metabolite_id":"MYXNWGACZJSMBT-VJXVFPJBSA-N","pvalue":0.0066398674515382,"ratio":2.149240791654096,"synonym_name":"6-C-Glucosylapigenin"}],"totalFeatures":139},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"TZWUYONGXAHBAL-UBTPLURJSA-N","pvalue":0.0012636919614022,"ratio":3.187360395485555,"synonym_name":""},{"chebi_id":"145230","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VUYXIQLBLBPRDY-VOHILQMLSA-N","pvalue":0.0020910038631132,"ratio":2.244922623961366,"synonym_name":""},{"chebi_id":"74343","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)-icosa-5,8,11-trienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YHGXYYIGHBPDMX-BUTFDPNWSA-N","pvalue":0.000180523046009,"ratio":1.7759534507368329,"synonym_name":"lysophosphatidylcholine(20:3(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)/0:0)"},{"chebi_id":"86094","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IWXJKHSPEQSQMD-GMGFYYQASA-N","pvalue":0.0003313258452874,"ratio":1.8057830149666123,"synonym_name":"Phosphatidylcholine(14:0/18:2w6)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RUOVJPPUXXFZPC-JMWCFZJPSA-N","pvalue":0.0049394043954887,"ratio":2.2890730275514364,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MTWYSKGJIDFSRC-SOEJSTAXSA-N","pvalue":0.0025291702580325,"ratio":2.0779210184641257,"synonym_name":""},{"chebi_id":"86102","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SRQSAJRUMDQMMS-NLDJLLEISA-N","pvalue":0.0017681665125272,"ratio":1.9355024324592212,"synonym_name":"PC(14:0/20:4)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DOEBPNOTMREOMP-FZTZZYPMSA-N","pvalue":0.007289048486083,"ratio":2.2853873993691898,"synonym_name":""},{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":0.0007182369363642,"ratio":1.7172592983511956,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"89517","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XWHIBISICRMDDW-ZLBNXBDKSA-N","pvalue":0.000295926572758,"ratio":1.560202291539602,"synonym_name":"GPCho(14:0/20:3n9)"}],"totalFeatures":124},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs immune tolerant phase HBV infection","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":8.647206419792836e-08,"ratio":2.3117399707142887,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"131738","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-hydroxy-2-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IGZPHNNYPPAPLA-OAQYLSRUSA-N","pvalue":8.405758691368748e-06,"ratio":2.0937971410244134,"synonym_name":"PC(0:0/14:0)"},{"chebi_id":"131924","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RJZVWDTYEWCUAR-JOCHJYFZSA-N","pvalue":9.223299265247036e-05,"ratio":1.6167745311258164,"synonym_name":"1-Pentadecanoyl-glycero-3-phosphocholine"}],"totalFeatures":11},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":8.647206419792836e-08,"ratio":2.3117399707142887,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"131738","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-hydroxy-2-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IGZPHNNYPPAPLA-OAQYLSRUSA-N","pvalue":8.405758691368748e-06,"ratio":2.0937971410244134,"synonym_name":"PC(0:0/14:0)"},{"chebi_id":"131924","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RJZVWDTYEWCUAR-JOCHJYFZSA-N","pvalue":9.223299265247036e-05,"ratio":1.6167745311258164,"synonym_name":"1-Pentadecanoyl-glycero-3-phosphocholine"}],"totalFeatures":11},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0005_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"TZWUYONGXAHBAL-UBTPLURJSA-N","pvalue":0.0012636919614022,"ratio":3.187360395485555,"synonym_name":""},{"chebi_id":"145230","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VUYXIQLBLBPRDY-VOHILQMLSA-N","pvalue":0.0020910038631132,"ratio":2.244922623961366,"synonym_name":""},{"chebi_id":"74343","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)-icosa-5,8,11-trienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YHGXYYIGHBPDMX-BUTFDPNWSA-N","pvalue":0.000180523046009,"ratio":1.7759534507368329,"synonym_name":"lysophosphatidylcholine(20:3(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)/0:0)"},{"chebi_id":"86094","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IWXJKHSPEQSQMD-GMGFYYQASA-N","pvalue":0.0003313258452874,"ratio":1.8057830149666123,"synonym_name":"Phosphatidylcholine(14:0/18:2w6)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RUOVJPPUXXFZPC-JMWCFZJPSA-N","pvalue":0.0049394043954887,"ratio":2.2890730275514364,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MTWYSKGJIDFSRC-SOEJSTAXSA-N","pvalue":0.0025291702580325,"ratio":2.0779210184641257,"synonym_name":""},{"chebi_id":"86102","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SRQSAJRUMDQMMS-NLDJLLEISA-N","pvalue":0.0017681665125272,"ratio":1.9355024324592212,"synonym_name":"PC(14:0/20:4)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DOEBPNOTMREOMP-FZTZZYPMSA-N","pvalue":0.007289048486083,"ratio":2.2853873993691898,"synonym_name":""},{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":0.0007182369363642,"ratio":1.7172592983511956,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"89517","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XWHIBISICRMDDW-ZLBNXBDKSA-N","pvalue":0.000295926572758,"ratio":1.560202291539602,"synonym_name":"GPCho(14:0/20:3n9)"}],"totalFeatures":125},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase of HBV infection.","id":"MTBLS279_0006_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS279","studyUrl":"http://integmet.org/study/MTBLS279","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"TZWUYONGXAHBAL-UBTPLURJSA-N","pvalue":0.0012636919614022,"ratio":3.187360395485555,"synonym_name":""},{"chebi_id":"145230","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VUYXIQLBLBPRDY-VOHILQMLSA-N","pvalue":0.0020910038631132,"ratio":2.244922623961366,"synonym_name":""},{"chebi_id":"74343","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)-icosa-5,8,11-trienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YHGXYYIGHBPDMX-BUTFDPNWSA-N","pvalue":0.000180523046009,"ratio":1.7759534507368329,"synonym_name":"lysophosphatidylcholine(20:3(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>)/0:0)"},{"chebi_id":"86094","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IWXJKHSPEQSQMD-GMGFYYQASA-N","pvalue":0.0003313258452874,"ratio":1.8057830149666123,"synonym_name":"Phosphatidylcholine(14:0/18:2w6)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RUOVJPPUXXFZPC-JMWCFZJPSA-N","pvalue":0.0049394043954887,"ratio":2.2890730275514364,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MTWYSKGJIDFSRC-SOEJSTAXSA-N","pvalue":0.0025291702580325,"ratio":2.0779210184641257,"synonym_name":""},{"chebi_id":"86102","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SRQSAJRUMDQMMS-NLDJLLEISA-N","pvalue":0.0017681665125272,"ratio":1.9355024324592212,"synonym_name":"PC(14:0/20:4)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DOEBPNOTMREOMP-FZTZZYPMSA-N","pvalue":0.007289048486083,"ratio":2.2853873993691898,"synonym_name":""},{"chebi_id":"64489","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":0.0007182369363642,"ratio":1.7172592983511956,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"89517","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XWHIBISICRMDDW-ZLBNXBDKSA-N","pvalue":0.000295926572758,"ratio":1.560202291539602,"synonym_name":"GPCho(14:0/20:3n9)"}],"totalFeatures":125},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV: Control vs immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"70997","direction":"up","inn_name":"","iupac_name":"3-(nonanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"MPSPNFAQQQMFLK-UHFFFAOYSA-N","pvalue":0.000290209711451,"ratio":2.8082319435031144,"synonym_name":"3-(nonanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"84098","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-4-(trimethylammonio)butanoate","metabolite_id":"MJLXQSQYKZWZCB-DQFWFXSYSA-N","pvalue":0.000900872925535,"ratio":0.5144992790937025,"synonym_name":"Octadecadienyl-L-carnitine"}],"totalFeatures":26},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV: Control vs Immune Tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"70997","direction":"up","inn_name":"","iupac_name":"3-(nonanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"MPSPNFAQQQMFLK-UHFFFAOYSA-N","pvalue":0.000290209711451,"ratio":2.8082319435031144,"synonym_name":"3-(nonanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"73072","direction":"down","inn_name":"","iupac_name":"3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"MJLXQSQYKZWZCB-UTJQPWESSA-N","pvalue":0.000900872925535,"ratio":0.5144992790937025,"synonym_name":"linoleylcarnitine"}],"totalFeatures":26},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV infection: immune tolerant phase vs control","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"57959","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-azaniumyl-4-oxobutanoate","metabolite_id":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","pvalue":4.72233803959192e-05,"ratio":1.7180768421509902,"synonym_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-ammonio-4-oxobutanoate"},{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0019861206248476,"ratio":1.6595665181261314,"synonym_name":"L-Saccharopine"},{"chebi_id":"73707","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamine","metabolite_id":"JBFYFLXEJFQWMU-WDSKDSINSA-N","pvalue":0.002798025457996,"ratio":1.689870109010492,"synonym_name":"\u03b3-<small>L</small>-Glu-<small>L</small>-Gln"},{"chebi_id":"58375","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidinium-2-carboxylate","metabolite_id":"PMMYEEVYMWASQN-DMTCNVIQSA-N","pvalue":0.0212344803187443,"ratio":0.5935793833607781,"synonym_name":"hydroxyproline zwitterion"},{"chebi_id":"133545","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-azaniumyl-3-(methylsulfanyl)propanoate","metabolite_id":"IDIDJDIHTAOVLG-VKHMYHEASA-N","pvalue":0.024713072876712,"ratio":0.6051787853290395,"synonym_name":"methylcysteine zwitterion"}],"totalFeatures":38},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase infection","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"57959","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-azaniumyl-4-oxobutanoate","metabolite_id":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","pvalue":4.72233803959192e-05,"ratio":1.7180768421509902,"synonym_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-ammonio-4-oxobutanoate"},{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0019861206248476,"ratio":1.6595665181261314,"synonym_name":"L-Saccharopine"},{"chebi_id":"73707","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamine","metabolite_id":"JBFYFLXEJFQWMU-WDSKDSINSA-N","pvalue":0.002798025457996,"ratio":1.689870109010492,"synonym_name":"\u03b3-<small>L</small>-Glu-<small>L</small>-Gln"},{"chebi_id":"20392","direction":"down","inn_name":"","iupac_name":"4-hydroxyproline","metabolite_id":"PMMYEEVYMWASQN-UHFFFAOYSA-N","pvalue":0.0212344803187443,"ratio":0.5935793833607781,"synonym_name":"4Hyp"},{"chebi_id":"41531","direction":"down","inn_name":"mecysteine","iupac_name":"methyl <small>L</small>-cysteinate","metabolite_id":"MCYHPZGUONZRGO-VKHMYHEASA-N","pvalue":0.024713072876712,"ratio":0.6051787853290395,"synonym_name":"O-METHYLCYSTEINE"}],"totalFeatures":38},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs HBV immune tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0005_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"70997","direction":"up","inn_name":"","iupac_name":"3-(nonanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"MPSPNFAQQQMFLK-UHFFFAOYSA-N","pvalue":0.000290209711451,"ratio":2.8082319435031144,"synonym_name":"3-(nonanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"73072","direction":"down","inn_name":"","iupac_name":"3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"MJLXQSQYKZWZCB-UTJQPWESSA-N","pvalue":0.000900872925535,"ratio":0.5144992790937025,"synonym_name":"linoleylcarnitine"}],"totalFeatures":26},{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV: Control vs Immune Tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0006_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"57959","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-azaniumyl-4-oxobutanoate","metabolite_id":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","pvalue":4.72233803959192e-05,"ratio":1.7180768421509902,"synonym_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-ammonio-4-oxobutanoate"},{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0019861206248476,"ratio":1.6595665181261314,"synonym_name":"L-Saccharopine"},{"chebi_id":"73707","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamine","metabolite_id":"JBFYFLXEJFQWMU-WDSKDSINSA-N","pvalue":0.002798025457996,"ratio":1.689870109010492,"synonym_name":"\u03b3-<small>L</small>-Glu-<small>L</small>-Gln"},{"chebi_id":"20392","direction":"down","inn_name":"","iupac_name":"4-hydroxyproline","metabolite_id":"PMMYEEVYMWASQN-UHFFFAOYSA-N","pvalue":0.0212344803187443,"ratio":0.5935793833607781,"synonym_name":"4Hyp"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IDIDJDIHTAOVLG-GSVOUGTGSA-N","pvalue":0.024713072876712,"ratio":0.6051787853290395,"synonym_name":""}],"totalFeatures":38},{"comparisonGroups":["Brewer_Spend_Yeast","Whey"],"dateCreated":"2025-09-26 00:00:00","display_title":"Brewer's yeast vs whey extracellular vesicles","group_a_title":"Extracellular vesicles derived from brewer spend yeast.. Represents a potential source of biocompatible EVs from the food industry.","group_b_title":"Extracellular vesicles derived from whey.. Represents a potential source of biocompatible EVs from the food industry.","id":"MTBLS2801_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":40,"studyId":"MTBLS2801","studyUrl":"http://integmet.org/study/MTBLS2801","title":"Brewer_Spend_Yeast_vs_Whey","topHits":[{"chebi_id":"170247","direction":"down","inn_name":"","iupac_name":"[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"QFVHCMLUKNHDSH-WTWBAFHPSA-N","pvalue":4.436772561824867e-06,"ratio":2.6426130157499735e-05,"synonym_name":""},{"chebi_id":"170239","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-icos-11-enoate","metabolite_id":"BPFXNETZQIVTNB-OBYUZFALSA-N","pvalue":4.436772561824867e-06,"ratio":2.6426130157499735e-05,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SREIKPJHNNEWRO-PEZBUJJGSA-N","pvalue":4.436772561824867e-06,"ratio":2.6426130157499735e-05,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RMARBPFAEGEQBO-VLGSPTGOSA-N","pvalue":2.838844296372332e-05,"ratio":4.48846464586014e-05,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RIDOWFTTZGQBMI-HNENSFHCSA-N","pvalue":2.838844296372332e-05,"ratio":4.48846464586014e-05,"synonym_name":""},{"chebi_id":"170442","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-docos-13-enoate","metabolite_id":"RETPVUGMYRRYPF-SGFDTVKUSA-N","pvalue":2.838844296372332e-05,"ratio":4.48846464586014e-05,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DWRAYHLBWPXNEO-WEDIAHCFSA-N","pvalue":5.724886919502137e-05,"ratio":26234.666666666668,"synonym_name":""},{"chebi_id":"172741","direction":"up","inn_name":"","iupac_name":"[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate","metabolite_id":"IHIWKNWPECHDKE-UFDIJAIZSA-N","pvalue":5.724886919502137e-05,"ratio":26234.666666666668,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AICSQJDCTIYZBR-OQESNJPLSA-N","pvalue":0.0004853463886202,"ratio":151573.66666666666,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FAXQZWVYZWTJMU-XRHYJLGASA-N","pvalue":0.0004853463886202,"ratio":151573.66666666666,"synonym_name":""}],"totalFeatures":41},{"comparisonGroups":["Brewer_Spend_Yeast","Whey"],"dateCreated":"2025-09-26 00:00:00","display_title":"Brewer spent yeast EVs vs whey EVs comparison","group_a_title":"Extracellular vesicles derived from brewer spend yeast.. Represents a potential source of biocompatible EVs from the food industry.","group_b_title":"Extracellular vesicles derived from whey.. Represents a potential source of biocompatible EVs from the food industry.","id":"MTBLS2801_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS2801","studyUrl":"http://integmet.org/study/MTBLS2801","title":"Brewer_Spend_Yeast_vs_Whey","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DICYCLUXEYFAQX-ORMHLZIJSA-N","pvalue":6.006532539177218e-08,"ratio":1.3659025200901496e-05,"synonym_name":""},{"chebi_id":"197257","direction":"down","inn_name":"","iupac_name":"[(2S)-3-hydroxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate","metabolite_id":"ZXBDMMYPYQQALX-BJXCJIDGSA-N","pvalue":3.3493147720013097e-07,"ratio":8.171158534094159e-06,"synonym_name":""},{"chebi_id":"187960","direction":"down","inn_name":"","iupac_name":"[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate","metabolite_id":"GZCNJZBJTMDVCJ-UQYJLNGWSA-N","pvalue":2.204822239918809e-06,"ratio":1.8570561945204464e-05,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XSVAKXYZKYCILC-WARPBGNWSA-N","pvalue":5.747015440892024e-06,"ratio":1.0969884011759715e-05,"synonym_name":""},{"chebi_id":"73264","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(phosphonooxy)-2-(tetradecanoyloxy)propyl hexadecanoate","metabolite_id":"GLOXZZHEZYKXNV-WJOKGBTCSA-N","pvalue":2.4393717287995786e-06,"ratio":2.820185004136271e-05,"synonym_name":"PA(16:0/14:0)"},{"chebi_id":"73246","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(phosphonooxy)propane-1,2-diyl dihexadecanoate","metabolite_id":"PORPENFLTBBHSG-MGBGTMOVSA-N","pvalue":7.187005611085836e-06,"ratio":1.2545267506920807e-05,"synonym_name":"1,2-Dipalmitoyl-3-sn-phosphatidic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JAEPSURECWOMRY-PGUFJCEWSA-N","pvalue":1.1642099837694902e-05,"ratio":9.525351723612394e-06,"synonym_name":""},{"chebi_id":"187991","direction":"down","inn_name":"","iupac_name":"[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate","metabolite_id":"HDAUCJLPCSEZAQ-ILFYFWIOSA-N","pvalue":8.260046075792903e-06,"ratio":1.5309403035344307e-05,"synonym_name":""},{"chebi_id":"84385","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl hexadecanoate","metabolite_id":"NYNQTTOUQMCOEM-HKBQPEDESA-N","pvalue":9.020447551562737e-06,"ratio":1.5826040166489943e-05,"synonym_name":"1-tetradecanoyl-2-hexadecanoyl-<em>sn</em>-glycerol"},{"chebi_id":"170896","direction":"down","inn_name":"","iupac_name":"[(2S)-1-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"NKWCJWBTGOMXKM-JNFYRXNCSA-N","pvalue":6.56638978519514e-06,"ratio":2.773463501220324e-05,"synonym_name":""}],"totalFeatures":50},{"comparisonGroups":["Wild_Type","YQ2-gal"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild-type vs YQ2-gal strain: glucose utilization","group_a_title":"Wild type samples with no added substrate.. Provides a reference point for evaluating the effects of genetic modifications.","group_b_title":"Engineered strain YQ2-gal utilizing glucose.. Evaluates the metabolic changes and efficiency of glucose utilization in engineered strains.","id":"MTBLS2825_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":455,"studyId":"MTBLS2825","studyUrl":"http://integmet.org/study/MTBLS2825","title":"Wild_Type_vs_YQ2-gal","topHits":[{"chebi_id":"180905","direction":"up","inn_name":"","iupac_name":"2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","metabolite_id":"ZBBHBTPTTSWHBA-UHFFFAOYSA-N","pvalue":8.15093549039181e-10,"ratio":294.79635324890967,"synonym_name":"2-(benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(<em>m</em>-nitrophenyl)pyridine-3,5-dicarboxylate"},{"chebi_id":"9044","direction":"down","inn_name":"","iupac_name":"(3<i>E</i>,4<i>R</i>)-4-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylmethylidene)dihydrofuran-2(3<em>H</em>)-one","metabolite_id":"CMJGAYUQSLJSCR-ULIPXBITSA-N","pvalue":2.1093120135548112e-11,"ratio":0.012911446468779,"synonym_name":"savinin"},{"chebi_id":"1679","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VYCMOHPABBFZCR-CRKKBNSPSA-N","pvalue":1.5763084042605282e-09,"ratio":143.4746604204949,"synonym_name":"3-beta-D-Glucopyranuronosyloxy-5-methylisoxazole"},{"chebi_id":"18239","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>,6<i>E</i>,10<i>Z</i>,14<i>Z</i>,18<i>Z</i>,22<i>Z</i>,26<i>Z</i>,30<i>Z</i>,34<i>Z</i>)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl trihydrogen diphosphate","metabolite_id":"FSCYHDCTHRVSKN-GPLVPVLESA-N","pvalue":2.685434486670049e-09,"ratio":0.0123429171755845,"synonym_name":"<em>ditrans</em>,<em>polycis</em>-decaprenyl diphosphate"},{"chebi_id":"34653","direction":"down","inn_name":"","iupac_name":"disodium 3,3'-(biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate)","metabolite_id":"IQFVPQOLBLOTPF-UHFFFAOYSA-L","pvalue":2.235594016269943e-12,"ratio":0.0406534871384864,"synonym_name":"Direct red 28"},{"chebi_id":"8932","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"POHHFIIXXRDDJW-STQMWFEESA-N","pvalue":1.6062125699502598e-07,"ratio":0.0046046098781717,"synonym_name":"S-(4-Azidophenacyl)glutathione"},{"chebi_id":"4419","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YAAQITKFMRGHMP-JKYGLUIKSA-N","pvalue":2.721216816605593e-09,"ratio":63.97620004055791,"synonym_name":"Deoxyloganin tetraacetate"},{"chebi_id":"87732","direction":"down","inn_name":"","iupac_name":"4-hydroxy-3-(3-oxo-1-phenylbutyl)-2<em>H</em>-chromen-2-one","metabolite_id":"PJVWKTKQMONHTI-UHFFFAOYSA-N","pvalue":8.269796298724772e-07,"ratio":0.0047761142676771,"synonym_name":"4-hydroxy-3-(3-oxo-1-phenylbutyl)-2<em>H</em>-1-benzopyran-2-one"},{"chebi_id":"18416","direction":"down","inn_name":"","iupac_name":"<em>N</em>-{<em>N</em>-[(2<i>R</i>)-2,4-dihydroxy-3,3-dimethylbutanoyl]-\u03b2-alanyl}-<small>L</small>-cysteine","metabolite_id":"QSYCTARXWYLMOF-CBAPKCEASA-N","pvalue":1.710344317423607e-09,"ratio":0.0299804187474285,"synonym_name":"D-Pantothenoyl-L-cysteine"},{"chebi_id":"34830","direction":"up","inn_name":"","iupac_name":"2-(1,3-benzothiazol-2-yloxy)-<em>N</em>-methyl-<em>N</em>-phenylacetamide","metabolite_id":"XIGAUIHYSDTJHW-UHFFFAOYSA-N","pvalue":5.8755343885921784e-08,"ratio":46.81982291205129,"synonym_name":"m\u00e9f\u00e9nacet"}],"totalFeatures":905},{"comparisonGroups":["Wild_Type","YQ2-gal"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild-type vs YQ2-gal strain glucose utilization","group_a_title":"Wild type samples with no added substrate.. Provides a reference point for evaluating the effects of genetic modifications.","group_b_title":"Engineered strain YQ2-gal utilizing glucose.. Evaluates the metabolic changes and efficiency of glucose utilization in engineered strains.","id":"MTBLS2825_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":597,"studyId":"MTBLS2825","studyUrl":"http://integmet.org/study/MTBLS2825","title":"Wild_Type_vs_YQ2-gal","topHits":[{"chebi_id":"16536","direction":"down","inn_name":"","iupac_name":"5-methylbenzene-1,3-diol","metabolite_id":"OIPPWFOQEKKFEE-UHFFFAOYSA-N","pvalue":1.7538280596300896e-15,"ratio":0.0059582099124831,"synonym_name":"3-Hydroxy-5-methylphenol"},{"chebi_id":"9018","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BHRGGWSNTHQGED-QNHMRRABSA-N","pvalue":4.83922377602754e-12,"ratio":0.0077792749125242,"synonym_name":"Samaderin A"},{"chebi_id":"4887","direction":"down","inn_name":"ethosuximidum","iupac_name":"3-ethyl-3-methylpyrrolidine-2,5-dione","metabolite_id":"HAPOVYFOVVWLRS-UHFFFAOYSA-N","pvalue":4.2327011875826054e-13,"ratio":0.0184576328045434,"synonym_name":"\u03b1-methyl-\u03b1-ethylsuccinimide"},{"chebi_id":"10022","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one","metabolite_id":"LINOMUASTDIRTM-QGRHZQQGSA-N","pvalue":3.409523095945961e-09,"ratio":0.0100964336049163,"synonym_name":"DON"},{"chebi_id":"8245","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VQDBNKDJNJQRDG-UHFFFAOYSA-N","pvalue":1.7031018610558743e-10,"ratio":0.0291801502077201,"synonym_name":"Pirbuterol"},{"chebi_id":"39091","direction":"down","inn_name":"","iupac_name":"(<i>S</i>)-cyano(3-phenoxyphenyl)methyl (1<i>R</i>,3<i>S</i>)-2,2-dimethyl-3-{(1<i>Z</i>)-3-oxo-3-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]prop-1-en-1-yl}cyclopropanecarboxylate","metabolite_id":"YLFSVIMMRPNPFK-WEQBUNFVSA-N","pvalue":2.191786965659251e-09,"ratio":0.0360747535605968,"synonym_name":"Acrinathrin"},{"chebi_id":"85332","direction":"down","inn_name":"","iupac_name":"3-{[(2<i>E</i>)-4-amino-4-oxobut-2-enoyl]amino}-<small>L</small>-alanyl-<small>L</small>-isoleucine","metabolite_id":"WSFQKSIBZODGPB-RWWNVWANSA-N","pvalue":6.776515491940697e-14,"ratio":0.1257716737131233,"synonym_name":""},{"chebi_id":"3367","direction":"down","inn_name":"","iupac_name":"3,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-1-benzopyran-1-ium","metabolite_id":"GYLVPQXQQPMCKK-UHFFFAOYSA-O","pvalue":1.305892241013703e-09,"ratio":0.0494453260903871,"synonym_name":""},{"chebi_id":"49537","direction":"down","inn_name":"","iupac_name":"9,9'-[(2<i>R</i>,3<i>R</i>,3a<i>S</i>,7a<i>R</i>,9<i>R</i>,10<i>R</i>,10a<i>S</i>,14a<i>R</i>)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2<em>H</em>,7<em>H</em>-difuro[3,2-<em>d</em>:3',2'-<em>j</em>][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6<em>H</em>-purin-6-one)","metabolite_id":"PKFDLKSEZWEFGL-MHARETSRSA-N","pvalue":3.2550354681607006e-08,"ratio":0.02888516624402,"synonym_name":"Cyclic di-3',5'-guanylate"},{"chebi_id":"5270","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RTEDIEITOBJPNI-MMKMIGCXSA-N","pvalue":1.6357336430999587e-10,"ratio":0.0687837931125236,"synonym_name":"Gallocatechin-(4alpha->8)-epigallocatechin"}],"totalFeatures":1358},{"comparisonGroups":["Calu3_Mock_DMEM","Calu3_10uM_NIC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Calu-3 cells: 10\u03bcM Niclosamide vs mock control","group_a_title":"Calu-3 cells treated with DMEM as mock control for SARS-CoV-2.. Provides baseline data for evaluating the effects of treatments on Calu-3 cells.","group_b_title":"Calu-3 cells treated with 10 \u00b5M Niclosamide.. Evaluates the effect of Niclosamide on SARS-CoV-2 propagation in Calu-3 cells.","id":"MTBLS2840_0001_00000026","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":44,"studyId":"MTBLS2840","studyUrl":"http://integmet.org/study/MTBLS2840","title":"Calu3_Mock_DMEM_vs_Calu3_10uM_NIC","topHits":[{"chebi_id":"15721","direction":"down","inn_name":"","iupac_name":"<small>D</small>-<i>altro</i>-hept-2-ulose 7-phosphate","metabolite_id":"JDTUMPKOJBQPKX-GBNDHIKLSA-N","pvalue":8.449888839293823e-09,"ratio":0.1829257464099536,"synonym_name":"D-Sedoheptulose 7-phosphate"},{"chebi_id":"16761","direction":"down","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":1.0841621220738157e-06,"ratio":0.1822876755549907,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"17239","direction":"down","inn_name":"","iupac_name":"cytidine 5'-(trihydrogen diphosphate)","metabolite_id":"ZWIADYZPOWUWEW-XVFCMESISA-N","pvalue":3.708774156655833e-06,"ratio":0.1710330753842641,"synonym_name":"Cytidine, 5'-(trihydrogen pyrophosphate)"},{"chebi_id":"17677","direction":"down","inn_name":"","iupac_name":"cytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PCDQPRRSZKQHHS-XVFCMESISA-N","pvalue":4.047700989871183e-05,"ratio":0.1147970863827622,"synonym_name":"5'-CTP"},{"chebi_id":"16311","direction":"down","inn_name":"","iupac_name":"2'-deoxycytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"RGWHQCVHVJXOKC-SHYZEUOFSA-N","pvalue":1.715119113773129e-05,"ratio":0.1406172487858146,"synonym_name":"dCTP"},{"chebi_id":"15996","direction":"down","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":2.842585429905498e-05,"ratio":0.1368869217935489,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"16264","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":7.405105607414391e-06,"ratio":0.1792482257436381,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"15422","direction":"down","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":6.799773852788756e-05,"ratio":0.1233166189448792,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"44897","direction":"down","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0013778141323965,"ratio":0.0527022005864255,"synonym_name":"PEP"},{"chebi_id":"18105","direction":"down","inn_name":"","iupac_name":"<small>D</small>-fructose 1-(dihydrogen phosphate)","metabolite_id":"ZKLLSNQJRLJIGT-UYFOZJQFSA-N","pvalue":9.272860759223992e-05,"ratio":0.1283785534849081,"synonym_name":"D-Fructose 1-phosphate"}],"totalFeatures":44},{"comparisonGroups":["Calu3_Mock_DMEM","Calu3_10uM_NIC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Calu-3 cells: 10\u03bcM Niclosamide vs mock control","group_a_title":"Calu-3 cells treated with DMEM as mock control for SARS-CoV-2.. Provides baseline data for evaluating the effects of treatments on Calu-3 cells.","group_b_title":"Calu-3 cells treated with 10 \u00b5M Niclosamide.. Evaluates the effect of Niclosamide on SARS-CoV-2 propagation in Calu-3 cells.","id":"MTBLS2840_0002_00000026","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":36,"studyId":"MTBLS2840","studyUrl":"http://integmet.org/study/MTBLS2840","title":"Calu3_Mock_DMEM_vs_Calu3_10uM_NIC","topHits":[{"chebi_id":"58048","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":1.4839874673189137e-06,"ratio":0.1544353425010461,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"67040","direction":"down","inn_name":"","iupac_name":"[(3<i>S</i>)-3-amino-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonioacetate","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-N","pvalue":3.507087747013727e-05,"ratio":0.1382325010398264,"synonym_name":"AdoMet"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":7.705199774466203e-05,"ratio":0.1272745609390572,"synonym_name":"Adenosin"},{"chebi_id":"33384","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":6.178608910771382e-07,"ratio":0.3078787350215112,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"15903","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":0.001108790582021,"ratio":0.1241463757397362,"synonym_name":"beta-D-Glucose"},{"chebi_id":"16610","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)butane-1,4-diamine","metabolite_id":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","pvalue":0.001496769576921,"ratio":0.1352694141219134,"synonym_name":"N-(3-Aminopropyl)-1,4-butane-diamine"},{"chebi_id":"17927","direction":"down","inn_name":"","iupac_name":"<em>N</em>-{3-[(4-aminobutyl)amino]propyl}acetamide","metabolite_id":"MQTAVJHICJWXBR-UHFFFAOYSA-N","pvalue":0.0002026896158911,"ratio":0.2183657352912129,"synonym_name":"1-<em>N</em>-acetylspermidine"},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":0.0003024015272857,"ratio":0.2026149834205834,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"57595","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-imidazol-4-yl)propanoate","metabolite_id":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","pvalue":8.292319772378586e-06,"ratio":0.3881145347744176,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"17509","direction":"down","inn_name":"","iupac_name":"5'-deoxy-5'-(methylsulfanyl)adenosine","metabolite_id":"WUUGFSXJNOTRMR-IOSLPCCCSA-N","pvalue":0.0046716128973955,"ratio":0.1293952499940405,"synonym_name":"5'-Deoxy-5'-(methylthio)adenosine"}],"totalFeatures":47},{"comparisonGroups":["Ardisia_crenata_leaf_lamina_Stage_I","Ardisia_crenata_leaf_nodule_Stage_I"],"dateCreated":"2025-09-26 00:00:00","display_title":"Ardisia crenata leaf: lamina vs nodule at Stage I","group_a_title":"Ardisia crenata leaf lamina samples at Stage I. Provides baseline data for leaf lamina at the initial stage.","group_b_title":"Ardisia crenata leaf nodule samples at Stage I. Provides baseline data for leaf nodules at the initial stage.","id":"MTBLS2870_0001_00000277","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS2870","studyUrl":"http://integmet.org/study/MTBLS2870","title":"Ardisia_crenata_Stage_I_lamina_vs_nodule","topHits":[{"chebi_id":"30835","direction":"down","inn_name":"","iupac_name":"2-hydroxybutane-1,2,3-tricarboxylic acid","metabolite_id":"YNOXCRMFGMSKIJ-UHFFFAOYSA-N","pvalue":0.0005158000085483,"ratio":1e-06,"synonym_name":"2-hydroxy-1,2,3-butanetricarboxylic acid"},{"chebi_id":"17306","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":3.550800993879404e-06,"ratio":0.036119234588707,"synonym_name":"Malzzucker"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0084820661603625,"ratio":0.2760759689853416,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"28645","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":0.0072899800843484,"ratio":2.4022458450764725,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0216617335567709,"ratio":0.3704548218920731,"synonym_name":"colamine phosphate"},{"chebi_id":"15978","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-N","pvalue":0.0252501476938538,"ratio":0.368293687809328,"synonym_name":"Phosphors\u00e4ure-mono-((<i>R</i>)-2,3-dihydroxy-propylester)"},{"chebi_id":"62383","direction":"down","inn_name":"","iupac_name":"1<small>D</small>-<em>myo</em>-inositol 2-(dihydrogen phosphate)","metabolite_id":"INAPMGSXUVUWAF-QWBQGLJISA-N","pvalue":0.0268657067192335,"ratio":0.3813899519057796,"synonym_name":"Inositol 2-monophosphate"},{"chebi_id":"58045","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":0.0404741061057893,"ratio":0.3675022412012353,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"}],"totalFeatures":51},{"comparisonGroups":["Control","Day 12"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sausage microbiota: baseline vs 12-day changes","group_a_title":"Baseline control group at time point 0 days. Baseline group for comparison with samples at later time points.","group_b_title":"Experimental group at time point 12 days. Represents changes in the sausage microbiota and metabolites at 12 days.","id":"MTBLS2871_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":860,"studyId":"MTBLS2871","studyUrl":"http://integmet.org/study/MTBLS2871","title":"Control_vs_Day_12","topHits":[{"chebi_id":"73916","direction":"up","inn_name":"","iupac_name":"3-<em>O</em>-\u03b2-<small>D</small>-galactopyranosyl-<small>D</small>-arabinose","metabolite_id":"ZTTRCZJSZGZSTB-XGWBRSPTSA-N","pvalue":1.4975439705220316e-10,"ratio":218.11180806818808,"synonym_name":"<em>O</em><small><sup>3</small></sup>-\u03b2-<small>D</small>-galactopyranosyl-<small>D</small>-arabinose"},{"chebi_id":"47943","direction":"down","inn_name":"","iupac_name":"1-(4-methoxybenzoyl)pyrrolidin-2-one","metabolite_id":"ZXNRTKGTQJPIJK-UHFFFAOYSA-N","pvalue":9.156489416402452e-10,"ratio":0.003389390047594,"synonym_name":"Aniracetam"},{"chebi_id":"89747","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YLCGQCCCWXNFOA-YAAUQWKMSA-N","pvalue":6.8199772668843124e-09,"ratio":0.0019744059436302,"synonym_name":"3-Hydroxy-5E,8E-tetradecadiencarnitine"},{"chebi_id":"5292","direction":"down","inn_name":"","iupac_name":"(4<i>E</i>,6<i>Z</i>,8<i>S</i>,9<i>S</i>,10<i>E</i>,12<i>S</i>,13<i>R</i>,14<i>S</i>,16<i>R</i>)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate","metabolite_id":"QTQAWLPCGQOSGP-KSRBKZBZSA-N","pvalue":3.772949408484143e-07,"ratio":0.0005674784753568,"synonym_name":"GELDANAMYCIN"},{"chebi_id":"158723","direction":"down","inn_name":"","iupac_name":"(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid","metabolite_id":"XPSGESXVBSQZPL-SRVKXCTJSA-N","pvalue":1.854774014881565e-07,"ratio":0.0017633891223378,"synonym_name":""},{"chebi_id":"177731","direction":"down","inn_name":"","iupac_name":"1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-luorophenoxy)propan-2-ol","metabolite_id":"IGMKTIJBFUMVIN-UHFFFAOYSA-N","pvalue":2.453533358238037e-08,"ratio":0.0038000931277317,"synonym_name":""},{"chebi_id":"31837","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SIDLZWOQUZRBRU-UHFFFAOYSA-N","pvalue":3.6252222730529055e-08,"ratio":0.0040818062707968,"synonym_name":"Methyprylon"},{"chebi_id":"177675","direction":"down","inn_name":"","iupac_name":"(5R,6S)-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4S,5R)-4,5-dihydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one","metabolite_id":"YKKUKLUVLWQEBJ-RWLMSABTSA-N","pvalue":6.754543890709521e-10,"ratio":0.0127098401388214,"synonym_name":""},{"chebi_id":"38221","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-2,2'-{[(5<i>R</i>,6<i>R</i>,7<i>S</i>,9<i>S</i>,11<i>R</i>,16<i>R</i>,18<i>S</i>,19<i>S</i>)-19-amino-11,16,18-trihydroxy-5,9-dimethylicosane-6,7-diyl]bis[oxy(2-oxoethane-2,1-diyl)]}dibutanedioic acid","metabolite_id":"UVBUBMSSQKOIBE-DSLOAKGESA-N","pvalue":4.47020760667119e-08,"ratio":0.0044121123209738,"synonym_name":"Macrofusine"},{"chebi_id":"135480","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UDUSOMRJOPCWHT-UHFFFAOYSA-N","pvalue":1.3683940633792356e-08,"ratio":0.0070830661736852,"synonym_name":"DISIDA"}],"totalFeatures":1206},{"comparisonGroups":["Control","Day 12"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sausage microbiota: baseline vs 12-day changes","group_a_title":"Baseline control group at time point 0 days. Baseline group for comparison with samples at later time points.","group_b_title":"Experimental group at time point 12 days. Represents changes in the sausage microbiota and metabolites at 12 days.","id":"MTBLS2871_0002_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1383,"studyId":"MTBLS2871","studyUrl":"http://integmet.org/study/MTBLS2871","title":"Control_vs_Day_12","topHits":[{"chebi_id":"177859","direction":"down","inn_name":"","iupac_name":"(3a<i>R</i>,4<i>R</i>,5<i>S</i>,6a<i>R</i>,7a<i>S</i>,7b<i>R</i>,12a<i>R</i>,14a<i>S</i>,14b<i>R</i>)-4-hydroxy-5,6a,7b,12,12-pentamethyl-4,5,6a,7,7a,7b,12,12a,13,14-decahydro-5,14a-methanofuro[3',4':4b,5]fluoreno[2,1-<em>c</em>]oxepine-3,6,10(3a<em>H</em>)-trione","metabolite_id":"SJSNDUDHAXBERS-ABGUQTIISA-N","pvalue":1.4171335530509899e-09,"ratio":0.0084903383766642,"synonym_name":"andilesin"},{"chebi_id":"2487","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UEKRHVIBSZVFQN-KYJUHHDHSA-N","pvalue":1.6065990478700491e-09,"ratio":0.008534215822622,"synonym_name":"Adiantifoline"},{"chebi_id":"31821","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HOKDBMAJZXIPGC-UHFFFAOYSA-N","pvalue":1.6452642374334584e-08,"ratio":0.0059036798832294,"synonym_name":"Mequitazine"},{"chebi_id":"31858","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HZQDCMWJEBCWBR-UUOKFMHZSA-N","pvalue":1.597802528534185e-09,"ratio":0.0132192328970493,"synonym_name":"Mizoribine"},{"chebi_id":"81646","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZZAJNFHIGVVCFT-UHFFFAOYSA-N","pvalue":3.738539451527155e-09,"ratio":0.0128403825472686,"synonym_name":"Pretetramide"},{"chebi_id":"8411","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RETPFDTUCPKFEC-UHFFFAOYSA-N","pvalue":1.9874732716276757e-08,"ratio":0.0146525292902296,"synonym_name":"Primidolol"},{"chebi_id":"177698","direction":"down","inn_name":"","iupac_name":"7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one","metabolite_id":"VPAOSFFTKWUGAD-TVKJYDDYSA-N","pvalue":8.921568124290342e-06,"ratio":0.0019421345276098,"synonym_name":""},{"chebi_id":"33012","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-{(3<i>S</i>)-3-[(2<i>E</i>)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetamido]-2-oxoazetidin-1-yl}(4-hydroxyphenyl)acetic acid","metabolite_id":"NMMOYDKOFASOBV-ORWLQXDRSA-N","pvalue":2.5838379112072077e-10,"ratio":0.0412952735233844,"synonym_name":""},{"chebi_id":"177852","direction":"down","inn_name":"","iupac_name":"3-[3-tert-butylsulanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid","metabolite_id":"DFQGDHBGRSTTHX-UHFFFAOYSA-N","pvalue":3.910879105343985e-08,"ratio":0.0165224582461072,"synonym_name":""},{"chebi_id":"27831","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NXJOCELNFPGKIV-ARHXXGKOSA-N","pvalue":5.786923107820761e-07,"ratio":0.0081442148043275,"synonym_name":"Glucoproscillaridin A"}],"totalFeatures":1752},{"comparisonGroups":["Control","Paramycin"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs Paramycin antibiotic treatment","group_a_title":"Control group with no treatment. Provides a reference point for all treatment comparisons","group_b_title":"Group treated with the antibiotic Paramycin. Allows assessment of the impact of Paramycin on metabolic responses","id":"MTBLS2878_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS2878","studyUrl":"http://integmet.org/study/MTBLS2878","title":"Control_vs_Paramycin","topHits":[{"chebi_id":"2969","direction":"up","inn_name":"","iupac_name":"1-[(ethoxycarbonyl)oxy]ethyl 6\u03b2-[(2<i>R</i>)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3\u03b1-carboxylate hydrochloride","metabolite_id":"IWVTXAGTHUECPN-ANBBSHPLSA-N","pvalue":1.021389117241419e-05,"ratio":1000000.0,"synonym_name":"bacampicillin HCl"},{"chebi_id":"80927","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BWXKGZVAOLOFJU-UHFFFAOYSA-N","pvalue":2.337370407937654e-06,"ratio":378.6270065739627,"synonym_name":""},{"chebi_id":"45868","direction":"down","inn_name":"","iupac_name":"thymidine 5'-[3-(6-deoxy-\u03b2-<small>L</small>-<i>lyxo</i>-hexopyranosyl-4-ulose) dihydrogen diphosphate]","metabolite_id":"PSXWNITXWWECNY-LPVGZGSHSA-N","pvalue":0.0183857489816788,"ratio":1e-06,"synonym_name":"dTDP-6-deoxy-\u03b2-<small>L</small>-<i>lyxo</i>-hex-4-ulose"},{"chebi_id":"32805","direction":"down","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":8.429121391547063e-06,"ratio":0.0512801398737642,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"3752","direction":"up","inn_name":"clomifeno","iupac_name":"2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-<em>N</em>,<em>N</em>-diethylethanamine","metabolite_id":"GKIRPKYJQBWNGO-UHFFFAOYSA-N","pvalue":1.3582271660032082e-05,"ratio":9.522427546921024,"synonym_name":"Clomifene"},{"chebi_id":"34899","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NZFNABGZEQPYBX-NZVKSUHHSA-N","pvalue":0.0002651943175366,"ratio":0.0506062110559427,"synonym_name":"ORG 20599"},{"chebi_id":"189877","direction":"up","inn_name":"","iupac_name":"2-[4-[3-(2-chloroethyl)-2,3-diphenyloxiran-2-yl]phenoxy]-N,N-dimethylethanamine","metabolite_id":"FKGRILOUOJJTDR-UHFFFAOYSA-N","pvalue":0.0004413137382646,"ratio":16.06522828504155,"synonym_name":""},{"chebi_id":"135888","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KASDHRXLYQOAKZ-XDSKOBMDSA-N","pvalue":0.0329353286147426,"ratio":0.0164139408415952,"synonym_name":"elidel"},{"chebi_id":"82192","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DXXVCXKMSWHGTF-UHFFFAOYSA-N","pvalue":2.0515914014293745e-05,"ratio":3.284426466205625,"synonym_name":""},{"chebi_id":"28335","direction":"up","inn_name":"","iupac_name":"3,5-dibromo-<small>L</small>-tyrosine","metabolite_id":"COESHZUDRKCEPA-ZETCQYMHSA-N","pvalue":6.439867595133669e-07,"ratio":2.453443460818075,"synonym_name":"DiBrY"}],"totalFeatures":494},{"comparisonGroups":["Control","Paramycin"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs Paramycin antibiotic treatment","group_a_title":"Control group with no treatment. Provides a reference point for all treatment comparisons","group_b_title":"Group treated with the antibiotic Paramycin. Allows assessment of the impact of Paramycin on metabolic responses","id":"MTBLS2878_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":133,"studyId":"MTBLS2878","studyUrl":"http://integmet.org/study/MTBLS2878","title":"Control_vs_Paramycin","topHits":[{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":2.139997438789587e-05,"ratio":1000000.0,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"2681","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BZXBQQGSSIQELG-HVQQJYASSA-N","pvalue":2.5562330032731216e-05,"ratio":1e-06,"synonym_name":"Amphibine B"},{"chebi_id":"174802","direction":"up","inn_name":"","iupac_name":"15-hydroxy-13,14-dimethoxy-10-azatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,4,6,8,12,14-heptaen-11-one","metabolite_id":"PHKYZFGDNGACRM-UHFFFAOYSA-N","pvalue":6.382710312763607e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"6738","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DNBWHNVLJOVDJI-UHFFFAOYSA-N","pvalue":0.0005648902583075,"ratio":1e-06,"synonym_name":"Melochinone"},{"chebi_id":"38960","direction":"down","inn_name":"","iupac_name":"<em>S</em>-[(<em>tert</em>-butylsulfanyl)methyl] <em>O</em>,<em>O</em>-diethyl phosphorodithioate","metabolite_id":"XLNZEKHULJKQBA-UHFFFAOYSA-N","pvalue":0.0007820673713107,"ratio":1e-06,"synonym_name":"<em>S</em>-[(<em>tert</em>-butylsulfanyl)methyl] <em>O</em>,<em>O</em>-diethyl dithiophosphate"},{"chebi_id":"17041","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol","metabolite_id":"BOKVLBSSPUTWLV-INIZCTEOSA-N","pvalue":0.0023026251935942,"ratio":1000000.0,"synonym_name":"(S)-N-Methylcoclaurine"},{"chebi_id":"35012","direction":"down","inn_name":"","iupac_name":"2,2'-thiodiacetic acid","metabolite_id":"UVZICZIVKIMRNE-UHFFFAOYSA-N","pvalue":8.862675455873621e-07,"ratio":0.0050704397455307,"synonym_name":"2,2'-thiobisacetic acid"},{"chebi_id":"16750","direction":"down","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.0001170138522557,"ratio":0.0057624335572744,"synonym_name":"G"},{"chebi_id":"5828","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MXURVUIFJOLZNZ-SVFDORGDSA-N","pvalue":1.7288291544743487e-05,"ratio":56.01637851228439,"synonym_name":"Hymexazol O-glucoside"},{"chebi_id":"18917","direction":"down","inn_name":"","iupac_name":"1,3-dichloropropan-2-ol","metabolite_id":"DEWLEGDTCGBNGU-UHFFFAOYSA-N","pvalue":8.636336641870797e-05,"ratio":0.0158035728788606,"synonym_name":"1,3-Dichloro-2-propanol"}],"totalFeatures":1077},{"comparisonGroups":["Diet_D2","Diet_D5"],"dateCreated":"2025-09-26 00:00:00","display_title":"Diet D2 vs Diet D5 growth performance comparison","group_a_title":"Experimental group fed with diet D2.. Helps in understanding the impact of diet D2 on growth performance.","group_b_title":"Experimental group fed with diet D5.. Helps in understanding the impact of diet D5 on growth performance.","id":"MTBLS2887_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS2887","studyUrl":"http://integmet.org/study/MTBLS2887","title":"Diet_D2_vs_Diet_D5","topHits":[],"totalFeatures":9},{"comparisonGroups":["Diet_D2","Diet_D5"],"dateCreated":"2025-09-26 00:00:00","display_title":"Diet D2 vs D5 impact on growth performance","group_a_title":"Experimental group fed with diet D2.. Helps in understanding the impact of diet D2 on growth performance.","group_b_title":"Experimental group fed with diet D5.. Helps in understanding the impact of diet D5 on growth performance.","id":"MTBLS2887_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS2887","studyUrl":"http://integmet.org/study/MTBLS2887","title":"Diet_D2_vs_Diet_D5","topHits":[{"chebi_id":"16708","direction":"up","inn_name":"","iupac_name":"9<em>H</em>-purin-6-amine","metabolite_id":"GFFGJBXGBJISGV-UHFFFAOYSA-N","pvalue":0.0004632411524414,"ratio":4.127155583459719,"synonym_name":"Adenin"}],"totalFeatures":10},{"comparisonGroups":["16_May_2012","8_June_2012"],"dateCreated":"2025-09-26 00:00:00","display_title":"Initial vs final timepoint (May 16 to June 8, 2012)","group_a_title":"Samples collected on 16 May 2012. Represents the initial time point in the study.","group_b_title":"Samples collected on 8 June 2012. Represents the final time point in the study.","id":"MTBLS293_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS293","studyUrl":"http://integmet.org/study/MTBLS293","title":"16_May_2012_vs_8_June_2012","topHits":[],"totalFeatures":35},{"comparisonGroups":["16_May_2012","8_June_2012"],"dateCreated":"2025-09-26 00:00:00","display_title":"Initial vs final timepoint (May 16 to June 8, 2012)","group_a_title":"Samples collected on 16 May 2012. Represents the initial time point in the study.","group_b_title":"Samples collected on 8 June 2012. Represents the final time point in the study.","id":"MTBLS293_0002_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS293","studyUrl":"http://integmet.org/study/MTBLS293","title":"16_May_2012_vs_8_June_2012","topHits":[{"chebi_id":"77267","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxypropane-1-sulfonic acid","metabolite_id":"YPFUJZAAZJXMIP-UHFFFAOYSA-N","pvalue":2.677822724087912e-07,"ratio":1000000.0,"synonym_name":"2,3-Dihydroxypropanesulphonic acid"}],"totalFeatures":43},{"comparisonGroups":["Control","Lithogenic Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs lithogenic diet effects on gut-liver axis","group_a_title":"Control group receiving a normal diet. Provides baseline data for comparison with the lithogenic diet group.","group_b_title":"Test group receiving a lithogenic diet. Allows assessment of the impact of a lithogenic diet on the gut-liver axis.","id":"MTBLS2945_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":131,"studyId":"MTBLS2945","studyUrl":"http://integmet.org/study/MTBLS2945","title":"Control_vs_Lithogenic_Diet","topHits":[{"chebi_id":"37998","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1-hydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"XBSQTYHEGZTYJE-OETIFKLTSA-N","pvalue":0.0018332748817209,"ratio":236747308.34732145,"synonym_name":"Lithocholic acid glycine conjugate"},{"chebi_id":"89929","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b2-dihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"GHCZAUBVMUEKKP-XROMFQGDSA-N","pvalue":5.829319377888115e-07,"ratio":0.0101536075727459,"synonym_name":"GUDCA"},{"chebi_id":"16755","direction":"down","inn_name":"","iupac_name":"3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-BSWAIDMHSA-N","pvalue":8.765055133263029e-07,"ratio":0.1028552433502262,"synonym_name":"anthropodesoxycholic acid"},{"chebi_id":"137921","direction":"up","inn_name":"","iupac_name":"24-hydroxy-24-oxo-5\u03b2-cholan-3\u03b1-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"GIQXKAXWRLHLDD-VYACWCJYSA-N","pvalue":6.085879974559977e-08,"ratio":6.412868231903852,"synonym_name":"lithocholic acid 3-\u03b2-glucuronide"},{"chebi_id":"7351","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-4-(acetylamino)-2-aminobutanoic acid","metabolite_id":"YLZRFVZUZIJABA-YFKPBYRVSA-N","pvalue":7.544512568351413e-05,"ratio":0.0495818414516541,"synonym_name":"N-gamma-Acetyldiaminobutyrate"},{"chebi_id":"17687","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"RFDAIACWWDREDC-FRVQLJSFSA-N","pvalue":0.0001417628915807,"ratio":23.916217568524477,"synonym_name":"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine"},{"chebi_id":"16962","direction":"up","inn_name":"","iupac_name":"17,21-dihydroxypregn-4-ene-3,11,20-trione","metabolite_id":"MFYSYFVPBJMHGN-ZPOLXVRWSA-N","pvalue":2.048247969496073e-05,"ratio":9.732298819096128,"synonym_name":"17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione"},{"chebi_id":"21615","direction":"down","inn_name":"","iupac_name":"2-acetamido-3-<em>O</em>-[(1<i>R</i>)-1-carboxyethyl]-2-deoxy-<small>D</small>-glucopyranose","metabolite_id":"MNLRQHMNZILYPY-MKFCKLDKSA-N","pvalue":1.3874477952937524e-06,"ratio":0.170450333729266,"synonym_name":"N-Acetylmuramic acid"},{"chebi_id":"15651","direction":"up","inn_name":"","iupac_name":"(5<i>S</i>,6<i>S</i>,7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-5,6-epoxyicosa-7,9,11,14-tetraenoic acid","metabolite_id":"UFPQIRYSPUYQHK-WAQVJNLQSA-N","pvalue":8.399726127772958e-07,"ratio":5.3843468428941135,"synonym_name":"5<i>S</i>,6<i>S</i>-epoxy-7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid"},{"chebi_id":"88108","direction":"up","inn_name":"","iupac_name":"7\u03b1,12\u03b1-dihydroxy-3-oxo-5\u03b2-cholan-24-oic acid","metabolite_id":"OEKUSRBIIZNLHZ-DJDNIQJZSA-N","pvalue":0.0010264640000394,"ratio":14.56812112072606,"synonym_name":"3-ketocholic acid"}],"totalFeatures":400},{"comparisonGroups":["Control","Lithogenic Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs lithogenic diet effects on gut-liver axis","group_a_title":"Control group receiving a normal diet. Provides baseline data for comparison with the lithogenic diet group.","group_b_title":"Test group receiving a lithogenic diet. Allows assessment of the impact of a lithogenic diet on the gut-liver axis.","id":"MTBLS2945_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":246,"studyId":"MTBLS2945","studyUrl":"http://integmet.org/study/MTBLS2945","title":"Control_vs_Lithogenic_Diet","topHits":[{"chebi_id":"80097","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XPRWWANUPMYKMF-UUHDPGOWSA-N","pvalue":2.1184383291292626e-07,"ratio":99.76119348047705,"synonym_name":""},{"chebi_id":"28374","direction":"down","inn_name":"","iupac_name":"solanid-5-en-3\u03b2-ol","metabolite_id":"JVKYZPBMZPJNAJ-OQFNDJACSA-N","pvalue":2.8516700843205925e-12,"ratio":0.0714356116487807,"synonym_name":"(3\u03b2)-solanid-5-en-3-ol"},{"chebi_id":"15737","direction":"down","inn_name":"","iupac_name":"[carbamoyl(methyl)amino]acetic acid","metabolite_id":"SREKYKXYSQMOIB-UHFFFAOYSA-N","pvalue":0.0182924824057117,"ratio":2.8765248786935034e-07,"synonym_name":"N-Carbamoylsarcosine"},{"chebi_id":"23929","direction":"up","inn_name":"","iupac_name":"5\u03b1-ergosta-7,24(28)-dien-3\u03b2-ol","metabolite_id":"BTCAEOLDEYPGGE-JVAZTMFWSA-N","pvalue":6.140868259815794e-08,"ratio":31.86541626939307,"synonym_name":"(3\u03b2,5\u03b1)-ergosta-7,24(28)-dien-3-ol"},{"chebi_id":"16933","direction":"up","inn_name":"","iupac_name":"(22<i>E</i>)-ergosta-5,7,22-trien-3\u03b2-ol","metabolite_id":"DNVPQKQSNYMLRS-APGDWVJJSA-N","pvalue":3.0748740014985564e-08,"ratio":23.011481477767724,"synonym_name":"Provitamin D2"},{"chebi_id":"177277","direction":"up","inn_name":"","iupac_name":"(3S,4S,10S,13R)-3-hydroxy-4,10,13-trimethyl-17-[(2S)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylic acid","metabolite_id":"MYWAIWDQTCHPTH-IUGQOUSLSA-N","pvalue":1.610775111770621e-08,"ratio":10.657672609285466,"synonym_name":""},{"chebi_id":"15650","direction":"down","inn_name":"","iupac_name":"(5<i>S</i>,6<i>R</i>,7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-6-(<small>L</small>-cystein-<em>S</em>-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid","metabolite_id":"OTZRAYGBFWZKMX-FRFVZSDQSA-N","pvalue":4.511611599815014e-06,"ratio":0.039576894858818,"synonym_name":"(7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyeicosa-7,9,11,14-tetraenoate"},{"chebi_id":"28824","direction":"up","inn_name":"","iupac_name":"(22<i>E</i>)-stigmasta-5,22-dien-3\u03b2-ol","metabolite_id":"HCXVJBMSMIARIN-PHZDYDNGSA-N","pvalue":2.0429381263679073e-08,"ratio":9.2092554402967,"synonym_name":"Stigmasterol"},{"chebi_id":"165291","direction":"up","inn_name":"","iupac_name":"(5S,6Z,8E)-5-hydroxy-12-oxoicosa-6,8-dienoic acid","metabolite_id":"RRTYEHFGQWNQKK-KIQAWMAPSA-N","pvalue":7.713642640300612e-08,"ratio":10.318715946842676,"synonym_name":""},{"chebi_id":"168659","direction":"up","inn_name":"","iupac_name":"(3S,4S,5R,10S,13R)-3-hydroxy-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylic acid","metabolite_id":"MYWAIWDQTCHPTH-YCIQJMEESA-N","pvalue":3.5349819164995753e-07,"ratio":9.296035253320737,"synonym_name":""}],"totalFeatures":863},{"comparisonGroups":["Intracellular","Extracellular"],"dateCreated":"2025-09-26 00:00:00","display_title":"Micromonas pusilla: intracellular vs extracellular metabolites","group_a_title":"Samples representing intracellular metabolites of Micromonas pusilla.. Understanding intracellular metabolic changes under phosphate deficiency.","group_b_title":"Samples representing extracellular metabolites of Micromonas pusilla.. Understanding extracellular metabolic changes under phosphate deficiency.","id":"MTBLS295_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS295","studyUrl":"http://integmet.org/study/MTBLS295","title":"Intracellular_vs_Extracellular","topHits":[{"chebi_id":"9533","direction":"up","inn_name":"","iupac_name":"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium","metabolite_id":"HZSAJDVWZRBGIF-UHFFFAOYSA-O","pvalue":0.0008224136350356,"ratio":1000000.0,"synonym_name":"vitamin B<small><sub>1</sub></small> monophosphate"},{"chebi_id":"59789","direction":"up","inn_name":"","iupac_name":"[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-O","pvalue":0.0012768491617065,"ratio":1000000.0,"synonym_name":"S-adenosyl-L-methionine"},{"chebi_id":"18385","direction":"up","inn_name":"","iupac_name":"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium","metabolite_id":"JZRWCGZRTZMZEH-UHFFFAOYSA-N","pvalue":0.0013766567142046,"ratio":1000000.0,"synonym_name":"Thiamine"},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":0.0051511817471139,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"15573","direction":"up","inn_name":"","iupac_name":"(2-aminoethyl)phosphonic acid","metabolite_id":"QQVDJLLNRSOCEL-UHFFFAOYSA-N","pvalue":0.0132466653285299,"ratio":1000000.0,"synonym_name":"2-Aminoethylphosphonate"},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":1.5542590719166367e-05,"ratio":192.83483612954444,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"28681","direction":"down","inn_name":"","iupac_name":"2-(acetylamino)-4-<em>O</em>-[2-(acetylamino)-2-deoxy-\u03b2-<small>D</small>-glucopyranosyl]-2-deoxy-<small>D</small>-glucopyranose","metabolite_id":"CDOJPCSDOXYJJF-CBTAGEKQSA-N","pvalue":0.0155378481965966,"ratio":1e-06,"synonym_name":"Chitobiose"},{"chebi_id":"17015","direction":"down","inn_name":"riboflavine","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUNGANRZJHBGPY-SCRDCRAPSA-N","pvalue":0.0358435836115269,"ratio":1e-06,"synonym_name":"E101"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0451973266059435,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"17750","direction":"up","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0007433979602344,"ratio":26.0343720148438,"synonym_name":"Bet"}],"totalFeatures":61},{"comparisonGroups":["Intracellular","Extracellular"],"dateCreated":"2025-09-26 00:00:00","display_title":"Micromonas pusilla: intracellular vs extracellular metabolites","group_a_title":"Samples representing intracellular metabolites of Micromonas pusilla.. Understanding intracellular metabolic changes under phosphate deficiency.","group_b_title":"Samples representing extracellular metabolites of Micromonas pusilla.. Understanding extracellular metabolic changes under phosphate deficiency.","id":"MTBLS295_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS295","studyUrl":"http://integmet.org/study/MTBLS295","title":"Intracellular_vs_Extracellular","topHits":[{"chebi_id":"9533","direction":"up","inn_name":"","iupac_name":"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium","metabolite_id":"HZSAJDVWZRBGIF-UHFFFAOYSA-O","pvalue":0.0008224136350356,"ratio":1000000.0,"synonym_name":"vitamin B<small><sub>1</sub></small> monophosphate"},{"chebi_id":"59789","direction":"up","inn_name":"","iupac_name":"[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-O","pvalue":0.0012768491617065,"ratio":1000000.0,"synonym_name":"S-adenosyl-L-methionine"},{"chebi_id":"18385","direction":"up","inn_name":"","iupac_name":"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium","metabolite_id":"JZRWCGZRTZMZEH-UHFFFAOYSA-N","pvalue":0.0013766567142046,"ratio":1000000.0,"synonym_name":"Thiamine"},{"chebi_id":"29016","direction":"up","inn_name":"","iupac_name":"arginine","metabolite_id":"ODKSFYDXXFIFQN-UHFFFAOYSA-N","pvalue":0.0051511817471139,"ratio":1000000.0,"synonym_name":"Arginin"},{"chebi_id":"15573","direction":"up","inn_name":"","iupac_name":"(2-aminoethyl)phosphonic acid","metabolite_id":"QQVDJLLNRSOCEL-UHFFFAOYSA-N","pvalue":0.0132466653285299,"ratio":1000000.0,"synonym_name":"2-Aminoethylphosphonate"},{"chebi_id":"18237","direction":"up","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":1.5542590719166367e-05,"ratio":192.83483612954444,"synonym_name":"Glutaminic acid"},{"chebi_id":"28681","direction":"down","inn_name":"","iupac_name":"2-(acetylamino)-4-<em>O</em>-[2-(acetylamino)-2-deoxy-\u03b2-<small>D</small>-glucopyranosyl]-2-deoxy-<small>D</small>-glucopyranose","metabolite_id":"CDOJPCSDOXYJJF-CBTAGEKQSA-N","pvalue":0.0155378481965966,"ratio":1e-06,"synonym_name":"Chitobiose"},{"chebi_id":"17015","direction":"down","inn_name":"riboflavine","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUNGANRZJHBGPY-SCRDCRAPSA-N","pvalue":0.0358435836115269,"ratio":1e-06,"synonym_name":"E101"},{"chebi_id":"28300","direction":"up","inn_name":"","iupac_name":"glutamine","metabolite_id":"ZDXPYRJPNDTMRX-UHFFFAOYSA-N","pvalue":0.0451973266059435,"ratio":1000000.0,"synonym_name":"Glutamine"},{"chebi_id":"17750","direction":"up","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0007433979602344,"ratio":26.0343720148438,"synonym_name":"Bet"}],"totalFeatures":67},{"comparisonGroups":["Solanum_habrochaites_leaf","Solanum_habrochaites_glandular_trichome"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. habrochaites: leaf vs glandular trichome","group_a_title":"Leaf samples from Solanum habrochaites. Provides baseline data for leaf tissue in Solanum habrochaites","group_b_title":"Glandular trichome samples from Solanum habrochaites. Provides data on glandular trichomes in Solanum habrochaites for metabolic analysis","id":"MTBLS297_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":91,"studyId":"MTBLS297","studyUrl":"http://integmet.org/study/MTBLS297","title":"Solanum_habrochaites_leaf_vs_glandular_trichome","topHits":[{"chebi_id":"17401","direction":"down","inn_name":"acido fitico","iupac_name":"<i>myo</i>-inositol hexakis(dihydrogen phosphate)","metabolite_id":"IMQLKJBTEOYOSI-GPIVLXJGSA-N","pvalue":0.0015449363323882,"ratio":6.358636476249261e-05,"synonym_name":"Inosithexaphosphors\u00e4ure"},{"chebi_id":"35491","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":3.628764502101804e-07,"ratio":0.0729522544294978,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":1.0389878286778076e-06,"ratio":0.1056310732888425,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"16235","direction":"down","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":0.000112421148607,"ratio":0.0699351156597019,"synonym_name":"GUANINE"},{"chebi_id":"17239","direction":"down","inn_name":"","iupac_name":"cytidine 5'-(trihydrogen diphosphate)","metabolite_id":"ZWIADYZPOWUWEW-XVFCMESISA-N","pvalue":1.064320142770414e-05,"ratio":0.1392615561741243,"synonym_name":"Cytidine, 5'-(trihydrogen pyrophosphate)"},{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":3.9647174033366286e-05,"ratio":0.1286921819362163,"synonym_name":"GMP"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":3.504283324317023e-05,"ratio":0.1339927975873975,"synonym_name":"u"},{"chebi_id":"15531","direction":"down","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-{3-[(3<i>R</i>)-4-{[3-({2-[(3-carboxyacetyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}","metabolite_id":"LTYOQGRJFJAKNA-DVVLENMVSA-N","pvalue":0.0003734773781694,"ratio":0.0768914927177215,"synonym_name":"Malonyl coenzyme A"},{"chebi_id":"17489","direction":"down","inn_name":"","iupac_name":"adenosine 3',5'-(hydrogen phosphate)","metabolite_id":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","pvalue":0.0006014460416844,"ratio":0.0833888799860887,"synonym_name":"Adenosine 3',5'-phosphate"},{"chebi_id":"28907","direction":"down","inn_name":"","iupac_name":"2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-N","pvalue":0.000694880625778,"ratio":0.0814585303260367,"synonym_name":""}],"totalFeatures":112},{"comparisonGroups":["Solanum_habrochaites_leaf","Solanum_habrochaites_glandular_trichome"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. habrochaites: leaf vs glandular trichome tissue","group_a_title":"Leaf samples from Solanum habrochaites. Provides baseline data for leaf tissue in Solanum habrochaites","group_b_title":"Glandular trichome samples from Solanum habrochaites. Provides data on glandular trichomes in Solanum habrochaites for metabolic analysis","id":"MTBLS297_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS297","studyUrl":"http://integmet.org/study/MTBLS297","title":"Solanum_habrochaites_leaf_vs_glandular_trichome","topHits":[{"chebi_id":"131494","direction":"up","inn_name":"","iupac_name":"(3\u03b2,25S)-spirosol-5-en-3-yl \u03b2-<small>D</small>-glucopyranosyl-(1\u21922)-[\u03b2-<small>D</small>-xylopyranosyl-(1\u21923)]-\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-galactopyranoside","metabolite_id":"BYMOGFTUZUEFHY-SIUCFGLGSA-N","pvalue":0.0080829520294127,"ratio":1000000.0,"synonym_name":"dehydrotomatin"},{"chebi_id":"9630","direction":"up","inn_name":"","iupac_name":"(22<i>S</i>,25<i>S</i>)-5\u03b1-spirosolan-3\u03b2-yl \u03b2-<small>D</small>-glucopyranosyl-(1\u21922)-[\u03b2-<small>D</small>-xylopyranosyl-(1\u21923)]-\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-galactopyranoside","metabolite_id":"REJLGAUYTKNVJM-SGXCCWNXSA-N","pvalue":0.0006168030068877,"ratio":462.924841957387,"synonym_name":"Tomatine"},{"chebi_id":"15843","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoic acid","metabolite_id":"YZXBAPSDXZZRGB-DOFZRALJSA-N","pvalue":0.0001048699004595,"ratio":0.0352262193116234,"synonym_name":"Arachidonate"},{"chebi_id":"27432","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoic acid","metabolite_id":"DTOSIQBPPRVQHS-PDBXOOCHSA-N","pvalue":4.878107021549281e-05,"ratio":0.1763847440396156,"synonym_name":"(9,12,15)-linolenic acid"},{"chebi_id":"17351","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":1.1942585611737991e-05,"ratio":0.2448201024110685,"synonym_name":"Linoleic acid"},{"chebi_id":"17521","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid","metabolite_id":"AAWZDTNXLSGCEK-WYWMIBKRSA-N","pvalue":0.0011785268667845,"ratio":5.031711943085291,"synonym_name":"(\u2212)-Quinic acid"},{"chebi_id":"16196","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":0.0001531410018049,"ratio":2.05947625388371,"synonym_name":"Oleate"},{"chebi_id":"28527","direction":"down","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4<em>H</em>-chromen-3-yl 6-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"IKGXIBQEEMLURG-NVPNHPEKSA-N","pvalue":0.003891667136769,"ratio":0.5781132901308041,"synonym_name":"Rutin"},{"chebi_id":"15756","direction":"down","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":0.0434403041600505,"ratio":0.6204459579232169,"synonym_name":"<em>n</em>-hexadecoic acid"}],"totalFeatures":18},{"comparisonGroups":["Control","Ethephon_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Melon: ethephon treatment vs control","group_a_title":"Control group without ethephon treatment. Provides baseline data for comparison with ethephon-treated samples.","group_b_title":"Group treated with ethephon. Represents the effect of ethephon treatment on melon samples.","id":"MTBLS2993_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS2993","studyUrl":"http://integmet.org/study/MTBLS2993","title":"Control_vs_Ethephon_Treatment","topHits":[{"chebi_id":"34494","direction":"down","inn_name":"","iupac_name":"8-{3-[(2<i>Z</i>)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid","metabolite_id":"FBUKMFOXMZRGRB-YFHOEESVSA-N","pvalue":0.0275532707054757,"ratio":0.1688225538971807,"synonym_name":"Coronaric acid"},{"chebi_id":"36090","direction":"down","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)prop-2-enoic acid","metabolite_id":"NGSWKAQJJWESNS-UHFFFAOYSA-N","pvalue":0.0010968348470219,"ratio":0.4957983193277311,"synonym_name":"<em>para</em>-coumaric acid"},{"chebi_id":"17716","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QKKXKWKRSA-N","pvalue":0.0018415494838302,"ratio":1.8174523570712136,"synonym_name":"milk sugar"},{"chebi_id":"16119","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid","metabolite_id":"JXOHGGNKMLTUBP-HSUXUTPPSA-N","pvalue":0.0024577465443942,"ratio":1.7170511384572729,"synonym_name":"Shikimate"},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0226529599757943,"ratio":0.4456958970233305,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"182972","direction":"down","inn_name":"","iupac_name":"(2S,3S,9R,13R,14S,16R)-2,16-dihydroxy-17-[(2R)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one","metabolite_id":"KISJFUMXCJBLJV-NNNWQWOPSA-N","pvalue":0.0120779454367993,"ratio":0.5383228133453561,"synonym_name":""},{"chebi_id":"182973","direction":"down","inn_name":"","iupac_name":"5-acetyl-2-hydroxybenzoic acid","metabolite_id":"NZRDKNBIPVLNHA-UHFFFAOYSA-N","pvalue":0.0131239302106,"ratio":0.6030640668523677,"synonym_name":""}],"totalFeatures":21},{"comparisonGroups":["Control","Ethephon_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Melon: ethephon treatment vs control","group_a_title":"Control group without ethephon treatment. Provides baseline data for comparison with ethephon-treated samples.","group_b_title":"Group treated with ethephon. Represents the effect of ethephon treatment on melon samples.","id":"MTBLS2993_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS2993","studyUrl":"http://integmet.org/study/MTBLS2993","title":"Control_vs_Ethephon_Treatment","topHits":[{"chebi_id":"167401","direction":"down","inn_name":"","iupac_name":"4-propan-2-ylcyclohexene-1-carbaldehyde","metabolite_id":"AEVLWICMAHGAMS-UHFFFAOYSA-N","pvalue":0.007819514223773,"ratio":0.0106128133704735,"synonym_name":""},{"chebi_id":"61993","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucose","metabolite_id":"RXVWSYJTUUKTEA-CGQAXDJHSA-N","pvalue":0.0064012233071044,"ratio":3.379832956691396,"synonym_name":"<small>D</small>-maltotriose"},{"chebi_id":"181854","direction":"down","inn_name":"","iupac_name":"(E)-7-(4-methoxy-5-methyl-6-oxopyran-2-yl)-5-methyloct-6-enoic acid","metabolite_id":"HXLDSEPZKLJMIQ-DHZHZOJOSA-N","pvalue":0.0208605278252495,"ratio":0.2097333333333333,"synonym_name":""},{"chebi_id":"4609","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NIQCNGHVCWTJSM-UHFFFAOYSA-N","pvalue":0.0200837860283002,"ratio":0.2543375394321766,"synonym_name":"Dimethyl phthalate"},{"chebi_id":"47925","direction":"down","inn_name":"","iupac_name":"3-(3-hydroxyphenyl)prop-2-enoic acid","metabolite_id":"KKSDGJDHHZEWEP-UHFFFAOYSA-N","pvalue":0.0031223885234423,"ratio":0.4569420035149386,"synonym_name":"3-coumaric acid"},{"chebi_id":"74389","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[(2<i>S</i>)-2-azaniumylpropanoyl]amino}-4-methylpentanoate","metabolite_id":"RDIKFPRVLJLMER-BQBZGAKWSA-N","pvalue":0.0002268415151989,"ratio":0.6388783630162941,"synonym_name":"AL zwitterion"},{"chebi_id":"158508","direction":"down","inn_name":"","iupac_name":"(2S,3S)-2-[[(2S,3S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoic acid","metabolite_id":"BBQABUDWDUKJMB-LZXPERKUSA-N","pvalue":0.0001756238674291,"ratio":0.6539597841488047,"synonym_name":""},{"chebi_id":"15406","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>,6<i>R</i>)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-ol","metabolite_id":"OLAKPNFIICOONC-ZJUUUORDSA-N","pvalue":0.009674454037593,"ratio":2.0874769797421733,"synonym_name":"(-)-trans-isopiperitenol"},{"chebi_id":"159447","direction":"down","inn_name":"","iupac_name":"(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]pentanedioic acid","metabolite_id":"ULBHWNVWSCJLCO-NHCYSSNCSA-N","pvalue":0.0064805072211015,"ratio":0.5103448275862069,"synonym_name":""},{"chebi_id":"73427","direction":"down","inn_name":"","iupac_name":"<small>L</small>-asparaginyl-<small>L</small>-tyrosine","metabolite_id":"FYRVDDJMNISIKJ-UWVGGRQHSA-N","pvalue":0.0019474043066001,"ratio":0.5897009966777409,"synonym_name":"NY"}],"totalFeatures":116},{"comparisonGroups":["SRC1_Knockout_Fed_Liver","SRC1_Wildtype_Fed_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse liver: SRC1 knockout vs wild-type (fed state)","group_a_title":"SRC1 knockout mice in fed state, liver tissue. Helps to understand the role of SRC1 in liver metabolism under fed conditions.","group_b_title":"SRC1 wild-type mice in fed state, liver tissue. Provides baseline for comparing SRC1 knockout effects in liver under fed conditions.","id":"MTBLS30_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS30","studyUrl":"http://integmet.org/study/MTBLS30","title":"SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver","topHits":[{"chebi_id":"73049","direction":"down","inn_name":"","iupac_name":"4-[(6-carboxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"AUWRHMAICBSXMC-UHFFFAOYSA-N","pvalue":0.0085541125023693,"ratio":0.4952198852772466,"synonym_name":"4-[(6-carboxyhexanoyl)oxy]-4-(trimethylammonio)butanoate"},{"chebi_id":"73076","direction":"down","inn_name":"","iupac_name":"3-{[(9<i>Z</i>)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate","metabolite_id":"YBCVTTMMURGSEY-SEYXRHQNSA-N","pvalue":0.0138499414958706,"ratio":0.6000000000000001,"synonym_name":"3-{[(9<i>Z</i>)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylammonio)butanoate"},{"chebi_id":"68830","direction":"down","inn_name":"","iupac_name":"3-(decanoyloxy)-4-(trimethylammonio)butanoate","metabolite_id":"LZOSYCMHQXPBFU-UHFFFAOYSA-N","pvalue":0.0264407248397859,"ratio":0.6470588235294118,"synonym_name":"decanoylcarnitine"},{"chebi_id":"73075","direction":"down","inn_name":"","iupac_name":"3-{[(9<i>Z</i>,12<i>Z</i>)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate","metabolite_id":"WQYXCASYXUFNSI-UTJQPWESSA-N","pvalue":0.0489955787219886,"ratio":0.6206896551724139,"synonym_name":"(9<i>Z</i>,12<i>Z</i>)-3-hydroxyoctadeca-9,12-dienoylcarnitine"}],"totalFeatures":67},{"comparisonGroups":["SRC1_Knockout_Fed_Liver","SRC1_Wildtype_Fed_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse liver: SRC1 knockout vs wild-type (fed state)","group_a_title":"SRC1 knockout mice in fed state, liver tissue. Helps to understand the role of SRC1 in liver metabolism under fed conditions.","group_b_title":"SRC1 wild-type mice in fed state, liver tissue. Provides baseline for comparing SRC1 knockout effects in liver under fed conditions.","id":"MTBLS30_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS30","studyUrl":"http://integmet.org/study/MTBLS30","title":"SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver","topHits":[],"totalFeatures":7},{"comparisonGroups":["SRC1_Knockout_Fed_Liver","SRC1_Wildtype_Fed_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse liver: SRC1 knockout vs wild-type (fed state)","group_a_title":"SRC1 knockout mice in fed state, liver tissue. Helps to understand the role of SRC1 in liver metabolism under fed conditions.","group_b_title":"SRC1 wild-type mice in fed state, liver tissue. Provides baseline for comparing SRC1 knockout effects in liver under fed conditions.","id":"MTBLS30_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS30","studyUrl":"http://integmet.org/study/MTBLS30","title":"SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver","topHits":[],"totalFeatures":7},{"comparisonGroups":["SRC1_Knockout_Fed_Liver","SRC1_Wildtype_Fed_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse liver: SRC1 knockout vs wild-type (fed)","group_a_title":"SRC1 knockout mice in fed state, liver tissue. Helps to understand the role of SRC1 in liver metabolism under fed conditions.","group_b_title":"SRC1 wild-type mice in fed state, liver tissue. Provides baseline for comparing SRC1 knockout effects in liver under fed conditions.","id":"MTBLS30_0004_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS30","studyUrl":"http://integmet.org/study/MTBLS30","title":"SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver","topHits":[{"chebi_id":"73049","direction":"down","inn_name":"","iupac_name":"4-[(6-carboxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"AUWRHMAICBSXMC-UHFFFAOYSA-N","pvalue":0.0085541125023693,"ratio":0.4952198852772466,"synonym_name":"4-[(6-carboxyhexanoyl)oxy]-4-(trimethylammonio)butanoate"},{"chebi_id":"73076","direction":"down","inn_name":"","iupac_name":"3-{[(9<i>Z</i>)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate","metabolite_id":"YBCVTTMMURGSEY-SEYXRHQNSA-N","pvalue":0.0138499414958706,"ratio":0.6000000000000001,"synonym_name":"3-{[(9<i>Z</i>)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylammonio)butanoate"},{"chebi_id":"68830","direction":"down","inn_name":"","iupac_name":"3-(decanoyloxy)-4-(trimethylammonio)butanoate","metabolite_id":"LZOSYCMHQXPBFU-UHFFFAOYSA-N","pvalue":0.0264407248397859,"ratio":0.6470588235294118,"synonym_name":"decanoylcarnitine"},{"chebi_id":"73075","direction":"down","inn_name":"","iupac_name":"3-{[(9<i>Z</i>,12<i>Z</i>)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate","metabolite_id":"WQYXCASYXUFNSI-UTJQPWESSA-N","pvalue":0.0489955787219886,"ratio":0.6206896551724139,"synonym_name":"(9<i>Z</i>,12<i>Z</i>)-3-hydroxyoctadeca-9,12-dienoylcarnitine"}],"totalFeatures":38},{"comparisonGroups":["Sham","UIR"],"dateCreated":"2025-09-26 00:00:00","display_title":"Kidney: control vs unilateral ischemia-reperfusion","group_a_title":"Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.","group_b_title":"Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows assessment of the effects of UIR on kidney function and structure.","id":"MTBLS3003_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS3003","studyUrl":"http://integmet.org/study/MTBLS3003","title":"Sham_vs_UIR","topHits":[{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":2.984703255899726e-05,"ratio":0.0396483937500833,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"46823","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-purine-2,6,8-triol","metabolite_id":"LEHOTFFKMJEONL-UHFFFAOYSA-N","pvalue":8.840603887152917e-05,"ratio":0.1632786290481813,"synonym_name":""},{"chebi_id":"27820","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid","metabolite_id":"MYHXHCUNDDAEOZ-FOSBLDSVSA-N","pvalue":0.0002158554160469,"ratio":0.2707515185983085,"synonym_name":"Prostaglandin A2"},{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.002412614524069,"ratio":0.2140108295991188,"synonym_name":"colamine phosphate"},{"chebi_id":"17268","direction":"down","inn_name":"","iupac_name":"<i>myo</i>-inositol","metabolite_id":"CDAISMWEOUEBRE-GPIVLXJGSA-N","pvalue":0.0006069017061082,"ratio":0.3414914708892356,"synonym_name":"D-myo-Inositol"},{"chebi_id":"17794","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UWTATZPHSA-N","pvalue":0.006076166937683,"ratio":4.7163707828146055,"synonym_name":"3-Phospho-D-glycerate"},{"chebi_id":"18333","direction":"up","inn_name":"","iupac_name":"<small>D</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-QWWZWVQMSA-N","pvalue":0.0032602034259622,"ratio":3.118066154735896,"synonym_name":"D-Arabinitol"},{"chebi_id":"30763","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":0.0117305065869246,"ratio":4.066041282543936,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"28689","direction":"up","inn_name":"","iupac_name":"3\u03b2-hydroxyandrost-5-en-17-one","metabolite_id":"FMGSKLZLMKYGDP-USOAJAOKSA-N","pvalue":0.0381523961265071,"ratio":5.590306427225598,"synonym_name":"Prasterone"},{"chebi_id":"17164","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-glucopyranoside","metabolite_id":"UQZIYBXSHAGNOE-XNSRJBNMSA-N","pvalue":0.0366695848617662,"ratio":0.1853401198322213,"synonym_name":"Stachyose"}],"totalFeatures":88},{"comparisonGroups":["Sham","UIR"],"dateCreated":"2025-09-26 00:00:00","display_title":"Kidney: unilateral ischemia-reperfusion vs sham control","group_a_title":"Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.","group_b_title":"Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows assessment of the effects of UIR on kidney function and structure.","id":"MTBLS3003_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS3003","studyUrl":"http://integmet.org/study/MTBLS3003","title":"Sham_vs_UIR","topHits":[{"chebi_id":"27814","direction":"down","inn_name":"","iupac_name":"(5<i>S</i>,6<i>Z</i>,8<i>E</i>,10<i>E</i>,14<i>Z</i>)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid","metabolite_id":"SJVWVCVZWMJXOK-NOJHDUNKSA-N","pvalue":0.0008560909363204,"ratio":0.0937250860577718,"synonym_name":"12-oxo-LTB4"},{"chebi_id":"15552","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-6,9\u03b1-epoxy-11\u03b1,15-dihydroxyprosta-5,13-dienoic acid","metabolite_id":"KAQKFAOMNZTLHT-OZUDYXHBSA-N","pvalue":0.0007325139066425,"ratio":0.1193755074060678,"synonym_name":"(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate"},{"chebi_id":"30531","direction":"down","inn_name":"","iupac_name":"heptanedioic acid","metabolite_id":"WLJVNTCWHIRURA-UHFFFAOYSA-N","pvalue":0.0441941589962082,"ratio":0.0155830122065193,"synonym_name":"PIMELIC ACID"},{"chebi_id":"28645","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":0.0037215814645054,"ratio":5.792565905991571,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"60175","direction":"up","inn_name":"","iupac_name":"5-hydroxylysine","metabolite_id":"YSMODUONRAFBET-UHFFFAOYSA-N","pvalue":0.0066776039961952,"ratio":6.519216420607149,"synonym_name":"hydroxylysine"},{"chebi_id":"139123","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DQAKJEWZWDQURW-UHFFFAOYSA-N","pvalue":0.0029335573226251,"ratio":4.729938350353857,"synonym_name":""},{"chebi_id":"57947","direction":"down","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.0003186997547937,"ratio":0.3655666993966615,"synonym_name":""},{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0006173529584396,"ratio":2.9440352024034073,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"57563","direction":"up","inn_name":"","iupac_name":"2-azaniumyl-4-oxopentanoate","metabolite_id":"QUCHWTCTBHQQDU-UHFFFAOYSA-N","pvalue":0.0025003031086352,"ratio":3.0096416140537916,"synonym_name":"2-ammonio-4-oxopentanoate"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0133005728667039,"ratio":3.1940587995790524,"synonym_name":"hypoxanthine <small>D</small>-riboside"}],"totalFeatures":176},{"comparisonGroups":["Control","High"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose treatment","group_a_title":"Control group with no treatment. Provides baseline data for comparison with treated groups","group_b_title":"High dose treatment group. Represents the effect of high dose treatment","id":"MTBLS303_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS303","studyUrl":"http://integmet.org/study/MTBLS303","title":"Control_vs_High","topHits":[{"chebi_id":"73070","direction":"up","inn_name":"","iupac_name":"3-[(3-hydroxyhexadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"XKAZIAFZAQAHHG-UHFFFAOYSA-N","pvalue":0.0034512207219645,"ratio":2.4873369335375988,"synonym_name":"3-hydroxypalmitoylcarnitine"}],"totalFeatures":28},{"comparisonGroups":["Control","High"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose treatment comparison","group_a_title":"Control group with no treatment. Provides baseline data for comparison with treated groups","group_b_title":"High dose treatment group. Represents the effect of high dose treatment","id":"MTBLS303_0002_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS303","studyUrl":"http://integmet.org/study/MTBLS303","title":"Control_vs_High","topHits":[{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0001644402753036,"ratio":2.0514327700220427,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.009324182196376,"ratio":1.814300509373745,"synonym_name":""},{"chebi_id":"59789","direction":"up","inn_name":"","iupac_name":"[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-O","pvalue":0.0471941110605187,"ratio":1.5059607928398016,"synonym_name":"S-adenosyl-L-methionine"}],"totalFeatures":36},{"comparisonGroups":["2:00 AM_Membrane","2:00 AM_Net"],"dateCreated":"2025-09-26 00:00:00","display_title":"2:00 AM sampling: membrane vs net collection methods","group_a_title":"Samples collected at 2:00 AM using membrane method.. Represents early morning sampling using membrane method, crucial for understanding diel variations.","group_b_title":"Samples collected at 2:00 AM using net method.. Represents early morning sampling using net method, crucial for understanding diel variations.","id":"MTBLS3038_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":185,"studyId":"MTBLS3038","studyUrl":"http://integmet.org/study/MTBLS3038","title":"2:00 AM_Membrane_vs_2:00 AM_Net","topHits":[{"chebi_id":"68434","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-isoleucine","metabolite_id":"SNCKGJWJABDZHI-ZKWXMUAHSA-N","pvalue":1.1591886375014732e-05,"ratio":1000000.0,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Ile"},{"chebi_id":"16039","direction":"up","inn_name":"","iupac_name":"inosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"HAEJPQIATWHALX-KQYNXXCUSA-N","pvalue":1.481213034021932e-05,"ratio":1000000.0,"synonym_name":"ITP"},{"chebi_id":"178675","direction":"up","inn_name":"","iupac_name":"1-(2,6-diaminohexanoyl)-4-hydroxypyrrolidine-2-carboxylic acid","metabolite_id":"BFDLYDRHDPSQHM-UHFFFAOYSA-N","pvalue":2.0073546378023584e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"167948","direction":"up","inn_name":"","iupac_name":"2-oxo-6-pentyloxane-3-carboxylic acid","metabolite_id":"UYZBRJHRPDMUHS-UHFFFAOYSA-N","pvalue":0.0001849003599822,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"178214","direction":"up","inn_name":"","iupac_name":"2-[[(2S)-2-hydroxypropanoyl]amino]-3-methylbutanoic acid","metabolite_id":"IJKKTQLUXOILBQ-ZBHICJROSA-N","pvalue":1.34627074658943e-05,"ratio":27644.348542180694,"synonym_name":""},{"chebi_id":"89344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ALTAAUJNHYWOGS-UHFFFAOYSA-N","pvalue":0.0005308220547104,"ratio":1000000.0,"synonym_name":"4-Hydroxycyclohexylacetate"},{"chebi_id":"176327","direction":"down","inn_name":"","iupac_name":"[(2R,5S,6R)-2-[(E,2S,3R)-2-(docosanoylamino)-3-hydroxyoctadec-4-enoxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulate","metabolite_id":"UAKYQMHTPLVMJD-GJOJTGTQSA-N","pvalue":0.0005562118275512,"ratio":1e-06,"synonym_name":""},{"chebi_id":"170123","direction":"down","inn_name":"","iupac_name":"(1-hydroxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate","metabolite_id":"ZOOLJLSXNRZLDH-KTKRTIGZSA-N","pvalue":0.0013252595599146,"ratio":1e-06,"synonym_name":""},{"chebi_id":"189895","direction":"up","inn_name":"","iupac_name":"2-(pentanoylamino)-3-phenylpropanoic acid","metabolite_id":"YXQLJEQFZUMUPB-UHFFFAOYSA-N","pvalue":0.0013448824500701,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"138751","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SYRVWXFZYGDVTF-UHFFFAOYSA-N","pvalue":0.0015398566423155,"ratio":1000000.0,"synonym_name":"(1beta,2beta,5beta)-p-Menth-3-ene-1,2,5-triol"}],"totalFeatures":329},{"comparisonGroups":["2:00 AM_Membrane","2:00 AM_Net"],"dateCreated":"2025-09-26 00:00:00","display_title":"2:00 AM sampling: membrane vs net collection method","group_a_title":"Samples collected at 2:00 AM using membrane method.. Represents early morning sampling using membrane method, crucial for understanding diel variations.","group_b_title":"Samples collected at 2:00 AM using net method.. Represents early morning sampling using net method, crucial for understanding diel variations.","id":"MTBLS3038_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":305,"studyId":"MTBLS3038","studyUrl":"http://integmet.org/study/MTBLS3038","title":"2:00 AM_Membrane_vs_2:00 AM_Net","topHits":[{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":2.364602238921964e-06,"ratio":1e-06,"synonym_name":"L-Lysine"},{"chebi_id":"176297","direction":"down","inn_name":"","iupac_name":"(3S,5S,8R,9S,10S,13R,14S,17R)-3-[(2R,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-uran-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde","metabolite_id":"CAYUJEAJKPLCAV-TZOZDROWSA-N","pvalue":6.596622271105367e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"8990","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SSJQVDUAKDRWTA-CAYKMONMSA-N","pvalue":6.186196257266394e-06,"ratio":2.689115947106474e-06,"synonym_name":"SN-38G"},{"chebi_id":"177404","direction":"down","inn_name":"","iupac_name":"[(2R)-3-[(Z)-hexadec-1-enoxy]-2-hydroxypropyl] dihydrogen phosphate","metabolite_id":"LBGSRVIXIVDRQM-OAXWQBPPSA-N","pvalue":2.5448244851608977e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"73612","direction":"up","inn_name":"","iupac_name":"<small>L</small>-methionyl-<small>L</small>-proline","metabolite_id":"DZMGFGQBRYWJOR-YUMQZZPRSA-N","pvalue":2.9817173923254135e-05,"ratio":1000000.0,"synonym_name":"<small>L</small>-Met-<small>L</small>-Pro"},{"chebi_id":"49259","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(1<i>R</i>)-1-carboxyethyl]-<small>L</small>-norvaline","metabolite_id":"AMDDRMIFTJHJGD-RITPCOANSA-N","pvalue":0.0001478925382691,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"176228","direction":"down","inn_name":"","iupac_name":"[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"OOLXGDSPUCDFAL-WQRHYEAKSA-N","pvalue":0.0001577609262611,"ratio":1e-06,"synonym_name":""},{"chebi_id":"174217","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>)-2-hydroxypropanoyl]-<small>L</small>-phenylalanine","metabolite_id":"IIRJJZHHNGABMQ-WPRPVWTQSA-N","pvalue":0.0001656261785853,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-2-[[(2<i>S</i>)-2-hydroxypropanoyl]amino]-3-phenylpropanoic acid"},{"chebi_id":"74541","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DNDWZFHLZVYOGF-KKUMJFAQSA-N","pvalue":0.0005803950852678,"ratio":1000000.0,"synonym_name":"Leucyl-leucyl-leucine"},{"chebi_id":"16856","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0007005399559129,"ratio":1000000.0,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"}],"totalFeatures":648},{"comparisonGroups":["Sham","UIR"],"dateCreated":"2025-09-26 00:00:00","display_title":"Kidney: unilateral ischemia-reperfusion vs sham control","group_a_title":"Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.","group_b_title":"Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows for the assessment of the effects of UIR on kidney function and structure.","id":"MTBLS3056_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS3056","studyUrl":"http://integmet.org/study/MTBLS3056","title":"Sham_vs_UIR","topHits":[{"chebi_id":"17405","direction":"up","inn_name":"","iupac_name":"3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid","metabolite_id":"HXACOUQIXZGNBF-UHFFFAOYSA-N","pvalue":2.0518650503162705e-08,"ratio":8.20495694839066,"synonym_name":"4-pyridoxinecarboxylic acid"},{"chebi_id":"16960","direction":"up","inn_name":"","iupac_name":"adenosine 5'-[3-(<small>D</small>-ribofuranos-5-<em>O</em>-yl) dihydrogen diphosphate]","metabolite_id":"SRNWOUGRCWSEMX-TYASJMOZSA-N","pvalue":9.06589255536561e-06,"ratio":16.61504476093817,"synonym_name":"ribose adenosinediphosphate"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":1.7998957779814534e-06,"ratio":9.918552543653854,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"35697","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-phenylprop-2-enoic acid","metabolite_id":"WBYWAXJHAXSJNI-VOTSOKGWSA-N","pvalue":0.0011783440491053,"ratio":73.06836766946067,"synonym_name":"trans-Cinnamic acid"},{"chebi_id":"18333","direction":"up","inn_name":"","iupac_name":"<small>D</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-QWWZWVQMSA-N","pvalue":1.6084663536814663e-06,"ratio":8.644830665202981,"synonym_name":"D-Arabinitol"},{"chebi_id":"16238","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(3-{<small>D</small>-<i>ribo</i>-5-[7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)","metabolite_id":"VWWQXMAJTJZDQX-UYBVJOGSSA-N","pvalue":3.952522494638279e-06,"ratio":7.124143556676143,"synonym_name":"FAD"},{"chebi_id":"28728","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11,15-trihydroxythromboxa-5,13-dien-1-oic acid","metabolite_id":"XNRNNGPBEPRNAR-JQBLCGNGSA-N","pvalue":0.0002120541825235,"ratio":0.0817833425357855,"synonym_name":"TXB2"},{"chebi_id":"17621","direction":"up","inn_name":"","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-5-<em>O</em>-phosphono-<small>D</small>-ribitol","metabolite_id":"FVTCRASFADXXNN-SCRDCRAPSA-N","pvalue":3.272215105055255e-05,"ratio":4.6488826975216035,"synonym_name":"riboflavin 5'-(dihydrogen phosphate)"},{"chebi_id":"17363","direction":"up","inn_name":"","iupac_name":"5-<em>O</em>-phosphono-<small>D</small>-ribulose","metabolite_id":"FNZLKVNUWIIPSJ-UHNVWZDZSA-N","pvalue":4.421590594352974e-06,"ratio":3.3631180182953164,"synonym_name":"D-Ribulose 5-phosphate"},{"chebi_id":"16259","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetyl-<small>L</small>-phenylalanine","metabolite_id":"CBQJSKKFNMDLON-JTQLQIEISA-N","pvalue":5.313547539100824e-05,"ratio":4.034149457503161,"synonym_name":"Acetylphenylalanine"}],"totalFeatures":80},{"comparisonGroups":["Sham","UIR"],"dateCreated":"2025-09-26 00:00:00","display_title":"Kidney: control vs unilateral ischemia-reperfusion","group_a_title":"Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.","group_b_title":"Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows for the assessment of the effects of UIR on kidney function and structure.","id":"MTBLS3056_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":74,"studyId":"MTBLS3056","studyUrl":"http://integmet.org/study/MTBLS3056","title":"Sham_vs_UIR","topHits":[{"chebi_id":"17650","direction":"up","inn_name":"hidrocortisona","iupac_name":"11\u03b2,17,21-trihydroxypregn-4-ene-3,20-dione","metabolite_id":"JYGXADMDTFJGBT-VWUMJDOOSA-N","pvalue":1.4878792263458496e-07,"ratio":355.74934803520756,"synonym_name":"Kendall's compound F"},{"chebi_id":"16436","direction":"up","inn_name":"citicolina","iupac_name":"5'-<em>O</em>-[hydroxy({[2-(trimethylammonio)ethoxy]phosphinato}oxy)phosphoryl]cytidine","metabolite_id":"RZZPDXZPRHQOCG-OJAKKHQRSA-N","pvalue":2.0324452749602863e-06,"ratio":59.24887714860732,"synonym_name":"Citicoline"},{"chebi_id":"17515","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteine","metabolite_id":"RITKHVBHSGLULN-WHFBIAKZSA-N","pvalue":5.114095484207955e-05,"ratio":149.63674648992253,"synonym_name":"Glu(-Cys)"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":2.2630981238250656e-06,"ratio":28.308994753505143,"synonym_name":""},{"chebi_id":"60175","direction":"up","inn_name":"","iupac_name":"5-hydroxylysine","metabolite_id":"YSMODUONRAFBET-UHFFFAOYSA-N","pvalue":4.879987861809261e-06,"ratio":16.243879991025278,"synonym_name":"hydroxylysine"},{"chebi_id":"176875","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-5-[[(1S)-1-carboxypropyl]amino]-5-oxopentanoic acid","metabolite_id":"FUZOZPRKGAXGOB-WDSKDSINSA-N","pvalue":1.1338707680130564e-05,"ratio":18.80579759652716,"synonym_name":""},{"chebi_id":"29009","direction":"up","inn_name":"","iupac_name":"2-(1-methyl-1<em>H</em>-imidazol-4-yl)ethanamine","metabolite_id":"FHQDWPCFSJMNCT-UHFFFAOYSA-N","pvalue":1.9139490845060927e-05,"ratio":18.44921106171972,"synonym_name":"Ntau-Methylhistamine"},{"chebi_id":"18335","direction":"up","inn_name":"","iupac_name":"[4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl dihydrogen phosphate","metabolite_id":"ZMJGSOSNSPKHNH-UHFFFAOYSA-N","pvalue":0.0014360155210426,"ratio":124.41030353466796,"synonym_name":"pyridoxamine 5'-(dihydrogen phosphate)"},{"chebi_id":"18089","direction":"up","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":5.2013972283925305e-05,"ratio":20.07382341385681,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"27480","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(phenylacetyl)glycine","metabolite_id":"UTYVDVLMYQPLQB-UHFFFAOYSA-N","pvalue":1.7199203599129766e-05,"ratio":7.974423085580675,"synonym_name":"Phenaceturic acid"}],"totalFeatures":135},{"comparisonGroups":["Mock_18_days","X31_19_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mock infection (18d) vs X31 virus infection (19d)","group_a_title":"Mock infected samples collected at 18 days post-infection. Serves as the reference point for all comparisons with infected groups.","group_b_title":"Samples infected with X31 virus collected at 19 days post-infection. Represents the maximum time point for X31 infection, providing insight into the long-term host response.","id":"MTBLS31_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS31","studyUrl":"http://integmet.org/study/MTBLS31","title":"Mock_18_days_vs_X31_19_days","topHits":[{"chebi_id":"15555","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"BHMBVRSPMRCCGG-OUTUXVNYSA-N","pvalue":0.0132242935941999,"ratio":0.4753800771499886,"synonym_name":"(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate"},{"chebi_id":"72663","direction":"up","inn_name":"","iupac_name":"(12<i>Z</i>)-9,10-dihydroxyoctadec-12-enoic acid","metabolite_id":"XEBKSQSGNGRGDW-YFHOEESVSA-N","pvalue":0.0199161518806636,"ratio":1.9641550841258228,"synonym_name":"9,10-DHOA"},{"chebi_id":"38299","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid","metabolite_id":"CCPPLLJZDQAOHD-FLIBITNWSA-N","pvalue":0.0289743364270087,"ratio":2.055346587855991,"synonym_name":"(9<i>Z</i>)-12,13-epoxyoctadecenoic acid"},{"chebi_id":"72665","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-12,13-dihydroxyoctadec-9-enoic acid","metabolite_id":"CQSLTKIXAJTQGA-FLIBITNWSA-N","pvalue":0.0215324519860253,"ratio":1.8560176433522368,"synonym_name":"12,13-DHOME"}],"totalFeatures":53},{"comparisonGroups":["400ppm_0min","800ppm_60min"],"dateCreated":"2025-09-26 00:00:00","display_title":"400ppm CO2 baseline vs 800ppm CO2 at 60min","group_a_title":"Samples exposed to 400ppm CO2 at 0 minutes.. Serves as the reference point for all subsequent time points and CO2 concentrations.","group_b_title":"Samples exposed to 800ppm CO2 at 60 minutes.. Shows long-term metabolic changes due to 800ppm CO2 exposure.","id":"MTBLS312_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS312","studyUrl":"http://integmet.org/study/MTBLS312","title":"400ppm_0min_vs_800ppm_60min","topHits":[{"chebi_id":"25017","direction":"down","inn_name":"","iupac_name":"leucine","metabolite_id":"ROHFNLRQFUQHCH-UHFFFAOYSA-N","pvalue":0.0002324960259497,"ratio":1e-06,"synonym_name":"DL-Leucine"},{"chebi_id":"17327","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>,7<i>R</i>,11<i>R</i>)-3,7,11,15-tetramethylhexadec-2-en-1-ol","metabolite_id":"BOTWFXYSPFMFNR-PYDDKJGSSA-N","pvalue":0.0004789881216394,"ratio":1e-06,"synonym_name":"(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-ol"},{"chebi_id":"14336","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-UHFFFAOYSA-N","pvalue":0.0005815165589632,"ratio":1e-06,"synonym_name":"<small>D</small>,<small>L</small>-\u03b1-glycerol-phosphate"},{"chebi_id":"17351","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":0.0008704738408207,"ratio":1e-06,"synonym_name":"Linoleic acid"},{"chebi_id":"27432","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoic acid","metabolite_id":"DTOSIQBPPRVQHS-PDBXOOCHSA-N","pvalue":0.0039844780830331,"ratio":1e-06,"synonym_name":"(9,12,15)-linolenic acid"},{"chebi_id":"22660","direction":"down","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0059757101690724,"ratio":1e-06,"synonym_name":"Aspartic acid"},{"chebi_id":"17754","direction":"down","inn_name":"glycerolum","iupac_name":"propane-1,2,3-triol","metabolite_id":"PEDCQBHIVMGVHV-UHFFFAOYSA-N","pvalue":0.043135401377669,"ratio":0.4807518758597157,"synonym_name":"Glycerol"}],"totalFeatures":44},{"comparisonGroups":["400ppm_0min","800ppm_60min"],"dateCreated":"2025-09-26 00:00:00","display_title":"400ppm CO2 baseline vs 800ppm CO2 at 60min","group_a_title":"Samples exposed to 400ppm CO2 at 0 minutes.. Serves as the reference point for all subsequent time points and CO2 concentrations.","group_b_title":"Samples exposed to 800ppm CO2 at 60 minutes.. Shows long-term metabolic changes due to 800ppm CO2 exposure.","id":"MTBLS312_0002_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS312","studyUrl":"http://integmet.org/study/MTBLS312","title":"400ppm_0min_vs_800ppm_60min","topHits":[{"chebi_id":"17482","direction":"down","inn_name":"","iupac_name":"<small>L</small>-cystathionine","metabolite_id":"ILRYLPWNYFXEMH-WHFBIAKZSA-N","pvalue":1.0831642397664938e-05,"ratio":1e-06,"synonym_name":"S-(beta-amino-beta-carboxyethyl)homocysteine"},{"chebi_id":"27596","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03c0</small></sup>-methyl-<small>L</small>-histidine","metabolite_id":"JDHILDINMRGULE-LURJTMIESA-N","pvalue":7.427153672877318e-05,"ratio":1e-06,"synonym_name":"(2<i>S</i>)-2-amino-3-(1-methyl-1<em>H</em>-imidazol-5-yl)propanoic acid"},{"chebi_id":"58065","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-sulfanylbutanoate","metabolite_id":"FFFHZYDWPBMWHY-UHFFFAOYSA-N","pvalue":0.0002947581680689,"ratio":1e-06,"synonym_name":"2-ammonio-4-sulfanylbutanoate"},{"chebi_id":"15873","direction":"down","inn_name":"","iupac_name":"2-amino-2-deoxy-\u03b1-<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"XHMJOUIAFHJHBW-UKFBFLRUSA-N","pvalue":0.0040083082380968,"ratio":1e-06,"synonym_name":"2-amino-2-deoxy-6-<em>O</em>-phosphono-\u03b1-<small>D</small>-glucopyranose"},{"chebi_id":"27994","direction":"down","inn_name":"","iupac_name":"7-(\u03b2-<small>D</small>-glucopyranosyloxy)-5-hydroxy-2-(3,4-dihydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"PEFNSGRTCBGNAN-QNDFHXLGSA-N","pvalue":0.012097119057393,"ratio":0.2758597204800649,"synonym_name":"Luteolin 7-monoglucoside"},{"chebi_id":"36219","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-XLOQQCSPSA-N","pvalue":0.0092026132724181,"ratio":0.3193323234086542,"synonym_name":"LACTOSE"},{"chebi_id":"15611","direction":"down","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0001405227968742,"ratio":0.5757304813909253,"synonym_name":"L-sarcosine"},{"chebi_id":"17460","direction":"up","inn_name":"","iupac_name":"5-(1,2-dithiolan-3-yl)pentanamide","metabolite_id":"FCCDDURTIIUXBY-UHFFFAOYSA-N","pvalue":0.0008900323744612,"ratio":2.002510815652275,"synonym_name":"lipoacin"},{"chebi_id":"16695","direction":"up","inn_name":"","iupac_name":"5'-uridylic acid","metabolite_id":"DJJCXFVJDGTHFX-XVFCMESISA-N","pvalue":0.0497859004805207,"ratio":3.4502023813560747,"synonym_name":"pU"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":0.0005118398883583,"ratio":0.6170596878295378,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"}],"totalFeatures":179},{"comparisonGroups":["400ppm_0min","800ppm_60min"],"dateCreated":"2025-09-26 00:00:00","display_title":"400ppm CO2 baseline vs 800ppm CO2 at 60min","group_a_title":"Samples exposed to 400ppm CO2 at 0 minutes.. Serves as the reference point for all subsequent time points and CO2 concentrations.","group_b_title":"Samples exposed to 800ppm CO2 at 60 minutes.. Shows long-term metabolic changes due to 800ppm CO2 exposure.","id":"MTBLS312_0003_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS312","studyUrl":"http://integmet.org/study/MTBLS312","title":"400ppm_0min_vs_800ppm_60min","topHits":[{"chebi_id":"90552","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-3-(\u03b2-<small>D</small>-galactopyranosyloxy)-2-{[(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>)-hexadeca-7,10,13-trienoyl]oxy}propyl (9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoate","metabolite_id":"ZRLAOEYZSKXGSL-RZRNQMRLSA-N","pvalue":8.652366710910046e-06,"ratio":0.1897426869729674,"synonym_name":"monogalactosyldiacylglycerol (18:3(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)/16:3(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>))"},{"chebi_id":"80435","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HCZDGTUAMVKZNE-KMKFZPLVSA-O","pvalue":0.0001852917913258,"ratio":0.1294966857220138,"synonym_name":""},{"chebi_id":"136802","direction":"down","inn_name":"","iupac_name":"3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-(hexadecanoyloxy)propyl (9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoate","metabolite_id":"LZCSTAJDQULBAS-SVNQLWEDSA-N","pvalue":0.003271713260031,"ratio":0.0477428599566354,"synonym_name":"phosphatidylglycerol (18:3(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)/16:0)"},{"chebi_id":"136773","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,8<i>S</i>)-2-(hexadecanoyloxy)-5,8,11,11-tetrahydroxy-5,11-dioxo-4,6,10-trioxa-5\u03bb<small><sup>5</small></sup>,11\u03bb<small><sup>5</small></sup>-diphosphaundecan-1-yl hexadecanoate","metabolite_id":"ONJBJMDJKLHMEK-MPQUPPDSSA-N","pvalue":0.0095333005093996,"ratio":0.0535558709268591,"synonym_name":"1,2-dipalmitoyl-<em>sn</em>-glycero-3-phospho-(1'-<em>sn</em>-glycerol-3'-phosphate)"},{"chebi_id":"64023","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YNDYKPRNFWPPFU-UHFFFAOYSA-N","pvalue":5.870806357316506e-06,"ratio":0.358510780077341,"synonym_name":"1-Hexadecanoyl-sn-glycero-3-phosphate"},{"chebi_id":"136787","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-{[(3<i>E</i>)-hexadec-3-enoyl]oxy}propyl (9<i>Z</i>)-octadec-9-enoate","metabolite_id":"RKUHYANOZYJDLK-OCRJEFKGSA-N","pvalue":0.0211845655343352,"ratio":0.1164054395097568,"synonym_name":"1-18:1-2-trans-16:1-phosphatidylglycerol"},{"chebi_id":"89351","direction":"down","inn_name":"","iupac_name":"[(2S)-2,3-dihydroxypropoxy][(2R)-2-(hexadecanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphinic acid","metabolite_id":"IYKXCQWBMRYBPI-WLGRLVTESA-N","pvalue":0.0069887916614277,"ratio":0.250824383513169,"synonym_name":"Phosphatidylglycerol(18:2/16:0)"},{"chebi_id":"136808","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OBUOSIHPWVNVJN-GRFIIANRSA-N","pvalue":6.30289634590842e-05,"ratio":1.7236253221078754,"synonym_name":"<em>S</em>-(carboxymethyl)-coenzyme A"},{"chebi_id":"136790","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-{[(3<i>E</i>)-hexadec-3-enoyl]oxy}propyl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"QKKVMRCIRQQMDU-VTKVFKEISA-N","pvalue":0.0229142653895428,"ratio":0.2607693591927885,"synonym_name":"1-(9<i>Z</i>,12<i>Z</i>-octadecadienoyl)-2-(3<i>E</i>-hexadecenoyl)-<em>sn</em>-glycero-3-phosphoglycerol"},{"chebi_id":"20000","direction":"down","inn_name":"","iupac_name":"(22<i>R</i>,23<i>R</i>)-22,23-dihydroxy-5\u03b1-campestane-3,6-dione","metabolite_id":"SVBMASFUJDIDJC-XFJIFGBKSA-N","pvalue":0.0134741138109491,"ratio":0.3751351488770113,"synonym_name":"(22<i>R</i>,23<i>R</i>,24<em>S</em>)-22,23-dihydroxy-5\u03b1-ergostane-3,6-dione"}],"totalFeatures":147},{"comparisonGroups":["0_volume_percentage","2_volume_percentage"],"dateCreated":"2025-09-26 00:00:00","display_title":"0% vs 2% glucose concentration (control vs highest)","group_a_title":"Samples with 0 volume percentage glucose concentration.. Serves as the control group for comparison with all other glucose concentrations.","group_b_title":"Samples with 2 volume percentage glucose concentration.. Represents the condition with the highest glucose concentration for comparison.","id":"MTBLS316_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS316","studyUrl":"http://integmet.org/study/MTBLS316","title":"G10_0_volume_percentage_vs_G1_2_volume_percentage","topHits":[{"chebi_id":"16856","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":5.9347303432049736e-05,"ratio":5227.937499999999,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"17677","direction":"up","inn_name":"","iupac_name":"cytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PCDQPRRSZKQHHS-XVFCMESISA-N","pvalue":0.0046794691758104,"ratio":1000000.0,"synonym_name":"5'-CTP"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":0.0009112342138092,"ratio":8533.888888888889,"synonym_name":"UDP-glucose"},{"chebi_id":"15713","direction":"up","inn_name":"","iupac_name":"uridine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PGAVKCOVUIYSFO-XVFCMESISA-N","pvalue":0.0072936542656933,"ratio":846.0344827586207,"synonym_name":"H<small><sub>4</sub></small>utp"},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0053743390264789,"ratio":525.5,"synonym_name":"PEP"},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0183175880152115,"ratio":304.8072289156626,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":0.0022815069564852,"ratio":17.027027027027028,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"16551","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"HDTRYLNUVZCQOY-LIZSDCNHSA-N","pvalue":0.0008432886232435,"ratio":4.420382165605096,"synonym_name":"alpha,alpha-Trehalose"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.002945711652754,"ratio":3.1911292675809753,"synonym_name":"hypoxanthine <small>D</small>-riboside"}],"totalFeatures":11},{"comparisonGroups":["0_volume_percentage","2_volume_percentage"],"dateCreated":"2025-09-26 00:00:00","display_title":"Glucose concentration: 0% vs 2% volume percentage","group_a_title":"Samples with 0 volume percentage glucose concentration.. Serves as the control group for comparison with all other glucose concentrations.","group_b_title":"Samples with 2 volume percentage glucose concentration.. Represents the condition with the highest glucose concentration for comparison.","id":"MTBLS316_0002_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS316","studyUrl":"http://integmet.org/study/MTBLS316","title":"G10_0_volume_percentage_vs_G1_2_volume_percentage","topHits":[{"chebi_id":"15956","direction":"up","inn_name":"biotine","iupac_name":"5-[(3a<i>S</i>,4<i>S</i>,6a<i>R</i>)-2-oxohexahydro-1<em>H</em>-thieno[3,4-<em>d</em>]imidazol-4-yl]pentanoic acid","metabolite_id":"YBJHBAHKTGYVGT-ZKWXMUAHSA-N","pvalue":2.4467723096770333e-07,"ratio":376.80952380952385,"synonym_name":"Vitamin H"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.017797404893688,"ratio":1000000.0,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":4.445763974356865e-05,"ratio":93.9348739495798,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"16436","direction":"down","inn_name":"citicolina","iupac_name":"5'-<em>O</em>-[hydroxy({[2-(trimethylammonio)ethoxy]phosphinato}oxy)phosphoryl]cytidine","metabolite_id":"RZZPDXZPRHQOCG-OJAKKHQRSA-N","pvalue":0.0009502746242633,"ratio":0.0093244923331951,"synonym_name":"Citicoline"},{"chebi_id":"5019","direction":"up","inn_name":"","iupac_name":"(cyclo{glycyl-<em>N</em><small><sup>5</small></sup>-(hydroxy-<small><sub>\u03ba</sub></small><em>O</em>)-<em>N</em><small><sup>5</small></sup>-[1-(oxo-<small><sub>\u03ba</sub></small><em>O</em>)ethyl]-<small>L</small>-ornithyl-<em>N</em><small><sup>5</small></sup>-(hydroxy-<small><sub>\u03ba</sub></small><em>O</em>)-<em>N</em><small><sup>5</small></sup>-[1-(oxo-<small><sub>\u03ba</sub></small><em>O</em>)ethyl]-<small>L</small>-ornithyl-<em>N</em><small><sup>5</small></sup>-(hydroxy-<small><sub>\u03ba</sub></small><em>O</em>)-<em>N</em><small><sup>5</small></sup>-[1-(oxo-<small><sub>\u03ba</sub></small><em>O</em>)ethyl]-<small>L</small>-ornithylglycylglycyl})iron","metabolite_id":"GGUNGDGGXMHBMJ-OCIDDWSYSA-N","pvalue":0.0001212807802857,"ratio":21.66062176165803,"synonym_name":"Ferrichrome"},{"chebi_id":"15781","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(1<em>H</em>-imidazol-4-yl)-2-(trimethylammonio)propanoate","metabolite_id":"GPPYTCRVKHULJH-QMMMGPOBSA-N","pvalue":1.886822569143689e-05,"ratio":7.669117647058823,"synonym_name":"Hercynine"},{"chebi_id":"16732","direction":"down","inn_name":"","iupac_name":"5'-<em>O</em>-[{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine","metabolite_id":"WVIMUEUQJFPNDK-PEBGCTIMSA-N","pvalue":0.0020824521017432,"ratio":0.0520880107768298,"synonym_name":"CDP ethanolamine"},{"chebi_id":"57610","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-(dimethylazaniumyl)-3-(1<em>H</em>-imidazol-4-yl)propanoate","metabolite_id":"IMOBSLOLPCWZKQ-ZETCQYMHSA-N","pvalue":4.9522698491551794e-05,"ratio":6.141068447412354,"synonym_name":""},{"chebi_id":"15351","direction":"up","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-(3-{(3<i>R</i>)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} dihydrogen diphosphate)","metabolite_id":"ZSLZBFCDCINBPY-ZSJPKINUSA-N","pvalue":0.0100573392885811,"ratio":44.166666666666664,"synonym_name":"Acetyl-CoA"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0100269243310619,"ratio":0.0588709136067664,"synonym_name":"Adenosin"}],"totalFeatures":21},{"comparisonGroups":["Wild_Type","TMAVA_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: Wild type vs TMAVA treatment","group_a_title":"Wild type mice with no treatment or knockout.. Serves as the reference group for evaluating the effects of TMAVA treatment and BBOX knockout.","group_b_title":"Wild type mice treated with TMAVA.. Crucial for evaluating the pathophysiological effects of TMAVA on cardiac hypertrophy.","id":"MTBLS3174_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS3174","studyUrl":"http://integmet.org/study/MTBLS3174","title":"Wild_Type_vs_TMAVA_Treatment","topHits":[{"chebi_id":"74963","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IESVDEZGAHUQJU-ZLBXKVHBSA-N","pvalue":1.0558507185627774e-08,"ratio":14.076632132872884,"synonym_name":"Phosphatidylcholine(16:0/22:6\u03c93)"},{"chebi_id":"76233","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"SVRBKLJIDJHADS-USWSLJGRSA-N","pvalue":4.466283926091906e-05,"ratio":0.149090909090909,"synonym_name":"LPE(18:2)"},{"chebi_id":"28733","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"SPJFYYJXNPEZDW-FTJOPAKQSA-N","pvalue":2.516211614378414e-05,"ratio":0.2618282039503904,"synonym_name":"1-Linoleoylglycerophosphocholine"},{"chebi_id":"72749","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"TWBVHOYVCUOMJY-PAUXXPOVSA-N","pvalue":2.064414158151323e-05,"ratio":3.107717041800643,"synonym_name":"LPE 0:0/22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)"},{"chebi_id":"74344","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LAXQYRRMGGEGOH-JXRLJXCWSA-N","pvalue":3.764474650486878e-05,"ratio":2.6636597938144333,"synonym_name":"PC(20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)/0:0)"},{"chebi_id":"72741","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoate","metabolite_id":"YWOCITMXHHTBAW-XSQXPFHXSA-N","pvalue":0.0001406732332456,"ratio":0.5,"synonym_name":"Lyso-PE(0:0/20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>))"},{"chebi_id":"145254","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CZYOFWNORPEFDG-KOIKXXGWSA-N","pvalue":8.66589564105886e-05,"ratio":0.5768511093290564,"synonym_name":"LysoPE(0:0/18:1(11Z))"}],"totalFeatures":11},{"comparisonGroups":["Wild_Type","TMAVA_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wild type mice: control vs TMAVA treatment","group_a_title":"Wild type mice with no treatment or knockout.. Serves as the reference group for evaluating the effects of TMAVA treatment and BBOX knockout.","group_b_title":"Wild type mice treated with TMAVA.. Crucial for evaluating the pathophysiological effects of TMAVA on cardiac hypertrophy.","id":"MTBLS3174_0004_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":47,"studyId":"MTBLS3174","studyUrl":"http://integmet.org/study/MTBLS3174","title":"Wild_Type_vs_TMAVA_Treatment","topHits":[{"chebi_id":"84829","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FAUYAENFVCNTAL-PFFNLMTBSA-N","pvalue":1.2937901678777143e-11,"ratio":9.668134100914324,"synonym_name":"GPC(18:0/22:6)"},{"chebi_id":"137197","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KSRURLYJRNYEOH-SHHFQLSYSA-N","pvalue":2.0581080851658343e-08,"ratio":13.626482213438736,"synonym_name":"1-heptadecanoyl-2-((4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosahexaenoyl)-<em>sn</em>-glycero-3-phosphocholine"},{"chebi_id":"189602","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"HRPRHMPJUIFSCB-KYPHJRDXSA-N","pvalue":1.331990224115438e-06,"ratio":22.10231814548361,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"APEHGLQXFOZAEF-MHNOHXJZSA-N","pvalue":3.5410688340109065e-08,"ratio":5.870906502135738,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SBYLHTNKEWSLBA-CPRJDYHCSA-N","pvalue":2.969867770766195e-11,"ratio":3.078183172002978,"synonym_name":""},{"chebi_id":"75062","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-(hexadecanoyloxy)-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RFVFQQWKPSOBED-PSXMRANNSA-N","pvalue":2.406269738208474e-08,"ratio":4.291333587108236,"synonym_name":"1-tetradecanoyl-2-hexadecanoyl-<em>sn</em>-glycero-3-phosphocholine"},{"chebi_id":"73873","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LSOWKZULVQWMLY-APPDJCNMSA-N","pvalue":0.0013824360670657,"ratio":16.764132553606238,"synonym_name":"Lyso(22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)/0:0)"},{"chebi_id":"176739","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"SGQIECCWAOPTNL-LEFPGAKQSA-N","pvalue":1.4191906754002915e-06,"ratio":3.911309244486157,"synonym_name":""},{"chebi_id":"86221","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(icosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"WAFWSBFKIPCFOF-ZDAJSWCOSA-N","pvalue":5.459526299539377e-06,"ratio":4.125954198473282,"synonym_name":"PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))"},{"chebi_id":"72999","direction":"up","inn_name":"colfoscerili palmitas","iupac_name":"(2<i>R</i>)-2,3-bis(hexadecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"KILNVBDSWZSGLL-KXQOOQHDSA-N","pvalue":2.863730073434377e-07,"ratio":3.1139355424421247,"synonym_name":"GPC(16:0/16:0)"}],"totalFeatures":62},{"comparisonGroups":["WT","GM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cryptomeria fortunei: evergreen mutation vs wild-type","group_a_title":"Wild-type samples from Cryptomeria fortunei.. Serves as the baseline for evaluating the effects of the evergreen mutation.","group_b_title":"Experimental samples from Cryptomeria fortunei with evergreen mutation.. Key group for understanding the genetic and metabolic differences due to the evergreen mutation.","id":"MTBLS3183_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":35,"studyId":"MTBLS3183","studyUrl":"http://integmet.org/study/MTBLS3183","title":"WT_vs_GM","topHits":[{"chebi_id":"82931","direction":"down","inn_name":"","iupac_name":"4-ethenylphenyl hydrogen sulfate","metabolite_id":"IETVQHUKTKKBFF-UHFFFAOYSA-N","pvalue":5.7443413570331744e-08,"ratio":2.6769137213992006e-10,"synonym_name":""},{"chebi_id":"169057","direction":"up","inn_name":"","iupac_name":"3-[3,4-dihydroxy-6-methyl-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxane-2,4,5-triol","metabolite_id":"UQYIWBRIELHTMI-UHFFFAOYSA-N","pvalue":3.963694463919357e-16,"ratio":63.22079912189836,"synonym_name":""},{"chebi_id":"16914","direction":"up","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":1.5698209204043784e-09,"ratio":143.9646265332326,"synonym_name":"o-Hydroxybenzoic acid"},{"chebi_id":"18026","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxybenzoic acid","metabolite_id":"GLDQAMYCGOIJDV-UHFFFAOYSA-N","pvalue":7.898784786354025e-12,"ratio":13.272511850933702,"synonym_name":"2,3-Dihydroxybenzoic acid"},{"chebi_id":"15551","direction":"up","inn_name":"dinoprostona","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-11\u03b1,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"XEYBRNLFEZDVAW-ARSRFYASSA-N","pvalue":9.597464506552179e-10,"ratio":18.480389211380015,"synonym_name":"PGE2"},{"chebi_id":"28833","direction":"up","inn_name":"","iupac_name":"(1<i>R</i>,2<i>R</i>,5<i>S</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>,12<i>S</i>)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1<small><sup>5,8</small></sup>.0<small><sup>1,10</small></sup>.0<small><sup>2,8</small></sup>]heptadec-13-ene-9-carboxylic acid","metabolite_id":"IXORZMNAPKEEDV-OBDJNFEBSA-N","pvalue":1.7463679015913054e-09,"ratio":7.527598516354448,"synonym_name":"gibberellin 3"},{"chebi_id":"16112","direction":"down","inn_name":"","iupac_name":"edit(1<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3-{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid","metabolite_id":"CWVRJTMFETXNAD-JUHZACGLSA-N","pvalue":1.5645776051978468e-10,"ratio":0.2180832799006447,"synonym_name":"5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid"},{"chebi_id":"192852","direction":"down","inn_name":"","iupac_name":"6-[(2S,4S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-[4-[(2S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one","metabolite_id":"GYIKGLVKALOGDP-MMUPBISGSA-N","pvalue":2.778221293942246e-11,"ratio":0.2815097836658018,"synonym_name":""},{"chebi_id":"66906","direction":"down","inn_name":"","iupac_name":"3,5-dihydroxy-4-[(2<i>E</i>)-3-(4-hydroxyphenyl)prop-2-enoyl]phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"ZYUSTWOCCKABCY-JSYAWONVSA-N","pvalue":9.693527970912343e-10,"ratio":0.2487811880686601,"synonym_name":"naringenin chalcone 4'-O-glucoside"},{"chebi_id":"28635","direction":"up","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":2.6031598319269048e-11,"ratio":3.166598953306019,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"}],"totalFeatures":65},{"comparisonGroups":["WT","GM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cryptomeria fortunei: evergreen mutation vs wild-type","group_a_title":"Wild-type samples from Cryptomeria fortunei.. Serves as the baseline for evaluating the effects of the evergreen mutation.","group_b_title":"Experimental samples from Cryptomeria fortunei with evergreen mutation.. Key group for understanding the genetic and metabolic differences due to the evergreen mutation.","id":"MTBLS3183_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":165,"studyId":"MTBLS3183","studyUrl":"http://integmet.org/study/MTBLS3183","title":"WT_vs_GM","topHits":[{"chebi_id":"168331","direction":"up","inn_name":"","iupac_name":"5-hydroxy-7-methoxy-2-[4-methoxy-3-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one","metabolite_id":"VHGJMSVFUPCQGC-ZCKZEFSYSA-N","pvalue":8.951932293117495e-09,"ratio":1008175075.6660428,"synonym_name":""},{"chebi_id":"131434","direction":"up","inn_name":"","iupac_name":"5-hydroxyhexanoic acid","metabolite_id":"YDCRNMJQROAWFT-UHFFFAOYSA-N","pvalue":0.0015152294785838,"ratio":227283641.612666,"synonym_name":"5-hydroxy caproic acid"},{"chebi_id":"191433","direction":"up","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]oxane-2-carboxylic acid","metabolite_id":"OUQZCILJSVDJFB-JENRNSKYSA-N","pvalue":2.524288709160385e-13,"ratio":51.84064656468283,"synonym_name":""},{"chebi_id":"192950","direction":"down","inn_name":"","iupac_name":"(3Z,6E,8E)-dodeca-3,6,8-trien-1-ol","metabolite_id":"KWVQYNPBWXUHHT-QSOMBXJKSA-N","pvalue":6.9169725656454764e-09,"ratio":0.0023239961190038,"synonym_name":""},{"chebi_id":"192945","direction":"up","inn_name":"","iupac_name":"pentadec-3-ynoic acid","metabolite_id":"JXPFDNOLLLAYDO-UHFFFAOYSA-N","pvalue":5.19637274730697e-14,"ratio":37.49184809558744,"synonym_name":""},{"chebi_id":"134608","direction":"up","inn_name":"","iupac_name":"(4<i>Z</i>)-6-{3-[(1<i>E</i>,3<i>E</i>,5<i>Z</i>,7<i>E</i>,9<i>S</i>,11<i>Z</i>)-9-hydroxytetradeca-1,3,5,7,11-pentaen-1-yl]oxiran-2-yl}hex-4-enoic acid","metabolite_id":"BOFBVWROGCPAFH-VEYGSZKMSA-N","pvalue":1.004106732460834e-11,"ratio":68.51541985791648,"synonym_name":"7,8-epoxy-17S-hydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid"},{"chebi_id":"17992","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"CZMRCDWAGMRECN-UGDNZRGBSA-N","pvalue":3.6219587215387808e-12,"ratio":56.59021088827515,"synonym_name":"1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside"},{"chebi_id":"46615","direction":"up","inn_name":"","iupac_name":"3\u03b2,14,16\u03b2-trihydroxy-19-oxo-5\u03b2-card-20(22)-enolide","metabolite_id":"IMQSXGFUSQSPIM-IMLMFIFQSA-N","pvalue":2.094818357809963e-12,"ratio":26.31053336455938,"synonym_name":"Glaucorigenin"},{"chebi_id":"168236","direction":"up","inn_name":"","iupac_name":"(2S,4S,5S)-2-[(3R,6R)-6-[[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-3,4-dihydro-2H-chromen-3-yl]oxy]-4,5-dihydroxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"UATBGOUAROWWQR-RGYOVVGASA-N","pvalue":1.869408337494328e-12,"ratio":22.69469220291719,"synonym_name":""},{"chebi_id":"34584","direction":"up","inn_name":"bold\u00e9none","iupac_name":"(17\u03b2)-17-hydroxyandrosta-1,4-dien-3-one","metabolite_id":"RSIHSRDYCUFFLA-DYKIIFRCSA-N","pvalue":1.3930825385573504e-11,"ratio":20.289245428416,"synonym_name":"17beta-Boldenone"}],"totalFeatures":286},{"comparisonGroups":["Wild Type","Evergreen Mutant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cryptomeria fortunei: wild-type vs evergreen mutant","group_a_title":"Experimental samples from the wild-type variant of Cryptomeria fortunei.. Serves as a baseline for understanding the effects of genetic modifications.","group_b_title":"Experimental samples from the evergreen mutant variant of Cryptomeria fortunei.. Provides insights into the genetic modifications and their effects on cold resistance and needle discoloration.","id":"MTBLS3184_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS3184","studyUrl":"http://integmet.org/study/MTBLS3184","title":"Wild_Type_vs_Evergreen_Mutant","topHits":[{"chebi_id":"16914","direction":"up","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":4.517634614371149e-16,"ratio":1128883642.8333783,"synonym_name":"o-Hydroxybenzoic acid"},{"chebi_id":"18026","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxybenzoic acid","metabolite_id":"GLDQAMYCGOIJDV-UHFFFAOYSA-N","pvalue":1.0161668932064284e-22,"ratio":102.76300490037112,"synonym_name":"2,3-Dihydroxybenzoic acid"},{"chebi_id":"82931","direction":"down","inn_name":"","iupac_name":"4-ethenylphenyl hydrogen sulfate","metabolite_id":"IETVQHUKTKKBFF-UHFFFAOYSA-N","pvalue":3.399268798583759e-13,"ratio":0.0003866818551555,"synonym_name":""},{"chebi_id":"28833","direction":"up","inn_name":"","iupac_name":"(1<i>R</i>,2<i>R</i>,5<i>S</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,11<i>S</i>,12<i>S</i>)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1<small><sup>5,8</small></sup>.0<small><sup>1,10</small></sup>.0<small><sup>2,8</small></sup>]heptadec-13-ene-9-carboxylic acid","metabolite_id":"IXORZMNAPKEEDV-OBDJNFEBSA-N","pvalue":3.688911811450165e-19,"ratio":163.89071783807614,"synonym_name":"gibberellin 3"},{"chebi_id":"15551","direction":"up","inn_name":"dinoprostona","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-11\u03b1,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"XEYBRNLFEZDVAW-ARSRFYASSA-N","pvalue":1.6658632846379684e-19,"ratio":17.23908378224508,"synonym_name":"PGE2"},{"chebi_id":"169057","direction":"up","inn_name":"","iupac_name":"3-[3,4-dihydroxy-6-methyl-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxane-2,4,5-triol","metabolite_id":"UQYIWBRIELHTMI-UHFFFAOYSA-N","pvalue":5.6716952383300186e-18,"ratio":17.776148589530088,"synonym_name":""},{"chebi_id":"185250","direction":"down","inn_name":"","iupac_name":"[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-pentadec-9-enoate","metabolite_id":"WMIBCBLHUXDTKT-JTGQJZMRSA-N","pvalue":1.7306868146377278e-15,"ratio":0.1310857540088899,"synonym_name":""},{"chebi_id":"168321","direction":"up","inn_name":"","iupac_name":"(2E,4E,6S)-6-methylocta-2,4-dienoic acid","metabolite_id":"DNUJBTBPCOIYRL-QALPAXIDSA-N","pvalue":1.3789178641576598e-17,"ratio":5.656728156183139,"synonym_name":""},{"chebi_id":"177966","direction":"up","inn_name":"","iupac_name":"[(3S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl 4-hydroxy-2-methylidenebutanoate","metabolite_id":"NABVFHUVYXEKSQ-NOJITZFGSA-N","pvalue":9.104210092424905e-21,"ratio":2.8563609173094275,"synonym_name":""},{"chebi_id":"143871","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PUKLOSMRXIAWPE-UHFFFAOYSA-N","pvalue":5.369935649550568e-08,"ratio":0.1186927317239139,"synonym_name":""}],"totalFeatures":65},{"comparisonGroups":["Wild Type","Evergreen Mutant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cryptomeria fortunei: wild-type vs evergreen mutant","group_a_title":"Experimental samples from the wild-type variant of Cryptomeria fortunei.. Serves as a baseline for understanding the effects of genetic modifications.","group_b_title":"Experimental samples from the evergreen mutant variant of Cryptomeria fortunei.. Provides insights into the genetic modifications and their effects on cold resistance and needle discoloration.","id":"MTBLS3184_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":173,"studyId":"MTBLS3184","studyUrl":"http://integmet.org/study/MTBLS3184","title":"Wild_Type_vs_Evergreen_Mutant","topHits":[{"chebi_id":"192950","direction":"down","inn_name":"","iupac_name":"(3Z,6E,8E)-dodeca-3,6,8-trien-1-ol","metabolite_id":"KWVQYNPBWXUHHT-QSOMBXJKSA-N","pvalue":3.2187743171879314e-08,"ratio":4.057216243563037e-10,"synonym_name":""},{"chebi_id":"166769","direction":"down","inn_name":"","iupac_name":"(3S,8R,9S,10R,13S,14S,16S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16,17-triol","metabolite_id":"GUGSXATYPSGVAY-CUZKMJQKSA-N","pvalue":1.3066407329968668e-27,"ratio":0.037273506124325,"synonym_name":""},{"chebi_id":"17992","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"CZMRCDWAGMRECN-UGDNZRGBSA-N","pvalue":3.5484254924348315e-25,"ratio":35.12359290942096,"synonym_name":"1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside"},{"chebi_id":"192945","direction":"up","inn_name":"","iupac_name":"pentadec-3-ynoic acid","metabolite_id":"JXPFDNOLLLAYDO-UHFFFAOYSA-N","pvalue":2.601498923606878e-28,"ratio":13.46893814182084,"synonym_name":""},{"chebi_id":"192956","direction":"up","inn_name":"","iupac_name":"8-oxooctadeca-9,11-diynoic acid","metabolite_id":"MNEYSZJSCYXZQM-UHFFFAOYSA-N","pvalue":1.792946944443108e-18,"ratio":43.235853127788296,"synonym_name":""},{"chebi_id":"88349","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-17,18-dihydroxyicosa-5,8,11,14-tetraenoic acid","metabolite_id":"XYDVGNAQQFWZEF-JPURVOHMSA-N","pvalue":1.1741344215501354e-32,"ratio":0.1343991592411847,"synonym_name":"17,18-dihydroxyarachidonic acid"},{"chebi_id":"52317","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,5a<i>R</i>,7<i>S</i>,9a<i>S</i>)-3-[(2<i>R</i>,5<i>E</i>)-6,10-dimethylundeca-5,9-dien-2-yl]-3,6,6,9a-tetramethyl-2,3,4,5,5a,6,7,8,9,9a-decahydro-1<em>H</em>-cyclopenta[<em>a</em>]naphthalen-7-ol","metabolite_id":"DGAGPZOBTQYNRE-VMSIWEJCSA-N","pvalue":2.105800492080492e-23,"ratio":0.0799330700951319,"synonym_name":"(3<i>S</i>,13<i>S</i>,14<i>R</i>)-malabarica-8,17,21-trien-3-ol"},{"chebi_id":"34980","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GYBGISLVORKLBN-YNZDMMAESA-N","pvalue":1.721216968360481e-16,"ratio":24.31719052715368,"synonym_name":"17beta-Hydroxy-2-methyl-5alpha-androst-1-en-3-one"},{"chebi_id":"192953","direction":"down","inn_name":"","iupac_name":"(4Z,8Z,11Z)-heptadeca-4,8,11-triene","metabolite_id":"OAYDMMCXTDDLIW-JHJOJVAOSA-N","pvalue":2.2971879281865224e-17,"ratio":0.0695071374518394,"synonym_name":""},{"chebi_id":"134608","direction":"up","inn_name":"","iupac_name":"(4<i>Z</i>)-6-{3-[(1<i>E</i>,3<i>E</i>,5<i>Z</i>,7<i>E</i>,9<i>S</i>,11<i>Z</i>)-9-hydroxytetradeca-1,3,5,7,11-pentaen-1-yl]oxiran-2-yl}hex-4-enoic acid","metabolite_id":"BOFBVWROGCPAFH-VEYGSZKMSA-N","pvalue":1.1723685756666044e-14,"ratio":21.732009100707465,"synonym_name":"7,8-epoxy-17S-hydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid"}],"totalFeatures":286},{"comparisonGroups":["Mock_19d","PR8_19d"],"dateCreated":"2025-09-26 00:00:00","display_title":"PR8 infection vs mock control at 19 days post-infection","group_a_title":"Mock-infected group at 19 days post-infection. Serves as the reference point for all PR8-infected groups.","group_b_title":"PR8-infected group at 19 days post-infection. Assesses the long-term effects of PR8 infection.","id":"MTBLS32_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":36,"studyId":"MTBLS32","studyUrl":"http://integmet.org/study/MTBLS32","title":"Mock_19d_vs_PR8_19d","topHits":[{"chebi_id":"72801","direction":"down","inn_name":"","iupac_name":"(6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid","metabolite_id":"FTAGQROYQYQRHF-FCWZHQICSA-N","pvalue":0.0287422726630255,"ratio":1e-06,"synonym_name":"(\u00b1)-5-hydroxy-6<i>E</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>-eicosapentaenoic acid"},{"chebi_id":"72789","direction":"down","inn_name":"","iupac_name":"(5<i>S</i>,6<i>R</i>,7<i>E</i>,9<i>E</i>,11<i>Z</i>,13<i>E</i>,15<i>R</i>)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid","metabolite_id":"IXAQOQZEOGMIQS-JEWNPAEBSA-N","pvalue":0.012236129010741,"ratio":0.0031916902738432,"synonym_name":"15<i>R</i>-LXA<small><sub>4</sub></small>"},{"chebi_id":"72605","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,6<i>E</i>,8<i>R</i>,10<i>Z</i>)-8-hydroxyhexadeca-4,6,10-trienoic acid","metabolite_id":"KBOVKDIBOBQLRS-QCNAHCIUSA-N","pvalue":0.0010254378825818,"ratio":0.0309474768280123,"synonym_name":""},{"chebi_id":"72785","direction":"down","inn_name":"","iupac_name":"(5<i>E</i>,7<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-9-hydroxyicosa-5,7,11,14-tetraenoic acid","metabolite_id":"KATOYYZUTNAWSA-DLJQHUEDSA-N","pvalue":6.845632605427266e-05,"ratio":0.2859120803046037,"synonym_name":"9-HETE"},{"chebi_id":"72856","direction":"down","inn_name":"","iupac_name":"(6<i>E</i>,8<i>Z</i>,11<i>Z</i>)-5-hydroxyicosa-6,8,11-trienoic acid","metabolite_id":"LSADDRSUZRRBAN-SRMUOKRHSA-N","pvalue":0.0009982003413441,"ratio":0.1773803526448363,"synonym_name":"5-hydroxy-6<i>E</i>,8<i>Z</i>,11<i>Z</i>-icosatrienoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OZXAIGIRPOOJTI-UHFFFAOYSA-N","pvalue":0.0024468329725393,"ratio":0.1802305475504322,"synonym_name":""},{"chebi_id":"27485","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oic acid","metabolite_id":"UQOQENZZLBSFKO-POPPZSFYSA-N","pvalue":0.0029446146057119,"ratio":0.1722297955209347,"synonym_name":"9-Deoxy-delta-9-pgd2"},{"chebi_id":"72653","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoic acid","metabolite_id":"OSXOPUBJJDUAOJ-MBYQGORISA-N","pvalue":0.0035083738189696,"ratio":0.166967916854948,"synonym_name":"19(20)-epoxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>-docosapentaenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZHBVYDMSPDDAKE-UHFFFAOYSA-N","pvalue":0.0019003092448521,"ratio":0.2157303370786517,"synonym_name":""},{"chebi_id":"72637","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,15<i>E</i>,19<i>Z</i>)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid","metabolite_id":"SWTYBBUBEPPYCX-VIIQGJSXSA-N","pvalue":0.0002776641914108,"ratio":0.3199695894576786,"synonym_name":"17-Hydroxy-DHA"}],"totalFeatures":79},{"comparisonGroups":["Healthy","HIAE"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs hyperinsulinaemic androgen excess (HIAE)","group_a_title":"Samples from healthy individuals.. Serves as the baseline for comparison with samples from individuals with HIAE.","group_b_title":"Samples from individuals with hyperinsulinaemic androgen excess.. Allows for the identification of metabolic differences associated with HIAE.","id":"MTBLS321_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS321","studyUrl":"http://integmet.org/study/MTBLS321","title":"Healthy_vs_HIAE","topHits":[{"chebi_id":"18257","direction":"down","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":4.523080441427872e-05,"ratio":0.6135081985585042,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"18237","direction":"down","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0179433523984726,"ratio":0.496009231850585,"synonym_name":"Glutaminic acid"},{"chebi_id":"35243","direction":"down","inn_name":"","iupac_name":"2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-UHFFFAOYSA-N","pvalue":0.0020119105612632,"ratio":0.6444786564058534,"synonym_name":"serine zwitterion"}],"totalFeatures":26},{"comparisonGroups":["Rheumatoid_Arthritis","Healthy_Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Rheumatoid arthritis patients vs healthy controls","group_a_title":"Samples from untreated rheumatoid arthritis patients. Key group for understanding the metabolic and microbiome changes associated with rheumatoid arthritis","group_b_title":"Samples from healthy control individuals. Provides a reference point for identifying disease-specific changes","id":"MTBLS3233_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS3233","studyUrl":"http://integmet.org/study/MTBLS3233","title":"Rheumatoid_Arthritis_vs_Healthy_Control","topHits":[{"chebi_id":"180509","direction":"down","inn_name":"","iupac_name":"propylthiourea","metabolite_id":"UHGKYJXJYJWDAM-UHFFFAOYSA-N","pvalue":0.000158165491396,"ratio":0.3355132726203975,"synonym_name":""},{"chebi_id":"29750","direction":"up","inn_name":"","iupac_name":"3-(1<em>H</em>-indol-3-yl)-2-oxopropanoic acid","metabolite_id":"RSTKLPZEZYGQPY-UHFFFAOYSA-N","pvalue":0.0370282851731776,"ratio":7.123708358466472,"synonym_name":"Indolepyruvic acid"},{"chebi_id":"168754","direction":"down","inn_name":"","iupac_name":"(1R,4S,5R,8S,9R,10R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol","metabolite_id":"BJDCWCLMFKKGEE-KDTBHNEXSA-N","pvalue":0.0040662271574953,"ratio":0.3426909934205854,"synonym_name":""},{"chebi_id":"545687","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-dodec-2-enedioic acid","metabolite_id":"MAZWDMBCPDUFDJ-VQHVLOKHSA-N","pvalue":0.0280005089686364,"ratio":0.3047645951332033,"synonym_name":"trans-2-dodecenedioic acid"},{"chebi_id":"15978","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-N","pvalue":0.0408786759265034,"ratio":2.650211489585349,"synonym_name":"Phosphors\u00e4ure-mono-((<i>R</i>)-2,3-dihydroxy-propylester)"}],"totalFeatures":95},{"comparisonGroups":["Rheumatoid_Arthritis","Healthy_Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Rheumatoid arthritis patients vs healthy controls","group_a_title":"Samples from untreated rheumatoid arthritis patients. Key group for understanding the metabolic and microbiome changes associated with rheumatoid arthritis","group_b_title":"Samples from healthy control individuals. Provides a reference point for identifying disease-specific changes","id":"MTBLS3233_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS3233","studyUrl":"http://integmet.org/study/MTBLS3233","title":"Rheumatoid_Arthritis_vs_Healthy_Control","topHits":[{"chebi_id":"85261","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]dodecanamide","metabolite_id":"UHWYQXNZIBLESO-URLMMPGGSA-N","pvalue":2.1296840562643485e-13,"ratio":0.4288529181400212,"synonym_name":"C12:0 DHCer"},{"chebi_id":"67045","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]tetradecanamide","metabolite_id":"UDTSZXVRDXQARY-IOWSJCHKSA-N","pvalue":5.796298916763415e-10,"ratio":0.3926363915239292,"synonym_name":"DHC-A 18:0/14:0"},{"chebi_id":"180507","direction":"up","inn_name":"","iupac_name":"N-[(1S,2R)-2,3-dihydroxy-1-phenylpropyl]benzamide","metabolite_id":"OCRUDDLKDFDNGT-GJZGRUSLSA-N","pvalue":0.0308977893735236,"ratio":6.059790207791894,"synonym_name":""},{"chebi_id":"48294","direction":"down","inn_name":"","iupac_name":"3-[2-(methylamino)ethyl]-1<em>H</em>-indol-5-ol","metabolite_id":"ASUSBMNYRHGZIG-UHFFFAOYSA-N","pvalue":0.0087897923170842,"ratio":0.2731359115468817,"synonym_name":"N-Methylserotonin"},{"chebi_id":"180510","direction":"down","inn_name":"","iupac_name":"2-methylquinolin-8-ol","metabolite_id":"NBYLBWHHTUWMER-UHFFFAOYSA-N","pvalue":0.0149701997668865,"ratio":0.2590016037662761,"synonym_name":""},{"chebi_id":"173719","direction":"down","inn_name":"","iupac_name":"(1S,2S,5S,8R,9S)-2-methyl-6-methylidene-9-propan-2-yl-11-oxatricyclo[6.2.1.01,5]undecan-8-ol","metabolite_id":"QRMPRVXWPCLVNI-YYFQZIEXSA-N","pvalue":0.018283152594408,"ratio":0.2675891273759163,"synonym_name":""},{"chebi_id":"6916","direction":"up","inn_name":"mexiletine","iupac_name":"1-(2,6-dimethylphenoxy)propan-2-amine","metabolite_id":"VLPIATFUUWWMKC-UHFFFAOYSA-N","pvalue":0.0208416511639646,"ratio":3.574093922039248,"synonym_name":"Mexiletine"},{"chebi_id":"180516","direction":"down","inn_name":"","iupac_name":"2-amino-4-hydroxy-1H-pyrimidin-6-one","metabolite_id":"AUFJTVGCSJNQIF-UHFFFAOYSA-N","pvalue":0.0290067666304794,"ratio":0.2514521422125415,"synonym_name":""},{"chebi_id":"17715","direction":"down","inn_name":"","iupac_name":"quinoline-2,8-diol","metabolite_id":"ZXZKYYHTWHJHFT-UHFFFAOYSA-N","pvalue":0.0122101209181658,"ratio":0.3463999815392037,"synonym_name":"Quinolin-2,8-diol"},{"chebi_id":"15815","direction":"down","inn_name":"","iupac_name":"quinolin-4-ol","metabolite_id":"PMZDQRJGMBOQBF-UHFFFAOYSA-N","pvalue":0.0456983023380217,"ratio":0.2443345185364406,"synonym_name":"Quinolin-4-ol"}],"totalFeatures":76},{"comparisonGroups":["RU- Control","RU+ Switch"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs RU+ switch treatment","group_a_title":"Control group with no RU treatment. Serves as a baseline for comparison with treated samples","group_b_title":"Treated group with RU+ switch. Represents the effect of RU+ switch treatment","id":"MTBLS3251_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":135,"studyId":"MTBLS3251","studyUrl":"http://integmet.org/study/MTBLS3251","title":"RU-_Control_vs_RU+_Switch","topHits":[{"chebi_id":"179765","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate","metabolite_id":"LSMZHQKGKWMNRR-TWSQBWPKSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179764","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"GHHCEXBJBUVAMW-XMMSBNOZSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"169778","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"CTRNSVCYDUIICT-FFLBNGNKSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179763","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate","metabolite_id":"VKGJBKWFGHBXMN-ITYCCWCBSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179762","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"WSXPDGFXIPEFAL-KRTJINJGSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179761","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-pentadecanoyloxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"RMNLEOBVQMZLCN-JHFOFQKASA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"169501","direction":"down","inn_name":"","iupac_name":"S-methyl benzenecarbothioate","metabolite_id":"RQVWTMCUTHKGCM-UHFFFAOYSA-N","pvalue":0.0002420897582137,"ratio":0.3266665274318644,"synonym_name":""},{"chebi_id":"177818","direction":"up","inn_name":"","iupac_name":"3-(3-hydroxypentadecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"WJVDXGQFPKCLCW-UHFFFAOYSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":""},{"chebi_id":"79848","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BQIBBYLXJDSLIR-FTQGCKHGSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":"3beta,17beta-Diacetoxy-5alpha-androstane"},{"chebi_id":"74966","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(dodecanoyloxy)-2-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"BWKILASWCLJPBO-LJQANCHMSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":"1-lauroyllysophosphatidylcholine"}],"totalFeatures":3481},{"comparisonGroups":["Mock_11_day","PR8_11_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"PBS control vs PR8 infection at 11 days","group_a_title":"Control group treated with PBS at 11 days.. Provides baseline for comparison with infected groups.","group_b_title":"PR8 infected group at 11 days.. Represents resolution phase response to PR8 infection.","id":"MTBLS33_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":49,"studyId":"MTBLS33","studyUrl":"http://integmet.org/study/MTBLS33","title":"G1_Mock_11_day_vs_G5_PR8_11_day","topHits":[{"chebi_id":"91132","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,18<i>R</i>)-18-hydroxyicosa-5,8,11,14-tetraenoic acid","metabolite_id":"PPCHNRUZQWLEMF-LFFPGIGVSA-N","pvalue":6.111057715831483e-07,"ratio":0.0377879891984933,"synonym_name":"18(R)-Hydroxyeicosatetraenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZHBVYDMSPDDAKE-UHFFFAOYSA-N","pvalue":8.527056534176086e-06,"ratio":0.0395657947642902,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YUZXOJOCNGKDNI-UHFFFAOYSA-N","pvalue":1.9970402869612382e-05,"ratio":0.065662001911761,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CIMMACURCPXICP-TVFCKZIOSA-N","pvalue":7.137195616827266e-05,"ratio":0.0457527539128987,"synonym_name":""},{"chebi_id":"72853","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-16-(3-ethyloxiran-2-yl)hexadeca-5,8,11,14-tetraenoic acid","metabolite_id":"GPQVVJQEBXAKBJ-JPURVOHMSA-N","pvalue":4.649402570605748e-05,"ratio":0.0731294864450022,"synonym_name":"17,18-epoxyicosatetraenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LRWYBGFSVUBWMO-NQZHIPPKSA-N","pvalue":0.0001224140274281,"ratio":0.0693945708575953,"synonym_name":""},{"chebi_id":"53487","direction":"down","inn_name":"","iupac_name":"(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoic acid","metabolite_id":"TWSWSIQAPQLDBP-DOFZRALJSA-N","pvalue":6.4654621540889765e-06,"ratio":0.1456385166211414,"synonym_name":"Adrenic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LTERDCBCHFKFRI-UHFFFAOYSA-N","pvalue":0.0001883458708193,"ratio":0.0692282078537751,"synonym_name":""},{"chebi_id":"72653","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoic acid","metabolite_id":"OSXOPUBJJDUAOJ-MBYQGORISA-N","pvalue":2.4391004456142768e-05,"ratio":0.1214391003021052,"synonym_name":"19(20)-epoxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>-docosapentaenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CSXQXWHAGLIFIH-UHFFFAOYSA-N","pvalue":1.5903322873236532e-05,"ratio":0.1512357466145902,"synonym_name":""}],"totalFeatures":62},{"comparisonGroups":["Mock_11_day","PR8_11_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mock PBS vs PR8 infection at 11 days","group_a_title":"Control group treated with PBS at 11 days.. Provides baseline for comparison with infected groups.","group_b_title":"PR8 infected group at 11 days.. Represents resolution phase response to PR8 infection.","id":"MTBLS33_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":54,"studyId":"MTBLS33","studyUrl":"http://integmet.org/study/MTBLS33","title":"G1_Mock_11_day_vs_G5_PR8_11_day","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OTZRAYGBFWZKMX-PCCBWWKXSA-N","pvalue":0.000147828274108,"ratio":1e-06,"synonym_name":""},{"chebi_id":"63579","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-18-hydroxy-5,8,11,14-icosatetraenoic acid","metabolite_id":"PPCHNRUZQWLEMF-XBOCNYGYSA-N","pvalue":6.111057715831483e-07,"ratio":0.0377879891984933,"synonym_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-18-hydroxyeicosa-5,8,11,14-tetraenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZHBVYDMSPDDAKE-UHFFFAOYSA-N","pvalue":8.527056534176086e-06,"ratio":0.0395657947642902,"synonym_name":""},{"chebi_id":"72657","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-19,20-dihydroxydocosa-4,7,10,13,16-pentaenoic acid","metabolite_id":"FFXKPSNQCPNORO-MBYQGORISA-N","pvalue":1.0486651609150732e-07,"ratio":0.1304883988346775,"synonym_name":"19,20-dihydroxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>-docosapentaenoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YUZXOJOCNGKDNI-UHFFFAOYSA-N","pvalue":1.9970402869612382e-05,"ratio":0.065662001911761,"synonym_name":""},{"chebi_id":"27696","direction":"down","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-9\u03b1,15-dihydroxy-11-oxoprost-13-en-1-oic acid","metabolite_id":"CIMMACURCPXICP-PNQRDDRVSA-N","pvalue":7.137195616827266e-05,"ratio":0.0457527539128987,"synonym_name":"Prostaglandin D1"},{"chebi_id":"72853","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-16-(3-ethyloxiran-2-yl)hexadeca-5,8,11,14-tetraenoic acid","metabolite_id":"GPQVVJQEBXAKBJ-JPURVOHMSA-N","pvalue":4.649402570605748e-05,"ratio":0.0731294864450022,"synonym_name":"17,18-epoxyicosatetraenoic acid"},{"chebi_id":"72802","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid","metabolite_id":"LRWYBGFSVUBWMO-UXNZXXPISA-N","pvalue":0.0001224140274281,"ratio":0.0693945708575953,"synonym_name":"(\u00b1)-18-hydroxy-5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>-eicosapentaenoic acid"},{"chebi_id":"53487","direction":"down","inn_name":"","iupac_name":"(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoic acid","metabolite_id":"TWSWSIQAPQLDBP-DOFZRALJSA-N","pvalue":6.4654621540889765e-06,"ratio":0.1456385166211414,"synonym_name":"Adrenic acid"},{"chebi_id":"72794","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,9<i>E</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid","metabolite_id":"LTERDCBCHFKFRI-BGKMTWLOSA-N","pvalue":0.0001883458708193,"ratio":0.0692282078537751,"synonym_name":"(\u00b1)-11-HDoHE"}],"totalFeatures":77},{"comparisonGroups":["Control_14dpi","Infected_14dpi"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs infected at 14 days post-infection","group_a_title":"Control group at 14 days post-infection. Provides baseline data for comparison with infected samples at 14dpi","group_b_title":"Infected group at 14 days post-infection. Allows for assessment of infection effects at 14dpi","id":"MTBLS3306_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS3306","studyUrl":"http://integmet.org/study/MTBLS3306","title":"Control_14dpi_vs_Infected_14dpi","topHits":[{"chebi_id":"48430","direction":"up","inn_name":"","iupac_name":"4-methyl-2-oxopentanoic acid","metabolite_id":"BKAJNAXTPSGJCU-UHFFFAOYSA-N","pvalue":0.0041143805774275,"ratio":7.677872036703715,"synonym_name":"2-Oxoisocaproate"},{"chebi_id":"16040","direction":"up","inn_name":"","iupac_name":"4-aminopyrimidin-2(1<em>H</em>)-one","metabolite_id":"OPTASPLRGRRNAP-UHFFFAOYSA-N","pvalue":0.0015223397971137,"ratio":2.8893193349414954,"synonym_name":"Zytosin"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":0.004438729255938,"ratio":2.833937877723423,"synonym_name":"Purine-6-ol"},{"chebi_id":"17924","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucitol","metabolite_id":"FBPFZTCFMRRESA-JGWLITMVSA-N","pvalue":0.010337059816333,"ratio":3.1780622974479495,"synonym_name":"D-SORBITOL"},{"chebi_id":"28315","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-pyrazolo[3,4-<em>d</em>]pyrimidine-4,6(5<em>H</em>,7<em>H</em>)-dione","metabolite_id":"HXNFUBHNUDHIGC-UHFFFAOYSA-N","pvalue":0.0052797277059417,"ratio":2.60402060036578,"synonym_name":"Alloxanthine"},{"chebi_id":"15603","direction":"up","inn_name":"","iupac_name":"<small>L</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","pvalue":0.0077797681219442,"ratio":2.6797788518130647,"synonym_name":"<small>L</small>-Leuzin"},{"chebi_id":"42717","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranuronic acid","metabolite_id":"AEMOLEFTQBMNLQ-WAXACMCWSA-N","pvalue":0.0036069406736367,"ratio":2.18817452838759,"synonym_name":"D-GLUCURONIC ACID"},{"chebi_id":"16132","direction":"up","inn_name":"","iupac_name":"2-deoxy-<small>D</small>-<i>erythro</i>-pentose 5-(dihydrogen phosphate)","metabolite_id":"ALQNUOMIEBHXQG-CRCLSJGQSA-N","pvalue":0.0228441480313031,"ratio":3.0963077311390332,"synonym_name":"2-Deoxy-D-ribose 5-phosphate"},{"chebi_id":"114444","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MYEVEFULPUKTSZ-UHFFFAOYSA-N","pvalue":0.0276633305102267,"ratio":2.8474184999880987,"synonym_name":""},{"chebi_id":"46823","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-purine-2,6,8-triol","metabolite_id":"LEHOTFFKMJEONL-UHFFFAOYSA-N","pvalue":0.0276600409397145,"ratio":2.4136843966714876,"synonym_name":""}],"totalFeatures":186},{"comparisonGroups":["Control_14dpi","Infected_14dpi"],"dateCreated":"2025-09-26 00:00:00","display_title":"Infection effects at 14 days post-infection","group_a_title":"Control group at 14 days post-infection. Provides baseline data for comparison with infected samples at 14dpi","group_b_title":"Infected group at 14 days post-infection. Allows for assessment of infection effects at 14dpi","id":"MTBLS3306_0002_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS3306","studyUrl":"http://integmet.org/study/MTBLS3306","title":"Control_14dpi_vs_Infected_14dpi","topHits":[{"chebi_id":"28875","direction":"up","inn_name":"","iupac_name":"myristic acid","metabolite_id":"TUNFSRHWOTWDNC-UHFFFAOYSA-N","pvalue":0.0012448239816886,"ratio":2.6078623767772826,"synonym_name":"n-Tetradecan-1-oic acid"},{"chebi_id":"48517","direction":"up","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":0.0073702595287809,"ratio":3.119616761397245,"synonym_name":"Xanthine"},{"chebi_id":"17981","direction":"up","inn_name":"","iupac_name":"<em>O</em>-acetyl-<small>L</small>-serine","metabolite_id":"VZXPDPZARILFQX-BYPYZUCNSA-N","pvalue":0.0029675113561202,"ratio":2.4299829613379225,"synonym_name":"O-acetyl-L-serine"},{"chebi_id":"30860","direction":"up","inn_name":"","iupac_name":"methylpropanedioic acid","metabolite_id":"ZIYVHBGGAOATLY-UHFFFAOYSA-N","pvalue":0.0036129081358695,"ratio":2.4955677882302414,"synonym_name":"1,1-Ethanedicarboxylic acid"},{"chebi_id":"15756","direction":"up","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":0.0016876236797991,"ratio":2.1408370413993207,"synonym_name":"<em>n</em>-hexadecoic acid"},{"chebi_id":"16176","direction":"up","inn_name":"","iupac_name":"<small>D</small>-ornithine","metabolite_id":"AHLPHDHHMVZTML-SCSAIBSYSA-N","pvalue":0.0133325873802148,"ratio":3.0067277398691186,"synonym_name":"D-Ornithine"},{"chebi_id":"46372","direction":"up","inn_name":"","iupac_name":"2-[(2<i>E</i>)-3,7-dimethylocta-2,6-dien-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione","metabolite_id":"SQQWBSBBCSFQGC-JLHYYAGUSA-N","pvalue":0.0056084615096163,"ratio":2.3588228621151788,"synonym_name":"2-[(2<i>E</i>)-3,7-dimethylocta-2,6-dien-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0019612688150052,"ratio":1.9749011175825768,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"28842","direction":"up","inn_name":"","iupac_name":"octadecanoic acid","metabolite_id":"QIQXTHQIDYTFRH-UHFFFAOYSA-N","pvalue":0.0106524948282817,"ratio":2.4275846726871455,"synonym_name":"Stearins\u00e4ure"},{"chebi_id":"62462","direction":"up","inn_name":"","iupac_name":"6-amino-3,7-dihydro-2<em>H</em>-purin-2-one","metabolite_id":"DRAVOWXCEBXPTN-UHFFFAOYSA-N","pvalue":0.008516674310127,"ratio":2.154493514936744,"synonym_name":"6-amino-3,7-dihydro-purin-2-one"}],"totalFeatures":145},{"comparisonGroups":["Iso31 Control","Fumin Homozygous Sleep Mutants"],"dateCreated":"2025-09-26 00:00:00","display_title":"Drosophila: fumin sleep mutants vs normal sleep control","group_a_title":"Control group of Drosophila melanogaster with normal sleep patterns.. Provides a reference point for assessing the impact of sleep mutations.","group_b_title":"Group of Drosophila melanogaster with fumin mutation causing sleep loss.. Helps in understanding the metabolic impact of the fumin mutation.","id":"MTBLS3318_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS3318","studyUrl":"http://integmet.org/study/MTBLS3318","title":"Iso31_Control_vs_Fumin_Homozygous_Sleep_Mutants","topHits":[{"chebi_id":"48517","direction":"up","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":5.910191911823108e-06,"ratio":21.340144786412793,"synonym_name":"Xanthine"},{"chebi_id":"15927","direction":"up","inn_name":"","iupac_name":"3-carbamoyl-1-\u03b2-<small>D</small>-ribofuranosylpyridinium","metabolite_id":"JLEBZPBDRKPWTD-TURQNECASA-O","pvalue":0.0004610450516531,"ratio":6.417774450191985,"synonym_name":"1-(beta-D-Ribofuranosyl)nicotinamide"},{"chebi_id":"15611","direction":"up","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":1.5392526005997193e-05,"ratio":3.2696889720451545,"synonym_name":"L-sarcosine"},{"chebi_id":"18107","direction":"up","inn_name":"","iupac_name":"xanthosine","metabolite_id":"UBORTCNDUKBEOP-UUOKFMHZSA-N","pvalue":9.965566879664212e-05,"ratio":3.4625512349573095,"synonym_name":"9-\u03b2-<small>D</small>-ribofuranosyl-3,9-dihydro-1<em>H</em>-purine-2,6-dione"},{"chebi_id":"16750","direction":"up","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":7.54298016272606e-06,"ratio":2.3926169020154027,"synonym_name":"G"},{"chebi_id":"17562","direction":"up","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":0.0001546261387237,"ratio":2.989415601164376,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"40521","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SNEIUMQYRCDYCH-LURJTMIESA-N","pvalue":9.555663140619336e-07,"ratio":0.5238741065367075,"synonym_name":"<em>N</em>-Ac-<small>L</small>-Arg-OH"},{"chebi_id":"176478","direction":"down","inn_name":"","iupac_name":"4-(3-acetamidopropylamino)butanoic acid","metabolite_id":"YGIAGXACEXFIDU-UHFFFAOYSA-N","pvalue":9.264001525102173e-05,"ratio":0.4643933330387116,"synonym_name":""},{"chebi_id":"71018","direction":"up","inn_name":"","iupac_name":"[(4-hydroxybenzoyl)amino]acetic acid","metabolite_id":"ZMHLUFWWWPBTIU-UHFFFAOYSA-N","pvalue":0.0005740895769921,"ratio":2.460506610837625,"synonym_name":"4-Hydroxybenzoylglycine"},{"chebi_id":"16708","direction":"up","inn_name":"","iupac_name":"9<em>H</em>-purin-6-amine","metabolite_id":"GFFGJBXGBJISGV-UHFFFAOYSA-N","pvalue":0.0007726513657006,"ratio":2.3108395567949027,"synonym_name":"Adenin"}],"totalFeatures":277},{"comparisonGroups":["WT","16R"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fungal samples: 16R genotype vs wild-type control","group_a_title":"Wild-type control samples. This group serves as the control for comparing the effects of genetic modifications.","group_b_title":"Samples with genotype 16R. This group is crucial for understanding the effects of the 16R genotype on fungal pathogenicity.","id":"MTBLS3332_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS3332","studyUrl":"http://integmet.org/study/MTBLS3332","title":"WT_vs_16R","topHits":[{"chebi_id":"15351","direction":"up","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-(3-{(3<i>R</i>)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} dihydrogen diphosphate)","metabolite_id":"ZSLZBFCDCINBPY-ZSJPKINUSA-N","pvalue":4.808650485201325e-05,"ratio":2.08217765923521,"synonym_name":"Acetyl-CoA"},{"chebi_id":"17489","direction":"up","inn_name":"","iupac_name":"adenosine 3',5'-(hydrogen phosphate)","metabolite_id":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","pvalue":0.0148973835250094,"ratio":1.603008860913825,"synonym_name":"Adenosine 3',5'-phosphate"}],"totalFeatures":30},{"comparisonGroups":["GAT-2_Knockout","Wild_Type"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: GAT-2 knockout vs wild-type","group_a_title":"Samples from GAT-2 knockout mice.. Key group for understanding the role of GAT-2 in immune cell function.","group_b_title":"Samples from wild-type mice.. Provides baseline data for comparison with the knockout group to assess the effects of GAT-2 deficiency.","id":"MTBLS3358_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS3358","studyUrl":"http://integmet.org/study/MTBLS3358","title":"GAT-2_Knockout_vs_Wild_Type","topHits":[{"chebi_id":"340824","direction":"down","inn_name":"","iupac_name":"methyl dihydrogen phosphate","metabolite_id":"CAAULPUQFIIOTL-UHFFFAOYSA-N","pvalue":1.4155399734825169e-05,"ratio":0.6342934428833279,"synonym_name":"monomethyl phosphate"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0046766836829971,"ratio":0.5048214731887174,"synonym_name":"Adenosin"},{"chebi_id":"28837","direction":"down","inn_name":"octanoic acid","iupac_name":"octanoic acid","metabolite_id":"WWZKQHOCKIZLMA-UHFFFAOYSA-N","pvalue":0.0110402964422741,"ratio":0.4998158879275031,"synonym_name":"Octans\u00e4ure"},{"chebi_id":"15978","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxypropyl dihydrogen phosphate","metabolite_id":"AWUCVROLDVIAJX-GSVOUGTGSA-N","pvalue":0.0362221270309588,"ratio":0.5062670305407402,"synonym_name":"Phosphors\u00e4ure-mono-((<i>R</i>)-2,3-dihydroxy-propylester)"},{"chebi_id":"19475","direction":"down","inn_name":"","iupac_name":"norvaline","metabolite_id":"SNDPXSYFESPGGJ-UHFFFAOYSA-N","pvalue":0.0193411387627031,"ratio":0.6596116536701352,"synonym_name":"\u03b1-aminovaleric acid"}],"totalFeatures":167},{"comparisonGroups":["Ws","Wu"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis: Ws-0 vs Wu-0 accession comparison","group_a_title":"Samples from Arabidopsis thaliana accession Ws-0. Represents the genetic variation of the Ws-0 accession in the study.","group_b_title":"Samples from Arabidopsis thaliana accession Wu-0. Represents the genetic variation of the Wu-0 accession in the study.","id":"MTBLS338_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS338","studyUrl":"http://integmet.org/study/MTBLS338","title":"G1_Ws_vs_G2_Wu","topHits":[{"chebi_id":"27506","direction":"down","inn_name":"","iupac_name":"1-<em>S</em>-[2-(1-methoxy-1<em>H</em>-indol-3-yl)-<em>N</em>-(sulfooxy)ethanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"PKKMITFKYRCCOL-CMZRPVNOSA-N","pvalue":3.464168924308354e-13,"ratio":0.276605158177256,"synonym_name":"MIMG"},{"chebi_id":"16546","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"XRKBRPFTFKKHEF-DGDBGZAXSA-N","pvalue":9.332689920319444e-05,"ratio":0.1792297217916542,"synonym_name":"1-O-Sinapoyl beta-D-glucoside"},{"chebi_id":"16914","direction":"up","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":0.0033917215642324,"ratio":2.3979630126218288,"synonym_name":"o-Hydroxybenzoic acid"},{"chebi_id":"181647","direction":"down","inn_name":"","iupac_name":"[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"SKNVKBJSSSJNCI-UIBFFPKISA-N","pvalue":0.0061759650850525,"ratio":0.4059347709110383,"synonym_name":""},{"chebi_id":"24809","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-indole-3-carboxylic acid","metabolite_id":"KMAKOBLIOCQGJP-UHFFFAOYSA-N","pvalue":0.0041578756132985,"ratio":0.5658078963608733,"synonym_name":"indole-3-carboxylic acid"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0233997670240466,"ratio":0.4417449410888797,"synonym_name":"Adenosin"},{"chebi_id":"83535","direction":"up","inn_name":"","iupac_name":"3,5-dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"ITVGXXMINPYUHD-CUVHLRMHSA-N","pvalue":0.0015322663058077,"ratio":1.5287683992635293,"synonym_name":""},{"chebi_id":"65021","direction":"down","inn_name":"","iupac_name":"1-<em>O</em>-(1<em>H</em>-indol-3-ylcarbonyl)-<small>D</small>-glucopyranose","metabolite_id":"OQZPHKHJQADXAS-CKMVWSRUSA-N","pvalue":0.0218917486656676,"ratio":0.4906850577440536,"synonym_name":"I3CO2Glc"}],"totalFeatures":69},{"comparisonGroups":["Mock_13d","PR8_13d"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mock vs PR8 infection at 13 days (lipidomics)","group_a_title":"Mock-infected control group at 13 days post-infection. Provides baseline lipidomic profile for comparison with infected groups.","group_b_title":"PR8-infected group at 13 days post-infection. Crucial for understanding the full extent of lipidomic changes at the end of the infection period.","id":"MTBLS34_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS34","studyUrl":"http://integmet.org/study/MTBLS34","title":"Mock_13d_vs_PR8_13d","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OZXAIGIRPOOJTI-UHFFFAOYSA-N","pvalue":0.0002166928512097,"ratio":1e-06,"synonym_name":""},{"chebi_id":"72866","direction":"down","inn_name":"","iupac_name":"(9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-8-hydroxyicosa-9,11,14-trienoic acid","metabolite_id":"SKIQVURLERJJCK-SFULQBOPSA-N","pvalue":0.0004756234910683,"ratio":1e-06,"synonym_name":"8-hydroxy-9<i>E</i>,11<i>Z</i>,14<i>Z</i>-icosatrienoic acid"},{"chebi_id":"72779","direction":"down","inn_name":"","iupac_name":"(5<i>S</i>,6<i>R</i>,7<i>E</i>,9<i>E</i>,11<i>E</i>,14<i>Z</i>)-6-{[(2<i>R</i>)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid","metabolite_id":"OTZRAYGBFWZKMX-DVFCZEDWSA-N","pvalue":0.006543045860488,"ratio":0.008628160083881,"synonym_name":"11t-LTE<small><sub>4</sub></small>"},{"chebi_id":"72802","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid","metabolite_id":"LRWYBGFSVUBWMO-UXNZXXPISA-N","pvalue":0.0077380736377356,"ratio":0.0098264341691364,"synonym_name":"(\u00b1)-18-hydroxy-5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,16<i>E</i>-eicosapentaenoic acid"},{"chebi_id":"72794","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,9<i>E</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid","metabolite_id":"LTERDCBCHFKFRI-BGKMTWLOSA-N","pvalue":0.0004149562634876,"ratio":0.0619716693522994,"synonym_name":"(\u00b1)-11-HDoHE"},{"chebi_id":"15843","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoic acid","metabolite_id":"YZXBAPSDXZZRGB-DOFZRALJSA-N","pvalue":3.4678120193385986e-08,"ratio":0.2996889102200201,"synonym_name":"Arachidonate"},{"chebi_id":"72808","direction":"down","inn_name":"","iupac_name":"(6<i>Z</i>,9<i>Z</i>,11<i>E</i>)-13-hydroxyoctadeca-6,9,11-trienoic acid","metabolite_id":"HNBLUNXZQNJFRB-YSHIPJNPSA-N","pvalue":0.0002665318360876,"ratio":0.1398750306290574,"synonym_name":"13-HOTrE(\u03b3)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YEESKJGWJFYOOK-FBYZWIJMSA-N","pvalue":0.0095171984897972,"ratio":28.41013507539275,"synonym_name":""},{"chebi_id":"72605","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,6<i>E</i>,8<i>R</i>,10<i>Z</i>)-8-hydroxyhexadeca-4,6,10-trienoic acid","metabolite_id":"KBOVKDIBOBQLRS-QCNAHCIUSA-N","pvalue":0.0046810120555398,"ratio":0.1238555468909736,"synonym_name":""},{"chebi_id":"53487","direction":"down","inn_name":"","iupac_name":"(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoic acid","metabolite_id":"TWSWSIQAPQLDBP-DOFZRALJSA-N","pvalue":0.0013288211955162,"ratio":0.2025865904346744,"synonym_name":"Adrenic acid"}],"totalFeatures":73},{"comparisonGroups":["FB_0h","FB_120h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fast-browning cultivar: 0h vs 120h storage","group_a_title":"Fast-browning cultivar at 0 hours storage. Serves as the reference point for evaluating changes in the fast-browning cultivar over time.","group_b_title":"Fast-browning cultivar at 120 hours storage. Allows for the assessment of storage effects on the fast-browning cultivar.","id":"MTBLS343_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":21,"studyId":"MTBLS343","studyUrl":"http://integmet.org/study/MTBLS343","title":"FB_0h_vs_FB_120h","topHits":[{"chebi_id":"16112","direction":"up","inn_name":"","iupac_name":"edit(1<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3-{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid","metabolite_id":"CWVRJTMFETXNAD-JUHZACGLSA-N","pvalue":0.0007747724501036,"ratio":1000000.0,"synonym_name":"5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid"},{"chebi_id":"138086","direction":"up","inn_name":"","iupac_name":"2,3,4-tris-<em>O</em>-[(4-hydroxyphenyl)acetyl]-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"AGDWYCPHDLXFTO-VLYBHXKQSA-N","pvalue":1.5716498425116616e-06,"ratio":22.01293484679434,"synonym_name":""},{"chebi_id":"90280","direction":"up","inn_name":"","iupac_name":"{[(3a<i>R</i>,4<i>S</i>,9a<i>S</i>,9b<i>R</i>)-4-{[(4-hydroxyphenyl)acetyl]oxy}-6-methyl-3-methylidene-2,7-dioxo-2,3,3a,4,5,7,9a,9b-octahydroazuleno[4,5-<em>b</em>]furan-9-yl]methoxy}(oxo)acetic acid","metabolite_id":"AUULYUITRYGGJX-XGARDCMYSA-N","pvalue":0.0004808612007074,"ratio":23.63317808921648,"synonym_name":"Lactucopicrin-15-oxalate"},{"chebi_id":"520","direction":"down","inn_name":"","iupac_name":"(1<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-1,3-bis{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexane-1-carboxylic acid","metabolite_id":"YDDUMTOHNYZQPO-RVXRWRFUSA-N","pvalue":0.000187246483779,"ratio":0.0627410527731336,"synonym_name":"1,5-Dicaffeoylquinic acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UMVSOHBRAQTGQI-WGJNNHPISA-N","pvalue":0.0001180708071013,"ratio":11.560580029155652,"synonym_name":""},{"chebi_id":"138080","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"WJDJGSFANBTCOF-XUNJKSNWSA-N","pvalue":8.497800639894704e-05,"ratio":6.096570323871441,"synonym_name":""},{"chebi_id":"138083","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZMKDEQUXYDZSNN-OKLKQMLOSA-N","pvalue":0.0192536950557786,"ratio":29.844352303276075,"synonym_name":""},{"chebi_id":"138085","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LLHYFNVRZDNGJG-CPGAUMDZSA-N","pvalue":0.0027993037578948,"ratio":7.815938949187213,"synonym_name":"1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phospho-(1'-myo-inositol)"},{"chebi_id":"138082","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JHGVFGJXFVIYSM-BSHMHQBXSA-N","pvalue":0.0002702490906099,"ratio":3.89706690826827,"synonym_name":""},{"chebi_id":"6358","direction":"up","inn_name":"","iupac_name":"(3a<i>R</i>,4<i>S</i>,9a<i>S</i>,9b<i>R</i>)-4-hydroxy-9-(hydroxymethyl)-6-methyl-3-methylidene-3,3a,4,5,9a,9b-hexahydroazuleno[4,5-<em>b</em>]furan-2,7-dione","metabolite_id":"VJQAFLAZRVKAKM-VZLIPTOUSA-N","pvalue":0.0163754580568862,"ratio":14.427217727457691,"synonym_name":"Lactucine"}],"totalFeatures":21},{"comparisonGroups":["ZH11_Mock","ZH11_OsPep3"],"dateCreated":"2025-09-26 00:00:00","display_title":"ZH11 genotype: OsPep3 treatment vs mock control","group_a_title":"Mock-treated samples of ZH11 genotype. Provides baseline for comparison with OsPep3-treated ZH11 samples.","group_b_title":"OsPep3-treated samples of ZH11 genotype. Evaluates the effect of OsPep3 treatment on ZH11 genotype.","id":"MTBLS3518_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":76,"studyId":"MTBLS3518","studyUrl":"http://integmet.org/study/MTBLS3518","title":"ZH11_Mock_vs_ZH11_OsPep3","topHits":[{"chebi_id":"17716","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QKKXKWKRSA-N","pvalue":5.088050856835621e-05,"ratio":7.930722198242574,"synonym_name":"milk sugar"},{"chebi_id":"16551","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"HDTRYLNUVZCQOY-LIZSDCNHSA-N","pvalue":0.0001642989806895,"ratio":7.574401425779822,"synonym_name":"alpha,alpha-Trehalose"},{"chebi_id":"189493","direction":"down","inn_name":"","iupac_name":"4-hydroxy-1,5,6-trimethyl-2,2-dioxo-N-phenylthieno[2,3-c]thiazine-3-carboxamide","metabolite_id":"XXAWYHRGGJFCLJ-UHFFFAOYSA-N","pvalue":0.0495855862562337,"ratio":0.0033433670163221,"synonym_name":""},{"chebi_id":"5870","direction":"up","inn_name":"","iupac_name":"1-[(6-chloropyridin-3-yl)methyl]-<em>N</em>-nitroimidazolidin-2-imine","metabolite_id":"YWTYJOPNNQFBPC-UHFFFAOYSA-N","pvalue":0.0251599086633738,"ratio":62.18144471162965,"synonym_name":"Imidacloprid"},{"chebi_id":"27082","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HDTRYLNUVZCQOY-MFAKQEFJSA-N","pvalue":0.0009446799496229,"ratio":6.478254403001265,"synonym_name":""},{"chebi_id":"189452","direction":"up","inn_name":"","iupac_name":"methyl (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate","metabolite_id":"LNIVUWPCHRNJLG-SXFAUFNYSA-N","pvalue":0.0002773296495875,"ratio":4.779861168118182,"synonym_name":""},{"chebi_id":"9370","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HEYZWPRKKUGDCR-QBXMEVCASA-N","pvalue":0.0002700611802453,"ratio":4.120734023369743,"synonym_name":"Swertiamarin"},{"chebi_id":"189448","direction":"up","inn_name":"","iupac_name":"8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one","metabolite_id":"QQBFHNKJGBCSLG-YMPKARJTSA-N","pvalue":0.0028684816561854,"ratio":5.13601508861801,"synonym_name":""},{"chebi_id":"5321","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DUAGQYUORDTXOR-GPQRQXLASA-N","pvalue":0.000360757323013,"ratio":0.3417729745309232,"synonym_name":"Gentiopicrin"},{"chebi_id":"83457","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenyl}acetamide","metabolite_id":"LJKAKWDUZRJNPJ-UHFFFAOYSA-N","pvalue":0.0006544287538369,"ratio":3.0705730483757803,"synonym_name":"4-acetylamino-<em>N</em>-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide"}],"totalFeatures":295},{"comparisonGroups":["Control_Uninfected_healthy_plants","Asymptomatic_Wood_black_streak_esca_plants"],"dateCreated":"2025-09-26 00:00:00","display_title":"Wood: healthy control vs asymptomatic esca disease","group_a_title":"Healthy control group with no esca disease symptoms.. Provides a reference for understanding the metabolic changes associated with esca disease symptoms.","group_b_title":"Asymptomatic group with wood black streak esca disease.. Helps in identifying early metabolic changes before symptom expression.","id":"MTBLS353_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS353","studyUrl":"http://integmet.org/study/MTBLS353","title":"Control_vs_Asymptomatic","topHits":[{"chebi_id":"27881","direction":"up","inn_name":"","iupac_name":"5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol","metabolite_id":"LUKBXSAWLPMMSZ-UHFFFAOYSA-N","pvalue":0.0004416827391111,"ratio":1.8002533201326485,"synonym_name":"Resveratrol"},{"chebi_id":"132989","direction":"up","inn_name":"","iupac_name":"4-(acetyloxy)-2-azaniumylbutanoate","metabolite_id":"FCXZBWSIAGGPCB-UHFFFAOYSA-N","pvalue":0.014903356130875,"ratio":2.8552698219721075,"synonym_name":""},{"chebi_id":"15784","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"BRGMHAYQAZFZDJ-RTRLPJTCSA-N","pvalue":0.0134565260808792,"ratio":2.605631041049622,"synonym_name":"2-acetamido-2-deoxy-6-<em>O</em>-phosphono-<small>D</small>-glucopyranose"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MKWKYAGEJHBUOX-QMMMGPOBSA-N","pvalue":0.0203296652730153,"ratio":2.53885558706493,"synonym_name":""},{"chebi_id":"15927","direction":"up","inn_name":"","iupac_name":"3-carbamoyl-1-\u03b2-<small>D</small>-ribofuranosylpyridinium","metabolite_id":"JLEBZPBDRKPWTD-TURQNECASA-O","pvalue":0.0073062418521689,"ratio":1.9561174289561016,"synonym_name":"1-(beta-D-Ribofuranosyl)nicotinamide"},{"chebi_id":"58527","direction":"up","inn_name":"","iupac_name":"1-(\u03b2-<small>D</small>-ribofuranosyl)pyridinium-3-carboxylate","metabolite_id":"PUEDDPCUCPRQNY-ZYUZMQFOSA-N","pvalue":0.0006451308576045,"ratio":1.561249164395849,"synonym_name":""},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":0.0077859263216211,"ratio":1.9317693394912767,"synonym_name":"Purine-6-ol"},{"chebi_id":"70959","direction":"down","inn_name":"","iupac_name":"3-methylhistidine","metabolite_id":"JDHILDINMRGULE-UHFFFAOYSA-N","pvalue":0.0427091340404426,"ratio":0.3911834775983721,"synonym_name":"3-methyl-<small>D</small><small>L</small>-histidine"},{"chebi_id":"46823","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-purine-2,6,8-triol","metabolite_id":"LEHOTFFKMJEONL-UHFFFAOYSA-N","pvalue":0.0080616605618084,"ratio":1.8373438228871115,"synonym_name":""},{"chebi_id":"18305","direction":"up","inn_name":"","iupac_name":"4-hydroxyphenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"BJRNKVDFDLYUGJ-RMPHRYRLSA-N","pvalue":0.0012851697204563,"ratio":1.546859852239486,"synonym_name":"Ursin"}],"totalFeatures":288},{"comparisonGroups":["CAP_Cases","Non-CAP_Controls"],"dateCreated":"2025-09-26 00:00:00","display_title":"CAP patients vs healthy controls","group_a_title":"Patients diagnosed with community-acquired pneumonia.. This group is crucial for identifying biomarkers specific to CAP.","group_b_title":"Patients without community-acquired pneumonia.. This group serves as the baseline for identifying CAP-specific biomarkers.","id":"MTBLS354_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS354","studyUrl":"http://integmet.org/study/MTBLS354","title":"CAP_Cases_vs_Non_CAP_Controls","topHits":[{"chebi_id":"73004","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate","metabolite_id":"YVYMBNSKXOXSKW-HXUWFJFHSA-N","pvalue":1.1066096120007415e-22,"ratio":0.4269200867690177,"synonym_name":"1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"72742","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl (8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-8,11,14,17-tetraenoate","metabolite_id":"JPNPIRVRGLGTRE-YSKCIPFOSA-N","pvalue":2.2188655486044753e-18,"ratio":0.3651522810558171,"synonym_name":"LPE 20:4(8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)/0:0"},{"chebi_id":"133732","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl phosphate","metabolite_id":"DBHKHNGBVGWQJE-USWSLJGRSA-N","pvalue":4.012135218017626e-16,"ratio":0.3457385234515904,"synonym_name":"lysophosphatidylethanolamine (18:2(9<i>Z</i>,12<i>Z</i>)) zwitterion"},{"chebi_id":"72747","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"XEVRBOQZSXWGQO-PAUXXPOVSA-N","pvalue":6.16732477019142e-16,"ratio":0.3591825520716625,"synonym_name":"PE 22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)/0:0"},{"chebi_id":"75036","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl phosphate","metabolite_id":"BBYWOYAFBUOUFP-JOCHJYFZSA-N","pvalue":1.004730277128244e-14,"ratio":0.5117311744049743,"synonym_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(stearoyloxy)propyl phosphate"}],"totalFeatures":5},{"comparisonGroups":["CAP_Cases","Non-CAP_Controls"],"dateCreated":"2025-09-26 00:00:00","display_title":"CAP patients vs non-CAP controls","group_a_title":"Patients diagnosed with community-acquired pneumonia.. This group is crucial for identifying biomarkers specific to CAP.","group_b_title":"Patients without community-acquired pneumonia.. This group serves as the baseline for identifying CAP-specific biomarkers.","id":"MTBLS354_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS354","studyUrl":"http://integmet.org/study/MTBLS354","title":"CAP_Cases_vs_Non_CAP_Controls","topHits":[{"chebi_id":"84758","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1-{[4-<em>O</em>-(\u03b2-<small>D</small>-galactopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide","metabolite_id":"HLIJNIKSBCIDGO-QKLMXXKVSA-N","pvalue":3.0953722316621683e-19,"ratio":2.3182189251774656,"synonym_name":"N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine"},{"chebi_id":"84687","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1-{[\u03b1-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide","metabolite_id":"MGOOTGNGBOPVIV-VVNLPLDBSA-N","pvalue":2.7302456377341165e-18,"ratio":2.1807445235102745,"synonym_name":"Gb3(d18:1/16:0)"},{"chebi_id":"78647","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>)-2-(hexadecanoylamino)-3-hydroxyoctadecyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"QHZIGNLCLJPLCU-QPPIDDCLSA-N","pvalue":9.525302627892937e-14,"ratio":2.785764597513495,"synonym_name":"{[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}[2-(trimethylazaniumyl)ethoxy]phosphinic acid"},{"chebi_id":"17490","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-hexadecanoyloxy-4-(trimethylammonio)butanoate","metabolite_id":"XOMRRQXKHMYMOC-OAQYLSRUSA-N","pvalue":1.0387259386615793e-12,"ratio":2.9835622663707277,"synonym_name":"Hexadecenoyl carnitine"},{"chebi_id":"78646","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RWKUXQNLWDTSLO-GWQJGLRPSA-N","pvalue":1.6367436793745085e-25,"ratio":1.5409140318526335,"synonym_name":"<em>N</em>-hexadecanoylsphingomyelin"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BLRBAJXLYBVISP-FQSSPVBCSA-N","pvalue":1.0653700600651797e-13,"ratio":2.0571995221013832,"synonym_name":""},{"chebi_id":"28610","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YAMUFBLWGFFICM-PTGWMXDISA-N","pvalue":1.212450596007781e-09,"ratio":2.4027993261380862,"synonym_name":"1-Oleoylglycerophosphocholine"}],"totalFeatures":7},{"comparisonGroups":["E1777_Intracellular_MidLog","E1777_Intracellular_EarlyStationary"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. coli E1777: mid-log vs early stationary phase","group_a_title":"Escherichia coli E1777 intracellular samples at mid-log phase.. Provides insight into gene expression and metabolite production during mid-log phase.","group_b_title":"Escherichia coli E1777 intracellular samples at early stationary phase.. Provides insight into gene expression and metabolite production during early stationary phase.","id":"MTBLS3540_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS3540","studyUrl":"http://integmet.org/study/MTBLS3540","title":"E1777_Intracellular_MidLog_vs_E1777_Intracellular_EarlyStationary","topHits":[{"chebi_id":"16440","direction":"down","inn_name":"","iupac_name":"<em>N</em>-methyl-<small>L</small>-glutamic acid","metabolite_id":"XLBVNMSMFQMKEY-BYPYZUCNSA-N","pvalue":1.6296747307590506e-06,"ratio":0.1785166511146447,"synonym_name":"N-methyl-L-glutamic acid"},{"chebi_id":"88824","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(5-aminopentyl)acetamide","metabolite_id":"RMOIHHAKNOFHOE-UHFFFAOYSA-N","pvalue":0.0001017506518253,"ratio":0.1632089199341353,"synonym_name":"Monoacetyl cadaverine"},{"chebi_id":"21547","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidobutanedioic acid","metabolite_id":"OTCCIMWXFLJLIA-BYPYZUCNSA-N","pvalue":0.0010164000483623,"ratio":9.18409761384546,"synonym_name":"<em>N</em>-acetylaspartic acid"},{"chebi_id":"59789","direction":"down","inn_name":"","iupac_name":"[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-O","pvalue":0.0002896042955,"ratio":0.188337064108845,"synonym_name":"S-adenosyl-L-methionine"},{"chebi_id":"177535","direction":"down","inn_name":"","iupac_name":"2-amino-5-[[1-(carboxymethylamino)-1-oxo-3-sulanylpropan-2-yl]amino]-5-oxopentanoic acid","metabolite_id":"RWSXRVCMGQZWBV-UHFFFAOYSA-N","pvalue":0.0005895244682727,"ratio":0.2020835067519468,"synonym_name":""},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":2.8556532083260112e-06,"ratio":0.395958347582803,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":0.0005742974624121,"ratio":0.3661786014292193,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"16908","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BOPGDPNILDQYTO-NNYOXOHSSA-N","pvalue":0.0014953215371307,"ratio":0.3295135894877396,"synonym_name":"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE"},{"chebi_id":"16217","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one","metabolite_id":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","pvalue":0.0157340699709496,"ratio":0.2409285921936335,"synonym_name":"<small>D</small>-gluconic acid lactone"},{"chebi_id":"17659","direction":"down","inn_name":"","iupac_name":"uridine 5'-(trihydrogen diphosphate)","metabolite_id":"XCCTYIAWTASOJW-XVFCMESISA-N","pvalue":0.0007745518261352,"ratio":0.4433400298078537,"synonym_name":"Uridine 5'-diphosphate"}],"totalFeatures":285},{"comparisonGroups":["No_Tea_0min","Tea_240min"],"dateCreated":"2025-09-26 00:00:00","display_title":"No tea vs tea treatment at 240min","group_a_title":"Control group with no tea treatment at 0 minutes. Provides baseline data for comparison with treated samples at the same time point.","group_b_title":"Treated group with tea at 240 minutes. Allows for assessment of effects of tea treatment at 240 minutes.","id":"MTBLS359_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS359","studyUrl":"http://integmet.org/study/MTBLS359","title":"No_Tea_0min_vs_Tea_240min","topHits":[{"chebi_id":"15918","direction":"down","inn_name":"","iupac_name":"2'-deoxy-5'-cytidylic acid","metabolite_id":"NCMVOABPESMRCP-SHYZEUOFSA-N","pvalue":0.0048181128437924,"ratio":1e-06,"synonym_name":"Deoxycytidylate"},{"chebi_id":"90364","direction":"down","inn_name":"","iupac_name":"(2<em>S</em>)-2-Amino-4-({[(2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3,4,5-trihydroxytetrahydro-2-furanyl]methyl}sulfanyl)butanoic acid","metabolite_id":"IQFWYNFDWRYSRA-OEQWSMLSSA-N","pvalue":0.0374151081209593,"ratio":1e-06,"synonym_name":"S-(5-Deoxy-D-ribos-5-yl)-L-homocysteine"},{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":0.0004804578847655,"ratio":0.010834323380363,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"17489","direction":"down","inn_name":"","iupac_name":"adenosine 3',5'-(hydrogen phosphate)","metabolite_id":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","pvalue":0.0138005891411016,"ratio":0.0021257140607316,"synonym_name":"Adenosine 3',5'-phosphate"},{"chebi_id":"18009","direction":"down","inn_name":"","iupac_name":"2'-<em>O</em>-phosphonoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"XJLXINKUBYWONI-NNYOXOHSSA-O","pvalue":0.0002933380723388,"ratio":0.1495649867235738,"synonym_name":"Nicotinamide adenine dinucleotide phosphate"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0012669873004645,"ratio":0.1193615601659751,"synonym_name":"E363"},{"chebi_id":"30860","direction":"down","inn_name":"","iupac_name":"methylpropanedioic acid","metabolite_id":"ZIYVHBGGAOATLY-UHFFFAOYSA-N","pvalue":0.0012669873004645,"ratio":0.1193615601659751,"synonym_name":"1,1-Ethanedicarboxylic acid"},{"chebi_id":"15676","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(2,5-dioxoimidazolidin-4-yl)urea","metabolite_id":"POJWUDADGALRAB-UHFFFAOYSA-N","pvalue":0.0259100899927402,"ratio":0.0224352670888162,"synonym_name":"(2,5-Dioxo-4-imidazolidinyl)urea"},{"chebi_id":"15846","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BAWFJGJZGIEFAR-NNYOXOHSSA-O","pvalue":0.0020469923319914,"ratio":0.115919150028558,"synonym_name":"NAD+"},{"chebi_id":"18012","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":0.0375201836619165,"ratio":0.0236285277586189,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"}],"totalFeatures":87},{"comparisonGroups":["Control","OXPA_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"OXPA treatment vs control in Trypanosoma brucei","group_a_title":"Control samples without OXPA treatment. Provides a reference point for evaluating the effects of OXPA treatment","group_b_title":"Samples treated with OXPA compound. Key group for assessing the efficacy of the OXPA compound against Trypanosoma brucei","id":"MTBLS360_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS360","studyUrl":"http://integmet.org/study/MTBLS360","title":"Control_vs_OXPA_Treatment","topHits":[{"chebi_id":"34405","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZRVIYEJYXIDATJ-UHFFFAOYSA-N","pvalue":0.0241477974520829,"ratio":0.2504293574801785,"synonym_name":"4-Heptyloxybenzoic acid"},{"chebi_id":"16347","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-hydroxy-4-(trimethylammonio)butanoate","metabolite_id":"PHIQHXFUZVPYII-ZCFIWIBFSA-N","pvalue":0.0014642139521785,"ratio":0.504700313188495,"synonym_name":"L-Carnitine"},{"chebi_id":"138507","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QBFXCLDNTKBAPQ-STSAHMJASA-N","pvalue":0.0043737563371726,"ratio":1.9494336093012856,"synonym_name":"<em>N</em>-(heptadecanoyl)-hexdecasphing-4-enine"},{"chebi_id":"72959","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide","metabolite_id":"YDNKGFDKKRUKPY-TURZORIXSA-N","pvalue":0.0036944988017563,"ratio":1.8876518962550628,"synonym_name":"<em>N</em>-(hexadecanoyl)-sphing-4-enine"},{"chebi_id":"73024","direction":"down","inn_name":"","iupac_name":"3-(acetyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"RDHQFKQIGNGIED-UHFFFAOYSA-N","pvalue":0.0216835051616149,"ratio":0.4195754098972111,"synonym_name":"Acetyl-DL-carnitine"},{"chebi_id":"48928","direction":"down","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0265371032079535,"ratio":0.4433703636485208,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"77996","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enamide","metabolite_id":"OBFSLMQLPNKVRW-RHPAUOISSA-N","pvalue":0.0196752157663817,"ratio":2.075912907727974,"synonym_name":"C18:1 Cer"},{"chebi_id":"86513","direction":"up","inn_name":"","iupac_name":"N-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]heptadecanamide","metabolite_id":"ICWGMOFDULMCFL-QKSCFGQVSA-N","pvalue":0.0085700176773206,"ratio":1.763472842973603,"synonym_name":"Cer(d18:1/17:0)"},{"chebi_id":"65107","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>S</i>,4<i>R</i>)-1,3,4-trihydroxyoctadecan-2-yl]hexadecanamide","metabolite_id":"IVBULNXGVIHEKN-MVIDNBQJSA-N","pvalue":0.0198630607767747,"ratio":1.8783591919936389,"synonym_name":"N-(hexadecanoyl)-phytoceramide"},{"chebi_id":"17015","direction":"up","inn_name":"riboflavine","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUNGANRZJHBGPY-SCRDCRAPSA-N","pvalue":0.0134844489540279,"ratio":1.7181315700671904,"synonym_name":"E101"}],"totalFeatures":503},{"comparisonGroups":["Control","OXPA_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. brucei: OXPA treatment vs control","group_a_title":"Control samples without OXPA treatment. Provides a reference point for evaluating the effects of OXPA treatment","group_b_title":"Samples treated with OXPA compound. Key group for assessing the efficacy of the OXPA compound against Trypanosoma brucei","id":"MTBLS360_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS360","studyUrl":"http://integmet.org/study/MTBLS360","title":"Control_vs_OXPA_Treatment","topHits":[{"chebi_id":"34405","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZRVIYEJYXIDATJ-UHFFFAOYSA-N","pvalue":0.0241477974520829,"ratio":0.2504293574801785,"synonym_name":"4-Heptyloxybenzoic acid"},{"chebi_id":"16347","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-hydroxy-4-(trimethylammonio)butanoate","metabolite_id":"PHIQHXFUZVPYII-ZCFIWIBFSA-N","pvalue":0.0014642139521785,"ratio":0.504700313188495,"synonym_name":"L-Carnitine"},{"chebi_id":"138507","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QBFXCLDNTKBAPQ-STSAHMJASA-N","pvalue":0.0043737563371726,"ratio":1.9494336093012856,"synonym_name":"<em>N</em>-(heptadecanoyl)-hexdecasphing-4-enine"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YDNKGFDKKRUKPY-JHOUSYSJSA-N","pvalue":0.0036944988017563,"ratio":1.8876518962550628,"synonym_name":""},{"chebi_id":"15960","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-(acetyloxy)-3-carboxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylpropan-1-aminium","metabolite_id":"RDHQFKQIGNGIED-MRVPVSSYSA-O","pvalue":0.0216835051616149,"ratio":0.4195754098972111,"synonym_name":"O-Acetylcarnitine"},{"chebi_id":"48928","direction":"down","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0265371032079535,"ratio":0.4433703636485208,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OBFSLMQLPNKVRW-OIDHKYIRSA-N","pvalue":0.0196752157663817,"ratio":2.075912907727974,"synonym_name":""},{"chebi_id":"86513","direction":"up","inn_name":"","iupac_name":"N-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]heptadecanamide","metabolite_id":"ICWGMOFDULMCFL-QKSCFGQVSA-N","pvalue":0.0085700176773206,"ratio":1.763472842973603,"synonym_name":"Cer(d18:1/17:0)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IVBULNXGVIHEKN-AUOMWKRBSA-N","pvalue":0.0198630607767747,"ratio":1.8783591919936389,"synonym_name":""},{"chebi_id":"95299","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AUNGANRZJHBGPY-MBNYWOFBSA-N","pvalue":0.0134844489540279,"ratio":1.7181315700671904,"synonym_name":""}],"totalFeatures":501},{"comparisonGroups":["T_septentrionalis_cold","T_septentrionalis_warm"],"dateCreated":"2025-09-26 00:00:00","display_title":"T. septentrionalis: cold vs warm temperature treatment","group_a_title":"Takydromus septentrionalis under cold treatment. Helps in understanding the cold acclimatization response of T. septentrionalis","group_b_title":"Takydromus septentrionalis under warm treatment. Helps in understanding the warm acclimatization response of T. septentrionalis","id":"MTBLS3627_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS3627","studyUrl":"http://integmet.org/study/MTBLS3627","title":"T_septentrionalis_cold_vs_T_septentrionalis_warm","topHits":[{"chebi_id":"87625","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>R</i>)-3,4-dihydroxyoxolan-2-one","metabolite_id":"SGMJBNSHAZVGMC-PWNYCUMCSA-N","pvalue":0.0002614118139852,"ratio":3.5251054393777426,"synonym_name":"<small>D</small>-erythronolactone"},{"chebi_id":"16070","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"MPCAJMNYNOGXPB-SLPGGIOYSA-N","pvalue":0.0006547250042525,"ratio":3.657720923466148,"synonym_name":"1,5-Anhydro-D-sorbitol"},{"chebi_id":"30744","direction":"up","inn_name":"","iupac_name":"2-oxobutanedioic acid","metabolite_id":"KHPXUQMNIQBQEV-UHFFFAOYSA-N","pvalue":0.0007952122121801,"ratio":3.4699531805211437,"synonym_name":"3-carboxy-3-oxopropanoic acid"},{"chebi_id":"17716","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QKKXKWKRSA-N","pvalue":0.0070988371686873,"ratio":3.296710663111279,"synonym_name":"milk sugar"},{"chebi_id":"18305","direction":"up","inn_name":"","iupac_name":"4-hydroxyphenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"BJRNKVDFDLYUGJ-RMPHRYRLSA-N","pvalue":0.0137628259762287,"ratio":3.633934039219501,"synonym_name":"Ursin"},{"chebi_id":"55481","direction":"up","inn_name":"","iupac_name":"4-<em>O</em>-\u03b2-<small>D</small>-galactopyranosyl-<small>D</small>-gluconic acid","metabolite_id":"JYTUSYBCFIZPBE-AMTLMPIISA-N","pvalue":0.0082192675895341,"ratio":2.7851498386435893,"synonym_name":"4-(\u03b2-<small>D</small>-galactosido)-<small>D</small>-gluconic acid"},{"chebi_id":"15908","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonic acid","metabolite_id":"JPIJQSOTBSSVTP-STHAYSLISA-N","pvalue":0.0193344229829519,"ratio":2.5665793789069324,"synonym_name":""},{"chebi_id":"64850","direction":"down","inn_name":"","iupac_name":"<em>N</em>-carbamoylaspartic acid","metabolite_id":"HLKXYZVTANABHZ-UHFFFAOYSA-N","pvalue":0.0418701295549807,"ratio":0.3227897456580583,"synonym_name":"<em>N</em>-(Aminocarbonyl)-<small>D</small><small>L</small>-aspartic acid"},{"chebi_id":"74168","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3<em>H</em>)-one","metabolite_id":"CUOKHACJLGPRHD-BXXZVTAOSA-N","pvalue":0.0259660230431795,"ratio":2.240836140049149,"synonym_name":"D-Ribono-gamma-lactone"},{"chebi_id":"33033","direction":"up","inn_name":"","iupac_name":"2-oxopentanoic acid","metabolite_id":"KDVFRMMRZOCFLS-UHFFFAOYSA-N","pvalue":0.0142652578623647,"ratio":1.7955101427600828,"synonym_name":"2-oxovaleric acid"}],"totalFeatures":149},{"comparisonGroups":["Normal_control_no_tumor","FH_deficient_RCC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs FH-deficient renal cell carcinoma","group_a_title":"Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.","group_b_title":"Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.","id":"MTBLS3628_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":53,"studyId":"MTBLS3628","studyUrl":"http://integmet.org/study/MTBLS3628","title":"Normal_control_no_tumor_vs_FH_deficient_RCC","topHits":[{"chebi_id":"18319","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-[5-amino-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribosyl)imidazole-4-carboxamido]succinic acid","metabolite_id":"NAQGHJTUZRHGAC-ZZZDFHIKSA-N","pvalue":0.0095694641749237,"ratio":626.74917,"synonym_name":"5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole"},{"chebi_id":"168247","direction":"up","inn_name":"","iupac_name":"2-[[N'-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]carbamimidoyl]-methylamino]acetic acid","metabolite_id":"BGJFEKXALPJEGN-XVFCMESISA-N","pvalue":2.5913702167221557e-05,"ratio":15.297328956258683,"synonym_name":""},{"chebi_id":"135063","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SUHOQUVVVLNYQR-UHFFFAOYSA-N","pvalue":1.2457014044765238e-06,"ratio":0.2237074031726345,"synonym_name":"glycerophosphoric acid choline ester"},{"chebi_id":"71169","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-({9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-9<em>H</em>-purin-6-yl}amino)butanedioic acid","metabolite_id":"VKGZCEJTCKHMRL-VWJPMABRSA-N","pvalue":0.0009232849460072,"ratio":18.045955091318717,"synonym_name":"<em>N</em>-(9-\u03b2-<small>D</small>-ribofuranosyl-9<em>H</em>-purin-6-yl)-<small>L</small>-aspartic acid"},{"chebi_id":"15903","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":3.3944953909102315e-05,"ratio":4.6300294681093055,"synonym_name":"beta-D-Glucose"},{"chebi_id":"17012","direction":"up","inn_name":"aceneuramic acid","iupac_name":"5-acetamido-3,5-dideoxy-<small>D</small>-<i>glycero</i>-<small>D</small>-<i>galacto</i>-non-2-ulopyranosonic acid","metabolite_id":"SQVRNKJHWKZAKO-LUWBGTNYSA-N","pvalue":6.188372936946965e-06,"ratio":3.5546369253446928,"synonym_name":"Aceneuramic acid"},{"chebi_id":"15354","direction":"down","inn_name":"","iupac_name":"2-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","pvalue":1.7304303731053033e-05,"ratio":0.2607511108282222,"synonym_name":"Choline"},{"chebi_id":"46755","direction":"down","inn_name":"","iupac_name":"2-[4-(2-hydroxyethyl)piperazin-4-ium-1-yl]ethanesulfonate","metabolite_id":"JKMHFZQWWAIEOD-UHFFFAOYSA-N","pvalue":1.607305963282829e-05,"ratio":0.3462402182857026,"synonym_name":""},{"chebi_id":"18183","direction":"down","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":5.453826410287965e-05,"ratio":0.3733779455040947,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"17821","direction":"up","inn_name":"","iupac_name":"thymine","metabolite_id":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","pvalue":3.598571330975281e-06,"ratio":1.968129841507021,"synonym_name":"5-Methyluracil"}],"totalFeatures":251},{"comparisonGroups":["Normal_control_no_tumor","FH_deficient_RCC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs FH-deficient renal cell carcinoma","group_a_title":"Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.","group_b_title":"Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.","id":"MTBLS3628_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS3628","studyUrl":"http://integmet.org/study/MTBLS3628","title":"Normal_control_no_tumor_vs_FH_deficient_RCC","topHits":[{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":3.127725787746892e-05,"ratio":0.3037775800125216,"synonym_name":"Acetylformic acid"},{"chebi_id":"27082","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HDTRYLNUVZCQOY-MFAKQEFJSA-N","pvalue":0.0024156443085115,"ratio":5.8428601091190515,"synonym_name":""},{"chebi_id":"36274","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"GHCZAUBVMUEKKP-GYPHWSFCSA-N","pvalue":0.0046014606772044,"ratio":4.978884221156608,"synonym_name":"glycine chenodeoxycholate"},{"chebi_id":"28832","direction":"down","inn_name":"","iupac_name":"(3\u03b1,5\u03b1)-17-oxoandrostan-3-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"VFUIRAVTUVCQTF-BSOWLZGZSA-N","pvalue":2.268686040047183e-05,"ratio":0.4656472013112291,"synonym_name":"3\u03b1-hydroxy-5\u03b1-androstan-17-one glucuronide"},{"chebi_id":"73959","direction":"up","inn_name":"","iupac_name":"1-methyl-1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"KIQMCGMHGVXDFW-UHFFFAOYSA-N","pvalue":4.558104641862098e-05,"ratio":2.1938540065332437,"synonym_name":"1-methyl-hypoxanthine"},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0008575100989656,"ratio":0.4498652573568292,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"16040","direction":"up","inn_name":"","iupac_name":"4-aminopyrimidin-2(1<em>H</em>)-one","metabolite_id":"OPTASPLRGRRNAP-UHFFFAOYSA-N","pvalue":0.0029463263686017,"ratio":2.2294380869645436,"synonym_name":"Zytosin"},{"chebi_id":"70989","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetylcytidine","metabolite_id":"NIDVTARKFBZMOT-PEBGCTIMSA-N","pvalue":0.0045278786582886,"ratio":2.3058246527302977,"synonym_name":"4-acetyl-1-(\u03b2-<small>D</small>-ribofuranosyl)cytosine"},{"chebi_id":"170123","direction":"down","inn_name":"","iupac_name":"(1-hydroxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate","metabolite_id":"ZOOLJLSXNRZLDH-KTKRTIGZSA-N","pvalue":0.0002886638643976,"ratio":0.5969791948771319,"synonym_name":""},{"chebi_id":"192720","direction":"up","inn_name":"","iupac_name":"(2S)-2-(propanoylamino)propanoic acid","metabolite_id":"INPGLFHHFHOGRM-BYPYZUCNSA-N","pvalue":0.0048445613430496,"ratio":2.1158560277988117,"synonym_name":""}],"totalFeatures":85},{"comparisonGroups":["Normal_control_no_tumor","FH_deficient_RCC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs FH-deficient renal cell carcinoma","group_a_title":"Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.","group_b_title":"Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.","id":"MTBLS3628_0003_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS3628","studyUrl":"http://integmet.org/study/MTBLS3628","title":"Normal_control_no_tumor_vs_FH_deficient_RCC","topHits":[{"chebi_id":"88488","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-({[(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid","metabolite_id":"ZTNFQEXYTMNFHG-SOFXVBFTSA-N","pvalue":4.622536328133627e-05,"ratio":4.914368606334175,"synonym_name":"Phosphatidylserine(36:4)"},{"chebi_id":"90041","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IULWELDCBXQXED-DWOSIAKHSA-N","pvalue":5.0640132963234433e-05,"ratio":3.1294506209675226,"synonym_name":"1-Stearoyl-2-eicsoic acid"},{"chebi_id":"75096","direction":"up","inn_name":"","iupac_name":"<em>O</em>-(hydroxy{(2<i>R</i>)-2-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propoxy}phosphoryl)-<small>L</small>-serine","metabolite_id":"MWONMGIZXLAUBR-QUBHBNJHSA-N","pvalue":0.0003497506348657,"ratio":3.2219440598979925,"synonym_name":"18:1-18:2-PS"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SSRRIJSEUKHYFB-DFCPKGTFSA-N","pvalue":0.0309734013607552,"ratio":7.344454412630889,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SKGJYUSTRBEFGF-IPXPVBFCSA-N","pvalue":0.0105869648522012,"ratio":4.078612342836987,"synonym_name":""},{"chebi_id":"133599","direction":"up","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-{[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyl]oxy}-3-(octadecanoyloxy)propyl phosphate","metabolite_id":"YDTWOEYVDRKKCR-KNERPIHHSA-N","pvalue":0.011811375789835,"ratio":3.8758048082972505,"synonym_name":"1-octadecanoyl-2-[(9<i>Z</i>,12<i>Z</i>)-octadecadienoyl]-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"171215","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate","metabolite_id":"GMJZFMGAYZSOKQ-YBHUKKJQSA-N","pvalue":0.005396015887743,"ratio":0.3419182968048632,"synonym_name":""},{"chebi_id":"84513","direction":"up","inn_name":"","iupac_name":"<em>O</em>-{hydroxy[(2<i>R</i>)-2-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]-3-(octadecanoyloxy)propoxy]phosphoryl}-<small>L</small>-serine","metabolite_id":"AGTPCXBHIGMTEU-NREGDSCDSA-N","pvalue":0.0227676969469845,"ratio":3.300433477417301,"synonym_name":"Phosphatidylserine(18:0/18:2w6)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RPLIGUADJKNWQR-MBYQFZCISA-N","pvalue":0.0053704293814154,"ratio":0.4513749342252429,"synonym_name":""},{"chebi_id":"74484","direction":"up","inn_name":"","iupac_name":"(21<i>R</i>)-27-amino-24-hydroxy-24-oxido-18-oxo-19,23,25-trioxa-24\u03bb<small><sup>5</small></sup>-phosphaheptacosan-21-yl (7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoate","metabolite_id":"HNFSZKRUPTYBOQ-ZDYOIFAYSA-N","pvalue":0.0153029896058016,"ratio":2.5001274799750304,"synonym_name":"PE(40:4)"}],"totalFeatures":70},{"comparisonGroups":["Normal_control_no_tumor","FH_deficient_RCC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs FH-deficient renal cell carcinoma","group_a_title":"Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.","group_b_title":"Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.","id":"MTBLS3628_0004_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":57,"studyId":"MTBLS3628","studyUrl":"http://integmet.org/study/MTBLS3628","title":"Normal_control_no_tumor_vs_FH_deficient_RCC","topHits":[{"chebi_id":"170382","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"DPPYJZPUMHOJFQ-IASQADCASA-N","pvalue":1.2244750666370197e-06,"ratio":3.477300518728701,"synonym_name":""},{"chebi_id":"73851","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(9<i>Z</i>)-hexadec-9-enoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LFUDDCMNKWEORN-ZXEGGCGDSA-N","pvalue":7.696607031736092e-07,"ratio":0.3110422091950033,"synonym_name":"GPC(16:1)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XOLZNHXNFMEUGA-MCPSVCLNSA-N","pvalue":1.6627359915135783e-05,"ratio":0.2330595323482071,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BHOBAXXVADYYDE-WJOKGBTCSA-N","pvalue":1.836348772290052e-05,"ratio":0.2504380190594232,"synonym_name":""},{"chebi_id":"170442","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-docos-13-enoate","metabolite_id":"RETPVUGMYRRYPF-SGFDTVKUSA-N","pvalue":0.0001735861859182,"ratio":4.539415849143415,"synonym_name":""},{"chebi_id":"172815","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"VZPPRGZNTVUBLP-UKNPSHDRSA-N","pvalue":0.0010512405294615,"ratio":6.231006104301119,"synonym_name":""},{"chebi_id":"176402","direction":"down","inn_name":"","iupac_name":"[(2R)-2-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"VRVDEVSSPPTZQJ-JKCKFMQZSA-N","pvalue":4.490720025601378e-06,"ratio":0.3617931205883247,"synonym_name":""},{"chebi_id":"167588","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UJMUDAMKHIWLCZ-OTHSKKDYSA-N","pvalue":0.0004053200676847,"ratio":4.175968920221611,"synonym_name":"PC 15:0/20:5(5Z,8Z,11Z,14Z,17Z)"},{"chebi_id":"64489","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VXUOFDJKYGDUJI-OAQYLSRUSA-N","pvalue":0.0002201127963641,"ratio":0.2711323621136706,"synonym_name":"1-myristoyl-glycero-3-phosphocholine"},{"chebi_id":"172752","direction":"down","inn_name":"","iupac_name":"[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (6Z,9Z,12Z)-octadeca-6,9,12-trienoate","metabolite_id":"YTQRLPWDUKCRNO-MULSWCQISA-N","pvalue":0.0009758653692686,"ratio":0.2610014187272222,"synonym_name":""}],"totalFeatures":254},{"comparisonGroups":["Normal_control_no_tumor","FH_deficient_RCC"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs FH-deficient renal cell carcinoma","group_a_title":"Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.","group_b_title":"Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.","id":"MTBLS3628_0005_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS3628","studyUrl":"http://integmet.org/study/MTBLS3628","title":"Normal_control_no_tumor_vs_FH_deficient_RCC","topHits":[{"chebi_id":"157780","direction":"up","inn_name":"","iupac_name":"2-(2-amino-2-carboxyethyl)sulanylbutanedioic acid","metabolite_id":"XPKKFTKCRVIDAG-UHFFFAOYSA-N","pvalue":2.8174538915692017e-06,"ratio":39.146200892941934,"synonym_name":""},{"chebi_id":"71169","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-({9-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-9<em>H</em>-purin-6-yl}amino)butanedioic acid","metabolite_id":"VKGZCEJTCKHMRL-VWJPMABRSA-N","pvalue":0.000249236329671,"ratio":17.738188072825867,"synonym_name":"<em>N</em>-(9-\u03b2-<small>D</small>-ribofuranosyl-9<em>H</em>-purin-6-yl)-<small>L</small>-aspartic acid"}],"totalFeatures":2},{"comparisonGroups":["Control_Hindgut","Lactobacillus apis_Hindgut"],"dateCreated":"2025-09-26 00:00:00","display_title":"Bombus terrestris hindgut: L. apis treatment vs control","group_a_title":"Control samples from the hindgut of Bombus terrestris.. Provides baseline data for comparison with Lactobacillus apis treated hindgut samples.","group_b_title":"Samples from the hindgut of Bombus terrestris treated with Lactobacillus apis.. Key group for assessing the impact of Lactobacillus apis on hindgut microbiome and memory.","id":"MTBLS3637_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":46,"studyId":"MTBLS3637","studyUrl":"http://integmet.org/study/MTBLS3637","title":"Hindgut_Control_vs_Lactobacillus_apis","topHits":[{"chebi_id":"16508","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>,4<i>Z</i>)-hexa-2,4-dienedioic acid","metabolite_id":"TXXHDPDFNKHHGW-CCAGOZQPSA-N","pvalue":0.0001508106242209,"ratio":4.488501011589972,"synonym_name":"(2Z,4Z)-HEXA-2,4-DIENEDIOIC ACID"},{"chebi_id":"16264","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":7.0672902796738055e-06,"ratio":0.3892616374412065,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"181508","direction":"down","inn_name":"","iupac_name":"9-[3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-1H-purin-6-one","metabolite_id":"ABXDBVMGRKZFRC-UHFFFAOYSA-N","pvalue":0.0002472780893945,"ratio":0.2700349120014118,"synonym_name":""},{"chebi_id":"17050","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":0.000152183751038,"ratio":3.3081516827823196,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"25013","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DWPCPZJAHOETAG-UHFFFAOYSA-N","pvalue":2.4107942637346786e-06,"ratio":0.4699562215910365,"synonym_name":""},{"chebi_id":"174902","direction":"down","inn_name":"","iupac_name":"(4aS,7R,7aR,12bS)-9-methoxy-2,3,4,5,6,7,7a,13-octahydro-1H-4,12-methanobenzouro[3,2-e]isoquinoline-4a,7-diol","metabolite_id":"KFWOOLJUSYSBAD-SGPGVZRMSA-N","pvalue":0.0003844302260702,"ratio":0.50527530694267,"synonym_name":""},{"chebi_id":"507393","direction":"down","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":0.0001892990605067,"ratio":0.5541444399160897,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"67119","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-galactopyranosyl) dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-ABVWGUQPSA-N","pvalue":0.0007362184424814,"ratio":0.5067588529264668,"synonym_name":"Uridinediphosphogalactose"},{"chebi_id":"1904","direction":"down","inn_name":"","iupac_name":"4-methyl-2-oxo-2<em>H</em>-1-benzopyran-7-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"ARQXEQLMMNGFDU-JHZZJYKESA-N","pvalue":0.0202977781401878,"ratio":0.3226325894433298,"synonym_name":"4-Methylumbelliferyl glucuronide"},{"chebi_id":"30778","direction":"down","inn_name":"","iupac_name":"3,4,5-trihydroxybenzoic acid","metabolite_id":"LNTHITQWFMADLM-UHFFFAOYSA-N","pvalue":0.0264065471093959,"ratio":0.3058212813229651,"synonym_name":"3,4,5-trihydroxybenzoic acid"}],"totalFeatures":416},{"comparisonGroups":["Control_Hindgut","Lactobacillus apis_Hindgut"],"dateCreated":"2025-09-26 00:00:00","display_title":"Bombus terrestris hindgut: L. apis vs control","group_a_title":"Control samples from the hindgut of Bombus terrestris.. Provides baseline data for comparison with Lactobacillus apis treated hindgut samples.","group_b_title":"Samples from the hindgut of Bombus terrestris treated with Lactobacillus apis.. Key group for assessing the impact of Lactobacillus apis on hindgut microbiome and memory.","id":"MTBLS3637_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":39,"studyId":"MTBLS3637","studyUrl":"http://integmet.org/study/MTBLS3637","title":"Hindgut_Control_vs_Lactobacillus_apis","topHits":[{"chebi_id":"17306","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":6.523448254212215e-06,"ratio":5.380025772564534,"synonym_name":"Malzzucker"},{"chebi_id":"183333","direction":"up","inn_name":"","iupac_name":"methyl 4-methyl-6-oxopyran-2-carboxylate","metabolite_id":"SPRJFRZJUCOGBC-UHFFFAOYSA-N","pvalue":3.342710569473221e-05,"ratio":3.1849664882626065,"synonym_name":""},{"chebi_id":"28460","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucose","metabolite_id":"UYQJCPNSAVWAFU-KVXMBEGHSA-N","pvalue":0.0007707566815123,"ratio":5.031305179414008,"synonym_name":"Maltotetraose"},{"chebi_id":"19229","direction":"down","inn_name":"","iupac_name":"2'-<em>O</em>-methylguanosine","metabolite_id":"OVYNGSFVYRPRCG-KQYNXXCUSA-N","pvalue":0.000759253865944,"ratio":0.2113789226017724,"synonym_name":"Gm19"},{"chebi_id":"183504","direction":"up","inn_name":"","iupac_name":"5,6-dimethyl-4-oxopyran-2-carboxylic acid","metabolite_id":"FDBZURJIEXDCCQ-UHFFFAOYSA-N","pvalue":0.0001117995051556,"ratio":2.9684284421024474,"synonym_name":""},{"chebi_id":"183427","direction":"up","inn_name":"","iupac_name":"3-pyridin-3-ylpropanoic acid","metabolite_id":"WDGXIUUWINKTGP-UHFFFAOYSA-N","pvalue":0.0004235532051888,"ratio":2.7904325718606744,"synonym_name":""},{"chebi_id":"44510","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxy-4-methylpentanoic acid","metabolite_id":"LVRFTAZAXQPQHI-YFKPBYRVSA-N","pvalue":0.0001721570623258,"ratio":2.4626349434599533,"synonym_name":"2-HYDROXY-4-METHYL-PENTANOIC ACID"},{"chebi_id":"183412","direction":"down","inn_name":"","iupac_name":"6-cyclohex-3-en-1-yl-5-nitropiperidin-2-one","metabolite_id":"CGLPKGVDOFMFCQ-UHFFFAOYSA-N","pvalue":1.9331936099684786e-05,"ratio":0.5157141728100896,"synonym_name":""},{"chebi_id":"83481","direction":"up","inn_name":"","iupac_name":"phenyl(piperidin-2-yl)acetic acid","metabolite_id":"INGSNVSERUZOAK-UHFFFAOYSA-N","pvalue":0.0019267710207547,"ratio":2.7644554462599933,"synonym_name":"\u03b1-phenyl-2-piperidineacetic acid"},{"chebi_id":"64349","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-methyllysine","metabolite_id":"PQNASZJZHFPQLE-UHFFFAOYSA-N","pvalue":0.0001088360492518,"ratio":0.5514960315716095,"synonym_name":"<em>N</em>-methyllysine"}],"totalFeatures":592},{"comparisonGroups":["Embryo_S1","Embryo_S4"],"dateCreated":"2025-09-26 00:00:00","display_title":"Embryo: early vs late fruit ripening stages","group_a_title":"Embryo samples at fruit ripening stage S1. Represents the embryo at the initial stage of fruit ripening.","group_b_title":"Embryo samples at fruit ripening stage S4. Represents the embryo at the final stage of fruit ripening.","id":"MTBLS3657_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":194,"studyId":"MTBLS3657","studyUrl":"http://integmet.org/study/MTBLS3657","title":"Embryo_S1_vs_Embryo_S4","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FLDFNEBHEXLZRX-UHFFFAOYSA-N","pvalue":9.912689540186371e-09,"ratio":540.0593471810089,"synonym_name":""},{"chebi_id":"86655","direction":"down","inn_name":"","iupac_name":"(3,4-dimethoxyphenyl)acetic acid","metabolite_id":"WUAXWQRULBZETB-UHFFFAOYSA-N","pvalue":1.068170841534959e-06,"ratio":0.0004981549815498,"synonym_name":"2-(3,4-dimethoxyphenyl)acetic acid"},{"chebi_id":"17659","direction":"down","inn_name":"","iupac_name":"uridine 5'-(trihydrogen diphosphate)","metabolite_id":"XCCTYIAWTASOJW-XVFCMESISA-N","pvalue":9.687707033599088e-05,"ratio":2.134387351778656e-05,"synonym_name":"Uridine 5'-diphosphate"},{"chebi_id":"18321","direction":"up","inn_name":"","iupac_name":"1<small>D</small>-<i>myo</i>-inositol 1-[(2<i>R</i>)-2,3-dihydroxypropyl hydrogen phosphate]","metabolite_id":"BMVUIWJCUQSHLZ-UJGXJMNGSA-N","pvalue":0.0012668375924289,"ratio":487777.77777777775,"synonym_name":"GroPIns"},{"chebi_id":"17645","direction":"down","inn_name":"","iupac_name":"4-acetamidobutanoic acid","metabolite_id":"UZTFMUBKZQVKLK-UHFFFAOYSA-N","pvalue":0.0006881390061293,"ratio":6.78391959798995e-06,"synonym_name":"4-Acetamidobutyric acid"},{"chebi_id":"18026","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxybenzoic acid","metabolite_id":"GLDQAMYCGOIJDV-UHFFFAOYSA-N","pvalue":0.0001509218580064,"ratio":5.708245243128965e-05,"synonym_name":"2,3-Dihydroxybenzoic acid"},{"chebi_id":"16802","direction":"down","inn_name":"","iupac_name":"<small>D</small>-<i>altro</i>-hept-2-ulose","metabolite_id":"HSNZZMHEPUFJNZ-SHUUEZRQSA-N","pvalue":0.0012681190970353,"ratio":2.732793522267206e-06,"synonym_name":"altro-Heptulose"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DEDGUGJNLNLJSR-VURMDHGXSA-N","pvalue":0.0004836313908121,"ratio":6.192660550458715e-05,"synonym_name":""},{"chebi_id":"86612","direction":"down","inn_name":"","iupac_name":"3-(4-hydroxy-3-methoxyphenyl)propanoic acid","metabolite_id":"BOLQJTPHPSDZHR-UHFFFAOYSA-N","pvalue":0.0006815306681963,"ratio":8.272058823529411e-05,"synonym_name":"dihydroconiferylic acid"},{"chebi_id":"16108","direction":"down","inn_name":"","iupac_name":"3-hydroxy-2-oxopropyl dihydrogen phosphate","metabolite_id":"GNGACRATGGDKBX-UHFFFAOYSA-N","pvalue":0.0046181756875393,"ratio":7.401315789473684e-06,"synonym_name":"2-Propanone, 1-hydroxy-3-(phosphonooxy)-"}],"totalFeatures":374},{"comparisonGroups":["Control","Basal cold"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs basal cold stress treatment","group_a_title":"Baseline control group without any stress treatment.. Provides a reference point for evaluating the effects of stress treatments.","group_b_title":"Group exposed to basal cold stress.. Helps in understanding the metabolic response to cold stress.","id":"MTBLS3672_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS3672","studyUrl":"http://integmet.org/study/MTBLS3672","title":"Control_vs_Basal_cold","topHits":[{"chebi_id":"17306","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":0.0027909897153861,"ratio":0.0279234972677595,"synonym_name":"Malzzucker"},{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":0.0032603944479618,"ratio":0.3838383838383838,"synonym_name":"Acetylformic acid"},{"chebi_id":"16199","direction":"up","inn_name":"carbamide","iupac_name":"urea","metabolite_id":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","pvalue":0.0399951255859063,"ratio":2.888888888888889,"synonym_name":"H<small><sub>2</sub></small>NC(O)NH<small><sub>2</sub></small>"},{"chebi_id":"64554","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-UHFFFAOYSA-N","pvalue":0.0105855982595228,"ratio":0.5058823529411766,"synonym_name":"2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"}],"totalFeatures":27},{"comparisonGroups":["wild_type","irHQT"],"dateCreated":"2025-09-26 00:00:00","display_title":"Manduca sexta: irHQT vs wild-type","group_a_title":"Wild type group representing the natural state of Manduca sexta.. Serves as the reference group for evaluating the effects of genetic modifications.","group_b_title":"Group with irHQT genetic modification.. Allows for the assessment of the impact of HQT suppression on metabolism.","id":"MTBLS3676_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS3676","studyUrl":"http://integmet.org/study/MTBLS3676","title":"wild_type_vs_irHQT","topHits":[],"totalFeatures":6},{"comparisonGroups":["CC406_t2","Stm6Glc4_t2"],"dateCreated":"2025-09-26 00:00:00","display_title":"CC406 wild-type vs Stm6Glc4 mutant during H2 production","group_a_title":"Wild type strain CC406 at time point t2. Provides data on the wild type strain during H_2 production.","group_b_title":"Mutant strain Stm6Glc4 at time point t2. Shows the metabolic state of the mutant strain during H_2 production.","id":"MTBLS37_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS37","studyUrl":"http://integmet.org/study/MTBLS37","title":"CC406_t2_vs_Stm6Glc4_t2","topHits":[{"chebi_id":"15725","direction":"up","inn_name":"","iupac_name":"propane-1,3-diamine","metabolite_id":"XFNJVJPLKCPIBV-UHFFFAOYSA-N","pvalue":1.2353780330059124e-05,"ratio":1000000.0,"synonym_name":"tn"},{"chebi_id":"73918","direction":"up","inn_name":"","iupac_name":"3-<em>O</em>-methyl-<small>D</small>-glucose","metabolite_id":"RMTFNDVZYPHUEF-XZBKPIIZSA-N","pvalue":4.3604024704677714e-05,"ratio":1000000.0,"synonym_name":"3-<em>O</em>-methylglucose"},{"chebi_id":"46905","direction":"up","inn_name":"","iupac_name":"3-[(2<i>R</i>)-2,4-dihydroxy-3,3-dimethylbutanamido]propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-ZETCQYMHSA-N","pvalue":0.0008362235706553,"ratio":1000000.0,"synonym_name":"Pantothenic acid"},{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0010551718870774,"ratio":1000000.0,"synonym_name":"colamine phosphate"},{"chebi_id":"28661","direction":"up","inn_name":"","iupac_name":"(6<i>Z</i>,9<i>Z</i>,12<i>Z</i>)-octadeca-6,9,12-trienoic acid","metabolite_id":"VZCCETWTMQHEPK-QNEBEIHSSA-N","pvalue":0.0185790214730199,"ratio":4.839859708865741,"synonym_name":"(6Z,9Z,12Z)-Octadecatrienoic acid"},{"chebi_id":"30754","direction":"up","inn_name":"","iupac_name":"2-aminobenzoic acid","metabolite_id":"RWZYAGGXGHYGMB-UHFFFAOYSA-N","pvalue":0.0449555272003354,"ratio":6.877796901893288,"synonym_name":"o-Aminobenzoic acid"}],"totalFeatures":37},{"comparisonGroups":["Control","Exercise"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs exercise treatment comparison","group_a_title":"Control group with no exercise treatment. Provides a reference point for evaluating the effects of exercise treatment.","group_b_title":"Exercise treatment group. Allows assessment of the impact of exercise on the measured parameters.","id":"MTBLS3725_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":43,"studyId":"MTBLS3725","studyUrl":"http://integmet.org/study/MTBLS3725","title":"Control_vs_Exercise","topHits":[{"chebi_id":"184226","direction":"down","inn_name":"","iupac_name":"(2S)-6-(hydroxymethyl)-2-methyl-2,3-dihydropyran-4-one","metabolite_id":"FXGUGSUNHREWBM-YFKPBYRVSA-N","pvalue":0.0044809165364516,"ratio":0.0183954902906844,"synonym_name":""},{"chebi_id":"184150","direction":"up","inn_name":"","iupac_name":"[3-(2-hydroxyphenyl)oxiran-2-yl]methyl hydrogen sulate","metabolite_id":"KWCRYNJDRFCELS-UHFFFAOYSA-N","pvalue":1.529465928283548e-05,"ratio":5.347133648640139,"synonym_name":""},{"chebi_id":"1427","direction":"up","inn_name":"","iupac_name":"3-(3-hydroxyphenyl)propanoic acid","metabolite_id":"QVWAEZJXDYOKEH-UHFFFAOYSA-N","pvalue":0.00051800636786,"ratio":7.927956110067614,"synonym_name":"3-(3-hydroxyphenyl)propionic acid"},{"chebi_id":"88744","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IAHCDPVIVIKDFJ-DIACKHNESA-N","pvalue":0.0043451470323237,"ratio":0.1333528088471597,"synonym_name":"(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-[(5-hydroxy-1H-indol-6-yl)oxy]oxane-2-carboxylic acid"},{"chebi_id":"184125","direction":"down","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-3-hexadecanoyloxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"XIVOBOJQPNEUSC-UXHICEINSA-N","pvalue":6.274326805535968e-05,"ratio":0.364740478444457,"synonym_name":""},{"chebi_id":"82932","direction":"down","inn_name":"","iupac_name":"4-ethylphenyl hydrogen sulfate","metabolite_id":"DWZGLEPNCRFCEP-UHFFFAOYSA-N","pvalue":0.0012922465074755,"ratio":0.2352984309661538,"synonym_name":""},{"chebi_id":"184192","direction":"up","inn_name":"","iupac_name":"(5-hydroxy-2-methylchromen-2-yl)methyl hydrogen sulate","metabolite_id":"UYXDMSXIMGQHKE-UHFFFAOYSA-N","pvalue":0.0037095457753586,"ratio":4.5189602012340195,"synonym_name":""},{"chebi_id":"64414","direction":"up","inn_name":"","iupac_name":"3-[3-(sulfooxy)phenyl]propanoic acid","metabolite_id":"IQWLPDPKVFZEOK-UHFFFAOYSA-N","pvalue":0.0018455144814084,"ratio":3.184368778237584,"synonym_name":"3-(3-hydroxyphenyl)propanoic acid sulfate"},{"chebi_id":"167579","direction":"down","inn_name":"","iupac_name":"(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(2-phenylethoxy)oxane-2-carboxylic acid","metabolite_id":"HIXLLXLCNONZRH-BYNIDDHOSA-N","pvalue":0.0140853251123304,"ratio":0.1814578101970295,"synonym_name":""},{"chebi_id":"17202","direction":"down","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":0.0389561793654447,"ratio":0.1221402929173733,"synonym_name":"Inosine 5'-phosphate"}],"totalFeatures":378},{"comparisonGroups":["Control","Exercise"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs exercise treatment effects","group_a_title":"Control group with no exercise treatment. Provides a reference point for evaluating the effects of exercise treatment.","group_b_title":"Exercise treatment group. Allows assessment of the impact of exercise on the measured parameters.","id":"MTBLS3725_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":71,"studyId":"MTBLS3725","studyUrl":"http://integmet.org/study/MTBLS3725","title":"Control_vs_Exercise","topHits":[{"chebi_id":"9410","direction":"down","inn_name":"","iupac_name":"2-[(3\u03b1,12\u03b1-dihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"AWDRATDZQPNJFN-VAYUFCLWSA-N","pvalue":0.0336903407116979,"ratio":1.5197131497024417e-08,"synonym_name":"Taurodeoxycholate"},{"chebi_id":"68616","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>E</i>)-3-phenylprop-2-enoyl]glycine","metabolite_id":"YAADMLWHGMUGQL-VOTSOKGWSA-N","pvalue":0.0022466282821513,"ratio":0.0225041820504096,"synonym_name":"<em>N</em>-Cinnamylglycine"},{"chebi_id":"168170","direction":"down","inn_name":"","iupac_name":"7-hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-1,4-benzoxazin-3-one","metabolite_id":"VUFDXOACUHDTLI-UHFFFAOYSA-N","pvalue":0.0093918719509369,"ratio":0.017371067518345,"synonym_name":""},{"chebi_id":"18089","direction":"down","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":0.0043728311941295,"ratio":0.062991168374628,"synonym_name":"Benzamidoessigs\u00e4ure"},{"chebi_id":"75728","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-1-hydroxy-3-(octadecanoyloxy)propan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoate","metabolite_id":"NSXLMTYRMFVYNT-IUJDHQGTSA-N","pvalue":0.0002337650350374,"ratio":0.1743446992966875,"synonym_name":"DG(18:0/20:4(\u03c9-6)/0:0)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KRTOMQDUKGRFDJ-LWFBQQSYSA-N","pvalue":0.0003406620920245,"ratio":0.1813306083518975,"synonym_name":""},{"chebi_id":"29571","direction":"down","inn_name":"","iupac_name":"abieta-8,11,13-trien-18-oic acid","metabolite_id":"NFWKVWVWBFBAOV-MISYRCLQSA-N","pvalue":0.0035773788386395,"ratio":0.0931826935378226,"synonym_name":"1,2,3,4,4a,9,10,10a-Octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic acid"},{"chebi_id":"47780","direction":"up","inn_name":"","iupac_name":"3-(3-chloro-10,11-dihydro-5<em>H</em>-dibenzo[<em>b</em>,<em>f</em>]azepin-5-yl)-<em>N</em>,<em>N</em>-dimethylpropan-1-amine","metabolite_id":"GDLIGKIOYRNHDA-UHFFFAOYSA-N","pvalue":0.0004132578228117,"ratio":4.976733260780999,"synonym_name":"chlorimipramine"},{"chebi_id":"184172","direction":"down","inn_name":"","iupac_name":"(5Z,8Z,14Z)-icosa-5,8,14-trien-11-ynoic acid","metabolite_id":"VGCBBIXUNNBXPC-IJJPYCETSA-N","pvalue":6.112155406701643e-08,"ratio":0.5250887412778387,"synonym_name":""},{"chebi_id":"184143","direction":"down","inn_name":"","iupac_name":"(10E)-heptadeca-10,16-dien-8-ynoic acid","metabolite_id":"YABWMILQFXOECJ-BQYQJAHWSA-N","pvalue":3.689014848651643e-06,"ratio":0.4551915556328302,"synonym_name":""}],"totalFeatures":686},{"comparisonGroups":["WT_no_treatment","opr3_8h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis: wild-type vs opr3 mutant (8h treatment)","group_a_title":"Wild type Arabidopsis thaliana with no treatment.. Serves as the reference point for all subsequent comparisons with opr3 mutants.","group_b_title":"opr3 mutant Arabidopsis thaliana at 8 hours after treatment.. Captures metabolic changes in opr3 mutants at a later time point after treatment.","id":"MTBLS375_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":61,"studyId":"MTBLS375","studyUrl":"http://integmet.org/study/MTBLS375","title":"WT_no_treatment_vs_opr3_8h","topHits":[{"chebi_id":"89935","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YVOCTABTPCVYNG-UHFFFAOYSA-N","pvalue":3.920147339968169e-23,"ratio":0.0062019536504904,"synonym_name":"3,4-dimethylidenedecanedioic acid"},{"chebi_id":"138773","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ABFHVQPVDSMGNR-UHFFFAOYSA-N","pvalue":1.0114646739818016e-21,"ratio":0.011022285788089,"synonym_name":"methyl 3-(2,3-dihydroxy-3-methylbutyl)-4-hydroxybenzoate"},{"chebi_id":"18292","direction":"down","inn_name":"","iupac_name":"{(1<i>R</i>,2<i>R</i>)-3-oxo-2-[(2<i>Z</i>)-pent-2-en-1-yl]cyclopentyl}acetic acid","metabolite_id":"ZNJFBWYDHIGLCU-HWKXXFMVSA-N","pvalue":1.4012650022837317e-21,"ratio":0.0135298077874107,"synonym_name":"2-{(1<i>R</i>,2<i>R</i>)-3-oxo-2-[(<i>Z</i>)-pent-2-enyl]cyclopentyl}acetate"},{"chebi_id":"79318","direction":"down","inn_name":"","iupac_name":"1-<em>S</em>-[(1<i>Z</i>)-<em>N</em>-(sulfooxy)hex-5-enimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"XMJFVIGTHMOGNZ-AHMUMSBHSA-N","pvalue":4.814066665530593e-18,"ratio":0.0265727793063227,"synonym_name":"4-Pentenyl glucosinolate"},{"chebi_id":"80545","direction":"down","inn_name":"","iupac_name":"1-<em>S</em>-[<em>N</em>-hydroxy-2-(1<em>H</em>-indol-3-yl)ethanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"CWNIQCOMWQROPA-JZYAIQKZSA-N","pvalue":2.3121786255165213e-16,"ratio":0.0215400044824313,"synonym_name":"indol-3-yl-methyl desulfoGS"},{"chebi_id":"74704","direction":"down","inn_name":"","iupac_name":"<small>L</small>-methionyl-<small>L</small>-isoleucine","metabolite_id":"OGGRSJFVXREKOR-CIUDSAMLSA-N","pvalue":7.261946485531848e-18,"ratio":0.1163075615533123,"synonym_name":"Methionyl-Isoleucine"},{"chebi_id":"80989","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CWOJBEDMJKZKAB-JZYAIQKZSA-N","pvalue":4.459581135253026e-09,"ratio":0.0121587766675441,"synonym_name":""},{"chebi_id":"70354","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HRAXJWRHSUTMCS-UHFFFAOYSA-N","pvalue":4.166459495036302e-18,"ratio":0.1236319745243028,"synonym_name":"1,2,3,4-tetramethoxy-5-prop-2-enylbenzene"},{"chebi_id":"88473","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KBHWKXNXTURZCD-UHFFFAOYSA-N","pvalue":2.238439965615565e-20,"ratio":0.1606553015709332,"synonym_name":"p-Propyl-Anisole"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QJAPFSSVKIZTMR-UHFFFAOYSA-N","pvalue":1.5536697553281518e-15,"ratio":0.1144989917696325,"synonym_name":""}],"totalFeatures":109},{"comparisonGroups":["PBS","DSS"],"dateCreated":"2025-09-26 00:00:00","display_title":"PBS control vs DSS-induced intestinal infection","group_a_title":"Vehicle control group treated with PBS.. Provides baseline for evaluating the effects of other treatments.","group_b_title":"Group treated with DSS to induce intestinal infection.. Models the disease state for comparison with treatment effects.","id":"MTBLS3750_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2064,"studyId":"MTBLS3750","studyUrl":"http://integmet.org/study/MTBLS3750","title":"G1_PBS_vs_G2_DSS","topHits":[{"chebi_id":"169242","direction":"up","inn_name":"","iupac_name":"(E)-hept-3-en-2-one","metabolite_id":"JHHZQADGLDKIPM-AATRIKPKSA-N","pvalue":8.372854130356232e-11,"ratio":3793360735.134004,"synonym_name":""},{"chebi_id":"186493","direction":"up","inn_name":"","iupac_name":"methyl (E,7S)-7-acetyloxy-7-[(1R,2S)-4-chloro-2-hydroxy-2-[(Z)-oct-2-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoate","metabolite_id":"LAWSLZINBLIPFW-NRPCDHBGSA-N","pvalue":9.000851406842492e-07,"ratio":8053978648.659967,"synonym_name":""},{"chebi_id":"38561","direction":"up","inn_name":"fluvastatin","iupac_name":"<em>rac</em>-(3<i>R</i>,5<i>S</i>,6<i>E</i>)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1<em>H</em>-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid","metabolite_id":"FJLGEFLZQAZZCD-JUFISIKESA-N","pvalue":1.2303478023410592e-06,"ratio":11922082188.651588,"synonym_name":"<em>rac</em>-(3<i>R</i>,5<i>S</i>,6<i>E</i>)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1<em>H</em>-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid"},{"chebi_id":"185805","direction":"up","inn_name":"","iupac_name":"1-ethyl-6-luoro-7-(4-methylpiperazin-1-yl)-1-oxido-4-oxoquinolin-1-ium-3-carboxylic acid","metabolite_id":"LJTKAUAKTFMWRP-UHFFFAOYSA-N","pvalue":5.741582189470505e-07,"ratio":2115408454.564489,"synonym_name":""},{"chebi_id":"185700","direction":"up","inn_name":"","iupac_name":"(E,9S)-11-(2-ethyl-3-oxocyclopenten-1-yl)-9-hydroxyundec-10-enoic acid","metabolite_id":"KXMANOZDITZERP-PABFRNLHSA-N","pvalue":1.1012233346313344e-05,"ratio":6645762277.42881,"synonym_name":""},{"chebi_id":"69679","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KSBALECVCJXYHU-IBGZPJMESA-N","pvalue":1.2167041964125689e-05,"ratio":2815764131.4698496,"synonym_name":"(2S)-5,7-Dihydroxy-6-(2-hydroxybenzyl)-2-phenyl-2,3-dihydro-4H-chromen-4-one"},{"chebi_id":"186449","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate","metabolite_id":"LIBLKFXXSFBDCF-RZTQZAHISA-N","pvalue":3.9768920309968176e-05,"ratio":34826398626.46566,"synonym_name":""},{"chebi_id":"186204","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(Z)-hexadec-1-enoxy]propan-2-yl] (Z)-tetradec-9-enoate","metabolite_id":"UERLHGISINMPNT-ADWHDFFQSA-N","pvalue":1.3029422758457754e-05,"ratio":2547698625.2093806,"synonym_name":""},{"chebi_id":"3494","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"NCFTXMQPRQZFMZ-WERGMSTESA-M","pvalue":0.0002090429336483,"ratio":4062888320.896148,"synonym_name":"Cefoperazone sodium"},{"chebi_id":"186431","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate","metabolite_id":"ZXTZNOMUNZDWOM-SVTFAFHISA-N","pvalue":0.000128945151161,"ratio":8.746034080790728e-10,"synonym_name":""}],"totalFeatures":4548},{"comparisonGroups":["PBS","DSS"],"dateCreated":"2025-09-26 00:00:00","display_title":"PBS control vs DSS-induced intestinal infection","group_a_title":"Vehicle control group treated with PBS.. Provides baseline for evaluating the effects of other treatments.","group_b_title":"Group treated with DSS to induce intestinal infection.. Models the disease state for comparison with treatment effects.","id":"MTBLS3750_0002_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1576,"studyId":"MTBLS3750","studyUrl":"http://integmet.org/study/MTBLS3750","title":"G1_PBS_vs_G2_DSS","topHits":[{"chebi_id":"51922","direction":"up","inn_name":"","iupac_name":"(3<i>E</i>,5<i>E</i>)-7-hydroxy-6-methylhepta-3,5-dienal","metabolite_id":"ARBHCEGTLUXZRX-YNRRLODASA-N","pvalue":1.0086886233657944e-10,"ratio":1081898762.835008,"synonym_name":"7-hydroxy-6-methylhepta-3,5-dienal"},{"chebi_id":"183146","direction":"up","inn_name":"","iupac_name":"[(2R)-1-octadecoxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z)-octadeca-6,9,12-trienoate","metabolite_id":"BMAXIMHASVHMKO-NVPSEEHGSA-N","pvalue":3.4879844337921473e-08,"ratio":2785612265.4941373,"synonym_name":""},{"chebi_id":"187578","direction":"down","inn_name":"","iupac_name":"(5Z,8Z,11Z,14Z)-N-butylicosa-5,8,11,14-tetraenamide","metabolite_id":"UFBCBSNKWKPSRJ-SNPVRQPZSA-N","pvalue":6.533144702394313e-10,"ratio":0.0004016602956122,"synonym_name":""},{"chebi_id":"77890","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(5-oxopentanoyl)oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RKIDALSACBQVTN-HHHXNRCGSA-N","pvalue":0.0004167082230374,"ratio":1398815630.360134,"synonym_name":"POVPC"},{"chebi_id":"27969","direction":"down","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-{3-[(3<i>R</i>)-4-({3-[(2-{[(2<i>E</i>)-3-carboxy-2-methylprop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}","metabolite_id":"LVBVWNJPMXCQJE-CBBDEUQJSA-N","pvalue":0.001516671292616,"ratio":6.3315613945414e-11,"synonym_name":"Mesaconyl-C1-CoA"},{"chebi_id":"187470","direction":"up","inn_name":"","iupac_name":"5,14-dihydroxy-3-[4-hydroxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-13-methyl-17-(5-oxo-2H-uran-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde","metabolite_id":"KQBVSIZPUWODNU-UHFFFAOYSA-N","pvalue":0.0007906715965735,"ratio":1742902123.722781,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LMDZBCPBFSXMTL-UHFFFAOYSA-N","pvalue":0.0008946383774728,"ratio":4.950679052945175e-10,"synonym_name":""},{"chebi_id":"73816","direction":"up","inn_name":"","iupac_name":"<small>L</small>-arginyl-<small>L</small>-lysine","metabolite_id":"JQFZHHSQMKZLRU-IUCAKERBSA-N","pvalue":5.312031133654232e-06,"ratio":209230.9637997441,"synonym_name":"arginyllysine"},{"chebi_id":"187302","direction":"down","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-2-[(E)-5,8-dioxooct-6-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"JWSLONXEOIUDBS-RUNYOZRHSA-N","pvalue":0.0015831816598777,"ratio":4.333006137862137e-10,"synonym_name":""},{"chebi_id":"16530","direction":"down","inn_name":"","iupac_name":"3-methyl-2-oxobutanoic acid","metabolite_id":"QHKABHOOEWYVLI-UHFFFAOYSA-N","pvalue":0.0011619538822751,"ratio":1.364100388612415e-09,"synonym_name":"2-Ketovaline"}],"totalFeatures":3411},{"comparisonGroups":["Untreated","Antibiotic Treated"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: untreated vs antibiotic treatment","group_a_title":"Samples from untreated mice. Serves as the reference group for evaluating the effects of antibiotic treatment.","group_b_title":"Samples from mice treated with antibiotics. Allows for the assessment of the impact of antibiotic treatment on the intestinal microbiome and metabolome.","id":"MTBLS376_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":78,"studyId":"MTBLS376","studyUrl":"http://integmet.org/study/MTBLS376","title":"Untreated_vs_Antibiotic_Treated","topHits":[{"chebi_id":"16737","direction":"down","inn_name":"","iupac_name":"2-imino-1-methylimidazolidin-4-one","metabolite_id":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","pvalue":3.1695345047572777e-17,"ratio":0.0451378311527696,"synonym_name":"cr\u00e9atinine"},{"chebi_id":"16927","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":6.232456119885598e-13,"ratio":0.0189409285935476,"synonym_name":"L-Saccharopine"},{"chebi_id":"60175","direction":"down","inn_name":"","iupac_name":"5-hydroxylysine","metabolite_id":"YSMODUONRAFBET-UHFFFAOYSA-N","pvalue":3.1899849994911564e-17,"ratio":0.0779989203064613,"synonym_name":"hydroxylysine"},{"chebi_id":"53014","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-(carboxymethyl)-<small>L</small>-lysine","metabolite_id":"NUXSIDPKKIEIMI-LURJTMIESA-N","pvalue":6.078720282929534e-20,"ratio":0.1411784477451858,"synonym_name":"N(epsilon)-(Carboxymethyl)lysine"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":4.2222079482027263e-16,"ratio":8.645923737420366,"synonym_name":"Purine-6-ol"},{"chebi_id":"16135","direction":"up","inn_name":"","iupac_name":"2-methylpropanoic acid","metabolite_id":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","pvalue":5.987355773105551e-15,"ratio":7.776322565355374,"synonym_name":"2-METHYL-PROPIONIC ACID"},{"chebi_id":"86564","direction":"down","inn_name":"","iupac_name":"4-carbamimidamidobutanoic acid","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-N","pvalue":2.5928710344882153e-16,"ratio":0.1598221776697865,"synonym_name":"4-(diaminomethylideneamino)butanoic acid"},{"chebi_id":"1606","direction":"up","inn_name":"","iupac_name":"(1-methyl-1<em>H</em>-imidazol-4-yl)acetic acid","metabolite_id":"ZHCKPJGJQOPTLB-UHFFFAOYSA-N","pvalue":4.3702841839098637e-20,"ratio":4.020123533393503,"synonym_name":"Methylimidazoleacetic acid"},{"chebi_id":"17768","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(4-aminobutyl)acetamide","metabolite_id":"KLZGKIDSEJWEDW-UHFFFAOYSA-N","pvalue":1.8107604521025027e-09,"ratio":0.0570548820428017,"synonym_name":"N-Acetylputrescine"},{"chebi_id":"356010","direction":"down","inn_name":"","iupac_name":"5-azaniumylpentanoate","metabolite_id":"JJMDCOVWQOJGCB-UHFFFAOYSA-N","pvalue":1.2221318825739786e-11,"ratio":0.1057675772714278,"synonym_name":"5-ammoniopentanoate"}],"totalFeatures":126},{"comparisonGroups":["Untreated","Antibiotic Treated"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse gut: untreated vs antibiotic treated","group_a_title":"Samples from untreated mice. Serves as the reference group for evaluating the effects of antibiotic treatment.","group_b_title":"Samples from mice treated with antibiotics. Allows for the assessment of the impact of antibiotic treatment on the intestinal microbiome and metabolome.","id":"MTBLS376_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS376","studyUrl":"http://integmet.org/study/MTBLS376","title":"Untreated_vs_Antibiotic_Treated","topHits":[{"chebi_id":"16135","direction":"up","inn_name":"","iupac_name":"2-methylpropanoic acid","metabolite_id":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","pvalue":5.987355773105551e-15,"ratio":7.776322565355374,"synonym_name":"2-METHYL-PROPIONIC ACID"},{"chebi_id":"28484","direction":"up","inn_name":"","iupac_name":"3-methylbutanoic acid","metabolite_id":"GWYFCOCPABKNJV-UHFFFAOYSA-N","pvalue":3.3706100819478473e-17,"ratio":3.8631596182028014,"synonym_name":"isovalerianic acid"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":7.967458710973114e-07,"ratio":0.0735045883250679,"synonym_name":"E363"},{"chebi_id":"32980","direction":"up","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)propanoic acid","metabolite_id":"NMHMNPHRMNGLLB-UHFFFAOYSA-N","pvalue":1.3781888131260854e-12,"ratio":3.5984580454646755,"synonym_name":"3-(4-Hydroxyphenyl)propionic acid"},{"chebi_id":"16010","direction":"down","inn_name":"","iupac_name":"5-oxopyrrolidine-2-carboxylic acid","metabolite_id":"ODHCTXKNWHHXJC-UHFFFAOYSA-N","pvalue":2.0626305360593093e-08,"ratio":0.156496368816587,"synonym_name":"2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"74324","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2,3-dihydroxypropanoic acid","metabolite_id":"RBNPOMFGQQGHHO-REOHCLBHSA-N","pvalue":2.1917894087700555e-10,"ratio":3.766187763892431,"synonym_name":"(<i>S</i>)-Glyceric acid"},{"chebi_id":"28865","direction":"down","inn_name":"","iupac_name":"2-[(3\u03b1,7\u03b1,12\u03b1-trihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"WBWWGRHZICKQGZ-HZAMXZRMSA-N","pvalue":0.0083394864810815,"ratio":0.0059606227695557,"synonym_name":"cholic acid taurine conjugate"},{"chebi_id":"48131","direction":"up","inn_name":"","iupac_name":"nonanedioic acid","metabolite_id":"BDJRBEYXGGNYIS-UHFFFAOYSA-N","pvalue":9.38726029651808e-14,"ratio":2.186822668475868,"synonym_name":"acide az\u00e9la\u00efque"},{"chebi_id":"48517","direction":"up","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":5.497417579178675e-09,"ratio":2.872971838598024,"synonym_name":"Xanthine"},{"chebi_id":"30915","direction":"up","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":4.6385090610308707e-10,"ratio":2.3989279247146618,"synonym_name":"\u03b1-ketoglutaric acid"}],"totalFeatures":40},{"comparisonGroups":["Untreated","Antibiotic Treated"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse intestinal: antibiotic treatment vs untreated","group_a_title":"Samples from untreated mice. Serves as the reference group for evaluating the effects of antibiotic treatment.","group_b_title":"Samples from mice treated with antibiotics. Allows for the assessment of the impact of antibiotic treatment on the intestinal microbiome and metabolome.","id":"MTBLS376_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":57,"studyId":"MTBLS376","studyUrl":"http://integmet.org/study/MTBLS376","title":"Untreated_vs_Antibiotic_Treated","topHits":[{"chebi_id":"16737","direction":"down","inn_name":"","iupac_name":"2-imino-1-methylimidazolidin-4-one","metabolite_id":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","pvalue":3.1695345047572777e-17,"ratio":0.0451378311527696,"synonym_name":"cr\u00e9atinine"},{"chebi_id":"16927","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":6.232456119885598e-13,"ratio":0.0189409285935476,"synonym_name":"L-Saccharopine"},{"chebi_id":"60175","direction":"down","inn_name":"","iupac_name":"5-hydroxylysine","metabolite_id":"YSMODUONRAFBET-UHFFFAOYSA-N","pvalue":3.1899849994911564e-17,"ratio":0.0779989203064613,"synonym_name":"hydroxylysine"},{"chebi_id":"53014","direction":"down","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-(carboxymethyl)-<small>L</small>-lysine","metabolite_id":"NUXSIDPKKIEIMI-LURJTMIESA-N","pvalue":6.078720282929534e-20,"ratio":0.1411784477451858,"synonym_name":"N(epsilon)-(Carboxymethyl)lysine"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":4.2222079482027263e-16,"ratio":8.645923737420366,"synonym_name":"Purine-6-ol"},{"chebi_id":"86564","direction":"down","inn_name":"","iupac_name":"4-carbamimidamidobutanoic acid","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-N","pvalue":2.5928710344882153e-16,"ratio":0.1598221776697865,"synonym_name":"4-(diaminomethylideneamino)butanoic acid"},{"chebi_id":"1606","direction":"up","inn_name":"","iupac_name":"(1-methyl-1<em>H</em>-imidazol-4-yl)acetic acid","metabolite_id":"ZHCKPJGJQOPTLB-UHFFFAOYSA-N","pvalue":4.3702841839098637e-20,"ratio":4.020123533393503,"synonym_name":"Methylimidazoleacetic acid"},{"chebi_id":"17768","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(4-aminobutyl)acetamide","metabolite_id":"KLZGKIDSEJWEDW-UHFFFAOYSA-N","pvalue":1.8107604521025027e-09,"ratio":0.0570548820428017,"synonym_name":"N-Acetylputrescine"},{"chebi_id":"356010","direction":"down","inn_name":"","iupac_name":"5-azaniumylpentanoate","metabolite_id":"JJMDCOVWQOJGCB-UHFFFAOYSA-N","pvalue":1.2221318825739786e-11,"ratio":0.1057675772714278,"synonym_name":"5-ammoniopentanoate"},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":4.110977880424425e-10,"ratio":0.0976076022843001,"synonym_name":"Butane-1,4-diamine"}],"totalFeatures":91},{"comparisonGroups":["Flower","Kernel"],"dateCreated":"2025-09-26 00:00:00","display_title":"Camellia lanceoleosa: flower vs kernel tissue","group_a_title":"Samples from the flower part of Camellia lanceoleosa.. Provides insights into the metabolic profile of the flower tissue.","group_b_title":"Samples from the kernel part of Camellia lanceoleosa.. Provides insights into the metabolic profile of the kernel tissue.","id":"MTBLS3769_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":77,"studyId":"MTBLS3769","studyUrl":"http://integmet.org/study/MTBLS3769","title":"Flower_vs_Kernel","topHits":[{"chebi_id":"17276","direction":"up","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one","metabolite_id":"VGEREEWJJVICBM-UHFFFAOYSA-N","pvalue":9.381054800060164e-06,"ratio":19307.592592592595,"synonym_name":"3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone"},{"chebi_id":"16610","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)butane-1,4-diamine","metabolite_id":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","pvalue":0.0003512494542741,"ratio":32308.51851851852,"synonym_name":"N-(3-Aminopropyl)-1,4-butane-diamine"},{"chebi_id":"172755","direction":"up","inn_name":"","iupac_name":"1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,6-trihydroxy-5-oxobenzo[7]annulene-8-carboxylic acid","metabolite_id":"RQTWDINIJYBFNS-UHFFFAOYSA-N","pvalue":0.0086970399779828,"ratio":961298.1481481482,"synonym_name":""},{"chebi_id":"67986","direction":"down","inn_name":"","iupac_name":"(\u03b2,6\u03b1,12\u03b2)-3,12,20-trihydroxydammar-24-en-6-yl 2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"UZIOUZHBUYLDHW-XUBRWZAZSA-N","pvalue":1.4964284586801816e-05,"ratio":0.0078820099768055,"synonym_name":"Panaxoside RF"},{"chebi_id":"18127","direction":"up","inn_name":"","iupac_name":"pentane-1,5-diamine","metabolite_id":"VHRGRCVQAFMJIZ-UHFFFAOYSA-N","pvalue":0.0013831785065523,"ratio":2394.0555555555557,"synonym_name":"Pentamethylenediamine"},{"chebi_id":"70693","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OELWYQGRQUQQPD-IOMDMTNGSA-N","pvalue":0.0428562215955652,"ratio":535632.7777777778,"synonym_name":""},{"chebi_id":"75750","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4<em>H</em>-chromen-3-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"CQLRUIIRRZYHHS-LFXZADKFSA-N","pvalue":0.0427608922270148,"ratio":530278.7037037037,"synonym_name":""},{"chebi_id":"75752","direction":"up","inn_name":"","iupac_name":"3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4<em>H</em>-chromen-7-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"YCUNOXSUHVGZRI-XMHBHJPISA-N","pvalue":0.0440761661138585,"ratio":572372.2222222222,"synonym_name":""},{"chebi_id":"183907","direction":"down","inn_name":"","iupac_name":"3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one","metabolite_id":"LLPRITPJQPQXIR-BVDHFOMSSA-N","pvalue":3.344189599237416e-06,"ratio":0.0376213618932669,"synonym_name":""},{"chebi_id":"69657","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4<em>H</em>-chromen-3-yl 6-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"RTATXGUCZHCSNG-QHWHWDPRSA-N","pvalue":0.0102756364436695,"ratio":0.0001421509010787,"synonym_name":"nicotiflorin"}],"totalFeatures":183},{"comparisonGroups":["Mite_Infestation","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Apis cerana brain: mite infestation vs control","group_a_title":"Samples from Apis cerana brains under mite infestation. Key group for understanding the metabolic changes due to mite infestation","group_b_title":"Control samples from Apis cerana brains without mite infestation. Provides a reference point to identify changes due to mite infestation","id":"MTBLS379_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS379","studyUrl":"http://integmet.org/study/MTBLS379","title":"Mite_Infestation_vs_Control","topHits":[{"chebi_id":"472805","direction":"down","inn_name":"","iupac_name":"3-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyloxy)-1\u03b2,5\u03b2,11\u03b1,14,19-pentahydroxy-5\u03b2-card-20(22)-enolide","metabolite_id":"LPMXVESGRSUGHW-HBYQJFLCSA-N","pvalue":0.0276569699739772,"ratio":0.20313186604892,"synonym_name":"3-(\u03b1-<small>L</small>-rhamnopyranosyloxy)-1\u03b2,5\u03b2,11\u03b1,14,19-pentahydroxy-5\u03b2-card-20(22)-enolide"},{"chebi_id":"75117","direction":"up","inn_name":"","iupac_name":"(13<i>Z</i>,16<i>Z</i>)-docosa-13,16-dienoic acid","metabolite_id":"HVGRZDASOHMCSK-HZJYTTRNSA-N","pvalue":0.0436266604277102,"ratio":1.8505635068280313,"synonym_name":"<i>cis</i>-13,16 docosadienoic acid"}],"totalFeatures":1823},{"comparisonGroups":["Mite_Infestation","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Apis cerana brains: mite infestation vs control","group_a_title":"Samples from Apis cerana brains under mite infestation. Key group for understanding the metabolic changes due to mite infestation","group_b_title":"Control samples from Apis cerana brains without mite infestation. Provides a reference point to identify changes due to mite infestation","id":"MTBLS379_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS379","studyUrl":"http://integmet.org/study/MTBLS379","title":"Mite_Infestation_vs_Control","topHits":[{"chebi_id":"472805","direction":"down","inn_name":"","iupac_name":"3-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyloxy)-1\u03b2,5\u03b2,11\u03b1,14,19-pentahydroxy-5\u03b2-card-20(22)-enolide","metabolite_id":"LPMXVESGRSUGHW-HBYQJFLCSA-N","pvalue":0.0276569699739772,"ratio":0.20313186604892,"synonym_name":"3-(\u03b1-<small>L</small>-rhamnopyranosyloxy)-1\u03b2,5\u03b2,11\u03b1,14,19-pentahydroxy-5\u03b2-card-20(22)-enolide"},{"chebi_id":"88774","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YSGVSTJGBYXXIM-OVUVNFMNSA-N","pvalue":0.0436266604277102,"ratio":1.8505635068280313,"synonym_name":""}],"totalFeatures":1873},{"comparisonGroups":["LLIR","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Radiation workers: long-term low-dose exposure vs control","group_a_title":"Samples from radiation workers exposed to long-term low-dose ionizing radiation. Key group for assessing the metabolic effects of long-term low-dose ionizing radiation exposure","group_b_title":"Samples from healthy non-radiation workers. Serves as the reference group to evaluate the effects of radiation exposure","id":"MTBLS3854_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":105,"studyId":"MTBLS3854","studyUrl":"http://integmet.org/study/MTBLS3854","title":"LLIR_vs_Control","topHits":[{"chebi_id":"18280","direction":"up","inn_name":"","iupac_name":"oxo(phenyl)acetic acid","metabolite_id":"FAQJJMHZNSSFSM-UHFFFAOYSA-N","pvalue":1.8032051182217037e-09,"ratio":12.333707860779828,"synonym_name":"2-phenylethanoic acid"},{"chebi_id":"38023","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-sulfopropanoic acid","metabolite_id":"CQQGIWJSICOUON-UHFFFAOYSA-N","pvalue":3.9608873226497986e-07,"ratio":11.77338327252842,"synonym_name":""},{"chebi_id":"47904","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-4,6-dioxooct-2-enedioic acid","metabolite_id":"GACSIVHAIFQKTC-UPHRSURJSA-N","pvalue":5.099094503070683e-18,"ratio":2.169299252627926,"synonym_name":"4-Maleylacetoacetic acid"},{"chebi_id":"1449","direction":"up","inn_name":"","iupac_name":"3-amino-2-oxopropyl dihydrogen phosphate","metabolite_id":"HIQNVODXENYOFK-UHFFFAOYSA-N","pvalue":3.818567317061083e-17,"ratio":2.1454332146542536,"synonym_name":"3-Amino-2-oxopropyl phosphate"},{"chebi_id":"46996","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-arabinopyranose","metabolite_id":"SRBFZHDQGSBBOR-SQOUGZDYSA-N","pvalue":7.2437937321680175e-12,"ratio":2.7659166248853513,"synonym_name":""},{"chebi_id":"77064","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetyl-<small>L</small>-\u03b1-aspartyl-<small>L</small>-\u03b1-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"XNHNFLZMOUNVIW-GUBZILKMSA-N","pvalue":4.5085854546797316e-12,"ratio":2.655021538136749,"synonym_name":"<em>N</em>-acetylaspartylglutamylglutamic acid"},{"chebi_id":"43034","direction":"up","inn_name":"","iupac_name":"1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-<em>b</em>]quinolin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUEILLWDYUBWCM-XQQFMLRXSA-N","pvalue":3.465123544642495e-14,"ratio":2.0548486071403156,"synonym_name":"FO"},{"chebi_id":"16750","direction":"up","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":5.601991903181156e-12,"ratio":2.3018409670701456,"synonym_name":"G"},{"chebi_id":"16772","direction":"up","inn_name":"","iupac_name":"<small>D</small>-xylitol 5-(dihydrogen phosphate)","metabolite_id":"VJDOAZKNBQCAGE-VPENINKCSA-N","pvalue":3.3160825602804565e-08,"ratio":2.994112006415846,"synonym_name":"Xylitol 5-phosphate"},{"chebi_id":"18299","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxy-3-(1<em>H</em>-indol-3-yl)propyl dihydrogen phosphate","metabolite_id":"NQEQTYPJSIEPHW-UHFFFAOYSA-N","pvalue":6.265522998064312e-07,"ratio":2.8715687577829625,"synonym_name":"(3-Indolyl)-glycerol phosphate"}],"totalFeatures":668},{"comparisonGroups":["LLIR","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"Radiation workers: long-term low-dose exposure vs control","group_a_title":"Samples from radiation workers exposed to long-term low-dose ionizing radiation. Key group for assessing the metabolic effects of long-term low-dose ionizing radiation exposure","group_b_title":"Samples from healthy non-radiation workers. Serves as the reference group to evaluate the effects of radiation exposure","id":"MTBLS3854_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":81,"studyId":"MTBLS3854","studyUrl":"http://integmet.org/study/MTBLS3854","title":"LLIR_vs_Control","topHits":[{"chebi_id":"1162","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>,4<i>E</i>)-2-hydroxyhepta-2,4-dienedioic acid","metabolite_id":"ZBCBETMBSDTINL-WFTYEQLWSA-N","pvalue":6.684178669896877e-20,"ratio":4.575591865032373,"synonym_name":""},{"chebi_id":"17915","direction":"up","inn_name":"","iupac_name":"oxepan-2-one","metabolite_id":"PAPBSGBWRJIAAV-UHFFFAOYSA-N","pvalue":5.093540740715953e-15,"ratio":6.541621159391741,"synonym_name":"hexanoic acid, \u03b5-lactone"},{"chebi_id":"64362","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-3-<em>O</em>-phosphono-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"OGVYJNPFVHQJJS-CFRASDGPSA-N","pvalue":1.6204636698156556e-14,"ratio":4.265049318655499,"synonym_name":"UDP-<em>N</em>-acetyl-\u03b1-<small>D</small>-glucosamine 3'-phosphate"},{"chebi_id":"57938","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-3-hydroxypyrrolidinium-2-carboxylate","metabolite_id":"BJBUEDPLEOHJGE-IMJSIDKUSA-N","pvalue":5.1705131348855804e-09,"ratio":5.456758660289374,"synonym_name":""},{"chebi_id":"18319","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-[5-amino-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribosyl)imidazole-4-carboxamido]succinic acid","metabolite_id":"NAQGHJTUZRHGAC-ZZZDFHIKSA-N","pvalue":2.3649487201459015e-16,"ratio":2.3385577903303685,"synonym_name":"5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole"},{"chebi_id":"18349","direction":"up","inn_name":"","iupac_name":"<em>N</em>-glycyl-<small>D</small>-ribofuranosylamine 5-(dihydrogen phosphate)","metabolite_id":"OBQMLSFOUZUIOB-HJZCUYRDSA-N","pvalue":8.044551809876848e-15,"ratio":2.4547683845188155,"synonym_name":"5'-Phosphoribosylglycinamide"},{"chebi_id":"57853","direction":"up","inn_name":"","iupac_name":"2-azaniumylethanesulfinate","metabolite_id":"VVIUBCNYACGLLV-UHFFFAOYSA-N","pvalue":1.057795515743724e-12,"ratio":2.795131851507883,"synonym_name":"2-mmonioethane-1-sulfinate"},{"chebi_id":"16190","direction":"up","inn_name":"","iupac_name":"<i>rel</i>-(1<i>R</i>,2<i>S</i>)-cyclohexa-3,5-diene-1,2-diol","metabolite_id":"YDRSQRPHLBEPTP-OLQVQODUSA-N","pvalue":6.948187979290341e-08,"ratio":5.297492287808477,"synonym_name":"cis-Benzeneglycol"},{"chebi_id":"28972","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-propane-1,2-diol","metabolite_id":"DNIAPMSPPWPWGF-GSVOUGTGSA-N","pvalue":7.071229322744581e-06,"ratio":6.752274121409996,"synonym_name":"(R)-1,2-Propanediol"},{"chebi_id":"17415","direction":"up","inn_name":"","iupac_name":"2,5-dioxopentanoic acid","metabolite_id":"VHKNBDIQDAXGBL-UHFFFAOYSA-N","pvalue":2.8378792958000975e-17,"ratio":1.7950750368107846,"synonym_name":"2-Oxoglutarate semialdehyde"}],"totalFeatures":483},{"comparisonGroups":["Control","Isoproterenol"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs Isoproterenol treatment","group_a_title":"Control group with no treatment. Provides a reference point for comparison with treated groups","group_b_title":"Group treated with Isoproterenol. Allows assessment of the effects of Isoproterenol treatment","id":"MTBLS3886_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":157,"studyId":"MTBLS3886","studyUrl":"http://integmet.org/study/MTBLS3886","title":"Control_vs_Isoproterenol","topHits":[{"chebi_id":"137782","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FNYMOMSUWLCHBY-UXLLHSPISA-N","pvalue":0.0024003268244088,"ratio":64414578295.62123,"synonym_name":"11-(5S-hydroxy-6S-methylpiperidin-2R-yl)undecan-3-one"},{"chebi_id":"35021","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IQOASJJGUQMXDW-GHQVIJFQSA-N","pvalue":0.0006978045502603,"ratio":13954.385076675626,"synonym_name":"Trichloroethanol glucuronide"},{"chebi_id":"176474","direction":"down","inn_name":"","iupac_name":"2-(4-sulooxyphenyl)acetic acid","metabolite_id":"IIODELUADFSHIZ-UHFFFAOYSA-N","pvalue":2.530085985578897e-07,"ratio":0.1116886648912491,"synonym_name":""},{"chebi_id":"177976","direction":"down","inn_name":"","iupac_name":"3-hydroxy-N-(2-oxooxolan-3-yl)hexanamide","metabolite_id":"CRCIHGGZGGATGM-UHFFFAOYSA-N","pvalue":1.6072614335467426e-06,"ratio":0.1060995154721372,"synonym_name":""},{"chebi_id":"17858","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":7.092144857261779e-05,"ratio":0.0609337637378828,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"188428","direction":"down","inn_name":"","iupac_name":"3-hydroxy-2-(3-methoxyphenyl)-7-sulinooxy-3,4-dihydro-2H-chromen-5-olate","metabolite_id":"XZLXLDIIKCIORP-UHFFFAOYSA-M","pvalue":7.153043890950361e-06,"ratio":0.1084228671280218,"synonym_name":""},{"chebi_id":"143251","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-alanylglycine","metabolite_id":"RPVCUZZJCXVVDW-WDSKDSINSA-N","pvalue":4.490207942561817e-06,"ratio":0.1234750794133308,"synonym_name":"\u03b3-Glu-Ala-Gly"},{"chebi_id":"35549","direction":"up","inn_name":"","iupac_name":"pentadecafluorooctanoic acid","metabolite_id":"SNGREZUHAYWORS-UHFFFAOYSA-N","pvalue":5.481177877579531e-05,"ratio":10.005816379193586,"synonym_name":"PFOA"},{"chebi_id":"184213","direction":"down","inn_name":"","iupac_name":"3-phenylpropyl hydrogen sulate","metabolite_id":"YLMGHAIVYBOKKH-UHFFFAOYSA-N","pvalue":3.695785660206689e-07,"ratio":0.228022979072261,"synonym_name":""},{"chebi_id":"184536","direction":"down","inn_name":"","iupac_name":"[3-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenyl] hydrogen sulate","metabolite_id":"CWRNEUUVEJKRFX-UHFFFAOYSA-N","pvalue":0.0006074946655825,"ratio":0.0751874473235624,"synonym_name":""}],"totalFeatures":401},{"comparisonGroups":["Control","Isoproterenol"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs Isoproterenol treatment","group_a_title":"Control group with no treatment. Provides a reference point for comparison with treated groups","group_b_title":"Group treated with Isoproterenol. Allows assessment of the effects of Isoproterenol treatment","id":"MTBLS3886_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":146,"studyId":"MTBLS3886","studyUrl":"http://integmet.org/study/MTBLS3886","title":"Control_vs_Isoproterenol","topHits":[{"chebi_id":"89513","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZAUFLMLTXNKVAB-AFYHZPHLSA-N","pvalue":3.112965299247523e-07,"ratio":0.1399290730248156,"synonym_name":"PC(14:0/20:3)"},{"chebi_id":"136694","direction":"down","inn_name":"","iupac_name":"2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid","metabolite_id":"GOCUAJYOYBLQRH-UHFFFAOYSA-N","pvalue":1.3330013486239793e-08,"ratio":0.2520170397282422,"synonym_name":"2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propionic acid"},{"chebi_id":"6257","direction":"down","inn_name":"Levisoprenalinum","iupac_name":"4-[(1<i>R</i>)-1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol","metabolite_id":"JWZZKOKVBUJMES-NSHDSACASA-N","pvalue":1.954185870235234e-06,"ratio":0.1553791801852466,"synonym_name":"L-(-)-Isoproterenol"},{"chebi_id":"8391","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ADUKCCWBEDSMEB-NSHDSACASA-N","pvalue":1.1484743827701144e-05,"ratio":0.1395579843425327,"synonym_name":"Prenalterol"},{"chebi_id":"82583","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PRZJYJAOZVCBCB-UHFFFAOYSA-N","pvalue":0.0017464282018961,"ratio":0.0525267730454063,"synonym_name":""},{"chebi_id":"16973","direction":"up","inn_name":"","iupac_name":"21-hydroxypregn-4-ene-3,20-dione","metabolite_id":"ZESRJSPZRDMNHY-YFWFAHHUSA-N","pvalue":0.0013734329324939,"ratio":15.362045345400531,"synonym_name":"desoxycortone"},{"chebi_id":"72783","direction":"down","inn_name":"","iupac_name":"12-hydroxyheptadeca-5,8,10-trienoic acid","metabolite_id":"KUKJHGXXZWHSBG-GMPNNLDHSA-N","pvalue":4.875134324098363e-05,"ratio":0.194897480181646,"synonym_name":"12-HHT"},{"chebi_id":"188397","direction":"down","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-2-carboxylic acid","metabolite_id":"XDPLKWRSVXUQBN-LVEHSUOCSA-N","pvalue":2.5537869901646488e-05,"ratio":0.2716618340011266,"synonym_name":""},{"chebi_id":"29461","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,7<i>R</i>,9<i>E</i>,11<i>R</i>,12<i>R</i>)-12-ethyl-4-hydroxy-3,5,7,11-tetramethyloxacyclododec-9-ene-2,8-dione","metabolite_id":"NZUJVBSYQXETNF-PQWITYJESA-N","pvalue":0.0001512765444453,"ratio":0.2092885317770898,"synonym_name":""},{"chebi_id":"28595","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(4-hydroxyphenyl)acetyl]glycine","metabolite_id":"CPPDWYIPKSSNNM-UHFFFAOYSA-N","pvalue":0.0451848189298878,"ratio":75.15207684766894,"synonym_name":"4-Hydroxyphenylacetylglycine"}],"totalFeatures":497},{"comparisonGroups":["Decane","Difluorodecane"],"dateCreated":"2025-09-26 00:00:00","display_title":"Decane vs Difluorodecane treatment comparison","group_a_title":"Samples treated with Decane. Serves as a baseline treatment group for comparison with fluorinated treatments","group_b_title":"Samples treated with Difluorodecane. Allows for assessment of the effects of difluorinated compounds on the organism","id":"MTBLS3893_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS3893","studyUrl":"http://integmet.org/study/MTBLS3893","title":"Decane_vs_Difluorodecane","topHits":[{"chebi_id":"178264","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate","metabolite_id":"YMEQXDCYZVOOFR-NOLSVFIGSA-N","pvalue":2.94673308221423e-07,"ratio":49.57504936551716,"synonym_name":""},{"chebi_id":"189604","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] octadecanoate","metabolite_id":"JEGMUNDQDSSICV-SZAHLOSFSA-N","pvalue":1.1448091103823187e-06,"ratio":51.769514268415456,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ILDWNJKEBWLREM-DCLNZNATSA-N","pvalue":1.9062228935082325e-06,"ratio":30.250374622550524,"synonym_name":""},{"chebi_id":"89266","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JPRWHUSRRGNLOV-KKUBIFFLSA-N","pvalue":1.6353591280988263e-06,"ratio":22.778555212578155,"synonym_name":"Phosphatidylglycerol(18:0/18:2)"},{"chebi_id":"178174","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-octadec-11-enoate","metabolite_id":"LKUKJIYAXQFZTD-MRDDHZETSA-N","pvalue":1.230828321339758e-07,"ratio":12.984651008221084,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LPQPHLDFHDAGBP-SIFNWRCISA-N","pvalue":2.5061609982720255e-06,"ratio":13.156054384361562,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AZKOMSGSPCBHKK-AVKQKRQHSA-N","pvalue":3.028508141201172e-05,"ratio":24.080306276305116,"synonym_name":""},{"chebi_id":"170423","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate","metabolite_id":"OUEUPCHAIFZTKH-LSWZYRHBSA-N","pvalue":3.561533099255238e-07,"ratio":8.313801183010261,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IFVBZNWVWZLXTQ-WQQOROIJSA-N","pvalue":6.175674379548684e-05,"ratio":23.63367980564622,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QCCFIGOPROAYMX-NHZJTUAKSA-N","pvalue":8.770371630700618e-05,"ratio":22.624878425055343,"synonym_name":""}],"totalFeatures":38},{"comparisonGroups":["Raw_Water","Aeration_Tank"],"dateCreated":"2025-09-26 00:00:00","display_title":"Industrial wastewater: raw water vs aeration tank","group_a_title":"Samples from raw water stage of industrial wastewater treatment.. Provides baseline data for untreated wastewater.","group_b_title":"Samples from the aeration tank stage of industrial wastewater treatment.. Represents the effect of aeration on wastewater treatment.","id":"MTBLS3916_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":42,"studyId":"MTBLS3916","studyUrl":"http://integmet.org/study/MTBLS3916","title":"Raw_Water_vs_Aeration_Tank","topHits":[{"chebi_id":"1215","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FSCXZVPPDJYLDD-UHFFFAOYSA-N","pvalue":1.709366573112496e-05,"ratio":0.0070393143755411,"synonym_name":"2-Methylquinoline-3,4-diol"},{"chebi_id":"90333","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-3-(1<em>H</em>-indol-2-yl)prop-2-enoic acid","metabolite_id":"SXOUIMVOMIGLHO-AATRIKPKSA-N","pvalue":2.973934102490352e-05,"ratio":0.0098442484069702,"synonym_name":"indole-2-acrylic acid"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.0001075951179907,"ratio":0.0087633979513869,"synonym_name":"E363"},{"chebi_id":"17015","direction":"down","inn_name":"riboflavine","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-<small>D</small>-ribitol","metabolite_id":"AUNGANRZJHBGPY-SCRDCRAPSA-N","pvalue":9.368963465634128e-05,"ratio":0.0138923118583688,"synonym_name":"E101"},{"chebi_id":"15684","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-dihydroxy-3-methylbutanoic acid","metabolite_id":"JTEYKUFKXGDTEU-VKHMYHEASA-N","pvalue":3.273125793036687e-07,"ratio":9.654320480502372,"synonym_name":"(R)-2,3-Dihydroxy-isovaleric acid"},{"chebi_id":"15582","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>)-2-hydroxy-2,3-dimethylbutanedioic acid","metabolite_id":"WTIIULQJLZEHGZ-AWFVSMACSA-N","pvalue":2.1764580393373217e-06,"ratio":12.499431403217104,"synonym_name":"(2R,3S)-2,3-dimethylmalate"},{"chebi_id":"7916","direction":"down","inn_name":"","iupac_name":"3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid","metabolite_id":"GHOKWGTUZJEAQD-UHFFFAOYSA-N","pvalue":0.003338522927306,"ratio":0.004767274063119,"synonym_name":"<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-\u03b2-alanine"},{"chebi_id":"20067","direction":"up","inn_name":"","iupac_name":"3-hydroxybutanoic acid","metabolite_id":"WHBMMWSBFZVSSR-UHFFFAOYSA-N","pvalue":5.806124019587758e-06,"ratio":10.281633300605623,"synonym_name":"\u03b2-hydroxy-<em>n</em>-butyric acid"},{"chebi_id":"182892","direction":"up","inn_name":"","iupac_name":"2,2-dimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione","metabolite_id":"PJWHOPKRRBUSDH-UHFFFAOYSA-N","pvalue":1.225029069189191e-07,"ratio":5.68959908023428,"synonym_name":""},{"chebi_id":"68641","direction":"down","inn_name":"cotininum","iupac_name":"(5<i>S</i>)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one","metabolite_id":"UIKROCXWUNQSPJ-VIFPVBQESA-N","pvalue":1.472907358216042e-05,"ratio":0.0881306242219758,"synonym_name":"(S)-(-)-Cotinine"}],"totalFeatures":118},{"comparisonGroups":["Sham","Heart Failure Sedentary"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs heart failure (sedentary)","group_a_title":"Control group with no heart failure induction. Provides baseline for comparison with heart failure groups.","group_b_title":"Heart failure group without exercise intervention. Serves as a comparison for exercise and BAIBA treatment effects.","id":"MTBLS3927_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS3927","studyUrl":"http://integmet.org/study/MTBLS3927","title":"Sham_vs_Heart_Failure_Sedentary","topHits":[{"chebi_id":"57485","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alaniniumyl)-<small>L</small>-histidinate","metabolite_id":"CQOVPNPJLQNMDC-ZETCQYMHSA-N","pvalue":0.0018259764800832,"ratio":2.772098706131276,"synonym_name":"(2<i>S</i>)-2-[(3-azaniumylpropanoyl)amino]-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"17794","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UWTATZPHSA-N","pvalue":0.0085147637484208,"ratio":2.691137193480861,"synonym_name":"3-Phospho-D-glycerate"},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":0.0055732691941534,"ratio":2.3876953382299364,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"18323","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alanyl)-<em>N</em><small><sup>\u03c0</small></sup>-methylhistidine","metabolite_id":"MYYIAHXIVFADCU-QMMMGPOBSA-N","pvalue":0.0076387454965797,"ratio":2.4392643852258487,"synonym_name":"beta-Alanyl-N(pai)-methyl-L-histidine"},{"chebi_id":"28158","direction":"down","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1,15-trihydroxy-6-oxoprost-13-en-1-oic acid","metabolite_id":"KFGOFTHODYBSGM-ZUNNJUQCSA-N","pvalue":0.0382376456403607,"ratio":0.3055725074342273,"synonym_name":"6-Oxoprostaglandin F1alpha"},{"chebi_id":"57947","direction":"up","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.0066164924053357,"ratio":1.9774806601805297,"synonym_name":""},{"chebi_id":"16732","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-[{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine","metabolite_id":"WVIMUEUQJFPNDK-PEBGCTIMSA-N","pvalue":0.0013663260034952,"ratio":1.6420171776528172,"synonym_name":"CDP ethanolamine"},{"chebi_id":"17363","direction":"up","inn_name":"","iupac_name":"5-<em>O</em>-phosphono-<small>D</small>-ribulose","metabolite_id":"FNZLKVNUWIIPSJ-UHNVWZDZSA-N","pvalue":0.0125407958183685,"ratio":1.54655289392484,"synonym_name":"D-Ribulose 5-phosphate"},{"chebi_id":"27468","direction":"down","inn_name":"","iupac_name":"5-methyldihydropyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"NBAKTGXDIBVZOO-UHFFFAOYSA-N","pvalue":0.0246344280227679,"ratio":0.6436399022618787,"synonym_name":"5,6-Dihydro-5-methyluracil"},{"chebi_id":"35374","direction":"up","inn_name":"","iupac_name":"<small>D</small>-mannopyranose 1-(dihydrogen phosphate)","metabolite_id":"HXXFSFRBOHSIMQ-QTVWNMPRSA-N","pvalue":0.0421557570770482,"ratio":1.640712313868124,"synonym_name":"D-mannose 1-phosphates"}],"totalFeatures":134},{"comparisonGroups":["Sham","Heart Failure Sedentary"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sham control vs heart failure sedentary group","group_a_title":"Control group with no heart failure induction. Provides baseline for comparison with heart failure groups.","group_b_title":"Heart failure group without exercise intervention. Serves as a comparison for exercise and BAIBA treatment effects.","id":"MTBLS3927_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS3927","studyUrl":"http://integmet.org/study/MTBLS3927","title":"Sham_vs_Heart_Failure_Sedentary","topHits":[{"chebi_id":"57485","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alaniniumyl)-<small>L</small>-histidinate","metabolite_id":"CQOVPNPJLQNMDC-ZETCQYMHSA-N","pvalue":0.0003898825995664,"ratio":2.46738206444828,"synonym_name":"(2<i>S</i>)-2-[(3-azaniumylpropanoyl)amino]-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"73924","direction":"up","inn_name":"","iupac_name":"<small>L</small>-histidyl-<small>L</small>-alanine","metabolite_id":"FRJIAZKQGSCKPQ-FSPLSTOPSA-N","pvalue":0.0004041998435886,"ratio":2.319812604800243,"synonym_name":"Histidinoalanine"},{"chebi_id":"28661","direction":"up","inn_name":"","iupac_name":"(6<i>Z</i>,9<i>Z</i>,12<i>Z</i>)-octadeca-6,9,12-trienoic acid","metabolite_id":"VZCCETWTMQHEPK-QNEBEIHSSA-N","pvalue":0.0091700551103557,"ratio":3.09730881801917,"synonym_name":"(6Z,9Z,12Z)-Octadecatrienoic acid"},{"chebi_id":"15724","direction":"up","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>-dimethylmethanamine oxide","metabolite_id":"UYPYRKYUKCHHIB-UHFFFAOYSA-N","pvalue":0.006974051372149,"ratio":2.536575081518203,"synonym_name":"TMAO"},{"chebi_id":"28468","direction":"up","inn_name":"","iupac_name":"(7<i>R</i>)-4,7-dihydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide","metabolite_id":"ASWBNKHCZGQVJV-HSZRJFAPSA-O","pvalue":0.0037317787007282,"ratio":2.080747782047352,"synonym_name":"1-Palmitoylglycerophosphocholine"},{"chebi_id":"18323","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alanyl)-<em>N</em><small><sup>\u03c0</small></sup>-methylhistidine","metabolite_id":"MYYIAHXIVFADCU-QMMMGPOBSA-N","pvalue":0.0074761994124142,"ratio":2.3070713193052512,"synonym_name":"beta-Alanyl-N(pai)-methyl-L-histidine"},{"chebi_id":"73788","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanyl-<small>L</small>-glutamine","metabolite_id":"HJCMDXDYPOUFDY-WHFBIAKZSA-N","pvalue":0.0014842691500236,"ratio":1.6281129827473193,"synonym_name":"<small>L</small>-Ala-<small>L</small>-Gln"},{"chebi_id":"16410","direction":"down","inn_name":"","iupac_name":"4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol","metabolite_id":"NHZMQXZHNVQTQA-UHFFFAOYSA-N","pvalue":0.0194995252107125,"ratio":0.4986010576512915,"synonym_name":"4-(AMINOMETHYL)-5-(HYDROXYMETHYL)-2-METHYLPYRIDIN-3-OL"},{"chebi_id":"16732","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-[{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine","metabolite_id":"WVIMUEUQJFPNDK-PEBGCTIMSA-N","pvalue":0.0076812233185947,"ratio":1.6928905312331302,"synonym_name":"CDP ethanolamine"},{"chebi_id":"141441","direction":"up","inn_name":"","iupac_name":"<small>L</small>-isoleucyl-<small>L</small>-threonine","metabolite_id":"DRCKHKZYDLJYFQ-YWIQKCBGSA-N","pvalue":0.0095206398239042,"ratio":1.694292044198335,"synonym_name":"isoleucylthreonine"}],"totalFeatures":196},{"comparisonGroups":["Control","Endometrial_Cancer"],"dateCreated":"2025-09-26 00:00:00","display_title":"Endometrial tissue: cancer vs healthy control","group_a_title":"Samples from healthy control group. Provides baseline for comparison with endometrial cancer samples","group_b_title":"Samples from endometrial cancer group. Represents the disease state for comparison with healthy controls","id":"MTBLS3935_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":43,"studyId":"MTBLS3935","studyUrl":"http://integmet.org/study/MTBLS3935","title":"Control_vs_Endometrial_Cancer","topHits":[{"chebi_id":"28931","direction":"up","inn_name":"","iupac_name":"3'-adenylic acid","metabolite_id":"LNQVTSROQXJCDD-KQYNXXCUSA-N","pvalue":0.0037915686799238,"ratio":6.320143375577173,"synonym_name":"Adenosine 3'-phosphate"},{"chebi_id":"17417","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-<em>N</em>-(4-aminobutyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide","metabolite_id":"KTZNZCYTXQYEHT-GQCTYLIASA-N","pvalue":0.0179256537182188,"ratio":0.1240496348628848,"synonym_name":"N-Caffeoylputrescine"},{"chebi_id":"16294","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4,6(1<em>H</em>,3<em>H</em>,5<em>H</em>)-trione","metabolite_id":"HNYOPLTXPVRDBG-UHFFFAOYSA-N","pvalue":0.0005103977517885,"ratio":2.8088071222017317,"synonym_name":"2,4,6(1<em>H</em>,3<em>H</em>,5<em>H</em>)-pyrimidinetrione"},{"chebi_id":"18357","direction":"up","inn_name":"norepinephrine","iupac_name":"4-[(1<i>R</i>)-2-amino-1-hydroxyethyl]benzene-1,2-diol","metabolite_id":"SFLSHLFXELFNJZ-QMMMGPOBSA-N","pvalue":0.0006935691949585,"ratio":2.788663642214604,"synonym_name":"Noradrenaline"},{"chebi_id":"15901","direction":"up","inn_name":"","iupac_name":"dihydropyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"OIVLITBTBDPEFK-UHFFFAOYSA-N","pvalue":0.0009885254641506,"ratio":2.9025000057487977,"synonym_name":"2,4(1H,3H)-Pyrimidinedione, dihydro-"},{"chebi_id":"16160","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-4-(3-carboxypropanoyloxy)butanoic acid","metabolite_id":"GNISQJGXJIDKDJ-YFKPBYRVSA-N","pvalue":0.0018607591988346,"ratio":2.6572283027600068,"synonym_name":"O-succinyl-L-homoserine"},{"chebi_id":"15896","direction":"down","inn_name":"","iupac_name":"3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione","metabolite_id":"YUHVBHDSVLKFNI-NJSLBKSFSA-N","pvalue":0.0173892430570302,"ratio":0.2229555549496437,"synonym_name":"3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione"},{"chebi_id":"17347","direction":"up","inn_name":"testosterona","iupac_name":"17\u03b2-hydroxyandrost-4-en-3-one","metabolite_id":"MUMGGOZAMZWBJJ-DYKIIFRCSA-N","pvalue":0.010804584868788,"ratio":3.4593075597076286,"synonym_name":"Androderm"},{"chebi_id":"16581","direction":"up","inn_name":"","iupac_name":"3\u03b2-hydroxypregn-5-en-20-one","metabolite_id":"ORNBQBCIOKFOEO-QGVNFLHTSA-N","pvalue":0.0074259782507628,"ratio":3.1261877790773713,"synonym_name":"3beta-Hydroxypregn-5-en-20-one"},{"chebi_id":"32096","direction":"up","inn_name":"","iupac_name":"methyl (1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-[(3-amino-2,3,6-trideoxy-\u03b1-<small>L</small>-<i>lyxo</i>-hexopyranosyl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate","metabolite_id":"CADJZGPRUYOSGU-QWWLYEKJSA-N","pvalue":0.0107718512860095,"ratio":3.3773756393931467,"synonym_name":"Rhodomycin D"}],"totalFeatures":411},{"comparisonGroups":["Unfermented","Fermented"],"dateCreated":"2025-09-26 00:00:00","display_title":"Bee pollen: fermented vs unfermented samples","group_a_title":"Unfermented bee pollen samples. Serves as the reference point for evaluating the effects of fermentation on allergenicity and nutritional properties.","group_b_title":"Fermented bee pollen samples. Represents the effect of fermentation on bee pollen, providing insights into potential allergenicity reduction and nutritional enhancement.","id":"MTBLS3950_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":834,"studyId":"MTBLS3950","studyUrl":"http://integmet.org/study/MTBLS3950","title":"Unfermented_vs_Fermented","topHits":[{"chebi_id":"172686","direction":"down","inn_name":"","iupac_name":"aluminum;2-(3-hydroxy-5-sulo-1H-indol-2-yl)-3-oxoindole-5-sulonic acid","metabolite_id":"INHYHTBURMMHBG-UHFFFAOYSA-N","pvalue":4.279418074589877e-11,"ratio":1.852995676343422e-05,"synonym_name":""},{"chebi_id":"168874","direction":"down","inn_name":"","iupac_name":"[3-[5-(dimethylarsorylmethyl)-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxypropyl] hydrogen sulite","metabolite_id":"GTSZMQQESJQGCI-UHFFFAOYSA-N","pvalue":1.0804678222003926e-08,"ratio":9.77198697068404e-06,"synonym_name":""},{"chebi_id":"185102","direction":"down","inn_name":"","iupac_name":"(2E,4E,12Z)-N-(2-methylpropyl)octadeca-2,4,12-trienamide","metabolite_id":"PCWWIOUZYOPZHT-VBUSEHTESA-N","pvalue":4.58996490292547e-09,"ratio":1.7751479289940828e-05,"synonym_name":""},{"chebi_id":"43","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KYBOBXNXZQTAKA-NXHRZFHOSA-N","pvalue":1.1464418704776474e-08,"ratio":1.1627906976744184e-05,"synonym_name":"(+)-Prosopinine"},{"chebi_id":"175250","direction":"down","inn_name":"","iupac_name":"4-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid","metabolite_id":"IPHNMKITOREFLW-UHFFFAOYSA-N","pvalue":1.2301789347045555e-08,"ratio":1.3458950201884253e-05,"synonym_name":""},{"chebi_id":"175354","direction":"down","inn_name":"","iupac_name":"(1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E)-3,7,12,16-tetramethylheptadeca-1,3,5,7,9,11,13,15-octaenyl]cyclohex-3-en-1-ol","metabolite_id":"GKMHSJYLRXLVRG-QZMSTDJESA-N","pvalue":5.3738307823940265e-08,"ratio":6.696428571428571e-06,"synonym_name":""},{"chebi_id":"79646","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XAPHYNIJAGNNNA-YFTOQCAPSA-N","pvalue":9.382778514101153e-08,"ratio":4.444444444444444e-06,"synonym_name":""},{"chebi_id":"82268","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PNAAEIYEUKNTMO-UHFFFAOYSA-N","pvalue":1.6806594146434483e-08,"ratio":2.0905923344947732e-05,"synonym_name":"EPBP"},{"chebi_id":"4188","direction":"down","inn_name":"","iupac_name":"(5<i>R</i>)-5-[(1<i>R</i>)-1-hydroxy-2-(phosphonooxy)ethyl]-1-<em>O</em>-phosphono-<small>D</small>-lyxopyranose","metabolite_id":"LMTGTTLGDUACSJ-NNPWBXLPSA-N","pvalue":1.59405637193893e-08,"ratio":2.521008403361345e-05,"synonym_name":""},{"chebi_id":"190092","direction":"down","inn_name":"","iupac_name":"[(2S)-2-(12-methoxydodecanoyloxy)-3-phosphonooxypropyl] 12-methoxydodecanoate","metabolite_id":"CONGBQWZYAQGJB-MHZLTWQESA-N","pvalue":3.0274702862251012e-09,"ratio":7.109004739336493e-05,"synonym_name":""}],"totalFeatures":851},{"comparisonGroups":["Control","Arginine Addition"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs arginine supplementation","group_a_title":"Control group with no amino acid modification. Provides baseline for comparison with amino acid modified groups","group_b_title":"Group with increased arginine concentration. Examines the effect of increased arginine on metabolic profiles","id":"MTBLS3963_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":53,"studyId":"MTBLS3963","studyUrl":"http://integmet.org/study/MTBLS3963","title":"G1_Control_vs_G2_Arginine_Addition","topHits":[{"chebi_id":"70958","direction":"up","inn_name":"","iupac_name":"2-amino-3-(1-methyl-1<em>H</em>-imidazol-4-yl)propanoic acid","metabolite_id":"BRMWTNUJHUMWMS-UHFFFAOYSA-N","pvalue":1.0622571598421078e-06,"ratio":2.188059884360308,"synonym_name":"1-methyl-<small>D</small><small>L</small>-histidine"},{"chebi_id":"49662","direction":"down","inn_name":"indometacina","iupac_name":"[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1<em>H</em>-indol-3-yl]acetic acid","metabolite_id":"CGIGDMFJXJATDK-UHFFFAOYSA-N","pvalue":0.0013487289456007,"ratio":0.2016312164956143,"synonym_name":"Indomethacin"},{"chebi_id":"9352","direction":"down","inn_name":"sulindac","iupac_name":"{(1<i>Z</i>)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1<em>H</em>-inden-3-yl}acetic acid","metabolite_id":"MLKXDPUZXIRXEP-MFOYZWKCSA-N","pvalue":0.0029351120421809,"ratio":0.1654327935144492,"synonym_name":"cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid"},{"chebi_id":"168345","direction":"up","inn_name":"","iupac_name":"(2Z)-2-[(4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-11-hydroxy-4,8,10,14-tetramethyl-3-oxo-1,2,4,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid","metabolite_id":"DEKASDKLVVYODQ-UKHRKFAVSA-N","pvalue":0.001795468708021,"ratio":3.865302502525858,"synonym_name":""},{"chebi_id":"15765","direction":"down","inn_name":"levodopa","iupac_name":"<small>L</small>-dopa","metabolite_id":"WTDRDQBEARUVNC-LURJTMIESA-N","pvalue":0.0215564092173523,"ratio":0.1542622620782885,"synonym_name":"L-DOPA"},{"chebi_id":"69833","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"INBMTJJPUABOQJ-VGOFMYFVSA-N","pvalue":0.0070741282400375,"ratio":0.2534044465441332,"synonym_name":"6-Geranyl-7-hydroxycoumarin"},{"chebi_id":"7781","direction":"down","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-8-\u03b2-<small>D</small>-glucopyranosyl-5,7-dihydroxy-4<em>H</em>-chromen-4-one","metabolite_id":"PLAPMLGJVGLZOV-VPRICQMDSA-N","pvalue":0.0031855454570363,"ratio":0.3124695073970619,"synonym_name":"Luteolin 8-C-glucoside"},{"chebi_id":"191049","direction":"down","inn_name":"","iupac_name":"(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid","metabolite_id":"ODCZJZWSXPVLAW-KXCGKLMDSA-N","pvalue":0.0033013957912802,"ratio":0.3348256995644765,"synonym_name":""},{"chebi_id":"191078","direction":"down","inn_name":"","iupac_name":"[3-hexadecoxy-2-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoyloxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"QJGSHDSRWAWLNA-ROBKWHOESA-N","pvalue":0.0305516416851698,"ratio":0.1772083664215535,"synonym_name":""},{"chebi_id":"135574","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GECBBEABIDMGGL-UHFFFAOYSA-N","pvalue":0.0011495659392852,"ratio":0.4368460466929869,"synonym_name":"LY 109514"}],"totalFeatures":707},{"comparisonGroups":["Control","Arginine Addition"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs arginine addition treatment","group_a_title":"Control group with no amino acid modification. Provides baseline for comparison with amino acid modified groups","group_b_title":"Group with increased arginine concentration. Examines the effect of increased arginine on metabolic profiles","id":"MTBLS3963_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":76,"studyId":"MTBLS3963","studyUrl":"http://integmet.org/study/MTBLS3963","title":"G1_Control_vs_G2_Arginine_Addition","topHits":[{"chebi_id":"28262","direction":"up","inn_name":"dimethyl sulfoxide","iupac_name":"dimethyl sulfoxide","metabolite_id":"IAZDPXIOMUYVGZ-UHFFFAOYSA-N","pvalue":3.0304748936490873e-07,"ratio":12.028270612373156,"synonym_name":"dmso"},{"chebi_id":"18211","direction":"down","inn_name":"","iupac_name":"citrulline","metabolite_id":"RHGKLRLOHDJJDR-UHFFFAOYSA-N","pvalue":0.0018056077412531,"ratio":0.1443855287470197,"synonym_name":"2-Amino-5-uredovaleric acid"},{"chebi_id":"991","direction":"down","inn_name":"","iupac_name":"2-amino-2-methylpropane-1,3-diol","metabolite_id":"UXFQFBNBSPQBJW-UHFFFAOYSA-N","pvalue":0.0018857237989056,"ratio":0.1630465982328016,"synonym_name":"2-Amino-2-methyl-1,3-propandiol"},{"chebi_id":"29016","direction":"down","inn_name":"","iupac_name":"arginine","metabolite_id":"ODKSFYDXXFIFQN-UHFFFAOYSA-N","pvalue":0.0083217430176729,"ratio":0.134225441708166,"synonym_name":"Arginin"},{"chebi_id":"190962","direction":"down","inn_name":"","iupac_name":"N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide","metabolite_id":"ROGUAPYLUCHQGK-UHFFFAOYSA-N","pvalue":0.0236944978366268,"ratio":0.0943929626981679,"synonym_name":""},{"chebi_id":"28544","direction":"up","inn_name":"","iupac_name":"3\u03b2-[2,6-dideoxy-\u03b2-<small>D</small>-<i>ribo</i>-hexopyranosyl-(1\u21924)-2,6-dideoxy-\u03b2-<small>D</small>-<i>ribo</i>-hexopyranosyl-(1\u21924)-2,6-dideoxy-\u03b2-<small>D</small>-<i>ribo</i>-hexopyranosyloxy]-14-hydroxy-5\u03b2-card-20(22)-enolide","metabolite_id":"WDJUZGPOPHTGOT-XUDUSOBPSA-N","pvalue":0.0012865740766922,"ratio":3.52275962222293,"synonym_name":"Digitoxoside"},{"chebi_id":"157844","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b1-glutamyl-<small>L</small>-arginine","metabolite_id":"MPZWMIIOPAPAKE-BQBZGAKWSA-N","pvalue":0.0419009860492108,"ratio":0.0895836896726388,"synonym_name":"(4<i>S</i>)-4-amino-5-[[(1<i>S</i>)-1-carboxy-4-(diaminomethylideneamino)butyl]amino]-5-oxopentanoic acid"},{"chebi_id":"74767","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-(4<i>R</i>)-4-hydroxy-<small>L</small>-proline","metabolite_id":"ONPXCLZMBSJLSP-CSMHCCOUSA-N","pvalue":0.0171261617511584,"ratio":0.1542442763064196,"synonym_name":"<small>L</small>-Pro-<small>L</small>-Hyp"},{"chebi_id":"16726","direction":"down","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl 6-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside chloride","metabolite_id":"ADZHXBNWNZIHIX-XYGAWYNKSA-N","pvalue":0.0049919489051803,"ratio":0.25134517280191,"synonym_name":"Keracyanin"},{"chebi_id":"162759","direction":"down","inn_name":"","iupac_name":"(2S)-6-amino-2-[[(2S)-3-(4-hydroxyphenyl)-2-[[(2S)-pyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoic acid","metabolite_id":"UIUWGMRJTWHIJZ-ULQDDVLXSA-N","pvalue":0.0066198636786182,"ratio":0.2352526554374099,"synonym_name":""}],"totalFeatures":905},{"comparisonGroups":["Col-0","tt4"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis: tt4 mutation vs wild-type","group_a_title":"Wild-type Arabidopsis thaliana samples.. Serves as the reference group for evaluating the effects of mutations in mto1 and tt4.","group_b_title":"Arabidopsis thaliana samples with tt4 mutation.. Allows for the assessment of metabolic network changes due to the tt4 mutation.","id":"MTBLS40_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS40","studyUrl":"http://integmet.org/study/MTBLS40","title":"Col-0_vs_tt4","topHits":[{"chebi_id":"24996","direction":"up","inn_name":"","iupac_name":"2-hydroxypropanoate","metabolite_id":"JVTAAEKCZFNVCJ-UHFFFAOYSA-M","pvalue":0.0010981585319924,"ratio":1.5560303214624962,"synonym_name":"MeCH(OH)CO2 anion"},{"chebi_id":"17270","direction":"down","inn_name":"","iupac_name":"glycerol 2-(dihydrogen phosphate)","metabolite_id":"DHCLVCXQIBBOPH-UHFFFAOYSA-N","pvalue":0.0015504546898891,"ratio":0.6300447999300445,"synonym_name":"\u03b2-glycerophosphoric acid"}],"totalFeatures":70},{"comparisonGroups":["Wild-Type","Mutant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Photoreceptor outer segment: Bbs1 mutant vs wild-type","group_a_title":"Wild-type samples from photoreceptor outer segment layer.. Provides a reference point for assessing the effects of the mutant genotype on the photoreceptor outer segment layer.","group_b_title":"Mutant samples from photoreceptor outer segment layer.. Allows for the investigation of the effects of Bbs1 mutation on the photoreceptor outer segment layer.","id":"MTBLS4013_0001_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS4013","studyUrl":"http://integmet.org/study/MTBLS4013","title":"Wild-Type_vs_Mutant","topHits":[{"chebi_id":"75557","direction":"up","inn_name":"","iupac_name":"<em>rac</em>-2,3-dihydroxypropyl octadecanoate","metabolite_id":"VBICKXHEKHSIBG-UHFFFAOYSA-N","pvalue":0.013065351031295,"ratio":3.235319086836062,"synonym_name":"(\u00b1)-glyceryl monostearate"},{"chebi_id":"16113","direction":"up","inn_name":"","iupac_name":"cholest-5-en-3\u03b2-ol","metabolite_id":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","pvalue":0.0016319511985973,"ratio":2.035104158670955,"synonym_name":"CHOLESTEROL"}],"totalFeatures":4},{"comparisonGroups":["Control_12h","Toxocara canis_12h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Toxocara canis infection vs control at 12h","group_a_title":"Control samples at 12 hours post infection. Serves as a reference for comparing early infection effects","group_b_title":"Samples infected with Toxocara canis at 12 hours post infection. Provides insight into early lipid alterations due to Toxocara canis infection","id":"MTBLS4015_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":43,"studyId":"MTBLS4015","studyUrl":"http://integmet.org/study/MTBLS4015","title":"Control_12h_vs_Toxocara canis_12h","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RZFIPFIGUWXYNB-WHQCWMRFSA-N","pvalue":0.0047243632418494,"ratio":7.1103725315571,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YMQXVTUOIKUZOT-VANZJBBMSA-N","pvalue":0.0077824737717293,"ratio":0.1386672277165145,"synonym_name":""},{"chebi_id":"75376","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-({[(2<i>S</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropyl palmitate","metabolite_id":"BVJSKAUUFXBDOB-LEWJYISDSA-N","pvalue":0.000594130765633,"ratio":2.527950025507225,"synonym_name":"PG(16:0/0:0)"},{"chebi_id":"187564","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate","metabolite_id":"GXPOZJZFGYCEMT-VEKMRQFKSA-N","pvalue":0.0005977753013646,"ratio":2.3486605138339045,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UWHSPTWBPTXYMF-KUBAVDMBSA-N","pvalue":2.3671644822586112e-05,"ratio":1.7383920969841602,"synonym_name":""},{"chebi_id":"137128","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SFSBFLYKKKQXNO-LLQBBXEXSA-N","pvalue":0.0115618814253053,"ratio":0.3285377033092902,"synonym_name":""},{"chebi_id":"88387","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UJENRFPZRNBKKL-UWKRNJIGSA-N","pvalue":0.0043210217414713,"ratio":2.3205009656949205,"synonym_name":"1-Palmitoyl-2-eicosadienoyl-sn-glycero-3-phosphoinositol"},{"chebi_id":"89382","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"TZGMUGQUTJEGJC-SMHLWGDZSA-N","pvalue":0.0061278199036054,"ratio":0.4185764772517736,"synonym_name":"GPG(18:1n7/22:6n3)"},{"chebi_id":"75304","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"UIXXHROAQSBBOV-PSXMRANNSA-N","pvalue":0.0003121691964411,"ratio":1.7243242951266722,"synonym_name":"1-hexadecanoyl-2-tetradecanoyl-<em>sn</em>-phosphatidylcholine"},{"chebi_id":"183041","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"MGCOSBZSSKOQOR-HBJUBMHUSA-N","pvalue":0.0002155498337383,"ratio":1.680443209121086,"synonym_name":""}],"totalFeatures":213},{"comparisonGroups":["Control_12h","Toxocara canis_12h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Toxocara canis infection vs control at 12h","group_a_title":"Control samples at 12 hours post infection. Serves as a reference for comparing early infection effects","group_b_title":"Samples infected with Toxocara canis at 12 hours post infection. Provides insight into early lipid alterations due to Toxocara canis infection","id":"MTBLS4015_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS4015","studyUrl":"http://integmet.org/study/MTBLS4015","title":"Control_12h_vs_Toxocara canis_12h","topHits":[{"chebi_id":"190200","direction":"up","inn_name":"","iupac_name":"[(2S)-2-hexadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] octadecanoate","metabolite_id":"SXWAFZSPSNNGGS-AXYZMXSISA-N","pvalue":2.0006854571662767e-05,"ratio":10.914392564927295,"synonym_name":""},{"chebi_id":"88998","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XWOGDCXWTYZPKJ-QCSIWSIHSA-N","pvalue":3.2240719249055486e-05,"ratio":9.983018562194609,"synonym_name":"TG(18:0/16:0/18:1n7)"},{"chebi_id":"89970","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(octadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)di-octadec-9-enoate","metabolite_id":"RYNHWWNZNIGDAQ-BMTCQUSZSA-N","pvalue":5.7000430119208835e-05,"ratio":4.820103997851173,"synonym_name":"TAG(54:2)"},{"chebi_id":"127309","direction":"up","inn_name":"","iupac_name":"3-(heptadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)di-octadec-9-enoate","metabolite_id":"ANBFFIILUQJIQL-XFGXVVNZSA-N","pvalue":0.0002769813979699,"ratio":5.956717408541738,"synonym_name":"1-heptadecanoyl-2,3-bis[(9<i>Z</i>)-octadecenoyl]-<em>sn</em>-glycerol"},{"chebi_id":"88940","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"WLFXGZDFDKIDIL-AVVZNEQPSA-N","pvalue":0.0014379713046198,"ratio":8.612902904746171,"synonym_name":"Tracylglycerol(50:3)"},{"chebi_id":"89779","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KGLAHZTWGPHKFF-RISKEULASA-N","pvalue":0.0013468324712227,"ratio":5.915733487812124,"synonym_name":"(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl (9Z,12Z)-octadeca-9,12-dienoate"},{"chebi_id":"132773","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZGVGTPFSVCXVNJ-UHFFFAOYSA-N","pvalue":0.0002407398613504,"ratio":3.909412197658455,"synonym_name":"1,3-dioctadecanoyl-2-hexadecanoylglycerol"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YHMDGPZOSGBQRH-OIVKDUIRSA-N","pvalue":0.008884667484859,"ratio":8.950974375935449,"synonym_name":""},{"chebi_id":"53753","direction":"up","inn_name":"","iupac_name":"propane-1,2,3-triyl tris[(9<i>Z</i>)-octadec-9-enoate]","metabolite_id":"PHYFQTYBJUILEZ-IUPFWZBJSA-N","pvalue":9.803938440761518e-05,"ratio":3.061915219390385,"synonym_name":"1,2,3-tri-(9Z-octadecenoyl)-glycerol"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"WLMHJNWKLOYTGX-JFIUGZSTSA-N","pvalue":0.0001711853400023,"ratio":2.681545563565482,"synonym_name":""}],"totalFeatures":215},{"comparisonGroups":["White_Tea_0h","White_Tea_36h"],"dateCreated":"2025-09-26 00:00:00","display_title":"White tea: 0h vs 36h withering duration","group_a_title":"White tea samples with 0h withering duration.. Serves as the reference point for all subsequent withering durations.","group_b_title":"White tea samples with 36h withering duration.. Captures the full extent of changes in metabolite profile due to withering.","id":"MTBLS403_0001_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":49,"studyId":"MTBLS403","studyUrl":"http://integmet.org/study/MTBLS403","title":"White_Tea_0h_vs_White_Tea_36h","topHits":[{"chebi_id":"9518","direction":"down","inn_name":"","iupac_name":"(4,4',5,5',6,6'-hexahydroxy[biphenyl]-2,2'-diyl)bis[(2<i>R</i>,3<i>R</i>)-5,7-dihydroxy-3,4-dihydro-2<em>H</em>-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)","metabolite_id":"YUULFXAQUWEYNP-GXAWFILRSA-N","pvalue":2.065247221613571e-07,"ratio":1.906050758131689e-06,"synonym_name":"theasinensin A"},{"chebi_id":"136610","direction":"down","inn_name":"","iupac_name":"(2R,3R)-2-{2',3',4,4',5,6-Hexahydroxy-6'-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-2-biphenylyl}-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate","metabolite_id":"CTVAVEOYQKVFFY-DUSGSIEYSA-N","pvalue":9.839451897995928e-08,"ratio":5.82824171661146e-06,"synonym_name":""},{"chebi_id":"65854","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>,8<i>S</i>,14<i>R</i>,15<i>R</i>)-2-(3,4-dihydroxyphenyl)-8-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2<em>H</em>,14<em>H</em>-8,14-methanochromeno[7,8-<em>d</em>][1,3]benzodioxocine-3,5,11,13,15-pentol","metabolite_id":"WODBGULXKVZGQF-QCPBNORNSA-N","pvalue":3.6422680230039874e-06,"ratio":3.1255811627474484e-06,"synonym_name":""},{"chebi_id":"2106","direction":"up","inn_name":"","iupac_name":"5-(<i>trans</i>-caffeoyl)shikimic acid","metabolite_id":"QMPHZIPNNJOWQI-GDDAOPKQSA-N","pvalue":2.9807537944493e-06,"ratio":32630.666666666668,"synonym_name":"5-caffeoylshikimic acid"},{"chebi_id":"58315","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":1.5874278599658676e-15,"ratio":0.0572940902549307,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":9.393086913436245e-16,"ratio":0.0858064131179351,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"136561","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FAVRCIXPIVJIPN-VJDSNFAGSA-N","pvalue":0.001589206562806,"ratio":2.7120715661444875e-06,"synonym_name":"<em>N</em>-(<small>D</small>-fructos-1-yl)phenylalanine"},{"chebi_id":"16414","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":1.5686584811124092e-11,"ratio":0.0683398133523738,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"},{"chebi_id":"58359","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0159582314994928,"ratio":2.991990889188276e-07,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":7.772274286277137e-12,"ratio":0.0887920667283297,"synonym_name":"L-Lysine"}],"totalFeatures":98},{"comparisonGroups":["AMAD_Log","AMAE_Sta"],"dateCreated":"2025-09-26 00:00:00","display_title":"Amastigote stage: Log vs Sta treatment","group_a_title":"Amastigote stage under Log treatment. Provides insight into the effects of Log treatment on amastigote stage.","group_b_title":"Amastigote stage under Sta treatment. Provides insight into the effects of Sta treatment on amastigote stage.","id":"MTBLS4046_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS4046","studyUrl":"http://integmet.org/study/MTBLS4046","title":"AMAD_Log_vs_AMAE_Sta","topHits":[{"chebi_id":"47013","direction":"up","inn_name":"","iupac_name":"<small>D</small>-ribofuranose","metabolite_id":"HMFHBZSHGGEWLO-SOOFDHNKSA-N","pvalue":0.0001218123586426,"ratio":51.27789462855443,"synonym_name":"D-Ribose"},{"chebi_id":"15903","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":0.0002358180714956,"ratio":17.727714193275023,"synonym_name":"beta-D-Glucose"},{"chebi_id":"507393","direction":"up","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":0.000985491662937,"ratio":12.283062872277576,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":3.493771791390136e-05,"ratio":4.730308982776006,"synonym_name":"L-Aspartic acid"},{"chebi_id":"15676","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(2,5-dioxoimidazolidin-4-yl)urea","metabolite_id":"POJWUDADGALRAB-UHFFFAOYSA-N","pvalue":0.0006558234922024,"ratio":3.169971952801881,"synonym_name":"(2,5-Dioxo-4-imidazolidinyl)urea"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0019165317996705,"ratio":0.4918638046513326,"synonym_name":"u"},{"chebi_id":"18189","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-ribofuranose 5-(dihydrogen phosphate)","metabolite_id":"KTVPXOYAKDPRHY-AIHAYLRMSA-N","pvalue":0.0439810466653107,"ratio":1.7560193012818273,"synonym_name":"5-<em>O</em>-phosphono-\u03b1-<small>D</small>-ribofuranose"}],"totalFeatures":10},{"comparisonGroups":["AMAD_Log","AMAE_Sta"],"dateCreated":"2025-09-26 00:00:00","display_title":"Amastigotes: Log vs Sta treatment","group_a_title":"Amastigote stage under Log treatment. Provides insight into the effects of Log treatment on amastigote stage.","group_b_title":"Amastigote stage under Sta treatment. Provides insight into the effects of Sta treatment on amastigote stage.","id":"MTBLS4046_0002_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS4046","studyUrl":"http://integmet.org/study/MTBLS4046","title":"AMAD_Log_vs_AMAE_Sta","topHits":[{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":3.4213891181938133e-05,"ratio":24.69301206307088,"synonym_name":""},{"chebi_id":"16737","direction":"up","inn_name":"","iupac_name":"2-imino-1-methylimidazolidin-4-one","metabolite_id":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","pvalue":2.8428041495899632e-05,"ratio":10.052377712292737,"synonym_name":"cr\u00e9atinine"},{"chebi_id":"30831","direction":"up","inn_name":"","iupac_name":"2-oxobutanoic acid","metabolite_id":"TYEYBOSBBBHJIV-UHFFFAOYSA-N","pvalue":1.371871066749144e-05,"ratio":5.650191870868152,"synonym_name":"\u03b1-ketobutyric acid"},{"chebi_id":"17750","direction":"up","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0002052481619858,"ratio":7.204055052239219,"synonym_name":"Bet"},{"chebi_id":"33384","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":0.001682731717862,"ratio":10.052377047723736,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"15428","direction":"up","inn_name":"","iupac_name":"glycine","metabolite_id":"DHMQDGOQFOQNFH-UHFFFAOYSA-N","pvalue":0.0006914654784855,"ratio":7.108867150426863,"synonym_name":"aminoethanoic acid"},{"chebi_id":"16865","direction":"up","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":0.0008029843276238,"ratio":7.09107705613945,"synonym_name":"GABA"},{"chebi_id":"48517","direction":"down","inn_name":"","iupac_name":"3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"LRFVTYWOQMYALW-UHFFFAOYSA-N","pvalue":0.0012778218814361,"ratio":0.149731274693616,"synonym_name":"Xanthine"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":1.0239824054255591e-05,"ratio":2.835815177564293,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"16643","direction":"up","inn_name":"","iupac_name":"<small>L</small>-methionine","metabolite_id":"FFEARJCKVFRZRR-BYPYZUCNSA-N","pvalue":0.0001829926233308,"ratio":3.4321765972565426,"synonym_name":"L-Methionine"}],"totalFeatures":29},{"comparisonGroups":["Control_No_Glycine","SHMT2_Upregulated_No_Glycine"],"dateCreated":"2025-09-26 00:00:00","display_title":"SHMT2 upregulation effect without glycine treatment","group_a_title":"Control group with no glycine treatment. Provides baseline for comparison with glycine-depleted and treated samples","group_b_title":"SHMT2 upregulated group with no glycine treatment. Examines the effect of SHMT2 upregulation in glycine-depleted conditions","id":"MTBLS405_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS405","studyUrl":"http://integmet.org/study/MTBLS405","title":"Control_No_Glycine_vs_SHMT2_Upregulated_No_Glycine","topHits":[],"totalFeatures":30},{"comparisonGroups":["Control_No_Glycine","SHMT2_Upregulated_No_Glycine"],"dateCreated":"2025-09-26 00:00:00","display_title":"SHMT2 upregulation vs control (no glycine)","group_a_title":"Control group with no glycine treatment. Provides baseline for comparison with glycine-depleted and treated samples","group_b_title":"SHMT2 upregulated group with no glycine treatment. Examines the effect of SHMT2 upregulation in glycine-depleted conditions","id":"MTBLS405_0004_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS405","studyUrl":"http://integmet.org/study/MTBLS405","title":"Control_No_Glycine_vs_SHMT2_Upregulated_No_Glycine","topHits":[],"totalFeatures":21},{"comparisonGroups":["Larva","Pupa"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. japonica: 3-day larva vs 5-day pupa stages","group_a_title":"3-days-old Lysiphlebia japonica larva samples. Provides insight into lipid and gene transcript changes during the larval stage.","group_b_title":"5-days-old Lysiphlebia japonica pupa samples. Provides insight into lipid and gene transcript changes during the pupal stage.","id":"MTBLS409_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS409","studyUrl":"http://integmet.org/study/MTBLS409","title":"Larva_vs_Pupa","topHits":[{"chebi_id":"89113","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SKQBFCOATFWTGJ-GGVIMJHGSA-N","pvalue":1.9131039240202103e-09,"ratio":0.1844563029507664,"synonym_name":"GPCho(38:5)"},{"chebi_id":"72838","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl (1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl phosphate","metabolite_id":"BSNJSZUDOMPYIR-CUKLWHKZSA-M","pvalue":0.0004069465862234,"ratio":0.096929710644974,"synonym_name":"1-palmitoyl-2-linoleoyl-GPI"},{"chebi_id":"42027","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FVXDQWZBHIXIEJ-LNDKUQBDSA-N","pvalue":1.727055455064026e-06,"ratio":0.3066716883882129,"synonym_name":"1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"73858","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IHNKQIMGVNPMTC-RUZDIDTESA-N","pvalue":0.0001064863067198,"ratio":0.2307584250763046,"synonym_name":"Lysophosphatidylcholine(18:0)"},{"chebi_id":"89968","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QQZAQKGMSREYHF-KDEBBMLKSA-N","pvalue":0.0001516707271429,"ratio":0.2279240785529747,"synonym_name":"PC(18:0/18:3)"},{"chebi_id":"72998","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"ASWBNKHCZGQVJV-HSZRJFAPSA-N","pvalue":0.0013715566979959,"ratio":0.1514546832493425,"synonym_name":"PC(16:0/0:0)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KZVRAFHIKMDULK-PDPKURFXSA-N","pvalue":0.0001254674469299,"ratio":0.4722172770983753,"synonym_name":""},{"chebi_id":"89372","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DLZPSAPMHALIOA-YNCVDBFYSA-N","pvalue":3.506055858765526e-05,"ratio":0.5321044803542557,"synonym_name":"1-Arachidonyl-2-g-linolenoyl-sn-glycero-3-phosphocholine"},{"chebi_id":"89999","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MVDFTRYOOPZXII-JEPFLRBFSA-N","pvalue":0.0001484497266148,"ratio":0.4809572151269041,"synonym_name":"(2-{[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(11Z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium"},{"chebi_id":"89144","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SRBHCRWAHUOXQL-WNWAWKNRSA-N","pvalue":0.0009462698937013,"ratio":0.4287935231655388,"synonym_name":"Phosphatidylinositol(20:1w9/18:2w6)"}],"totalFeatures":18},{"comparisonGroups":["Larva","Pupa"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. japonica: 3-day larva vs 5-day pupa development","group_a_title":"3-days-old Lysiphlebia japonica larva samples. Provides insight into lipid and gene transcript changes during the larval stage.","group_b_title":"5-days-old Lysiphlebia japonica pupa samples. Provides insight into lipid and gene transcript changes during the pupal stage.","id":"MTBLS409_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS409","studyUrl":"http://integmet.org/study/MTBLS409","title":"Larva_vs_Pupa","topHits":[{"chebi_id":"88945","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZKEWGTVAIGJNBK-VLBIAFCBSA-N","pvalue":4.352786709262766e-07,"ratio":0.1103084385562033,"synonym_name":"Tracylglycerol(16:0/16:0/18:1n7)"},{"chebi_id":"127309","direction":"down","inn_name":"","iupac_name":"3-(heptadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)di-octadec-9-enoate","metabolite_id":"ANBFFIILUQJIQL-XFGXVVNZSA-N","pvalue":1.3996070836773807e-05,"ratio":0.1881521801461789,"synonym_name":"1-heptadecanoyl-2,3-bis[(9<i>Z</i>)-octadecenoyl]-<em>sn</em>-glycerol"},{"chebi_id":"42027","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FVXDQWZBHIXIEJ-LNDKUQBDSA-N","pvalue":2.2682618675749124e-05,"ratio":0.1973943139412661,"synonym_name":"1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"89541","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FEFYKLQDFZXIQW-ATJXVOTKSA-N","pvalue":2.9857322442038648e-05,"ratio":0.2853422424600207,"synonym_name":"PC(18:2w6/18:1w9)"},{"chebi_id":"131977","direction":"down","inn_name":"","iupac_name":"2,3-bis{[(9<i>Z</i>)-octadec-9-enoyl]oxy}propyl (11<i>Z</i>)-icos-11-enoate","metabolite_id":"QXMHHXQBBKDSSL-BAQZNRHJSA-N","pvalue":2.7770187991106108e-05,"ratio":0.2911688404813501,"synonym_name":"TAG(18:1n9/18:1n9/20:1n9)"},{"chebi_id":"45956","direction":"down","inn_name":"","iupac_name":"propane-1,2,3-triyl trioctadecanoate","metabolite_id":"DCXXMTOCNZCJGO-UHFFFAOYSA-N","pvalue":0.0004904705526953,"ratio":0.2564613330666588,"synonym_name":"2,3-di(octadecanoyloxy)propyl octadecanoate"},{"chebi_id":"89439","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QFDYIDGUKXRPKH-VSLGLSMXSA-N","pvalue":1.9957604488766513e-05,"ratio":0.4005243053663822,"synonym_name":"Phosphatidylcholine(36:5)"},{"chebi_id":"75036","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl phosphate","metabolite_id":"BBYWOYAFBUOUFP-JOCHJYFZSA-N","pvalue":6.432352897610478e-05,"ratio":0.3905029415030151,"synonym_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(stearoyloxy)propyl phosphate"},{"chebi_id":"89970","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(octadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)di-octadec-9-enoate","metabolite_id":"RYNHWWNZNIGDAQ-BMTCQUSZSA-N","pvalue":0.0002518762331304,"ratio":0.4004102643236778,"synonym_name":"TAG(54:2)"},{"chebi_id":"84831","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(6<i>Z</i>,9<i>Z</i>)-octadeca-6,9-dienoyloxy]-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"BXRLDROZWDUSGM-ZRYFCQOPSA-N","pvalue":0.001021218931088,"ratio":0.4687687390608684,"synonym_name":"PC(18:1/18:2)"}],"totalFeatures":27},{"comparisonGroups":["Summer","Winter"],"dateCreated":"2025-09-26 00:00:00","display_title":"C. fortunei: summer vs winter seasonal comparison","group_a_title":"Samples collected during the summer season. Represents the metabolic profile of C. fortunei during summer","group_b_title":"Samples collected during the winter season. Represents the metabolic profile of C. fortunei during winter","id":"MTBLS4099_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":137,"studyId":"MTBLS4099","studyUrl":"http://integmet.org/study/MTBLS4099","title":"Summer_vs_Winter","topHits":[{"chebi_id":"63154","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-\u03b2-<small>D</small>-mannopyranose","metabolite_id":"OVRNDRQMDRJTHS-OZRXBMAMSA-N","pvalue":3.360148858060736e-06,"ratio":50.152408290333035,"synonym_name":"<em>N</em>-acetyl-\u03b2-mannosamine"},{"chebi_id":"37655","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2,3,4-trihydroxybutanoic acid","metabolite_id":"JPIJQSOTBSSVTP-PWNYCUMCSA-N","pvalue":2.1204646569668135e-09,"ratio":0.1065660199501505,"synonym_name":"erythro-2,3,4-Trihydroxybutyric acid"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":1.2895250583739664e-05,"ratio":0.0386781840410827,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"16112","direction":"down","inn_name":"","iupac_name":"edit(1<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3-{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid","metabolite_id":"CWVRJTMFETXNAD-JUHZACGLSA-N","pvalue":0.0004670149656398,"ratio":0.0092489194008149,"synonym_name":"5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid"},{"chebi_id":"177941","direction":"up","inn_name":"","iupac_name":"(2S)-2-[(2-aminoacetyl)amino]-3-(4-hydroxyphenyl)propanoic acid;dihydrate","metabolite_id":"VELZBUAWAUZDLF-WWPIYYJJSA-N","pvalue":1.021264892970068e-07,"ratio":6.779839182841081,"synonym_name":""},{"chebi_id":"16695","direction":"down","inn_name":"","iupac_name":"5'-uridylic acid","metabolite_id":"DJJCXFVJDGTHFX-XVFCMESISA-N","pvalue":2.5646699237883677e-05,"ratio":0.0545670515157224,"synonym_name":"pU"},{"chebi_id":"90","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","pvalue":0.0002465220844825,"ratio":0.0256680785823725,"synonym_name":"(-)-Epicatechin"},{"chebi_id":"192856","direction":"down","inn_name":"","iupac_name":"N-[(E)-1H-indol-3-ylmethylideneamino]benzamide","metabolite_id":"GPZLLYBQEWHEKL-WOJGMQOQSA-N","pvalue":1.3471244222091645e-06,"ratio":0.1085774658313,"synonym_name":""},{"chebi_id":"17566","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-indol-3-ylacetonitrile","metabolite_id":"DMCPFOBLJMLSNX-UHFFFAOYSA-N","pvalue":1.3906645790911209e-06,"ratio":0.1271281768532277,"synonym_name":"(Indole-3-yl)acetonitrile"},{"chebi_id":"15584","direction":"down","inn_name":"","iupac_name":"2-hydroxy-2-methylbutanedioic acid","metabolite_id":"XFTRTWQBIOMVPK-UHFFFAOYSA-N","pvalue":9.399517619863156e-07,"ratio":0.164055174209639,"synonym_name":"2-methylmalic acid"}],"totalFeatures":269},{"comparisonGroups":["Summer","Winter"],"dateCreated":"2025-09-26 00:00:00","display_title":"C. fortunei: summer vs winter metabolic profiles","group_a_title":"Samples collected during the summer season. Represents the metabolic profile of C. fortunei during summer","group_b_title":"Samples collected during the winter season. Represents the metabolic profile of C. fortunei during winter","id":"MTBLS4099_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":307,"studyId":"MTBLS4099","studyUrl":"http://integmet.org/study/MTBLS4099","title":"Summer_vs_Winter","topHits":[{"chebi_id":"50202","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4<em>H</em>-chromen-4-one","metabolite_id":"FTVWIRXFELQLPI-UHFFFAOYSA-N","pvalue":6.901388561690678e-06,"ratio":1.6320442776598183e-10,"synonym_name":""},{"chebi_id":"176313","direction":"up","inn_name":"","iupac_name":"(2R,3S,4S,5R,6S)-2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol","metabolite_id":"KWRQPASKWCJCPI-DOGUGFTJSA-N","pvalue":3.634576080576097e-06,"ratio":575313415.0040162,"synonym_name":""},{"chebi_id":"133420","direction":"up","inn_name":"","iupac_name":"(3\u03b2,21\u03b2,22\u03b2)-21,22,24-trihydroxyolean-12-en-3-yl 6-deoxy-\u03b1-<small>L</small>-mannopyranosyl-(1\u21922)-\u03b2-<small>D</small>-galactopyranosyl-(1\u21922)-\u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"NQGDGFITHGCDAO-ULCPARNTSA-N","pvalue":8.149268987410128e-06,"ratio":690210000.7068273,"synonym_name":""},{"chebi_id":"168987","direction":"up","inn_name":"","iupac_name":"2-(1-hydroxy-2,4,6-trimethyl-3-oxo-1,2-dihydroinden-5-yl)ethyl acetate","metabolite_id":"KBPAOKSMUDDOIN-UHFFFAOYSA-N","pvalue":5.225139537987741e-06,"ratio":202058885.5196787,"synonym_name":""},{"chebi_id":"174152","direction":"up","inn_name":"","iupac_name":"1-(2,4,5-trimethoxyphenyl)propan-2-one","metabolite_id":"AQZHZTTUVYQMIN-UHFFFAOYSA-N","pvalue":5.916347201052071e-06,"ratio":97744019.99036144,"synonym_name":""},{"chebi_id":"169040","direction":"down","inn_name":"","iupac_name":"2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxybutanedioic acid","metabolite_id":"PMKQSEYPLQIEAY-DUXPYHPUSA-N","pvalue":4.5514835248068414e-05,"ratio":3.457118235403184e-09,"synonym_name":""},{"chebi_id":"174178","direction":"down","inn_name":"","iupac_name":"4-methoxy-7-methyluro[2,3-g]isochromen-5-one","metabolite_id":"BUZQIMYNOWPYHH-UHFFFAOYSA-N","pvalue":9.33933522491091e-05,"ratio":3.583628161137456e-09,"synonym_name":""},{"chebi_id":"176242","direction":"up","inn_name":"","iupac_name":"methyl 1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-(3,4,5-trihydroxyoxan-2-yl)oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate","metabolite_id":"ZCWVJVNYHGWIEF-UHFFFAOYSA-N","pvalue":0.000653543274342,"ratio":698049934.7148594,"synonym_name":""},{"chebi_id":"191758","direction":"down","inn_name":"","iupac_name":"[(2R,3S,4S,5R,6S)-6-[3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"GVLNXQDHAFPPFW-HESOAOHTSA-N","pvalue":3.73054634452348e-06,"ratio":1.11307283695342e-05,"synonym_name":""},{"chebi_id":"192891","direction":"down","inn_name":"","iupac_name":"3-[(2S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxychromen-4-one","metabolite_id":"MFWGLPLRRMATKY-NZMIIWMXSA-N","pvalue":0.0012589635298736,"ratio":1.6497098880296002e-09,"synonym_name":""}],"totalFeatures":409},{"comparisonGroups":["Summer","Winter"],"dateCreated":"2025-09-26 00:00:00","display_title":"C. fortunei: summer vs winter metabolic profiles","group_a_title":"Samples collected during the summer season. Represents the metabolic profile of C. fortunei during summer","group_b_title":"Samples collected during the winter season. Represents the metabolic profile of C. fortunei during winter","id":"MTBLS4099_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":389,"studyId":"MTBLS4099","studyUrl":"http://integmet.org/study/MTBLS4099","title":"Summer_vs_Winter","topHits":[{"chebi_id":"185320","direction":"down","inn_name":"","iupac_name":"5-[[6-[2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid","metabolite_id":"VGZBSVLZAQPYAD-UHFFFAOYSA-N","pvalue":5.248763982470175e-05,"ratio":5.540311296215768e-10,"synonym_name":""},{"chebi_id":"83032","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-3-[4-(\u03b2-<small>D</small>-glucopyranosyloxy)phenyl]prop-2-enoic acid","metabolite_id":"LJFYQZQUAULRDF-FDGSXQGBSA-N","pvalue":4.304870808070738e-05,"ratio":5.734672309867812e-09,"synonym_name":"4-O-beta-D-Glucosyl-4-coumaric acid"},{"chebi_id":"191498","direction":"down","inn_name":"","iupac_name":"1-O-methyl 3-O-[[3,4,5-trihydroxy-6-[3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl] propanedioate","metabolite_id":"DQNRUSGVMUYAHO-UHFFFAOYSA-N","pvalue":8.591177050411904e-05,"ratio":3.2381115466542395e-09,"synonym_name":""},{"chebi_id":"190407","direction":"down","inn_name":"","iupac_name":"(2S,3S,4S,5R,6S)-6-[[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-chromen-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"FDWDKTKDGDLDTP-BBGDWMAASA-N","pvalue":6.802431167300935e-07,"ratio":0.0005220793335687,"synonym_name":""},{"chebi_id":"186226","direction":"up","inn_name":"","iupac_name":"2-[5-hydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"DFFIGKBKMNZWMC-UHFFFAOYSA-N","pvalue":3.729203294151946e-06,"ratio":4675.833902446032,"synonym_name":""},{"chebi_id":"81227","direction":"down","inn_name":"","iupac_name":"(1<small><sup>2</small></sup><i>R</i>,1<small><sup>3</small></sup><i>R</i>,1<small><sup>4</small></sup><i>R</i>,2<small><sup>2</small></sup><i>R</i>,2<small><sup>3</small></sup><i>R</i>,2<small><sup>4</small></sup>R,3<small><sup>2</small></sup><i>R</i>,3<small><sup>3</small></sup><i>R</i>,3<small><sup>4</small></sup><i>S</i>,4<small><sup>2</small></sup><i>R</i>,4<small><sup>3</small></sup><i>R</i>)-1<small><sup>2</small></sup>,2<small><sup>2</small></sup>,3<small><sup>2</small></sup>,4<small><sup>2</small></sup>-tetrakis(3,4-dihydroxyphenyl)-1<small><sup>3</small></sup>,1<small><sup>4</small></sup>,2<small><sup>3</small></sup>,2<small><sup>4</small></sup>,3<small><sup>3</small></sup>,3<small><sup>4</small></sup>,4<small><sup>3</small></sup>,4<small><sup>4</small></sup>-octahydro-1<small><sup>2</small></sup><em>H</em>,2<small><sup>2</small></sup><em>H</em>,3<small><sup>2</small></sup>H,4<small><sup>2</small></sup>2<em>H</em>-[1<small><sup>4</small></sup>,2<small><sup>8</small></sup>:2<small><sup>4</small></sup>,3<small><sup>8</small></sup>:3<small><sup>4</small></sup>,4<small><sup>8</small></sup>-quater-1-benzopyran]-1<small><sup>3</small></sup>,1<small><sup>5</small></sup>,1<small><sup>7</small></sup>,2<small><sup>3</small></sup>,2<small><sup>5</small></sup>,2<small><sup>7</small></sup>,3<small><sup>3</small></sup>,3<small><sup>5</small></sup>,3<small><sup>7</small></sup>,4<small><sup>3</small></sup>,4<small><sup>5</small></sup>,4<small><sup>7</small></sup>-dodecol","metabolite_id":"QFLMUASKTWGRQE-JNIIMKSASA-N","pvalue":3.839770007747799e-06,"ratio":0.0012584567570871,"synonym_name":""},{"chebi_id":"168370","direction":"down","inn_name":"","iupac_name":"7,13-bis(3,4-dihydroxyphenyl)-6,12,14-trioxapentacyclo[11.7.1.02,11.05,10.015,20]henicosa-2(11),3,5(10),15,17,19-hexaene-3,8,17,19,21-pentol","metabolite_id":"SHYPVJZSIOEHJY-UHFFFAOYSA-N","pvalue":1.6915842305819958e-05,"ratio":0.0005244996099936,"synonym_name":""},{"chebi_id":"169282","direction":"down","inn_name":"","iupac_name":"3-(1,3-benzodioxol-5-yl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one","metabolite_id":"GWACEFYEIOPAJV-MIUGBVLSSA-N","pvalue":5.686200478866472e-06,"ratio":0.0024309580755966,"synonym_name":""},{"chebi_id":"156174","direction":"up","inn_name":"","iupac_name":"(3R,3aR,6aR,8S,9S,9aR,9bR)-3,8-dihydroxy-3-(hydroxymethyl)-9-methyl-6-methylidene-4,5,6a,7,8,9,9a,9b-octahydro-3aH-azuleno[4,5-b]uran-2-one","metabolite_id":"OHBHGGYGWZIWCX-UOHBJPFUSA-N","pvalue":1.3399601499273725e-07,"ratio":96.4472181333384,"synonym_name":""},{"chebi_id":"185657","direction":"down","inn_name":"","iupac_name":"[2,4-dihydroxy-6-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]phenyl] acetate","metabolite_id":"MZWQVUHXBWQZLY-MLAGYPMBSA-N","pvalue":0.0205379435835459,"ratio":8.896737791087221e-09,"synonym_name":""}],"totalFeatures":564},{"comparisonGroups":["Unparasitized_Aphids","Parasitized_Aphids"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aphids: parasitized vs unparasitized by L. japonica","group_a_title":"Aphids that have not been parasitized by Lysiphlebia japonica.. Provides a reference point for understanding the effects of parasitization on lipid metabolism.","group_b_title":"Aphids that have been parasitized by Lysiphlebia japonica.. Key to understanding the molecular changes induced by parasitization.","id":"MTBLS410_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS410","studyUrl":"http://integmet.org/study/MTBLS410","title":"Unparasitized_vs_Parasitized","topHits":[{"chebi_id":"73858","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IHNKQIMGVNPMTC-RUZDIDTESA-N","pvalue":1.3228904044315698e-07,"ratio":0.0564872407590835,"synonym_name":"Lysophosphatidylcholine(18:0)"},{"chebi_id":"86088","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(pentadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"LJARBVLDSOWRJT-PSXMRANNSA-N","pvalue":5.104372573250292e-10,"ratio":7.142510565190084,"synonym_name":"Phosphatidylcholine(15:0/15:0)"},{"chebi_id":"133623","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(9<i>Z</i>)-octadec-9-enoyl]oxy}-3-(pentadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"ZEWLMKXMNQOCOQ-KUNNKMQBSA-N","pvalue":8.885934530770739e-05,"ratio":18.847364497744383,"synonym_name":"1-pentadecanoyl-2-oleoyl-GPC"},{"chebi_id":"88602","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FTAJUMMOKVEZBE-BPSMPOADSA-N","pvalue":7.155710069080784e-07,"ratio":6.355667313431914,"synonym_name":"1-(11Z-Octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KZVRAFHIKMDULK-PDPKURFXSA-N","pvalue":7.630324239342044e-07,"ratio":4.824097296827305,"synonym_name":""},{"chebi_id":"72998","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"ASWBNKHCZGQVJV-HSZRJFAPSA-N","pvalue":0.0001335550536649,"ratio":0.0943685124780014,"synonym_name":"PC(16:0/0:0)"},{"chebi_id":"88560","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AWOYEONIQYBDHZ-HGTJTCKHSA-N","pvalue":0.0001238251116324,"ratio":4.161849520850201,"synonym_name":"PI(34:0)"},{"chebi_id":"74968","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(icosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"UATOAILWGVYRQS-HHHXNRCGSA-N","pvalue":2.759135500603147e-05,"ratio":0.3702317806162414,"synonym_name":"LPC(20:0)"},{"chebi_id":"72838","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl (1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl phosphate","metabolite_id":"BSNJSZUDOMPYIR-CUKLWHKZSA-M","pvalue":0.0002442168061993,"ratio":2.8088260068031157,"synonym_name":"1-palmitoyl-2-linoleoyl-GPI"},{"chebi_id":"89372","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DLZPSAPMHALIOA-YNCVDBFYSA-N","pvalue":0.0001167855119817,"ratio":0.3979663220003231,"synonym_name":"1-Arachidonyl-2-g-linolenoyl-sn-glycero-3-phosphocholine"}],"totalFeatures":18},{"comparisonGroups":["Unparasitized_Aphids","Parasitized_Aphids"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aphids: parasitized vs unparasitized by L. japonica","group_a_title":"Aphids that have not been parasitized by Lysiphlebia japonica.. Provides a reference point for understanding the effects of parasitization on lipid metabolism.","group_b_title":"Aphids that have been parasitized by Lysiphlebia japonica.. Key to understanding the molecular changes induced by parasitization.","id":"MTBLS410_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS410","studyUrl":"http://integmet.org/study/MTBLS410","title":"Unparasitized_vs_Parasitized","topHits":[{"chebi_id":"89439","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QFDYIDGUKXRPKH-VSLGLSMXSA-N","pvalue":2.1148425371281574e-09,"ratio":16.279286397703054,"synonym_name":"Phosphatidylcholine(36:5)"},{"chebi_id":"90036","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BWQAJZLCZFRDSD-FQGNUJBYSA-N","pvalue":3.7409578280746675e-08,"ratio":21.303721721015144,"synonym_name":"PS(18:0/16:1n7)"},{"chebi_id":"86162","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"HAIPHKFLSXSDAN-BLOCXYQCSA-N","pvalue":1.4333842342335222e-06,"ratio":39.08113824871734,"synonym_name":"PC(14:0/22:6)"},{"chebi_id":"88488","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-({[(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid","metabolite_id":"ZTNFQEXYTMNFHG-SOFXVBFTSA-N","pvalue":1.7660843916573305e-08,"ratio":10.431559346409673,"synonym_name":"Phosphatidylserine(36:4)"},{"chebi_id":"89601","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PPCVNZFMCABQCL-KXESGEQTSA-N","pvalue":3.2909421401450833e-06,"ratio":17.684743460858133,"synonym_name":"PC(18:2n6/16:1n7)"},{"chebi_id":"88486","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HCMPQQOKSNDTHI-UTJDFHGQSA-N","pvalue":2.014897394481243e-05,"ratio":22.454326573819767,"synonym_name":"PS(18:2n6/18:1n9)"},{"chebi_id":"75101","direction":"up","inn_name":"","iupac_name":"<em>O</em>-[{(2<i>R</i>)-2-[(9<i>Z</i>)-hexadec-9-enoyloxy]-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propoxy}(hydroxy)phosphoryl]-<small>L</small>-serine","metabolite_id":"JSCZUPSIMWRJHP-KQQJSZDRSA-N","pvalue":2.7315931105108537e-05,"ratio":14.5857843999076,"synonym_name":"1-Oleoyl-2-palmitoleoyl-sn-glycero-3-phosphoserine"},{"chebi_id":"42027","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FVXDQWZBHIXIEJ-LNDKUQBDSA-N","pvalue":1.2239889922131854e-06,"ratio":7.815948975428136,"synonym_name":"1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"84831","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(6<i>Z</i>,9<i>Z</i>)-octadeca-6,9-dienoyloxy]-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"BXRLDROZWDUSGM-ZRYFCQOPSA-N","pvalue":1.678013349772615e-06,"ratio":8.09720021951335,"synonym_name":"PC(18:1/18:2)"},{"chebi_id":"88430","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XYZGDARMQJBJAP-WKOATJLPSA-N","pvalue":5.0823154673672675e-06,"ratio":6.054347822895817,"synonym_name":"Phosphatidylcholine(36:6)"}],"totalFeatures":27},{"comparisonGroups":["Control","FJ_intake"],"dateCreated":"2025-09-26 00:00:00","display_title":"Fruit juice intake vs control (normal saline)","group_a_title":"Control group with normal saline. Provides a baseline for comparison with FJ and FB intake groups.","group_b_title":"Fruit juice intake group. Evaluates the health outcomes of fruit juice intake.","id":"MTBLS4108_0001_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS4108","studyUrl":"http://integmet.org/study/MTBLS4108","title":"Control_vs_FJ_intake","topHits":[],"totalFeatures":8},{"comparisonGroups":["Control","FJ_intake"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs fruit juice intake comparison","group_a_title":"Control group with normal saline. Provides a baseline for comparison with FJ and FB intake groups.","group_b_title":"Fruit juice intake group. Evaluates the health outcomes of fruit juice intake.","id":"MTBLS4108_0002_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS4108","studyUrl":"http://integmet.org/study/MTBLS4108","title":"Control_vs_FJ_intake","topHits":[],"totalFeatures":83},{"comparisonGroups":["Susceptible","Resistant"],"dateCreated":"2025-09-26 00:00:00","display_title":"K. pneumoniae: Polymyxin B resistant vs susceptible","group_a_title":"Experimental samples of Klebsiella pneumoniae susceptible to Polymyxin B.. Serves as the reference point for comparing resistant strains.","group_b_title":"Experimental samples of Klebsiella pneumoniae resistant to Polymyxin B.. Allows for the study of resistance mechanisms and comparison with susceptible strains.","id":"MTBLS4132_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS4132","studyUrl":"http://integmet.org/study/MTBLS4132","title":"Susceptible_vs_Resistant","topHits":[{"chebi_id":"71052","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-2-aminohexadec-4-ene-1,3-diol","metabolite_id":"BTUSGZZCQZACPT-YYZTVXDQSA-N","pvalue":1.3474523736403492e-09,"ratio":0.2226774147643971,"synonym_name":"hexadecasphingosine"},{"chebi_id":"46961","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>,4<i>R</i>)-2-aminooctadecane-1,3,4-triol","metabolite_id":"AERBNCYCJBRYDG-KSZLIROESA-N","pvalue":4.66844177932908e-06,"ratio":0.1641031171209712,"synonym_name":"4-D-Hydroxysphinganine"},{"chebi_id":"189567","direction":"down","inn_name":"","iupac_name":"[(2S,3S,4R)-3,4-dihydroxy-2-(2-hydroxyicosanoylamino)octadecyl] [(5R)-2,3,4,5,6-pentahydroxycyclohexyl] hydrogen phosphate","metabolite_id":"JDDPIZZUPYSPAY-ZSQVXSMXSA-N","pvalue":9.0248609825435e-06,"ratio":0.1790031472501481,"synonym_name":""},{"chebi_id":"165589","direction":"down","inn_name":"","iupac_name":"N-(2-hydroxyethyl)pentadecanamide","metabolite_id":"UHPXXKLAACDXGS-UHFFFAOYSA-N","pvalue":0.0004038338235521,"ratio":0.1580047111147454,"synonym_name":""},{"chebi_id":"90028","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YQBIRCWGTRXVEA-NUZFNMCPSA-N","pvalue":1.9513865352048937e-05,"ratio":0.511249918282635,"synonym_name":"PSer(16:1n7/16:0)"},{"chebi_id":"28123","direction":"down","inn_name":"","iupac_name":"2,2'-iminodiethanol","metabolite_id":"ZBCBWPMODOFKDW-UHFFFAOYSA-N","pvalue":2.423314954482577e-05,"ratio":0.5150051618669316,"synonym_name":"<em>N</em>,<em>N</em>-di(hydroxyethyl)amine"},{"chebi_id":"189566","direction":"down","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-2-dodecanoyloxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"QKISPFFHFYCBQG-ZWXJPIIXSA-N","pvalue":0.0002479330117395,"ratio":0.6536039827244814,"synonym_name":""},{"chebi_id":"165721","direction":"up","inn_name":"","iupac_name":"2-[(Z)-octadec-9-enoyl]oxyethyl (Z)-octadec-9-enoate","metabolite_id":"NKSOSPOXQKNIKJ-CLFAGFIQSA-N","pvalue":0.0038315404087299,"ratio":1.6061874866081212,"synonym_name":""},{"chebi_id":"170217","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (Z)-octadec-11-enoate","metabolite_id":"QVUWNEQTPVMHQT-RLSIPVDZSA-N","pvalue":0.0085186361422684,"ratio":0.5991564041799715,"synonym_name":""},{"chebi_id":"189564","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-2-dodecanoyloxy-3-[(Z)-octadec-1-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"YHFQOJAJZJQFEQ-MHBUEFIPSA-N","pvalue":0.0172231429578932,"ratio":1.5445697293902645,"synonym_name":""}],"totalFeatures":18},{"comparisonGroups":["Control","Myocardial-intrinsic defects"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs myocardial intrinsic defects","group_a_title":"Control group with no myocardial defects. Provides a reference point for comparison with the myocardial-intrinsic defects group.","group_b_title":"Group with myocardial-intrinsic defects. Represents the experimental group with induced myocardial defects for comparison against the control group.","id":"MTBLS4176_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS4176","studyUrl":"http://integmet.org/study/MTBLS4176","title":"Control_vs_Myocardial_intrinsic_defects","topHits":[{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0382097857614167,"ratio":0.0006962573395319,"synonym_name":"GMP"},{"chebi_id":"456215","direction":"down","inn_name":"","iupac_name":"5'-<em>O</em>-phosphonatoadenosine","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-L","pvalue":1.36813886753243e-05,"ratio":0.342615069942859,"synonym_name":"AMP dianion"},{"chebi_id":"46398","direction":"up","inn_name":"","iupac_name":"uridine 5'-triphosphate(4\u2212)","metabolite_id":"PGAVKCOVUIYSFO-XVFCMESISA-J","pvalue":0.0031057016256652,"ratio":7.232553147692429,"synonym_name":"URIDINE 5'-TRIPHOSPHATE"},{"chebi_id":"57600","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]guanosine","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-K","pvalue":0.0054435892167359,"ratio":5.8114033322939544,"synonym_name":"GTP trianion"},{"chebi_id":"57299","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-K","pvalue":0.0243410870455475,"ratio":2.1525077658869973,"synonym_name":""}],"totalFeatures":11},{"comparisonGroups":["Sham","Radiofrequency"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sham vs 4.9 GHz radiofrequency exposure","group_a_title":"Control group with sham exposure to radiofrequency field.. Provides baseline data to compare against the effects of radiofrequency exposure.","group_b_title":"Treatment group exposed to 4.9 GHz radiofrequency field.. Key group for assessing the impact of radiofrequency exposure on biological parameters.","id":"MTBLS4186_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS4186","studyUrl":"http://integmet.org/study/MTBLS4186","title":"Sham_vs_Radiofrequency","topHits":[{"chebi_id":"134470","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(4-{[(2-amino-5-methyl-4-oxo-1,4,5,8-tetrahydropteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid","metabolite_id":"VWNDXSYYCICZGD-ZDUSSCGKSA-N","pvalue":0.0044275403235738,"ratio":1.6328032972111,"synonym_name":"5-Methyldihydrofolate"},{"chebi_id":"173889","direction":"up","inn_name":"","iupac_name":"1-(2-aminopropanoyl)pyrrolidine-2-carboxylic acid","metabolite_id":"WPWUFUBLGADILS-UHFFFAOYSA-N","pvalue":0.0035732967752463,"ratio":1.5860777982276315,"synonym_name":""},{"chebi_id":"169285","direction":"up","inn_name":"","iupac_name":"6-[3-[(1E)-buta-1,3-dienyl]-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"JTWWNKDAYGMPDG-HWKANZROSA-N","pvalue":0.0048644676783839,"ratio":1.6071322773160428,"synonym_name":""},{"chebi_id":"168730","direction":"up","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[2-hydroxy-6-methoxy-3-[1-oxo-1-(2,4,6-trihydroxyphenyl)propan-2-yl]phenoxy]oxane-2-carboxylic acid","metabolite_id":"PIXBPENFPLPJLW-UHFFFAOYSA-N","pvalue":0.0060438260775521,"ratio":1.5592558605944788,"synonym_name":""},{"chebi_id":"17713","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-adenylic acid","metabolite_id":"KHWCHTKSEGGWEX-RRKCRQDMSA-N","pvalue":0.0145593994136099,"ratio":1.5377164085727415,"synonym_name":"2'-deoxyadenosine monophosphate"}],"totalFeatures":589},{"comparisonGroups":["Sham","Radiofrequency"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sham vs 4.9 GHz radiofrequency exposure","group_a_title":"Control group with sham exposure to radiofrequency field.. Provides baseline data to compare against the effects of radiofrequency exposure.","group_b_title":"Treatment group exposed to 4.9 GHz radiofrequency field.. Key group for assessing the impact of radiofrequency exposure on biological parameters.","id":"MTBLS4186_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS4186","studyUrl":"http://integmet.org/study/MTBLS4186","title":"Sham_vs_Radiofrequency","topHits":[{"chebi_id":"165526","direction":"down","inn_name":"","iupac_name":"(2E,8E)-N-(2-methylpropyl)dodeca-2,8-dienamide","metabolite_id":"JNPRQUIWDVDHIT-GYIPPJPDSA-N","pvalue":0.0035209440875456,"ratio":0.6470212636390339,"synonym_name":""}],"totalFeatures":471},{"comparisonGroups":["Healthy Control","Osteoarticular Tuberculosis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs osteoarticular tuberculosis patients","group_a_title":"Samples from healthy control group. Serves as a reference for identifying deviations in metabolic profiles due to disease.","group_b_title":"Samples from patients with osteoarticular tuberculosis. Crucial for identifying metabolic changes associated with osteoarticular tuberculosis.","id":"MTBLS4187_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS4187","studyUrl":"http://integmet.org/study/MTBLS4187","title":"Healthy_Control_vs_Osteoarticular_Tuberculosis","topHits":[{"chebi_id":"28125","direction":"up","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoic acid","metabolite_id":"MBMBGCFOFBJSGT-KUBAVDMBSA-N","pvalue":7.11787808170186e-08,"ratio":2.102163593306061,"synonym_name":"Docosahexaenoic acid"},{"chebi_id":"28842","direction":"up","inn_name":"","iupac_name":"octadecanoic acid","metabolite_id":"QIQXTHQIDYTFRH-UHFFFAOYSA-N","pvalue":0.0004341671567886,"ratio":1.5988268782928572,"synonym_name":"Stearins\u00e4ure"}],"totalFeatures":6},{"comparisonGroups":["Healthy Control","Osteoarticular Tuberculosis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy control vs osteoarticular tuberculosis","group_a_title":"Samples from healthy control group. Serves as a reference for identifying deviations in metabolic profiles due to disease.","group_b_title":"Samples from patients with osteoarticular tuberculosis. Crucial for identifying metabolic changes associated with osteoarticular tuberculosis.","id":"MTBLS4187_0002_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS4187","studyUrl":"http://integmet.org/study/MTBLS4187","title":"Healthy_Control_vs_Osteoarticular_Tuberculosis","topHits":[{"chebi_id":"16643","direction":"up","inn_name":"","iupac_name":"<small>L</small>-methionine","metabolite_id":"FFEARJCKVFRZRR-BYPYZUCNSA-N","pvalue":2.5125751728081107e-16,"ratio":1.881862425766497,"synonym_name":"L-Methionine"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":2.683387911892511e-16,"ratio":1.5320046038332205,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":5.153646403990803e-12,"ratio":1.6615487938457585,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"57912","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":4.2395352623288035e-12,"ratio":1.646664287361871,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"18019","direction":"up","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":1.022918301836497e-11,"ratio":1.6696264574896325,"synonym_name":"L-Lysine"},{"chebi_id":"15699","direction":"up","inn_name":"","iupac_name":"<small>L</small>-homoserine","metabolite_id":"UKAUYVFTDYCKQA-VKHMYHEASA-N","pvalue":2.0018211367908585e-11,"ratio":1.612498201066842,"synonym_name":"2-Amino-4-hydroxybutanoic acid"},{"chebi_id":"57595","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-imidazol-4-yl)propanoate","metabolite_id":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","pvalue":6.591257389720728e-06,"ratio":1.725356944590552,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"133660","direction":"up","inn_name":"","iupac_name":"2-azaniumyloctanoate","metabolite_id":"AKVBCGQVQXPRLD-UHFFFAOYSA-N","pvalue":4.19319347595399e-05,"ratio":1.7553002897773136,"synonym_name":"2-aminooctanoic acid"},{"chebi_id":"18211","direction":"up","inn_name":"","iupac_name":"citrulline","metabolite_id":"RHGKLRLOHDJJDR-UHFFFAOYSA-N","pvalue":0.0005940486326294,"ratio":1.5801162696638569,"synonym_name":"2-Amino-5-uredovaleric acid"},{"chebi_id":"73054","direction":"up","inn_name":"","iupac_name":"3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"FUJLYHJROOYKRA-UHFFFAOYSA-N","pvalue":0.0193336855979347,"ratio":1.7326742058585496,"synonym_name":"dodecanoylcarnitine"}],"totalFeatures":41},{"comparisonGroups":["Healthy Control","Osteoarticular Tuberculosis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs osteoarticular tuberculosis patients","group_a_title":"Samples from healthy control group. Serves as a reference for identifying deviations in metabolic profiles due to disease.","group_b_title":"Samples from patients with osteoarticular tuberculosis. Crucial for identifying metabolic changes associated with osteoarticular tuberculosis.","id":"MTBLS4187_0003_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":14,"studyId":"MTBLS4187","studyUrl":"http://integmet.org/study/MTBLS4187","title":"Healthy_Control_vs_Osteoarticular_Tuberculosis","topHits":[{"chebi_id":"189930","direction":"up","inn_name":"","iupac_name":"3-[14-hydroxy-3-[4-hydroxy-6-methyl-5-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-uran-5-one","metabolite_id":"NQKAYUABNWNCPK-UHFFFAOYSA-N","pvalue":3.661651040436294e-10,"ratio":167516.17123892525,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IVBULNXGVIHEKN-AUOMWKRBSA-N","pvalue":8.883164175163909e-12,"ratio":55.64695765360584,"synonym_name":""},{"chebi_id":"28374","direction":"up","inn_name":"","iupac_name":"solanid-5-en-3\u03b2-ol","metabolite_id":"JVKYZPBMZPJNAJ-OQFNDJACSA-N","pvalue":9.35784412836615e-12,"ratio":34.26960311804731,"synonym_name":"(3\u03b2)-solanid-5-en-3-ol"},{"chebi_id":"190465","direction":"up","inn_name":"","iupac_name":"[(2S)-2-(16-methylheptadecanoyloxy)-3-(14-methylhexadecanoyloxy)propyl] 22-methyltetracosanoate","metabolite_id":"QTORYHKBWLFXAA-AYMZASOTSA-N","pvalue":1.2146065709148516e-11,"ratio":20.66267600229322,"synonym_name":""},{"chebi_id":"67045","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]tetradecanamide","metabolite_id":"UDTSZXVRDXQARY-IOWSJCHKSA-N","pvalue":6.7534970026395294e-12,"ratio":12.212071309552716,"synonym_name":"DHC-A 18:0/14:0"},{"chebi_id":"67042","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]hexadecanamide","metabolite_id":"GCGTXOVNNFGTPQ-JHOUSYSJSA-N","pvalue":9.916056932471128e-12,"ratio":12.274323439336383,"synonym_name":"<em>N</em>-palmitoyldihydroceramide"},{"chebi_id":"72959","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide","metabolite_id":"YDNKGFDKKRUKPY-TURZORIXSA-N","pvalue":9.252127711812267e-11,"ratio":10.751833390566937,"synonym_name":"<em>N</em>-(hexadecanoyl)-sphing-4-enine"},{"chebi_id":"134073","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>)-3-hydroxy-2-{[(11<i>Z</i>)-octadec-11-enoyl]amino}octadecyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"HHAUPBIWIXBMEU-MMVRYLQTSA-N","pvalue":3.8907457036190195e-06,"ratio":0.6111651444779198,"synonym_name":"sphingomyelin (d18:0/18:1(11<i>Z</i>))"},{"chebi_id":"86176","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QXDDDGCNWRUEFM-UMKMFDOBSA-N","pvalue":0.0001768089478322,"ratio":0.6094089178592261,"synonym_name":"Phosphatidylcholine(18:0/20:3)"},{"chebi_id":"74340","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(heptadecanoyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"SRRQPVVYXBTRQK-XMMPIXPASA-N","pvalue":0.0001493917032156,"ratio":1.5498426511995316,"synonym_name":"LysoPC 17:0/0:0"}],"totalFeatures":70},{"comparisonGroups":["Control_0mM","75mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 75mM salt treatment","group_a_title":"Control group with 0mM salt concentration.. Provides baseline metabolic profile for comparison with salt-treated groups.","group_b_title":"Group with 75mM salt concentration.. Demonstrates the full extent of metabolic changes at the highest salt concentration.","id":"MTBLS42_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":37,"studyId":"MTBLS42","studyUrl":"http://integmet.org/study/MTBLS42","title":"Control_0mM_vs_75mM","topHits":[{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":4.82910721321261e-06,"ratio":63.09710699400915,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":1.3740016393172148e-07,"ratio":8.73308397217973,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":8.025905279743267e-06,"ratio":0.0776809927543065,"synonym_name":""},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":2.6636535643767224e-09,"ratio":0.2355757477674736,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"26078","direction":"up","inn_name":"","iupac_name":"trihydrogen tetraoxophosphate(3\u2212)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","pvalue":1.8860550563927769e-06,"ratio":8.322075468847597,"synonym_name":"phosphoric acid"},{"chebi_id":"15741","direction":"up","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":3.3332903674988164e-05,"ratio":9.555266402720507,"synonym_name":"E363"},{"chebi_id":"17505","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactosyl-(1\u21923)-1<small>D</small>-<em>myo</em>-inositol","metabolite_id":"VCWMRQDBPZKXKG-DXNLKLAMSA-N","pvalue":2.052636745887943e-06,"ratio":0.2060904483399584,"synonym_name":"3-O-alpha-D-Galactosyl-1D-myo-inositol"},{"chebi_id":"32805","direction":"up","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":6.287243390135851e-06,"ratio":4.5172154708995045,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"193884","direction":"down","inn_name":"","iupac_name":"2-[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"CZMRCDWAGMRECN-UHFFFAOYSA-N","pvalue":6.9746313481300775e-09,"ratio":0.3969255020612774,"synonym_name":""},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":7.169807109609019e-06,"ratio":0.2423083481611197,"synonym_name":"Butane-1,4-diamine"}],"totalFeatures":63},{"comparisonGroups":["Healthy Control","Psoriatic Arthritis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs psoriatic arthritis patients","group_a_title":"Samples from healthy individuals without any disease condition.. Provides a reference for comparing metabolic changes in disease conditions.","group_b_title":"Samples from patients diagnosed with Psoriatic Arthritis.. Key group for identifying metabolic changes specific to Psoriatic Arthritis.","id":"MTBLS4206_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS4206","studyUrl":"http://integmet.org/study/MTBLS4206","title":"Healthy_Control_vs_Psoriatic_Arthritis","topHits":[{"chebi_id":"88542","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QFOHBWFCKVYLES-UHFFFAOYSA-N","pvalue":3.033897276738337e-23,"ratio":2.2697276599741696,"synonym_name":"Butylparaben [usan]"},{"chebi_id":"183816","direction":"down","inn_name":"","iupac_name":"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate","metabolite_id":"RMLFYKFCGMSLTB-ZBDFTZOCSA-N","pvalue":3.529925503897591e-09,"ratio":0.2296772906713977,"synonym_name":""},{"chebi_id":"16390","direction":"up","inn_name":"","iupac_name":"3\u03b1,12\u03b1-dihydroxy-7-oxo-5\u03b2-cholan-24-oic acid","metabolite_id":"RHCPKKNRWFXMAT-RRWYKFPJSA-N","pvalue":3.1465183096279992e-06,"ratio":2.055271722303024,"synonym_name":"7-oxodeoxycholic acid"},{"chebi_id":"42717","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranuronic acid","metabolite_id":"AEMOLEFTQBMNLQ-WAXACMCWSA-N","pvalue":0.0004597398707615,"ratio":2.8979289513059414,"synonym_name":"D-GLUCURONIC ACID"},{"chebi_id":"545959","direction":"up","inn_name":"","iupac_name":"2-(4-hydroxy-3-methoxyphenyl)acetic acid","metabolite_id":"QRMZSPFSDQBLIX-UHFFFAOYSA-N","pvalue":0.0006607374697051,"ratio":2.4080692420434975,"synonym_name":"3-Methoxy-4-hydroxyphenylacetate"},{"chebi_id":"45996","direction":"up","inn_name":"","iupac_name":"5-methyluridine","metabolite_id":"DWRXFEITVBNRMK-JXOAFFINSA-N","pvalue":0.0156013086455528,"ratio":3.680380612773716,"synonym_name":"t"},{"chebi_id":"72842","direction":"up","inn_name":"","iupac_name":"(10<i>E</i>,12<i>Z</i>)-9-oxooctadeca-10,12-dienoic acid","metabolite_id":"LUZSWWYKKLTDHU-ZJHFMPGASA-N","pvalue":0.0172114658553403,"ratio":2.47175391822269,"synonym_name":"9-keto-10<i>E</i>,12<i>Z</i>-octadecadienoic acid"},{"chebi_id":"135791","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FNPXMHRZILFCKX-KAJVQRHHSA-N","pvalue":0.017925478510798,"ratio":2.4219232114856286,"synonym_name":"prednitop"},{"chebi_id":"27584","direction":"up","inn_name":"","iupac_name":"11\u03b2,21-dihydroxy-3,20-dioxopregn-4-en-18-al","metabolite_id":"PQSUYGKTWSAVDQ-ZVIOFETBSA-N","pvalue":0.0227568332001177,"ratio":2.4454552806950747,"synonym_name":"(+)-aldosterone"},{"chebi_id":"49584","direction":"up","inn_name":"","iupac_name":"4-ethylphenol","metabolite_id":"HXDOZKJGKXYMEW-UHFFFAOYSA-N","pvalue":0.026418554290201,"ratio":2.1867349411061667,"synonym_name":"4-Ethylphenol"}],"totalFeatures":16},{"comparisonGroups":["Healthy Control","Psoriatic Arthritis"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy controls vs psoriatic arthritis patients","group_a_title":"Samples from healthy individuals without any disease condition.. Provides a reference for comparing metabolic changes in disease conditions.","group_b_title":"Samples from patients diagnosed with Psoriatic Arthritis.. Key group for identifying metabolic changes specific to Psoriatic Arthritis.","id":"MTBLS4206_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":35,"studyId":"MTBLS4206","studyUrl":"http://integmet.org/study/MTBLS4206","title":"Healthy_Control_vs_Psoriatic_Arthritis","topHits":[{"chebi_id":"71464","direction":"up","inn_name":"palmidrol","iupac_name":"<em>N</em>-(2-hydroxyethyl)hexadecanamide","metabolite_id":"HXYVTAGFYLMHSO-UHFFFAOYSA-N","pvalue":5.05307503601674e-37,"ratio":51.08068667437877,"synonym_name":"Palmitic acid monoethanolamide"},{"chebi_id":"46968","direction":"up","inn_name":"","iupac_name":"2-aminooctadecane-1,3-diol","metabolite_id":"OTKJDMGTUTTYMP-UHFFFAOYSA-N","pvalue":1.249351187816141e-40,"ratio":12.800850177026147,"synonym_name":"2-amino-1,3-octadecanediol"},{"chebi_id":"15947","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-\u03b2-<small>D</small>-glucopyranosylamine","metabolite_id":"MCGXOCXFFNKASF-FMDGEEDCSA-N","pvalue":1.116445524487151e-31,"ratio":5.936171508759369,"synonym_name":"N-Acetyl-beta-D-glucosaminylamine"},{"chebi_id":"81132","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FZPYMZUVXJUAQA-ZDUSSCGKSA-N","pvalue":3.4577547083220606e-21,"ratio":0.0948326825108707,"synonym_name":""},{"chebi_id":"140570","direction":"up","inn_name":"","iupac_name":"alanylalanine","metabolite_id":"DEFJQIDDEAULHB-UHFFFAOYSA-N","pvalue":1.553285498068362e-32,"ratio":4.33907661434202,"synonym_name":"alanyl-alanine"},{"chebi_id":"180283","direction":"up","inn_name":"","iupac_name":"(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enoic acid","metabolite_id":"WDWBNNBRPVEEOD-PFXVRADUSA-N","pvalue":1.20074398340494e-18,"ratio":4.735231028382561,"synonym_name":""},{"chebi_id":"28579","direction":"down","inn_name":"","iupac_name":"azepan-2-one","metabolite_id":"JBKVHLHDHHXQEQ-UHFFFAOYSA-N","pvalue":2.311794882815148e-17,"ratio":0.245384484607576,"synonym_name":"aminocaproic lactam"},{"chebi_id":"178475","direction":"down","inn_name":"","iupac_name":"hexadecanoic acid;propane-1,2,3-triol","metabolite_id":"CGBXSWXZXBQCMR-UHFFFAOYSA-N","pvalue":6.264761469385272e-22,"ratio":0.3767818649503688,"synonym_name":""},{"chebi_id":"15756","direction":"down","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":1.5373719240735885e-11,"ratio":0.4262016335375765,"synonym_name":"<em>n</em>-hexadecoic acid"},{"chebi_id":"28617","direction":"up","inn_name":"","iupac_name":"4-methylbenzaldehyde","metabolite_id":"FXLOVSHXALFLKQ-UHFFFAOYSA-N","pvalue":1.534666461134633e-05,"ratio":3.619694859646214,"synonym_name":"<em>para</em>-Tolualdehyde"}],"totalFeatures":45},{"comparisonGroups":["Wild_Type","Gene_Knockdown"],"dateCreated":"2025-09-26 00:00:00","display_title":"hESCs: OGDH gene knockdown vs wild-type","group_a_title":"Wild type hESCs serving as the control group.. Provides a reference point to assess the impact of gene knockdown on hESCs.","group_b_title":"hESCs with OGDH gene knockdown.. Key to understanding the role of OGDH in mitochondrial respiration and pluripotency maintenance in hESCs.","id":"MTBLS4223_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS4223","studyUrl":"http://integmet.org/study/MTBLS4223","title":"Wild_Type_vs_Gene_Knockdown","topHits":[{"chebi_id":"30797","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-REOHCLBHSA-N","pvalue":1.6200541561953806e-12,"ratio":7.472031082927102,"synonym_name":"<small>L</small>-malic acid"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":5.202367414306975e-09,"ratio":4.248931694897144,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":7.354785735131953e-08,"ratio":0.2432743508916227,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":7.894453534883543e-09,"ratio":2.9465365892744244,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"17345","direction":"down","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":1.0520170232296476e-06,"ratio":0.3701168614313283,"synonym_name":"GMP"},{"chebi_id":"17552","direction":"down","inn_name":"","iupac_name":"guanosine 5'-(trihydrogen diphosphate)","metabolite_id":"QGWNDRXFNXRZMB-UUOKFMHZSA-N","pvalue":1.241864405115776e-06,"ratio":0.4448775653068921,"synonym_name":"Guanosine diphosphate"},{"chebi_id":"32805","direction":"up","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":8.850589950094173e-08,"ratio":1.9000219753117704,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"28013","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":8.535350055448957e-07,"ratio":0.4791156635493411,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0002477656467174,"ratio":0.3406172320657355,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"16084","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 6-(dihydrogen phosphate)","metabolite_id":"BGWGXPAPYGQALX-ARQDHWQXSA-N","pvalue":6.315214402157285e-05,"ratio":0.5696281371501327,"synonym_name":"6-<em>O</em>-phosphono-\u03b2-<small>D</small>-fructofuranose"}],"totalFeatures":28},{"comparisonGroups":["Baseline","Post-Intervention"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline vs 6-month lifestyle intervention","group_a_title":"Samples collected at baseline (0 months) before intervention.. Serves as the reference point for evaluating the effects of the lifestyle intervention.","group_b_title":"Samples collected after 6 months of lifestyle intervention.. Critical for assessing the impact of the lifestyle intervention on metabolic signatures.","id":"MTBLS423_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS423","studyUrl":"http://integmet.org/study/MTBLS423","title":"Baseline_vs_Post-Intervention","topHits":[{"chebi_id":"84765","direction":"up","inn_name":"","iupac_name":"(15<i>Z</i>)-<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1-{[4-<em>O</em>-(\u03b2-<small>D</small>-galactopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enamide","metabolite_id":"MKOKWBRPIBQYJJ-WZBOJYASSA-N","pvalue":5.809176959896546e-05,"ratio":1.626053125289568,"synonym_name":"N-(15Z-tetracosenoyl)-1-b-lactosyl-sphing-4-enine"},{"chebi_id":"72962","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide","metabolite_id":"XWBWIAOWSABHFI-NUKVNZTCSA-N","pvalue":9.043656981884132e-05,"ratio":1.5302429106282358,"synonym_name":"<em>N</em>-(eicosanoyl)ceramide"}],"totalFeatures":6},{"comparisonGroups":["Baseline","Post-Intervention"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline vs 6-month lifestyle intervention","group_a_title":"Samples collected at baseline (0 months) before intervention.. Serves as the reference point for evaluating the effects of the lifestyle intervention.","group_b_title":"Samples collected after 6 months of lifestyle intervention.. Critical for assessing the impact of the lifestyle intervention on metabolic signatures.","id":"MTBLS423_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS423","studyUrl":"http://integmet.org/study/MTBLS423","title":"Baseline_vs_Post-Intervention","topHits":[{"chebi_id":"84765","direction":"up","inn_name":"","iupac_name":"(15<i>Z</i>)-<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1-{[4-<em>O</em>-(\u03b2-<small>D</small>-galactopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enamide","metabolite_id":"MKOKWBRPIBQYJJ-WZBOJYASSA-N","pvalue":5.809176959896546e-05,"ratio":1.626053125289568,"synonym_name":"N-(15Z-tetracosenoyl)-1-b-lactosyl-sphing-4-enine"},{"chebi_id":"72962","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide","metabolite_id":"XWBWIAOWSABHFI-NUKVNZTCSA-N","pvalue":9.043656981884132e-05,"ratio":1.5302429106282358,"synonym_name":"<em>N</em>-(eicosanoyl)ceramide"}],"totalFeatures":6},{"comparisonGroups":["Glu_BW25113","Pyr_BW25113"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. coli BW25113: glucose vs pyruvate medium","group_a_title":"Escherichia coli BW25113 grown in glucose medium.. Represents the response of E. coli BW25113 to glucose as a carbon source.","group_b_title":"Escherichia coli BW25113 grown in pyruvate medium.. Represents the response of E. coli BW25113 to pyruvate as a carbon source.","id":"MTBLS4249_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS4249","studyUrl":"http://integmet.org/study/MTBLS4249","title":"Glu_BW25113_vs_Pyr_BW25113","topHits":[{"chebi_id":"15539","direction":"up","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-(3-{(3<i>R</i>)-3-hydroxy-2,2-dimethyl-4-oxo-4-[(3-oxo-3-{[2-(propanoylsulfanyl)ethyl]amino}propyl)amino]butyl} dihydrogen diphosphate)","metabolite_id":"QAQREVBBADEHPA-IEXPHMLFSA-N","pvalue":2.693703007291267e-05,"ratio":7.616144990889534,"synonym_name":"<em>S</em>-Propionylcoenzyme A"},{"chebi_id":"17239","direction":"up","inn_name":"","iupac_name":"cytidine 5'-(trihydrogen diphosphate)","metabolite_id":"ZWIADYZPOWUWEW-XVFCMESISA-N","pvalue":0.0037173375372064,"ratio":10.545117562411004,"synonym_name":"Cytidine, 5'-(trihydrogen pyrophosphate)"},{"chebi_id":"48000","direction":"up","inn_name":"","iupac_name":"<em>N</em>-carboxy-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)-1<em>H</em>-imidazol-5-amine","metabolite_id":"JHLXDWGVSYMXPL-XVFCMESISA-N","pvalue":0.0038534248874881,"ratio":8.482427412736525,"synonym_name":"5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole"},{"chebi_id":"17361","direction":"up","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":4.105591452629293e-05,"ratio":3.174366678266839,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"15350","direction":"down","inn_name":"","iupac_name":"acetic phosphoric monoanhydride","metabolite_id":"LIPOUNRJVLNBCD-UHFFFAOYSA-N","pvalue":0.0001228166986651,"ratio":0.2801009920563381,"synonym_name":"ACETYLPHOSPHATE"},{"chebi_id":"44897","direction":"down","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0012119768835138,"ratio":0.2550547651003171,"synonym_name":"PEP"},{"chebi_id":"15919","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[9-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)-9<em>H</em>-purin-6-yl]aspartic acid","metabolite_id":"OFBHPPMPBOJXRT-DPXQIYNJSA-N","pvalue":0.0031285836816008,"ratio":4.601876988697741,"synonym_name":"N6-(1,2-dicarboxyethyl)-AMP"},{"chebi_id":"16865","direction":"down","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":0.0003883694734503,"ratio":0.3293504497691276,"synonym_name":"GABA"},{"chebi_id":"17202","direction":"up","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":0.0003621249410022,"ratio":2.856459866124498,"synonym_name":"Inosine 5'-phosphate"},{"chebi_id":"15763","direction":"up","inn_name":"","iupac_name":"3-carboxy-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)pyridinium","metabolite_id":"JOUIQRNQJGXQDC-ZYUZMQFOSA-O","pvalue":0.0037002596584933,"ratio":4.045722439459415,"synonym_name":"Nicotinate D-ribonucleotide"}],"totalFeatures":68},{"comparisonGroups":["Glu_BW25113","Pyr_BW25113"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. coli BW25113: glucose vs pyruvate carbon source","group_a_title":"Escherichia coli BW25113 grown in glucose medium.. Represents the response of E. coli BW25113 to glucose as a carbon source.","group_b_title":"Escherichia coli BW25113 grown in pyruvate medium.. Represents the response of E. coli BW25113 to pyruvate as a carbon source.","id":"MTBLS4249_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS4249","studyUrl":"http://integmet.org/study/MTBLS4249","title":"Glu_BW25113_vs_Pyr_BW25113","topHits":[{"chebi_id":"17363","direction":"up","inn_name":"","iupac_name":"5-<em>O</em>-phosphono-<small>D</small>-ribulose","metabolite_id":"FNZLKVNUWIIPSJ-UHNVWZDZSA-N","pvalue":0.0005189447069196,"ratio":8.392552694309309,"synonym_name":"D-Ribulose 5-phosphate"},{"chebi_id":"17768","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(4-aminobutyl)acetamide","metabolite_id":"KLZGKIDSEJWEDW-UHFFFAOYSA-N","pvalue":0.0005703512092789,"ratio":0.1810004772497516,"synonym_name":"N-Acetylputrescine"},{"chebi_id":"138560","direction":"up","inn_name":"","iupac_name":"1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)-1<em>H</em>-imidazol-5-amine","metabolite_id":"PDACUKOKVHBVHJ-XVFCMESISA-N","pvalue":0.0002917162982527,"ratio":4.438665375750365,"synonym_name":"5-Amino-1-ribofuranosylimidazole 5'-phosphate"},{"chebi_id":"57822","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(2<i>R</i>)-2-ammoniopropanoyl]amino}propanoate","metabolite_id":"DEFJQIDDEAULHB-QWWZWVQMSA-N","pvalue":1.4550420204481238e-05,"ratio":0.3384672049479434,"synonym_name":""},{"chebi_id":"2247","direction":"down","inn_name":"","iupac_name":"7,8-diaminononanoic acid","metabolite_id":"KCEGBPIYGIWCDH-UHFFFAOYSA-N","pvalue":0.0009631421258358,"ratio":0.2209009493037061,"synonym_name":"7,8-Diaminononanoate"},{"chebi_id":"15859","direction":"up","inn_name":"","iupac_name":"<em>N</em>-carbamoyl-<small>L</small>-aspartic acid","metabolite_id":"HLKXYZVTANABHZ-REOHCLBHSA-N","pvalue":0.0001335011625808,"ratio":2.568737876068426,"synonym_name":"<em>N</em>-(aminocarbonyl)-<small>L</small>-aspartic acid"},{"chebi_id":"27512","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2,3-dihydroxy-3-methylpentanoic acid","metabolite_id":"PDGXJDXVGMHUIR-UJURSFKZSA-N","pvalue":0.0002230852681432,"ratio":0.4184303145067123,"synonym_name":"(2<i>R</i>,3<i>R</i>)-2,3-dihydroxy-3-methylvaleric acid"},{"chebi_id":"15721","direction":"up","inn_name":"","iupac_name":"<small>D</small>-<i>altro</i>-hept-2-ulose 7-phosphate","metabolite_id":"JDTUMPKOJBQPKX-GBNDHIKLSA-N","pvalue":0.0005541783565246,"ratio":2.5001923716568255,"synonym_name":"D-Sedoheptulose 7-phosphate"},{"chebi_id":"15918","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-cytidylic acid","metabolite_id":"NCMVOABPESMRCP-SHYZEUOFSA-N","pvalue":0.0013251289319926,"ratio":2.2382029605665106,"synonym_name":"Deoxycytidylate"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0020625019206558,"ratio":0.4252462059960264,"synonym_name":"\u03b1-ketoglutaric acid"}],"totalFeatures":78},{"comparisonGroups":["Control_Female","Restricted_Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Female baboons: control vs restricted diet","group_a_title":"Control group of female baboons. Provides baseline data for female baboons to compare against restricted diet effects","group_b_title":"Restricted diet group of female baboons. Allows assessment of restricted diet effects on female baboons","id":"MTBLS426_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS426","studyUrl":"http://integmet.org/study/MTBLS426","title":"Control_Female_vs_Restricted_Female","topHits":[{"chebi_id":"84816","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(9<i>Z</i>)-hexadec-9-enoyloxy]-2-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"DYDDZDMJSQYFGN-OIVUZXIWSA-N","pvalue":0.0065991081469003,"ratio":0.3182904101170291,"synonym_name":"13.Phosphatidylcholine(16:1n7/20:4n6)"},{"chebi_id":"89739","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IITWSVMUNFGFQI-MMWBFVNXSA-N","pvalue":0.0112590238055758,"ratio":0.3213261907878233,"synonym_name":"Phosphatidylcholine(16:1/20:5)"},{"chebi_id":"45240","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"CITHEXJVPOWHKC-UUWRZZSWSA-N","pvalue":0.012153102757962,"ratio":0.3521636169400253,"synonym_name":"1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"138576","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PEJGMBUENJSLLH-RHAKMSQVSA-N","pvalue":0.0284781601892063,"ratio":0.3392080451234067,"synonym_name":"SM(d18:2/14:0)"},{"chebi_id":"74968","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(icosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"UATOAILWGVYRQS-HHHXNRCGSA-N","pvalue":0.0287699147661271,"ratio":0.3470043836325578,"synonym_name":"LPC(20:0)"},{"chebi_id":"75216","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"XKBJVQHMEXMFDZ-AREMUKBSSA-N","pvalue":0.0244693979956111,"ratio":0.372690157400918,"synonym_name":"LysoPC(O-18:0)"},{"chebi_id":"89521","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VZQRMZUULSWEHB-XCFXQIAYSA-N","pvalue":0.0325464738275176,"ratio":0.3549107362202697,"synonym_name":"PC(32:3)"},{"chebi_id":"76076","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-hydroxy-2-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IQGPMZRCLCCXAG-RUZDIDTESA-N","pvalue":0.0394950324500648,"ratio":0.3469987878969912,"synonym_name":"2-stearoyllysophosphatidylcholine"},{"chebi_id":"84753","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dien-1-yloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"KJUNGQXFZYMUOH-FKWLWHCOSA-N","pvalue":0.0429419403736466,"ratio":0.3433181094695087,"synonym_name":"LPC(O-18:2(1Z,9Z))"},{"chebi_id":"84578","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(9<i>Z</i>)-hexadec-9-enoyloxy]-3-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"XGGMHQYOVYWRLV-IZNHTBNISA-N","pvalue":0.0344002161485772,"ratio":0.4120059019535726,"synonym_name":"GPCho(14:0/16:1n7)"}],"totalFeatures":163},{"comparisonGroups":["Control_Female","Restricted_Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Female baboons: control vs restricted diet","group_a_title":"Control group of female baboons. Provides baseline data for female baboons to compare against restricted diet effects","group_b_title":"Restricted diet group of female baboons. Allows assessment of restricted diet effects on female baboons","id":"MTBLS426_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS426","studyUrl":"http://integmet.org/study/MTBLS426","title":"Control_Female_vs_Restricted_Female","topHits":[{"chebi_id":"134548","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]pentacosanamide","metabolite_id":"QHPYSHVSWAOLHS-PVNBSDFKSA-N","pvalue":0.0105758956654313,"ratio":0.252442588911652,"synonym_name":"Cer(d18:1/25:0)"},{"chebi_id":"67027","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]icosanamide","metabolite_id":"ZWAUSWHRQBSECP-PQQNNWGCSA-N","pvalue":0.0492983528936201,"ratio":0.324992304298164,"synonym_name":"C20DH Cer"},{"chebi_id":"72968","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]hexacosanamide","metabolite_id":"CJROVRTUSFQVMR-GVOPMEMSSA-N","pvalue":0.0498509806909612,"ratio":0.3352754414570788,"synonym_name":"<em>N</em>-hexacosanoylsphing-4-enine"},{"chebi_id":"72962","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide","metabolite_id":"XWBWIAOWSABHFI-NUKVNZTCSA-N","pvalue":0.0418189275018125,"ratio":0.3682578126067518,"synonym_name":"<em>N</em>-(eicosanoyl)ceramide"},{"chebi_id":"73005","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2,3-bis(hexadecanoyloxy)propyl phosphate","metabolite_id":"SLKDGVPOSSLUAI-PGUFJCEWSA-N","pvalue":0.0485962404283095,"ratio":0.5284947015382209,"synonym_name":"1,2-dipalmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"}],"totalFeatures":34},{"comparisonGroups":["Control_Female","Restricted_Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Female baboons: control vs restricted diet","group_a_title":"Control group of female baboons. Provides baseline data for female baboons to compare against restricted diet effects","group_b_title":"Restricted diet group of female baboons. Allows assessment of restricted diet effects on female baboons","id":"MTBLS426_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS426","studyUrl":"http://integmet.org/study/MTBLS426","title":"Control_Female_vs_Restricted_Female","topHits":[{"chebi_id":"134548","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]pentacosanamide","metabolite_id":"QHPYSHVSWAOLHS-PVNBSDFKSA-N","pvalue":0.0105758956654313,"ratio":0.252442588911652,"synonym_name":"Cer(d18:1/25:0)"},{"chebi_id":"67027","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>)-1,3-dihydroxyoctadecan-2-yl]icosanamide","metabolite_id":"ZWAUSWHRQBSECP-PQQNNWGCSA-N","pvalue":0.0492983528936201,"ratio":0.324992304298164,"synonym_name":"C20DH Cer"},{"chebi_id":"72968","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]hexacosanamide","metabolite_id":"CJROVRTUSFQVMR-GVOPMEMSSA-N","pvalue":0.0498509806909612,"ratio":0.3352754414570788,"synonym_name":"<em>N</em>-hexacosanoylsphing-4-enine"},{"chebi_id":"72962","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide","metabolite_id":"XWBWIAOWSABHFI-NUKVNZTCSA-N","pvalue":0.0418189275018125,"ratio":0.3682578126067518,"synonym_name":"<em>N</em>-(eicosanoyl)ceramide"},{"chebi_id":"178346","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-octadec-11-enoate","metabolite_id":"UFSJDLNEPCFOCJ-JUOLSMOWSA-N","pvalue":0.030583785255779,"ratio":0.4245397861388615,"synonym_name":""},{"chebi_id":"73999","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-[(9<i>Z</i>)-hexadec-9-enoyloxy]propyl phosphate","metabolite_id":"CZOSTDZGCCEZTJ-WMHOIYFHSA-N","pvalue":0.030583785255779,"ratio":0.4245397861388615,"synonym_name":"1-C<small><sub>16:0</sub></small>-2-C<small><sub>16:1</sub></small>(\u03c9-7)-phosphatidylethanolamine zwitterion"},{"chebi_id":"73005","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2,3-bis(hexadecanoyloxy)propyl phosphate","metabolite_id":"SLKDGVPOSSLUAI-PGUFJCEWSA-N","pvalue":0.0485962404283095,"ratio":0.5284947015382209,"synonym_name":"1,2-dipalmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"}],"totalFeatures":52},{"comparisonGroups":["Control_Female","Restricted_Female"],"dateCreated":"2025-09-26 00:00:00","display_title":"Female baboons: control vs restricted diet","group_a_title":"Control group of female baboons. Provides baseline data for female baboons to compare against restricted diet effects","group_b_title":"Restricted diet group of female baboons. Allows assessment of restricted diet effects on female baboons","id":"MTBLS426_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":30,"studyId":"MTBLS426","studyUrl":"http://integmet.org/study/MTBLS426","title":"Control_Female_vs_Restricted_Female","topHits":[{"chebi_id":"131989","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(nonadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"WYIMORDZGCUBAA-AREMUKBSSA-N","pvalue":0.0111359692881006,"ratio":0.2727502067083092,"synonym_name":"PC(19:0/0:0)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KKASQLHJLDPKHK-MUKBVWGOSA-N","pvalue":0.0150025417870214,"ratio":0.2947698922271854,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QCEZSXZDLSGARX-JTDYEGOHSA-N","pvalue":0.0150025417870214,"ratio":0.2947698922271854,"synonym_name":""},{"chebi_id":"89739","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IITWSVMUNFGFQI-MMWBFVNXSA-N","pvalue":0.0112590238055758,"ratio":0.3213261907878233,"synonym_name":"Phosphatidylcholine(16:1/20:5)"},{"chebi_id":"61042","direction":"down","inn_name":"","iupac_name":"(7<i>R</i>)-4-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-10-oxo-7-[(9-oxononanoyl)oxy]-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide","metabolite_id":"PPTNNIINSOQWCE-WJOKGBTCSA-N","pvalue":0.0122021995849272,"ratio":0.3275218923094649,"synonym_name":"1-hexadecanoyl-2-(9-oxononanoyl)glycerophosphocholine"},{"chebi_id":"77890","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-[(5-oxopentanoyl)oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RKIDALSACBQVTN-HHHXNRCGSA-N","pvalue":0.0158584889843085,"ratio":0.3262899406002326,"synonym_name":"POVPC"},{"chebi_id":"45240","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"CITHEXJVPOWHKC-UUWRZZSWSA-N","pvalue":0.012153102757962,"ratio":0.3521636169400253,"synonym_name":"1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"64496","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"VLBPIWYTPAXCFJ-XMMPIXPASA-N","pvalue":0.028021442809005,"ratio":0.3356531466156513,"synonym_name":"GPC(O-16:0/0:0)"},{"chebi_id":"131738","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-hydroxy-2-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IGZPHNNYPPAPLA-OAQYLSRUSA-N","pvalue":0.0379958209472368,"ratio":0.3076692797924827,"synonym_name":"PC(0:0/14:0)"},{"chebi_id":"138576","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PEJGMBUENJSLLH-RHAKMSQVSA-N","pvalue":0.0284781601892063,"ratio":0.3392080451234067,"synonym_name":"SM(d18:2/14:0)"}],"totalFeatures":228},{"comparisonGroups":["Control","150mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 150mM salt stress response","group_a_title":"Control group with 0 mM salt concentration.. Provides baseline data for comparison with salt-treated groups.","group_b_title":"Group with 150 mM salt concentration.. Helps in understanding the response to very high salt stress.","id":"MTBLS43_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":35,"studyId":"MTBLS43","studyUrl":"http://integmet.org/study/MTBLS43","title":"Control_vs_150mM","topHits":[{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":4.581319763974372e-10,"ratio":4.599636189311728,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"61185","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-piperidinium-2-carboxylate","metabolite_id":"HXEACLLIILLPRG-YFKPBYRVSA-N","pvalue":1.1811244740502876e-05,"ratio":0.091029619239519,"synonym_name":"(<i>S</i>)-2-carboxypiperidinium betaine"},{"chebi_id":"32374","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxyphenyl)prop-2-enoic acid","metabolite_id":"NGSWKAQJJWESNS-ZZXKWVIFSA-N","pvalue":5.557933348723472e-07,"ratio":6.31026531053264,"synonym_name":"4'-HYDROXYCINNAMIC ACID"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0006157066427201,"ratio":0.037954289085977,"synonym_name":""},{"chebi_id":"18266","direction":"down","inn_name":"","iupac_name":"1<small>D</small>-4-<em>O</em>-methyl-<em>myo</em>-inositol","metabolite_id":"DSCFFEYYQKSRSV-GESKJZQWSA-N","pvalue":7.178821678472119e-06,"ratio":0.1589635698886072,"synonym_name":"1D-4-O-Methyl-myo-inositol"},{"chebi_id":"18300","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UPHRSURJSA-N","pvalue":5.8451458295676555e-06,"ratio":3.2852433530493057,"synonym_name":"Maleic acid"},{"chebi_id":"26078","direction":"up","inn_name":"","iupac_name":"trihydrogen tetraoxophosphate(3\u2212)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","pvalue":1.958528278335568e-05,"ratio":3.4041241678608674,"synonym_name":"phosphoric acid"},{"chebi_id":"53455","direction":"up","inn_name":"","iupac_name":"<small>D</small>-xylopyranose","metabolite_id":"SRBFZHDQGSBBOR-IOVATXLUSA-N","pvalue":1.0641597648204385e-08,"ratio":2.0075506429579013,"synonym_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-tetrahydro-2<em>H</em>-pyran-2,3,4,5-tetrol"},{"chebi_id":"16119","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid","metabolite_id":"JXOHGGNKMLTUBP-HSUXUTPPSA-N","pvalue":5.98490458796065e-09,"ratio":1.8817247262789325,"synonym_name":"Shikimate"},{"chebi_id":"30769","direction":"up","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":1.1930495818017942e-06,"ratio":2.396298500101917,"synonym_name":"Citronens\u00e4ure"}],"totalFeatures":105},{"comparisonGroups":["Control_Cytoplasm","TFAM_Knockdown_Cytoplasm"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cytoplasm: TFAM knockdown vs control","group_a_title":"Control group with samples from the cytoplasm. Provides baseline data for cytoplasmic conditions in control genotype","group_b_title":"TFAM knockdown group with samples from the cytoplasm. Allows assessment of TFAM knockdown effects in the cytoplasm","id":"MTBLS4307_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS4307","studyUrl":"http://integmet.org/study/MTBLS4307","title":"Control_Cytoplasm_vs_TFAM_Knockdown_Cytoplasm","topHits":[{"chebi_id":"18189","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-ribofuranose 5-(dihydrogen phosphate)","metabolite_id":"KTVPXOYAKDPRHY-AIHAYLRMSA-N","pvalue":6.181615866639845e-08,"ratio":0.0389130765311963,"synonym_name":"5-<em>O</em>-phosphono-\u03b1-<small>D</small>-ribofuranose"},{"chebi_id":"17552","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(trihydrogen diphosphate)","metabolite_id":"QGWNDRXFNXRZMB-UUOKFMHZSA-N","pvalue":1.366223723171745e-07,"ratio":30.237102458824936,"synonym_name":"Guanosine diphosphate"},{"chebi_id":"29042","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranose 1-(dihydrogen phosphate)","metabolite_id":"HXXFSFRBOHSIMQ-VFUOTHLCSA-N","pvalue":3.6821262088543584e-10,"ratio":4.784051561292436,"synonym_name":"ALPHA-D-GLUCOSE-1-PHOSPHATE"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":0.0010117127968966,"ratio":49.51509745197568,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":4.89757747095076e-06,"ratio":7.541564929704026,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":9.711458750896871e-06,"ratio":5.030747702529936,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"18066","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":5.839781108830885e-09,"ratio":0.4035403797523124,"synonym_name":"UDP-glucose"},{"chebi_id":"16908","direction":"up","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BOPGDPNILDQYTO-NNYOXOHSSA-N","pvalue":3.269285287143529e-09,"ratio":2.3371830548021615,"synonym_name":"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE"},{"chebi_id":"4170","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":2.1889171406886457e-06,"ratio":0.2997920363140777,"synonym_name":"Glc6P"},{"chebi_id":"15946","direction":"down","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.000913285462271,"ratio":0.1731008518010003,"synonym_name":"D-Fructose 6-phosphate"}],"totalFeatures":24},{"comparisonGroups":["Labeled_Leaf","Unlabeled_Leaf"],"dateCreated":"2025-09-26 00:00:00","display_title":"Leaf tissue: 13C labeled vs unlabeled samples","group_a_title":"Leaf samples labeled with 13C. Represents the effect of 13C labeling on leaf tissue.","group_b_title":"Leaf samples without 13C labeling. Serves as the baseline for comparison with labeled leaf samples.","id":"MTBLS435_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS435","studyUrl":"http://integmet.org/study/MTBLS435","title":"Labeled_Leaf_vs_Unlabeled_Leaf","topHits":[],"totalFeatures":25},{"comparisonGroups":["Labeled_Leaf","Unlabeled_Leaf"],"dateCreated":"2025-09-26 00:00:00","display_title":"Leaf tissue: 13C labeled vs unlabeled samples","group_a_title":"Leaf samples labeled with 13C. Represents the effect of 13C labeling on leaf tissue.","group_b_title":"Leaf samples without 13C labeling. Serves as the baseline for comparison with labeled leaf samples.","id":"MTBLS435_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS435","studyUrl":"http://integmet.org/study/MTBLS435","title":"Labeled_Leaf_vs_Unlabeled_Leaf","topHits":[],"totalFeatures":22},{"comparisonGroups":["Ziyun_No.1_0h","Ziyun_No.1_96h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Ziyun No.1 cultivar: 0h vs 96h post-inoculation","group_a_title":"Ziyun No.1 cultivar at 0 hours post-inoculation. Serves as the reference point for all subsequent time points and treatments for Ziyun No.1.","group_b_title":"Ziyun No.1 cultivar at 96 hours post-inoculation. Represents the late response phase of the resistant cultivar.","id":"MTBLS4365_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":142,"studyId":"MTBLS4365","studyUrl":"http://integmet.org/study/MTBLS4365","title":"Ziyun_No.1_0h_vs_Ziyun_No.1_96h","topHits":[{"chebi_id":"28158","direction":"down","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1,15-trihydroxy-6-oxoprost-13-en-1-oic acid","metabolite_id":"KFGOFTHODYBSGM-ZUNNJUQCSA-N","pvalue":6.925897760188187e-07,"ratio":0.020690839366969,"synonym_name":"6-Oxoprostaglandin F1alpha"},{"chebi_id":"89553","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HBQGHTRBYUFZLV-MIJQFFSFSA-N","pvalue":4.323209629863596e-05,"ratio":0.0123017779913503,"synonym_name":"(2S,3S,4S,5R)-3,4,5-trihydroxy-6-{2-methoxy-4-[(1E)-prop-1-en-1-yl]phenoxy}oxane-2-carboxylic acid"},{"chebi_id":"16968","direction":"down","inn_name":"","iupac_name":"1,8-diazacyclotetradecane-2,9-dione","metabolite_id":"HERSSAVMHCMYSQ-UHFFFAOYSA-N","pvalue":2.319968442146817e-08,"ratio":0.1354963749061966,"synonym_name":"1,8-Diazacyclotetradecane-2,9-dione"},{"chebi_id":"138763","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"TXIKNNOOLCGADE-PAPYEOQZSA-N","pvalue":0.0029114591253352,"ratio":0.0024391345589231,"synonym_name":""},{"chebi_id":"172510","direction":"down","inn_name":"","iupac_name":"4-(5,6-dihydroxy-6-methylhept-1-en-2-yl)-1-methylcyclohexane-1,2-diol","metabolite_id":"DIVJRNQAZRYCIO-UHFFFAOYSA-N","pvalue":0.0010221854146328,"ratio":0.0102437737963771,"synonym_name":""},{"chebi_id":"168154","direction":"down","inn_name":"","iupac_name":"4-hydroxy-3,5,5-trimethyl-4-[(1E,3E)-3-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypenta-1,3-dienyl]cyclohex-2-en-1-one","metabolite_id":"PMGQCIZHFNQTAO-YTEPGLGFSA-N","pvalue":6.271418246949362e-09,"ratio":0.2007212914551769,"synonym_name":""},{"chebi_id":"52486","direction":"down","inn_name":"","iupac_name":"abieta-8,11,13-trien-18-ol","metabolite_id":"WSKGRAGZAQRSED-SLFFLAALSA-N","pvalue":0.0019335698544829,"ratio":0.0145946521785447,"synonym_name":"Dehydroabietol"},{"chebi_id":"170109","direction":"down","inn_name":"","iupac_name":"(1R,2S,4R,6S,7R,10S,13R)-6-(hydroxymethyl)-2,6,12-trimethyltetracyclo[11.2.1.01,10.02,7]hexadec-11-en-4-ol","metabolite_id":"OXKYBEZXRLIPKC-OSIAAWHGSA-N","pvalue":0.012849636799072,"ratio":0.0028919610170341,"synonym_name":""},{"chebi_id":"172556","direction":"down","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propanoic acid","metabolite_id":"LEEDEKWKJVUWGA-BJMVGYQFSA-N","pvalue":0.0132800979607568,"ratio":0.0038329074547272,"synonym_name":""},{"chebi_id":"185526","direction":"down","inn_name":"","iupac_name":"(5E,7E,9E,11E)-tetradeca-5,7,9,11,13-pentaenoic acid","metabolite_id":"LQROPCHYRPLGPB-BYFNFPHLSA-N","pvalue":0.0028063019686523,"ratio":0.0232156035846072,"synonym_name":""}],"totalFeatures":802},{"comparisonGroups":["MR-CTB51A","NPB-HP"],"dateCreated":"2025-09-26 00:00:00","display_title":"Rice seeds: CTB modified + gene suppression vs hydroponic","group_a_title":"Group with modified CTB expression and gene suppression of 13 kDa prolamin clone RM1 and GluB1.. This group is crucial for understanding the effects of modified CTB expression and gene suppression on rice seed metabolism.","group_b_title":"Group grown hydroponically in a growth chamber without specific genetic modifications.. This group serves as a reference for understanding the effects of hydroponic growth conditions on rice seed metabolism.","id":"MTBLS437_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS437","studyUrl":"http://integmet.org/study/MTBLS437","title":"MR-CTB51A_vs_NPB-HP","topHits":[{"chebi_id":"173045","direction":"up","inn_name":"","iupac_name":"(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol","metabolite_id":"ONQRKEUAIJMULO-SPBTXPORSA-N","pvalue":4.0709395931636705e-05,"ratio":11.08634700990372,"synonym_name":""},{"chebi_id":"18257","direction":"up","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":3.582950535325695e-05,"ratio":9.565097033626667,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BDHQMRXFDYJGII-UHFFFAOYSA-N","pvalue":4.520847813082713e-05,"ratio":8.696270594268862,"synonym_name":""},{"chebi_id":"16414","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":1.0729303523657183e-05,"ratio":4.578940625228786,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"},{"chebi_id":"17148","direction":"up","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":0.0002079951518941,"ratio":6.718146135265699,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"58315","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":4.293353381144227e-05,"ratio":3.987412715913266,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"30769","direction":"up","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0001433910055854,"ratio":4.637361659439519,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"15603","direction":"up","inn_name":"","iupac_name":"<small>L</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","pvalue":6.786911476236481e-05,"ratio":3.627117896223085,"synonym_name":"<small>L</small>-Leuzin"},{"chebi_id":"37024","direction":"up","inn_name":"","iupac_name":"2-aminohexanedioic acid","metabolite_id":"OYIFNHCXNCRBQI-UHFFFAOYSA-N","pvalue":0.0005250003614431,"ratio":4.609181141439206,"synonym_name":"2-aminoadipic acid"},{"chebi_id":"28822","direction":"up","inn_name":"","iupac_name":"icosanoic acid","metabolite_id":"VKOBVWXKNCXXDE-UHFFFAOYSA-N","pvalue":0.0002317627461068,"ratio":3.6779404927940496,"synonym_name":"C20:0"}],"totalFeatures":41},{"comparisonGroups":["Uninfected_BALB/c","Plasmodium_yoelii_17XL_BALB/c"],"dateCreated":"2025-09-26 00:00:00","display_title":"BALB/c mice: Plasmodium yoelii 17XL infection vs control","group_a_title":"Uninfected BALB/c mice serum samples. Provides baseline metabolic profile for comparison with infected BALB/c samples.","group_b_title":"BALB/c mice infected with Plasmodium yoelii 17XL. Allows for the study of metabolic changes due to Plasmodium yoelii 17XL infection in BALB/c mice.","id":"MTBLS4387_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS4387","studyUrl":"http://integmet.org/study/MTBLS4387","title":"Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c","topHits":[{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":3.894716994206269e-06,"ratio":0.0579943763657996,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"15903","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"beta-D-Glucose"},{"chebi_id":"25858","direction":"up","inn_name":"","iupac_name":"1,7-dimethyl-3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"QUNWUDVFRNGTCO-UHFFFAOYSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"1,7-Dimethylxanthine"},{"chebi_id":"28946","direction":"up","inn_name":"","iupac_name":"3,7-dimethyl-3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"YAPQBXQYLJRXSA-UHFFFAOYSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"3,7-dihydro-3,7-dimethyl-1<em>H</em>-purine-2,6-dione"},{"chebi_id":"17268","direction":"up","inn_name":"","iupac_name":"<i>myo</i>-inositol","metabolite_id":"CDAISMWEOUEBRE-GPIVLXJGSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"D-myo-Inositol"},{"chebi_id":"17925","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-DVKNGEFBSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"alpha-D-Glucose"},{"chebi_id":"28729","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-mannopyranose","metabolite_id":"WQZGKKKJIJFFOK-PQMKYFCFSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"ALPHA-D-MANNOSE"},{"chebi_id":"28061","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactopyranose","metabolite_id":"WQZGKKKJIJFFOK-PHYPRBDBSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"ALPHA D-GALACTOSE"},{"chebi_id":"28645","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":1.6086485405271478e-07,"ratio":4.092079034510356,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"34450","direction":"up","inn_name":"","iupac_name":"4-{3-[(2<i>Z</i>,5<i>Z</i>,8<i>Z</i>)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid","metabolite_id":"VBQNSZQZRAGRIX-QNEBEIHSSA-N","pvalue":0.0005589989775924,"ratio":3.807804792651045,"synonym_name":"5,6-EpETrE"}],"totalFeatures":19},{"comparisonGroups":["Uninfected_BALB/c","Plasmodium_yoelii_17XL_BALB/c"],"dateCreated":"2025-09-26 00:00:00","display_title":"BALB/c mice serum: P. yoelii 17XL infection vs control","group_a_title":"Uninfected BALB/c mice serum samples. Provides baseline metabolic profile for comparison with infected BALB/c samples.","group_b_title":"BALB/c mice infected with Plasmodium yoelii 17XL. Allows for the study of metabolic changes due to Plasmodium yoelii 17XL infection in BALB/c mice.","id":"MTBLS4387_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS4387","studyUrl":"http://integmet.org/study/MTBLS4387","title":"Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c","topHits":[{"chebi_id":"17033","direction":"down","inn_name":"","iupac_name":"biliverdin","metabolite_id":"QBUVFDKTZJNUPP-BBROENKCSA-N","pvalue":0.0164006711137152,"ratio":1e-06,"synonym_name":"Biliverdine"},{"chebi_id":"17964","direction":"down","inn_name":"","iupac_name":"piperidine-2-carboxylic acid","metabolite_id":"HXEACLLIILLPRG-UHFFFAOYSA-N","pvalue":2.439764319684747e-06,"ratio":0.0875793818654216,"synonym_name":"homoproline"},{"chebi_id":"7386","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(4-oxobutyl)acetamide","metabolite_id":"DDSLGZOYEPKPSJ-UHFFFAOYSA-N","pvalue":2.439764319684747e-06,"ratio":0.0875793818654216,"synonym_name":"<em>N</em>-acetyl-4-aminobutanal"},{"chebi_id":"17295","direction":"down","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":4.365374306895789e-07,"ratio":0.2990898881018481,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"17568","direction":"down","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":1.5057071759423592e-05,"ratio":0.2234816789406336,"synonym_name":"Urazil"},{"chebi_id":"16893","direction":"up","inn_name":"","iupac_name":"sphinganine 1-(dihydrogen phosphate)","metabolite_id":"YHEDRJPUIRMZMP-ZWKOTPCHSA-N","pvalue":8.606185524982784e-05,"ratio":3.284806332841379,"synonym_name":"Sphinganine 1-phosphate"},{"chebi_id":"17748","direction":"down","inn_name":"","iupac_name":"thymidine","metabolite_id":"IQFYYKKMVGJFEH-XLPZGREQSA-N","pvalue":0.0008126740501235,"ratio":0.2391951403578559,"synonym_name":"T"},{"chebi_id":"18089","direction":"up","inn_name":"","iupac_name":"<em>N</em>-benzoylglycine","metabolite_id":"QIAFMBKCNZACKA-UHFFFAOYSA-N","pvalue":0.0277512677626239,"ratio":5.0100847964083774,"synonym_name":"Benzamidoessigs\u00e4ure"}],"totalFeatures":8},{"comparisonGroups":["Uninfected_BALB/c","Plasmodium_yoelii_17XL_BALB/c"],"dateCreated":"2025-09-26 00:00:00","display_title":"BALB/c mice serum: P. yoelii 17XL infection vs control","group_a_title":"Uninfected BALB/c mice serum samples. Provides baseline metabolic profile for comparison with infected BALB/c samples.","group_b_title":"BALB/c mice infected with Plasmodium yoelii 17XL. Allows for the study of metabolic changes due to Plasmodium yoelii 17XL infection in BALB/c mice.","id":"MTBLS4387_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":43,"studyId":"MTBLS4387","studyUrl":"http://integmet.org/study/MTBLS4387","title":"Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c","topHits":[{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":3.777585848961181e-07,"ratio":23.906231040547272,"synonym_name":""},{"chebi_id":"82517","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UZKWBBZEYBCHIN-UHFFFAOYSA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":""},{"chebi_id":"16015","direction":"down","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"82590","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HVGNLIKFFBYBQM-UHFFFAOYSA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":"DMBA-5,6-epoxide"},{"chebi_id":"82559","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JCBBZYDVQJQMMB-UHFFFAOYSA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":"12-Methylbenz[a]anthracene-7-methanol"},{"chebi_id":"27809","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,4<i>R</i>)-2-amino-4-hydroxy-5-oxopentanoic acid","metabolite_id":"XCXUZPXOFFRGGP-DMTCNVIQSA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":"(4<i>R</i>)-4-hydroxy-5-oxo-<small>L</small>-norvaline"},{"chebi_id":"15966","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glutamic acid","metabolite_id":"WHUUTDBJXJRKMK-GSVOUGTGSA-N","pvalue":3.5846635703542664e-08,"ratio":0.138007260101666,"synonym_name":"D-2-Aminoglutaric acid"},{"chebi_id":"47977","direction":"up","inn_name":"","iupac_name":"2-amino-2-deoxy-<small>D</small>-glucopyranose","metabolite_id":"MSWZFWKMSRAUBD-IVMDWMLBSA-N","pvalue":3.8284075942215576e-08,"ratio":3.7130472207520566,"synonym_name":"Chitosamine"},{"chebi_id":"28712","direction":"down","inn_name":"","iupac_name":"\u03b2-alanyl-<small>L</small>-arginine","metabolite_id":"DLRGFJGVZXSSTP-LURJTMIESA-N","pvalue":4.3076907639317027e-07,"ratio":0.2372945514540917,"synonym_name":"(2<i>S</i>)-5-{[amino(imino)methyl]amino}-2-[(3-aminopropanoyl)amino]pentanoic acid"},{"chebi_id":"15611","direction":"down","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":1.843169004373808e-07,"ratio":0.2935777739077405,"synonym_name":"L-sarcosine"}],"totalFeatures":43},{"comparisonGroups":["Uninfected_BALB/c","Plasmodium_yoelii_17XL_BALB/c"],"dateCreated":"2025-09-26 00:00:00","display_title":"BALB/c mice: Plasmodium yoelii 17XL infection vs control","group_a_title":"Uninfected BALB/c mice serum samples. Provides baseline metabolic profile for comparison with infected BALB/c samples.","group_b_title":"BALB/c mice infected with Plasmodium yoelii 17XL. Allows for the study of metabolic changes due to Plasmodium yoelii 17XL infection in BALB/c mice.","id":"MTBLS4387_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":21,"studyId":"MTBLS4387","studyUrl":"http://integmet.org/study/MTBLS4387","title":"Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c","topHits":[{"chebi_id":"15746","direction":"up","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>'-bis(3-aminopropyl)butane-1,4-diamine","metabolite_id":"PFNFFQXMRSDOHW-UHFFFAOYSA-N","pvalue":0.0054810284722879,"ratio":638.4394582755449,"synonym_name":"4,9-diaza-1,12-dodecanediamine"},{"chebi_id":"2482","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OCNLJCZKGHKJGF-NQYRMHKHSA-M","pvalue":0.0001251784841689,"ratio":0.0719210520307151,"synonym_name":"Adenosylcobyrinic acid a,c-diamide"},{"chebi_id":"30154","direction":"down","inn_name":"","iupac_name":"5\u03b2-pregnane-3,20-dione","metabolite_id":"XMRPGKVKISIQBV-XWOJZHJZSA-N","pvalue":4.941721018857729e-06,"ratio":0.2441839297534118,"synonym_name":"5\u03b2-dihydroprogesterone"},{"chebi_id":"28453","direction":"down","inn_name":"","iupac_name":"(20<i>S</i>)-20-hydroxypregn-4-en-3-one","metabolite_id":"RWBRUCCWZPSBFC-RXRZZTMXSA-N","pvalue":4.941721018857729e-06,"ratio":0.2441839297534118,"synonym_name":"20alpha-Hydroxyprogesterone"},{"chebi_id":"28952","direction":"down","inn_name":"","iupac_name":"5\u03b1-pregnane-3,20-dione","metabolite_id":"XMRPGKVKISIQBV-BJMCWZGWSA-N","pvalue":4.941721018857729e-06,"ratio":0.2441839297534118,"synonym_name":"3,20-allopregnanedione"},{"chebi_id":"16581","direction":"down","inn_name":"","iupac_name":"3\u03b2-hydroxypregn-5-en-20-one","metabolite_id":"ORNBQBCIOKFOEO-QGVNFLHTSA-N","pvalue":4.941721018857729e-06,"ratio":0.2441839297534118,"synonym_name":"3beta-Hydroxypregn-5-en-20-one"},{"chebi_id":"18086","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-indol-3-ylacetaldehyde","metabolite_id":"WHOOUMGHGSPMGR-UHFFFAOYSA-N","pvalue":5.334220440395097e-05,"ratio":3.244418275577595,"synonym_name":"Indole-3-acetaldehyde"},{"chebi_id":"64860","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)pentane-1,5-diamine","metabolite_id":"QZBYOYPROVGOGE-UHFFFAOYSA-N","pvalue":9.38736330009474e-05,"ratio":3.250882975092588,"synonym_name":"N-(3-Aminopropyl)cadaverine"},{"chebi_id":"17311","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>,<em>N</em><small><sup>6</small></sup>,<em>N</em><small><sup>6</small></sup>-trimethyl-<small>L</small>-lysin-<em>N</em><small><sup>6</small></sup>-ium","metabolite_id":"MXNRLFUSFKVQSK-QMMMGPOBSA-O","pvalue":0.000118383931815,"ratio":3.206614260194522,"synonym_name":"N6,N6,N6-Trimethyl-L-lysine"},{"chebi_id":"18067","direction":"down","inn_name":"phytom\u00e9nadione","iupac_name":"2-methyl-3-[(2<i>E</i>,7<i>R</i>,11<i>R</i>)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-dione","metabolite_id":"MBWXNTAXLNYFJB-NKFFZRIASA-N","pvalue":0.0085251064692084,"ratio":0.120419767270621,"synonym_name":"2-methyl-3-phytyl-1,4-naphthoquinone"}],"totalFeatures":21},{"comparisonGroups":["Control","150mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 150mM salt stress","group_a_title":"Control group with 0 mM salt concentration.. Provides a reference point for evaluating the effects of salt stress.","group_b_title":"Group exposed to 150 mM salt concentration.. Helps in understanding the response to very high salt stress.","id":"MTBLS44_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS44","studyUrl":"http://integmet.org/study/MTBLS44","title":"Control_vs_150mM","topHits":[{"chebi_id":"42717","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranuronic acid","metabolite_id":"AEMOLEFTQBMNLQ-WAXACMCWSA-N","pvalue":2.0096776081457256e-05,"ratio":0.054956547109955,"synonym_name":"D-GLUCURONIC ACID"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":3.058397810366008e-07,"ratio":0.1723741882079839,"synonym_name":""},{"chebi_id":"87753","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2,3,4,5,6-pentahydroxyhexanoic acid","metabolite_id":"RGHNJXZEOKUKBD-KKQCNMDGSA-N","pvalue":1.3814578696770503e-05,"ratio":0.1628424686162218,"synonym_name":"Gulonic acid"},{"chebi_id":"16002","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>S</i>)-2,3,4,5-tetrahydroxyhexanedioic acid","metabolite_id":"DSLZVSRJTYRBFB-LLEIAEIESA-N","pvalue":4.912381435912768e-09,"ratio":0.4009088773507143,"synonym_name":"saccharic acid"},{"chebi_id":"16899","direction":"down","inn_name":"","iupac_name":"<small>D</small>-mannitol","metabolite_id":"FBPFZTCFMRRESA-KVTDHHQDSA-N","pvalue":5.460018237746456e-07,"ratio":0.4404266974808507,"synonym_name":"E-421"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0059653158812009,"ratio":8.243555175889053,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"33384","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":0.0018714166243138,"ratio":0.203013732806359,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"26078","direction":"up","inn_name":"","iupac_name":"trihydrogen tetraoxophosphate(3\u2212)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","pvalue":0.0140845614341389,"ratio":10.25927542543188,"synonym_name":"phosphoric acid"},{"chebi_id":"18147","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QUYVBRFLSA-N","pvalue":0.0029954366753555,"ratio":0.3317380731799102,"synonym_name":"4-(alpha-D-Glucopyranosido)-alpha-glucopyranose"},{"chebi_id":"4170","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":0.0006838477483339,"ratio":2.2419483243468568,"synonym_name":"Glc6P"}],"totalFeatures":102},{"comparisonGroups":["CD_feces","CD+HF_feces"],"dateCreated":"2025-09-26 00:00:00","display_title":"Feces: standard diet vs high-fat diet","group_a_title":"Control group with standard diet, feces samples. Serves as a reference for comparing the effects of different diets on feces samples.","group_b_title":"High-fat diet group, feces samples. Used to assess the impact of a high-fat diet on feces samples.","id":"MTBLS4431_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS4431","studyUrl":"http://integmet.org/study/MTBLS4431","title":"CD_feces_vs_CD+HF_feces","topHits":[{"chebi_id":"81299","direction":"up","inn_name":"","iupac_name":"3\u03b1,6\u03b1,7\u03b2-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DKPMWHFRUGMUKF-NTPBNISXSA-N","pvalue":4.713096380487713e-09,"ratio":462.8998151850987,"synonym_name":"(3\u03b1,5\u03b2,6\u03b1,7\u03b2)-3,6,7-trihydroxycholan-24-oic acid"},{"chebi_id":"52023","direction":"up","inn_name":"","iupac_name":"3\u03b1,6\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DGABKXLVXPYZII-SIBKNCMHSA-N","pvalue":1.1245297843826535e-07,"ratio":1349.878731751745,"synonym_name":"Hyodesoxycholic acid"},{"chebi_id":"81243","direction":"up","inn_name":"","iupac_name":"3\u03b1,6\u03b2,7\u03b1-trihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"DKPMWHFRUGMUKF-GDYCBZMLSA-N","pvalue":1.221746070557234e-07,"ratio":626.7447916220018,"synonym_name":"5beta-Cholanic acid-3alpha,6beta,7alpha-triol"},{"chebi_id":"16755","direction":"up","inn_name":"","iupac_name":"3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-BSWAIDMHSA-N","pvalue":3.7224117359454575e-08,"ratio":240.65996237386696,"synonym_name":"anthropodesoxycholic acid"},{"chebi_id":"16525","direction":"up","inn_name":"","iupac_name":"2-[(3\u03b1,7\u03b1-dihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"BHTRKEVKTKCXOH-BJLOMENOSA-N","pvalue":7.273176896547696e-06,"ratio":2504.622650344505,"synonym_name":"taurochenodeoxycholic acid"},{"chebi_id":"139132","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PLRQOCVIINWCFA-AHFDLSHQSA-N","pvalue":4.8076695524998894e-06,"ratio":1622.9310344827588,"synonym_name":""},{"chebi_id":"17687","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b1,12\u03b1-trihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"RFDAIACWWDREDC-FRVQLJSFSA-N","pvalue":2.502518161822222e-06,"ratio":1021.5202780996524,"synonym_name":"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine"},{"chebi_id":"80774","direction":"up","inn_name":"","iupac_name":"2-[(3\u03b1,7\u03b2-dihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"BHTRKEVKTKCXOH-LBSADWJPSA-N","pvalue":5.598522303355942e-06,"ratio":826.1926891308698,"synonym_name":"Taurolite"},{"chebi_id":"139136","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XSOLDPYUICCHJX-QQXJNSDFSA-N","pvalue":7.452322073672188e-06,"ratio":686.2926104162499,"synonym_name":""},{"chebi_id":"28834","direction":"up","inn_name":"","iupac_name":"3\u03b1,12\u03b1-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"KXGVEGMKQFWNSR-LLQZFEROSA-N","pvalue":9.959066439981831e-06,"ratio":773.4547680590687,"synonym_name":"Desoxychols\u00e4ure"}],"totalFeatures":27},{"comparisonGroups":["CcPmk1","Wild type"],"dateCreated":"2025-09-26 00:00:00","display_title":"CcPmk1 knockout vs wild-type fungal comparison","group_a_title":"Experimental group with CcPmk1 genotype.. Key group for understanding the role of CcPmk1 in fungal growth and virulence.","group_b_title":"Control group with wild type genotype.. Provides a baseline for evaluating the effects of CcPmk1 manipulation.","id":"MTBLS4463_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":121,"studyId":"MTBLS4463","studyUrl":"http://integmet.org/study/MTBLS4463","title":"CcPmk1_vs_Wild_type","topHits":[{"chebi_id":"81395","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HAWSQZCWOQZXHI-FQEVSTJZSA-N","pvalue":7.718938033891944e-06,"ratio":3.1140453577110363,"synonym_name":""},{"chebi_id":"71176","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>)-3,4-dihydroxydihydrofuran-2(3<em>H</em>)-one","metabolite_id":"SGMJBNSHAZVGMC-STHAYSLISA-N","pvalue":7.97658647133894e-05,"ratio":3.983705036483157,"synonym_name":"L-threonic acid-1,4-lactone"},{"chebi_id":"14648","direction":"up","inn_name":"","iupac_name":"3-carbamoyl-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)pyridinium","metabolite_id":"DAYLJWODMCOQEW-TURQNECASA-O","pvalue":3.3741963852549695e-05,"ratio":3.3401165010732687,"synonym_name":""},{"chebi_id":"183418","direction":"down","inn_name":"","iupac_name":"4-morpholin-4-ylbenzoic acid","metabolite_id":"XVAJKPNTGSKZSQ-UHFFFAOYSA-N","pvalue":0.0374799866864972,"ratio":0.0249091998422617,"synonym_name":""},{"chebi_id":"67040","direction":"up","inn_name":"","iupac_name":"[(3<i>S</i>)-3-amino-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonioacetate","metabolite_id":"MEFKEPWMEQBLKI-AIRLBKTGSA-N","pvalue":0.0003575720942769,"ratio":4.5622802061242105,"synonym_name":"AdoMet"},{"chebi_id":"183741","direction":"down","inn_name":"","iupac_name":"(2S,3S)-3-hydroxy-2-methyl-7-[(E)-prop-1-enyl]-2,3-dihydropyrano[3,2-c]pyran-4,5-dione","metabolite_id":"SDKXGAICTNHFCN-DCJAWTJCSA-N","pvalue":0.0402194407873596,"ratio":0.0249313856445196,"synonym_name":""},{"chebi_id":"15553","direction":"down","inn_name":"dinoprost","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1,15-trihydroxyprosta-5,13-dien-1-oic acid","metabolite_id":"PXGPLTODNUVGFL-YNNPMVKQSA-N","pvalue":0.0006240329107987,"ratio":0.2247053154624811,"synonym_name":"PGF2a"},{"chebi_id":"545687","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-dodec-2-enedioic acid","metabolite_id":"MAZWDMBCPDUFDJ-VQHVLOKHSA-N","pvalue":0.0002549588101863,"ratio":0.325382752632567,"synonym_name":"trans-2-dodecenedioic acid"},{"chebi_id":"26756","direction":"down","inn_name":"","iupac_name":"stercobilin","metabolite_id":"DEEUSUJLZQQESV-UHFFFAOYSA-N","pvalue":0.0191041702673111,"ratio":0.0982418460764495,"synonym_name":"stercobilin IX\u03b1"},{"chebi_id":"192581","direction":"up","inn_name":"","iupac_name":"N-[3-chloro-4-[(3-luorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulonylethylamino)methyl]uran-2-yl]quinazolin-4-amine;4-methylbenzenesulonic acid;hydrate","metabolite_id":"XNRVGTHNYCNCFF-UHFFFAOYSA-N","pvalue":0.0070667906800694,"ratio":6.1983636454141156,"synonym_name":""}],"totalFeatures":860},{"comparisonGroups":["Basal","High Fat"],"dateCreated":"2025-09-26 00:00:00","display_title":"Basal diet vs high-fat diet effects on metabolism","group_a_title":"Control group with basal diet and no AAP treatment. Provides baseline data for comparison with high-fat and AAP treated groups.","group_b_title":"Group with high-fat diet and no AAP treatment. Allows for the assessment of the effects of a high-fat diet on obesity and metabolism.","id":"MTBLS4469_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS4469","studyUrl":"http://integmet.org/study/MTBLS4469","title":"Basal_vs_High_Fat","topHits":[{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.012993649015482,"ratio":1.4039911631664508e-05,"synonym_name":"colamine phosphate"},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.012887747547408,"ratio":2.5263562754801243e-05,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"9481","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RHQQHZQUAMFINJ-DTDWNVJFSA-N","pvalue":0.0017666349064362,"ratio":0.0805599892628595,"synonym_name":"Tetrahydrocorticosterone"},{"chebi_id":"16196","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":0.0130687850203778,"ratio":6.5094762543274,"synonym_name":"Oleate"},{"chebi_id":"16032","direction":"down","inn_name":"","iupac_name":"3\u03b1-hydroxy-5\u03b1-androstan-17-one","metabolite_id":"QGXBDMJGAMFCBF-HLUDHZFRSA-N","pvalue":0.0482812718559692,"ratio":0.2157947532492949,"synonym_name":"5\u03b1-androsterone"},{"chebi_id":"90143","direction":"down","inn_name":"","iupac_name":"<em>N</em>-carbamimidoylaspartic acid","metabolite_id":"VVHOUVWJCQOYGG-UHFFFAOYSA-N","pvalue":0.0016040239940455,"ratio":0.5129328255939161,"synonym_name":"guanidinosuccinic acid"},{"chebi_id":"17929","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(dimethylamino)(imino)methyl]amino}pentanoic acid","metabolite_id":"YDGMGEXADBMOMJ-LURJTMIESA-N","pvalue":0.0139328239617852,"ratio":0.4072987158080903,"synonym_name":"NG,NG-Dimethyl-L-arginine"},{"chebi_id":"18186","direction":"up","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0191360685064369,"ratio":2.6208838407091477,"synonym_name":"Tyrosin"},{"chebi_id":"30860","direction":"down","inn_name":"","iupac_name":"methylpropanedioic acid","metabolite_id":"ZIYVHBGGAOATLY-UHFFFAOYSA-N","pvalue":0.0100287229516519,"ratio":0.4398276330040681,"synonym_name":"1,1-Ethanedicarboxylic acid"},{"chebi_id":"28837","direction":"down","inn_name":"octanoic acid","iupac_name":"octanoic acid","metabolite_id":"WWZKQHOCKIZLMA-UHFFFAOYSA-N","pvalue":0.0395112319575978,"ratio":0.3166557749110382,"synonym_name":"Octans\u00e4ure"}],"totalFeatures":189},{"comparisonGroups":["Col-0_Root","tt4_Root"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis roots: wild-type vs tt4 mutant","group_a_title":"Wild-type Arabidopsis thaliana root samples.. Serves as the reference group for evaluating the effects of genetic mutations.","group_b_title":"Arabidopsis thaliana root samples with tt4 genotype.. Allows for the assessment of the tt4 mutation's impact on metabolomic profiles.","id":"MTBLS45_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS45","studyUrl":"http://integmet.org/study/MTBLS45","title":"Col-0_Root_vs_tt4_Root","topHits":[{"chebi_id":"4167","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-GASJEMHNSA-N","pvalue":0.0015833151596243,"ratio":1.956265472120712,"synonym_name":"Dextrose"},{"chebi_id":"58359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-5-amino-2-azaniumyl-5-oxopentanoate","metabolite_id":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","pvalue":0.0216066422912693,"ratio":1.7381950581209318,"synonym_name":"(2<i>S</i>)-5-amino-2-ammonio-5-oxopentanoate"},{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.025291292153846,"ratio":1.5967634978486722,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"}],"totalFeatures":70},{"comparisonGroups":["med17","col"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis: med17 mutant vs wild-type","group_a_title":"Samples from Arabidopsis thaliana Mediator mutant med17.. Helps in understanding the role of the med17 subunit in gene regulation.","group_b_title":"Wild-type Arabidopsis thaliana samples.. Serves as the baseline for understanding the effects of mutations in the Mediator complex.","id":"MTBLS450_0001_00000012","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS450","studyUrl":"http://integmet.org/study/MTBLS450","title":"G1_med17_vs_G13_col","topHits":[{"chebi_id":"27993","direction":"up","inn_name":"","iupac_name":"1-<em>O</em>-[(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-2-<em>O</em>-[(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"KQDOTXAUJBODDM-STUNQXDBSA-N","pvalue":0.0047355757890473,"ratio":28.68310528646242,"synonym_name":"1,2-bis-O-sinapoyl-beta-D-glucoside"},{"chebi_id":"77131","direction":"up","inn_name":"","iupac_name":"3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid","metabolite_id":"PCMORTLOPMLEFB-UHFFFAOYSA-N","pvalue":0.0002448406424566,"ratio":6.262391308027011,"synonym_name":"3,5-dimethoxy-4-hydroxycinnamic acid"},{"chebi_id":"27949","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal","metabolite_id":"CDICDSOGTRCHMG-ONEGZZNKSA-N","pvalue":0.0175625404308185,"ratio":1.5327577447915586,"synonym_name":"Sinapoyl aldehyde"},{"chebi_id":"47807","direction":"up","inn_name":"","iupac_name":"1-isothiocyanato-4-(methylsulfinyl)butane","metabolite_id":"SUVMJBTUFCVSAD-UHFFFAOYSA-N","pvalue":0.0303711111416555,"ratio":1.5092887328995186,"synonym_name":"Sulforafan"}],"totalFeatures":16},{"comparisonGroups":["RCON","RFW"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep: fermented Lycium barbarum residue vs control diet","group_a_title":"Control group with standard diet.. Serves as a reference point for comparing the effects of Lycium barbarum residue supplementation.","group_b_title":"Sheep fed with fermented Lycium barbarum residues.. This group helps assess the impact of fermented Lycium barbarum residues on sheep.","id":"MTBLS4507_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS4507","studyUrl":"http://integmet.org/study/MTBLS4507","title":"RCON_vs_RFW","topHits":[{"chebi_id":"18347","direction":"up","inn_name":"","iupac_name":"<small>L</small>-norleucine","metabolite_id":"LRQKBLKVPFOOQJ-YFKPBYRVSA-N","pvalue":1.47991038777367e-05,"ratio":5.357926790041209,"synonym_name":"\u03b1-aminocaproic acid"},{"chebi_id":"18183","direction":"up","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":4.005109148837516e-05,"ratio":4.770072044385833,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"60039","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":1.5060788507621496e-05,"ratio":4.077302933428658,"synonym_name":""},{"chebi_id":"18257","direction":"up","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":2.6231878849751244e-05,"ratio":2.9944038510737983,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"17568","direction":"up","inn_name":"","iupac_name":"pyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","pvalue":8.044412399854883e-05,"ratio":1.8751882423887345,"synonym_name":"Urazil"},{"chebi_id":"18211","direction":"up","inn_name":"","iupac_name":"citrulline","metabolite_id":"RHGKLRLOHDJJDR-UHFFFAOYSA-N","pvalue":0.0078708408033046,"ratio":2.6100524002739616,"synonym_name":"2-Amino-5-uredovaleric acid"},{"chebi_id":"169990","direction":"up","inn_name":"","iupac_name":"1H-indole-2-carboxylic acid","metabolite_id":"HCUARRIEZVDMPT-UHFFFAOYSA-N","pvalue":0.002757286862873,"ratio":2.043636772545964,"synonym_name":""},{"chebi_id":"74903","direction":"up","inn_name":"","iupac_name":"4-methylpentanoic acid","metabolite_id":"FGKJLKRYENPLQH-UHFFFAOYSA-N","pvalue":0.0047038680051707,"ratio":2.101447954878688,"synonym_name":"4-Methylvaleric acid"},{"chebi_id":"87625","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>R</i>)-3,4-dihydroxyoxolan-2-one","metabolite_id":"SGMJBNSHAZVGMC-PWNYCUMCSA-N","pvalue":0.0002284425223704,"ratio":1.5973121788101614,"synonym_name":"<small>D</small>-erythronolactone"},{"chebi_id":"45571","direction":"up","inn_name":"","iupac_name":"heptanoic acid","metabolite_id":"MNWFXJYAOYHMED-UHFFFAOYSA-N","pvalue":0.0050041720558903,"ratio":2.0870438032898493,"synonym_name":"heptoic acid"}],"totalFeatures":24},{"comparisonGroups":["RCON","RFW"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep: fermented Lycium barbarum vs control diet","group_a_title":"Control group with standard diet.. Serves as a reference point for comparing the effects of Lycium barbarum residue supplementation.","group_b_title":"Sheep fed with fermented Lycium barbarum residues.. This group helps assess the impact of fermented Lycium barbarum residues on sheep.","id":"MTBLS4507_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS4507","studyUrl":"http://integmet.org/study/MTBLS4507","title":"RCON_vs_RFW","topHits":[{"chebi_id":"166814","direction":"down","inn_name":"","iupac_name":"(1S,2R,5S,7S,10S,11S,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracosan-7-ol","metabolite_id":"JALVTHFTYRPDMB-HRRTYWNUSA-N","pvalue":1.0753828720745751e-08,"ratio":0.0043636387954323,"synonym_name":""},{"chebi_id":"17295","direction":"up","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":5.724794740704439e-06,"ratio":6.777345069090587,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"16414","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valine","metabolite_id":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","pvalue":4.513175176705274e-06,"ratio":5.704316589676304,"synonym_name":"L-alpha-Amino-beta-methylbutyric acid"},{"chebi_id":"17597","direction":"up","inn_name":"","iupac_name":"4-hydroxybenzaldehyde","metabolite_id":"RGHHSNMVTDWUBI-UHFFFAOYSA-N","pvalue":0.0008531147341066,"ratio":18.10727582750224,"synonym_name":"p-Hydroxybenzaldehyde"},{"chebi_id":"58245","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-<em>O</em>-phosphonatoadenosine","metabolite_id":"KHWCHTKSEGGWEX-RRKCRQDMSA-L","pvalue":0.0012684288174815,"ratio":15.563946114599258,"synonym_name":"2'-deoxyadenosine 5'-monophosphate"},{"chebi_id":"134761","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YNBADRVTZLEFNH-UHFFFAOYSA-N","pvalue":7.422059669327113e-06,"ratio":4.657770012860529,"synonym_name":"methyl 3-pyridinecarboxylate"},{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":5.4837089957763925e-05,"ratio":6.173773015592504,"synonym_name":"L-Aspartic acid"},{"chebi_id":"57726","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-SCSAIBSYSA-N","pvalue":2.161321700244455e-06,"ratio":3.726342459806455,"synonym_name":""},{"chebi_id":"16235","direction":"up","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":4.0594262435529686e-06,"ratio":3.669182306944058,"synonym_name":"GUANINE"},{"chebi_id":"28871","direction":"up","inn_name":"","iupac_name":"<em>N</em>-methyl-9<em>H</em>-purin-6-amine","metabolite_id":"CKOMXBHMKXXTNW-UHFFFAOYSA-N","pvalue":7.441972176114275e-07,"ratio":2.832814709393177,"synonym_name":"6-MAP"}],"totalFeatures":30},{"comparisonGroups":["Mock_Non_Inoculated_0d","Rhamnol_Non_Inoculated_0d"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mock vs Rhamnolipid treatment at day 0 (non-inoculated)","group_a_title":"Mock treated, non-inoculated samples at day 0. Provides baseline data for comparison with treated and inoculated samples.","group_b_title":"Rhamnolipid treated, non-inoculated samples at day 0. Allows assessment of Rhamnolipid effects without pathogen presence.","id":"MTBLS4542_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS4542","studyUrl":"http://integmet.org/study/MTBLS4542","title":"Mock_Non_Inoculated_0d_vs_Rhamnol_Non_Inoculated_0d","topHits":[{"chebi_id":"22653","direction":"up","inn_name":"","iupac_name":"asparagine","metabolite_id":"DCXYFEDJOCDNAF-UHFFFAOYSA-N","pvalue":4.192660108845098e-05,"ratio":3.0935421656384228,"synonym_name":"Asparagin"},{"chebi_id":"64554","direction":"up","inn_name":"","iupac_name":"2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-UHFFFAOYSA-N","pvalue":0.0019153982400202,"ratio":4.541015553337937,"synonym_name":"2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"25094","direction":"up","inn_name":"","iupac_name":"2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-UHFFFAOYSA-N","pvalue":0.0004939139049258,"ratio":2.723613140209542,"synonym_name":"K"},{"chebi_id":"27570","direction":"up","inn_name":"","iupac_name":"histidine","metabolite_id":"HNDVDQJCIGZPNO-UHFFFAOYSA-N","pvalue":0.022765867689533,"ratio":6.68062719631738,"synonym_name":"Histidine"},{"chebi_id":"58045","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":0.0013406783613782,"ratio":2.6363348581153554,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"},{"chebi_id":"18186","direction":"up","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0014780279428217,"ratio":2.2347853111020792,"synonym_name":"Tyrosin"},{"chebi_id":"59979","direction":"down","inn_name":"","iupac_name":"5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"HRGUSFBJBOKSML-UHFFFAOYSA-N","pvalue":0.0012231353147209,"ratio":0.4956647362692466,"synonym_name":"3',5'-O-Dimethyltricetin"},{"chebi_id":"9299","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SFUVCMKSYKHYLD-FNORWQNLSA-N","pvalue":0.0166732250996279,"ratio":0.3458856230207504,"synonym_name":"Feruloylputrescine"},{"chebi_id":"29016","direction":"up","inn_name":"","iupac_name":"arginine","metabolite_id":"ODKSFYDXXFIFQN-UHFFFAOYSA-N","pvalue":0.0075939720067112,"ratio":1.7634799481345924,"synonym_name":"Arginin"}],"totalFeatures":38},{"comparisonGroups":["Passage 4","Passage 20"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cell passage: early (P4) vs late (P20) stages","group_a_title":"Experimental samples at passage 4. Represents the initial stage of cell passage for comparison with later passages.","group_b_title":"Experimental samples at passage 20. Represents the late stage of cell passage for comparison with earlier passages.","id":"MTBLS4568_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":83,"studyId":"MTBLS4568","studyUrl":"http://integmet.org/study/MTBLS4568","title":"Passage_4_vs_Passage_20","topHits":[{"chebi_id":"27468","direction":"down","inn_name":"","iupac_name":"5-methyldihydropyrimidine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"NBAKTGXDIBVZOO-UHFFFAOYSA-N","pvalue":2.2258129008731088e-10,"ratio":0.16691227248644,"synonym_name":"5,6-Dihydro-5-methyluracil"},{"chebi_id":"64307","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OGNSCSPNOLGXSM-UHFFFAOYSA-N","pvalue":2.0261123178394537e-08,"ratio":0.2044099159449691,"synonym_name":"\u03b1,\u03b3-diaminobutanoic acid"},{"chebi_id":"139419","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1-(dihydrogen phosphate)","metabolite_id":"RHKKZBWRNHGJEZ-ARQDHWQXSA-N","pvalue":2.1593954586820537e-06,"ratio":0.2641935934459187,"synonym_name":"\u03b2-<small>D</small>-fructose 1-phosphate"},{"chebi_id":"16043","direction":"down","inn_name":"","iupac_name":"2-deoxy-<small>D</small>-<i>arabino</i>-hexose 6-(dihydrogen phosphate)","metabolite_id":"MBPFNOMGYSRGQZ-PBXRRBTRSA-N","pvalue":2.4483915739262076e-06,"ratio":0.2996287598659904,"synonym_name":"2-Deoxy-D-glucose 6-phosphate"},{"chebi_id":"16493","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>)-2,3-dihydroxy-4-oxopentyl dihydrogen phosphate","metabolite_id":"AJPADPZSRRUGHI-RFZPGFLSSA-N","pvalue":8.142244862104108e-06,"ratio":0.2713026175307191,"synonym_name":"1-Deoxy-D-xylulose 5-phosphate"},{"chebi_id":"16600","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-2-methylbut-2-enedioic acid","metabolite_id":"HNEGQIOMVPPMNR-NSCUHMNNSA-N","pvalue":3.625328027339671e-05,"ratio":4.415196874529861,"synonym_name":"Mesaconic acid"},{"chebi_id":"32805","direction":"up","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":6.143515617313425e-05,"ratio":3.258973874346079,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"24344","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":2.475992688118353e-05,"ratio":0.3703856930617528,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"4047","direction":"down","inn_name":"","iupac_name":"<small>L</small>-cysteinylglycine","metabolite_id":"ZUKPVRWZDMRIEO-VKHMYHEASA-N","pvalue":3.0142314815282245e-05,"ratio":0.3808192108312842,"synonym_name":"<em>N</em>-<small>L</small>-cysteinylglycine"},{"chebi_id":"16119","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid","metabolite_id":"JXOHGGNKMLTUBP-HSUXUTPPSA-N","pvalue":0.0001323040273666,"ratio":2.9861789303553095,"synonym_name":"Shikimate"}],"totalFeatures":380},{"comparisonGroups":["Wild type","Knock-out"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse left ventricle: Sdhaf4 knockout vs wild-type","group_a_title":"Wild type mice samples from the left ventricle.. Serves as the control group for evaluating the effects of Sdhaf4 knock-out.","group_b_title":"Knock-out mice samples from the left ventricle.. Allows for the assessment of the impact of Sdhaf4 knock-out on cardiac function.","id":"MTBLS4579_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS4579","studyUrl":"http://integmet.org/study/MTBLS4579","title":"Wild_type_vs_Knock_out","topHits":[{"chebi_id":"89951","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YNYAYWLBAHXHLL-UHFFFAOYSA-N","pvalue":7.394933480725936e-06,"ratio":3.637614678899083,"synonym_name":"3-Methoxy-Noradrenaline"},{"chebi_id":"33198","direction":"down","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":0.0001764834776589,"ratio":0.27632529250325,"synonym_name":"Hexonic acid"},{"chebi_id":"16070","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-2-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"MPCAJMNYNOGXPB-SLPGGIOYSA-N","pvalue":0.0001444976876796,"ratio":0.2951228928065886,"synonym_name":"1,5-Anhydro-D-sorbitol"},{"chebi_id":"18019","direction":"up","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":3.510426556442501e-05,"ratio":2.521142911749248,"synonym_name":"L-Lysine"},{"chebi_id":"37741","direction":"down","inn_name":"","iupac_name":"<small>L</small>-allopyranose","metabolite_id":"WQZGKKKJIJFFOK-HOWGCPQDSA-N","pvalue":6.898524016204251e-06,"ratio":0.4582241630276565,"synonym_name":""},{"chebi_id":"84309","direction":"down","inn_name":"","iupac_name":"<em>rac</em>-2,3-dihydroxypropyl octanoate","metabolite_id":"GHBFNMLVSPCDGN-UHFFFAOYSA-N","pvalue":0.0002865008765376,"ratio":0.4363636363636363,"synonym_name":"Glyceryl 1-monooctanoate"},{"chebi_id":"15999","direction":"down","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)-2-oxopropanoic acid","metabolite_id":"KKADPXVIOXHVKN-UHFFFAOYSA-N","pvalue":0.0016109274747059,"ratio":0.3823529411764705,"synonym_name":"3-(4-HYDROXY-PHENYL)PYRUVIC ACID"},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":0.0010128964041368,"ratio":2.411764705882353,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"16865","direction":"up","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":0.0013013372065798,"ratio":2.402510696318586,"synonym_name":"GABA"},{"chebi_id":"27781","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-tetradec-9-enoic acid","metabolite_id":"YWWVWXASSLXJHU-WAYWQWQTSA-N","pvalue":0.0012821968335956,"ratio":2.1152542372881356,"synonym_name":"Myristoleic acid"}],"totalFeatures":133},{"comparisonGroups":["Control_1_day","Inoculated_12_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control 1 day vs inoculated 12 days post-treatment","group_a_title":"Control group at 1 day post-inoculation. Provides baseline metabolic profile for comparison with inoculated samples at 1 day.","group_b_title":"Inoculated group at 12 days post-inoculation. Shows metabolic changes due to inoculation at 12 days.","id":"MTBLS460_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS460","studyUrl":"http://integmet.org/study/MTBLS460","title":"Control_1_day_vs_Inoculated_12_days","topHits":[{"chebi_id":"137096","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YGQLHDJHNTUZJJ-UHFFFAOYSA-N","pvalue":1.8894335523014463e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"16323","direction":"down","inn_name":"","iupac_name":"2,3-dimethyl-5-(3-methylbut-2-en-1-yl)benzene-1,4-diol","metabolite_id":"WKFUDLTXRQQGHB-UHFFFAOYSA-N","pvalue":2.852417901854687e-05,"ratio":1e-06,"synonym_name":"Plastoquinol-1"},{"chebi_id":"137105","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GPOXRFICYIWOMY-YWEYNIOJSA-N","pvalue":8.452167808606142e-05,"ratio":1e-06,"synonym_name":"(3Z)-1-phenyl-3-hepten-1-ol"},{"chebi_id":"74475","direction":"down","inn_name":"","iupac_name":"hexadecanamide","metabolite_id":"HSEMFIZWXHQJAE-UHFFFAOYSA-N","pvalue":0.0453639948443733,"ratio":1e-06,"synonym_name":"Cetyl amide"},{"chebi_id":"133743","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-1-methylpyrrolidin-1-ium-2-carboxylate","metabolite_id":"CWLQUGTUXBXTLF-YFKPBYRVSA-N","pvalue":6.939808922807813e-05,"ratio":0.0131591601988901,"synonym_name":""},{"chebi_id":"137092","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KLWPMNOQFSPVII-UONOGXRCSA-N","pvalue":0.0274855843408127,"ratio":0.0010445646201451,"synonym_name":"1-deoxy-tetradecasphing-13-enine"},{"chebi_id":"137095","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RLRGETOSWKYBHX-UHFFFAOYSA-N","pvalue":4.372382187050867e-07,"ratio":4.970702298731461,"synonym_name":""},{"chebi_id":"17488","direction":"up","inn_name":"","iupac_name":"7-hydroxy-6-methoxy-2<em>H</em>-chromen-2-one","metabolite_id":"RODXRVNMMDRFIK-UHFFFAOYSA-N","pvalue":7.313137508831937e-05,"ratio":3.646897794207968,"synonym_name":"6-Methylesculetin"},{"chebi_id":"137098","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YLNUIYBUKLGVDS-UHFFFAOYSA-N","pvalue":0.0022418025879336,"ratio":2.333499887957975,"synonym_name":""},{"chebi_id":"137093","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HROUEPWZUPHWDY-UHFFFAOYSA-N","pvalue":0.0255720748241281,"ratio":0.3643859489966434,"synonym_name":""}],"totalFeatures":17},{"comparisonGroups":["Hank's balanced salt solution","doxycycline"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs doxycycline treatment","group_a_title":"Control group treated with Hank's balanced salt solution.. Provides baseline for comparison with doxycycline-treated samples.","group_b_title":"Treatment group receiving doxycycline.. Represents the effect of doxycycline treatment on the samples.","id":"MTBLS4709_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS4709","studyUrl":"http://integmet.org/study/MTBLS4709","title":"Hanks_balanced_salt_solution_vs_doxycycline","topHits":[{"chebi_id":"170696","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"XSSUJRSOHXBICQ-GPDPEMMZSA-N","pvalue":5.1819352599762525e-05,"ratio":1.7033426812806196,"synonym_name":""},{"chebi_id":"89516","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LOVKBDFNFACEND-HSEDGGQWSA-N","pvalue":0.0001636280487149,"ratio":1.8008764322091493,"synonym_name":"PC(14:0/22:1)"},{"chebi_id":"75038","direction":"up","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(octadecanoyloxy)-2-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl phosphate","metabolite_id":"JQKOHRZNEOQNJE-DJEJVYNPSA-N","pvalue":0.0397508643642145,"ratio":2.274809650875029,"synonym_name":"2-azaniumylethyl (2<i>R</i>)-2-[(9<i>Z</i>)-octadec-9-enoyloxy]-3-(stearoyloxy)propyl phosphate"}],"totalFeatures":18},{"comparisonGroups":["Wild_Type","Gene_Knockout"],"dateCreated":"2025-09-26 00:00:00","display_title":"IDH1 knockout vs wild-type under nutrient deprivation","group_a_title":"Wild-type IDH1 samples under nutrient-deprived conditions.. Serves as the control group to evaluate the effects of IDH1 gene knockout.","group_b_title":"IDH1 gene knockout samples under nutrient-deprived conditions.. Allows for the assessment of the impact of IDH1 gene knockout on cell viability under nutrient-deprived conditions.","id":"MTBLS4722_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":82,"studyId":"MTBLS4722","studyUrl":"http://integmet.org/study/MTBLS4722","title":"Wild_Type_vs_Gene_Knockout","topHits":[{"chebi_id":"167608","direction":"up","inn_name":"","iupac_name":"[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate","metabolite_id":"HSCJRCZFDFQWRP-LPTOLDDLSA-N","pvalue":9.088246248075275e-10,"ratio":449.9378844643453,"synonym_name":""},{"chebi_id":"35491","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":4.961177053418571e-09,"ratio":225.12901013861003,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"67119","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-galactopyranosyl) dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-ABVWGUQPSA-N","pvalue":1.0552378990998026e-09,"ratio":149.23009029243968,"synonym_name":"Uridinediphosphogalactose"},{"chebi_id":"18107","direction":"up","inn_name":"","iupac_name":"xanthosine","metabolite_id":"UBORTCNDUKBEOP-UUOKFMHZSA-N","pvalue":2.1920187262086506e-07,"ratio":305.87166971730727,"synonym_name":"9-\u03b2-<small>D</small>-ribofuranosyl-3,9-dihydro-1<em>H</em>-purine-2,6-dione"},{"chebi_id":"71028","direction":"up","inn_name":"acide carglumique","iupac_name":"<em>N</em>-carbamoyl-<small>L</small>-glutamic acid","metabolite_id":"LCQLHJZYVOQKHU-VKHMYHEASA-N","pvalue":7.120546510586984e-08,"ratio":108.99553042050536,"synonym_name":"Carbamylglutamic acid"},{"chebi_id":"15713","direction":"up","inn_name":"","iupac_name":"uridine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PGAVKCOVUIYSFO-XVFCMESISA-N","pvalue":4.980006577024818e-09,"ratio":44.800975487195,"synonym_name":"H<small><sub>4</sub></small>utp"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":1.198774091383229e-07,"ratio":66.7563007337493,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":4.810871190500238e-08,"ratio":42.438220343568666,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":1.2939133579437209e-08,"ratio":26.0265739532039,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"17677","direction":"up","inn_name":"","iupac_name":"cytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PCDQPRRSZKQHHS-XVFCMESISA-N","pvalue":4.6896607432136784e-08,"ratio":29.374708051572693,"synonym_name":"5'-CTP"}],"totalFeatures":228},{"comparisonGroups":["WT","Gene9_Line1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Populus trees: SCAMP3 RNAi line 1 vs wild-type","group_a_title":"Wild-type Populus trees.. Serves as the baseline for evaluating the effects of the RNAi construct.","group_b_title":"Transgenic Populus trees with RNAi construct for PttSCAMP3, line 1.. Represents the effect of RNAi construct on SCAMP3 in line 1.","id":"MTBLS478_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS478","studyUrl":"http://integmet.org/study/MTBLS478","title":"WT_vs_Gene9_Line1","topHits":[{"chebi_id":"9300","direction":"up","inn_name":"","iupac_name":"octanedioic acid","metabolite_id":"TYFQFVWCELRYAO-UHFFFAOYSA-N","pvalue":2.426281121241183e-05,"ratio":3.359888385745045,"synonym_name":"Cork acid"},{"chebi_id":"67119","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-galactopyranosyl) dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-ABVWGUQPSA-N","pvalue":0.0077948153687213,"ratio":0.5093329892917043,"synonym_name":"Uridinediphosphogalactose"},{"chebi_id":"86592","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-3-[2-(4-{[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal","metabolite_id":"UYNCCRHOWNHDMT-AATRIKPKSA-N","pvalue":0.0086482682727113,"ratio":0.626555902834896,"synonym_name":"G(8-O-4)S(8-5)G'"}],"totalFeatures":16},{"comparisonGroups":["Purple_Bark","Green_Bark"],"dateCreated":"2025-09-26 00:00:00","display_title":"Salix bark: purple vs green varieties","group_a_title":"Samples from purple bark of Salix x Jiangsunesis 1053. Provides insight into the metabolomic and transcriptomic profile of purple bark","group_b_title":"Samples from green bark of Salix integra. Provides insight into the metabolomic and transcriptomic profile of green bark","id":"MTBLS4820_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":365,"studyId":"MTBLS4820","studyUrl":"http://integmet.org/study/MTBLS4820","title":"Purple_vs_Green","topHits":[{"chebi_id":"545959","direction":"up","inn_name":"","iupac_name":"2-(4-hydroxy-3-methoxyphenyl)acetic acid","metabolite_id":"QRMZSPFSDQBLIX-UHFFFAOYSA-N","pvalue":5.733214805316641e-12,"ratio":130.84326599094496,"synonym_name":"3-Methoxy-4-hydroxyphenylacetate"},{"chebi_id":"50207","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4<em>H</em>-chromen-4-one","metabolite_id":"LPEPZZAVFJPLNZ-SFHVURJKSA-N","pvalue":1.2651921267754823e-09,"ratio":0.0033486922847567,"synonym_name":"(\u2212)-(2<i>S</i>)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FLDFNEBHEXLZRX-UHFFFAOYSA-N","pvalue":4.120159898678964e-10,"ratio":0.0071759137271408,"synonym_name":""},{"chebi_id":"190617","direction":"down","inn_name":"","iupac_name":"4,5-diphenyl-1,2-dihydropyrazolo[3,4-c]pyridazin-3-one","metabolite_id":"UIHDHURJKAPXSN-UHFFFAOYSA-N","pvalue":7.417083880361799e-09,"ratio":0.0044161261873161,"synonym_name":""},{"chebi_id":"167752","direction":"up","inn_name":"","iupac_name":"1-[2-hydroxy-6-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone","metabolite_id":"CFJLERBDXYGARW-TVKJYDDYSA-N","pvalue":3.240293576647353e-11,"ratio":33.559318730123806,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KHPCPRHQVVSZAH-UHFFFAOYSA-N","pvalue":7.292544584188082e-10,"ratio":40.678630187924036,"synonym_name":""},{"chebi_id":"75815","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4<em>H</em>-chromen-3-yl \u03b2-<small>D</small>-galactopyranoside","metabolite_id":"FOHXFLPXBUAOJM-MGMURXEASA-N","pvalue":5.9818778487707965e-09,"ratio":42.511589632002654,"synonym_name":"myricetin-3-<em>O</em>-\u03b2-<small>D</small>-galactoside"},{"chebi_id":"190626","direction":"down","inn_name":"","iupac_name":"(NE)-N-[(2-amino-5-chlorophenyl)-phenylmethylidene]hydroxylamine","metabolite_id":"GCAVNCINXJNLED-DTQAZKPQSA-N","pvalue":1.3525895621552272e-07,"ratio":0.0140703855343756,"synonym_name":""},{"chebi_id":"183014","direction":"up","inn_name":"","iupac_name":"(Z)-9-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]non-7-enoic acid","metabolite_id":"ZCTAOAWRUXSOQF-GWSKAPOCSA-N","pvalue":1.3828668676123153e-07,"ratio":56.92564903254988,"synonym_name":""},{"chebi_id":"73688","direction":"up","inn_name":"isospaglumic acid","iupac_name":"<em>N</em>-acetyl-<small>L</small>-\u03b1-aspartyl-<small>L</small>-glutamic acid","metabolite_id":"OPVPGKGADVGKTG-BQBZGAKWSA-N","pvalue":1.2748031166120206e-07,"ratio":54.02650624561347,"synonym_name":"N-Acetyl-1-aspartylglutamic acid"}],"totalFeatures":498},{"comparisonGroups":["Purple_Bark","Green_Bark"],"dateCreated":"2025-09-26 00:00:00","display_title":"Salix bark: purple vs green varieties","group_a_title":"Samples from purple bark of Salix x Jiangsunesis 1053. Provides insight into the metabolomic and transcriptomic profile of purple bark","group_b_title":"Samples from green bark of Salix integra. Provides insight into the metabolomic and transcriptomic profile of green bark","id":"MTBLS4820_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":604,"studyId":"MTBLS4820","studyUrl":"http://integmet.org/study/MTBLS4820","title":"Purple_vs_Green","topHits":[{"chebi_id":"177606","direction":"up","inn_name":"","iupac_name":"4,6,8-trihydroxy-7-methoxy-3-methyl-3,4-dihydroisochromen-1-one","metabolite_id":"ZLLQQKITWRWKTD-UHFFFAOYSA-N","pvalue":1.5990963112226194e-10,"ratio":105.45091040062891,"synonym_name":""},{"chebi_id":"10429","direction":"up","inn_name":"","iupac_name":"2,2-dimethyl-3,4-dihydro-2<em>H</em>-benzo[<em>h</em>]chromene-5,6-dione","metabolite_id":"QZPQTZZNNJUOLS-UHFFFAOYSA-N","pvalue":9.039522924194366e-11,"ratio":60.01431648316295,"synonym_name":"beta-Lapachone"},{"chebi_id":"131775","direction":"up","inn_name":"","iupac_name":"7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-oxo-4<em>H</em>-1-benzopyran-5-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"FLSOTPIEFVBPBU-LDBVRRDLSA-N","pvalue":1.4070154387180912e-08,"ratio":107.90784166310296,"synonym_name":"tricin 5-\u03b2-<small>D</small>-glucoside"},{"chebi_id":"3193","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RRKTZKIUPZVBMF-IBTVXLQLSA-N","pvalue":1.151996618323586e-07,"ratio":160.57914336699622,"synonym_name":"Brucine"},{"chebi_id":"74992","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JGUZGNYPMHHYRK-UHFFFAOYSA-N","pvalue":3.1806434882236693e-09,"ratio":44.50923488075749,"synonym_name":"3,3',4',5-Tetrahydroxy-7-methoxyflavone"},{"chebi_id":"167400","direction":"up","inn_name":"","iupac_name":"4-ethylbenzaldehyde","metabolite_id":"QNGNSVIICDLXHT-UHFFFAOYSA-N","pvalue":3.190287379261481e-07,"ratio":135.91871037769647,"synonym_name":""},{"chebi_id":"4631","direction":"up","inn_name":"diosmine","iupac_name":"5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4<em>H</em>-1-benzopyran-7-yl 6-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"GZSOSUNBTXMUFQ-YFAPSIMESA-N","pvalue":2.7438824629913295e-06,"ratio":297.1229324450053,"synonym_name":"Diosmetin 7-O-rutinoside"},{"chebi_id":"41500","direction":"down","inn_name":"","iupac_name":"4-phenylbutanoic acid","metabolite_id":"OBKXEAXTFZPCHS-UHFFFAOYSA-N","pvalue":2.4036058277220913e-08,"ratio":0.0175089665682514,"synonym_name":"4-PHENYL-BUTANOIC ACID"},{"chebi_id":"190667","direction":"up","inn_name":"","iupac_name":"3-(5,7-dimethoxy-4-oxochromen-2-yl)propanoic acid","metabolite_id":"AKJIPZYHXYQVJT-UHFFFAOYSA-N","pvalue":3.116992132924811e-11,"ratio":17.295663618136466,"synonym_name":""},{"chebi_id":"8224","direction":"up","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methyl-4<em>H</em>-chromen-4-one","metabolite_id":"DTFXGVGIKNSCQQ-UHFFFAOYSA-N","pvalue":5.433236001185592e-10,"ratio":23.191558466489848,"synonym_name":"6-C-Methylquercetin"}],"totalFeatures":1052},{"comparisonGroups":["Normal","Neural_Tube_Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Normal vs neural tube defect conditions","group_a_title":"Control samples with normal condition.. Provides a reference point for identifying metabolic differences due to neural tube defects.","group_b_title":"Experimental samples with neural tube defect condition.. Crucial for understanding the metabolic changes associated with neural tube defects.","id":"MTBLS4893_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":260,"studyId":"MTBLS4893","studyUrl":"http://integmet.org/study/MTBLS4893","title":"Normal_vs_Neural_Tube_Defect","topHits":[{"chebi_id":"17154","direction":"down","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":1.4783485257648572e-10,"ratio":0.0003776595557478,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"16199","direction":"up","inn_name":"carbamide","iupac_name":"urea","metabolite_id":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","pvalue":4.5718017080273656e-14,"ratio":74.8632272060631,"synonym_name":"H<small><sub>2</sub></small>NC(O)NH<small><sub>2</sub></small>"},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":7.716661150924057e-08,"ratio":1174.826088098883,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"71018","direction":"down","inn_name":"","iupac_name":"[(4-hydroxybenzoyl)amino]acetic acid","metabolite_id":"ZMHLUFWWWPBTIU-UHFFFAOYSA-N","pvalue":4.879433309058808e-09,"ratio":0.0049729040532523,"synonym_name":"4-Hydroxybenzoylglycine"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":6.4870889660913e-10,"ratio":49.86554677291506,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"15671","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-2,3-dihydroxybutanedioic acid","metabolite_id":"FEWJPZIEWOKRBE-JCYAYHJZSA-N","pvalue":4.4684894950541603e-10,"ratio":36.593571708738565,"synonym_name":"(2R,3R)-Tartaric acid"},{"chebi_id":"29042","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranose 1-(dihydrogen phosphate)","metabolite_id":"HXXFSFRBOHSIMQ-VFUOTHLCSA-N","pvalue":1.2079952416210068e-07,"ratio":0.0130732312773401,"synonym_name":"ALPHA-D-GLUCOSE-1-PHOSPHATE"},{"chebi_id":"16016","direction":"up","inn_name":"","iupac_name":"1,3-dihydroxypropan-2-one","metabolite_id":"RXKJFZQQPQGTFL-UHFFFAOYSA-N","pvalue":5.993625468997738e-10,"ratio":21.99522673165637,"synonym_name":"DHA"},{"chebi_id":"18347","direction":"up","inn_name":"","iupac_name":"<small>L</small>-norleucine","metabolite_id":"LRQKBLKVPFOOQJ-YFKPBYRVSA-N","pvalue":2.3824979112291975e-08,"ratio":38.242925390808665,"synonym_name":"\u03b1-aminocaproic acid"},{"chebi_id":"7476","direction":"down","inn_name":"naproxen","iupac_name":"(2<i>S</i>)-2-(6-methoxynaphthalen-2-yl)propanoic acid","metabolite_id":"CMWTZPSULFXXJA-VIFPVBQESA-N","pvalue":1.0920442000609753e-07,"ratio":0.0224382491675992,"synonym_name":"Naproxen"}],"totalFeatures":355},{"comparisonGroups":["Normal","Neural_Tube_Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Normal vs neural tube defect condition","group_a_title":"Control samples with normal condition.. Provides a reference point for identifying metabolic differences due to neural tube defects.","group_b_title":"Experimental samples with neural tube defect condition.. Crucial for understanding the metabolic changes associated with neural tube defects.","id":"MTBLS4893_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1717,"studyId":"MTBLS4893","studyUrl":"http://integmet.org/study/MTBLS4893","title":"Normal_vs_Neural_Tube_Defect","topHits":[{"chebi_id":"81443","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IHPJPQIRNONWGH-WLWVOYFZSA-N","pvalue":1.993155420373435e-09,"ratio":22336427401.96078,"synonym_name":""},{"chebi_id":"165553","direction":"up","inn_name":"","iupac_name":"(2S)-2-(hexadecanoylamino)-3-(1H-imidazol-5-yl)propanoic acid","metabolite_id":"XHUZOURAPKCNRA-FQEVSTJZSA-N","pvalue":1.5665450310207298e-08,"ratio":2785794377.073906,"synonym_name":""},{"chebi_id":"185837","direction":"up","inn_name":"","iupac_name":"4-O-[[3,4-dihydroxy-5-[[(2R,3S)-6-hydroxy-2-[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzouran-3-yl]oxy]-6-methoxyoxan-2-yl]methyl] 1-O-methyl butanedioate","metabolite_id":"DFDBQOBSZWTRTL-CDUOHFAZSA-N","pvalue":1.98996545777944e-08,"ratio":2120215650.3393664,"synonym_name":""},{"chebi_id":"2565","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FIKOOQXJBAJJSE-YTQTXRHFSA-N","pvalue":9.438917610400557e-09,"ratio":745145893.6274508,"synonym_name":"Alectrol"},{"chebi_id":"168578","direction":"up","inn_name":"","iupac_name":"2-[[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-hexoxyoxane-3,4,5-triol","metabolite_id":"LOVPBJMHVBJKQS-UHFFFAOYSA-N","pvalue":4.1491933480885546e-08,"ratio":1177708724.3966815,"synonym_name":""},{"chebi_id":"46295","direction":"up","inn_name":"","iupac_name":"2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-<em>f</em>][1,2,4]triazin-4(1<em>H</em>)-one","metabolite_id":"SECKRCOLJRRGGV-UHFFFAOYSA-N","pvalue":1.061236240966157e-07,"ratio":3569492953.2428346,"synonym_name":"2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MSTNYGQPCMXVAQ-PXYINDEMSA-N","pvalue":7.742882379590951e-08,"ratio":2321435158.936651,"synonym_name":""},{"chebi_id":"49703","direction":"up","inn_name":"","iupac_name":"(4<i>R</i>)-4-[(1<i>R</i>,4<i>Z</i>,8<i>Z</i>,10<i>S</i>,13<i>R</i>,15<i>R</i>)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-1,3-thiazolidin-2-one","metabolite_id":"NSHPHXHGRHSMIK-JRIKCGFMSA-N","pvalue":7.905253871962541e-07,"ratio":24123115452.865757,"synonym_name":"LATRUNCULIN B"},{"chebi_id":"186757","direction":"up","inn_name":"","iupac_name":"(E)-3-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enamide","metabolite_id":"OZNUPWACHHUIKC-JXMROGBWSA-N","pvalue":3.921248967222159e-07,"ratio":2387447303.0920053,"synonym_name":""},{"chebi_id":"183136","direction":"up","inn_name":"","iupac_name":"[(2R)-3-heptanoyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RGIOGDXWJBHLCU-CQSZACIVSA-N","pvalue":6.261773257851167e-07,"ratio":2456535424.9999995,"synonym_name":""}],"totalFeatures":1992},{"comparisonGroups":["Normal","Neural_Tube_Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Normal vs neural tube defect condition","group_a_title":"Control samples with normal condition.. Provides a reference point for identifying metabolic differences due to neural tube defects.","group_b_title":"Experimental samples with neural tube defect condition.. Crucial for understanding the metabolic changes associated with neural tube defects.","id":"MTBLS4893_0003_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1484,"studyId":"MTBLS4893","studyUrl":"http://integmet.org/study/MTBLS4893","title":"Normal_vs_Neural_Tube_Defect","topHits":[{"chebi_id":"175366","direction":"up","inn_name":"","iupac_name":"5-hydroxy-N-[(6-oxopiperidin-2-yl)methyl]-2-(2,2,2-triluoroethoxy)benzamide","metabolite_id":"OIOMUGZSHNAEMH-UHFFFAOYSA-N","pvalue":6.353219803913781e-10,"ratio":3658286983.408748,"synonym_name":""},{"chebi_id":"17420","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{[4-({[(6<i>S</i>)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-<small>L</small>-\u03b3-glutamyl-<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"RXWVHRYZTWZATH-XSLAGTTESA-N","pvalue":4.0884937463166015e-08,"ratio":21069035852.941177,"synonym_name":"Tetrahydropteroyltri-L-glutamate"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DSZBEWXQBVATQX-UHFFFAOYSA-N","pvalue":3.9909349388226585e-08,"ratio":5593158446.07843,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FDYQQDJLOXIANP-BHVANESWSA-N","pvalue":5.993332184027279e-08,"ratio":2597873834.162895,"synonym_name":""},{"chebi_id":"175579","direction":"up","inn_name":"","iupac_name":"4-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]butan-2-one","metabolite_id":"GXSGZLLXMDVQAS-UHFFFAOYSA-N","pvalue":4.645888008097967e-07,"ratio":5475258671.191553,"synonym_name":""},{"chebi_id":"172533","direction":"down","inn_name":"","iupac_name":"[(5Z)-8-hydroxy-6,10,10-trimethyl-2-methylidene-3,7-dioxo-4-bicyclo[7.2.0]undec-5-enyl] acetate","metabolite_id":"BBRNVDBLOTVLMB-VURMDHGXSA-N","pvalue":3.359512033171249e-07,"ratio":6.352539202229765e-10,"synonym_name":""},{"chebi_id":"187470","direction":"up","inn_name":"","iupac_name":"5,14-dihydroxy-3-[4-hydroxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-13-methyl-17-(5-oxo-2H-uran-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde","metabolite_id":"KQBVSIZPUWODNU-UHFFFAOYSA-N","pvalue":8.435708560161242e-07,"ratio":3358961429.864252,"synonym_name":""},{"chebi_id":"8803","direction":"up","inn_name":"remikiren","iupac_name":"<em>N</em>\u03b1-[(2<i>S</i>)-2-benzyl-3-(<em>tert</em>-butylsulfonyl)propanoyl]-<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>S</i>)-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]-<small>L</small>-histidinamide","metabolite_id":"UXIGZRQVLGFTOU-VQXQMPIVSA-N","pvalue":9.97626606885013e-07,"ratio":3514050079.939667,"synonym_name":"Ro 42-5892"},{"chebi_id":"174234","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)-6-(2-hydroxypropoxy)oxane-3,4,5-triol","metabolite_id":"AJLVEHFNMNRXNI-UHFFFAOYSA-N","pvalue":1.1127147869490263e-06,"ratio":3384579585.6711907,"synonym_name":""},{"chebi_id":"172765","direction":"up","inn_name":"","iupac_name":"6-hydroxy-3-[(1E,3E,5E,7Z,9E,11E,13E,15Z)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15-octaen-17-ynyl]-2,4,4-trimethylcyclohex-2-en-1-one","metabolite_id":"BZQRJBLJDFPOBX-FOERLQQGSA-N","pvalue":1.7363565935908444e-06,"ratio":5596427123.303166,"synonym_name":""}],"totalFeatures":1677},{"comparisonGroups":["Normal","Neural Tube Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Normal vs neural tube defect samples","group_a_title":"Normal samples without any disease condition.. Serves as the reference group for evaluating disease effects.","group_b_title":"Experimental samples with neural tube defect.. Represents the pathological condition under investigation.","id":"MTBLS4894_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":91,"studyId":"MTBLS4894","studyUrl":"http://integmet.org/study/MTBLS4894","title":"Normal_vs_Neural_Tube_Defect","topHits":[{"chebi_id":"15903","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":4.867988162675169e-10,"ratio":0.0238305677227117,"synonym_name":"beta-D-Glucose"},{"chebi_id":"17295","direction":"up","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":2.631886688302602e-07,"ratio":167.42191837371445,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"146758","direction":"up","inn_name":"","iupac_name":"Xylf","metabolite_id":"HMFHBZSHGGEWLO-IOVATXLUSA-N","pvalue":1.7775248258653895e-09,"ratio":6.170752000461567,"synonym_name":"<small>D</small>-Xyl<em>f</em>"},{"chebi_id":"16865","direction":"up","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":7.929625420820355e-09,"ratio":6.899592085286537,"synonym_name":"GABA"},{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":6.45008144632669e-08,"ratio":0.120278465311951,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"18237","direction":"up","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":1.5364690888162094e-08,"ratio":6.874002683154353,"synonym_name":"Glutaminic acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RDIDGZFQASQXBU-UHFFFAOYSA-N","pvalue":3.208056062371709e-08,"ratio":7.337928514278997,"synonym_name":""},{"chebi_id":"61993","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucose","metabolite_id":"RXVWSYJTUUKTEA-CGQAXDJHSA-N","pvalue":0.0006038360563926,"ratio":0.0121215612018227,"synonym_name":"<small>D</small>-maltotriose"},{"chebi_id":"28415","direction":"up","inn_name":"","iupac_name":"hexacosan-1-ol","metabolite_id":"IRHTZOCLLONTOC-UHFFFAOYSA-N","pvalue":3.5938982840789306e-10,"ratio":4.283554003807182,"synonym_name":"ceryl alcohol"},{"chebi_id":"320055","direction":"down","inn_name":"","iupac_name":"methyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"HOVAGTYPODGVJG-XUUWZHRGSA-N","pvalue":1.293161436149398e-06,"ratio":0.1000409612076652,"synonym_name":"Beta-methyl-d-glucoside"}],"totalFeatures":266},{"comparisonGroups":["Sham","HIBD"],"dateCreated":"2025-09-26 00:00:00","display_title":"Neonatal brain: sham control vs hypoxic-ischemic damage","group_a_title":"Sham control group. Provides a baseline for comparing the effects of HIBD and the intervention.","group_b_title":"Neonatal hypoxic-ischemic brain damage group. Key group for understanding the baseline effects of HIBD.","id":"MTBLS4932_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":129,"studyId":"MTBLS4932","studyUrl":"http://integmet.org/study/MTBLS4932","title":"Sham_vs_HIBD","topHits":[{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":1.178417263982253e-10,"ratio":0.0975660250343868,"synonym_name":"E363"},{"chebi_id":"30776","direction":"down","inn_name":"","iupac_name":"hexanoic acid","metabolite_id":"FUZZWVXGSFPDMH-UHFFFAOYSA-N","pvalue":6.143143353695673e-05,"ratio":0.0171888452209698,"synonym_name":"HEXANOIC ACID"},{"chebi_id":"17066","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>)-3-hydroxybutanoic acid","metabolite_id":"WHBMMWSBFZVSSR-GSVOUGTGSA-N","pvalue":7.603829894242947e-08,"ratio":0.1078641972473989,"synonym_name":"(R)-3-Hydroxybutyric acid"},{"chebi_id":"18101","direction":"down","inn_name":"","iupac_name":"(4-hydroxyphenyl)acetic acid","metabolite_id":"XQXPVVBIMDBYFF-UHFFFAOYSA-N","pvalue":4.256681992778173e-11,"ratio":0.2315244140238629,"synonym_name":"4-Hydroxyphenylacetic acid"},{"chebi_id":"422","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-REOHCLBHSA-N","pvalue":2.0409231438451893e-08,"ratio":4.785815870065316,"synonym_name":"L-Lactic acid"},{"chebi_id":"33198","direction":"up","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":8.195207137629585e-08,"ratio":5.411775515149856,"synonym_name":"Hexonic acid"},{"chebi_id":"30745","direction":"down","inn_name":"","iupac_name":"phenylacetic acid","metabolite_id":"WLJVXDMOQOGPHL-UHFFFAOYSA-N","pvalue":7.757417513771275e-08,"ratio":0.1963005960410455,"synonym_name":"benzeneacetic acid"},{"chebi_id":"17418","direction":"down","inn_name":"","iupac_name":"pentanoic acid","metabolite_id":"NQPDZGIKBAWPEJ-UHFFFAOYSA-N","pvalue":7.498617577686695e-07,"ratio":0.1548411002872592,"synonym_name":"n-Valeric acid"},{"chebi_id":"166709","direction":"down","inn_name":"","iupac_name":"(4R)-4-[(3R,5R,6S,7S,8R,9S,10R,12S,13R,14S,17R)-3,6,7,12-tetrahydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","metabolite_id":"COCMFMBNEAMQMA-VGKGADPCSA-N","pvalue":0.0007563038702742,"ratio":0.0282746832802915,"synonym_name":""},{"chebi_id":"16708","direction":"up","inn_name":"","iupac_name":"9<em>H</em>-purin-6-amine","metabolite_id":"GFFGJBXGBJISGV-UHFFFAOYSA-N","pvalue":1.028161923350675e-06,"ratio":5.901809808076944,"synonym_name":"Adenin"}],"totalFeatures":310},{"comparisonGroups":["sham","HIBD"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs hypoxic-ischemic brain damage","group_a_title":"Control group with no hypoxic-ischemic brain damage or sodium butyrate treatment.. Provides a reference point for evaluating the effects of hypoxic-ischemic brain damage and sodium butyrate treatment.","group_b_title":"Group with hypoxic-ischemic brain damage without sodium butyrate treatment.. Essential for understanding the baseline impact of hypoxic-ischemic brain damage.","id":"MTBLS4933_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS4933","studyUrl":"http://integmet.org/study/MTBLS4933","title":"sham_vs_HIBD","topHits":[{"chebi_id":"16135","direction":"down","inn_name":"","iupac_name":"2-methylpropanoic acid","metabolite_id":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","pvalue":1.1868173815063341e-08,"ratio":1e-06,"synonym_name":"2-METHYL-PROPIONIC ACID"},{"chebi_id":"30772","direction":"up","inn_name":"","iupac_name":"butanoic acid","metabolite_id":"FERIUCNNQQJTOY-UHFFFAOYSA-N","pvalue":7.269927773968037e-09,"ratio":32.487450224966125,"synonym_name":"butyric acid"},{"chebi_id":"28484","direction":"down","inn_name":"","iupac_name":"3-methylbutanoic acid","metabolite_id":"GWYFCOCPABKNJV-UHFFFAOYSA-N","pvalue":1.8170232316792569e-07,"ratio":0.3038091574179704,"synonym_name":"isovalerianic acid"},{"chebi_id":"30768","direction":"down","inn_name":"","iupac_name":"propanoic acid","metabolite_id":"XBDQKXXYIPTUBI-UHFFFAOYSA-N","pvalue":7.678612056398756e-06,"ratio":0.5525758572070669,"synonym_name":"PROPANOIC ACID"}],"totalFeatures":7},{"comparisonGroups":["4_weeks","52_weeks"],"dateCreated":"2025-09-26 00:00:00","display_title":"Lipidome changes: 4 weeks vs 52 weeks aging","group_a_title":"Samples collected at 4 weeks of age. Serves as the youngest age group for studying lipidome changes with aging.","group_b_title":"Samples collected at 52 weeks of age. Serves as the oldest age group for studying lipidome changes with aging.","id":"MTBLS495_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":30,"studyId":"MTBLS495","studyUrl":"http://integmet.org/study/MTBLS495","title":"4_weeks_vs_52_weeks","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NNAMTGGOGLHJAZ-CHWHTWQNSA-N","pvalue":3.2792547733037268e-06,"ratio":0.2994856107888313,"synonym_name":""},{"chebi_id":"88904","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CVECNRQDBOYLEX-YUDFJFIPSA-N","pvalue":3.229747169209645e-06,"ratio":0.328096368262906,"synonym_name":"PC(42:4)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"WOOJFJAPBRHLEE-JZWMAQNHSA-N","pvalue":4.082502450543486e-06,"ratio":0.3463110256777888,"synonym_name":""},{"chebi_id":"170069","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"PMUXXFUNXMXIFC-OOPCQFHCSA-N","pvalue":2.3973812289349433e-05,"ratio":0.3801349208028227,"synonym_name":""},{"chebi_id":"170811","direction":"down","inn_name":"","iupac_name":"[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] (Z)-icos-11-enoate","metabolite_id":"VPDGQGZVNVFJGD-PCXMWBQASA-N","pvalue":0.000226960471023,"ratio":0.3573522149713689,"synonym_name":""},{"chebi_id":"191363","direction":"down","inn_name":"","iupac_name":"[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"YBAVZMWJCPETFA-QFTUWMPFSA-N","pvalue":1.512575852744686e-05,"ratio":0.4664733494856187,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YXDPOBBBWFMOCX-YNGVHRBASA-N","pvalue":2.73645757715519e-05,"ratio":0.4600783491059699,"synonym_name":""},{"chebi_id":"88392","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YVNORLDGMYIHEG-YXPBIPRFSA-N","pvalue":7.109484305070618e-05,"ratio":0.5057437418468168,"synonym_name":"PIno(34:1)"},{"chebi_id":"176694","direction":"down","inn_name":"","iupac_name":"[(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"AHWXJDWBIIDPKS-TZUVPVEASA-N","pvalue":0.0001933513042591,"ratio":0.4888305414422135,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ALJUYAAJNSNTHU-PVPDQLFYSA-N","pvalue":0.0019451904867797,"ratio":0.4464255820885051,"synonym_name":""}],"totalFeatures":79},{"comparisonGroups":["Control","CSD"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cervix: Control vs CSD samples","group_a_title":"Control group samples from the uterine cervix.. Provides baseline data for comparison with the CSD group to identify differences in microbiota, metabolome, and transcriptome.","group_b_title":"CSD group samples from the uterine cervix.. Allows for the investigation of the pathogenesis of CSD by comparing with the control group.","id":"MTBLS4967_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":75,"studyId":"MTBLS4967","studyUrl":"http://integmet.org/study/MTBLS4967","title":"Control_vs_CSD","topHits":[{"chebi_id":"191586","direction":"down","inn_name":"","iupac_name":"(E)-4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-ol","metabolite_id":"CNOPDZWOYFOHGN-BQYQJAHWSA-N","pvalue":0.0004893440352227,"ratio":0.2979518084878125,"synonym_name":""},{"chebi_id":"138761","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MOXJTUNOIGNZKZ-UHFFFAOYSA-N","pvalue":0.0124337092639834,"ratio":0.1684362158126743,"synonym_name":"6-(2-hydroxyethyl)-3,7-dimethyl-3,3a,4,7,8,8a-hexahydro-2H-cyclohepta[b]furan-2-one"},{"chebi_id":"62685","direction":"down","inn_name":"","iupac_name":"<em>N</em>-phenyl-<em>N</em>-(piperidin-4-yl)propanamide","metabolite_id":"PMCBDBWCQQBSRJ-UHFFFAOYSA-N","pvalue":0.0057577730117854,"ratio":0.2347571313074442,"synonym_name":"4-(<em>N</em>-propionylanilino)piperidine"},{"chebi_id":"175414","direction":"down","inn_name":"","iupac_name":"1,2-dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine","metabolite_id":"FYDZPRHXTQYOIW-UHFFFAOYSA-N","pvalue":0.0010079685402857,"ratio":0.3983395139094765,"synonym_name":""},{"chebi_id":"168824","direction":"down","inn_name":"","iupac_name":"6-[(4,7-dihydroxy-2,2-dimethyl-3,4-dihydrochromen-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"WUBQRXSKRKKODN-UHFFFAOYSA-N","pvalue":0.0227202335928187,"ratio":0.2039944380803793,"synonym_name":""},{"chebi_id":"145292","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OSRWIBSZJTWIKA-SCFYABBUSA-N","pvalue":0.029796357348304,"ratio":0.2126144222929206,"synonym_name":"LPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)"},{"chebi_id":"82308","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CZVHCFKUXGRABC-UHFFFAOYSA-N","pvalue":0.0228697040349066,"ratio":0.2474215166646804,"synonym_name":"4,4'-Diacetylbenzidine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GITOCQGOURWXPL-QNGBORIKSA-N","pvalue":0.005148340903466,"ratio":0.3678988006855181,"synonym_name":""},{"chebi_id":"17745","direction":"down","inn_name":"","iupac_name":"4-[(1<i>E</i>)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenol","metabolite_id":"JMFRWRFFLBVWSI-NSCUHMNNSA-N","pvalue":0.0262050004776361,"ratio":0.2408340033306509,"synonym_name":"<i>trans</i>-coniferol"},{"chebi_id":"87783","direction":"down","inn_name":"","iupac_name":"(25<i>R</i>)-3\u03b2-hydroxycholest-5-en-7-one-26-oic acid","metabolite_id":"QOEPZHFZXUROGV-BXDHRDAUSA-N","pvalue":0.0031948384618074,"ratio":0.427497463901298,"synonym_name":"(3\u03b2,25<i>R</i>)-3-hydroxy-7-oxocholest-5-en-26-oic acid"}],"totalFeatures":2874},{"comparisonGroups":["Control","CSD"],"dateCreated":"2025-09-26 00:00:00","display_title":"Uterine cervix: Control vs CSD condition","group_a_title":"Control group samples from the uterine cervix.. Provides baseline data for comparison with the CSD group to identify differences in microbiota, metabolome, and transcriptome.","group_b_title":"CSD group samples from the uterine cervix.. Allows for the investigation of the pathogenesis of CSD by comparing with the control group.","id":"MTBLS4967_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS4967","studyUrl":"http://integmet.org/study/MTBLS4967","title":"Control_vs_CSD","topHits":[{"chebi_id":"43208","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-heptane-1,2,3-triol","metabolite_id":"HXYCHJFUBNTKQR-RNFRBKRXSA-N","pvalue":0.0003951906875154,"ratio":0.2928992850949515,"synonym_name":"HEPTANE-1,2,3-TRIOL"},{"chebi_id":"187280","direction":"down","inn_name":"","iupac_name":"3-hydroxy-N-[(3S)-2-oxooxolan-3-yl]icosanamide","metabolite_id":"KERIGWGQSDLUFJ-KEKNWZKVSA-N","pvalue":0.0189461309750366,"ratio":0.1156884176940146,"synonym_name":""},{"chebi_id":"192123","direction":"up","inn_name":"","iupac_name":"(E)-undec-2-en-1-ol","metabolite_id":"SKBIQKQBLQHOSU-MDZDMXLPSA-N","pvalue":0.0044955170541693,"ratio":3.3091824836677897,"synonym_name":""},{"chebi_id":"88818","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NZLCAHVLJPDRBL-VSAQMIDASA-N","pvalue":0.0017291454891546,"ratio":0.3851339151478837,"synonym_name":"(2E,4E)-octa-2,4-diene"},{"chebi_id":"166492","direction":"down","inn_name":"","iupac_name":"3-hydroxypent-4-enenitrile","metabolite_id":"PBCLOVRWBLGJQA-UHFFFAOYSA-N","pvalue":0.017707758658855,"ratio":0.2331658832323875,"synonym_name":""},{"chebi_id":"138770","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IRKDZQZMTAKZKQ-UHFFFAOYSA-N","pvalue":0.0001845379876104,"ratio":1.9386126381892688,"synonym_name":"dimethylbenzyl carbinyl hexanoate"},{"chebi_id":"193545","direction":"down","inn_name":"","iupac_name":"(Z)-N-(2-hydroxyethyl)octadec-11-enamide","metabolite_id":"YVMBQTJWDFKKDQ-FPLPWBNLSA-N","pvalue":0.0268119795089405,"ratio":0.2740553718383234,"synonym_name":""},{"chebi_id":"49026","direction":"up","inn_name":"","iupac_name":"5-acetamido-3,5-dideoxy-<small>D</small>-<i>glycero</i>-\u03b1-<small>D</small>-<i>galacto</i>-non-2-ulopyranosonic acid","metabolite_id":"SQVRNKJHWKZAKO-YRMXFSIDSA-N","pvalue":0.0187888988719425,"ratio":3.1046672737209513,"synonym_name":"O-SIALIC ACID"},{"chebi_id":"73725","direction":"down","inn_name":"","iupac_name":"(11<i>Z</i>)-<em>N</em>-(2-hydroxyethyl)icos-11-enamide","metabolite_id":"YDKRGMXLBRWZJR-KTKRTIGZSA-N","pvalue":0.048966965974478,"ratio":0.2335927005976946,"synonym_name":"<em>N</em>-<i>cis</i>-11-eicosaenoylethanolamine"},{"chebi_id":"17781","direction":"up","inn_name":"","iupac_name":"7,8-dimethylbenzo[<em>g</em>]pteridine-2,4(1<em>H</em>,3<em>H</em>)-dione","metabolite_id":"ZJTJUVIJVLLGSP-UHFFFAOYSA-N","pvalue":0.0039730174409878,"ratio":2.1290066327540873,"synonym_name":"LUMICHROME"}],"totalFeatures":2531},{"comparisonGroups":["Control","ZYP_High_Dose"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose ZYP treatment in colitis model","group_a_title":"Control group with no disease and no ZYP treatment. Provides baseline data for comparison with disease and treatment groups.","group_b_title":"Colitis model group treated with high dose ZYP. Evaluates the effect of high dose ZYP treatment on colitis.","id":"MTBLS4980_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":578,"studyId":"MTBLS4980","studyUrl":"http://integmet.org/study/MTBLS4980","title":"Control_vs_ZYP_High_Dose","topHits":[{"chebi_id":"168098","direction":"up","inn_name":"","iupac_name":"2-butan-2-yloxy-6-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol","metabolite_id":"DANFNCOJRRFMIO-UHFFFAOYSA-N","pvalue":0.0001818714736718,"ratio":341149840.379538,"synonym_name":""},{"chebi_id":"174802","direction":"down","inn_name":"","iupac_name":"15-hydroxy-13,14-dimethoxy-10-azatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,4,6,8,12,14-heptaen-11-one","metabolite_id":"PHKYZFGDNGACRM-UHFFFAOYSA-N","pvalue":0.0070931664187461,"ratio":4.039696565921736e-09,"synonym_name":""},{"chebi_id":"15367","direction":"down","inn_name":"tr\u00e9tino\u00efne","iupac_name":"(2<i>E</i>,4<i>E</i>,6<i>E</i>,8<i>E</i>)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid","metabolite_id":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","pvalue":0.0210129321210583,"ratio":2.681478861175016e-08,"synonym_name":"(2<i>E</i>,4<i>E</i>,6<i>E</i>,8<i>E</i>)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid"},{"chebi_id":"175571","direction":"down","inn_name":"","iupac_name":"(1S,2S,4R,8S,9S,11S,12S,13R,19R)-11,19-dihydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one","metabolite_id":"JBVVDXJXIDYDMF-GVTADUIWSA-N","pvalue":1.6902187210658645e-07,"ratio":0.0340153620858339,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QXRLQTRFEMAPRP-MDZDMXLPSA-N","pvalue":9.73098616769921e-07,"ratio":0.029359830265248,"synonym_name":""},{"chebi_id":"183552","direction":"down","inn_name":"","iupac_name":"[16-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6,12-dihydroxy-2,17-dimethyl-3-oxo-8,15-dioxahexacyclo[9.8.0.02,7.07,9.012,17.014,16]nonadec-4-en-13-yl] acetate","metabolite_id":"VVQRJFUYBNCTQX-UHFFFAOYSA-N","pvalue":2.2873603521464855e-05,"ratio":0.0106500336274007,"synonym_name":""},{"chebi_id":"176250","direction":"down","inn_name":"","iupac_name":"(2R)-2-[(1S)-1-[(1S,3R,8S,9S,10R,13S,14S,17R)-1-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-5-(hydroxymethyl)-4-methyl-2,3-dihydropyran-6-one","metabolite_id":"KRHHFPJGGBLAAH-MYBCZMNMSA-N","pvalue":7.956215225138542e-05,"ratio":0.0156583613498753,"synonym_name":""},{"chebi_id":"168711","direction":"down","inn_name":"","iupac_name":"3,8-dihydroxy-16,17-dimethoxy-15-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaen-9-one","metabolite_id":"BSILZSYJTIBPFN-CNFGNZGNSA-N","pvalue":9.079263859363474e-06,"ratio":0.0364381360312434,"synonym_name":""},{"chebi_id":"175801","direction":"down","inn_name":"","iupac_name":"6-[3-[(1E,3E,5E,7E)-8-carboxy-3,7-dimethylocta-1,3,5,7-tetraenyl]-2,4,4-trimethylcyclohex-2-en-1-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"LVCMXFSJTNPFHH-FRCNGJHJSA-N","pvalue":0.0006514537441058,"ratio":0.005597114437684,"synonym_name":""},{"chebi_id":"70651","direction":"down","inn_name":"","iupac_name":"1,2-dimethoxy-7<em>H</em>-benzo[<em>de</em>][1,3]benzodioxolo[5,6-<em>g</em>]quinolin-7-one","metabolite_id":"NFDVJYPMLVMXRR-UHFFFAOYSA-N","pvalue":0.0013731957078442,"ratio":0.0032165806343026,"synonym_name":"1,2-dimethoxy-4,5,6,6a-tetradehydro-9,10-(methylenedioxy)noraprophin-7-one"}],"totalFeatures":2292},{"comparisonGroups":["Control","ZYP_High_Dose"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs high dose ZYP treatment in colitis model","group_a_title":"Control group with no disease and no ZYP treatment. Provides baseline data for comparison with disease and treatment groups.","group_b_title":"Colitis model group treated with high dose ZYP. Evaluates the effect of high dose ZYP treatment on colitis.","id":"MTBLS4980_0002_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":774,"studyId":"MTBLS4980","studyUrl":"http://integmet.org/study/MTBLS4980","title":"Control_vs_ZYP_High_Dose","topHits":[{"chebi_id":"186675","direction":"down","inn_name":"","iupac_name":"9-methoxy-6-phenyl-[1,3]dioxolo[4,5-g]chromen-8-one","metabolite_id":"NGLORVNWTNPBMU-UHFFFAOYSA-N","pvalue":0.0001355193956109,"ratio":5.116882069204201e-09,"synonym_name":""},{"chebi_id":"9914","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QRLBQXQEGMBXFM-JHIHKWCFSA-N","pvalue":0.0047216316555433,"ratio":760006462.8877888,"synonym_name":"Ustiloxin"},{"chebi_id":"175622","direction":"down","inn_name":"","iupac_name":"1-hydroxy-8-[(E)-3-hydroxy-3-methylbut-1-enyl]-3,6,7-trimethoxy-2-(3-methylbut-2-enyl)xanthen-9-one","metabolite_id":"SPRXFHBMQQEVDG-ZHACJKMWSA-N","pvalue":0.0001163202555263,"ratio":6.103983632384122e-06,"synonym_name":""},{"chebi_id":"5705","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CAWXEEYDBZRFPE-UHFFFAOYSA-N","pvalue":0.0036598741232704,"ratio":7.913279944505714e-09,"synonym_name":"Hexazinone"},{"chebi_id":"176045","direction":"up","inn_name":"","iupac_name":"(2S,3S,4S,5R)-4-[[3-amino-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]-3,5,6-trihydroxyoxane-2-carboxylic acid","metabolite_id":"RDVUSEMLHAXQRK-SMNQMHOSSA-N","pvalue":0.014712161227436,"ratio":1851392722.843234,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AWLYBJONQDYQAK-QTJNYWJXSA-N","pvalue":0.0143218202523567,"ratio":3.323928804969875e-09,"synonym_name":""},{"chebi_id":"133077","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(hydroxy{[(1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"SAHCQBPGXQFTRA-MUTGBQBKSA-N","pvalue":0.0416158804048707,"ratio":5338924807.262377,"synonym_name":"GPI(18:2)"},{"chebi_id":"175361","direction":"down","inn_name":"","iupac_name":"4-methoxy-5-methyl-6-[(1Z,3E,5Z)-6-(4,7,8-trihydroxy-1,3,5-trimethyl-2,6-dioxabicyclo[3.2.1]octan-3-yl)hexa-1,3,5-trienyl]pyran-2-one","metabolite_id":"IQOXOOYMXWDCEG-LXKJUNEMSA-N","pvalue":6.487827715188075e-07,"ratio":0.0306117338682157,"synonym_name":""},{"chebi_id":"168635","direction":"up","inn_name":"","iupac_name":"butyl 3-[(Z)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylate","metabolite_id":"VNLREARKISTOAD-ALCCZGGFSA-N","pvalue":2.9037427113896165e-05,"ratio":107.85451588383494,"synonym_name":""},{"chebi_id":"32663","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(2-{4-[(1<i>Z</i>)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)-<em>N</em>,<em>N</em>-dimethyl-\u03b2-<small>D</small>-glucopyranuronosylaminium","metabolite_id":"UKFQQYJAYUAYES-DTMHFWPESA-O","pvalue":2.757463068565677e-06,"ratio":0.0220294865059023,"synonym_name":"tamoxifen <em>N</em>-glucuronide"}],"totalFeatures":2813},{"comparisonGroups":["Aquatica_leii_Adults_Freshwater","Aquatica_leii_Larvae_Land"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aquatica leii: adults (freshwater) vs larvae (land)","group_a_title":"Adult Aquatica leii samples from freshwater environment.. Key group for understanding adult metabolic adaptations to freshwater.","group_b_title":"Larval Aquatica leii samples from land environment.. Important for comparing larval adaptations between aquatic and terrestrial environments.","id":"MTBLS4987_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS4987","studyUrl":"http://integmet.org/study/MTBLS4987","title":"Aquatica_leii_Adults_Freshwater_vs_Aquatica_leii_Larvae_Land","topHits":[],"totalFeatures":1},{"comparisonGroups":["WT","sll0404.ko"],"dateCreated":"2025-09-26 00:00:00","display_title":"Synechocystis: sll0404 knockout vs wild-type","group_a_title":"Wild-type Synechocystis sp. PCC 6803 under high CO2 conditions.. Provides a reference point for assessing the effects of genetic mutations.","group_b_title":"Synechocystis sp. PCC 6803 with sll0404 gene knockout.. Helps in understanding the role of the sll0404 gene in metabolic processes.","id":"MTBLS5_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS5","studyUrl":"http://integmet.org/study/MTBLS5","title":"WT_vs_sll0404.ko","topHits":[{"chebi_id":"17497","direction":"down","inn_name":"","iupac_name":"hydroxyacetic acid","metabolite_id":"AEMRFAOFKBGASW-UHFFFAOYSA-N","pvalue":2.430916041376495e-05,"ratio":0.1118157051978991,"synonym_name":"HOCH<small><sub>2</sub></small>COOH"},{"chebi_id":"4170","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":6.209991425555396e-06,"ratio":0.1992797688926425,"synonym_name":"Glc6P"},{"chebi_id":"78320","direction":"down","inn_name":"","iupac_name":"2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-UHFFFAOYSA-N","pvalue":0.0003795341610646,"ratio":0.2728990431927454,"synonym_name":"2-Hydroxypropanoic acid"},{"chebi_id":"4167","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-GASJEMHNSA-N","pvalue":0.0001466403345746,"ratio":0.4550017808877384,"synonym_name":"Dextrose"},{"chebi_id":"15946","direction":"down","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.0028248034087688,"ratio":0.4463866363356505,"synonym_name":"D-Fructose 6-phosphate"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0025409212079465,"ratio":0.4574060716900386,"synonym_name":"u"},{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.01441011401405,"ratio":2.1390818229603306,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"4208","direction":"down","inn_name":"","iupac_name":"<small>D</small>-mannopyranose","metabolite_id":"WQZGKKKJIJFFOK-QTVWNMPRSA-N","pvalue":0.0070371563524071,"ratio":0.5553801298771346,"synonym_name":"D-Mannose"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0362983413312843,"ratio":0.4288638950613037,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0167406284433588,"ratio":0.5915475634770132,"synonym_name":"Adenosin"}],"totalFeatures":68},{"comparisonGroups":["Control_Liver","Treatment_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Liver: DT-109 treatment vs H2O control","group_a_title":"Control group for liver samples treated with H20 (vehicle).. Provides baseline data for liver tissue to compare against treatment effects.","group_b_title":"Treatment group for liver samples treated with DT-109 (compound).. Evaluates the effect of DT-109 on liver tissue, providing insights into its therapeutic potential.","id":"MTBLS5005_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS5005","studyUrl":"http://integmet.org/study/MTBLS5005","title":"Control_Liver_vs_Treatment_Liver","topHits":[{"chebi_id":"194569","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (Z)-docos-11-enoate","metabolite_id":"IFCXODPCRNYZJX-LJUYVFDDSA-N","pvalue":0.0449398915961334,"ratio":71.22433708086287,"synonym_name":""},{"chebi_id":"194561","direction":"up","inn_name":"","iupac_name":"2-[3,4-bis(2-hydroxyethoxy)phenyl]-3,5-dihydroxy-7-(2-hydroxyethoxy)chromen-4-one","metabolite_id":"BYPUSJHQPRFYGB-UHFFFAOYSA-N","pvalue":0.0035184110140688,"ratio":8.021884924741709,"synonym_name":""},{"chebi_id":"174173","direction":"up","inn_name":"","iupac_name":"4-hydroxy-1-(pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid","metabolite_id":"ONPXCLZMBSJLSP-UHFFFAOYSA-N","pvalue":0.0136021732346053,"ratio":14.29533058635013,"synonym_name":""},{"chebi_id":"82966","direction":"up","inn_name":"","iupac_name":"\u03b3-glutamylphenylalanine","metabolite_id":"XHHOHZPNYFQJKL-UHFFFAOYSA-N","pvalue":0.00912672767634,"ratio":6.522639350032015,"synonym_name":"\u03b3-Glu-Phe"},{"chebi_id":"172785","direction":"up","inn_name":"","iupac_name":"(E,2S,10S)-2,10-diamino-5-[1-[(5S)-5-amino-5-carboxypentyl]-3,5-bis[(3S)-3-amino-3-carboxypropyl]pyridin-1-ium-2-yl]undec-5-enedioic acid","metabolite_id":"PQAACQBDHKVCSF-ZJGVIXKBSA-O","pvalue":0.0034350693848339,"ratio":4.4948100337588235,"synonym_name":""},{"chebi_id":"141521","direction":"up","inn_name":"trandolaprilate","iupac_name":"(2<i>S</i>,3a<i>R</i>,7a<i>S</i>)-1-[(2<i>S</i>)-2-{[(1<i>S</i>)-1-carboxy-3-phenylpropyl]amino}propanoyl]octahydro-1<em>H</em>-indole-2-carboxylic acid","metabolite_id":"AHYHTSYNOHNUSH-HXFGRODQSA-N","pvalue":0.0152160660813719,"ratio":7.391248666630455,"synonym_name":"(2<i>S</i>,3a<i>R</i>,7a<i>S</i>)-1-((<i>S</i>)-<em>N</em>-((<i>S</i>)-1-carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid"},{"chebi_id":"187993","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-[[(2R)-3-henicosanoyloxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid","metabolite_id":"IFZCAKDVWKLKEK-RPBOFIJWSA-N","pvalue":0.0058358695870514,"ratio":4.859202573294578,"synonym_name":""},{"chebi_id":"29673","direction":"up","inn_name":"rifamycine","iupac_name":"(2<i>S</i>,12<i>Z</i>,14<i>E</i>,16<i>S</i>,17<i>S</i>,18<i>R</i>,19<i>R</i>,20<i>R</i>,21<i>S</i>,22<i>R</i>,23<i>S</i>,24<i>E</i>)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-<em>b</em>]furan-21-yl acetate","metabolite_id":"HJYYPODYNSCCOU-ODRIEIDWSA-N","pvalue":0.0043545390393581,"ratio":4.372970901476694,"synonym_name":"Rifocin"},{"chebi_id":"79283","direction":"up","inn_name":"","iupac_name":"2-aminoethyl (2<i>R</i>)-3-(hexadecyloxy)-2-hydroxypropyl hydrogen phosphate","metabolite_id":"OKXWJISJKQKUTN-OAQYLSRUSA-N","pvalue":0.0087797987898263,"ratio":4.951846876875491,"synonym_name":"1-<em>O</em>-hexadecyl-2-lyso-<em>sn</em>-glycero-3-phosphoethanolamine"},{"chebi_id":"72794","direction":"down","inn_name":"","iupac_name":"(4<i>Z</i>,7<i>Z</i>,9<i>E</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid","metabolite_id":"LTERDCBCHFKFRI-BGKMTWLOSA-N","pvalue":0.0394861189091749,"ratio":0.0965960714785375,"synonym_name":"(\u00b1)-11-HDoHE"}],"totalFeatures":34},{"comparisonGroups":["Control_Liver","Treatment_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Liver: DT-109 compound treatment vs H2O control","group_a_title":"Control group for liver samples treated with H20 (vehicle).. Provides baseline data for liver tissue to compare against treatment effects.","group_b_title":"Treatment group for liver samples treated with DT-109 (compound).. Evaluates the effect of DT-109 on liver tissue, providing insights into its therapeutic potential.","id":"MTBLS5005_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS5005","studyUrl":"http://integmet.org/study/MTBLS5005","title":"Control_Liver_vs_Treatment_Liver","topHits":[{"chebi_id":"184896","direction":"down","inn_name":"","iupac_name":"[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (Z)-docos-13-enoate","metabolite_id":"ALWGEKGYDBQVFJ-DYFSFZQGSA-N","pvalue":0.0257949534764403,"ratio":0.0642781046264666,"synonym_name":""},{"chebi_id":"74535","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-3-hydroxy-2-[(15<i>Z</i>)-tetracos-15-enoylamino]octadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"WKZHECFHXLTOLJ-QYKFWSDSSA-N","pvalue":0.0063100883190183,"ratio":5.4623272016862225,"synonym_name":"C24:1 Sphingomyelin"},{"chebi_id":"86102","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SRQSAJRUMDQMMS-NLDJLLEISA-N","pvalue":0.0140818469822176,"ratio":0.1567928147999389,"synonym_name":"PC(14:0/20:4)"},{"chebi_id":"189014","direction":"up","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[1-(4-methoxyphenyl)-3-oxopentoxy]oxane-2-carboxylic acid","metabolite_id":"TWSHGCHPGCBTFY-UHFFFAOYSA-N","pvalue":0.0230166199333467,"ratio":5.948552315955247,"synonym_name":""},{"chebi_id":"175838","direction":"up","inn_name":"","iupac_name":"8-[6-hydroxy-5-(3-methylbut-2-enyl)-1-benzouran-2-yl]-2,2-dimethylchromen-5-ol","metabolite_id":"AKOSXIFOBUWPLU-UHFFFAOYSA-N","pvalue":0.0152173221469818,"ratio":4.010811007967077,"synonym_name":""},{"chebi_id":"63791","direction":"down","inn_name":"lenalidomide","iupac_name":"3-(4-amino-1-oxo-1,3-dihydro-2<em>H</em>-isoindol-2-yl)piperidine-2,6-dione","metabolite_id":"GOTYRUGSSMKFNF-UHFFFAOYSA-N","pvalue":0.0073110662962678,"ratio":0.3175633550067193,"synonym_name":"1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline"},{"chebi_id":"88773","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OKNSFVSKHQJVRN-XAYCFROHSA-N","pvalue":0.0194844821222233,"ratio":3.738905427769356,"synonym_name":"20beta-Cortolone-3-glucuronide"},{"chebi_id":"78745","direction":"up","inn_name":"","iupac_name":"(11<i>R</i>)-11-[3,6-dideoxy-4-<em>O</em>-(1<em>H</em>-indol-3-ylcarbonyl)-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyloxy]dodecanoic acid","metabolite_id":"AFPJDDPSVYDRDB-DRONAGRDSA-N","pvalue":0.0479737742011962,"ratio":4.842515988967167,"synonym_name":"(11<i>R</i>)-11-[3,6-dideoxy-4-<em>O</em>-(1<em>H</em>-indol-3-ylcarbonyl)-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyloxy]lauric acid"},{"chebi_id":"179993","direction":"down","inn_name":"","iupac_name":"4-methyl-2-propan-2-yl-1,3-dioxolane","metabolite_id":"NWXXKKDLGZLEGH-UHFFFAOYSA-N","pvalue":0.0017381841862606,"ratio":0.484822861442773,"synonym_name":""},{"chebi_id":"5556","direction":"down","inn_name":"","iupac_name":"1-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate","metabolite_id":"RTEVGQJRTFFMLL-UHFFFAOYSA-N","pvalue":0.0286938157329504,"ratio":0.2838649126147201,"synonym_name":"U 28288D"}],"totalFeatures":16},{"comparisonGroups":["Dc-N","Dc-HS"],"dateCreated":"2025-09-26 00:00:00","display_title":"Lactating cows: heat stress vs normal conditions","group_a_title":"Normal phase group for lactating cows. Serves as a baseline for comparison with heat-stressed lactating cows.","group_b_title":"Heat stress treatment group for lactating cows. Key group for assessing the impact of heat stress on lactating cows.","id":"MTBLS5132_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":40,"studyId":"MTBLS5132","studyUrl":"http://integmet.org/study/MTBLS5132","title":"Dc-N_vs_Dc-HS","topHits":[{"chebi_id":"27849","direction":"up","inn_name":"","iupac_name":"4-methylbenzenesulfonic acid","metabolite_id":"JOXIMZWYDAKGHI-UHFFFAOYSA-N","pvalue":2.695512526961154e-07,"ratio":9.704871900404235,"synonym_name":"toluene-4-sulfonic acid"},{"chebi_id":"190557","direction":"down","inn_name":"","iupac_name":"2-(benzotriazol-1-yl)-N-(2,3-dihydro-1H-inden-2-yl)acetamide","metabolite_id":"LFFFYYBOPNYXAT-UHFFFAOYSA-N","pvalue":0.0009793168789118,"ratio":0.0990483150470093,"synonym_name":""},{"chebi_id":"33070","direction":"up","inn_name":"","iupac_name":"4-(1<em>H</em>-indol-3-yl)butanoic acid","metabolite_id":"JTEDVYBZBROSJT-UHFFFAOYSA-N","pvalue":9.620550707424949e-06,"ratio":3.2003943609138834,"synonym_name":"indole-3-butanoic acid"},{"chebi_id":"183702","direction":"up","inn_name":"","iupac_name":"(E)-2-cyano-3-(3,4-dimethoxyphenyl)prop-2-enoic acid","metabolite_id":"DMACYVMZKYRYSL-WEVVVXLNSA-N","pvalue":0.0001085710441992,"ratio":2.9745671780852523,"synonym_name":""},{"chebi_id":"3359","direction":"down","inn_name":"","iupac_name":"2,4-dihydroxy-3-[(1<i>R</i>,6<i>R</i>)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-6-pentylbenzoic acid","metabolite_id":"WVOLTBSCXRRQFR-DLBZAZTESA-N","pvalue":0.0112576874094631,"ratio":0.1139966147543317,"synonym_name":"Cannabidiolic acid"},{"chebi_id":"194257","direction":"up","inn_name":"","iupac_name":"(Z)-7-[(1S,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid","metabolite_id":"MYHXHCUNDDAEOZ-UKUWKSPLSA-N","pvalue":0.0010056720459377,"ratio":3.835286821233848,"synonym_name":""},{"chebi_id":"16325","direction":"down","inn_name":"","iupac_name":"3\u03b1-hydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"SMEROWZSTRWXGI-HVATVPOCSA-N","pvalue":0.0070956990906729,"ratio":0.1951799026311708,"synonym_name":"(3\u03b1,5\u03b2)-3-hydroxycholan-24-oic acid"},{"chebi_id":"165324","direction":"up","inn_name":"","iupac_name":"5-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]pentanoic acid","metabolite_id":"GTUGBRJEKVKOKQ-LRSAKWJDSA-N","pvalue":0.0096763917173305,"ratio":5.572445479342859,"synonym_name":""},{"chebi_id":"75097","direction":"down","inn_name":"","iupac_name":"(10<i>E</i>)-heptadec-10-enoic acid","metabolite_id":"GDTXICBNEOEPAZ-BQYQJAHWSA-N","pvalue":0.0004254760761496,"ratio":0.3707246458119984,"synonym_name":"<i>trans</i>-tetradec-11-enoic acid"},{"chebi_id":"28680","direction":"up","inn_name":"cytarabinum","iupac_name":"4-amino-1-\u03b2-<small>D</small>-arabinofuranosylpyrimidin-2(1<em>H</em>)-one","metabolite_id":"UHDGCWIWMRVCDJ-CCXZUQQUSA-N","pvalue":0.0002854982660112,"ratio":2.4154506401529345,"synonym_name":"cytosine-\u03b2-<small>D</small>-arabinofuranoside"}],"totalFeatures":447},{"comparisonGroups":["Dc-N","Dc-HS"],"dateCreated":"2025-09-26 00:00:00","display_title":"Lactating cows: heat stress vs normal conditions","group_a_title":"Normal phase group for lactating cows. Serves as a baseline for comparison with heat-stressed lactating cows.","group_b_title":"Heat stress treatment group for lactating cows. Key group for assessing the impact of heat stress on lactating cows.","id":"MTBLS5132_0002_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":86,"studyId":"MTBLS5132","studyUrl":"http://integmet.org/study/MTBLS5132","title":"Dc-N_vs_Dc-HS","topHits":[{"chebi_id":"183684","direction":"up","inn_name":"","iupac_name":"(2,6-dimethylmorpholin-4-yl)-(1-methyl-5-nitropyrazol-4-yl)methanone","metabolite_id":"KXFIZCLANBNOOB-UHFFFAOYSA-N","pvalue":8.574867342532244e-05,"ratio":21.27839548123332,"synonym_name":""},{"chebi_id":"183740","direction":"up","inn_name":"","iupac_name":"2-(cyclopropanecarbonyl)-3-(4-luoroanilino)prop-2-enenitrile","metabolite_id":"HZBHZVSXZFCDJC-UHFFFAOYSA-N","pvalue":1.8987093818932176e-06,"ratio":6.848131058991853,"synonym_name":""},{"chebi_id":"132234","direction":"up","inn_name":"","iupac_name":"1-(1,3-benzodioxol-5-yl)-<em>N</em>-ethylpropan-2-amine","metabolite_id":"PVXVWWANJIWJOO-UHFFFAOYSA-N","pvalue":2.8627766750929074e-06,"ratio":6.951519042479607,"synonym_name":""},{"chebi_id":"170034","direction":"up","inn_name":"","iupac_name":"4-prop-2-enoxy-1H-quinolin-2-one","metabolite_id":"JLLZTZRBEFPDPA-UHFFFAOYSA-N","pvalue":3.563229706388318e-07,"ratio":4.951545600904125,"synonym_name":""},{"chebi_id":"165231","direction":"up","inn_name":"","iupac_name":"2-methoxybenzene-1,3-diol","metabolite_id":"QFYYAIBEHOEZKC-UHFFFAOYSA-N","pvalue":0.0007407054011206,"ratio":23.313141597919326,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FUIQBJHUESBZNU-UHFFFAOYSA-N","pvalue":3.453098163611769e-05,"ratio":6.546598315851394,"synonym_name":""},{"chebi_id":"136995","direction":"up","inn_name":"","iupac_name":"2-(3,4-dimethoxyphenyl)ethanamine","metabolite_id":"ANOUKFYBOAKOIR-UHFFFAOYSA-N","pvalue":1.5253728973463618e-08,"ratio":2.2630761383450166,"synonym_name":"DIMPEA"},{"chebi_id":"70959","direction":"up","inn_name":"","iupac_name":"3-methylhistidine","metabolite_id":"JDHILDINMRGULE-UHFFFAOYSA-N","pvalue":6.904507650704395e-05,"ratio":4.590640582440734,"synonym_name":"3-methyl-<small>D</small><small>L</small>-histidine"},{"chebi_id":"16870","direction":"up","inn_name":"choline alfoscerate","iupac_name":"2-{[(2<i>R</i>)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","pvalue":4.284973651327539e-05,"ratio":4.178085541185989,"synonym_name":"sn-glycero-3-phosphocholine"},{"chebi_id":"183416","direction":"up","inn_name":"","iupac_name":"(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide","metabolite_id":"VVRNYAJXAUQHEN-BNFZFUHLSA-N","pvalue":0.0010342206163373,"ratio":7.706402564009667,"synonym_name":""}],"totalFeatures":629},{"comparisonGroups":["Dcs_N","Dcs_HS"],"dateCreated":"2025-09-26 00:00:00","display_title":"Dcs group: heat stress vs normal conditions","group_a_title":"Dcs group under normal conditions. Serves as a baseline for comparison with heat stress conditions in Dcs group.","group_b_title":"Dcs group under heat stress treatment. Represents the effect of heat stress on Dcs group.","id":"MTBLS5148_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":50,"studyId":"MTBLS5148","studyUrl":"http://integmet.org/study/MTBLS5148","title":"Dcs_N_vs_Dcs_HS","topHits":[{"chebi_id":"190553","direction":"up","inn_name":"","iupac_name":"5-[3-[(1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl]indol-1-yl]pentanoic acid","metabolite_id":"YFFKBKQHLMKTJY-UHFFFAOYSA-N","pvalue":8.651394417027502e-06,"ratio":8.209681178396028,"synonym_name":""},{"chebi_id":"28837","direction":"up","inn_name":"octanoic acid","iupac_name":"octanoic acid","metabolite_id":"WWZKQHOCKIZLMA-UHFFFAOYSA-N","pvalue":1.8000743187837918e-07,"ratio":3.791816278156431,"synonym_name":"Octans\u00e4ure"},{"chebi_id":"165324","direction":"up","inn_name":"","iupac_name":"5-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]pentanoic acid","metabolite_id":"GTUGBRJEKVKOKQ-LRSAKWJDSA-N","pvalue":2.2077261818759253e-06,"ratio":4.282154433194788,"synonym_name":""},{"chebi_id":"16914","direction":"down","inn_name":"","iupac_name":"2-hydroxybenzoic acid","metabolite_id":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","pvalue":1.0261475841698156e-05,"ratio":0.3884890695778066,"synonym_name":"o-Hydroxybenzoic acid"},{"chebi_id":"27823","direction":"down","inn_name":"","iupac_name":"(5-hydroxy-1<em>H</em>-indol-3-yl)acetic acid","metabolite_id":"DUUGKQCEGZLZNO-UHFFFAOYSA-N","pvalue":6.581470809812579e-05,"ratio":0.345269040423091,"synonym_name":"5-Hydroxyindoleacetic acid"},{"chebi_id":"88522","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"YZBOVSFWWNVKRJ-UHFFFAOYSA-N","pvalue":2.9543064864427623e-05,"ratio":2.6263271111342816,"synonym_name":"Mono-N-butyl phthalate"},{"chebi_id":"16054","direction":"down","inn_name":"","iupac_name":"2-benzylbutanedioic acid","metabolite_id":"GTOFKXZQQDSVFH-UHFFFAOYSA-N","pvalue":0.0001340920498149,"ratio":0.3972593418255253,"synonym_name":"(phenylmethyl)butanedioic acid"},{"chebi_id":"88515","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GWNVDXQDILPJIG-CCHJCNDSSA-N","pvalue":0.0002308492608493,"ratio":0.4494315260961531,"synonym_name":"5S-Hydroxy-6R-(S-glutathionyl)-7E,9E,11E14Z-eicosatetraenoate"},{"chebi_id":"183852","direction":"up","inn_name":"","iupac_name":"3-[(1R,2R,3R,5R)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]propanoic acid","metabolite_id":"UIZLUZTVNFGFMX-KBUPBQIOSA-N","pvalue":0.0002126014768757,"ratio":2.0510213704544524,"synonym_name":""},{"chebi_id":"91218","direction":"down","inn_name":"","iupac_name":"(10<i>E</i>,15<i>Z</i>)-9,12,13-trihydroxyoctadeca-10,15-dienoic acid","metabolite_id":"MKYUCBXUUSZMQB-MKZMYESJSA-N","pvalue":4.82986096810734e-06,"ratio":0.6130271175355901,"synonym_name":"9,12,13-trihydroxy-10(<i>E</i>),15(<i>Z</i>)-octadecadienoic acid"}],"totalFeatures":447},{"comparisonGroups":["Dcs_N","Dcs_HS"],"dateCreated":"2025-09-26 00:00:00","display_title":"Dcs group: heat stress vs normal conditions","group_a_title":"Dcs group under normal conditions. Serves as a baseline for comparison with heat stress conditions in Dcs group.","group_b_title":"Dcs group under heat stress treatment. Represents the effect of heat stress on Dcs group.","id":"MTBLS5148_0002_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":60,"studyId":"MTBLS5148","studyUrl":"http://integmet.org/study/MTBLS5148","title":"Dcs_N_vs_Dcs_HS","topHits":[{"chebi_id":"183357","direction":"up","inn_name":"","iupac_name":"[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 2-methylbutanoate","metabolite_id":"XLVGCFIBECZCKR-NVGKCVISSA-N","pvalue":8.819563526061346e-08,"ratio":12.511950636085883,"synonym_name":""},{"chebi_id":"176815","direction":"down","inn_name":"","iupac_name":"N-methyl-N-octyloctan-1-amine","metabolite_id":"YJLYANLCNIKXMG-UHFFFAOYSA-N","pvalue":1.429543215985648e-06,"ratio":0.0475921848382171,"synonym_name":""},{"chebi_id":"70959","direction":"up","inn_name":"","iupac_name":"3-methylhistidine","metabolite_id":"JDHILDINMRGULE-UHFFFAOYSA-N","pvalue":2.583354727903009e-07,"ratio":3.821928405282878,"synonym_name":"3-methyl-<small>D</small><small>L</small>-histidine"},{"chebi_id":"94314","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DSFGXPJYDCSWTA-UHFFFAOYSA-N","pvalue":0.0003349760157465,"ratio":8.332586399686855,"synonym_name":"xanthinol"},{"chebi_id":"75557","direction":"up","inn_name":"","iupac_name":"<em>rac</em>-2,3-dihydroxypropyl octadecanoate","metabolite_id":"VBICKXHEKHSIBG-UHFFFAOYSA-N","pvalue":0.0004942207456655,"ratio":7.327996343584591,"synonym_name":"(\u00b1)-glyceryl monostearate"},{"chebi_id":"192634","direction":"up","inn_name":"","iupac_name":"N-(1,2,3,9-tetrahydrocarbazol-4-ylidene)hydroxylamine","metabolite_id":"MYJLWCZBXSLDMA-UHFFFAOYSA-N","pvalue":2.142760554187783e-05,"ratio":3.088313119216711,"synonym_name":""},{"chebi_id":"73261","direction":"up","inn_name":"","iupac_name":"1,5-dimethyl-4-(methylamino)-2-phenyl-1,2-dihydro-3<em>H</em>-pyrazol-3-one","metabolite_id":"JILCEWWZTBBOFS-UHFFFAOYSA-N","pvalue":0.0387679107467379,"ratio":22.15162045030026,"synonym_name":"4-methylaminoantipyrine"},{"chebi_id":"34741","direction":"down","inn_name":"","iupac_name":"(3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol","metabolite_id":"ADFCQWZHKCXPAJ-GFCCVEGCSA-N","pvalue":1.9148182991610007e-05,"ratio":0.3993414597687283,"synonym_name":"Equol"},{"chebi_id":"168507","direction":"up","inn_name":"","iupac_name":"heptadec-16-yne-1,2,4-triol","metabolite_id":"OHLQBKZXSJYBMK-UHFFFAOYSA-N","pvalue":2.0657308866556076e-05,"ratio":2.3297603655566643,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CDNHLXOFELOEOL-UHFFFAOYSA-N","pvalue":0.0001768738445464,"ratio":2.8324579410297024,"synonym_name":""}],"totalFeatures":629},{"comparisonGroups":["Leaf_00_a.m.","Leaf_00_p.m."],"dateCreated":"2025-09-26 00:00:00","display_title":"Leaf: morning (00 a.m.) vs evening (00 p.m.)","group_a_title":"Samples collected from leaf at 00 a.m.. Represents the early morning metabolic state of the leaf.","group_b_title":"Samples collected from leaf at 00 p.m.. Represents the late evening metabolic state of the leaf.","id":"MTBLS519_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS519","studyUrl":"http://integmet.org/study/MTBLS519","title":"Leaf_00_a.m._vs_Leaf_00_p.m.","topHits":[{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":3.529624963506985e-07,"ratio":5.799969587171776,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":7.78105268415864e-06,"ratio":5.712599309466698,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"18300","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UPHRSURJSA-N","pvalue":3.26069183294028e-05,"ratio":6.154462149951754,"synonym_name":"Maleic acid"},{"chebi_id":"32805","direction":"up","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":7.354233701280106e-05,"ratio":6.3546614531262735,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"15741","direction":"up","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":8.176955108663573e-05,"ratio":4.741014639149144,"synonym_name":"E363"},{"chebi_id":"30769","direction":"up","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.00016507684424,"ratio":5.272567972606256,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"18183","direction":"up","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0004565805304972,"ratio":2.67999511128523,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"17351","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":1.1726675644128845e-05,"ratio":0.5981378355429238,"synonym_name":"Linoleic acid"},{"chebi_id":"27432","direction":"down","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoic acid","metabolite_id":"DTOSIQBPPRVQHS-PDBXOOCHSA-N","pvalue":0.0001599586314016,"ratio":0.560320338206141,"synonym_name":"(9,12,15)-linolenic acid"},{"chebi_id":"16521","direction":"down","inn_name":"","iupac_name":"lanosta-8,24-dien-3\u03b2-ol","metabolite_id":"CAHGCLMLTWQZNJ-BQNIITSRSA-N","pvalue":0.0004508667129774,"ratio":0.5316052535075448,"synonym_name":"4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol"}],"totalFeatures":32},{"comparisonGroups":["Male_19_days","Male_1_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Male pigeons: 19 days vs 1 day breeding cycle","group_a_title":"Male pigeons at 19 days. Represents a specific time point in the breeding cycle for male pigeons.","group_b_title":"Male pigeons at 1 day. Represents a specific time point in the breeding cycle for male pigeons.","id":"MTBLS5195_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":359,"studyId":"MTBLS5195","studyUrl":"http://integmet.org/study/MTBLS5195","title":"Male_19_days_vs_Male_1_day","topHits":[{"chebi_id":"90025","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FZVOBDJBRIEKPS-SXFSXRSVSA-N","pvalue":6.08824323430926e-11,"ratio":1e-06,"synonym_name":"PS(40:7)"},{"chebi_id":"165389","direction":"down","inn_name":"","iupac_name":"triacontanedioic acid","metabolite_id":"JADFUOUIMWDTFX-UHFFFAOYSA-N","pvalue":6.402828200931482e-08,"ratio":1e-06,"synonym_name":""},{"chebi_id":"180048","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[9-(3,4-dimethyl-5-pentyluran-2-yl)nonanoyloxy]propan-2-yl] 11-(3-methyl-5-propyluran-2-yl)undecanoate","metabolite_id":"PECWTAFYUBFXOI-LDLOPFEMSA-N","pvalue":1.0154387711001893e-07,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XXPKIRJTDVKKCK-OXYODPPFSA-N","pvalue":8.918678277844413e-07,"ratio":1e-06,"synonym_name":""},{"chebi_id":"185734","direction":"down","inn_name":"","iupac_name":"2-[5,8-dihydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3-hydroxybutanedioic acid","metabolite_id":"DGJSSBCAHRQASY-UHFFFAOYSA-N","pvalue":2.225995583139997e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"193877","direction":"up","inn_name":"","iupac_name":"2-[[2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulanylbutanoic acid","metabolite_id":"BVZABQIRMYTKCF-UHFFFAOYSA-N","pvalue":2.27409490619693e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"17620","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid","metabolite_id":"KSEBMYQBYZTDHS-HWKANZROSA-N","pvalue":2.683141447055479e-06,"ratio":1000000.0,"synonym_name":"Ferulic acid"},{"chebi_id":"165575","direction":"up","inn_name":"","iupac_name":"(2S)-3-methyl-2-(octadecanoylamino)butanoic acid","metabolite_id":"SIPMISGYHBUSIB-QFIPXVFZSA-N","pvalue":9.179875775807864e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"86071","direction":"down","inn_name":"","iupac_name":"4-(3-hydroxyprop-1-en-1-yl)benzene-1,2-diol","metabolite_id":"ZCKDCRKBURQZPT-UHFFFAOYSA-N","pvalue":2.2520298636833227e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JGQGBGDIMHWYAX-QAZBPYKKSA-N","pvalue":2.4262595698995644e-05,"ratio":1e-06,"synonym_name":""}],"totalFeatures":2249},{"comparisonGroups":["Male_19_days","Male_1_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Male pigeons: 19 days vs 1 day breeding cycle","group_a_title":"Male pigeons at 19 days. Represents a specific time point in the breeding cycle for male pigeons.","group_b_title":"Male pigeons at 1 day. Represents a specific time point in the breeding cycle for male pigeons.","id":"MTBLS5195_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":351,"studyId":"MTBLS5195","studyUrl":"http://integmet.org/study/MTBLS5195","title":"Male_19_days_vs_Male_1_day","topHits":[{"chebi_id":"175932","direction":"down","inn_name":"","iupac_name":"2-(4,6-dihydroxyphenanthren-2-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"OLRKGPYAYTYJGF-UHFFFAOYSA-N","pvalue":8.799179796078723e-07,"ratio":1e-06,"synonym_name":""},{"chebi_id":"36812","direction":"up","inn_name":"","iupac_name":"1-phenylpentan-1-one","metabolite_id":"XKGLSKVNOSHTAD-UHFFFAOYSA-N","pvalue":6.74624345537998e-06,"ratio":1000000.0,"synonym_name":"valerophenone"},{"chebi_id":"5995","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UFCLZKMFXSILNL-PSEXTPKNSA-N","pvalue":7.11283923426793e-06,"ratio":1e-06,"synonym_name":"Isochlorogenic acid b"},{"chebi_id":"169518","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(Z)-icos-1-enoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"FAALIJRVOXTMQQ-SROFDFDDSA-N","pvalue":7.524835615912305e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"173784","direction":"up","inn_name":"","iupac_name":"heptadeca-8,11-dienal","metabolite_id":"JEBIMSVVDVTZIY-UHFFFAOYSA-N","pvalue":8.930430098804432e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"191178","direction":"up","inn_name":"goralatidum","iupac_name":"<em>N</em>-acetyl-<small>L</small>-seryl-<small>L</small>-\u03b1-aspartyl-<small>L</small>-lysyl-<small>L</small>-proline","metabolite_id":"HJDRXEQUFWLOGJ-AJNGGQMLSA-N","pvalue":2.819588365161865e-05,"ratio":1000000.0,"synonym_name":"acetyl-seryl-aspartyl-lysyl-proline"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BUIRDOGDCJQFDA-UHFFFAOYSA-N","pvalue":3.0728748197124286e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"186330","direction":"down","inn_name":"","iupac_name":"(2R,3S,6R)-2-(hydroxymethyl)-6-[(1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-[(4R)-2,6,6-trimethyl-4-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexen-1-yl]octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-yl]oxyoxane-3,4,5-triol","metabolite_id":"DHNSFMNURMJEQV-VPWOWJCISA-N","pvalue":3.609319402727791e-05,"ratio":1e-06,"synonym_name":""},{"chebi_id":"28909","direction":"up","inn_name":"","iupac_name":"3-(3,5-dichlorophenyl)-2,4-dioxo-<em>N</em>-(propan-2-yl)-imidazolidine-1-carboxamide","metabolite_id":"ONUFESLQCSAYKA-UHFFFAOYSA-N","pvalue":6.716237353393598e-05,"ratio":1000000.0,"synonym_name":"3-(3,5-dichlorophenyl)-<em>N</em>-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide"},{"chebi_id":"33111","direction":"down","inn_name":"","iupac_name":"2,2,4,4,6,6-hexakis(aziridin-1-yl)-1,3,5,2\u03bb<small><sup>5</small></sup>,4\u03bb<small><sup>5</small></sup>,6\u03bb<small><sup>5</small></sup>-triazatriphosphinine","metabolite_id":"PXZAWHSJYIECNQ-UHFFFAOYSA-N","pvalue":9.148977603870714e-05,"ratio":1e-06,"synonym_name":"2,2,4,4,6,6-hexakis(1-aziridinyl)-2,2,4,4,6,6-hexahydro-1,3,5,2,4,6-triazatriphosphorine"}],"totalFeatures":3263},{"comparisonGroups":["Control","Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"ECa233 treatment vs control (hepatoprotective study)","group_a_title":"Control group with no treatment. Provides baseline data for comparison with treated samples.","group_b_title":"Treatment group receiving ECa233. Evaluates the potential hepatoprotective effects of ECa233.","id":"MTBLS522_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":15,"studyId":"MTBLS522","studyUrl":"http://integmet.org/study/MTBLS522","title":"Control_vs_Treatment","topHits":[{"chebi_id":"46961","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>,4<i>R</i>)-2-aminooctadecane-1,3,4-triol","metabolite_id":"AERBNCYCJBRYDG-KSZLIROESA-N","pvalue":0.0007467200497793,"ratio":0.0428739938668021,"synonym_name":"4-D-Hydroxysphinganine"},{"chebi_id":"28281","direction":"down","inn_name":"","iupac_name":"2-(5-methoxy-1<em>H</em>-indol-3-yl)acetic acid","metabolite_id":"COCNDHOPIHDTHK-UHFFFAOYSA-N","pvalue":0.0002915448896647,"ratio":0.3287057061757728,"synonym_name":"2-(5-methoxyindole-3-yl)acetic acid"},{"chebi_id":"15611","direction":"down","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0151052661762816,"ratio":0.2828546203675467,"synonym_name":"L-sarcosine"},{"chebi_id":"17596","direction":"down","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0080906189528362,"ratio":0.3441617481795549,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"17151","direction":"up","inn_name":"","iupac_name":"<i>meso</i>-xylitol","metabolite_id":"HEBKCHPVOIAQTA-SCDXWVJYSA-N","pvalue":0.0231534761043541,"ratio":3.8448881513727855,"synonym_name":"Xylit"},{"chebi_id":"35235","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-ammonio-3-sulfanylpropanoate","metabolite_id":"XUJNEKJLAYXESH-REOHCLBHSA-N","pvalue":0.0043753594832671,"ratio":0.3991339751856683,"synonym_name":"<small>L</small>-cysteine zwitterion"},{"chebi_id":"64558","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-4-(methylsulfanyl)butanoate","metabolite_id":"FFEARJCKVFRZRR-UHFFFAOYSA-N","pvalue":0.0100105415175429,"ratio":0.3599884851746623,"synonym_name":"2-ammonio-4-(methylsulfanyl)butanoate"},{"chebi_id":"26271","direction":"down","inn_name":"","iupac_name":"proline","metabolite_id":"ONIBWKKTOPOVIA-UHFFFAOYSA-N","pvalue":0.0132623295278901,"ratio":0.347093567128444,"synonym_name":"DL-Proline"},{"chebi_id":"36405","direction":"down","inn_name":"","iupac_name":"2-aminohexanoic acid","metabolite_id":"LRQKBLKVPFOOQJ-UHFFFAOYSA-N","pvalue":0.0165500023735892,"ratio":0.4139784880477035,"synonym_name":"norleucine"},{"chebi_id":"27266","direction":"down","inn_name":"","iupac_name":"valine","metabolite_id":"KZSNJWFQEVHDMF-UHFFFAOYSA-N","pvalue":0.0171625934882338,"ratio":0.4285545074158629,"synonym_name":"2-amino-3-methylbutanoic acid"}],"totalFeatures":63},{"comparisonGroups":["Healthy","RAS4"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs rheumatoid arthritis stage 4","group_a_title":"Samples from healthy individuals.. Serves as the reference group for comparing with diseased states.","group_b_title":"Samples from individuals with rheumatoid arthritis stage 4.. Represents the final stage of RA for comparison with other stages.","id":"MTBLS5297_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":20,"studyId":"MTBLS5297","studyUrl":"http://integmet.org/study/MTBLS5297","title":"Healthy_vs_RAS4","topHits":[{"chebi_id":"17505","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactosyl-(1\u21923)-1<small>D</small>-<em>myo</em>-inositol","metabolite_id":"VCWMRQDBPZKXKG-DXNLKLAMSA-N","pvalue":8.780873269077566e-05,"ratio":0.0066730057769118,"synonym_name":"3-O-alpha-D-Galactosyl-1D-myo-inositol"},{"chebi_id":"36274","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(3\u03b1,7\u03b1-dihydroxy-5\u03b2-cholan-24-oyl)glycine","metabolite_id":"GHCZAUBVMUEKKP-GYPHWSFCSA-N","pvalue":0.0021792044470569,"ratio":5.139846282715473,"synonym_name":"glycine chenodeoxycholate"},{"chebi_id":"27891","direction":"down","inn_name":"","iupac_name":"3-(sulfosulfanyl)-<small>L</small>-alanine","metabolite_id":"NOKPBJYHPHHWAN-REOHCLBHSA-N","pvalue":1.6938385258650244e-05,"ratio":0.4241544018312539,"synonym_name":"S-Sulfo-L-cysteine"},{"chebi_id":"28816","direction":"up","inn_name":"","iupac_name":"2-deoxy-<small>D</small>-<i>erythro</i>-pentose","metabolite_id":"ASJSAQIRZKANQN-CRCLSJGQSA-N","pvalue":3.743226194348778e-06,"ratio":1.9079405532608804,"synonym_name":"Thyminose"},{"chebi_id":"29069","direction":"up","inn_name":"","iupac_name":"benzene-1,2-dicarboxylic acid","metabolite_id":"XNGIFLGASWRNHJ-UHFFFAOYSA-N","pvalue":0.0027264232607855,"ratio":3.300561942869746,"synonym_name":"Phthalic acid"},{"chebi_id":"30805","direction":"down","inn_name":"","iupac_name":"dodecanoic acid","metabolite_id":"POULHZVOKOAJMA-UHFFFAOYSA-N","pvalue":0.001337911761998,"ratio":0.4513586661959722,"synonym_name":"Dodecanoic acid"},{"chebi_id":"16525","direction":"up","inn_name":"","iupac_name":"2-[(3\u03b1,7\u03b1-dihydroxy-24-oxo-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"BHTRKEVKTKCXOH-BJLOMENOSA-N","pvalue":0.0020958465511555,"ratio":2.2624454733679076,"synonym_name":"taurochenodeoxycholic acid"},{"chebi_id":"28866","direction":"up","inn_name":"","iupac_name":"tetracosanoic acid","metabolite_id":"QZZGJDVWLFXDLK-UHFFFAOYSA-N","pvalue":0.0114622669902513,"ratio":2.547936930002566,"synonym_name":"CH<small><sub>3</sub></small>\u2012[CH<small><sub>2</sub></small>]<small><sub>22</sub></small>\u2012COOH"},{"chebi_id":"17600","direction":"down","inn_name":"","iupac_name":"hexadecanal","metabolite_id":"NIOYUNMRJMEDGI-UHFFFAOYSA-N","pvalue":0.0006236778877983,"ratio":0.6000854020623807,"synonym_name":"<em>n</em>-hexadecanal"},{"chebi_id":"18183","direction":"down","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0009621745483213,"ratio":0.6055542880145159,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"}],"totalFeatures":133},{"comparisonGroups":["Healthy","RAS4"],"dateCreated":"2025-09-26 00:00:00","display_title":"Healthy vs rheumatoid arthritis stage 4","group_a_title":"Samples from healthy individuals.. Serves as the reference group for comparing with diseased states.","group_b_title":"Samples from individuals with rheumatoid arthritis stage 4.. Represents the final stage of RA for comparison with other stages.","id":"MTBLS5297_0002_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":35,"studyId":"MTBLS5297","studyUrl":"http://integmet.org/study/MTBLS5297","title":"Healthy_vs_RAS4","topHits":[{"chebi_id":"53451","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-mannopyranosyl-(1\u21923)-<small>D</small>-mannopyranose","metabolite_id":"QIGJYVCQYDKYDW-VXSGSMIHSA-N","pvalue":4.327776701295653e-05,"ratio":0.0072440472968626,"synonym_name":"3-<em>O</em>-\u03b1-<small>D</small>-mannopyranosyl-<small>D</small>-mannopyranose"},{"chebi_id":"16269","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JLTDJTHDQAWBAV-UHFFFAOYSA-N","pvalue":4.68256317820534e-10,"ratio":2.3113306376462397,"synonym_name":"Dimethylaniline"},{"chebi_id":"73801","direction":"down","inn_name":"","iupac_name":"glycyl-<small>L</small>-glutamic acid","metabolite_id":"IEFJWDNGDZAYNZ-BYPYZUCNSA-N","pvalue":0.0003795935901173,"ratio":0.2111245313870359,"synonym_name":"GE"},{"chebi_id":"15710","direction":"up","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-oxoethanaminium","metabolite_id":"SXKNCCSPZDCRFD-UHFFFAOYSA-N","pvalue":4.567855767214122e-05,"ratio":3.2016846498791867,"synonym_name":"BETAINE ALDEHYDE"},{"chebi_id":"29750","direction":"up","inn_name":"","iupac_name":"3-(1<em>H</em>-indol-3-yl)-2-oxopropanoic acid","metabolite_id":"RSTKLPZEZYGQPY-UHFFFAOYSA-N","pvalue":1.8851057269799985e-07,"ratio":2.1127793770913184,"synonym_name":"Indolepyruvic acid"},{"chebi_id":"18019","direction":"up","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0002307353808275,"ratio":3.6806800099827015,"synonym_name":"L-Lysine"},{"chebi_id":"74807","direction":"up","inn_name":"","iupac_name":"<small>L</small>-seryl-<small>L</small>-aspartic acid","metabolite_id":"VBKBDLMWICBSCY-IMJSIDKUSA-N","pvalue":6.847246225042143e-07,"ratio":2.0019938983711496,"synonym_name":"Serinyl-Aspartate"},{"chebi_id":"42682","direction":"down","inn_name":"","iupac_name":"3-aminobenzoic acid","metabolite_id":"XFDUHJPVQKIXHO-UHFFFAOYSA-N","pvalue":1.5812849317690135e-05,"ratio":0.4793241072507343,"synonym_name":"<em>m</em>-carboxyaniline"},{"chebi_id":"17164","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-galactopyranosyl-(1\u21926)-\u03b1-<small>D</small>-glucopyranoside","metabolite_id":"UQZIYBXSHAGNOE-XNSRJBNMSA-N","pvalue":0.0018487253110219,"ratio":0.3343498928553211,"synonym_name":"Stachyose"},{"chebi_id":"74795","direction":"up","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-phenylalanine","metabolite_id":"IWIANZLCJVYEFX-RYUDHWBXSA-N","pvalue":0.0001126305947356,"ratio":1.941739590576525,"synonym_name":"PF"}],"totalFeatures":163},{"comparisonGroups":["Control","ABA"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs abscisic acid hormone treatment","group_a_title":"Control group with no hormone treatment. Provides baseline for comparison with hormone-treated groups","group_b_title":"Group treated with abscisic acid. Allows assessment of abscisic acid effects","id":"MTBLS531_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS531","studyUrl":"http://integmet.org/study/MTBLS531","title":"Control_vs_ABA","topHits":[{"chebi_id":"142247","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GMMBTTCHJJMJKQ-UHFFFAOYSA-N","pvalue":1.1587887322886709e-11,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"133395","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZMOZJTDOTOZVRT-DODNOZFWSA-N","pvalue":8.635217343155595e-10,"ratio":1e-06,"synonym_name":"6''-O-Acetyldaidzin"},{"chebi_id":"142249","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DXWGBJJLEDQBKS-UHFFFAOYSA-N","pvalue":2.5052802919600926e-08,"ratio":1e-06,"synonym_name":""},{"chebi_id":"142267","direction":"down","inn_name":"","iupac_name":"methyl 2-(methylamino)benzoate","metabolite_id":"GVOWHGSUZUUUDR-UHFFFAOYSA-N","pvalue":2.73104836474324e-08,"ratio":1e-06,"synonym_name":"methyl methylaminobenzoate"},{"chebi_id":"57912","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":0.0240355758921099,"ratio":1e-06,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"142265","direction":"down","inn_name":"","iupac_name":"3,9-dihydroxy-10-(3-methylbut-2-en-1-yl)-6<em>H</em>-[1]benzofuro[3,2-<em>c</em>]chromen-6-one","metabolite_id":"MQKLGUOASGICKG-UHFFFAOYSA-N","pvalue":0.0026522725224826,"ratio":0.1688152240638428,"synonym_name":"3,9-dihydroxy-10-prenylcoumestan"},{"chebi_id":"142241","direction":"up","inn_name":"","iupac_name":"(3<i>E</i>)-hexadec-3-enoic acid","metabolite_id":"PCBKWKNYISJGPJ-BUHFOSPRSA-N","pvalue":0.0440166227000466,"ratio":1.849416755037116,"synonym_name":"(3<i>E</i>)-3-Hexadecens\u00e4ure"}],"totalFeatures":65},{"comparisonGroups":["MCF-7_WT","MCF-7_PKM2_KO"],"dateCreated":"2025-09-26 00:00:00","display_title":"MCF-7 cells: PKM2 knockout vs wild-type","group_a_title":"Wild-type MCF-7 cells. Serves as a reference for comparing genetic modifications in MCF-7 cells.","group_b_title":"MCF-7 cells with PKM2 knockout. Helps in understanding the role of PKM2 in MCF-7 cells.","id":"MTBLS533_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":144,"studyId":"MTBLS533","studyUrl":"http://integmet.org/study/MTBLS533","title":"MCF-7_WT_vs_MCF-7_PKM2_KO","topHits":[{"chebi_id":"18406","direction":"up","inn_name":"","iupac_name":"5-amino-1-(5-<em>O</em>-phosphono-\u03b2-<small>D</small>-ribofuranosyl)-1<em>H</em>-imidazole-4-carboxamide","metabolite_id":"NOTGFIUVDGNKRI-UUOKFMHZSA-N","pvalue":5.2485120121670355e-06,"ratio":112.10013071805017,"synonym_name":"Aica ribonucleotide"},{"chebi_id":"17768","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(4-aminobutyl)acetamide","metabolite_id":"KLZGKIDSEJWEDW-UHFFFAOYSA-N","pvalue":1.224607466001932e-07,"ratio":12.41854131806235,"synonym_name":"N-Acetylputrescine"},{"chebi_id":"24344","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":9.58876972751489e-07,"ratio":0.0873410955837947,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"82968","direction":"up","inn_name":"","iupac_name":"\u03b3-glutamylthreonine","metabolite_id":"GWNXFCYUJXASDX-UHFFFAOYSA-N","pvalue":1.0475995754514521e-07,"ratio":7.334691943410256,"synonym_name":"\u03b3-Glu-Thr"},{"chebi_id":"18145","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,5,7,8-tetramethyl-2-[(4<i>R</i>,8<i>R</i>)-4,8,12-trimethyltridecyl]-3,4-dihydro-2<em>H</em>-chromen-6-ol","metabolite_id":"GVJHHUAWPYXKBD-IEOSBIPESA-N","pvalue":5.242014913592939e-07,"ratio":0.1144059672047352,"synonym_name":"<i>R</i><i>R</i><i>R</i>-\u03b1-tocopherol"},{"chebi_id":"17050","direction":"down","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":5.4417441537311465e-06,"ratio":0.0784222074265365,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"84058","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":2.6496864513209492e-08,"ratio":5.156250010631266,"synonym_name":""},{"chebi_id":"17148","direction":"up","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":3.674524225890033e-09,"ratio":4.0264600052674435,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"33198","direction":"up","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":2.979555040756065e-07,"ratio":4.6414767851084235,"synonym_name":"Hexonic acid"},{"chebi_id":"68848","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(1<i>S</i>)-1-carboxy-2-methylpropyl]amino}-5-oxopentanoic acid","metabolite_id":"AQAKHZVPOOGUCK-XPUUQOCRSA-N","pvalue":2.135178312226334e-07,"ratio":4.155450437167307,"synonym_name":"gamma-Glutamylvaline"}],"totalFeatures":351},{"comparisonGroups":["Control_0d","Treatment_180d"],"dateCreated":"2025-09-26 00:00:00","display_title":"Treatment effects: baseline vs 180-day intervention","group_a_title":"Baseline control group at day 0. Provides baseline data for comparison with samples collected at later time points.","group_b_title":"Treatment group at day 180. Captures the long-term effects of the intervention for comparison with baseline data.","id":"MTBLS5335_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":218,"studyId":"MTBLS5335","studyUrl":"http://integmet.org/study/MTBLS5335","title":"Control_0d_vs_Treatment_180d","topHits":[{"chebi_id":"173182","direction":"up","inn_name":"","iupac_name":"2-[4,5-dihydroxy-6-(hydroxymethyl)-2-(2,4,5-trihydroxyoxan-3-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol","metabolite_id":"DPTWUYFOEZBIEX-UHFFFAOYSA-N","pvalue":0.0047361056544315,"ratio":996.2517820276832,"synonym_name":""},{"chebi_id":"173854","direction":"up","inn_name":"","iupac_name":"1-methyl-2,3-dihydroindole-3,5,6-triol","metabolite_id":"ADHYBIYGSXQYDM-UHFFFAOYSA-N","pvalue":5.807273008883777e-06,"ratio":19.024777376486465,"synonym_name":""},{"chebi_id":"135654","direction":"down","inn_name":"imidaprilum","iupac_name":"(4<i>S</i>)-3-{<em>N</em>-[(2<i>S</i>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-<small>L</small>-alanyl}-1-methyl-2-oxoimidazolidine-4-carboxylic acid","metabolite_id":"KLZWOWYOHUKJIG-BPUTZDHNSA-N","pvalue":0.0029713469808978,"ratio":0.0026236366862064,"synonym_name":"(<i>S</i>)-3-(<em>N</em>-((<i>S</i>)-1-Ethoxycarbonyl-3-phenylpropyl)-<small>L</small>-alanyl)-1-methyl-2-oxoimidazoline-4-carboxylic acid"},{"chebi_id":"22526","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid","metabolite_id":"TVZGACDUOSZQKY-LBPRGKRZSA-N","pvalue":0.0005093103457198,"ratio":85.23589911762205,"synonym_name":"4-amino-PGA"},{"chebi_id":"79325","direction":"up","inn_name":"","iupac_name":"1-S-[(1<i>Z</i>)-5-(methylsulfanyl)-<em>N</em>-(sulfooxy)pentanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"GKUMMDFLKGFCKH-AHMUMSBHSA-N","pvalue":0.0005063336806538,"ratio":44.62128863107013,"synonym_name":"4-Methylthiobutyl glucosinolate"},{"chebi_id":"177738","direction":"down","inn_name":"","iupac_name":"10-chloroheptadec-1-en-4,6-diyne-3,9-diol","metabolite_id":"PBNFQEYKZLUTLH-UHFFFAOYSA-N","pvalue":0.001273338562427,"ratio":0.0179778154323612,"synonym_name":""},{"chebi_id":"172591","direction":"up","inn_name":"","iupac_name":"(2E)-2-[2,4-dihydroxy-3-methoxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexylidene]acetonitrile","metabolite_id":"SDYUFOBSNZFKRM-KXFIGUGUSA-N","pvalue":1.3606037852151438e-05,"ratio":9.189103699022896,"synonym_name":""},{"chebi_id":"189976","direction":"down","inn_name":"","iupac_name":"2-[[3-hydroxy-17-(3-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-16-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl]oxy]-6-methyloxane-3,4,5-triol","metabolite_id":"UFOUZKFFEDCDRA-UHFFFAOYSA-N","pvalue":0.0188361703977524,"ratio":0.002353005674135,"synonym_name":""},{"chebi_id":"168830","direction":"up","inn_name":"","iupac_name":"2-amino-5-[(5-hydroxy-4,6-dimethylpyrimidin-2-yl)amino]pentanoic acid","metabolite_id":"DCPBQSFZQHFSMR-UHFFFAOYSA-N","pvalue":0.0007494798990568,"ratio":25.03058638745706,"synonym_name":""},{"chebi_id":"168221","direction":"down","inn_name":"","iupac_name":"2-[3,4-dihydroxy-4-[(E)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"SGUOENJPMRQEMJ-AATRIKPKSA-N","pvalue":0.0008782373314411,"ratio":0.0379840393685362,"synonym_name":""}],"totalFeatures":1155},{"comparisonGroups":["Control_0d","Treatment_180d"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline control vs 180-day treatment comparison","group_a_title":"Baseline control group at day 0. Provides baseline data for comparison with samples collected at later time points.","group_b_title":"Treatment group at day 180. Captures the long-term effects of the intervention for comparison with baseline data.","id":"MTBLS5335_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":417,"studyId":"MTBLS5335","studyUrl":"http://integmet.org/study/MTBLS5335","title":"Control_0d_vs_Treatment_180d","topHits":[{"chebi_id":"180271","direction":"up","inn_name":"","iupac_name":"oxacyclohenicosan-2-one","metabolite_id":"XNVIXRMFBUDCLP-UHFFFAOYSA-N","pvalue":0.0108905093883309,"ratio":117576503781.62048,"synonym_name":""},{"chebi_id":"145277","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DSOWUEHXZJUNID-WHXUGTBJSA-N","pvalue":4.994624087115437e-07,"ratio":32.093361366949765,"synonym_name":"LysoPE 16:1(9Z)/0:0"},{"chebi_id":"193526","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OOBIPIXEFDBKDI-HWKANZROSA-N","pvalue":3.1864076078210765e-08,"ratio":10.027457029580054,"synonym_name":""},{"chebi_id":"186625","direction":"up","inn_name":"","iupac_name":"N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide","metabolite_id":"DDSIZVYRTNDIJL-UHFFFAOYSA-N","pvalue":6.924548065665668e-09,"ratio":8.086750358480067,"synonym_name":""},{"chebi_id":"137783","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"NDDJIMSGSZNACM-QWRGUYRKSA-N","pvalue":1.2776279152007644e-08,"ratio":7.659064058402317,"synonym_name":"N-(3S-hydroxydecanoyl)-L-serine"},{"chebi_id":"193224","direction":"up","inn_name":"","iupac_name":"(3S,8S,9S,10R,13S,14S,16R,17R)-10,13-dimethyl-17-[(1S)-1-[(2S,5S)-5-methylpiperidin-2-yl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol","metabolite_id":"IRRHFODGOMSPEE-IXCDTRSDSA-N","pvalue":0.0010724094698364,"ratio":98.08219665834037,"synonym_name":""},{"chebi_id":"196315","direction":"up","inn_name":"","iupac_name":"2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl]propan-2-yl acetate","metabolite_id":"AWMHMGFGCLBSAY-UHFFFAOYSA-N","pvalue":1.116865730508665e-09,"ratio":4.531302729445329,"synonym_name":""},{"chebi_id":"83051","direction":"up","inn_name":"","iupac_name":"(10<i>Z</i>)-nonadec-10-enoic acid","metabolite_id":"BBOWBNGUEWHNQZ-KTKRTIGZSA-N","pvalue":0.0039411610197557,"ratio":255.0006283045716,"synonym_name":""},{"chebi_id":"27387","direction":"up","inn_name":"","iupac_name":"Gal(a1-6)Gal(a1-6)Glc","metabolite_id":"FBJQEBRMDXPWNX-SMGIPPFUSA-N","pvalue":0.0051219895126217,"ratio":314.7822274520306,"synonym_name":"Manninotriose"},{"chebi_id":"84299","direction":"up","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl phosphate","metabolite_id":"RPXHXZNGZBHSMJ-GOSISDBHSA-N","pvalue":1.9751673808270923e-05,"ratio":15.344988160659495,"synonym_name":"1-tetradecanoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"}],"totalFeatures":1739},{"comparisonGroups":["Control_0d","Treatment_180d"],"dateCreated":"2025-09-26 00:00:00","display_title":"Treatment response: baseline vs 180-day intervention","group_a_title":"Baseline control group at day 0. Provides baseline data for comparison with samples collected at later time points.","group_b_title":"Treatment group at day 180. Captures the long-term effects of the intervention for comparison with baseline data.","id":"MTBLS5335_0003_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":218,"studyId":"MTBLS5335","studyUrl":"http://integmet.org/study/MTBLS5335","title":"Control_0d_vs_Treatment_180d","topHits":[{"chebi_id":"173182","direction":"up","inn_name":"","iupac_name":"2-[4,5-dihydroxy-6-(hydroxymethyl)-2-(2,4,5-trihydroxyoxan-3-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol","metabolite_id":"DPTWUYFOEZBIEX-UHFFFAOYSA-N","pvalue":0.0047361056544315,"ratio":996.2517820276832,"synonym_name":""},{"chebi_id":"173854","direction":"up","inn_name":"","iupac_name":"1-methyl-2,3-dihydroindole-3,5,6-triol","metabolite_id":"ADHYBIYGSXQYDM-UHFFFAOYSA-N","pvalue":5.807273008883777e-06,"ratio":19.024777376486465,"synonym_name":""},{"chebi_id":"135654","direction":"down","inn_name":"imidaprilum","iupac_name":"(4<i>S</i>)-3-{<em>N</em>-[(2<i>S</i>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-<small>L</small>-alanyl}-1-methyl-2-oxoimidazolidine-4-carboxylic acid","metabolite_id":"KLZWOWYOHUKJIG-BPUTZDHNSA-N","pvalue":0.0029713469808978,"ratio":0.0026236366862064,"synonym_name":"(<i>S</i>)-3-(<em>N</em>-((<i>S</i>)-1-Ethoxycarbonyl-3-phenylpropyl)-<small>L</small>-alanyl)-1-methyl-2-oxoimidazoline-4-carboxylic acid"},{"chebi_id":"22526","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid","metabolite_id":"TVZGACDUOSZQKY-LBPRGKRZSA-N","pvalue":0.0005093103457198,"ratio":85.23589911762205,"synonym_name":"4-amino-PGA"},{"chebi_id":"79325","direction":"up","inn_name":"","iupac_name":"1-S-[(1<i>Z</i>)-5-(methylsulfanyl)-<em>N</em>-(sulfooxy)pentanimidoyl]-1-thio-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"GKUMMDFLKGFCKH-AHMUMSBHSA-N","pvalue":0.0005063336806538,"ratio":44.62128863107013,"synonym_name":"4-Methylthiobutyl glucosinolate"},{"chebi_id":"177738","direction":"down","inn_name":"","iupac_name":"10-chloroheptadec-1-en-4,6-diyne-3,9-diol","metabolite_id":"PBNFQEYKZLUTLH-UHFFFAOYSA-N","pvalue":0.001273338562427,"ratio":0.0179778154323612,"synonym_name":""},{"chebi_id":"172591","direction":"up","inn_name":"","iupac_name":"(2E)-2-[2,4-dihydroxy-3-methoxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexylidene]acetonitrile","metabolite_id":"SDYUFOBSNZFKRM-KXFIGUGUSA-N","pvalue":1.3606037852151438e-05,"ratio":9.189103699022896,"synonym_name":""},{"chebi_id":"189976","direction":"down","inn_name":"","iupac_name":"2-[[3-hydroxy-17-(3-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-16-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl]oxy]-6-methyloxane-3,4,5-triol","metabolite_id":"UFOUZKFFEDCDRA-UHFFFAOYSA-N","pvalue":0.0188361703977524,"ratio":0.002353005674135,"synonym_name":""},{"chebi_id":"168830","direction":"up","inn_name":"","iupac_name":"2-amino-5-[(5-hydroxy-4,6-dimethylpyrimidin-2-yl)amino]pentanoic acid","metabolite_id":"DCPBQSFZQHFSMR-UHFFFAOYSA-N","pvalue":0.0007494798990568,"ratio":25.03058638745706,"synonym_name":""},{"chebi_id":"168221","direction":"down","inn_name":"","iupac_name":"2-[3,4-dihydroxy-4-[(E)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"SGUOENJPMRQEMJ-AATRIKPKSA-N","pvalue":0.0008782373314411,"ratio":0.0379840393685362,"synonym_name":""}],"totalFeatures":1155},{"comparisonGroups":["Control","150mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Salt stress: 0mM control vs 150mM treatment","group_a_title":"Control group with 0 millimolar salt concentration.. Provides baseline for comparison with treated samples.","group_b_title":"Group with 150 millimolar salt concentration.. Allows assessment of maximum salt stress effects.","id":"MTBLS54_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":39,"studyId":"MTBLS54","studyUrl":"http://integmet.org/study/MTBLS54","title":"Control_vs_150mM","topHits":[{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":4.5238659316516576e-10,"ratio":0.0189772236119389,"synonym_name":""},{"chebi_id":"18266","direction":"down","inn_name":"","iupac_name":"1<small>D</small>-4-<em>O</em>-methyl-<em>myo</em>-inositol","metabolite_id":"DSCFFEYYQKSRSV-GESKJZQWSA-N","pvalue":3.9430150674944993e-13,"ratio":0.178282023394423,"synonym_name":"1D-4-O-Methyl-myo-inositol"},{"chebi_id":"30794","direction":"up","inn_name":"","iupac_name":"propanedioic acid","metabolite_id":"OFOBLEOULBTSOW-UHFFFAOYSA-N","pvalue":3.96367773362314e-06,"ratio":22.512797045288185,"synonym_name":"Propanedioic acid"},{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":7.902147829361848e-08,"ratio":7.007744589329979,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"26078","direction":"up","inn_name":"","iupac_name":"trihydrogen tetraoxophosphate(3\u2212)","metabolite_id":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","pvalue":3.001939361035385e-08,"ratio":5.814762290039787,"synonym_name":"phosphoric acid"},{"chebi_id":"18300","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UPHRSURJSA-N","pvalue":5.551420402838066e-07,"ratio":8.115606018610587,"synonym_name":"Maleic acid"},{"chebi_id":"42717","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranuronic acid","metabolite_id":"AEMOLEFTQBMNLQ-WAXACMCWSA-N","pvalue":3.531705484812019e-05,"ratio":0.074251530788317,"synonym_name":"D-GLUCURONIC ACID"},{"chebi_id":"61185","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-piperidinium-2-carboxylate","metabolite_id":"HXEACLLIILLPRG-YFKPBYRVSA-N","pvalue":7.393675586286474e-08,"ratio":0.1974604035892169,"synonym_name":"(<i>S</i>)-2-carboxypiperidinium betaine"},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":4.792522440342958e-05,"ratio":13.88869124850796,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"340824","direction":"up","inn_name":"","iupac_name":"methyl dihydrogen phosphate","metabolite_id":"CAAULPUQFIIOTL-UHFFFAOYSA-N","pvalue":1.2877410790640587e-05,"ratio":6.8345386165668325,"synonym_name":"monomethyl phosphate"}],"totalFeatures":97},{"comparisonGroups":["Normal_Diet","High-fat_Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse gut: normal diet vs high-fat diet","group_a_title":"Mice fed with a normal diet.. Provides baseline data for comparison with high-fat diet samples.","group_b_title":"Mice fed with a high-fat diet.. Allows for the assessment of the impact of a high-fat diet on gut microbiota and bile acid metabolism.","id":"MTBLS545_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS545","studyUrl":"http://integmet.org/study/MTBLS545","title":"Normal_Diet_vs_High-fat_Diet","topHits":[{"chebi_id":"15611","direction":"up","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0237944280792536,"ratio":2.738067744418784,"synonym_name":"L-sarcosine"},{"chebi_id":"16217","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one","metabolite_id":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","pvalue":0.0408495887288133,"ratio":0.336082159355553,"synonym_name":"<small>D</small>-gluconic acid lactone"},{"chebi_id":"13172","direction":"down","inn_name":"","iupac_name":"<em>keto</em>-<small>L</small>-sorbose","metabolite_id":"BJHIKXHVCXFQLS-OTWZMJIISA-N","pvalue":0.0233782048870268,"ratio":0.4124766570382858,"synonym_name":"(3<i>S</i>,4<i>R</i>,5<i>S</i>)-1,3,4,5,6-pentahydroxyhexan-2-one"},{"chebi_id":"18403","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-IMJSIDKUSA-N","pvalue":0.0281867876635673,"ratio":0.4976421636615812,"synonym_name":"L-lyxitol"},{"chebi_id":"36219","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-XLOQQCSPSA-N","pvalue":0.0310702540527316,"ratio":0.4981628540950574,"synonym_name":"LACTOSE"},{"chebi_id":"30887","direction":"down","inn_name":"","iupac_name":"1-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"ODBLHEXUDAPZAU-UHFFFAOYSA-N","pvalue":0.0386557493545183,"ratio":0.6006655574043261,"synonym_name":"Isocitric acid"}],"totalFeatures":145},{"comparisonGroups":["Normal_Diet","High-fat_Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: normal diet vs high-fat diet","group_a_title":"Mice fed with a normal diet.. Provides baseline data for comparison with high-fat diet samples.","group_b_title":"Mice fed with a high-fat diet.. Allows for the assessment of the impact of a high-fat diet on gut microbiota and bile acid metabolism.","id":"MTBLS545_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS545","studyUrl":"http://integmet.org/study/MTBLS545","title":"Normal_Diet_vs_High-fat_Diet","topHits":[{"chebi_id":"15611","direction":"up","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0237944280792536,"ratio":2.738067744418784,"synonym_name":"L-sarcosine"},{"chebi_id":"16217","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one","metabolite_id":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","pvalue":0.0408495887288133,"ratio":0.336082159355553,"synonym_name":"<small>D</small>-gluconic acid lactone"},{"chebi_id":"10295","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>L</small>-sorbopyranose","metabolite_id":"LKDRXBCSQODPBY-BGPJRJDNSA-N","pvalue":0.0233782048870268,"ratio":0.4124766570382858,"synonym_name":"alpha-L-Sorbopyranose"},{"chebi_id":"18403","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-IMJSIDKUSA-N","pvalue":0.0281867876635673,"ratio":0.4976421636615812,"synonym_name":"L-lyxitol"},{"chebi_id":"36219","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-XLOQQCSPSA-N","pvalue":0.0310702540527316,"ratio":0.4981628540950574,"synonym_name":"LACTOSE"},{"chebi_id":"30887","direction":"down","inn_name":"","iupac_name":"1-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"ODBLHEXUDAPZAU-UHFFFAOYSA-N","pvalue":0.0386557493545183,"ratio":0.6006655574043261,"synonym_name":"Isocitric acid"}],"totalFeatures":138},{"comparisonGroups":["Normal_Diet","High-fat_Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse gut: normal diet vs high-fat diet","group_a_title":"Mice fed with a normal diet.. Provides baseline data for comparison with high-fat diet samples.","group_b_title":"Mice fed with a high-fat diet.. Allows for the assessment of the impact of a high-fat diet on gut microbiota and bile acid metabolism.","id":"MTBLS545_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS545","studyUrl":"http://integmet.org/study/MTBLS545","title":"Normal_Diet_vs_High-fat_Diet","topHits":[{"chebi_id":"15611","direction":"up","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0237944280792536,"ratio":2.738067744418784,"synonym_name":"L-sarcosine"},{"chebi_id":"16217","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one","metabolite_id":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","pvalue":0.0408495887288133,"ratio":0.336082159355553,"synonym_name":"<small>D</small>-gluconic acid lactone"},{"chebi_id":"10295","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>L</small>-sorbopyranose","metabolite_id":"LKDRXBCSQODPBY-BGPJRJDNSA-N","pvalue":0.0233782048870268,"ratio":0.4124766570382858,"synonym_name":"alpha-L-Sorbopyranose"},{"chebi_id":"18403","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arabinitol","metabolite_id":"HEBKCHPVOIAQTA-IMJSIDKUSA-N","pvalue":0.0281867876635673,"ratio":0.4976421636615812,"synonym_name":"L-lyxitol"},{"chebi_id":"36219","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-\u03b1-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-XLOQQCSPSA-N","pvalue":0.0310702540527316,"ratio":0.4981628540950574,"synonym_name":"LACTOSE"},{"chebi_id":"30887","direction":"down","inn_name":"","iupac_name":"1-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"ODBLHEXUDAPZAU-UHFFFAOYSA-N","pvalue":0.0386557493545183,"ratio":0.6006655574043261,"synonym_name":"Isocitric acid"}],"totalFeatures":138},{"comparisonGroups":["Normal Diet","High-fat Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice: normal diet vs high-fat diet (56 days)","group_a_title":"Mice fed with a normal diet for 56 days.. Serves as the reference group to assess the impact of high-fat diet on gut microbiota and bile acid metabolism.","group_b_title":"Mice fed with a high-fat diet for 56 days.. Key group for understanding the effects of high-fat diet on gut microbiota and bile acid metabolism.","id":"MTBLS546_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS546","studyUrl":"http://integmet.org/study/MTBLS546","title":"Normal_Diet_vs_High-fat_Diet","topHits":[],"totalFeatures":3},{"comparisonGroups":["Normal Diet","High-fat Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice gut: normal diet vs high-fat diet (56 days)","group_a_title":"Mice fed with a normal diet for 56 days.. Serves as the reference group to assess the impact of high-fat diet on gut microbiota and bile acid metabolism.","group_b_title":"Mice fed with a high-fat diet for 56 days.. Key group for understanding the effects of high-fat diet on gut microbiota and bile acid metabolism.","id":"MTBLS546_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS546","studyUrl":"http://integmet.org/study/MTBLS546","title":"Normal_Diet_vs_High-fat_Diet","topHits":[],"totalFeatures":3},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Prochlorococcus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":85,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"16160","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-4-(3-carboxypropanoyloxy)butanoic acid","metabolite_id":"GNISQJGXJIDKDJ-YFKPBYRVSA-N","pvalue":0.0001341991034271,"ratio":0.0051139150751208,"synonym_name":"O-succinyl-L-homoserine"},{"chebi_id":"73004","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate","metabolite_id":"YVYMBNSKXOXSKW-HXUWFJFHSA-N","pvalue":1.7911482669313916e-05,"ratio":0.0617047057985072,"synonym_name":"1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"52330","direction":"down","inn_name":"","iupac_name":"2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate","metabolite_id":"JZNWSCPGTDBMEW-UHFFFAOYSA-N","pvalue":0.0012495115372275,"ratio":0.0252685790374892,"synonym_name":"<em>sn</em>-Glycerol-3-phosphoethanolamine"},{"chebi_id":"16168","direction":"up","inn_name":"","iupac_name":"6-hydroxypyridine-3-carboxylic acid","metabolite_id":"BLHCMGRVFXRYRN-UHFFFAOYSA-N","pvalue":4.956985454152417e-05,"ratio":10.590965178671851,"synonym_name":"6-Hydroxynicotinic acid"},{"chebi_id":"17533","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidopentanedioic acid","metabolite_id":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","pvalue":0.0002003498000293,"ratio":0.0816332457172143,"synonym_name":"(S)-2-(acetylamino)pentanedioic acid"},{"chebi_id":"15903","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":6.48672196128248e-05,"ratio":8.398987236621869,"synonym_name":"beta-D-Glucose"},{"chebi_id":"58275","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-3-hydroxy-2-methylpropanoate","metabolite_id":"CDUUKBXTEOFITR-UHFFFAOYSA-N","pvalue":0.0004169669960294,"ratio":0.1257382475165238,"synonym_name":"2-ammonio-3-hydroxy-2-methylpropanoate"},{"chebi_id":"16666","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FPWMCUPFBRFMLH-UHFFFAOYSA-N","pvalue":0.0043279481104292,"ratio":0.057063902131862,"synonym_name":"PREPHENIC ACID"},{"chebi_id":"17992","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"CZMRCDWAGMRECN-UGDNZRGBSA-N","pvalue":0.0034025684209461,"ratio":14.903788727350346,"synonym_name":"1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside"},{"chebi_id":"7125","direction":"down","inn_name":"","iupac_name":"2-acetamido-2-deoxy-<small>D</small>-glucopyranose 1-(dihydrogen phosphate)","metabolite_id":"FZLJPEPAYPUMMR-RTRLPJTCSA-N","pvalue":0.0022502529870267,"ratio":0.0845965818901743,"synonym_name":"<em>N</em>-acetylglucosamine-1-phosphate"}],"totalFeatures":245},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"P. marinus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000050","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":66,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"52330","direction":"down","inn_name":"","iupac_name":"2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate","metabolite_id":"JZNWSCPGTDBMEW-UHFFFAOYSA-N","pvalue":0.0005398071930242,"ratio":0.0493076470461684,"synonym_name":"<em>sn</em>-Glycerol-3-phosphoethanolamine"},{"chebi_id":"16666","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FPWMCUPFBRFMLH-UHFFFAOYSA-N","pvalue":5.522035555928923e-05,"ratio":0.1214149100664086,"synonym_name":"PREPHENIC ACID"},{"chebi_id":"15351","direction":"down","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-(3-{(3<i>R</i>)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} dihydrogen diphosphate)","metabolite_id":"ZSLZBFCDCINBPY-ZSJPKINUSA-N","pvalue":0.0003195569793507,"ratio":0.0844410190426945,"synonym_name":"Acetyl-CoA"},{"chebi_id":"17533","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidopentanedioic acid","metabolite_id":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","pvalue":0.0013292502040636,"ratio":0.0515665695967195,"synonym_name":"(S)-2-(acetylamino)pentanedioic acid"},{"chebi_id":"32817","direction":"down","inn_name":"","iupac_name":"<em>keto</em>-3-deoxy-<small>D</small>-<i>manno</i>-oct-2-ulosonic acid","metabolite_id":"KYQCXUMVJGMDNG-SHUUEZRQSA-N","pvalue":8.097809045935981e-05,"ratio":0.1494112269611308,"synonym_name":"KDO"},{"chebi_id":"15356","direction":"down","inn_name":"","iupac_name":"cysteine","metabolite_id":"XUJNEKJLAYXESH-UHFFFAOYSA-N","pvalue":0.0025221795021165,"ratio":0.0669421215722398,"synonym_name":"Cystein"},{"chebi_id":"82965","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-methionine","metabolite_id":"RQNSKRXMANOPQY-BQBZGAKWSA-N","pvalue":5.221295325585681e-05,"ratio":0.2048670533806798,"synonym_name":""},{"chebi_id":"86564","direction":"up","inn_name":"","iupac_name":"4-carbamimidamidobutanoic acid","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-N","pvalue":0.0006244380764648,"ratio":7.222899462664761,"synonym_name":"4-(diaminomethylideneamino)butanoic acid"},{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":0.0018828789707197,"ratio":0.1031528516002712,"synonym_name":"Acetylformic acid"},{"chebi_id":"28116","direction":"up","inn_name":"","iupac_name":"5-carbamimidamido-2-oxopentanoic acid","metabolite_id":"ARBHXJXXVVHMET-UHFFFAOYSA-N","pvalue":0.0027523295613083,"ratio":8.15731682239364,"synonym_name":"\u03b1-keto-\u03b4-guanidinopentanoic acid"}],"totalFeatures":260},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Prochlorococcus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000089","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":45,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"52330","direction":"down","inn_name":"","iupac_name":"2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate","metabolite_id":"JZNWSCPGTDBMEW-UHFFFAOYSA-N","pvalue":1.2043470809283436e-06,"ratio":0.0173252885522517,"synonym_name":"<em>sn</em>-Glycerol-3-phosphoethanolamine"},{"chebi_id":"16160","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-4-(3-carboxypropanoyloxy)butanoic acid","metabolite_id":"GNISQJGXJIDKDJ-YFKPBYRVSA-N","pvalue":0.0059636057387311,"ratio":0.0100327255348576,"synonym_name":"O-succinyl-L-homoserine"},{"chebi_id":"73004","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate","metabolite_id":"YVYMBNSKXOXSKW-HXUWFJFHSA-N","pvalue":0.0007013921768377,"ratio":0.0446254898998779,"synonym_name":"1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":0.0007135734268478,"ratio":0.0791614025111272,"synonym_name":"Acetylformic acid"},{"chebi_id":"28635","direction":"down","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":0.000736575910603,"ratio":0.0823840588382143,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"},{"chebi_id":"5457","direction":"down","inn_name":"","iupac_name":"bis(2,3-dihydroxypropyl) hydrogen phosphate","metabolite_id":"LLCSXHMJULHSJN-UHFFFAOYSA-N","pvalue":0.0006475282703726,"ratio":0.0941792748380901,"synonym_name":""},{"chebi_id":"32817","direction":"down","inn_name":"","iupac_name":"<em>keto</em>-3-deoxy-<small>D</small>-<i>manno</i>-oct-2-ulosonic acid","metabolite_id":"KYQCXUMVJGMDNG-SHUUEZRQSA-N","pvalue":0.0005412824539377,"ratio":0.1436539646741355,"synonym_name":"KDO"},{"chebi_id":"64564","direction":"down","inn_name":"timonacicum","iupac_name":"1,3-thiazolidine-4-carboxylic acid","metabolite_id":"DZLNHFMRPBPULJ-UHFFFAOYSA-N","pvalue":0.0024510581326373,"ratio":0.0991942313571561,"synonym_name":"Thiazolidine-4-carboxylic acid"},{"chebi_id":"132989","direction":"down","inn_name":"","iupac_name":"4-(acetyloxy)-2-azaniumylbutanoate","metabolite_id":"FCXZBWSIAGGPCB-UHFFFAOYSA-N","pvalue":0.0041772065666693,"ratio":0.0913933503260014,"synonym_name":""},{"chebi_id":"17533","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidopentanedioic acid","metabolite_id":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","pvalue":0.0048619306918957,"ratio":0.0874015406919825,"synonym_name":"(S)-2-(acetylamino)pentanedioic acid"}],"totalFeatures":255},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"P. marinus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000119","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"91315","direction":"down","inn_name":"","iupac_name":"2-methylbutanedioic acid","metabolite_id":"WXUAQHNMJWJLTG-UHFFFAOYSA-N","pvalue":0.0088844781813126,"ratio":0.0632814413054197,"synonym_name":""},{"chebi_id":"16666","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FPWMCUPFBRFMLH-UHFFFAOYSA-N","pvalue":0.0036077889522492,"ratio":0.1032479120413294,"synonym_name":"PREPHENIC ACID"},{"chebi_id":"28635","direction":"down","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":0.0085875425191843,"ratio":0.1752641548279717,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"},{"chebi_id":"32817","direction":"down","inn_name":"","iupac_name":"<em>keto</em>-3-deoxy-<small>D</small>-<i>manno</i>-oct-2-ulosonic acid","metabolite_id":"KYQCXUMVJGMDNG-SHUUEZRQSA-N","pvalue":0.0023528121699003,"ratio":0.2722061161200445,"synonym_name":"KDO"},{"chebi_id":"52330","direction":"down","inn_name":"","iupac_name":"2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate","metabolite_id":"JZNWSCPGTDBMEW-UHFFFAOYSA-N","pvalue":0.0383151734186996,"ratio":0.1058372267198468,"synonym_name":"<em>sn</em>-Glycerol-3-phosphoethanolamine"},{"chebi_id":"27082","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HDTRYLNUVZCQOY-MFAKQEFJSA-N","pvalue":0.0390785444781887,"ratio":0.1073986094487886,"synonym_name":""},{"chebi_id":"16530","direction":"down","inn_name":"","iupac_name":"3-methyl-2-oxobutanoic acid","metabolite_id":"QHKABHOOEWYVLI-UHFFFAOYSA-N","pvalue":0.0148697313769394,"ratio":0.2301057306792735,"synonym_name":"2-Ketovaline"},{"chebi_id":"86564","direction":"up","inn_name":"","iupac_name":"4-carbamimidamidobutanoic acid","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-N","pvalue":0.0175746720747858,"ratio":3.4473673935934945,"synonym_name":"4-(diaminomethylideneamino)butanoic acid"},{"chebi_id":"18132","direction":"up","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-(phosphonooxy)ethanaminium","metabolite_id":"YHHSONZFOIEMCP-UHFFFAOYSA-O","pvalue":0.0244961378366152,"ratio":3.270507787660141,"synonym_name":"Phosphorylcholine"},{"chebi_id":"72665","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-12,13-dihydroxyoctadec-9-enoic acid","metabolite_id":"CQSLTKIXAJTQGA-FLIBITNWSA-N","pvalue":0.008142763496062,"ratio":2.3786507933881307,"synonym_name":"12,13-DHOME"}],"totalFeatures":248},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Prochlorococcus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000140","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":83,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"133144","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-hydroxy-2-(octadecanoyloxy)propyl phosphate","metabolite_id":"KIHAGWUUUHJRMS-JOCHJYFZSA-N","pvalue":0.0003872093951196,"ratio":0.0823488771922024,"synonym_name":"phosphatidylethanolamine zwitterion (18:0)"},{"chebi_id":"17200","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.0004768027703309,"ratio":0.0825949092716927,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"27082","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"HDTRYLNUVZCQOY-MFAKQEFJSA-N","pvalue":0.0003976661892699,"ratio":0.0891705259178998,"synonym_name":""},{"chebi_id":"28931","direction":"down","inn_name":"","iupac_name":"3'-adenylic acid","metabolite_id":"LNQVTSROQXJCDD-KQYNXXCUSA-N","pvalue":0.0005926785563046,"ratio":0.0934124025753981,"synonym_name":"Adenosine 3'-phosphate"},{"chebi_id":"32817","direction":"down","inn_name":"","iupac_name":"<em>keto</em>-3-deoxy-<small>D</small>-<i>manno</i>-oct-2-ulosonic acid","metabolite_id":"KYQCXUMVJGMDNG-SHUUEZRQSA-N","pvalue":0.000357925153009,"ratio":0.1147430477279695,"synonym_name":"KDO"},{"chebi_id":"15859","direction":"down","inn_name":"","iupac_name":"<em>N</em>-carbamoyl-<small>L</small>-aspartic acid","metabolite_id":"HLKXYZVTANABHZ-REOHCLBHSA-N","pvalue":0.0002817229232163,"ratio":0.1236599465402774,"synonym_name":"<em>N</em>-(aminocarbonyl)-<small>L</small>-aspartic acid"},{"chebi_id":"30918","direction":"down","inn_name":"","iupac_name":"(4<i>S</i>,5<i>R</i>)-4,5-dihydroxy-3-oxocyclohex-1-ene-1-carboxylic acid","metabolite_id":"SLWWJZMPHJJOPH-PHDIDXHHSA-N","pvalue":0.0370489208248101,"ratio":0.0078458306503803,"synonym_name":"(\u2212)-3-dehydroshikimic acid"},{"chebi_id":"73004","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate","metabolite_id":"YVYMBNSKXOXSKW-HXUWFJFHSA-N","pvalue":0.002208957848677,"ratio":0.0828336022136314,"synonym_name":"1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"16666","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FPWMCUPFBRFMLH-UHFFFAOYSA-N","pvalue":0.0101639930851697,"ratio":0.0423850661944716,"synonym_name":"PREPHENIC ACID"},{"chebi_id":"16742","direction":"down","inn_name":"","iupac_name":"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid","metabolite_id":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","pvalue":0.0029612147589002,"ratio":0.0968611975385076,"synonym_name":"OROTIC ACID"}],"totalFeatures":274},{"comparisonGroups":["SS120_Control","SS120_5mM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Prochlorococcus SS120: control vs 5mM glucose treatment","group_a_title":"Control group for Prochlorococcus marinus SS120. Provides baseline for comparison with glucose-treated samples","group_b_title":"5 mM glucose treatment group for Prochlorococcus marinus SS120. Assesses the effect of high glucose concentration on SS120 strain","id":"MTBLS5462_0001_00000152","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":36,"studyId":"MTBLS5462","studyUrl":"http://integmet.org/study/MTBLS5462","title":"SS120_Control_vs_SS120_5mM","topHits":[{"chebi_id":"52330","direction":"down","inn_name":"","iupac_name":"2-aminoethyl 2,3-dihydroxypropyl hydrogen phosphate","metabolite_id":"JZNWSCPGTDBMEW-UHFFFAOYSA-N","pvalue":0.0009719269782315,"ratio":0.0980444634833575,"synonym_name":"<em>sn</em>-Glycerol-3-phosphoethanolamine"},{"chebi_id":"133144","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-hydroxy-2-(octadecanoyloxy)propyl phosphate","metabolite_id":"KIHAGWUUUHJRMS-JOCHJYFZSA-N","pvalue":0.0034095340676072,"ratio":0.0838560735954967,"synonym_name":"phosphatidylethanolamine zwitterion (18:0)"},{"chebi_id":"32816","direction":"down","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":0.0468175976524276,"ratio":0.0123450630219496,"synonym_name":"Acetylformic acid"},{"chebi_id":"15689","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxy-3-methylbutanoic acid","metabolite_id":"JTEYKUFKXGDTEU-UHFFFAOYSA-N","pvalue":0.02486034181133,"ratio":0.030958268127068,"synonym_name":"2,3-Dihydroxy-isovaleric acid"},{"chebi_id":"73004","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate","metabolite_id":"YVYMBNSKXOXSKW-HXUWFJFHSA-N","pvalue":0.0040306930896332,"ratio":0.0995376338053837,"synonym_name":"1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"15356","direction":"down","inn_name":"","iupac_name":"cysteine","metabolite_id":"XUJNEKJLAYXESH-UHFFFAOYSA-N","pvalue":0.0315546345330289,"ratio":0.0941978707279739,"synonym_name":"Cystein"},{"chebi_id":"17924","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucitol","metabolite_id":"FBPFZTCFMRRESA-JGWLITMVSA-N","pvalue":0.0151109230269792,"ratio":0.1438265555326722,"synonym_name":"D-SORBITOL"},{"chebi_id":"30923","direction":"down","inn_name":"","iupac_name":"2-hydroxy-4-oxopentanedioic acid","metabolite_id":"WXSKVKPSMAHCSG-UHFFFAOYSA-N","pvalue":0.0064660127418891,"ratio":0.2426633371800031,"synonym_name":"4-Hydroxy-2-oxoglutaric acid"},{"chebi_id":"17050","direction":"down","inn_name":"","iupac_name":"2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UHFFFAOYSA-N","pvalue":0.0114975155558799,"ratio":0.2801105547290922,"synonym_name":"Glycerate 3-phosphate"},{"chebi_id":"16742","direction":"down","inn_name":"","iupac_name":"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid","metabolite_id":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","pvalue":0.0399475205010058,"ratio":0.174116648807134,"synonym_name":"OROTIC ACID"}],"totalFeatures":245},{"comparisonGroups":["Normal Diet","High-fat Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mice: normal diet vs high-fat diet","group_a_title":"Mice fed with a normal diet.. Serves as the control group for evaluating the effects of a high-fat diet.","group_b_title":"Mice fed with a high-fat diet.. Allows for the assessment of the impact of a high-fat diet on metabolic and microbial changes.","id":"MTBLS548_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS548","studyUrl":"http://integmet.org/study/MTBLS548","title":"Normal_Diet_vs_High-fat_Diet","topHits":[],"totalFeatures":27},{"comparisonGroups":["Normal Diet","High-fat Diet"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: normal diet vs high-fat diet","group_a_title":"Mice fed with a normal diet.. Serves as the control group for evaluating the effects of a high-fat diet.","group_b_title":"Mice fed with a high-fat diet.. Allows for the assessment of the impact of a high-fat diet on metabolic and microbial changes.","id":"MTBLS548_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS548","studyUrl":"http://integmet.org/study/MTBLS548","title":"Normal_Diet_vs_High-fat_Diet","topHits":[],"totalFeatures":29},{"comparisonGroups":["Blood_10h","Blood_58h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: 10h vs 58h fasting comparison","group_a_title":"Blood samples collected at 10 hours of fasting.. Serves as the reference point for blood samples at later fasting times.","group_b_title":"Blood samples collected at 58 hours of fasting.. Provides insight into metabolic changes at 58 hours of fasting.","id":"MTBLS549_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS549","studyUrl":"http://integmet.org/study/MTBLS549","title":"Blood_10h_vs_Blood_58h","topHits":[{"chebi_id":"48928","direction":"down","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":9.417367180836054e-05,"ratio":0.0192477667021761,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"30831","direction":"down","inn_name":"","iupac_name":"2-oxobutanoic acid","metabolite_id":"TYEYBOSBBBHJIV-UHFFFAOYSA-N","pvalue":0.0002126150825767,"ratio":0.0762858110486769,"synonym_name":"\u03b1-ketobutyric acid"},{"chebi_id":"30915","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":0.0025220260242522,"ratio":0.0797377302240231,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"84058","direction":"down","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":1.2911116048681495e-05,"ratio":0.2893539906865947,"synonym_name":""},{"chebi_id":"16530","direction":"down","inn_name":"","iupac_name":"3-methyl-2-oxobutanoic acid","metabolite_id":"QHKABHOOEWYVLI-UHFFFAOYSA-N","pvalue":8.399597957978682e-05,"ratio":0.2946725672956365,"synonym_name":"2-Ketovaline"},{"chebi_id":"1148","direction":"down","inn_name":"","iupac_name":"2-hydroxybutanoic acid","metabolite_id":"AFENDNXGAFYKQO-UHFFFAOYSA-N","pvalue":0.0011575429267798,"ratio":0.2115084643911611,"synonym_name":"2-Hydroxybutanoic acid"},{"chebi_id":"35932","direction":"down","inn_name":"","iupac_name":"3-methyl-2-oxopentanoic acid","metabolite_id":"JVQYSWDUAOAHFM-UHFFFAOYSA-N","pvalue":0.0004862195165373,"ratio":0.3027589811944539,"synonym_name":"2-Oxo-3-methylvalerate"},{"chebi_id":"48430","direction":"down","inn_name":"","iupac_name":"4-methyl-2-oxopentanoic acid","metabolite_id":"BKAJNAXTPSGJCU-UHFFFAOYSA-N","pvalue":0.0004862195165373,"ratio":0.3027589811944539,"synonym_name":"2-Oxoisocaproate"},{"chebi_id":"25017","direction":"down","inn_name":"","iupac_name":"leucine","metabolite_id":"ROHFNLRQFUQHCH-UHFFFAOYSA-N","pvalue":0.0006488144777061,"ratio":0.4485729481760929,"synonym_name":"DL-Leucine"},{"chebi_id":"16704","direction":"down","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0040105646690029,"ratio":0.4034904939135057,"synonym_name":"u"}],"totalFeatures":89},{"comparisonGroups":["Blood_10h","Blood_58h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: 58h vs 10h fasting comparison","group_a_title":"Blood samples collected at 10 hours of fasting.. Serves as the reference point for blood samples at later fasting times.","group_b_title":"Blood samples collected at 58 hours of fasting.. Provides insight into metabolic changes at 58 hours of fasting.","id":"MTBLS549_0002_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS549","studyUrl":"http://integmet.org/study/MTBLS549","title":"Blood_10h_vs_Blood_58h","topHits":[{"chebi_id":"73054","direction":"down","inn_name":"","iupac_name":"3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"FUJLYHJROOYKRA-UHFFFAOYSA-N","pvalue":0.0249287572243097,"ratio":0.267947104796818,"synonym_name":"dodecanoylcarnitine"},{"chebi_id":"73061","direction":"down","inn_name":"","iupac_name":"3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-UHFFFAOYSA-N","pvalue":0.0382366777967344,"ratio":0.2297790763586996,"synonym_name":"myristoylcarnitine"},{"chebi_id":"67249","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-{[3-(acetylamino)propanoyl]amino}-3-(1<em>H</em>-imidazol-5-yl)propanoic acid","metabolite_id":"BKAYIFDRRZZKNF-VIFPVBQESA-N","pvalue":0.0046684725200123,"ratio":0.4952414690184859,"synonym_name":"<em>N</em>-acetyl-<small>L</small>-carnosine"}],"totalFeatures":38},{"comparisonGroups":["4_week","52_week"],"dateCreated":"2025-09-26 00:00:00","display_title":"Young (4 weeks) vs aged (52 weeks) lipid changes","group_a_title":"Samples collected at 4 weeks of age.. Serves as the reference point for observing lipidomic changes with aging.","group_b_title":"Samples collected at 52 weeks of age.. Helps to identify lipidomic changes that occur at the final stage of the aging process.","id":"MTBLS562_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS562","studyUrl":"http://integmet.org/study/MTBLS562","title":"4_week_vs_52_week","topHits":[{"chebi_id":"72961","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]octadecanamide","metabolite_id":"VODZWWMEJITOND-NXCSZAMKSA-N","pvalue":1.388567422772196e-05,"ratio":0.3724410314959077,"synonym_name":"<em>N</em>-stearoylsphingosine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CDKITPQUODTFLF-CUWXFNSGSA-N","pvalue":0.0026249795347676,"ratio":0.3202425363481394,"synonym_name":""},{"chebi_id":"77686","direction":"down","inn_name":"","iupac_name":"3-(octadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)bis-octadec-9-enoate","metabolite_id":"RYNHWWNZNIGDAQ-WNMJAFDRSA-N","pvalue":0.0056549937093135,"ratio":0.3089000912593883,"synonym_name":"3-(stearoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)bis-octadec-9-enoate"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GBDGUGNAHCFRDF-MJWDKVSCSA-N","pvalue":0.0090241634738323,"ratio":0.2774931994668798,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SHYCFZYQNVKAAU-UZBXBHHFSA-N","pvalue":0.0185140183059771,"ratio":0.2390549439534211,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ANBFFIILUQJIQL-AWWAHHQNSA-N","pvalue":0.0053378442544405,"ratio":0.3548586205654739,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DUMVNGVOPMHAGK-AYXAOGTGSA-N","pvalue":0.0076560038747342,"ratio":0.3736653837655665,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XRTUKMLVVRMOLM-LSPMGEJTSA-N","pvalue":0.0130661469486051,"ratio":0.3320018655774479,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YONCDTJKIZDSKQ-UVIGLXQBSA-N","pvalue":0.0095054514945151,"ratio":0.3593913729901071,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DSCILNRDAOLXET-URFWVIAFSA-N","pvalue":0.0160782066327209,"ratio":0.353339125609627,"synonym_name":""}],"totalFeatures":20},{"comparisonGroups":["4_week","52_week"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aging comparison: 4 weeks vs 52 weeks old","group_a_title":"Samples collected at 4 weeks of age.. Serves as the reference point for observing lipidomic changes with aging.","group_b_title":"Samples collected at 52 weeks of age.. Helps to identify lipidomic changes that occur at the final stage of the aging process.","id":"MTBLS562_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS562","studyUrl":"http://integmet.org/study/MTBLS562","title":"4_week_vs_52_week","topHits":[{"chebi_id":"72961","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]octadecanamide","metabolite_id":"VODZWWMEJITOND-NXCSZAMKSA-N","pvalue":1.388567422772196e-05,"ratio":0.3724410314959077,"synonym_name":"<em>N</em>-stearoylsphingosine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CDKITPQUODTFLF-CUWXFNSGSA-N","pvalue":0.0026249795347676,"ratio":0.3202425363481394,"synonym_name":""},{"chebi_id":"77686","direction":"down","inn_name":"","iupac_name":"3-(octadecanoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)bis-octadec-9-enoate","metabolite_id":"RYNHWWNZNIGDAQ-WNMJAFDRSA-N","pvalue":0.0056549937093135,"ratio":0.3089000912593883,"synonym_name":"3-(stearoyloxy)propane-1,2-diyl (9<i>Z</i>,9'<i>Z</i>)bis-octadec-9-enoate"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GBDGUGNAHCFRDF-MJWDKVSCSA-N","pvalue":0.0090241634738323,"ratio":0.2774931994668798,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SHYCFZYQNVKAAU-UZBXBHHFSA-N","pvalue":0.0185140183059771,"ratio":0.2390549439534211,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ANBFFIILUQJIQL-AWWAHHQNSA-N","pvalue":0.0053378442544405,"ratio":0.3548586205654739,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DUMVNGVOPMHAGK-AYXAOGTGSA-N","pvalue":0.0076560038747342,"ratio":0.3736653837655665,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XRTUKMLVVRMOLM-LSPMGEJTSA-N","pvalue":0.0130661469486051,"ratio":0.3320018655774479,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YONCDTJKIZDSKQ-UVIGLXQBSA-N","pvalue":0.0095054514945151,"ratio":0.3593913729901071,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DSCILNRDAOLXET-URFWVIAFSA-N","pvalue":0.0160782066327209,"ratio":0.353339125609627,"synonym_name":""}],"totalFeatures":20},{"comparisonGroups":["Green_Leaf_GL","Purple_Leaf_PL"],"dateCreated":"2025-09-26 00:00:00","display_title":"Loropetalum leaves: green vs purple color variants","group_a_title":"Samples with green leaves from Loropetalum chinense var. rubrum.. Represents the baseline leaf color for comparison with other color variations.","group_b_title":"Samples with purple leaves from Loropetalum chinense var. rubrum.. Represents a significant variation in leaf color for comparison with other color variations.","id":"MTBLS5662_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS5662","studyUrl":"http://integmet.org/study/MTBLS5662","title":"Green_Leaf_vs_Purple_Leaf","topHits":[{"chebi_id":"5262","direction":"down","inn_name":"","iupac_name":"3,5,7-trihydroxy-2-phenyl-4<em>H</em>-chromen-4-one","metabolite_id":"VCCRNZQBSJXYJD-UHFFFAOYSA-N","pvalue":5.293601307984131e-05,"ratio":2.0705521472392637e-05,"synonym_name":"3,5,7-triOH-flavone"},{"chebi_id":"310312","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one","metabolite_id":"DXDRHHKMWQZJHT-FPYGCLRLSA-N","pvalue":2.4048089402540524e-06,"ratio":0.0007124010554089,"synonym_name":"<i>trans</i>-2',4,4'-trihydroxychalcone"},{"chebi_id":"18152","direction":"down","inn_name":"","iupac_name":"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"IKMDFBPHZNJCSN-UHFFFAOYSA-N","pvalue":6.227222599401212e-06,"ratio":0.013682505399568,"synonym_name":"Myricetin"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FTODBIPDTXRIGS-UHFFFAOYSA-N","pvalue":1.833837718575078e-06,"ratio":0.023456090651558,"synonym_name":""},{"chebi_id":"75630","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>,3<i>S</i>,3'<i>S</i>,4<i>S</i>)-2,2'-bis(3,4-dihydroxyphenyl)-3,3',4,4'-tetrahydro-2<em>H</em>,2'<em>H</em>-4,8'-bichromene-3,3',5,5',7,7'-hexol","metabolite_id":"XFZJEEAOWLFHDH-AVFWISQGSA-N","pvalue":0.0022585179423971,"ratio":0.0004477611940298,"synonym_name":"Proanthocyanidin B3"},{"chebi_id":"145096","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UIDGLYUNOUKLBM-GEBJFKNCSA-N","pvalue":1.6108209275795406e-05,"ratio":0.0144646098003629,"synonym_name":""},{"chebi_id":"75632","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>,3<i>R</i>,3'<i>R</i>,4<i>R</i>)-2,2'-bis(3,4-dihydroxyphenyl)-3,3',4,4'-tetrahydro-2<em>H</em>,2'<em>H</em>-4,8'-bichromene-3,3',5,5',7,7'-hexol","metabolite_id":"XFZJEEAOWLFHDH-NFJBMHMQSA-N","pvalue":0.0011204433297913,"ratio":0.0015807962529274,"synonym_name":"Epicathechin-(4\u03b2\u21928)-epicathechin"},{"chebi_id":"28499","direction":"up","inn_name":"","iupac_name":"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"IYRMWMYZSQPJKC-UHFFFAOYSA-N","pvalue":0.0027862676108403,"ratio":963.7037037037038,"synonym_name":"Kampherol"},{"chebi_id":"133365","direction":"down","inn_name":"","iupac_name":"3-(\u03b2-<small>D</small>-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-1-benzopyran-1-ium-5-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"SLCKJKWFULXZBD-ZOTFFYTFSA-O","pvalue":1.3520796124760328e-05,"ratio":0.037570385818561,"synonym_name":"pelargonidin 3,5-<em>O</em>-diglucoside"},{"chebi_id":"136609","direction":"down","inn_name":"","iupac_name":"3,4,5-trihydroxy-1,8-bis[(2<i>R</i>,3<i>R</i>)-3,5,7-trihydroxy-3,4-dihydro-2<em>H</em>-chromen-2-yl]-6<em>H</em>-benzocyclohepten-6-one","metabolite_id":"IPMYMEWFZKHGAX-ZKSIBHASSA-N","pvalue":0.0001910516993051,"ratio":0.0305945945945945,"synonym_name":"1,8-bis((2<i>R</i>,3<i>R</i>)-3,5,7-trihydroxy-2<em>H</em>-1-benzopyran-2-yl)-3,4,6-trihydroxy-5<em>H</em>-benzocyclohepten-5-one"}],"totalFeatures":93},{"comparisonGroups":["wt","G753R"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pombe: G753R mutation vs wild-type","group_a_title":"Wild-type Schizosaccharomyces pombe samples. Provides a reference for assessing the effects of the G753R mutation.","group_b_title":"Schizosaccharomyces pombe samples with G753R mutation. Essential for understanding the metabolic and phenotypic changes due to the G753R mutation.","id":"MTBLS578_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS578","studyUrl":"http://integmet.org/study/MTBLS578","title":"wt_vs_G753R","topHits":[{"chebi_id":"134027","direction":"down","inn_name":"","iupac_name":"3-(phosphonooxy)propane-1,2-diyl dioctadec-9-enoate","metabolite_id":"MHUWZNTUIIFHAS-UHFFFAOYSA-N","pvalue":0.0006662481098762,"ratio":0.6055292639757517,"synonym_name":"PA(36:2)"}],"totalFeatures":1},{"comparisonGroups":["wt","G753R"],"dateCreated":"2025-09-26 00:00:00","display_title":"S. pombe: G753R mutation vs wild-type","group_a_title":"Wild-type Schizosaccharomyces pombe samples. Provides a reference for assessing the effects of the G753R mutation.","group_b_title":"Schizosaccharomyces pombe samples with G753R mutation. Essential for understanding the metabolic and phenotypic changes due to the G753R mutation.","id":"MTBLS578_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS578","studyUrl":"http://integmet.org/study/MTBLS578","title":"wt_vs_G753R","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ACTIUHUUMQJHFO-UHFFFAOYSA-N","pvalue":0.0001502998102973,"ratio":0.3084677443487693,"synonym_name":""}],"totalFeatures":2},{"comparisonGroups":["Knockdown","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"ACSL1 gene knockdown vs control","group_a_title":"Samples with ACSL1 gene knockdown. Key group for understanding the role of ACSL1 in triglyceride synthesis","group_b_title":"Control samples without ACSL1 knockdown. Provides a reference point for evaluating the effects of ACSL1 knockdown","id":"MTBLS5808_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":56,"studyId":"MTBLS5808","studyUrl":"http://integmet.org/study/MTBLS5808","title":"Knockdown_vs_Control","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"WYCSIKFFWNBQTH-HPICKALHSA-N","pvalue":0.0007236187713497,"ratio":0.2262859553661254,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KFNJHCGHCLZZAS-VERBRUMSSA-N","pvalue":0.0001336381583258,"ratio":0.3213640640566769,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PQKVSFDPGGRPIJ-YXLBWYSVSA-N","pvalue":0.0004742490421032,"ratio":0.2992941949588965,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BLFWZVXARGMXGK-BSXLTLLISA-N","pvalue":0.0002618094080968,"ratio":0.3609786792557077,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YJIQPDYUKSNQSN-HVVTZQISSA-N","pvalue":0.0003175729384669,"ratio":0.3576996247079094,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ILEYBIJYKRCXQM-SNFLYYTFSA-N","pvalue":0.0003589196473348,"ratio":0.3620403321470937,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CALPQPPBXIEGRX-CQRNSFJNSA-N","pvalue":0.0003315447271749,"ratio":0.3975357556121268,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ODTSMODPVGNVHB-ARCWLUEOSA-N","pvalue":0.0006741662963542,"ratio":0.40134874650236,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QSYUHCUTOJZEHH-LHJVVSEHSA-N","pvalue":0.0018063998625846,"ratio":0.3589150907709362,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JVFAGALXCYHZAP-NBGOWFTESA-N","pvalue":0.0013896509972763,"ratio":0.3897599490183437,"synonym_name":""}],"totalFeatures":348},{"comparisonGroups":["Knockdown","Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"ACSL1 knockdown vs control for triglyceride synthesis","group_a_title":"Samples with ACSL1 gene knockdown. Key group for understanding the role of ACSL1 in triglyceride synthesis","group_b_title":"Control samples without ACSL1 knockdown. Provides a reference point for evaluating the effects of ACSL1 knockdown","id":"MTBLS5808_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":56,"studyId":"MTBLS5808","studyUrl":"http://integmet.org/study/MTBLS5808","title":"Knockdown_vs_Control","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"WYCSIKFFWNBQTH-HPICKALHSA-N","pvalue":0.0007236187713497,"ratio":0.2262859553661254,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KFNJHCGHCLZZAS-VERBRUMSSA-N","pvalue":0.0001336381583258,"ratio":0.3213640640566769,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PQKVSFDPGGRPIJ-YXLBWYSVSA-N","pvalue":0.0004742490421032,"ratio":0.2992941949588965,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BLFWZVXARGMXGK-BSXLTLLISA-N","pvalue":0.0002618094080968,"ratio":0.3609786792557077,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YJIQPDYUKSNQSN-HVVTZQISSA-N","pvalue":0.0003175729384669,"ratio":0.3576996247079094,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ILEYBIJYKRCXQM-SNFLYYTFSA-N","pvalue":0.0003589196473348,"ratio":0.3620403321470937,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CALPQPPBXIEGRX-CQRNSFJNSA-N","pvalue":0.0003315447271749,"ratio":0.3975357556121268,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ODTSMODPVGNVHB-ARCWLUEOSA-N","pvalue":0.0006741662963542,"ratio":0.40134874650236,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QSYUHCUTOJZEHH-LHJVVSEHSA-N","pvalue":0.0018063998625846,"ratio":0.3589150907709362,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JVFAGALXCYHZAP-NBGOWFTESA-N","pvalue":0.0013896509972763,"ratio":0.3897599490183437,"synonym_name":""}],"totalFeatures":348},{"comparisonGroups":["CIS_Mesocarp_2018","GG_Mesocarp_2018"],"dateCreated":"2025-09-26 00:00:00","display_title":"Apple mesocarp: cisgenic vs wild-type Gala Galaxy 2018","group_a_title":"Cisgenic Gala Galaxy C44.4.146 mesocarp samples from 2018. Key group for assessing the impact of cisgenesis on mesocarp tissue in 2018","group_b_title":"Wild-type Gala Galaxy mesocarp samples from 2018. Reference group for comparing cisgenic and wild-type mesocarp tissue in 2018","id":"MTBLS5810_0001_00000038","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS5810","studyUrl":"http://integmet.org/study/MTBLS5810","title":"CIS_Mesocarp_2018_vs_GG_Mesocarp_2018","topHits":[],"totalFeatures":61},{"comparisonGroups":["Control","Palmitate"],"dateCreated":"2025-09-26 00:00:00","display_title":"Palmitate treatment vs control (insulin signaling study)","group_a_title":"Control group with no palmitate treatment. Provides baseline data for comparison with palmitate-treated samples.","group_b_title":"Group treated with palmitate. Allows for the assessment of palmitate's effects on insulin signaling.","id":"MTBLS582_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS582","studyUrl":"http://integmet.org/study/MTBLS582","title":"Control_vs_Palmitate","topHits":[{"chebi_id":"73246","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(phosphonooxy)propane-1,2-diyl dihexadecanoate","metabolite_id":"PORPENFLTBBHSG-MGBGTMOVSA-N","pvalue":0.0009580092167376,"ratio":0.0193816910640157,"synonym_name":"1,2-Dipalmitoyl-3-sn-phosphatidic acid"},{"chebi_id":"77346","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-[(hydroxy{[(1<i>S</i>,2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]-3-(octadecanoyloxy)propan-2-yl (9<i>Z</i>)-octadec-9-enoate","metabolite_id":"YOBFISPJJWPPTK-BAAZTTAESA-N","pvalue":0.000203677734704,"ratio":0.32280152597085,"synonym_name":"1-18:0-2-18:1-phosphatidylinositol"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FGWZGYGIIUCSFO-HNOMVOJUSA-N","pvalue":0.0051725125617438,"ratio":0.2544930629669156,"synonym_name":""},{"chebi_id":"190847","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (6Z,9Z,12Z)-octadeca-6,9,12-trienoate","metabolite_id":"LDZPTHJGVVQFQZ-QKHBFQRPSA-N","pvalue":0.015290639387624,"ratio":0.226340751550529,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"WVTMWTSFRLILBN-BRIYTLMISA-N","pvalue":0.0189981884489219,"ratio":0.2203383500765582,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KZVRAFHIKMDULK-PDPKURFXSA-N","pvalue":0.0010755755512989,"ratio":0.4751856736308739,"synonym_name":""},{"chebi_id":"88396","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"QAWXBJDYTIBLRK-KHSFEHQMSA-N","pvalue":0.0113045641065479,"ratio":0.4225506628066433,"synonym_name":"PIno(32:1)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FJTAVAVJQBUEBP-DZHIZCKWSA-N","pvalue":0.0036530919697222,"ratio":1.7455670103092782,"synonym_name":""},{"chebi_id":"88392","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"YVNORLDGMYIHEG-YXPBIPRFSA-N","pvalue":0.020353983223863,"ratio":0.4951509606587373,"synonym_name":"PIno(34:1)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ZGKGYKIEXWZYEG-HCCKNBDGSA-N","pvalue":0.0352551636481752,"ratio":0.4547878787878788,"synonym_name":""}],"totalFeatures":46},{"comparisonGroups":["Control","Palmitate"],"dateCreated":"2025-09-26 00:00:00","display_title":"Palmitate treatment vs control (insulin signaling study)","group_a_title":"Control group with no palmitate treatment. Provides baseline data for comparison with palmitate-treated samples.","group_b_title":"Group treated with palmitate. Allows for the assessment of palmitate's effects on insulin signaling.","id":"MTBLS582_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":98,"studyId":"MTBLS582","studyUrl":"http://integmet.org/study/MTBLS582","title":"Control_vs_Palmitate","topHits":[{"chebi_id":"77393","direction":"down","inn_name":"","iupac_name":"propane-1,2,3-triyl trihexadecanoate","metabolite_id":"PVNIQBQSYATKKL-UHFFFAOYSA-N","pvalue":2.649049787781603e-06,"ratio":0.0284240790655885,"synonym_name":"Glycerin tripalmitate"},{"chebi_id":"138449","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NSQZMMPMMBEIIA-UHFFFAOYSA-N","pvalue":4.4589724248942166e-07,"ratio":0.0830555415680547,"synonym_name":"1,3-dihexadecanoyl-2-tetradecanoyl-sn-glycerol"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JVFAGALXCYHZAP-NBGOWFTESA-N","pvalue":7.185219367845492e-05,"ratio":0.0365539165818921,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RUOVJPPUXXFZPC-JMWCFZJPSA-N","pvalue":2.6095353323073704e-07,"ratio":0.1246947037371608,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FEKLSEFRUGWUOS-DNFNVERNSA-N","pvalue":2.755556105308113e-06,"ratio":0.1062891145993639,"synonym_name":""},{"chebi_id":"145230","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VUYXIQLBLBPRDY-VOHILQMLSA-N","pvalue":1.3531608053157362e-07,"ratio":0.1682125102025673,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NADPZDHMCOZNQI-ANFMRNGASA-N","pvalue":1.0747438519658712e-06,"ratio":0.1308601800629135,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LXAWUIOWWNQCQA-QOFSRLOCSA-N","pvalue":3.966468234360273e-06,"ratio":0.1242681845062093,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JJKLAPRFAPRJOG-LTVYIXHASA-N","pvalue":1.3269608984883098e-06,"ratio":0.1541807847852224,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GNADFLWMYUNMMR-SBSJFPCCSA-N","pvalue":0.0001906080049807,"ratio":0.0552742616033755,"synonym_name":""}],"totalFeatures":219},{"comparisonGroups":["CIDP_patient","healthy_control"],"dateCreated":"2025-09-26 00:00:00","display_title":"CIDP patients vs healthy controls","group_a_title":"Samples from patients diagnosed with CIDP.. Understanding the metabolic and microbiome differences in CIDP patients compared to healthy individuals.","group_b_title":"Samples from healthy individuals serving as controls.. Provides a baseline to identify deviations in CIDP patients.","id":"MTBLS5828_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":205,"studyId":"MTBLS5828","studyUrl":"http://integmet.org/study/MTBLS5828","title":"CIDP_patient_vs_healthy_control","topHits":[{"chebi_id":"177609","direction":"up","inn_name":"","iupac_name":"N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide","metabolite_id":"LGGHDPFKSSRQNS-UHFFFAOYSA-N","pvalue":1.2327546899669137e-21,"ratio":33.86842223326896,"synonym_name":""},{"chebi_id":"135446","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HCFSGRMEEXUOSS-JXEXPEPMSA-N","pvalue":5.999116489264566e-10,"ratio":492.56632093223703,"synonym_name":"medrogesterone"},{"chebi_id":"53168","direction":"up","inn_name":"","iupac_name":"(1<i>R</i>)-4-formyl-3,5,5-trimethylcyclohex-3-en-1-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"WMHJCSAICLADIN-WYWSWGBSSA-N","pvalue":2.5179549200992087e-12,"ratio":128.75152072501066,"synonym_name":"(R)-4-(beta-D-Glucopyranosyloxy)-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde"},{"chebi_id":"4913","direction":"up","inn_name":"\u00e9tr\u00e9tinate","iupac_name":"ethyl (2<i>E</i>,4<i>E</i>,6<i>E</i>,8<i>E</i>)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate","metabolite_id":"HQMNCQVAMBCHCO-DJRRULDNSA-N","pvalue":5.2245097355119814e-12,"ratio":144.93545064261343,"synonym_name":"3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonanetetraenoic acid ethyl ester"},{"chebi_id":"176286","direction":"up","inn_name":"","iupac_name":"(E)-3-(2,4-dihydroxyphenyl)-1-[3-[5-(2,4-dihydroxyphenyl)-6-(5-hydroxy-2,2-dimethylchromene-6-carbonyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]prop-2-en-1-one","metabolite_id":"JIQSDJNLGMFGDV-VZUCSPMQSA-N","pvalue":3.8920456239025864e-19,"ratio":15.757287255884831,"synonym_name":""},{"chebi_id":"15999","direction":"up","inn_name":"","iupac_name":"3-(4-hydroxyphenyl)-2-oxopropanoic acid","metabolite_id":"KKADPXVIOXHVKN-UHFFFAOYSA-N","pvalue":1.226175569840786e-13,"ratio":34.81835484042719,"synonym_name":"3-(4-HYDROXY-PHENYL)PYRUVIC ACID"},{"chebi_id":"111173","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PDMUULPVBYQBBK-UHFFFAOYSA-N","pvalue":3.7192624115219115e-15,"ratio":20.83406049951905,"synonym_name":""},{"chebi_id":"79137","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-10-[(3,6-dideoxy-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyl)oxy]dec-2-enoic acid","metabolite_id":"LNUSDHULQVPZFO-RYJVCDSQSA-N","pvalue":1.9098691276742722e-08,"ratio":162.02896680438627,"synonym_name":"10-(3'<i>R</i>,5'<i>R</i>-dihydroxy-6'<i>S</i>-methyl-(2<em>H</em>)-tetrahydropyran-2'-yloxy)-2<i>E</i>-decenoic acid"},{"chebi_id":"31459","direction":"up","inn_name":"","iupac_name":"3,7,12-trioxo-5\u03b2-cholan-24-oic acid","metabolite_id":"OHXPGWPVLFPUSM-KLRNGDHRSA-N","pvalue":2.5278255531589322e-09,"ratio":47.63155447797146,"synonym_name":"3,7,12-Triketo-5beta-cholanoic acid"},{"chebi_id":"115196","direction":"up","inn_name":"","iupac_name":"1,3-benzothiazol-2-ol","metabolite_id":"YEDUAINPPJYDJZ-UHFFFAOYSA-N","pvalue":8.035637697172287e-14,"ratio":10.127657847136769,"synonym_name":"HBT"}],"totalFeatures":610},{"comparisonGroups":["CIDP_patient","healthy_control"],"dateCreated":"2025-09-26 00:00:00","display_title":"CIDP patients vs healthy controls","group_a_title":"Samples from patients diagnosed with CIDP.. Understanding the metabolic and microbiome differences in CIDP patients compared to healthy individuals.","group_b_title":"Samples from healthy individuals serving as controls.. Provides a baseline to identify deviations in CIDP patients.","id":"MTBLS5828_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":407,"studyId":"MTBLS5828","studyUrl":"http://integmet.org/study/MTBLS5828","title":"CIDP_patient_vs_healthy_control","topHits":[{"chebi_id":"193227","direction":"down","inn_name":"","iupac_name":"(2S)-2-amino-3-[hydroxy-[(2R)-2-hydroxy-3-(2-methoxynonadecoxy)propoxy]phosphoryl]oxypropanoic acid","metabolite_id":"PMNIPCXKCBLOJO-PPCJQXESSA-N","pvalue":1.7165999532642558e-27,"ratio":0.0545266374017288,"synonym_name":""},{"chebi_id":"67991","direction":"down","inn_name":"","iupac_name":"(3\u03b2,12\u03b2)-12,20-dihydroxydammar-24-en-3-yl 2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"RWXIFXNRCLMQCD-JBVRGBGGSA-N","pvalue":2.805504935946154e-28,"ratio":0.0673939962630974,"synonym_name":"(20<i>S</i>)-propanaxadiol"},{"chebi_id":"184966","direction":"down","inn_name":"","iupac_name":"(2S)-2-amino-3-[hydroxy-[(2R)-2-hydroxy-3-(2-methoxy-14-methylpentadecoxy)propoxy]phosphoryl]oxypropanoic acid","metabolite_id":"XUZBBCVOLRBWDH-QFMSAKRMSA-N","pvalue":1.120552222133024e-25,"ratio":0.0583123978040771,"synonym_name":""},{"chebi_id":"80568","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"JMWFFJATYDQZCI-HOTGVXAUSA-N","pvalue":2.6488268225837528e-25,"ratio":0.0561682104243336,"synonym_name":""},{"chebi_id":"31572","direction":"down","inn_name":"","iupac_name":"ethyl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"FMMOOAYVCKXGMF-MURFETPASA-N","pvalue":7.9003104053979485e-25,"ratio":0.0780056188142898,"synonym_name":"9,12-Octadecadienoic acid ethyl ester"},{"chebi_id":"3154","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"WQTYIKZACFUZJB-SJORKVTESA-N","pvalue":6.54529364491122e-25,"ratio":12.487290904068638,"synonym_name":"Borreline"},{"chebi_id":"51078","direction":"down","inn_name":"","iupac_name":"13-{[6-<em>O</em>-acetyl-2-<em>O</em>-(6-<em>O</em>-acetyl-\u03b2-<small>D</small>-glucopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}docosanoic acid","metabolite_id":"LGIFCELMJBBHMO-SGQFWHNCSA-N","pvalue":4.052954512646378e-28,"ratio":0.1277418178955718,"synonym_name":"13-((2'-<em>O</em> \u03b2-<small>D</small>-glucopyranosyl \u03b2-<small>D</small>-glucopyranosyl)oxy)docosanoic acid 6',6''-diacetate"},{"chebi_id":"73813","direction":"up","inn_name":"","iupac_name":"<small>L</small>-arginyl-<small>L</small>-glutamine","metabolite_id":"PMGDADKJMCOXHX-BQBZGAKWSA-N","pvalue":3.4241599573464717e-14,"ratio":41.22661657660608,"synonym_name":"Arginyl-Glutamine"},{"chebi_id":"83810","direction":"up","inn_name":"","iupac_name":"(9<i>R</i>)-3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydro-4<em>H</em>-pyrido[1,2-<em>a</em>]pyrimidin-9-yl hexadecanoate","metabolite_id":"VOMKSBFLAZZBOW-UUWRZZSWSA-N","pvalue":6.369089313949379e-16,"ratio":26.084682974171535,"synonym_name":"(<i>R</i>)-paliperidone hexadecanoate"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SDDSJMXGJNWMJY-BRHAQHMBSA-N","pvalue":2.3740250436259686e-14,"ratio":34.86225187465184,"synonym_name":""}],"totalFeatures":1424},{"comparisonGroups":["Standard_condition_root","NaCl_treatment_root"],"dateCreated":"2025-09-26 00:00:00","display_title":"Root samples: standard vs NaCl salt stress treatment","group_a_title":"Root samples under standard conditions with no salt treatment.. Provides baseline data for comparison with treated root samples.","group_b_title":"Root samples treated with NaCl.. Allows for the assessment of salt stress effects on root samples.","id":"MTBLS583_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS583","studyUrl":"http://integmet.org/study/MTBLS583","title":"Standard_condition_root_vs_NaCl_treatment_root","topHits":[],"totalFeatures":0},{"comparisonGroups":["Control","DMXAA16h"],"dateCreated":"2025-09-26 00:00:00","display_title":"DMXAA treatment (16h) vs untreated control","group_a_title":"Control group with no treatment. Provides baseline for comparison with treated samples","group_b_title":"Samples treated with DMXAA for 16 hours. Represents later response to DMXAA treatment","id":"MTBLS5877_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":64,"studyId":"MTBLS5877","studyUrl":"http://integmet.org/study/MTBLS5877","title":"Control_vs_DMXAA16h","topHits":[{"chebi_id":"28262","direction":"down","inn_name":"dimethyl sulfoxide","iupac_name":"dimethyl sulfoxide","metabolite_id":"IAZDPXIOMUYVGZ-UHFFFAOYSA-N","pvalue":3.742407562111076e-05,"ratio":0.0041503937298416,"synonym_name":"dmso"},{"chebi_id":"75934","direction":"down","inn_name":"vadimezan","iupac_name":"(5,6-dimethyl-9-oxo-9<em>H</em>-xanthen-4-yl)acetic acid","metabolite_id":"XGOYIMQSIKSOBS-UHFFFAOYSA-N","pvalue":0.0030286457169717,"ratio":0.0015896678850318,"synonym_name":"(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid"},{"chebi_id":"86564","direction":"up","inn_name":"","iupac_name":"4-carbamimidamidobutanoic acid","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-N","pvalue":5.532655138603264e-05,"ratio":28.086722086181332,"synonym_name":"4-(diaminomethylideneamino)butanoic acid"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":0.0001447238529308,"ratio":0.0495885442292226,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"78226","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(decanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"MLKLDGSYMHFAOC-AREMUKBSSA-N","pvalue":4.1026788488583544e-06,"ratio":0.1187705894352106,"synonym_name":"<small>L</small>-didecanoylphosphatidylcholine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OOEWKJHFFYCQBM-ZHACJKMWSA-N","pvalue":6.059120252263869e-05,"ratio":0.0717951158955383,"synonym_name":""},{"chebi_id":"35280","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-1,1-dimethylpyrrolidinium-2-carboxylate","metabolite_id":"CMUNUTVVOOHQPW-LURJTMIESA-N","pvalue":8.56116439595599e-08,"ratio":3.167829274376699,"synonym_name":"<em>N</em>,<em>N</em>-dimethyl-<small>L</small>-proline"},{"chebi_id":"15873","direction":"down","inn_name":"","iupac_name":"2-amino-2-deoxy-\u03b1-<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"XHMJOUIAFHJHBW-UKFBFLRUSA-N","pvalue":4.32712011356903e-06,"ratio":0.2348777854076452,"synonym_name":"2-amino-2-deoxy-6-<em>O</em>-phosphono-\u03b1-<small>D</small>-glucopyranose"},{"chebi_id":"73705","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-N","pvalue":0.0002857350463838,"ratio":0.244555405156152,"synonym_name":"(5-L-Glutamyl)-L-glutamate"},{"chebi_id":"50619","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-alanine","metabolite_id":"WQXXXVRAFAKQJM-WHFBIAKZSA-N","pvalue":0.0011421852834733,"ratio":0.2118180757417211,"synonym_name":"<small>L</small>-\u03b3-Glu-<small>L</small>-Ala"}],"totalFeatures":346},{"comparisonGroups":["Sheep_ASA_SAT","Sheep_GOM_VAT"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep adipose tissue: subcutaneous vs visceral","group_a_title":"Sheep subcutaneous adipose tissue samples. Provides insight into subcutaneous adipose tissue characteristics in sheep.","group_b_title":"Sheep visceral adipose tissue samples. Provides insight into visceral adipose tissue characteristics in sheep.","id":"MTBLS5943_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS5943","studyUrl":"http://integmet.org/study/MTBLS5943","title":"G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT","topHits":[{"chebi_id":"174955","direction":"up","inn_name":"","iupac_name":"(2E,6E)-9-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydrochromen-2-yl]-2,6-dimethylnona-2,6-dienoic acid","metabolite_id":"QSRURDPJEKTSFH-ODPFLYRHSA-N","pvalue":0.0296212868882814,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MFDUGTOOXGORRX-ZROAIIAPSA-N","pvalue":0.0452188164940688,"ratio":1e-06,"synonym_name":""},{"chebi_id":"27956","direction":"down","inn_name":"","iupac_name":"(5<i>R</i>)-5-[(1<i>S</i>)-1,2-dihydroxyethyl]furan-2,3,4(5<em>H</em>)-trione","metabolite_id":"SBJKKFFYIZUCET-JLAZNSOCSA-N","pvalue":0.0028427575218121,"ratio":0.1301204623668314,"synonym_name":"dehydroascorbic acid"},{"chebi_id":"176203","direction":"down","inn_name":"","iupac_name":"(2S,3R,6S,8S,9R,12S,15S,21S,22R)-8-(2-hydroxypropan-2-yl)-2,3,23,23,25,25-hexamethyl-7,24-dioxa-31-azaoctacyclo[15.14.0.02,15.03,12.06,11.018,30.020,28.022,27]hentriaconta-1(17),10,18,20(28),26,29-hexaene-9,12,21-triol","metabolite_id":"TVRIMSLYKUNOPS-KYCQQYQOSA-N","pvalue":0.0052122755556862,"ratio":0.3363044440751313,"synonym_name":""},{"chebi_id":"74340","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-(heptadecanoyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"SRRQPVVYXBTRQK-XMMPIXPASA-N","pvalue":0.0356018735744347,"ratio":0.2918213021129667,"synonym_name":"LysoPC 17:0/0:0"},{"chebi_id":"79925","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HRGSZQQJTWZVHP-ZBRFXRBCSA-N","pvalue":0.0149776783343762,"ratio":1.902422325465955,"synonym_name":"Estra-1,3,5(10)-triene-3,17beta-diol 3-(dihydrogen phosphate)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"PYWBOTIEOHDIPF-FKFLSBRZSA-N","pvalue":0.049942189946923,"ratio":0.4183261307899194,"synonym_name":""},{"chebi_id":"185383","direction":"down","inn_name":"","iupac_name":"[(2S)-1-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-3-hydroxypropan-2-yl] tetracosanoate","metabolite_id":"JTRQUZDNVIYNEW-OJSYVTGYSA-N","pvalue":0.0246118701580808,"ratio":0.5340414659952869,"synonym_name":""},{"chebi_id":"184794","direction":"down","inn_name":"","iupac_name":"[(2S)-1-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hydroxypropan-2-yl] (Z)-tetracos-15-enoate","metabolite_id":"OZXKRESLHSIBQY-QUSLOAQQSA-N","pvalue":0.0435579845729216,"ratio":0.5346809907821253,"synonym_name":""},{"chebi_id":"18411","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranosyl-(1\u21923)-<small>D</small>-glucopyranose","metabolite_id":"QIGJYVCQYDKYDW-LCOYTZNXSA-N","pvalue":0.0458753043115607,"ratio":1.7705805293365178,"synonym_name":"\u03b2-<small>D</small>-Glc-(1\u21923)-<small>D</small>-Glc"}],"totalFeatures":610},{"comparisonGroups":["Sheep_ASA_SAT","Sheep_GOM_VAT"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep adipose: subcutaneous vs visceral tissue","group_a_title":"Sheep subcutaneous adipose tissue samples. Provides insight into subcutaneous adipose tissue characteristics in sheep.","group_b_title":"Sheep visceral adipose tissue samples. Provides insight into visceral adipose tissue characteristics in sheep.","id":"MTBLS5943_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":46,"studyId":"MTBLS5943","studyUrl":"http://integmet.org/study/MTBLS5943","title":"G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NLMKZTCCTRLERF-DWWIKOPFSA-N","pvalue":0.0075676877133718,"ratio":0.1448644671490075,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CEAZRRDELHUEMR-UHFFFAOYSA-N","pvalue":0.0414246728507499,"ratio":5.283439575567669,"synonym_name":""},{"chebi_id":"27531","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>,2<i>S</i>,3<i>S</i>,4<i>R</i>,8<i>R</i>,9<i>R</i>,12<i>S</i>)-12-hydroxy-8-(hydroxymethyl)-4-methyl-13-methylidenetetracyclo[10.2.1.0<small><sup>1,9</small></sup>.0<small><sup>3,8</small></sup>]pentadecane-2,4-dicarboxylic acid","metabolite_id":"AXEUUXHMKSPQAI-YTJHIPEWSA-N","pvalue":0.0212752052311891,"ratio":0.2863137123381014,"synonym_name":"Gibberellin A44 open lactone"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GBEMFUIMEORPGL-WFPLVJFUSA-N","pvalue":0.0188404677159936,"ratio":0.3651366699334362,"synonym_name":""},{"chebi_id":"169211","direction":"down","inn_name":"","iupac_name":"[6-(3-acetyl-2,4,6-trihydroxyphenyl)-3,4,5-tris[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate","metabolite_id":"GAJWEROGFQRXSF-UHFFFAOYSA-N","pvalue":0.0202628581313249,"ratio":0.3890567646928107,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"KAAHBDXVVGSEAD-QWUUBBNBSA-N","pvalue":0.0193067194695599,"ratio":0.4051457705847356,"synonym_name":""},{"chebi_id":"80722","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"AYJGABFBAYKWDX-IAGOWNOFSA-N","pvalue":0.0017504175215829,"ratio":0.581289486598882,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IROPKIGXUINUPQ-HAOPMPSJSA-N","pvalue":0.0170269805729648,"ratio":2.1260588231249007,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"TZLIHOHUFVBVKM-ZFADNZIISA-N","pvalue":0.0299923155653867,"ratio":2.364148444383759,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"WWPYVEZWNNLBRU-UHFFFAOYSA-O","pvalue":0.0092464211909176,"ratio":0.5274949954041054,"synonym_name":""}],"totalFeatures":1390},{"comparisonGroups":["DNA-PK KO UUO","DNA-PK KO Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"DNA-PK KO mice: UUO kidney injury vs control","group_a_title":"DNA-PK knockout mice with unilateral ureteral obstruction. Key group for studying the effects of DNA-PK knockout on CKD progression","group_b_title":"DNA-PK knockout mice without induced CKD. Provides baseline data for comparison with UUO-induced DNA-PK KO samples","id":"MTBLS5971_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS5971","studyUrl":"http://integmet.org/study/MTBLS5971","title":"DNA-PK_KO_UUO_vs_DNA-PK_KO_Control","topHits":[{"chebi_id":"35697","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-phenylprop-2-enoic acid","metabolite_id":"WBYWAXJHAXSJNI-VOTSOKGWSA-N","pvalue":0.0240437607871228,"ratio":98365.87344290658,"synonym_name":"trans-Cinnamic acid"},{"chebi_id":"60175","direction":"up","inn_name":"","iupac_name":"5-hydroxylysine","metabolite_id":"YSMODUONRAFBET-UHFFFAOYSA-N","pvalue":0.0270025048066933,"ratio":9.583461292452863,"synonym_name":"hydroxylysine"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":3.175812144185597e-06,"ratio":1.8319817458765904,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"48595","direction":"up","inn_name":"","iupac_name":"5'-deoxy-5'-(methylsulfanyl)inosine","metabolite_id":"GXYLOXCSJFJFKA-IOSLPCCCSA-N","pvalue":0.000162953559589,"ratio":2.3383575997168453,"synonym_name":"9-(5-<em>S</em>-methyl-5-thio-\u03b2-<small>D</small>-ribofuranosyl)-9<em>H</em>-purin-6-ol"},{"chebi_id":"16750","direction":"up","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.0001861476543598,"ratio":2.3299406239363862,"synonym_name":"G"},{"chebi_id":"16235","direction":"up","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":0.0001621843562518,"ratio":2.2936626159382323,"synonym_name":"GUANINE"},{"chebi_id":"16335","direction":"up","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":4.700241042664339e-05,"ratio":2.0607201029907207,"synonym_name":"Adenosin"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0174011938503362,"ratio":5.656189996918071,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"16704","direction":"up","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0007889211594925,"ratio":2.599641721302122,"synonym_name":"u"},{"chebi_id":"18183","direction":"up","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0062809326482317,"ratio":3.2711425735618462,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"}],"totalFeatures":75},{"comparisonGroups":["Scientific Control_MAM","Knock-out_MAM"],"dateCreated":"2025-09-26 00:00:00","display_title":"MAM: Mfn2 knockout vs control","group_a_title":"Scientific control group for Mitochondria-associated Endoplasmic Reticulum Membrane. Provides baseline data for evaluating the effects of Mfn2 knock-out in MAM.","group_b_title":"Knock-out group for Mitochondria-associated Endoplasmic Reticulum Membrane. Allows for the assessment of the impact of Mfn2 knock-out on MAM.","id":"MTBLS600_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS600","studyUrl":"http://integmet.org/study/MTBLS600","title":"Scientific_Control_MAM_vs_Knock-out_MAM","topHits":[{"chebi_id":"170463","direction":"up","inn_name":"","iupac_name":"[(2S)-2-tetradecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] icosanoate","metabolite_id":"FDWIGGGTKAUHLP-WZBLLWBYSA-N","pvalue":0.0192404421978622,"ratio":4.303702312916169,"synonym_name":""},{"chebi_id":"72998","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(hexadecanoyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"ASWBNKHCZGQVJV-HSZRJFAPSA-N","pvalue":0.0225644780794865,"ratio":2.270627647744307,"synonym_name":"PC(16:0/0:0)"},{"chebi_id":"167595","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RXKSKZZAOIRFLK-UQYDIMRYSA-N","pvalue":0.0154702288899126,"ratio":1.9745469671979912,"synonym_name":"PE(14:0/20:2(11Z,14Z))"},{"chebi_id":"170406","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] (13Z,16Z)-docosa-13,16-dienoate","metabolite_id":"XJLGATDALCZXFX-LSWZYRHBSA-N","pvalue":0.0436325123666965,"ratio":1.858922608200387,"synonym_name":""},{"chebi_id":"74667","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(9<i>Z</i>)-octadec-9-enoyloxy]-2-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RRVPPYNAZJRZFR-VYOBOKEXSA-N","pvalue":0.034926601933888,"ratio":1.7357538105585646,"synonym_name":"phosphatidylcholine(18:1\u03c99/16:0)"}],"totalFeatures":69},{"comparisonGroups":["D","DR"],"dateCreated":"2025-09-26 00:00:00","display_title":"Plant metabolism: drought vs drought recovery","group_a_title":"Samples collected during drought conditions.. Understanding plant metabolism during drought conditions.","group_b_title":"Samples collected during drought recovery.. Understanding plant recovery mechanisms post-drought.","id":"MTBLS613_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS613","studyUrl":"http://integmet.org/study/MTBLS613","title":"D_vs_DR","topHits":[{"chebi_id":"167535","direction":"down","inn_name":"","iupac_name":"5-hydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one","metabolite_id":"BISZYPSIZGKOFA-IPOZFMEPSA-N","pvalue":3.970569734066961e-05,"ratio":0.4182818245727296,"synonym_name":""},{"chebi_id":"131831","direction":"down","inn_name":"","iupac_name":"(1<i>S</i>)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-4<em>H</em>-1-benzopyran-6-yl]-2-<em>O</em>-{6-<em>O</em>-[(2<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-\u03b2-<small>D</small>-glucopyranosyl}-<small>D</small>-glucitol","metabolite_id":"DJZOTDSGEBENPL-LWHZWZDQSA-N","pvalue":0.0163272714803037,"ratio":0.5650963309349183,"synonym_name":"2''-(6-feruloylglucosyl)isoscoparin"},{"chebi_id":"167533","direction":"down","inn_name":"","iupac_name":"5-hydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one","metabolite_id":"HGUVPEBGCAVWID-MKTWGIEUSA-N","pvalue":0.0275625276437918,"ratio":0.6544122530237049,"synonym_name":""}],"totalFeatures":27},{"comparisonGroups":["Pregnant_Blood_Plasma_Day_1","Pregnant_Blood_Plasma_Day_4"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse blood plasma: pregnancy day 1 vs day 4","group_a_title":"Pregnant mice blood plasma samples collected on day 1.. Provides baseline metabolic profile for comparison with later time points.","group_b_title":"Pregnant mice blood plasma samples collected on day 4.. Captures metabolic changes occurring by day 4 of pregnancy.","id":"MTBLS627_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS627","studyUrl":"http://integmet.org/study/MTBLS627","title":"Pregnant_Blood_Plasma_Day_1_vs_Pregnant_Blood_Plasma_Day_4","topHits":[{"chebi_id":"18186","direction":"down","inn_name":"","iupac_name":"tyrosine","metabolite_id":"OUYCCCASQSFEME-UHFFFAOYSA-N","pvalue":0.0013055330537314,"ratio":0.3641548836133823,"synonym_name":"Tyrosin"},{"chebi_id":"30763","direction":"down","inn_name":"","iupac_name":"4-hydroxybenzoic acid","metabolite_id":"FJKROLUGYXJWQN-UHFFFAOYSA-N","pvalue":0.0011459373040323,"ratio":0.5433461849329221,"synonym_name":"<em>p</em>-salicylic acid"},{"chebi_id":"18183","direction":"down","inn_name":"","iupac_name":"5-oxo-<small>L</small>-proline","metabolite_id":"ODHCTXKNWHHXJC-VKHMYHEASA-N","pvalue":0.0044909500634788,"ratio":0.5531787136115797,"synonym_name":"(\u2212)-2-pyrrolidone-5-carboxylic acid"},{"chebi_id":"15741","direction":"down","inn_name":"","iupac_name":"succinic acid","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","pvalue":0.018512917611021,"ratio":0.4578893931136665,"synonym_name":"E363"},{"chebi_id":"64554","direction":"down","inn_name":"","iupac_name":"2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-UHFFFAOYSA-N","pvalue":0.005658703218983,"ratio":0.571236038591304,"synonym_name":"2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"27570","direction":"down","inn_name":"","iupac_name":"histidine","metabolite_id":"HNDVDQJCIGZPNO-UHFFFAOYSA-N","pvalue":0.0020189921633728,"ratio":0.6453125529319546,"synonym_name":"Histidine"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0078071137148147,"ratio":0.5975474427634168,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"25094","direction":"down","inn_name":"","iupac_name":"2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-UHFFFAOYSA-N","pvalue":0.0232948860962469,"ratio":0.6091007651757661,"synonym_name":"K"},{"chebi_id":"18101","direction":"down","inn_name":"","iupac_name":"(4-hydroxyphenyl)acetic acid","metabolite_id":"XQXPVVBIMDBYFF-UHFFFAOYSA-N","pvalue":0.0398135195317945,"ratio":0.6521196767044339,"synonym_name":"4-Hydroxyphenylacetic acid"}],"totalFeatures":98},{"comparisonGroups":["WT","PttVAP_Gene12_Line1"],"dateCreated":"2025-09-26 00:00:00","display_title":"Aspen: PttVAP27-17 overexpression vs wild-type","group_a_title":"Wild-type control group.. Serves as the reference group to evaluate the effects of genetic modifications.","group_b_title":"Transgenic hybrid aspen line 1 overexpressing PttVAP27-17.. Evaluates the effect of PttVAP27-17 overexpression on biomass and saccharification.","id":"MTBLS628_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS628","studyUrl":"http://integmet.org/study/MTBLS628","title":"WT_vs_PttVAP_Gene12_Line1","topHits":[{"chebi_id":"9300","direction":"up","inn_name":"","iupac_name":"octanedioic acid","metabolite_id":"TYFQFVWCELRYAO-UHFFFAOYSA-N","pvalue":6.078317981315369e-08,"ratio":3.3014800434766154,"synonym_name":"Cork acid"},{"chebi_id":"86542","direction":"up","inn_name":"","iupac_name":"2-hydroxyhexanoic acid","metabolite_id":"NYHNVHGFPZAZGA-UHFFFAOYSA-N","pvalue":1.8637936412162266e-07,"ratio":3.2148393583911896,"synonym_name":"2-hydroxycaproic acid"},{"chebi_id":"149479","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XGCJRRDNIMSYNC-INVBOZNNSA-N","pvalue":0.0029829223379216,"ratio":1.65756854531607,"synonym_name":""}],"totalFeatures":9},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: antibody treatment vs control","group_a_title":"Control group of peritoneal macrophages.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with antibodies.. Evaluates the impact of antibody treatment on macrophages.","id":"MTBLS629_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":13,"studyId":"MTBLS629","studyUrl":"http://integmet.org/study/MTBLS629","title":"Ctrl_vs_Ab","topHits":[{"chebi_id":"187042","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"ONSVAFNPEAEPSP-CPUBONDHSA-N","pvalue":0.0163975216665588,"ratio":5.381089874361095,"synonym_name":""},{"chebi_id":"15658","direction":"up","inn_name":"","iupac_name":"(7<i>S</i>,8<i>S</i>,9<i>Z</i>,12<i>Z</i>)-7,8-dihydroxyoctadeca-9,12-dienoic acid","metabolite_id":"NMONGVDUESEHOK-MPOZZNMKSA-N","pvalue":0.0091976500186549,"ratio":1.7656311452014897,"synonym_name":"(9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoate"},{"chebi_id":"15655","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>,11<i>E</i>,13<i>S</i>)-13-hydroperoxyoctadeca-9,11-dienoic acid","metabolite_id":"JDSRHVWSAMTSSN-IRQZEAMPSA-N","pvalue":0.0091976500186549,"ratio":1.7656311452014897,"synonym_name":"(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoate"},{"chebi_id":"15545","direction":"up","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic acid","metabolite_id":"BGKHCLZFGPIKKU-LDDQNKHRSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":"PGA1"},{"chebi_id":"27624","direction":"up","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-15-hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid","metabolite_id":"YBHMPNRDOVPQIN-VSOYFRJCSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":"PGB1"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UTLCNJREJFJDLH-UAAPODJFSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":""},{"chebi_id":"15647","direction":"up","inn_name":"","iupac_name":"(5<i>S</i>,6<i>Z</i>,8<i>E</i>,10<i>E</i>,12<i>R</i>,14<i>Z</i>)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid","metabolite_id":"VNYSSYRCGWBHLG-AMOLWHMGSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":"LTB4"},{"chebi_id":"36190","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,9<i>E</i>)-8-hydroxy-10-{(2<i>S</i>,3<i>S</i>)-3-[(2<i>Z</i>)-oct-2-en-1-yl]oxiran-2-yl}deca-5,9-dienoic acid","metabolite_id":"SGTUOBURCVMACZ-SEVPPISGSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":"(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid"},{"chebi_id":"34784","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>)-10-hydroxy-10-{(2<i>S</i>,3<i>S</i>)-3-[(2<i>Z</i>)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid","metabolite_id":"DWNBPRRXEVJMPO-RNGYDEEPSA-N","pvalue":0.0113496006486693,"ratio":1.787633522509021,"synonym_name":"10-hydroxy-11S,12S-epoxy-5Z,8Z,14Z-eicosatrienoic acid"},{"chebi_id":"34229","direction":"up","inn_name":"","iupac_name":"(13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1,15-trihydroxy-2,3-dinor-8\u03b2-prost-13-en-1-oic acid","metabolite_id":"XHHYJZGDOMKLEE-RLDLTEIJSA-N","pvalue":0.0165374009582084,"ratio":1.7337203012524445,"synonym_name":"2,3-Dinor-8-iso PGF1alpha"}],"totalFeatures":48},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: control vs antibody treatment","group_a_title":"Control group of peritoneal macrophages.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with antibodies.. Evaluates the impact of antibody treatment on macrophages.","id":"MTBLS629_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS629","studyUrl":"http://integmet.org/study/MTBLS629","title":"Ctrl_vs_Ab","topHits":[{"chebi_id":"193172","direction":"down","inn_name":"","iupac_name":"3-(6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl)propanoic acid","metabolite_id":"BNVXCCQXUZCRSR-UHFFFAOYSA-N","pvalue":2.3090921516929874e-06,"ratio":1e-06,"synonym_name":""},{"chebi_id":"46234","direction":"down","inn_name":"","iupac_name":"2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione","metabolite_id":"SOECUQMRSRVZQQ-UHFFFAOYSA-N","pvalue":2.3090921516929874e-06,"ratio":1e-06,"synonym_name":"2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-2,5-cyclohexadiene-1,4-dione"},{"chebi_id":"82387","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GUOSQNAUYHMCRU-UHFFFAOYSA-N","pvalue":1.4799381359286969e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"17368","direction":"down","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":0.0002172422049413,"ratio":1e-06,"synonym_name":"Purine-6-ol"},{"chebi_id":"82925","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-3-hydroxypropane-1,2-diyl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>,4'<i>Z</i>,7'<i>Z</i>,10'<i>Z</i>,13'<i>Z</i>,16'<i>Z</i>,19'<i>Z</i>)bis-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"XIAZEYRSKHAPND-CYDJSWNTSA-N","pvalue":1.3304635420417634e-07,"ratio":0.0495244588905196,"synonym_name":"DAG(22:6\u03c93/22:6\u03c93)"},{"chebi_id":"43355","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-indol-3-yl hydrogen sulfate","metabolite_id":"BXFFHSIDQOFMLE-UHFFFAOYSA-N","pvalue":0.0012080050973112,"ratio":0.1549081657578946,"synonym_name":"3-indolyl sulfate"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RDNHPNJCALITSY-MBZSPAKGSA-N","pvalue":0.0028550722596722,"ratio":8.310793390366811,"synonym_name":""},{"chebi_id":"72965","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide","metabolite_id":"ZJVVOYPTFQEGPH-AUTSUKAISA-N","pvalue":0.0057007347679207,"ratio":4.846369119042863,"synonym_name":"Ceramide (d18:1/24:0)"},{"chebi_id":"16960","direction":"up","inn_name":"","iupac_name":"adenosine 5'-[3-(<small>D</small>-ribofuranos-5-<em>O</em>-yl) dihydrogen diphosphate]","metabolite_id":"SRNWOUGRCWSEMX-TYASJMOZSA-N","pvalue":0.0346354222764182,"ratio":4.269153464347643,"synonym_name":"ribose adenosinediphosphate"}],"totalFeatures":62},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: antibody treatment vs control","group_a_title":"Control group of peritoneal macrophages.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with antibodies.. Evaluates the impact of antibody treatment on macrophages.","id":"MTBLS631_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS631","studyUrl":"http://integmet.org/study/MTBLS631","title":"G1_Ctrl_vs_G2_Ab","topHits":[{"chebi_id":"88427","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AXODOWFEFKOVSH-UHFFFAOYSA-N","pvalue":9.371242532947996e-05,"ratio":1000000.0,"synonym_name":"3-(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl)propanoic acid"},{"chebi_id":"84299","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(tetradecanoyloxy)propyl phosphate","metabolite_id":"RPXHXZNGZBHSMJ-GOSISDBHSA-N","pvalue":0.0087677618176677,"ratio":1e-06,"synonym_name":"1-tetradecanoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion"},{"chebi_id":"197257","direction":"down","inn_name":"","iupac_name":"[(2S)-3-hydroxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate","metabolite_id":"ZXBDMMYPYQQALX-BJXCJIDGSA-N","pvalue":0.0009341589002123,"ratio":0.129125389593961,"synonym_name":""},{"chebi_id":"170423","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate","metabolite_id":"OUEUPCHAIFZTKH-LSWZYRHBSA-N","pvalue":0.0017433699786024,"ratio":6.125073626272503,"synonym_name":""},{"chebi_id":"507393","direction":"down","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":0.0057780024979255,"ratio":0.1612834015993758,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"86243","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-(docosanoyloxy)-3-(hexadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"BIIIEBBIUJYGBZ-WBVITSLISA-N","pvalue":0.0049294942923338,"ratio":5.609498516479314,"synonym_name":"1-Palmityl-2-behenoyl-sn-glycero-3-phosphocholine"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GGTCSXOVHHAZTG-UXQBZAKQSA-N","pvalue":0.023545547469824,"ratio":10.264719885732424,"synonym_name":""},{"chebi_id":"88416","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LVTHUJDMZSSKKX-HOPZLNLWSA-N","pvalue":0.0080482288057639,"ratio":4.601056568346735,"synonym_name":"PIno(16:0/22:2w6)"},{"chebi_id":"75175","direction":"down","inn_name":"","iupac_name":"uridine 3',5'-(hydrogen phosphate)","metabolite_id":"NXIHNBWNDCFCGL-XVFCMESISA-N","pvalue":0.029644919795962,"ratio":0.2051894600385239,"synonym_name":"Cyclic ump"},{"chebi_id":"190232","direction":"up","inn_name":"","iupac_name":"[(2S,3R)-3-hydroxy-2-(tetracosanoylamino)octadec-5-enyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"OVUFCYJWDPYDIX-CRCOQUFZSA-N","pvalue":0.0281689107623361,"ratio":3.9391805764251417,"synonym_name":""}],"totalFeatures":50},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: antibody treatment vs control","group_a_title":"Control group of peritoneal macrophages.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with antibodies.. Evaluates the impact of antibody treatment on macrophages.","id":"MTBLS631_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS631","studyUrl":"http://integmet.org/study/MTBLS631","title":"G1_Ctrl_vs_G2_Ab","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JNSNGAGZRAXQPY-WBSLUPPMSA-N","pvalue":3.1522966060306765e-10,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"170423","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate","metabolite_id":"OUEUPCHAIFZTKH-LSWZYRHBSA-N","pvalue":6.63413604314078e-07,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"88789","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ILUYFTWKNLJHOS-BJTCJBOMSA-N","pvalue":1.8464704424285834e-12,"ratio":0.0130543183642756,"synonym_name":"(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LRRVZWFQNMJKBB-UHFFFAOYSA-N","pvalue":0.0002771784500561,"ratio":1e-06,"synonym_name":""},{"chebi_id":"76966","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenedioic acid","metabolite_id":"BGOJKUCHTMYINI-DTLRTWKJSA-N","pvalue":0.0002814004494029,"ratio":1e-06,"synonym_name":"Arachidonic acid-20-carboxylic acid"},{"chebi_id":"88493","direction":"down","inn_name":"","iupac_name":"(5<i>S</i>,6<i>Z</i>,8<i>E</i>,10<i>E</i>,12<i>R</i>,14<i>Z</i>,17<i>Z</i>)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoic acid","metabolite_id":"BISQPGCQOHLHQK-HDNPQISLSA-N","pvalue":0.0002814004494029,"ratio":1e-06,"synonym_name":"LTB5"},{"chebi_id":"27485","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oic acid","metabolite_id":"UQOQENZZLBSFKO-POPPZSFYSA-N","pvalue":0.0002814004494029,"ratio":1e-06,"synonym_name":"9-Deoxy-delta-9-pgd2"},{"chebi_id":"165273","direction":"down","inn_name":"","iupac_name":"(5Z,9E,11Z,14Z,16E)-8,18-dihydroxyicosa-5,9,11,14,16-pentaenoic acid","metabolite_id":"XFYXZNAYFJZWSH-WHXLDRDUSA-N","pvalue":0.0002814004494029,"ratio":1e-06,"synonym_name":""},{"chebi_id":"89568","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CGCZPIJMGKLVTQ-PAJBVNRRSA-N","pvalue":0.0002814004494029,"ratio":1e-06,"synonym_name":"(5Z,11beta)-9,15-Dioxo-11,16-cycloprost-5-en-1-oic acid"},{"chebi_id":"17126","direction":"up","inn_name":"","iupac_name":"3-hydroxy-4-(trimethylammonio)butanoate","metabolite_id":"PHIQHXFUZVPYII-UHFFFAOYSA-N","pvalue":0.0004695592850903,"ratio":10.942963928385083,"synonym_name":"<small>D</small>,<small>L</small>-carnitine"}],"totalFeatures":114},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: antibody treatment vs control","group_a_title":"Control group of peritoneal macrophages without any treatment.. Provides baseline data for comparison with other experimental groups.","group_b_title":"Group of peritoneal macrophages treated with antibodies.. Allows assessment of the impact of antibody treatment on macrophages.","id":"MTBLS633_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS633","studyUrl":"http://integmet.org/study/MTBLS633","title":"Ctrl_vs_Ab","topHits":[{"chebi_id":"16831","direction":"up","inn_name":"meglutol","iupac_name":"3-hydroxy-3-methylpentanedioic acid","metabolite_id":"NPOAOTPXWNWTSH-UHFFFAOYSA-N","pvalue":5.1167557994954625e-08,"ratio":1000000.0,"synonym_name":"3-HYDROXY-3-METHYL-GLUTARIC ACID"},{"chebi_id":"17126","direction":"down","inn_name":"","iupac_name":"3-hydroxy-4-(trimethylammonio)butanoate","metabolite_id":"PHIQHXFUZVPYII-UHFFFAOYSA-N","pvalue":0.0017404841460888,"ratio":1e-06,"synonym_name":"<small>D</small>,<small>L</small>-carnitine"},{"chebi_id":"26271","direction":"down","inn_name":"","iupac_name":"proline","metabolite_id":"ONIBWKKTOPOVIA-UHFFFAOYSA-N","pvalue":0.0018829971094071,"ratio":1e-06,"synonym_name":"DL-Proline"},{"chebi_id":"45441","direction":"down","inn_name":"","iupac_name":"<em>N</em>-acetylserine","metabolite_id":"JJIHLJJYMXLCOY-BYPYZUCNSA-N","pvalue":0.0489594891499376,"ratio":1e-06,"synonym_name":""},{"chebi_id":"58251","direction":"up","inn_name":"","iupac_name":"(dimethylazaniumyl)acetate","metabolite_id":"FFDGPVCHZBVARC-UHFFFAOYSA-N","pvalue":7.4096741929001715e-06,"ratio":8.087932391913593,"synonym_name":"(dimethylammonio)acetate"},{"chebi_id":"57440","direction":"up","inn_name":"","iupac_name":"(ethylazaniumyl)acetate","metabolite_id":"YPIGGYHFMKJNKV-UHFFFAOYSA-N","pvalue":7.4096741929001715e-06,"ratio":8.087932391913593,"synonym_name":"(ethylammonio)acetate"},{"chebi_id":"16865","direction":"up","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":7.4096741929001715e-06,"ratio":8.087932391913593,"synonym_name":"GABA"},{"chebi_id":"62084","direction":"up","inn_name":"","iupac_name":"3,5-dideoxy-5-(glycoloylamino)-<small>D</small>-<i>glycero</i>-\u03b2-<small>D</small>-<i>galacto</i>-non-2-ulopyranosonic acid","metabolite_id":"FDJKUWYYUZCUJX-AJKRCSPLSA-N","pvalue":0.0002191482783814,"ratio":5.895759792560061,"synonym_name":"Neu5Gc"},{"chebi_id":"73024","direction":"up","inn_name":"","iupac_name":"3-(acetyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"RDHQFKQIGNGIED-UHFFFAOYSA-N","pvalue":3.522074226086782e-05,"ratio":1.8280816156886055,"synonym_name":"Acetyl-DL-carnitine"},{"chebi_id":"63223","direction":"up","inn_name":"","iupac_name":"2'-deoxy-8-oxo-7,8-dihydroguanosine 5'-(dihydrogen phosphate)","metabolite_id":"AQIVLFLYHYFRKU-VPENINKCSA-N","pvalue":0.0304781179577044,"ratio":4.872585485387732,"synonym_name":"2'-deoxy-7,8-dihydro-8-oxoguanosine 5'-monophosphate"}],"totalFeatures":71},{"comparisonGroups":["Control_0h","GABA_0h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 40 mg/kg GABA treatment at 0h","group_a_title":"Control group with 0 mg/kg GABA dose at 0h.. Provides baseline data for comparison with GABA-treated samples.","group_b_title":"GABA-treated group with 40 mg/kg dose at 0h.. Shows the immediate effect of GABA treatment compared to control.","id":"MTBLS6337_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS6337","studyUrl":"http://integmet.org/study/MTBLS6337","title":"Control_0h_vs_GABA_0h","topHits":[{"chebi_id":"166843","direction":"down","inn_name":"","iupac_name":"2-amino-5-[(1-carboxy-2-methylpropyl)amino]-5-oxopentanoic acid","metabolite_id":"AQAKHZVPOOGUCK-UHFFFAOYSA-N","pvalue":0.0078115551347909,"ratio":0.0658128931620792,"synonym_name":""},{"chebi_id":"89582","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-phenylalanine","metabolite_id":"XHHOHZPNYFQJKL-QWRGUYRKSA-N","pvalue":0.0074129288647619,"ratio":0.1033470401852456,"synonym_name":"L-gamma-Glutamyl-L-phenylalanine"},{"chebi_id":"44215","direction":"down","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] hydrogen diphosphate}","metabolite_id":"BAWFJGJZGIEFAR-NNYOXOHSSA-N","pvalue":6.0957230369563594e-05,"ratio":0.3493512393311908,"synonym_name":"NICOTINAMIDE-ADENINE-DINUCLEOTIDE"},{"chebi_id":"15611","direction":"down","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0017336231481695,"ratio":0.3564889046264857,"synonym_name":"L-sarcosine"},{"chebi_id":"506227","direction":"down","inn_name":"","iupac_name":"2-acetamido-2-deoxy-<small>D</small>-glucopyranose","metabolite_id":"OVRNDRQMDRJTHS-RTRLPJTCSA-N","pvalue":0.0026496356343111,"ratio":0.3696294172972372,"synonym_name":"2-Acetamido-2-deoxy-D-glucose"},{"chebi_id":"9533","direction":"down","inn_name":"","iupac_name":"3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium","metabolite_id":"HZSAJDVWZRBGIF-UHFFFAOYSA-O","pvalue":0.0029185635240811,"ratio":0.387202951054505,"synonym_name":"vitamin B<small><sub>1</sub></small> monophosphate"},{"chebi_id":"16750","direction":"down","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.0155277693195121,"ratio":0.2873774609932634,"synonym_name":"G"},{"chebi_id":"17405","direction":"up","inn_name":"","iupac_name":"3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid","metabolite_id":"HXACOUQIXZGNBF-UHFFFAOYSA-N","pvalue":0.0108487049570798,"ratio":3.0695977943842516,"synonym_name":"4-pyridoxinecarboxylic acid"},{"chebi_id":"16865","direction":"down","inn_name":"","iupac_name":"4-aminobutanoic acid","metabolite_id":"BTCSSZJGUNDROE-UHFFFAOYSA-N","pvalue":2.707024526716169e-05,"ratio":0.6173408463852382,"synonym_name":"GABA"},{"chebi_id":"16238","direction":"down","inn_name":"","iupac_name":"adenosine 5'-(3-{<small>D</small>-<i>ribo</i>-5-[7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)","metabolite_id":"VWWQXMAJTJZDQX-UYBVJOGSSA-N","pvalue":0.0028331897481197,"ratio":0.451461150045966,"synonym_name":"FAD"}],"totalFeatures":110},{"comparisonGroups":["Ctrl","Ab"],"dateCreated":"2025-09-26 00:00:00","display_title":"Peritoneal macrophages: antibody treatment vs control","group_a_title":"Control group of peritoneal macrophages without any treatment.. Provides baseline data for comparison with other experimental groups.","group_b_title":"Group of peritoneal macrophages treated with antibodies.. Allows assessment of the impact of antibody treatment on macrophages.","id":"MTBLS634_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS634","studyUrl":"http://integmet.org/study/MTBLS634","title":"Ctrl_vs_Ab","topHits":[],"totalFeatures":14},{"comparisonGroups":["Control_Vehicle","FSCN1_Knockout_Vehicle"],"dateCreated":"2025-09-26 00:00:00","display_title":"FSCN1 knockout vs control (vehicle treatment)","group_a_title":"Control group treated with vehicle. Provides baseline for comparison with FSCN1 knockout under vehicle treatment","group_b_title":"FSCN1 knockout group treated with vehicle. Allows assessment of FSCN1 knockout effects compared to control under vehicle treatment","id":"MTBLS6402_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS6402","studyUrl":"http://integmet.org/study/MTBLS6402","title":"Control_Vehicle_vs_FSCN1_Knockout_Vehicle","topHits":[{"chebi_id":"30769","direction":"up","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0010685892913619,"ratio":1.9798183803397504,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"73688","direction":"up","inn_name":"isospaglumic acid","iupac_name":"<em>N</em>-acetyl-<small>L</small>-\u03b1-aspartyl-<small>L</small>-glutamic acid","metabolite_id":"OPVPGKGADVGKTG-BQBZGAKWSA-N","pvalue":0.0010515964965585,"ratio":1.929085568224451,"synonym_name":"N-Acetyl-1-aspartylglutamic acid"},{"chebi_id":"16695","direction":"up","inn_name":"","iupac_name":"5'-uridylic acid","metabolite_id":"DJJCXFVJDGTHFX-XVFCMESISA-N","pvalue":0.0228084332952831,"ratio":3.1864450049999893,"synonym_name":"pU"},{"chebi_id":"16761","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":0.0034499358437388,"ratio":2.1048533569324976,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"17858","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":0.0050292090314716,"ratio":2.0963723384165664,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"17013","direction":"up","inn_name":"","iupac_name":"5'-thymidylic acid","metabolite_id":"GYOZYWVXFNDGLU-XLPZGREQSA-N","pvalue":0.010688003903096,"ratio":2.332574861243629,"synonym_name":"Thymidylic acid"},{"chebi_id":"17345","direction":"up","inn_name":"","iupac_name":"5'-guanylic acid","metabolite_id":"RQFCJASXJCIDSX-UUOKFMHZSA-N","pvalue":0.0263155634031686,"ratio":2.700113596845111,"synonym_name":"GMP"},{"chebi_id":"16704","direction":"up","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":0.0458505266913906,"ratio":3.1889029143317265,"synonym_name":"u"},{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0231469829778585,"ratio":2.4133237564439045,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"16259","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetyl-<small>L</small>-phenylalanine","metabolite_id":"CBQJSKKFNMDLON-JTQLQIEISA-N","pvalue":0.0009464911438246,"ratio":1.6002793931006218,"synonym_name":"Acetylphenylalanine"}],"totalFeatures":37},{"comparisonGroups":["Control_Vehicle","FSCN1_Knockout_Vehicle"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs FSCN1 knockout (vehicle treatment)","group_a_title":"Control group treated with vehicle. Provides baseline for comparison with FSCN1 knockout under vehicle treatment","group_b_title":"FSCN1 knockout group treated with vehicle. Allows assessment of FSCN1 knockout effects compared to control under vehicle treatment","id":"MTBLS6402_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":28,"studyId":"MTBLS6402","studyUrl":"http://integmet.org/study/MTBLS6402","title":"Control_Vehicle_vs_FSCN1_Knockout_Vehicle","topHits":[{"chebi_id":"73688","direction":"up","inn_name":"isospaglumic acid","iupac_name":"<em>N</em>-acetyl-<small>L</small>-\u03b1-aspartyl-<small>L</small>-glutamic acid","metabolite_id":"OPVPGKGADVGKTG-BQBZGAKWSA-N","pvalue":1.0762159469610758e-05,"ratio":406.0549253573467,"synonym_name":"N-Acetyl-1-aspartylglutamic acid"},{"chebi_id":"17858","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":0.0043995277757766,"ratio":372.24094840452045,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"66892","direction":"up","inn_name":"","iupac_name":"2-methylaniline","metabolite_id":"RNVCVTLRINQCPJ-UHFFFAOYSA-N","pvalue":1.0515949330415695e-05,"ratio":10.889528059912154,"synonym_name":"2-Aminotoluene"},{"chebi_id":"17154","direction":"down","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":8.492590032119001e-06,"ratio":0.118637159830056,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"18347","direction":"up","inn_name":"","iupac_name":"<small>L</small>-norleucine","metabolite_id":"LRQKBLKVPFOOQJ-YFKPBYRVSA-N","pvalue":0.0040031571682858,"ratio":76.18928025044781,"synonym_name":"\u03b1-aminocaproic acid"},{"chebi_id":"91038","direction":"up","inn_name":"","iupac_name":"2-hydroxyphenylalanine","metabolite_id":"WRFPVMFCRNYQNR-UHFFFAOYSA-N","pvalue":0.0008020233518473,"ratio":27.77738879503473,"synonym_name":"2-amino-3-(2-hydroxyphenyl)propanoic acid"},{"chebi_id":"16709","direction":"up","inn_name":"pyridoxine","iupac_name":"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol","metabolite_id":"LXNHXLLTXMVWPM-UHFFFAOYSA-N","pvalue":0.0002619513738873,"ratio":13.582433474058586,"synonym_name":"vitamin B<small><sub>6</sub></small>"},{"chebi_id":"31445","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BQOHYSXSASDCEA-KEOHHSTQSA-N","pvalue":0.0012743161650909,"ratio":13.22940936348409,"synonym_name":"cADPR"},{"chebi_id":"27248","direction":"up","inn_name":"","iupac_name":"3-(1<em>H</em>-imidazol-4-yl)prop-2-enoic acid","metabolite_id":"LOIYMIARKYCTBW-UHFFFAOYSA-N","pvalue":0.0240276064070246,"ratio":99.13985295338104,"synonym_name":"3-(1<em>H</em>-imidazol-4-yl)-2-propenoic acid"},{"chebi_id":"17053","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-aminobutanedioic acid","metabolite_id":"CKLJMWTZIZZHCS-REOHCLBHSA-N","pvalue":0.0002271734304195,"ratio":2.53807892347245,"synonym_name":"L-Aspartic acid"}],"totalFeatures":102},{"comparisonGroups":["Control","Fermented_Mulberry_Leaves"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep: fermented mulberry leaves vs control feeding","group_a_title":"Control group with normal feeding without mulberry leaves. Provides baseline data for evaluating the effects of mulberry leaves supplementation","group_b_title":"Group of samples from sheep fed with fermented mulberry leaves. Key group for assessing the impact of fermented mulberry leaves on oxidative resistance and immunity","id":"MTBLS6516_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":24,"studyId":"MTBLS6516","studyUrl":"http://integmet.org/study/MTBLS6516","title":"Control_vs_Fermented_Mulberry_Leaves","topHits":[{"chebi_id":"132244","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(1<em>H</em>-indol-3-yl)prop-2-enoic acid","metabolite_id":"PLVPPLCLBIEYEA-AATRIKPKSA-N","pvalue":0.0014940993409458,"ratio":5.628135807881534,"synonym_name":"indole-3\u03b2-acrylic acid"},{"chebi_id":"81253","direction":"down","inn_name":"","iupac_name":"3\u03b2-hydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"SMEROWZSTRWXGI-WFVDQZAMSA-N","pvalue":0.0018486873054411,"ratio":0.2335238501457311,"synonym_name":"3\u03b2-lithocholic acid"},{"chebi_id":"27595","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b2,15-trihydroxyprosta-5,13-dien-1-oic acid","metabolite_id":"PXGPLTODNUVGFL-ZWAKLXPCSA-N","pvalue":0.0176964602976732,"ratio":0.1706929539222135,"synonym_name":"11\u03b2-prostaglandin F<small><sub>2\u03b1</sub></small>"},{"chebi_id":"141419","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arginyl-<small>L</small>-proline","metabolite_id":"LQJAALCCPOTJGB-YUMQZZPRSA-N","pvalue":0.0225781877417618,"ratio":0.1944155806670419,"synonym_name":"arginylproline"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ICBGQCZBEGKUTM-UHFFFAOYSA-N","pvalue":0.0259305136426675,"ratio":5.464194124805931,"synonym_name":""},{"chebi_id":"16119","direction":"down","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid","metabolite_id":"JXOHGGNKMLTUBP-HSUXUTPPSA-N","pvalue":0.0031529881256544,"ratio":0.3421359251939471,"synonym_name":"Shikimate"},{"chebi_id":"4170","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":0.0149853450610835,"ratio":3.902206559048589,"synonym_name":"Glc6P"},{"chebi_id":"190546","direction":"up","inn_name":"","iupac_name":"disodium;[(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl] phosphate","metabolite_id":"WJTRLMLMSLDAPQ-CCXTYWFUSA-L","pvalue":0.0149853450610835,"ratio":3.902206559048589,"synonym_name":""},{"chebi_id":"49728","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-\u03b2-<small>D</small>-mannopyranose","metabolite_id":"NBSCHQHZLSJFNQ-RWOPYEJCSA-N","pvalue":0.0149853450610835,"ratio":3.902206559048589,"synonym_name":""},{"chebi_id":"31445","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BQOHYSXSASDCEA-KEOHHSTQSA-N","pvalue":0.0293986184997461,"ratio":0.2819772999934867,"synonym_name":"cADPR"}],"totalFeatures":368},{"comparisonGroups":["Control","Fermented_Mulberry_Leaves"],"dateCreated":"2025-09-26 00:00:00","display_title":"Sheep: fermented mulberry leaves vs control feeding","group_a_title":"Control group with normal feeding without mulberry leaves. Provides baseline data for evaluating the effects of mulberry leaves supplementation","group_b_title":"Group of samples from sheep fed with fermented mulberry leaves. Key group for assessing the impact of fermented mulberry leaves on oxidative resistance and immunity","id":"MTBLS6516_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":20,"studyId":"MTBLS6516","studyUrl":"http://integmet.org/study/MTBLS6516","title":"Control_vs_Fermented_Mulberry_Leaves","topHits":[{"chebi_id":"192308","direction":"up","inn_name":"","iupac_name":"methylsulanylmethylbenzene","metabolite_id":"OFQPKKGMNWASPN-UHFFFAOYSA-N","pvalue":0.0006347474950389,"ratio":7.015398550724638,"synonym_name":""},{"chebi_id":"17780","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-3-(5-hydroxy-1<em>H</em>-indol-3-yl)propanoic acid","metabolite_id":"LDCYZAJDBXYCGN-VIFPVBQESA-N","pvalue":0.0068027297339259,"ratio":6.1334357213840445,"synonym_name":"<small>L</small>-5-hydroxytryptophan"},{"chebi_id":"28281","direction":"up","inn_name":"","iupac_name":"2-(5-methoxy-1<em>H</em>-indol-3-yl)acetic acid","metabolite_id":"COCNDHOPIHDTHK-UHFFFAOYSA-N","pvalue":0.0003906345813855,"ratio":1.762354149614008,"synonym_name":"2-(5-methoxyindole-3-yl)acetic acid"},{"chebi_id":"15946","direction":"up","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.0386340690691295,"ratio":3.4753830173102167,"synonym_name":"D-Fructose 6-phosphate"},{"chebi_id":"74566","direction":"up","inn_name":"","iupac_name":"<small>L</small>-lysyl-<small>L</small>-methionine","metabolite_id":"XBZOQGHZGQLEQO-IUCAKERBSA-N","pvalue":0.0155294543812445,"ratio":2.615418413688257,"synonym_name":"KM"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BVRPESWOSNFUCJ-UHFFFAOYSA-N","pvalue":0.0433302287995414,"ratio":3.223895793038122,"synonym_name":""},{"chebi_id":"52075","direction":"down","inn_name":"","iupac_name":"13,14-dihydroretinol","metabolite_id":"OVBOQVAIYMSUDT-HRYGCDPOSA-N","pvalue":0.0095084032237959,"ratio":0.6046493521520664,"synonym_name":"13,14-dihydroretinol"},{"chebi_id":"174331","direction":"up","inn_name":"","iupac_name":"3-(1H-imidazol-5-yl)-2-(pyrrolidine-2-carbonylamino)propanoic acid","metabolite_id":"BEPSGCXDIVACBU-UHFFFAOYSA-N","pvalue":0.0152256168179103,"ratio":1.692574692218529,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AJHCSUXXECOXOY-UHFFFAOYSA-N","pvalue":0.009046127290055,"ratio":1.5654197315409315,"synonym_name":""},{"chebi_id":"31882","direction":"down","inn_name":"","iupac_name":"<em>N</em>-methyl-<small>D</small>-aspartic acid","metabolite_id":"HOKKHZGPKSLGJE-GSVOUGTGSA-N","pvalue":0.0412323111559953,"ratio":0.536960292402798,"synonym_name":"NMDA"}],"totalFeatures":456},{"comparisonGroups":["Plasma_0h","Plasma_48h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Plasma: baseline (0h) vs 48h post-treatment","group_a_title":"Plasma samples collected at 0h. Provides baseline reference for plasma metabolomic changes over time.","group_b_title":"Plasma samples collected at 48h. Captures maximum plasma metabolomic changes post-baseline.","id":"MTBLS656_0001_00000031","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS656","studyUrl":"http://integmet.org/study/MTBLS656","title":"Plasma_0h_vs_Plasma_48h","topHits":[],"totalFeatures":116},{"comparisonGroups":["MC-producing_Exponential","MC-free_Exponential"],"dateCreated":"2025-09-26 00:00:00","display_title":"MC-producing vs MC-free strains (exponential phase)","group_a_title":"MC-producing strain at exponential growth phase. Helps in understanding the metabolite profile of MC-producing strains during active growth.","group_b_title":"MC-free strain at exponential growth phase. Helps in understanding the metabolite profile of MC-free strains during active growth.","id":"MTBLS6603_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":22,"studyId":"MTBLS6603","studyUrl":"http://integmet.org/study/MTBLS6603","title":"MC-producing_Exponential_vs_MC-free_Exponential","topHits":[{"chebi_id":"48861","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>,6<i>E</i>,10<i>E</i>)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl trihydrogen diphosphate","metabolite_id":"OINNEUNVOZHBOX-QIRCYJPOSA-N","pvalue":1.2461770279822904e-07,"ratio":1000000.0,"synonym_name":"Geranylgeranyl diphosphate"},{"chebi_id":"28813","direction":"down","inn_name":"","iupac_name":"4-(3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenol","metabolite_id":"LZFOPEXOUVTGJS-UHFFFAOYSA-N","pvalue":4.192530861992446e-05,"ratio":1e-06,"synonym_name":"Sinapoyl alcohol"},{"chebi_id":"64294","direction":"down","inn_name":"","iupac_name":"3\u03b2-hydroxycholest-5-en-7-one","metabolite_id":"YIKKMWSQVKJCOP-ABXCMAEBSA-N","pvalue":3.686128946326608e-09,"ratio":0.0071799543815067,"synonym_name":"3-beta-Hydroxycholest-5-en-7-one"},{"chebi_id":"17521","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid","metabolite_id":"AAWZDTNXLSGCEK-WYWMIBKRSA-N","pvalue":1.614716757484307e-08,"ratio":5.29195514116285,"synonym_name":"(\u2212)-Quinic acid"},{"chebi_id":"89315","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FMKLAIBZMCURLI-BFVRRIQPSA-N","pvalue":3.170515335225793e-05,"ratio":0.2186994990588475,"synonym_name":"(5Z)-9,15-dioxo-Prosta-5,10-dien-1-oic acid"},{"chebi_id":"175443","direction":"down","inn_name":"","iupac_name":"3,5,6-trihydroxy-4,6-bis(3-methylbut-2-enyl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one","metabolite_id":"DRSITEVYZGOOQG-UHFFFAOYSA-N","pvalue":1.7472976081498854e-06,"ratio":0.3132488934246764,"synonym_name":""},{"chebi_id":"89379","direction":"down","inn_name":"","iupac_name":"3-(6-hydroxy-2,7,8-trimethyl-3,4-dihydro-2<em>H</em>-chromen-2-yl)propanoic acid","metabolite_id":"VMJQLPNCUPGMNQ-UHFFFAOYSA-N","pvalue":9.356207818519e-05,"ratio":0.2525716016398967,"synonym_name":"gamma-CEHC"},{"chebi_id":"74661","direction":"up","inn_name":"","iupac_name":"imidazolidine-2,4,5-trione","metabolite_id":"ZFLIKDUSUDBGCD-UHFFFAOYSA-N","pvalue":1.989344413261971e-07,"ratio":2.147852180045812,"synonym_name":"imidazolidine-2,4,5-trione"},{"chebi_id":"90074","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"ZQVKTHRQIXSMGY-UHFFFAOYSA-N","pvalue":0.0002955271546539,"ratio":3.0810630280003557,"synonym_name":"4-Ethyl Benzoate"},{"chebi_id":"65585","direction":"down","inn_name":"","iupac_name":"11,12-dihydroxyabieta-8,11,13-trien-20-oic acid","metabolite_id":"QRYRORQUOLYVBU-VBKZILBWSA-N","pvalue":0.0003173788461485,"ratio":0.4359070489664832,"synonym_name":"Salvin"}],"totalFeatures":121},{"comparisonGroups":["MC-producing_Exponential","MC-free_Exponential"],"dateCreated":"2025-09-26 00:00:00","display_title":"MC-producing vs MC-free strains (exponential phase)","group_a_title":"MC-producing strain at exponential growth phase. Helps in understanding the metabolite profile of MC-producing strains during active growth.","group_b_title":"MC-free strain at exponential growth phase. Helps in understanding the metabolite profile of MC-free strains during active growth.","id":"MTBLS6603_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":46,"studyId":"MTBLS6603","studyUrl":"http://integmet.org/study/MTBLS6603","title":"MC-producing_Exponential_vs_MC-free_Exponential","topHits":[{"chebi_id":"177995","direction":"up","inn_name":"","iupac_name":"2-(hydroxymethyl)-6-[4-[3-(hydroxymethyl)-5-[(E)-3-hydroxyprop-1-enyl]-7-methoxy-2,3-dihydro-1-benzouran-2-yl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol","metabolite_id":"MQDDAWSOEYTMBZ-SNAWJCMRSA-N","pvalue":7.20593327158966e-10,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MEJLVLSNRYLDSG-MDCVPAOJSA-N","pvalue":4.448912960729264e-09,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"41674","direction":"up","inn_name":"","iupac_name":"cyclohexane-1,2-dione","metabolite_id":"OILAIQUEIWYQPH-UHFFFAOYSA-N","pvalue":3.842443493133157e-08,"ratio":1000000.0,"synonym_name":"1,2-cyclohexadione"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DEZRWCJGSULASM-YPJAHOAKSA-N","pvalue":9.93724058113388e-08,"ratio":1e-06,"synonym_name":""},{"chebi_id":"10120","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"SPFBVQWRJFUDBB-FYBFSNJASA-N","pvalue":8.883334366255567e-07,"ratio":1000000.0,"synonym_name":"Ziziphin"},{"chebi_id":"174681","direction":"up","inn_name":"","iupac_name":"1-methoxy-2'-methylsulanylspiro[2H-indole-3,5'-4H-1,3-thiazole]-2-ol","metabolite_id":"YMIMEAOCSJOCSI-UHFFFAOYSA-N","pvalue":1.1604297486970038e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"168078","direction":"up","inn_name":"","iupac_name":"[6-[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate","metabolite_id":"UZUDNVXQOKQTDO-DUXPYHPUSA-N","pvalue":2.9409283173229795e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"170694","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"LNGBVAOHJZCRIL-GPDPEMMZSA-N","pvalue":3.237367544530775e-05,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"34682","direction":"up","inn_name":"","iupac_name":"<em>O</em>,<em>O</em>-diethyl <em>O</em>-[6-methyl-2-(propan-2-yl)pyrimidin-4-yl] phosphorothioate","metabolite_id":"FHIVAFMUCKRCQO-UHFFFAOYSA-N","pvalue":1.1965152165308036e-08,"ratio":1318.4837307166406,"synonym_name":"Dimpylate"},{"chebi_id":"134480","direction":"up","inn_name":"","iupac_name":"egonol \u03b2-glucoside","metabolite_id":"RAMYDZNQLYKTGB-MXCHMSEPSA-N","pvalue":0.0001423484236231,"ratio":1000000.0,"synonym_name":"Egonol glucoside"}],"totalFeatures":291},{"comparisonGroups":["Col_ND_15h","Col_ND_27h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Col seeds: 15h vs 27h germination timepoints","group_a_title":"Col genotype seeds at 15 hours incubation. Helps understand early germination processes in Col genotype.","group_b_title":"Col genotype seeds at 27 hours incubation. Helps understand later germination processes in Col genotype.","id":"MTBLS662_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS662","studyUrl":"http://integmet.org/study/MTBLS662","title":"Col_ND_15h_vs_Col_ND_27h","topHits":[{"chebi_id":"30997","direction":"up","inn_name":"","iupac_name":"1,6-anhydro-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"TWNIBLMWSKIRAT-VFUOTHLCSA-N","pvalue":0.0001747347685754,"ratio":5.790173738471868,"synonym_name":"Leucoglucosan"},{"chebi_id":"57912","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":0.0045981613805073,"ratio":0.0767326433063624,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"40886","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>L</small>-arabinopyranose","metabolite_id":"SRBFZHDQGSBBOR-KLVWXMOXSA-N","pvalue":9.233429336203308e-05,"ratio":0.2262212827092382,"synonym_name":"BETA-L-ARABINOSE"},{"chebi_id":"15603","direction":"down","inn_name":"","iupac_name":"<small>L</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","pvalue":0.0008144135233147,"ratio":0.1591414730698093,"synonym_name":"<small>L</small>-Leuzin"},{"chebi_id":"15676","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(2,5-dioxoimidazolidin-4-yl)urea","metabolite_id":"POJWUDADGALRAB-UHFFFAOYSA-N","pvalue":0.0001058871260448,"ratio":3.7029392555197913,"synonym_name":"(2,5-Dioxo-4-imidazolidinyl)urea"},{"chebi_id":"47013","direction":"down","inn_name":"","iupac_name":"<small>D</small>-ribofuranose","metabolite_id":"HMFHBZSHGGEWLO-SOOFDHNKSA-N","pvalue":0.0002077474471615,"ratio":0.268296904700092,"synonym_name":"D-Ribose"},{"chebi_id":"60039","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-pyrrolidinium-2-carboxylate","metabolite_id":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","pvalue":0.0080834018703515,"ratio":0.1032269366158423,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LQXVFWRQNMEDEE-LMVFSUKVSA-N","pvalue":0.0001432449410851,"ratio":0.3718968260607718,"synonym_name":""},{"chebi_id":"46823","direction":"up","inn_name":"","iupac_name":"1<em>H</em>-purine-2,6,8-triol","metabolite_id":"LEHOTFFKMJEONL-UHFFFAOYSA-N","pvalue":0.0005728932872473,"ratio":3.041440355156065,"synonym_name":""},{"chebi_id":"48300","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,3<i>R</i>)-butane-1,2,3,4-tetrol","metabolite_id":"UNXHWFMMPAWVPI-QWWZWVQMSA-N","pvalue":9.916267180450224e-05,"ratio":2.396434018756446,"synonym_name":"<small>D</small>-<i>threo</i>-tetritol"}],"totalFeatures":103},{"comparisonGroups":["Cloned","Artificial insemination"],"dateCreated":"2025-09-26 00:00:00","display_title":"Pig fetuses: cloned vs artificial insemination","group_a_title":"Cloned pig fetuses derived from somatic cell nuclear transfer.. This group is crucial for understanding the developmental abnormalities associated with cloning.","group_b_title":"Pig fetuses derived from artificial insemination.. This group serves as a reference for normal development, allowing for comparison with cloned fetuses.","id":"MTBLS666_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":41,"studyId":"MTBLS666","studyUrl":"http://integmet.org/study/MTBLS666","title":"Cloned_vs_Artificial_insemination","topHits":[{"chebi_id":"145750","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"UDGAPAIDIJRPJY-WURSJIFCSA-N","pvalue":9.36201073787688e-07,"ratio":3.486876745385713,"synonym_name":""},{"chebi_id":"17489","direction":"up","inn_name":"","iupac_name":"adenosine 3',5'-(hydrogen phosphate)","metabolite_id":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","pvalue":0.0001353007409701,"ratio":6.485330344969338,"synonym_name":"Adenosine 3',5'-phosphate"},{"chebi_id":"74861","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonyl-<small>L</small>-methionine","metabolite_id":"APIDTRXFGYOLLH-VQVTYTSYSA-N","pvalue":1.6522958677447755e-05,"ratio":4.180886128390099,"synonym_name":"TM"},{"chebi_id":"16312","direction":"up","inn_name":"","iupac_name":"3\u03b1,7\u03b1-dihydroxy-12-oxo-5\u03b2-cholan-24-oic acid","metabolite_id":"MIHNUBCEFJLAGN-DMMBONCOSA-N","pvalue":1.0723990098009317e-06,"ratio":2.8513425834134623,"synonym_name":"3,7-dihydroxy-12-oxocholanoic acid"},{"chebi_id":"169953","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>)-2-{[(2<i>S</i>,3<i>R</i>)-2-azaniumyl-3-hydroxybutanoyl]amino}-3-hydroxybutanoate","metabolite_id":"DSGIVWSDDRDJIO-ZXXMMSQZSA-N","pvalue":5.487596992365582e-07,"ratio":2.429445105267115,"synonym_name":"<small>L</small>-threonyl-<small>L</small>-threonine zwitterion"},{"chebi_id":"62672","direction":"down","inn_name":"","iupac_name":"3,20-dioxopregn-4-en-11\u03b1-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"WVTMNZAPPOMZST-RKCIHFDFSA-N","pvalue":5.904369832610113e-06,"ratio":0.3607188792432711,"synonym_name":"11-Hydroxyprogesterone 11-glucuronide"},{"chebi_id":"18335","direction":"up","inn_name":"","iupac_name":"[4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl dihydrogen phosphate","metabolite_id":"ZMJGSOSNSPKHNH-UHFFFAOYSA-N","pvalue":4.569253011475913e-06,"ratio":2.3863380283250115,"synonym_name":"pyridoxamine 5'-(dihydrogen phosphate)"},{"chebi_id":"15651","direction":"up","inn_name":"","iupac_name":"(5<i>S</i>,6<i>S</i>,7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>)-5,6-epoxyicosa-7,9,11,14-tetraenoic acid","metabolite_id":"UFPQIRYSPUYQHK-WAQVJNLQSA-N","pvalue":0.0001163099963404,"ratio":2.9427702009330403,"synonym_name":"5<i>S</i>,6<i>S</i>-epoxy-7<i>E</i>,9<i>E</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid"},{"chebi_id":"50547","direction":"up","inn_name":"","iupac_name":"3-\u03b2-<small>D</small>-ribofuranosyl-7,9-dihydro-1<em>H</em>-purine-2,6,8(3<em>H</em>)-trione","metabolite_id":"MFGPUMDDJCTHOI-UMMCILCDSA-N","pvalue":0.0001763885861787,"ratio":2.925519065006541,"synonym_name":"Urate-3-ribonucleoside"},{"chebi_id":"28919","direction":"down","inn_name":"","iupac_name":"17-oxoestra-1,3,5(10)-trien-3-yl \u03b2-<small>D</small>-glucopyranosiduronic acid","metabolite_id":"FJAZVHYPASAQKM-JBAURARKSA-N","pvalue":0.0040494137740238,"ratio":0.1956385546054032,"synonym_name":"Estrone beta-D-glucuronide"}],"totalFeatures":46},{"comparisonGroups":["Control","Lactic_Acid"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs lactic acid treatment","group_a_title":"Control samples without treatment. Provides a reference point for evaluating the effects of lactic acid treatment.","group_b_title":"Samples treated with lactic acid. Represents the effect of lactic acid treatment on the samples.","id":"MTBLS6661_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":118,"studyId":"MTBLS6661","studyUrl":"http://integmet.org/study/MTBLS6661","title":"Control_vs_Lactic_Acid","topHits":[{"chebi_id":"16742","direction":"down","inn_name":"","iupac_name":"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid","metabolite_id":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","pvalue":7.270418738214775e-07,"ratio":0.0285691353088656,"synonym_name":"OROTIC ACID"},{"chebi_id":"194519","direction":"up","inn_name":"","iupac_name":"3,5-dihydroxy-3-methylpentanoic acid","metabolite_id":"KJTLQQUUPVSXIM-UHFFFAOYSA-N","pvalue":1.3958117733250796e-07,"ratio":13.214441284348997,"synonym_name":"\u03b2,\u03b4-dihydroxy-\u03b2-methylvaleric acid"},{"chebi_id":"57485","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alaniniumyl)-<small>L</small>-histidinate","metabolite_id":"CQOVPNPJLQNMDC-ZETCQYMHSA-N","pvalue":2.851028530771663e-05,"ratio":17.681482854595032,"synonym_name":"(2<i>S</i>)-2-[(3-azaniumylpropanoyl)amino]-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"74168","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3<em>H</em>)-one","metabolite_id":"CUOKHACJLGPRHD-BXXZVTAOSA-N","pvalue":7.585957429343663e-07,"ratio":7.539195412915733,"synonym_name":"D-Ribono-gamma-lactone"},{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":2.7735598830928717e-05,"ratio":13.627086481045334,"synonym_name":"colamine phosphate"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":6.586042878822142e-06,"ratio":8.401605709453948,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"50613","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-hydroxybutanoic acid","metabolite_id":"AFENDNXGAFYKQO-VKHMYHEASA-N","pvalue":2.739643867062606e-06,"ratio":6.360786808709245,"synonym_name":"(+)-\u03b1-hydroxybutyric acid"},{"chebi_id":"15555","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"BHMBVRSPMRCCGG-OUTUXVNYSA-N","pvalue":6.6435124395574204e-06,"ratio":0.1374147631822986,"synonym_name":"(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate"},{"chebi_id":"39236","direction":"down","inn_name":"","iupac_name":"3,7,11-trimethyldodeca-1,3,6,10-tetraene","metabolite_id":"CXENHBSYCFFKJS-UHFFFAOYSA-N","pvalue":6.339379041906701e-06,"ratio":0.1446168355851609,"synonym_name":"2,6,10-trimethyldodeca-2,6,9,11-tetraene"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BAPRUDZDYCKSOQ-RITPCOANSA-N","pvalue":2.7915706497501953e-06,"ratio":5.960700542106138,"synonym_name":""}],"totalFeatures":285},{"comparisonGroups":["Control","Lactic_Acid"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs lactic acid treatment","group_a_title":"Control samples without treatment. Provides a reference point for evaluating the effects of lactic acid treatment.","group_b_title":"Samples treated with lactic acid. Represents the effect of lactic acid treatment on the samples.","id":"MTBLS6661_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":144,"studyId":"MTBLS6661","studyUrl":"http://integmet.org/study/MTBLS6661","title":"Control_vs_Lactic_Acid","topHits":[{"chebi_id":"165142","direction":"up","inn_name":"","iupac_name":"(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid","metabolite_id":"PRONOHBTMLNXCZ-BZSNNMDCSA-N","pvalue":6.561039382442706e-07,"ratio":7.087534139418506,"synonym_name":""},{"chebi_id":"2003","direction":"up","inn_name":"","iupac_name":"5,6-dihydroxy-1<em>H</em>-indole-2-carboxylic acid","metabolite_id":"YFTGOBNOJKXZJC-UHFFFAOYSA-N","pvalue":7.940331004106972e-07,"ratio":7.221467945005803,"synonym_name":"5,6-dihydroxy-2-indolylcarboxylic acid"},{"chebi_id":"507393","direction":"up","inn_name":"","iupac_name":"2-azaniumylethane-1-sulfonate","metabolite_id":"XOAAWQZATWQOTB-UHFFFAOYSA-N","pvalue":3.975929607084693e-09,"ratio":3.873541052226911,"synonym_name":"2-ammonioethanesulfonate"},{"chebi_id":"194258","direction":"up","inn_name":"","iupac_name":"3-[4-(3,5-dichloropyridin-4-yl)piperazin-1-yl]-1,1,1-triluoropropan-2-ol","metabolite_id":"NOYVNTMPAIAKNS-UHFFFAOYSA-N","pvalue":1.5826102523555787e-06,"ratio":6.60838304278869,"synonym_name":""},{"chebi_id":"167858","direction":"down","inn_name":"","iupac_name":"(4E,6Z,8S,10Z)-8-hydroxyhexadeca-4,6,10-trienoic acid","metabolite_id":"KBOVKDIBOBQLRS-HBARYMQFSA-N","pvalue":1.298497382515018e-06,"ratio":0.2037185662323079,"synonym_name":""},{"chebi_id":"194280","direction":"up","inn_name":"","iupac_name":"methyl 6-(4-chlorophenyl)sulanyl-5-nitropyridine-3-carboxylate","metabolite_id":"NAYAHIXHOQSKND-UHFFFAOYSA-N","pvalue":5.465969725198942e-07,"ratio":4.213915412201352,"synonym_name":""},{"chebi_id":"21547","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidobutanedioic acid","metabolite_id":"OTCCIMWXFLJLIA-BYPYZUCNSA-N","pvalue":4.922172341748097e-06,"ratio":4.599411311045751,"synonym_name":"<em>N</em>-acetylaspartic acid"},{"chebi_id":"183464","direction":"down","inn_name":"","iupac_name":"N-(4-chlorophenyl)-5-hex-1-ynylpyridine-3-carboxamide","metabolite_id":"PFSBGLFXLNKGCH-UHFFFAOYSA-N","pvalue":4.653933562481339e-06,"ratio":0.2401262572288701,"synonym_name":""},{"chebi_id":"183468","direction":"up","inn_name":"","iupac_name":"4-oxododecanedioic acid","metabolite_id":"HHXMOTDTSDYYEI-UHFFFAOYSA-N","pvalue":3.1794835767983616e-05,"ratio":4.498078013025855,"synonym_name":""},{"chebi_id":"111284","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GODLCSLPZIBRMG-UHFFFAOYSA-N","pvalue":1.192789202650438e-05,"ratio":0.2665154221535309,"synonym_name":""}],"totalFeatures":382},{"comparisonGroups":["HRFI_Hepatopancreas","LRFI_Hepatopancreas"],"dateCreated":"2025-09-26 00:00:00","display_title":"Hepatopancreas: high vs low residual feed intake","group_a_title":"High Residual Feed Intake group with samples from hepatopancreas. This group helps in understanding the metabolic processes in hepatopancreas under high feed intake conditions.","group_b_title":"Low Residual Feed Intake group with samples from hepatopancreas. This group helps in understanding the metabolic processes in hepatopancreas under low feed intake conditions.","id":"MTBLS6663_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":313,"studyId":"MTBLS6663","studyUrl":"http://integmet.org/study/MTBLS6663","title":"HRFI_Hepatopancreas_vs_LRFI_Hepatopancreas","topHits":[{"chebi_id":"157747","direction":"up","inn_name":"","iupac_name":"(5Z,9E,11Z,14Z,17Z)-8-hydroxyicosa-5,9,11,14,17-pentaenoic acid","metabolite_id":"WLOUCHKFBGGNEB-GXIKJMEPSA-N","pvalue":3.325942726190136e-07,"ratio":11.475043135762188,"synonym_name":""},{"chebi_id":"85530","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxyphenyl)-<em>N</em>-{3-[(4-{[(2<i>E</i>)-3-(4-hydroxyphenyl)prop-2-enoyl]amino}butyl)amino]propyl}prop-2-enamide","metabolite_id":"QYBCBMVQSCJMSA-VOMDNODZSA-N","pvalue":0.0030574951773156,"ratio":203.03250275746055,"synonym_name":""},{"chebi_id":"30915","direction":"up","inn_name":"","iupac_name":"2-oxopentanedioic acid","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","pvalue":1.7555737799252455e-10,"ratio":3.621314213747442,"synonym_name":"\u03b1-ketoglutaric acid"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"QPRBEFUOPKPWPH-IHXLJJIQSA-N","pvalue":9.744296401354203e-07,"ratio":7.132158490522411,"synonym_name":""},{"chebi_id":"81563","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LRWYBGFSVUBWMO-UAAZXLHOSA-N","pvalue":9.941352105084186e-05,"ratio":15.903315753774606,"synonym_name":"18R-Hydroxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid"},{"chebi_id":"8207","direction":"up","inn_name":"","iupac_name":"(3<i>S</i>,4<i>R</i>)-3-ethyl-4-[(1-methyl-1<em>H</em>-imidazol-5-yl)methyl]dihydrofuran-2(3<em>H</em>)-one","metabolite_id":"QCHFTSOMWOSFHM-WPRPVWTQSA-N","pvalue":4.297264186404363e-05,"ratio":10.76850818592974,"synonym_name":"(3<i>S</i>,4<i>R</i>)-3-ethyldihydro-4-((1-methyl-1<em>H</em>-imidazol-5-yl)methyl)-2(3<em>H</em>)-furanone"},{"chebi_id":"193405","direction":"up","inn_name":"","iupac_name":"2,2-dimethylchromene-5,7-diol","metabolite_id":"YYXCJULMDCUPPI-UHFFFAOYSA-N","pvalue":1.6190792617825225e-07,"ratio":4.6068558796858055,"synonym_name":""},{"chebi_id":"180517","direction":"up","inn_name":"","iupac_name":"ethyl (E)-3-(4-hydroxyphenyl)prop-2-enoate","metabolite_id":"ZOQCEVXVQCPESC-VMPITWQZSA-N","pvalue":9.682095633180875e-08,"ratio":4.223437361490988,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"XSZLIUKGUQXBSG-UHFFFAOYSA-N","pvalue":9.156970690506404e-07,"ratio":4.784681285539252,"synonym_name":""},{"chebi_id":"57532","direction":"down","inn_name":"","iupac_name":"8-azaniumyl-7-oxononanoate","metabolite_id":"GUAHPAJOXVYFON-UHFFFAOYSA-N","pvalue":0.0002036663473554,"ratio":0.0955475994342955,"synonym_name":"8-ammonio-7-oxononanoate"}],"totalFeatures":361},{"comparisonGroups":["0_min","60_min"],"dateCreated":"2025-09-26 00:00:00","display_title":"Nitrogen starvation: 0 min baseline vs 60 min treatment","group_a_title":"Baseline control group at 0 minutes of nitrogen starvation.. Serves as the reference point for all subsequent time points.","group_b_title":"Group at 60 minutes of nitrogen starvation.. Highlights sustained metabolic changes over time.","id":"MTBLS67_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":21,"studyId":"MTBLS67","studyUrl":"http://integmet.org/study/MTBLS67","title":"0_min_vs_60_min","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"NAQGHJTUZRHGAC-LBGUGVGYSA-N","pvalue":4.702513534808414e-06,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"18272","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(<em>N</em>-formylglycyl)-5-<em>O</em>-phosphono-<small>D</small>-ribofuranosylamine","metabolite_id":"VDXLUNDMVKSKHO-ZRTZXPPTSA-N","pvalue":2.8853536148590947e-05,"ratio":1000000.0,"synonym_name":"5'-Phosphoribosyl-N-formylglycinamide"},{"chebi_id":"18413","direction":"up","inn_name":"","iupac_name":"1-deoxy-1-[2-(formamido)acetimidamido]-<small>D</small>-ribofuranose 5-(dihydrogen phosphate)","metabolite_id":"PMCOGCVKOAOZQM-ZRTZXPPTSA-N","pvalue":0.0021921298066929,"ratio":1000000.0,"synonym_name":"5'-Phosphoribosyl-N-formylglycinamidine"},{"chebi_id":"16551","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"HDTRYLNUVZCQOY-LIZSDCNHSA-N","pvalue":2.450390311477807e-05,"ratio":0.0115002225849532,"synonym_name":"alpha,alpha-Trehalose"},{"chebi_id":"17202","direction":"up","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":1.4562035933275868e-05,"ratio":62.25000000000001,"synonym_name":"Inosine 5'-phosphate"},{"chebi_id":"16810","direction":"down","inn_name":"","iupac_name":"2-oxopentanedioate","metabolite_id":"KPGXRSRHYNQIFN-UHFFFAOYSA-L","pvalue":0.0003802078098693,"ratio":0.0375615763546798,"synonym_name":"2-oxopentanedioic acid, ion(2\u2212)"},{"chebi_id":"17677","direction":"down","inn_name":"","iupac_name":"cytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"PCDQPRRSZKQHHS-XVFCMESISA-N","pvalue":0.000111968798589,"ratio":0.2463442069741282,"synonym_name":"5'-CTP"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LFTYTUAZOPRMMI-MPIASZHXSA-N","pvalue":0.0012910226917319,"ratio":0.1758530183727034,"synonym_name":""},{"chebi_id":"30031","direction":"down","inn_name":"","iupac_name":"butanedioate","metabolite_id":"KDYFGRWQOYBRFD-UHFFFAOYSA-L","pvalue":0.0189282242127932,"ratio":0.0617283950617283,"synonym_name":"<small><sup>\u2212</small></sup>OOC\u2012CH<small><sub>2</sub></small>\u2012CH<small><sub>2</sub></small>\u2012COO<small><sup>\u2212</small></sup>"},{"chebi_id":"16732","direction":"up","inn_name":"","iupac_name":"5'-<em>O</em>-[{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine","metabolite_id":"WVIMUEUQJFPNDK-PEBGCTIMSA-N","pvalue":0.0030163829306506,"ratio":6.666666666666665,"synonym_name":"CDP ethanolamine"}],"totalFeatures":30},{"comparisonGroups":["0_min","60_min"],"dateCreated":"2025-09-26 00:00:00","display_title":"Nitrogen starvation: 0 min baseline vs 60 min treatment","group_a_title":"Baseline control group at 0 minutes of nitrogen starvation.. Serves as the reference point for all subsequent time points.","group_b_title":"Group at 60 minutes of nitrogen starvation.. Highlights sustained metabolic changes over time.","id":"MTBLS67_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS67","studyUrl":"http://integmet.org/study/MTBLS67","title":"0_min_vs_60_min","topHits":[{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"GVQNHIYBRMFCMS-UHFFFAOYSA-N","pvalue":0.0021921298066929,"ratio":1e-06,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MSWKATKSSLJVEX-UHFFFAOYSA-J","pvalue":0.0161300899000926,"ratio":1000000.0,"synonym_name":""},{"chebi_id":"79057","direction":"down","inn_name":"","iupac_name":"(2<em>S</em>)-3-(2-{[(2<i>R</i>)-2-amino-2-carboxyethyl]sulfinyl}-1<em>H</em>-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"CSTNDZVKJNPMIG-PTZMPWRZSA-N","pvalue":0.000331839789339,"ratio":0.0119521912350597,"synonym_name":""},{"chebi_id":"18211","direction":"up","inn_name":"","iupac_name":"citrulline","metabolite_id":"RHGKLRLOHDJJDR-UHFFFAOYSA-N","pvalue":1.550452522367086e-05,"ratio":17.593220338983052,"synonym_name":"2-Amino-5-uredovaleric acid"},{"chebi_id":"27570","direction":"up","inn_name":"","iupac_name":"histidine","metabolite_id":"HNDVDQJCIGZPNO-UHFFFAOYSA-N","pvalue":3.251247819894686e-06,"ratio":11.710144927536234,"synonym_name":"Histidine"},{"chebi_id":"17562","direction":"down","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":5.2533728959137546e-05,"ratio":0.0949554896142433,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"84058","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":0.0001366397718709,"ratio":7.860465116279069,"synonym_name":""},{"chebi_id":"40521","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SNEIUMQYRCDYCH-LURJTMIESA-N","pvalue":3.596872243786467e-05,"ratio":0.2154942119323241,"synonym_name":"<em>N</em>-Ac-<small>L</small>-Arg-OH"},{"chebi_id":"28300","direction":"up","inn_name":"","iupac_name":"glutamine","metabolite_id":"ZDXPYRJPNDTMRX-UHFFFAOYSA-N","pvalue":0.0061293874505853,"ratio":15.588235294117649,"synonym_name":"Glutamine"},{"chebi_id":"86392","direction":"down","inn_name":"","iupac_name":"4-carbamimidamidobutanoate","metabolite_id":"TUHVEAJXIMEOSA-UHFFFAOYSA-M","pvalue":0.0023604080502446,"ratio":0.1285714285714285,"synonym_name":""}],"totalFeatures":41},{"comparisonGroups":["Female_Artificial_Feed","Female_Grass_Feed"],"dateCreated":"2025-09-26 00:00:00","display_title":"Female grass carp: artificial vs grass feed","group_a_title":"Female grass carp fed with artificial feed.. Helps in understanding the effects of artificial feed on female grass carp.","group_b_title":"Female grass carp fed with grass feed.. Helps in understanding the effects of grass feed on female grass carp.","id":"MTBLS673_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":79,"studyId":"MTBLS673","studyUrl":"http://integmet.org/study/MTBLS673","title":"Female_Artificial_Feed_vs_Female_Grass_Feed","topHits":[{"chebi_id":"3560","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IWSJXTCXZSUCNS-LXFSFDBISA-N","pvalue":3.3147655300158764e-11,"ratio":0.3136849680984239,"synonym_name":"Cernuine"},{"chebi_id":"82282","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"PQYJRMFWJJONBO-UHFFFAOYSA-N","pvalue":5.593736579183824e-09,"ratio":3.587657439152567,"synonym_name":"tris-BP"},{"chebi_id":"63924","direction":"down","inn_name":"","iupac_name":"(15<i>Z</i>)-12,18-dihydroxy-13,19-didehydrosenecionan-11,16-dione","metabolite_id":"SVCNNZDUGWLODJ-RAYFHMIRSA-N","pvalue":6.983598111669543e-13,"ratio":0.4248598911930948,"synonym_name":"Riddeliine"},{"chebi_id":"33388","direction":"down","inn_name":"","iupac_name":"plutonium","metabolite_id":"OYEHPCDNVJXUIW-UHFFFAOYSA-N","pvalue":1.9055348423417985e-12,"ratio":0.4462372450650411,"synonym_name":"plutonio"},{"chebi_id":"16096","direction":"down","inn_name":"","iupac_name":"2,3,9,10-tetramethoxy-5,6-dihydroisoquino[3,2-<em>a</em>]isoquinolinium","metabolite_id":"QUCQEUCGKKTEBI-UHFFFAOYSA-N","pvalue":9.39826286259373e-12,"ratio":0.4722780010798684,"synonym_name":"5,6-Dihydro-2,3,9,10-tetramethoxydibenzo[a,g]quinolizinium"},{"chebi_id":"6701","direction":"up","inn_name":"maitansinum","iupac_name":"(4\u03b2,5\u03b2,11<i>E</i>,13<i>E</i>)-maytansine","metabolite_id":"WKPWGQKGSOKKOO-RSFHAFMBSA-N","pvalue":1.898548667201432e-09,"ratio":2.362936101571446,"synonym_name":"Maytansine"},{"chebi_id":"9588","direction":"down","inn_name":"ticlopidina","iupac_name":"5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-<em>c</em>]pyridine","metabolite_id":"PHWBOXQYWZNQIN-UHFFFAOYSA-N","pvalue":1.629049956771905e-10,"ratio":0.489311862112421,"synonym_name":""},{"chebi_id":"34812","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IEMDOFXTVAPVLX-YWQHLDGFSA-N","pvalue":0.0003173819014916,"ratio":0.1436702409466445,"synonym_name":"Leucomycin A1"},{"chebi_id":"52099","direction":"down","inn_name":"","iupac_name":"2-{4-[4-(dimethylamino)phenyl]buta-1,3-dien-1-yl}-3-ethyl-1,3-benzothiazol-3-ium perchlorate","metabolite_id":"FWTLKTVVDHEQMM-UHFFFAOYSA-M","pvalue":9.823183622071368e-11,"ratio":0.5086102018422451,"synonym_name":"Styryl 8 perchlorate"},{"chebi_id":"71512","direction":"down","inn_name":"","iupac_name":"1-<em>O</em>-(4-hydroxy-3-methoxybenzoyl)-\u03b2-<small>D</small>-glucopyranose","metabolite_id":"YROOZUQRTLHXIO-DIACKHNESA-N","pvalue":4.1310563474039207e-05,"ratio":0.2283657581935879,"synonym_name":""}],"totalFeatures":1015},{"comparisonGroups":["Control_Group","PCOS_Group"],"dateCreated":"2025-09-26 00:00:00","display_title":"PCOS model (high-fat diet + DHEA) vs control","group_a_title":"Control group receiving normal chow diet and sesame oil.. Provides baseline data for comparison with treatment effects.","group_b_title":"PCOS model group induced by high-fat diet and DHEA.. Represents the disease model for evaluating treatment effects.","id":"MTBLS6736_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":11,"studyId":"MTBLS6736","studyUrl":"http://integmet.org/study/MTBLS6736","title":"Control_vs_PCOS","topHits":[{"chebi_id":"29073","direction":"up","inn_name":"\u00e1cido asc\u00f3rbico","iupac_name":"(5<i>R</i>)-5-[(1<i>S</i>)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5<em>H</em>)-one","metabolite_id":"CIWBSHSKHKDKBQ-JLAZNSOCSA-N","pvalue":6.339710593542794e-05,"ratio":9.897358438144934,"synonym_name":"Vitamin C"},{"chebi_id":"68352","direction":"up","inn_name":"","iupac_name":"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4<em>H</em>-chromen-3-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"OVSQVDMCBVZWGM-QSOFNFLRSA-N","pvalue":6.339710593542794e-05,"ratio":9.897358438144934,"synonym_name":"Isotrifoliin"},{"chebi_id":"28635","direction":"up","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":0.004931912506718,"ratio":38.75395044569952,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"},{"chebi_id":"27470","direction":"up","inn_name":"acide folique","iupac_name":"<em>N</em>-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid","metabolite_id":"OVBPIULPVIDEAO-LBPRGKRZSA-N","pvalue":0.004931912506718,"ratio":38.75395044569952,"synonym_name":"vitamin Be"},{"chebi_id":"32805","direction":"up","inn_name":"","iupac_name":"(1<i>Z</i>)-prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-IWQZZHSRSA-N","pvalue":0.024184738000677,"ratio":151.8810417567704,"synonym_name":"<i>cis</i>-1-propene-1,2,3-tricarboxylic acid"},{"chebi_id":"1879","direction":"up","inn_name":"","iupac_name":"4-(2-hydroxyethyl)phenol","metabolite_id":"YCCILVSKPBXVIP-UHFFFAOYSA-N","pvalue":0.024184738000677,"ratio":151.8810417567704,"synonym_name":"Tyrosol"},{"chebi_id":"17405","direction":"up","inn_name":"","iupac_name":"3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid","metabolite_id":"HXACOUQIXZGNBF-UHFFFAOYSA-N","pvalue":0.0004907414027341,"ratio":6.982945804342302,"synonym_name":"4-pyridoxinecarboxylic acid"},{"chebi_id":"30860","direction":"up","inn_name":"","iupac_name":"methylpropanedioic acid","metabolite_id":"ZIYVHBGGAOATLY-UHFFFAOYSA-N","pvalue":0.0004907414027341,"ratio":6.982945804342302,"synonym_name":"1,1-Ethanedicarboxylic acid"},{"chebi_id":"57924","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoate","metabolite_id":"AHMIDUVKSGCHAU-LURJTMIESA-N","pvalue":0.0001820312467766,"ratio":4.506034902798652,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoate"},{"chebi_id":"75095","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RTIXKCRFFJGDFG-UHFFFAOYSA-N","pvalue":0.0071288491982608,"ratio":12.096662833761268,"synonym_name":"5,7-dihydroxy-2-phenylchromen-4-one"}],"totalFeatures":12},{"comparisonGroups":["Control_Group","PCOS_Group"],"dateCreated":"2025-09-26 00:00:00","display_title":"PCOS model (high-fat diet + DHEA) vs control","group_a_title":"Control group receiving normal chow diet and sesame oil.. Provides baseline data for comparison with treatment effects.","group_b_title":"PCOS model group induced by high-fat diet and DHEA.. Represents the disease model for evaluating treatment effects.","id":"MTBLS6736_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS6736","studyUrl":"http://integmet.org/study/MTBLS6736","title":"Control_vs_PCOS","topHits":[{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":3.7637875518080554e-08,"ratio":0.0870679420566966,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"18300","direction":"up","inn_name":"","iupac_name":"(2<i>Z</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UPHRSURJSA-N","pvalue":1.0243598387076068e-05,"ratio":32.59381534581979,"synonym_name":"Maleic acid"},{"chebi_id":"16973","direction":"down","inn_name":"","iupac_name":"21-hydroxypregn-4-ene-3,20-dione","metabolite_id":"ZESRJSPZRDMNHY-YFWFAHHUSA-N","pvalue":1.8154126499882237e-06,"ratio":0.0564075897489082,"synonym_name":"desoxycortone"},{"chebi_id":"17620","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid","metabolite_id":"KSEBMYQBYZTDHS-HWKANZROSA-N","pvalue":2.3115190013635262e-06,"ratio":18.096427205179488,"synonym_name":"Ferulic acid"},{"chebi_id":"53487","direction":"down","inn_name":"","iupac_name":"(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>)-docosa-7,10,13,16-tetraenoic acid","metabolite_id":"TWSWSIQAPQLDBP-DOFZRALJSA-N","pvalue":0.0005215780584182,"ratio":0.0126741635524277,"synonym_name":"Adrenic acid"},{"chebi_id":"18067","direction":"up","inn_name":"phytom\u00e9nadione","iupac_name":"2-methyl-3-[(2<i>E</i>,7<i>R</i>,11<i>R</i>)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-dione","metabolite_id":"MBWXNTAXLNYFJB-NKFFZRIASA-N","pvalue":3.6133380360866817e-06,"ratio":12.83597448553797,"synonym_name":"2-methyl-3-phytyl-1,4-naphthoquinone"},{"chebi_id":"10043","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-8-methoxy-2-phenyl-4<em>H</em>-chromen-4-one","metabolite_id":"XLTFNNCXVBYBSX-UHFFFAOYSA-N","pvalue":0.0002580792726063,"ratio":38.25414405906616,"synonym_name":"Norwogonin 8-methyl ether"},{"chebi_id":"9901","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SYGWGHVTLUBCEM-ZIZPXRJBSA-N","pvalue":7.082153297429972e-05,"ratio":0.0630888353361375,"synonym_name":"Urocortisone"},{"chebi_id":"16827","direction":"down","inn_name":"","iupac_name":"11\u03b2,21-dihydroxypregn-4-ene-3,20-dione","metabolite_id":"OMFXVFTZEKFJBZ-HJTSIMOOSA-N","pvalue":0.0001431130284803,"ratio":0.0630086194169623,"synonym_name":"11beta,21-Dihydroxy-4-pregnene-3,20-dione"},{"chebi_id":"34778","direction":"up","inn_name":"","iupac_name":"7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4<em>H</em>-one","metabolite_id":"DXYUAIFZCFRPTH-UHFFFAOYSA-N","pvalue":0.0028411901878468,"ratio":46.96934547072928,"synonym_name":"7,4'-Dihydroxy-6-methoxyisoflavone"}],"totalFeatures":27},{"comparisonGroups":["wild_type","patA_deletion"],"dateCreated":"2025-09-26 00:00:00","display_title":"patA deletion vs wild-type comparison","group_a_title":"Wild type samples.. Provides a baseline for comparing the effects of patA deletion and overexpression.","group_b_title":"Samples with patA deletion genotype.. Helps in understanding the role of patA in drug resistance and biofilm formation.","id":"MTBLS6758_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS6758","studyUrl":"http://integmet.org/study/MTBLS6758","title":"wild_type_vs_patA_deletion","topHits":[{"chebi_id":"168422","direction":"up","inn_name":"","iupac_name":"2-(1-ethoxyethoxy)propanoic acid","metabolite_id":"FRGRNGNKLISCCU-UHFFFAOYSA-N","pvalue":4.184675776894743e-07,"ratio":6.206871219086767,"synonym_name":""},{"chebi_id":"194519","direction":"up","inn_name":"","iupac_name":"3,5-dihydroxy-3-methylpentanoic acid","metabolite_id":"KJTLQQUUPVSXIM-UHFFFAOYSA-N","pvalue":2.07809521785718e-06,"ratio":4.291668752947933,"synonym_name":"\u03b2,\u03b4-dihydroxy-\u03b2-methylvaleric acid"},{"chebi_id":"7865","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UQCNKQCJZOAFTQ-ISWURRPUSA-N","pvalue":0.0023209058075508,"ratio":0.104050142230944,"synonym_name":"Oxymorphone"},{"chebi_id":"88488","direction":"up","inn_name":"","iupac_name":"(2S)-2-amino-3-({[(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid","metabolite_id":"ZTNFQEXYTMNFHG-SOFXVBFTSA-N","pvalue":7.539118676172564e-05,"ratio":4.105221309682448,"synonym_name":"Phosphatidylserine(36:4)"},{"chebi_id":"167626","direction":"down","inn_name":"","iupac_name":"2-hydroxyethyl octadecanoate","metabolite_id":"RFVNOJDQRGSOEL-UHFFFAOYSA-N","pvalue":0.0012552699075958,"ratio":0.2602751622698279,"synonym_name":"ethylene glycol stearate"},{"chebi_id":"57822","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(2<i>R</i>)-2-ammoniopropanoyl]amino}propanoate","metabolite_id":"DEFJQIDDEAULHB-QWWZWVQMSA-N","pvalue":9.628384275809752e-05,"ratio":0.4729066353472315,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"DGYMUJFBJOIXMY-UHFFFAOYSA-N","pvalue":0.0040489864774271,"ratio":0.3226761220631663,"synonym_name":""},{"chebi_id":"45735","direction":"down","inn_name":"troleandomycinum","iupac_name":"(3<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,8<i>R</i>,11<i>R</i>,12<i>S</i>,13<i>R</i>,14<i>S</i>,15<i>S</i>)-12-[(4-<em>O</em>-acetyl-2,6-dideoxy-3-<em>O</em>-methyl-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyl)oxy]-14-{[2-<em>O</em>-acetyl-3,4,6-trideoxy-3-(dimethylamino)-\u03b2-<small>D</small>-<i>xylo</i>-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-6-yl acetate","metabolite_id":"LQCLVBQBTUVCEQ-QTFUVMRISA-N","pvalue":0.0081858317501712,"ratio":0.2831005182113865,"synonym_name":"Triacetyloleandomycin"},{"chebi_id":"133734","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16-pentaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"BIEOSECQPGGZMF-NAIWXXGBSA-N","pvalue":0.0068654331734865,"ratio":0.3610826562056574,"synonym_name":"Lysophosphatidylcholine(22:5n3/0:0)"},{"chebi_id":"24814","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-indol-3-ylmethanol","metabolite_id":"IVYPNXXAYMYVSP-UHFFFAOYSA-N","pvalue":0.0046927187914516,"ratio":0.4066330203302235,"synonym_name":"3-hydroxymethylindole"}],"totalFeatures":256},{"comparisonGroups":["wild_type","patA_deletion"],"dateCreated":"2025-09-26 00:00:00","display_title":"patA deletion vs wild-type comparison","group_a_title":"Wild type samples.. Provides a baseline for comparing the effects of patA deletion and overexpression.","group_b_title":"Samples with patA deletion genotype.. Helps in understanding the role of patA in drug resistance and biofilm formation.","id":"MTBLS6758_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":53,"studyId":"MTBLS6758","studyUrl":"http://integmet.org/study/MTBLS6758","title":"wild_type_vs_patA_deletion","topHits":[{"chebi_id":"177805","direction":"down","inn_name":"","iupac_name":"5-phenylpyridin-2-amine","metabolite_id":"OAPVIBHQRYFYSE-UHFFFAOYSA-N","pvalue":7.998914423854202e-08,"ratio":0.3045860921751082,"synonym_name":""},{"chebi_id":"87225","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-1-hydroxy-3-(icosanoyloxy)propan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i><i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"QEOYMVJQPHELJB-YXHLBBQNSA-N","pvalue":3.2749307414528473e-06,"ratio":3.798589545946712,"synonym_name":"Diacylglycerol(20:0/20:5n3)"},{"chebi_id":"165721","direction":"up","inn_name":"","iupac_name":"2-[(Z)-octadec-9-enoyl]oxyethyl (Z)-octadec-9-enoate","metabolite_id":"NKSOSPOXQKNIKJ-CLFAGFIQSA-N","pvalue":1.743331356249504e-05,"ratio":4.4363290623787615,"synonym_name":""},{"chebi_id":"17864","direction":"down","inn_name":"","iupac_name":"2-[(24-oxo-3\u03b1-sulfooxy-5\u03b2-cholan-24-yl)amino]ethanesulfonic acid","metabolite_id":"HSNPMXROZIQAQD-GBURMNQMSA-N","pvalue":0.0005303186421814,"ratio":0.1347740108858608,"synonym_name":"TLC-S"},{"chebi_id":"175145","direction":"up","inn_name":"","iupac_name":"(4R)-4-[(3R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","metabolite_id":"RUDATBOHQWOJDD-BYRKYSOESA-N","pvalue":5.8002251867221385e-08,"ratio":2.4451051896151395,"synonym_name":""},{"chebi_id":"174310","direction":"down","inn_name":"","iupac_name":"2-[(2-amino-4-methylpentanoyl)amino]-3-(1H-indol-3-yl)propanoic acid","metabolite_id":"BQVUABVGYYSDCJ-UHFFFAOYSA-N","pvalue":1.3662503574761182e-06,"ratio":0.367861422549431,"synonym_name":""},{"chebi_id":"60281","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>-dimethyl-9<em>H</em>-purin-6-amine","metabolite_id":"BVIAOQMSVZHOJM-UHFFFAOYSA-N","pvalue":4.709889330509957e-06,"ratio":0.4348782676560302,"synonym_name":"N,N-Dimethyl-6-aminopurine"},{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":0.000235581724405,"ratio":0.3274637699349316,"synonym_name":"Cytidine-5'-monophosphate"},{"chebi_id":"174826","direction":"down","inn_name":"","iupac_name":"(6aS,10aS)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-g]quinoline-9-carboxylic acid","metabolite_id":"YAICYXFUKKMAKO-DBQWNMKUSA-N","pvalue":3.9991622826996305e-06,"ratio":0.4995386448212434,"synonym_name":""},{"chebi_id":"3403","direction":"up","inn_name":"carboprost","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid","metabolite_id":"DLJKPYFALUEJCK-IIELGFQLSA-N","pvalue":0.0001145609730037,"ratio":2.3408485271721156,"synonym_name":"(15<i>S</i>)-15-methyl-PGF<small><sub>2\u03b1</sub></small>"}],"totalFeatures":206},{"comparisonGroups":["Mild","Severe"],"dateCreated":"2025-09-26 00:00:00","display_title":"COVID-19 patients: mild vs severe symptoms","group_a_title":"Samples from COVID-19 patients with mild symptoms.. Understanding the lipidomic profile of mild cases can help identify early markers of disease progression.","group_b_title":"Samples from COVID-19 patients with severe symptoms.. Understanding the lipidomic profile of severe cases can help identify critical markers of disease progression and potential therapeutic targets.","id":"MTBLS6844_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS6844","studyUrl":"http://integmet.org/study/MTBLS6844","title":"Mild_vs_Severe","topHits":[{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"AXCLECQLCBWNLZ-KZZBVOOISA-N","pvalue":0.0003729359933421,"ratio":1.6530757097791795,"synonym_name":""},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NDBJGSQZPQASQC-DTFBBOEISA-N","pvalue":0.0080492136152783,"ratio":0.537745633187773,"synonym_name":""},{"chebi_id":"72965","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide","metabolite_id":"ZJVVOYPTFQEGPH-AUTSUKAISA-N","pvalue":0.0031108980190886,"ratio":1.582607835377919,"synonym_name":"Ceramide (d18:1/24:0)"},{"chebi_id":"83360","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-3-hydroxy-2-(tetracosanoylamino)octadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"QEDPUVGSSDPBMD-XTAIVQBESA-N","pvalue":0.0050733845718357,"ratio":1.5686540501311896,"synonym_name":"C24 Sphingomyelin"},{"chebi_id":"72961","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]octadecanamide","metabolite_id":"VODZWWMEJITOND-NXCSZAMKSA-N","pvalue":0.0083203281747021,"ratio":0.6516616314199397,"synonym_name":"<em>N</em>-stearoylsphingosine"},{"chebi_id":"77096","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(hexadecanoyloxy)-1-hydroxypropan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoate","metabolite_id":"YJEMDFYSDGNQNM-NDUZERMISA-N","pvalue":0.0349946163087451,"ratio":1.6373049645390068,"synonym_name":"DG(36:4)"}],"totalFeatures":135},{"comparisonGroups":["Uninfected_1h","Anaplasma_phagocytophilum_1h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Anaplasma phagocytophilum infection vs uninfected (1h)","group_a_title":"Uninfected samples collected at 1 hour.. Provides baseline data for comparison with infected samples at 1 hour.","group_b_title":"Samples infected with Anaplasma phagocytophilum collected at 1 hour.. Allows for the study of early metabolic changes due to Anaplasma phagocytophilum infection.","id":"MTBLS686_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":74,"studyId":"MTBLS686","studyUrl":"http://integmet.org/study/MTBLS686","title":"Uninfected_1h_vs_Anaplasma_phagocytophilum_1h","topHits":[{"chebi_id":"16235","direction":"down","inn_name":"","iupac_name":"2-amino-1,9-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","pvalue":0.0013062176690332,"ratio":0.0202761615083912,"synonym_name":"GUANINE"},{"chebi_id":"73707","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamine","metabolite_id":"JBFYFLXEJFQWMU-WDSKDSINSA-N","pvalue":0.0034363459836814,"ratio":0.0240382437634715,"synonym_name":"\u03b3-<small>L</small>-Glu-<small>L</small>-Gln"},{"chebi_id":"28223","direction":"down","inn_name":"","iupac_name":"2'-adenylic acid","metabolite_id":"QDFHPFSBQFLLSW-KQYNXXCUSA-N","pvalue":0.000912789776055,"ratio":0.0711618779598745,"synonym_name":"adenosine 2'-monophosphate"},{"chebi_id":"17596","direction":"down","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0073157366870073,"ratio":0.0267395928145739,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"28284","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>-dimethyladenosine","metabolite_id":"WVGPGNPCZPYCLK-WOUKDFQISA-N","pvalue":5.5600849762931465e-05,"ratio":0.1789220217635318,"synonym_name":"6-Dimethyladenosine"},{"chebi_id":"77292","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-3-[(1<i>Z</i>)-hexadec-1-en-1-yloxy]-2-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IOYKZPNDXIIXLN-LOQSCQKMSA-N","pvalue":0.0103041438361748,"ratio":0.0418885741071569,"synonym_name":"1-(1<i>Z</i>)-hexadecenyl-2 (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosatetraenoyl-<em>sn</em>-glycero-3-phosphocholine"},{"chebi_id":"17084","direction":"down","inn_name":"","iupac_name":"2-hydroxypentanedioic acid","metabolite_id":"HWXBTNAVRSUOJR-UHFFFAOYSA-N","pvalue":0.0056641414704578,"ratio":0.0814773900827925,"synonym_name":"\u03b1-hydroxyglutaric acid"},{"chebi_id":"133139","direction":"down","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-{[(1<i>E</i>)-hexadec-1-en-1-yl]oxy}-2-hydroxypropyl phosphate","metabolite_id":"QYTPGOPLNFESQC-RLHAVTDZSA-N","pvalue":0.0025057956256881,"ratio":0.1424111514021973,"synonym_name":"phosphoethanolamine zwitterion (P-16:0/0:0)"},{"chebi_id":"84829","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-{[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"FAUYAENFVCNTAL-PFFNLMTBSA-N","pvalue":0.0144092258269208,"ratio":0.0683675526538704,"synonym_name":"GPC(18:0/22:6)"},{"chebi_id":"65101","direction":"down","inn_name":"","iupac_name":"2-hydroxyhexadecanoic acid","metabolite_id":"JGHSBPIZNUXPLA-UHFFFAOYSA-N","pvalue":0.0075835061067417,"ratio":0.112397972621648,"synonym_name":"2-hydroxypalmitic acid"}],"totalFeatures":362},{"comparisonGroups":["Control","TGF-beta_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Macrophages: TGF-beta treatment vs control","group_a_title":"Macrophages treated with control conditions. Provides baseline data for comparison with TGF-beta treated samples","group_b_title":"Macrophages treated with TGF-beta. Key group for assessing the impact of TGF-beta on macrophage metabolism","id":"MTBLS6886_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":29,"studyId":"MTBLS6886","studyUrl":"http://integmet.org/study/MTBLS6886","title":"Control_vs_TGF-beta_Treatment","topHits":[{"chebi_id":"174108","direction":"up","inn_name":"","iupac_name":"1-(2-amino-3-hydroxypropanoyl)-4-hydroxypyrrolidine-2-carboxylic acid","metabolite_id":"IISAHBYOIFITKV-UHFFFAOYSA-N","pvalue":0.0171793890786377,"ratio":6.653384043752419,"synonym_name":""},{"chebi_id":"57805","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamido-5-azaniumylpentanoate","metabolite_id":"JRLGPAXAGHMNOL-LURJTMIESA-N","pvalue":0.018292142321352,"ratio":6.624742431386184,"synonym_name":"(2<i>S</i>)-2-acetamido-5-ammoniopentanoate"},{"chebi_id":"17025","direction":"down","inn_name":"","iupac_name":"(4<i>S</i>)-2,6-dioxohexahydropyrimidine-4-carboxylic acid","metabolite_id":"UFIVEPVSAGBUSI-REOHCLBHSA-N","pvalue":0.0007320409069168,"ratio":0.3654422813745682,"synonym_name":"L-Dihydroorotic acid"},{"chebi_id":"17295","direction":"up","inn_name":"","iupac_name":"<small>L</small>-phenylalanine","metabolite_id":"COLNVLDHVKWLRT-QMMMGPOBSA-N","pvalue":1.903727882775104e-05,"ratio":1.8962799153881489,"synonym_name":"\u03b2-phenyl-<small>L</small>-alanine"},{"chebi_id":"16960","direction":"up","inn_name":"","iupac_name":"adenosine 5'-[3-(<small>D</small>-ribofuranos-5-<em>O</em>-yl) dihydrogen diphosphate]","metabolite_id":"SRNWOUGRCWSEMX-TYASJMOZSA-N","pvalue":0.0011977746335398,"ratio":2.4256672872699325,"synonym_name":"ribose adenosinediphosphate"},{"chebi_id":"80980","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ACNQSIOMZUBKCK-FWSONLODSA-N","pvalue":0.0010846475634633,"ratio":0.4185672226509673,"synonym_name":""},{"chebi_id":"146193","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"FDJKUWYYUZCUJX-PGIATKPXSA-N","pvalue":0.0006312436857859,"ratio":0.4599820533327681,"synonym_name":""},{"chebi_id":"18374","direction":"up","inn_name":"","iupac_name":"1-(5-phospho-\u03b2-<small>D</small>-ribofuranosyl)-5'-adenylic acid","metabolite_id":"RTQMRTSPTLIIHM-KEOHHSTQSA-N","pvalue":0.0063318239138778,"ratio":2.722522446307937,"synonym_name":"Phosphoribosyl-AMP"},{"chebi_id":"15947","direction":"up","inn_name":"","iupac_name":"2-acetamido-2-deoxy-\u03b2-<small>D</small>-glucopyranosylamine","metabolite_id":"MCGXOCXFFNKASF-FMDGEEDCSA-N","pvalue":0.04387511132053,"ratio":4.9642865231393625,"synonym_name":"N-Acetyl-beta-D-glucosaminylamine"},{"chebi_id":"68678","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-mannopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-ZYQOOJPVSA-N","pvalue":8.703578716234447e-05,"ratio":0.5874751244583206,"synonym_name":"UDP-N-acetyl-D-mannosamine"}],"totalFeatures":131},{"comparisonGroups":["Control","TGF-beta_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Macrophages: TGF-beta treatment vs control","group_a_title":"Macrophages treated with control conditions. Provides baseline data for comparison with TGF-beta treated samples","group_b_title":"Macrophages treated with TGF-beta. Key group for assessing the impact of TGF-beta on macrophage metabolism","id":"MTBLS6886_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS6886","studyUrl":"http://integmet.org/study/MTBLS6886","title":"Control_vs_TGF-beta_Treatment","topHits":[{"chebi_id":"87142","direction":"up","inn_name":"","iupac_name":"<em>N</em>-tetradecanoylglycine","metabolite_id":"DYUGTPXLDJQBRB-UHFFFAOYSA-N","pvalue":0.0041761260759136,"ratio":2.4887437868292968,"synonym_name":"Myristoylglycine"},{"chebi_id":"53486","direction":"up","inn_name":"","iupac_name":"(8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-8,11,14-trienoic acid","metabolite_id":"HOBAELRKJCKHQD-QNEBEIHSSA-N","pvalue":5.371620916156213e-05,"ratio":1.5017548242972891,"synonym_name":"(8Z,11Z,14Z)-Icosatrienoic acid"},{"chebi_id":"15551","direction":"down","inn_name":"dinoprostona","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-11\u03b1,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"XEYBRNLFEZDVAW-ARSRFYASSA-N","pvalue":0.0154007946675551,"ratio":0.5457553972373727,"synonym_name":"PGE2"},{"chebi_id":"28442","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>)-9\u03b1,11\u03b1-dihydroxy-15-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"LOLJEILMPWPILA-AMFHKTBMSA-N","pvalue":0.0154746750462768,"ratio":0.5459395103470506,"synonym_name":"15-Keto-prostaglandin F2alpha"},{"chebi_id":"36075","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>,17<i>Z</i>)-9\u03b1,11\u03b1,15-trihydroxyprosta-5,13,17-trien-1-oic acid","metabolite_id":"SAKGBZWJAIABSY-SAMSIYEGSA-N","pvalue":0.0155573934525325,"ratio":0.5463165331209897,"synonym_name":"Prostaglandin F3alpha"},{"chebi_id":"15554","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,11\u03b1-epidioxy-15-hydroxyprosta-5,13-dienoic acid","metabolite_id":"YIBNHAJFJUQSRA-YNNPMVKQSA-N","pvalue":0.0155950651891203,"ratio":0.5471107116460208,"synonym_name":"PGH2"}],"totalFeatures":52},{"comparisonGroups":["Control","TGF-beta_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Macrophages: TGF-beta treatment vs control","group_a_title":"Macrophages treated with control conditions. Provides baseline data for comparison with TGF-beta treated samples","group_b_title":"Macrophages treated with TGF-beta. Key group for assessing the impact of TGF-beta on macrophage metabolism","id":"MTBLS6886_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":33,"studyId":"MTBLS6886","studyUrl":"http://integmet.org/study/MTBLS6886","title":"Control_vs_TGF-beta_Treatment","topHits":[{"chebi_id":"17287","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[imino(phosphonoamino)methyl]-<em>N</em>-methylglycine","metabolite_id":"DRBBFCLWYRJSJZ-UHFFFAOYSA-N","pvalue":1.302635810068135e-05,"ratio":4.178411218471243,"synonym_name":"N-phosphocreatine"},{"chebi_id":"73653","direction":"up","inn_name":"","iupac_name":"<small>L</small>-seryl-<small>L</small>-serine","metabolite_id":"XZKQVQKUZMAADP-IMJSIDKUSA-N","pvalue":0.0029890597940913,"ratio":3.193752399809312,"synonym_name":"S-S"},{"chebi_id":"57485","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>\u03b1</small></sup>-(\u03b2-alaniniumyl)-<small>L</small>-histidinate","metabolite_id":"CQOVPNPJLQNMDC-ZETCQYMHSA-N","pvalue":0.0004743574023884,"ratio":2.371185012219091,"synonym_name":"(2<i>S</i>)-2-[(3-azaniumylpropanoyl)amino]-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"73788","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanyl-<small>L</small>-glutamine","metabolite_id":"HJCMDXDYPOUFDY-WHFBIAKZSA-N","pvalue":0.0095339988730958,"ratio":4.0579970638255665,"synonym_name":"<small>L</small>-Ala-<small>L</small>-Gln"},{"chebi_id":"15918","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-cytidylic acid","metabolite_id":"NCMVOABPESMRCP-SHYZEUOFSA-N","pvalue":0.0005258337642719,"ratio":2.218519189587981,"synonym_name":"Deoxycytidylate"},{"chebi_id":"19062","direction":"up","inn_name":"","iupac_name":"1-methylguanosine","metabolite_id":"UTAIYTHAJQNQDW-KQYNXXCUSA-N","pvalue":0.011677179485829,"ratio":3.799741073223368,"synonym_name":"N1-Methylguanosine"},{"chebi_id":"58315","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":0.0009314787399523,"ratio":2.326451328960624,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"16552","direction":"down","inn_name":"","iupac_name":"<em>N</em>-formyl-<small>L</small>-methionine","metabolite_id":"PYUSHNKNPOHWEZ-YFKPBYRVSA-N","pvalue":0.0020288275968596,"ratio":0.4089497443300853,"synonym_name":"N-formylmethionine"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VSNFQQXVMPSASB-SNVBAGLBSA-O","pvalue":2.1768641011725026e-05,"ratio":0.6130924311029915,"synonym_name":""},{"chebi_id":"16753","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,4-dihydroxy-3,3-dimethyl-<em>N</em>-{3-oxo-3-[(2-sulfanylethyl)amino]propyl}butanamide","metabolite_id":"ZNXZGRMVNNHPCA-VIFPVBQESA-N","pvalue":0.0101271307521542,"ratio":3.075012641247561,"synonym_name":"Pantetheine"}],"totalFeatures":107},{"comparisonGroups":["Control","TGF-beta_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Macrophages: TGF-beta treatment vs control","group_a_title":"Macrophages treated with control conditions. Provides baseline data for comparison with TGF-beta treated samples","group_b_title":"Macrophages treated with TGF-beta. Key group for assessing the impact of TGF-beta on macrophage metabolism","id":"MTBLS6886_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS6886","studyUrl":"http://integmet.org/study/MTBLS6886","title":"Control_vs_TGF-beta_Treatment","topHits":[{"chebi_id":"17154","direction":"up","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0003171735512114,"ratio":1.6263490451970808,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"15555","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"BHMBVRSPMRCCGG-OUTUXVNYSA-N","pvalue":0.0002007219978434,"ratio":1.551008487078695,"synonym_name":"(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate"},{"chebi_id":"15760","direction":"up","inn_name":"","iupac_name":"4-(2-aminoethyl)phenol","metabolite_id":"DZGWFCGJZKJUFP-UHFFFAOYSA-N","pvalue":0.0454423051143609,"ratio":1.5660317350721755,"synonym_name":"Tyramin"}],"totalFeatures":61},{"comparisonGroups":["Control","BP3 Low Concentration"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 2 mg/L oxybenzone (low dose) exposure","group_a_title":"Control group with 0 mg/L oxybenzone concentration.. Serves as the reference point for evaluating the effects of oxybenzone exposure.","group_b_title":"Group exposed to 2 mg/L oxybenzone concentration.. Demonstrates the effects of low oxybenzone concentration on cell growth and metabolism.","id":"MTBLS6890_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":188,"studyId":"MTBLS6890","studyUrl":"http://integmet.org/study/MTBLS6890","title":"Control_vs_BP3_Low_Concentration","topHits":[{"chebi_id":"193386","direction":"down","inn_name":"","iupac_name":"5-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-6,7-dimethoxy-2,3-dihydrochromen-4-one","metabolite_id":"ABIJRPKPVBZTCW-UHFFFAOYSA-N","pvalue":6.677857874851233e-11,"ratio":0.0002397569625406,"synonym_name":""},{"chebi_id":"176100","direction":"down","inn_name":"","iupac_name":"2-(3,4-dimethoxyphenyl)-3,5,6,7,8-pentamethoxychromen-4-one","metabolite_id":"SSXJHQZOHUYEGD-UHFFFAOYSA-N","pvalue":2.632363324435562e-12,"ratio":0.0007163228186729,"synonym_name":""},{"chebi_id":"8113","direction":"down","inn_name":"","iupac_name":"3,5-dihydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"IOUVKUPGCMBWBT-QNDFHXLGSA-N","pvalue":3.3373083030774156e-11,"ratio":0.0004071288842003,"synonym_name":"Phlorhizin"},{"chebi_id":"28814","direction":"down","inn_name":"","iupac_name":"4-[(1<i>E</i>)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol","metabolite_id":"CDRPUGZCRXZLFL-OWOJBTEDSA-N","pvalue":6.187666607368114e-12,"ratio":0.0008879889492457,"synonym_name":"3,5,3',4'-tetrahydroxystilbene"},{"chebi_id":"72631","direction":"down","inn_name":"","iupac_name":"3-phenoxybenzoic acid","metabolite_id":"NXTDJHZGHOFSQG-UHFFFAOYSA-N","pvalue":1.937287799847575e-12,"ratio":0.0015436873106729,"synonym_name":"3-carboxybiphenyl ether"},{"chebi_id":"191607","direction":"down","inn_name":"","iupac_name":"(2R,3R)-2-(3,4-dihydroxyphenyl)-6-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-chromene-3,5,7-triol","metabolite_id":"PWMSPKVTJLJDDS-NOCOPWLTSA-N","pvalue":7.771068806925755e-12,"ratio":0.0011407654579506,"synonym_name":""},{"chebi_id":"8222","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-5-hydroxy-4-oxo-2-phenyl-3,4-dihydro-2<em>H</em>-1-benzopyran-7-yl 2-O-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"UVPBNPUZWAOBQX-AFUJZTQMSA-N","pvalue":2.7085423259711724e-10,"ratio":0.0005703681078474,"synonym_name":"Pinocembrin 7-O-neohesperidoside"},{"chebi_id":"166606","direction":"down","inn_name":"","iupac_name":"3-hydroxybenzo[c]chromen-6-one","metabolite_id":"WXUQMTRHPNOXBV-UHFFFAOYSA-N","pvalue":2.726238922388487e-12,"ratio":0.00233928396008,"synonym_name":""},{"chebi_id":"2515","direction":"down","inn_name":"","iupac_name":"[(1<i>S</i>,4a<i>R</i>,5<i>S</i>,7a<i>S</i>)-1-(\u03b2-<small>D</small>-glucopyranosyloxy)-5-hydroxy-1,4a,5,7a-tetrahydrocyclopenta[<em>c</em>]pyran-7-yl]methyl 4-hydroxybenzoate","metabolite_id":"GLACGTLACKLUJX-QNAXTHAFSA-N","pvalue":6.734624076556667e-12,"ratio":0.0020320669209025,"synonym_name":"agnoside"},{"chebi_id":"7476","direction":"down","inn_name":"naproxen","iupac_name":"(2<i>S</i>)-2-(6-methoxynaphthalen-2-yl)propanoic acid","metabolite_id":"CMWTZPSULFXXJA-VIFPVBQESA-N","pvalue":6.206266404975004e-13,"ratio":0.0038721984896371,"synonym_name":"Naproxen"}],"totalFeatures":505},{"comparisonGroups":["Control","BP3 Low Concentration"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 2 mg/L oxybenzone exposure","group_a_title":"Control group with 0 mg/L oxybenzone concentration.. Serves as the reference point for evaluating the effects of oxybenzone exposure.","group_b_title":"Group exposed to 2 mg/L oxybenzone concentration.. Demonstrates the effects of low oxybenzone concentration on cell growth and metabolism.","id":"MTBLS6890_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":627,"studyId":"MTBLS6890","studyUrl":"http://integmet.org/study/MTBLS6890","title":"Control_vs_BP3_Low_Concentration","topHits":[{"chebi_id":"10089","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"XLHIYUYCSMZCCC-VMPITWQZSA-N","pvalue":2.634327484219852e-12,"ratio":0.0007849975074858,"synonym_name":"4-Methoxy-6-[2-(4-methoxyphenyl)ethenyl]-2H-pyran-2-one"},{"chebi_id":"136941","direction":"down","inn_name":"","iupac_name":"6-methoxy-3-(1,3-thiazol-2-yl)-1<em>H</em>-indole","metabolite_id":"FGXYYCWDPYDAOS-UHFFFAOYSA-N","pvalue":5.4776530205514904e-12,"ratio":0.001131781516957,"synonym_name":"6-methoxy-3-(thiazol-2-yl)indole"},{"chebi_id":"32046","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"RPAFQXAVFGSQFL-NYJNVLOGSA-N","pvalue":1.2491141594790592e-10,"ratio":0.0008657513533025,"synonym_name":"Premithramycin A1"},{"chebi_id":"82405","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"OMPJBNCRMGITSC-UHFFFAOYSA-N","pvalue":5.940587728473844e-12,"ratio":0.0023893358296616,"synonym_name":"diphenylglyoxal peroxide"},{"chebi_id":"9400","direction":"down","inn_name":"","iupac_name":"5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"ULSUXBXHSYSGDT-UHFFFAOYSA-N","pvalue":4.472462926137594e-13,"ratio":0.0057442938496217,"synonym_name":"4',5,6,7,8-pentamethoxyflavone"},{"chebi_id":"168599","direction":"down","inn_name":"","iupac_name":"2,3-dihydroxypropyl 3,4,5-trihydroxybenzoate","metabolite_id":"PDEQYQCQYAQJPN-UHFFFAOYSA-N","pvalue":3.1035192778004797e-10,"ratio":0.0015050228200714,"synonym_name":""},{"chebi_id":"81068","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"NEZONWMXZKDMKF-SNVBAGLBSA-N","pvalue":5.171387225072868e-10,"ratio":0.0014157963887978,"synonym_name":""},{"chebi_id":"32209","direction":"down","inn_name":"","iupac_name":"methyl (6a<i>R</i>,10a<i>R</i>)-6a,12-dihydroxy-3,8,10a-trimethoxy-1-methyl-6,7,10,11-tetraoxo-6,6a,7,10,10a,11-hexahydrotetracene-2-carboxylate","metabolite_id":"CCDBRFCICQZPPE-DNQXCXABSA-N","pvalue":3.2124963890845343e-13,"ratio":0.0081872870568888,"synonym_name":"Tetracenomycin X"},{"chebi_id":"9287","direction":"down","inn_name":"rufocromomycin","iupac_name":"5-amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid","metabolite_id":"PVYJZLYGTZKPJE-UHFFFAOYSA-N","pvalue":2.3450135743669325e-10,"ratio":0.0023540947730012,"synonym_name":"5-Amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic acid"},{"chebi_id":"8198","direction":"down","inn_name":"","iupac_name":"3-hydroxy-5-[(<i>E</i>)-2-(4-hydroxyphenyl)ethenyl]phenyl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"HSTZMXCBWJGKHG-CUYWLFDKSA-N","pvalue":4.5636874125911554e-11,"ratio":0.0036875277757564,"synonym_name":"<i>trans</i>-resveratrol 3-<em>O</em>-\u03b2-<small>D</small>-glucoside"}],"totalFeatures":1887},{"comparisonGroups":["Yellow_Skin","Green_Skin"],"dateCreated":"2025-09-26 00:00:00","display_title":"Yellow vs green skin color morphs","group_a_title":"Samples with yellow skin color. Represents one of the color morphs being studied for genetic and molecular differences","group_b_title":"Samples with green skin color. Represents one of the color morphs being studied for genetic and molecular differences","id":"MTBLS6927_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS6927","studyUrl":"http://integmet.org/study/MTBLS6927","title":"Yellow_Skin_vs_Green_Skin","topHits":[{"chebi_id":"190741","direction":"down","inn_name":"","iupac_name":"[(2R,3S,5R)-3,5-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate","metabolite_id":"KKZFLSZAWCYPOC-VPENINKCSA-N","pvalue":0.0002278087623321,"ratio":0.1203641161766588,"synonym_name":""},{"chebi_id":"28635","direction":"down","inn_name":"","iupac_name":"2-hydroxy-2-(propan-2-yl)butanedioic acid","metabolite_id":"BITYXLXUCSKTJS-UHFFFAOYSA-N","pvalue":0.0003192643210811,"ratio":0.13268516167252,"synonym_name":"2-hydroxy-2-isopropylsuccinic acid"},{"chebi_id":"16238","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(3-{<small>D</small>-<i>ribo</i>-5-[7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)","metabolite_id":"VWWQXMAJTJZDQX-UYBVJOGSSA-N","pvalue":0.0004005626326426,"ratio":4.239828716261772,"synonym_name":"FAD"},{"chebi_id":"27411","direction":"down","inn_name":"","iupac_name":"2-deoxy-<small>D</small>-<i>lyxo</i>-hexose","metabolite_id":"VRYALKFFQXWPIH-HSUXUTPPSA-N","pvalue":0.0097187932578326,"ratio":0.0945060147476257,"synonym_name":"2-Deoxy-D-galactose"},{"chebi_id":"17680","direction":"up","inn_name":"","iupac_name":"2,6-di-<em>O</em>-phosphono-<small>D</small>-glucose","metabolite_id":"ZJHWKVNJCGZAFV-JGWLITMVSA-N","pvalue":0.0150164440887343,"ratio":12.16122674294972,"synonym_name":"D-Glucose 1,6-biphosphate"},{"chebi_id":"72603","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,9\u03b1)-9-hydroxy-11,15-dioxoprost-5-en-1-oic acid","metabolite_id":"VSRXYLYXIXYEST-KZTWKYQFSA-N","pvalue":0.0388933482277387,"ratio":0.0650570882596989,"synonym_name":"13,14-dihydro-15-keto-PGD2"},{"chebi_id":"68566","direction":"down","inn_name":"","iupac_name":"3-methylpentanedioic acid","metabolite_id":"XJMMNTGIMDZPMU-UHFFFAOYSA-N","pvalue":0.016340350668396,"ratio":0.1305197714693108,"synonym_name":"\u03b2-methylglutaric acid"},{"chebi_id":"31445","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BQOHYSXSASDCEA-KEOHHSTQSA-N","pvalue":0.0368778032229057,"ratio":12.553122105688878,"synonym_name":"cADPR"},{"chebi_id":"183496","direction":"down","inn_name":"","iupac_name":"6-octyloxan-2-one","metabolite_id":"RZZLMGATMUAJPX-UHFFFAOYSA-N","pvalue":0.0124669863661776,"ratio":0.1580077371185578,"synonym_name":""},{"chebi_id":"48991","direction":"down","inn_name":"","iupac_name":"7-methyl-3,7-dihydro-1<em>H</em>-purine-2,6-dione","metabolite_id":"PFWLFWPASULGAN-UHFFFAOYSA-N","pvalue":0.0072637068377148,"ratio":0.2151816879425505,"synonym_name":"3,7-dihydro-7-methyl-1H-purine-2,6-dione"}],"totalFeatures":297},{"comparisonGroups":["Yellow_Skin","Green_Skin"],"dateCreated":"2025-09-26 00:00:00","display_title":"Yellow vs green skin color morphs","group_a_title":"Samples with yellow skin color. Represents one of the color morphs being studied for genetic and molecular differences","group_b_title":"Samples with green skin color. Represents one of the color morphs being studied for genetic and molecular differences","id":"MTBLS6927_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS6927","studyUrl":"http://integmet.org/study/MTBLS6927","title":"Yellow_Skin_vs_Green_Skin","topHits":[{"chebi_id":"190666","direction":"down","inn_name":"","iupac_name":"[3-carboxy-2-[(E)-dodec-5-enoyl]oxypropyl]-trimethylazanium","metabolite_id":"PETYOUXDCHQKTQ-ZHACJKMWSA-O","pvalue":0.0004913962411063,"ratio":0.1534814195448555,"synonym_name":""},{"chebi_id":"174217","direction":"down","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>)-2-hydroxypropanoyl]-<small>L</small>-phenylalanine","metabolite_id":"IIRJJZHHNGABMQ-WPRPVWTQSA-N","pvalue":0.0001931659565144,"ratio":0.2231026390719345,"synonym_name":"(2<i>S</i>)-2-[[(2<i>S</i>)-2-hydroxypropanoyl]amino]-3-phenylpropanoic acid"},{"chebi_id":"15354","direction":"down","inn_name":"","iupac_name":"2-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","pvalue":4.3522554147081054e-05,"ratio":0.2862935839402883,"synonym_name":"Choline"},{"chebi_id":"73024","direction":"down","inn_name":"","iupac_name":"3-(acetyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"RDHQFKQIGNGIED-UHFFFAOYSA-N","pvalue":0.01081102792525,"ratio":0.0878585985983262,"synonym_name":"Acetyl-DL-carnitine"},{"chebi_id":"86583","direction":"down","inn_name":"","iupac_name":"2-methoxy-4-[(1<i>E</i>)-prop-1-en-1-yl]phenyl acetate","metabolite_id":"IUSBVFZKQJGVEP-SNAWJCMRSA-N","pvalue":0.0126676647097631,"ratio":0.1387410096716459,"synonym_name":"acetylated isoeugenol"},{"chebi_id":"21626","direction":"down","inn_name":"afalaninum","iupac_name":"<em>N</em>-acetylphenylalanine","metabolite_id":"CBQJSKKFNMDLON-UHFFFAOYSA-N","pvalue":0.0033409701335696,"ratio":0.2405533716084147,"synonym_name":"N-Acetyl-3-phenyl-DL-alanine"},{"chebi_id":"52075","direction":"down","inn_name":"","iupac_name":"13,14-dihydroretinol","metabolite_id":"OVBOQVAIYMSUDT-HRYGCDPOSA-N","pvalue":0.0022020141055974,"ratio":0.272193283238158,"synonym_name":"13,14-dihydroretinol"},{"chebi_id":"135293","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"UXYRZJKIQKRJCF-TZPFWLJSSA-N","pvalue":0.0025526191787119,"ratio":0.2678308024251288,"synonym_name":"androviron"},{"chebi_id":"44897","direction":"down","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0071634322257174,"ratio":0.2034679481877995,"synonym_name":"PEP"},{"chebi_id":"17794","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-(phosphonooxy)propanoic acid","metabolite_id":"OSJPPGNTCRNQQC-UWTATZPHSA-N","pvalue":0.040707269440003,"ratio":8.00197031645975,"synonym_name":"3-Phospho-D-glycerate"}],"totalFeatures":416},{"comparisonGroups":["Infected_Treated","Infected_Untreated"],"dateCreated":"2025-09-26 00:00:00","display_title":"Infected cells: treated vs untreated comparison","group_a_title":"Infected and treated samples. This group helps in understanding the effect of treatment on infected cells.","group_b_title":"Infected and untreated samples. This group serves as a baseline to compare the effects of treatment on infected cells.","id":"MTBLS696_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS696","studyUrl":"http://integmet.org/study/MTBLS696","title":"G1_Infected_Treated_vs_G2_Infected_Untreated","topHits":[{"chebi_id":"17625","direction":"up","inn_name":"","iupac_name":"2'-deoxyuridine 5'-(tetrahydrogen triphosphate)","metabolite_id":"AHCYMLUZIRLXAA-SHYZEUOFSA-N","pvalue":2.095273857565449e-06,"ratio":35.493042553856846,"synonym_name":"dUTP"},{"chebi_id":"18405","direction":"down","inn_name":"","iupac_name":"(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate","metabolite_id":"NGVDGCNFYWLIFO-UHFFFAOYSA-N","pvalue":1.6783522223222363e-06,"ratio":0.1483849782043916,"synonym_name":"Pyridoxal 5'-phosphate"},{"chebi_id":"16436","direction":"up","inn_name":"citicolina","iupac_name":"5'-<em>O</em>-[hydroxy({[2-(trimethylammonio)ethoxy]phosphinato}oxy)phosphoryl]cytidine","metabolite_id":"RZZPDXZPRHQOCG-OJAKKHQRSA-N","pvalue":4.136327470999006e-09,"ratio":3.0714573324164274,"synonym_name":"Citicoline"},{"chebi_id":"7954","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"KQXKVJAGOJTNJS-HNNXBMFYSA-N","pvalue":5.072883180106453e-05,"ratio":5.017097145859258,"synonym_name":"Penbutolol"},{"chebi_id":"18321","direction":"up","inn_name":"","iupac_name":"1<small>D</small>-<i>myo</i>-inositol 1-[(2<i>R</i>)-2,3-dihydroxypropyl hydrogen phosphate]","metabolite_id":"BMVUIWJCUQSHLZ-UJGXJMNGSA-N","pvalue":0.0041328926938744,"ratio":11.43666218768072,"synonym_name":"GroPIns"},{"chebi_id":"28101","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>'-[butane-1,4-diylbis(iminopropane-3,1-diyl)]diacetamide","metabolite_id":"NPDTUDWGJMBVEP-UHFFFAOYSA-N","pvalue":2.58795002050901e-06,"ratio":0.359377065410901,"synonym_name":"DASpm"},{"chebi_id":"17858","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":0.0024083488283888,"ratio":6.170810755440689,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"15694","direction":"down","inn_name":"","iupac_name":"<em>S</em>-[(2<i>R</i>)-2-hydroxypropanoyl]-\u03b3-<small>L</small>-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"VDYDCVUWILIYQF-CSMHCCOUSA-N","pvalue":0.0226168607158407,"ratio":0.0769069519179138,"synonym_name":"S-D-Lactoylglutathione"},{"chebi_id":"17148","direction":"down","inn_name":"","iupac_name":"butane-1,4-diamine","metabolite_id":"KIDHWZJUCRJVML-UHFFFAOYSA-N","pvalue":4.241541728833408e-07,"ratio":0.5238485701353188,"synonym_name":"Butane-1,4-diamine"},{"chebi_id":"17515","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteine","metabolite_id":"RITKHVBHSGLULN-WHFBIAKZSA-N","pvalue":8.39477130290775e-08,"ratio":1.7744560295078018,"synonym_name":"Glu(-Cys)"}],"totalFeatures":60},{"comparisonGroups":["Normal_Heart_Development","Ventricular_Septal_Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Heart: normal development vs ventricular septal defect","group_a_title":"Samples from individuals with normal heart development.. Provides a baseline for understanding metabolic changes associated with congenital heart defects.","group_b_title":"Samples from individuals with ventricular septal defect.. Understanding the metabolic differences in individuals with ventricular septal defect compared to normal heart development.","id":"MTBLS6982_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS6982","studyUrl":"http://integmet.org/study/MTBLS6982","title":"Normal_Heart_Development_vs_Ventricular_Septal_Defect","topHits":[{"chebi_id":"16196","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":8.571827422736999e-05,"ratio":1.729015163236887,"synonym_name":"Oleate"},{"chebi_id":"32425","direction":"up","inn_name":"","iupac_name":"(11<i>Z</i>)-icos-11-enoic acid","metabolite_id":"BITHHVVYSMSWAG-KTKRTIGZSA-N","pvalue":0.0002795275151814,"ratio":1.820960587480095,"synonym_name":"<i>cis</i>-\u0394<small><sup>11</small></sup>-eicosenoic acid"},{"chebi_id":"15843","direction":"up","inn_name":"","iupac_name":"(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoic acid","metabolite_id":"YZXBAPSDXZZRGB-DOFZRALJSA-N","pvalue":0.0017866244325001,"ratio":1.9329809725158564,"synonym_name":"Arachidonate"},{"chebi_id":"15756","direction":"up","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":0.0004160758609032,"ratio":1.6973176424048873,"synonym_name":"<em>n</em>-hexadecoic acid"},{"chebi_id":"17351","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":0.001059828528241,"ratio":1.680873434078128,"synonym_name":"Linoleic acid"},{"chebi_id":"28842","direction":"up","inn_name":"","iupac_name":"octadecanoic acid","metabolite_id":"QIQXTHQIDYTFRH-UHFFFAOYSA-N","pvalue":0.0006319723776302,"ratio":1.571218854863001,"synonym_name":"Stearins\u00e4ure"},{"chebi_id":"44247","direction":"up","inn_name":"","iupac_name":"(15<i>Z</i>)-tetracos-15-enoic acid","metabolite_id":"GWHCXVQVJPWHRF-KTKRTIGZSA-N","pvalue":0.0055340120546369,"ratio":1.875311720698254,"synonym_name":"<i>cis</i>-15-tetracosenoic acid"},{"chebi_id":"28866","direction":"up","inn_name":"","iupac_name":"tetracosanoic acid","metabolite_id":"QZZGJDVWLFXDLK-UHFFFAOYSA-N","pvalue":0.0055175966616616,"ratio":1.8484596169858456,"synonym_name":"CH<small><sub>3</sub></small>\u2012[CH<small><sub>2</sub></small>]<small><sub>22</sub></small>\u2012COOH"},{"chebi_id":"27432","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>,15<i>Z</i>)-octadeca-9,12,15-trienoic acid","metabolite_id":"DTOSIQBPPRVQHS-PDBXOOCHSA-N","pvalue":0.0037784735195712,"ratio":1.6285913444053823,"synonym_name":"(9,12,15)-linolenic acid"},{"chebi_id":"28822","direction":"up","inn_name":"","iupac_name":"icosanoic acid","metabolite_id":"VKOBVWXKNCXXDE-UHFFFAOYSA-N","pvalue":0.0074038906667572,"ratio":1.5488500778142833,"synonym_name":"C20:0"}],"totalFeatures":11},{"comparisonGroups":["Saturating_Limiting","Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cobalamin limitation vs replete under saturating light","group_a_title":"Samples with saturating light and limiting cobalamin conditions.. Helps in understanding the metabolic changes under cobalamin limitation with saturating light.","group_b_title":"Samples with saturating light and replete cobalamin conditions.. Serves as a baseline to assess the impact of cobalamin limitation under saturating light.","id":"MTBLS703_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS703","studyUrl":"http://integmet.org/study/MTBLS703","title":"Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"16027","direction":"down","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":0.0011851416383164,"ratio":0.4042958879822576,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"29042","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranose 1-(dihydrogen phosphate)","metabolite_id":"HXXFSFRBOHSIMQ-VFUOTHLCSA-N","pvalue":0.0147534825545527,"ratio":0.5528024167197038,"synonym_name":"ALPHA-D-GLUCOSE-1-PHOSPHATE"}],"totalFeatures":5},{"comparisonGroups":["Saturating_Limiting","Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cobalamin limitation vs replete under saturating light","group_a_title":"Samples with saturating light and limiting cobalamin conditions.. Helps in understanding the metabolic changes under cobalamin limitation with saturating light.","group_b_title":"Samples with saturating light and replete cobalamin conditions.. Serves as a baseline to assess the impact of cobalamin limitation under saturating light.","id":"MTBLS703_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS703","studyUrl":"http://integmet.org/study/MTBLS703","title":"Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"16457","direction":"down","inn_name":"","iupac_name":"3-(dimethylsulfonio)propanoate","metabolite_id":"DFPOZTRSOAQFIK-UHFFFAOYSA-N","pvalue":3.714336216466613e-05,"ratio":0.1010462193765789,"synonym_name":"3-dimethylsulfoniopropionate"},{"chebi_id":"17750","direction":"down","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0002159226650093,"ratio":0.1928437451153538,"synonym_name":"Bet"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0026729751837483,"ratio":10.294713701187854,"synonym_name":""},{"chebi_id":"18019","direction":"down","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0039159406551125,"ratio":0.1727438551515103,"synonym_name":"L-Lysine"},{"chebi_id":"16467","direction":"up","inn_name":"arginine","iupac_name":"<small>L</small>-arginine","metabolite_id":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","pvalue":0.0024931930552674,"ratio":3.473028868922913,"synonym_name":"(2<i>S</i>)-2-amino-5-guanidinopentanoic acid"},{"chebi_id":"15699","direction":"down","inn_name":"","iupac_name":"<small>L</small>-homoserine","metabolite_id":"UKAUYVFTDYCKQA-VKHMYHEASA-N","pvalue":0.0006288123757485,"ratio":0.3654808117376071,"synonym_name":"2-Amino-4-hydroxybutanoic acid"},{"chebi_id":"15611","direction":"down","inn_name":"","iupac_name":"sarcosine","metabolite_id":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","pvalue":0.0010628448598493,"ratio":0.5115115395721599,"synonym_name":"L-sarcosine"},{"chebi_id":"16015","direction":"down","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":0.0010146085563769,"ratio":0.5369421101811205,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":0.0066496706917817,"ratio":1.871666478676293,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"16857","direction":"down","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0009113275956921,"ratio":0.655193695103608,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"}],"totalFeatures":21},{"comparisonGroups":["Saturating_Limiting","Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cobalamin limitation vs replete under saturating light","group_a_title":"Samples with saturating light and limiting cobalamin conditions.. Helps in understanding the metabolic changes under cobalamin limitation with saturating light.","group_b_title":"Samples with saturating light and replete cobalamin conditions.. Serves as a baseline to assess the impact of cobalamin limitation under saturating light.","id":"MTBLS703_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS703","studyUrl":"http://integmet.org/study/MTBLS703","title":"Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":7.443835755794599e-05,"ratio":13.670305700728704,"synonym_name":""},{"chebi_id":"17509","direction":"down","inn_name":"","iupac_name":"5'-deoxy-5'-(methylsulfanyl)adenosine","metabolite_id":"WUUGFSXJNOTRMR-IOSLPCCCSA-N","pvalue":0.0005542160794523,"ratio":0.2838870337796426,"synonym_name":"5'-Deoxy-5'-(methylthio)adenosine"},{"chebi_id":"58251","direction":"down","inn_name":"","iupac_name":"(dimethylazaniumyl)acetate","metabolite_id":"FFDGPVCHZBVARC-UHFFFAOYSA-N","pvalue":0.0015610787374691,"ratio":0.2688782262970309,"synonym_name":"(dimethylammonio)acetate"},{"chebi_id":"17621","direction":"down","inn_name":"","iupac_name":"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[<em>g</em>]pteridin-10(2<em>H</em>)-yl)-5-<em>O</em>-phosphono-<small>D</small>-ribitol","metabolite_id":"FVTCRASFADXXNN-SCRDCRAPSA-N","pvalue":8.945518380905351e-05,"ratio":0.482487438045888,"synonym_name":"riboflavin 5'-(dihydrogen phosphate)"},{"chebi_id":"57912","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":0.0053097084828126,"ratio":2.5967009810120216,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"58315","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":0.0014353631910283,"ratio":1.986338645971428,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"17858","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":0.0107611155766345,"ratio":0.4389709131963883,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"15354","direction":"down","inn_name":"","iupac_name":"2-hydroxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"OEYIOHPDSNJKLS-UHFFFAOYSA-N","pvalue":0.0088114035763533,"ratio":0.56649303239778,"synonym_name":"Choline"}],"totalFeatures":9},{"comparisonGroups":["Navicula_pelliculosa_Saturating_Limiting","Navicula_pelliculosa_Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Navicula pelliculosa: cobalamin limiting vs replete","group_a_title":"Navicula pelliculosa under saturating light and limiting cobalamin conditions. Helps in understanding the metabolic changes under cobalamin limitation with optimal light conditions.","group_b_title":"Navicula pelliculosa under saturating light and replete cobalamin conditions. Serves as a baseline for comparing the effects of cobalamin limitation.","id":"MTBLS708_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS708","studyUrl":"http://integmet.org/study/MTBLS708","title":"Navicula_pelliculosa_Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"18066","direction":"down","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":0.0167828005257893,"ratio":0.3147569096665261,"synonym_name":"UDP-glucose"},{"chebi_id":"15946","direction":"down","inn_name":"","iupac_name":"<small>D</small>-fructose 6-(dihydrogen phosphate)","metabolite_id":"GSXOAOHZAIYLCY-HSUXUTPPSA-N","pvalue":0.0102568618153931,"ratio":0.542917305402738,"synonym_name":"D-Fructose 6-phosphate"}],"totalFeatures":5},{"comparisonGroups":["Navicula_pelliculosa_Saturating_Limiting","Navicula_pelliculosa_Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Navicula pelliculosa: cobalamin limiting vs replete","group_a_title":"Navicula pelliculosa under saturating light and limiting cobalamin conditions. Helps in understanding the metabolic changes under cobalamin limitation with optimal light conditions.","group_b_title":"Navicula pelliculosa under saturating light and replete cobalamin conditions. Serves as a baseline for comparing the effects of cobalamin limitation.","id":"MTBLS708_0002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS708","studyUrl":"http://integmet.org/study/MTBLS708","title":"Navicula_pelliculosa_Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0007999922249406,"ratio":2.8329859388365266,"synonym_name":""},{"chebi_id":"57595","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-imidazol-4-yl)propanoate","metabolite_id":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","pvalue":0.0001264450976512,"ratio":2.1394754891274403,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-imidazol-4-yl)propanoate"},{"chebi_id":"57743","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"RHGKLRLOHDJJDR-BYPYZUCNSA-N","pvalue":0.0094348480011468,"ratio":2.282486456260122,"synonym_name":"(2<i>S</i>)-2-azaniumyl-5-(carbamoylamino)pentanoate"},{"chebi_id":"16015","direction":"up","inn_name":"acidum glutamicum","iupac_name":"(2<i>S</i>)-2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-VKHMYHEASA-N","pvalue":0.0033935347512106,"ratio":1.679627474928469,"synonym_name":"<small>L</small>-Glu"},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":0.0077429500838855,"ratio":1.8330422304694312,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"18019","direction":"up","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0074711773652991,"ratio":1.7970761929718055,"synonym_name":"L-Lysine"},{"chebi_id":"58315","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(4-hydroxyphenyl)propanoate","metabolite_id":"OUYCCCASQSFEME-QMMMGPOBSA-N","pvalue":0.0212738899917157,"ratio":1.6959292825314272,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(4-hydroxyphenyl)propanoate"}],"totalFeatures":14},{"comparisonGroups":["Navicula_pelliculosa_Saturating_Limiting","Navicula_pelliculosa_Saturating_Replete"],"dateCreated":"2025-09-26 00:00:00","display_title":"Navicula pelliculosa: cobalamin limiting vs replete","group_a_title":"Navicula pelliculosa under saturating light and limiting cobalamin conditions. Helps in understanding the metabolic changes under cobalamin limitation with optimal light conditions.","group_b_title":"Navicula pelliculosa under saturating light and replete cobalamin conditions. Serves as a baseline for comparing the effects of cobalamin limitation.","id":"MTBLS708_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS708","studyUrl":"http://integmet.org/study/MTBLS708","title":"Navicula_pelliculosa_Saturating_Limiting_vs_Saturating_Replete","topHits":[{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0045239873104043,"ratio":1.777450796814387,"synonym_name":""}],"totalFeatures":5},{"comparisonGroups":["ASD_Fecal","TD_Fecal"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse fecal: ASD vs TD microbiota colonization","group_a_title":"Fecal samples from mice colonized with ASD microbiota. Key group for understanding the role of ASD microbiota in inducing autistic behaviors","group_b_title":"Fecal samples from mice colonized with TD microbiota. Provides baseline for comparison with ASD microbiota effects","id":"MTBLS726_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":10,"studyId":"MTBLS726","studyUrl":"http://integmet.org/study/MTBLS726","title":"ASD_Fecal_vs_TD_Fecal","topHits":[{"chebi_id":"28197","direction":"up","inn_name":"","iupac_name":"7-hydroxy-3-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"ZQSIJRDFPHDXIC-UHFFFAOYSA-N","pvalue":2.367187338329255e-05,"ratio":3.098819283697002,"synonym_name":"daidzeol"},{"chebi_id":"28088","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-3-(4-hydroxyphenyl)-4<em>H</em>-chromen-4-one","metabolite_id":"TZBJGXHYKVUXJN-UHFFFAOYSA-N","pvalue":0.0008660532781927,"ratio":2.6087744856204544,"synonym_name":"4',5,7-trihydroxyisoflavone"},{"chebi_id":"356010","direction":"down","inn_name":"","iupac_name":"5-azaniumylpentanoate","metabolite_id":"JJMDCOVWQOJGCB-UHFFFAOYSA-N","pvalue":0.0085571112718812,"ratio":0.2424323836499066,"synonym_name":"5-ammoniopentanoate"},{"chebi_id":"78320","direction":"down","inn_name":"","iupac_name":"2-hydroxypropanoic acid","metabolite_id":"JVTAAEKCZFNVCJ-UHFFFAOYSA-N","pvalue":0.0281197072956406,"ratio":0.2548678803360052,"synonym_name":"2-Hydroxypropanoic acid"},{"chebi_id":"45564","direction":"down","inn_name":"","iupac_name":"5-hydroxypentanoic acid","metabolite_id":"PHOJOSOUIAQEDH-UHFFFAOYSA-N","pvalue":0.013831117722946,"ratio":0.4144512077469515,"synonym_name":"\u03b4-hydroxypentanoic acid"},{"chebi_id":"33508","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxypropanoic acid","metabolite_id":"RBNPOMFGQQGHHO-UHFFFAOYSA-N","pvalue":0.0009446309679781,"ratio":1.715319275904908,"synonym_name":"glyceric acid"},{"chebi_id":"30794","direction":"down","inn_name":"","iupac_name":"propanedioic acid","metabolite_id":"OFOBLEOULBTSOW-UHFFFAOYSA-N","pvalue":0.0244940720564643,"ratio":0.5253852551094893,"synonym_name":"Propanedioic acid"},{"chebi_id":"17057","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-CUHNMECISA-N","pvalue":0.0130148045182462,"ratio":0.5916600815630223,"synonym_name":"cellose"},{"chebi_id":"58375","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidinium-2-carboxylate","metabolite_id":"PMMYEEVYMWASQN-DMTCNVIQSA-N","pvalue":0.0260533030140312,"ratio":0.6020479869332129,"synonym_name":"hydroxyproline zwitterion"},{"chebi_id":"17505","direction":"up","inn_name":"","iupac_name":"\u03b1-<small>D</small>-galactosyl-(1\u21923)-1<small>D</small>-<em>myo</em>-inositol","metabolite_id":"VCWMRQDBPZKXKG-DXNLKLAMSA-N","pvalue":0.0445642132914005,"ratio":1.7419809852029384,"synonym_name":"3-O-alpha-D-Galactosyl-1D-myo-inositol"}],"totalFeatures":129},{"comparisonGroups":["Test_0min","Test_60min"],"dateCreated":"2025-09-26 00:00:00","display_title":"Treatment effect: baseline vs 60-minute response","group_a_title":"Baseline control group at 0 minutes. Serves as the reference point for all subsequent time points and treatments.","group_b_title":"Treated group at 60 minutes. Represents the full effect of treatment over time.","id":"MTBLS727_0001_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":6,"studyId":"MTBLS727","studyUrl":"http://integmet.org/study/MTBLS727","title":"Test_0min_vs_Test_60min","topHits":[{"chebi_id":"88539","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"LCYXYLLJXMAEMT-SAXRGWBVSA-N","pvalue":1.2531701561438628e-07,"ratio":0.0472002362992349,"synonym_name":"4-((2S)-2-Amino-2-carboxyethyl)-1-((2R,5S)-5-amino-5-carboxy-2-hydroxypentyl)-3-((3S)-3-amino-3-carboxypropyl)-5-hydroxy-Pyridinium inner salt"},{"chebi_id":"37157","direction":"down","inn_name":"","iupac_name":"3-oxodecanoic acid","metabolite_id":"YXTHWTPUTHTODU-UHFFFAOYSA-N","pvalue":7.102666484531164e-09,"ratio":0.1041673893299239,"synonym_name":"3-ketodecanoic acid"},{"chebi_id":"16469","direction":"down","inn_name":"","iupac_name":"estra-1,3,5(10)-triene-3,17\u03b2-diol","metabolite_id":"VOXZDWNPVJITMN-ZBRFXRBCSA-N","pvalue":8.782244518933055e-06,"ratio":0.0626377625898343,"synonym_name":"<i>cis</i>-estradiol"},{"chebi_id":"9907","direction":"up","inn_name":"","iupac_name":"3\u03b1,7\u03b2-dihydroxy-5\u03b2-cholan-24-oic acid","metabolite_id":"RUDATBOHQWOJDD-UZVSRGJWSA-N","pvalue":0.0001179538229903,"ratio":6.6150789686046965,"synonym_name":"Ursodeoxycholic acid"},{"chebi_id":"57502","direction":"down","inn_name":"","iupac_name":"1-(5-<em>O</em>-phosphonato-\u03b2-<small>D</small>-ribofuranosyl)pyridinium-3-carboxylate","metabolite_id":"JOUIQRNQJGXQDC-ZYUZMQFOSA-L","pvalue":0.0013842013760145,"ratio":0.0895051167303396,"synonym_name":"3-carboxylato-1-(5-<em>O</em>-phosphonato-\u03b2-<small>D</small>-ribofuranosyl)pyridinium"},{"chebi_id":"37024","direction":"down","inn_name":"","iupac_name":"2-aminohexanedioic acid","metabolite_id":"OYIFNHCXNCRBQI-UHFFFAOYSA-N","pvalue":0.0010430573406212,"ratio":0.1670174453954445,"synonym_name":"2-aminoadipic acid"}],"totalFeatures":13},{"comparisonGroups":["Low_Shear_Stress","High_Shear_Stress"],"dateCreated":"2025-09-26 00:00:00","display_title":"Endothelial cells: low vs high shear stress","group_a_title":"Endothelial cells under low shear stress conditions.. Represents the condition associated with upregulation of inflammatory, adhesion, and cellular permeability molecules.","group_b_title":"Endothelial cells under high shear stress conditions.. Represents the condition associated with increased expression of protective and anti-inflammatory factors.","id":"MTBLS739_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS739","studyUrl":"http://integmet.org/study/MTBLS739","title":"Low_Shear_Stress_vs_High_Shear_Stress","topHits":[{"chebi_id":"16977","direction":"up","inn_name":"","iupac_name":"<small>L</small>-alanine","metabolite_id":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","pvalue":0.0004697074802926,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-2-aminopropanoic acid"},{"chebi_id":"13172","direction":"up","inn_name":"","iupac_name":"<em>keto</em>-<small>L</small>-sorbose","metabolite_id":"BJHIKXHVCXFQLS-OTWZMJIISA-N","pvalue":0.0013717258753698,"ratio":1000000.0,"synonym_name":"(3<i>S</i>,4<i>R</i>,5<i>S</i>)-1,3,4,5,6-pentahydroxyhexan-2-one"},{"chebi_id":"144328","direction":"down","inn_name":"","iupac_name":"3-tetradecoxypropane-1,2-diol","metabolite_id":"JSSKAZULTFHXBH-UHFFFAOYSA-N","pvalue":0.0077719826169205,"ratio":1e-06,"synonym_name":""},{"chebi_id":"58048","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-amino-2-azaniumyl-4-oxobutanoate","metabolite_id":"DCXYFEDJOCDNAF-REOHCLBHSA-N","pvalue":0.0105383808058681,"ratio":1000000.0,"synonym_name":"(2<i>S</i>)-2-ammonio-3-carbamoylpropanoate"},{"chebi_id":"18019","direction":"up","inn_name":"lysine","iupac_name":"(2<i>S</i>)-2,6-diaminohexanoic acid","metabolite_id":"KDXKERNSBIXSRK-YFKPBYRVSA-N","pvalue":0.0195917318270082,"ratio":1000000.0,"synonym_name":"L-Lysine"},{"chebi_id":"84212","direction":"up","inn_name":"","iupac_name":"furan-2,5-dicarboxylic acid","metabolite_id":"CHTHALBTIRVDBM-UHFFFAOYSA-N","pvalue":0.0226683367419739,"ratio":1000000.0,"synonym_name":"Furane-alpha,alpha'-dicarboxylic acid"},{"chebi_id":"35704","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>2</small></sup>-acetyl-<small>L</small>-lysine","metabolite_id":"VEYYWZRYIYDQJM-ZETCQYMHSA-N","pvalue":0.0321613354089232,"ratio":1000000.0,"synonym_name":"<em>N</em><small><sup>\u03b1</small></sup>-acetyl-<small>L</small>-lysine"},{"chebi_id":"144330","direction":"up","inn_name":"","iupac_name":"3-methylpent-2-enedioic acid","metabolite_id":"WKRBKYFIJPGYQC-UHFFFAOYSA-N","pvalue":0.0414719535360103,"ratio":1000000.0,"synonym_name":"3-methyl-2-pentenedioic acid"},{"chebi_id":"75892","direction":"down","inn_name":"","iupac_name":"6-deoxy-\u03b1-<small>L</small>-mannofuranose","metabolite_id":"AFNUZVCFKQUDBJ-MDMQIMBFSA-N","pvalue":0.046688742711088,"ratio":1e-06,"synonym_name":""},{"chebi_id":"17361","direction":"down","inn_name":"","iupac_name":"5'-cytidylic acid","metabolite_id":"IERHLVCPSMICTF-XVFCMESISA-N","pvalue":0.0467652729307513,"ratio":1e-06,"synonym_name":"Cytidine-5'-monophosphate"}],"totalFeatures":104},{"comparisonGroups":["Arginine_Replenished_Ctrl","Arginine_Starved_48h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arginine replenished vs 48h arginine starved","group_a_title":"Control group with arginine replenishment.. Provides a reference point for evaluating the effects of arginine starvation.","group_b_title":"Group subjected to 48 hours of arginine starvation.. Helps in understanding the long-term effects of arginine starvation.","id":"MTBLS745_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":37,"studyId":"MTBLS745","studyUrl":"http://integmet.org/study/MTBLS745","title":"Arginine_Replenished_Ctrl_vs_Arginine_Starved_48h","topHits":[{"chebi_id":"17755","direction":"up","inn_name":"","iupac_name":"2-amino-4-[(2-amino-2-carboxyethyl)sulfanyl]butanoic acid","metabolite_id":"ILRYLPWNYFXEMH-UHFFFAOYSA-N","pvalue":1.5007784622217372e-08,"ratio":1000000.0,"synonym_name":"DL-Cystathionine"},{"chebi_id":"16732","direction":"down","inn_name":"","iupac_name":"5'-<em>O</em>-[{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine","metabolite_id":"WVIMUEUQJFPNDK-PEBGCTIMSA-N","pvalue":4.189296010667149e-05,"ratio":1e-06,"synonym_name":"CDP ethanolamine"},{"chebi_id":"17924","direction":"up","inn_name":"","iupac_name":"<small>D</small>-glucitol","metabolite_id":"FBPFZTCFMRRESA-JGWLITMVSA-N","pvalue":0.0005039366021828,"ratio":1000000.0,"synonym_name":"D-SORBITOL"},{"chebi_id":"16311","direction":"up","inn_name":"","iupac_name":"2'-deoxycytidine 5'-(tetrahydrogen triphosphate)","metabolite_id":"RGWHQCVHVJXOKC-SHYZEUOFSA-N","pvalue":0.0023276833190155,"ratio":1000000.0,"synonym_name":"dCTP"},{"chebi_id":"15996","direction":"down","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0026035857035819,"ratio":1e-06,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"16708","direction":"down","inn_name":"","iupac_name":"9<em>H</em>-purin-6-amine","metabolite_id":"GFFGJBXGBJISGV-UHFFFAOYSA-N","pvalue":0.0428440328499932,"ratio":1e-06,"synonym_name":"Adenin"},{"chebi_id":"74359","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumylbutanoate","metabolite_id":"QWCKQJZIFLGMSD-VKHMYHEASA-N","pvalue":1.2891328821369394e-05,"ratio":15.846244626439791,"synonym_name":"(2<i>S</i>)-2-ammoniobutanoate"},{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":2.7536221913790968e-05,"ratio":0.0680291034320629,"synonym_name":"colamine phosphate"},{"chebi_id":"20392","direction":"up","inn_name":"","iupac_name":"4-hydroxyproline","metabolite_id":"PMMYEEVYMWASQN-UHFFFAOYSA-N","pvalue":4.614128161579962e-06,"ratio":9.148262602833878,"synonym_name":"4Hyp"},{"chebi_id":"29016","direction":"up","inn_name":"","iupac_name":"arginine","metabolite_id":"ODKSFYDXXFIFQN-UHFFFAOYSA-N","pvalue":0.0015215633439944,"ratio":51.709688746064074,"synonym_name":"Arginin"}],"totalFeatures":96},{"comparisonGroups":["var_intermedia_Cameron_Highlands","var_intermedia_Kuala_Terengganu"],"dateCreated":"2025-09-26 00:00:00","display_title":"Ficus deltoidea: Cameron Highlands vs Kuala Terengganu","group_a_title":"Samples of Ficus deltoidea var. intermedia from Cameron Highlands.. Represents the chemotype-a group for intermedia variety.","group_b_title":"Samples of Ficus deltoidea var. intermedia from Kuala Terengganu.. Represents the chemotype-a group for intermedia variety.","id":"MTBLS756_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS756","studyUrl":"http://integmet.org/study/MTBLS756","title":"G1_var_intermedia_Cameron_Highlands_vs_G15_var_intermedia_Kuala_Terengganu","topHits":[],"totalFeatures":13},{"comparisonGroups":["BSA_Control","AA"],"dateCreated":"2025-09-26 00:00:00","display_title":"BSA control vs arachidonic acid treatment","group_a_title":"Control samples treated with BSA.. Provides a reference point for evaluating the effects of other treatments.","group_b_title":"Samples treated with arachidonic acid.. This group is crucial for understanding the effects of arachidonic acid on membrane fluidity.","id":"MTBLS757_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":132,"studyId":"MTBLS757","studyUrl":"http://integmet.org/study/MTBLS757","title":"BSA_Control_vs_AA","topHits":[{"chebi_id":"167585","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"ODKRDLFMXDISEG-BERHWORVSA-N","pvalue":1.488700390011511e-07,"ratio":0.0014070109625458,"synonym_name":"PC(14:1(9Z)/24:1(15Z))"},{"chebi_id":"145318","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"DGMIFZYXZKMMFC-QNRZDJQYSA-N","pvalue":4.320382555996099e-05,"ratio":156.96629857582172,"synonym_name":"PC 22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HKPSEVXESLHAAR-SDEIJOJQSA-N","pvalue":5.3882334146981355e-05,"ratio":161.49479759576127,"synonym_name":""},{"chebi_id":"191363","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"YBAVZMWJCPETFA-QFTUWMPFSA-N","pvalue":4.838836827049784e-05,"ratio":78.91661726963649,"synonym_name":""},{"chebi_id":"89098","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"MUFCWCXVLIXBJC-PIUCSNMVSA-N","pvalue":5.389214491628832e-08,"ratio":0.0765300909884037,"synonym_name":"Phosphatidylcholine(20:1n9/22:1n9)"},{"chebi_id":"176739","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"SGQIECCWAOPTNL-LEFPGAKQSA-N","pvalue":3.933009199377674e-06,"ratio":31.112707218538713,"synonym_name":""},{"chebi_id":"89521","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VZQRMZUULSWEHB-XCFXQIAYSA-N","pvalue":1.1841119898774446e-05,"ratio":32.56916659402231,"synonym_name":"PC(32:3)"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"TXTNDPNZKXBXAQ-FCWXPPSASA-N","pvalue":4.613740232993065e-06,"ratio":0.0497061001032419,"synonym_name":""},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"CQAZMJNMKVCUQL-PLTOFNHWSA-N","pvalue":2.8146544653654024e-05,"ratio":33.461574676217616,"synonym_name":""},{"chebi_id":"171359","direction":"down","inn_name":"","iupac_name":"[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (5Z,8Z,11Z)-icosa-5,8,11-trienoate","metabolite_id":"ZXGWUCRPMYBWGO-MICLNOPWSA-N","pvalue":0.001176330418295,"ratio":0.0053780691486054,"synonym_name":""}],"totalFeatures":221},{"comparisonGroups":["Normal","Abnormal"],"dateCreated":"2025-09-26 00:00:00","display_title":"CRS patients: with vs without olfactory dysfunction","group_a_title":"Samples from CRS patients without olfactory dysfunction. Serves as the baseline for evaluating changes in olfactory function","group_b_title":"Samples from CRS patients with olfactory dysfunction. Key group for understanding the impact of olfactory dysfunction","id":"MTBLS7584_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS7584","studyUrl":"http://integmet.org/study/MTBLS7584","title":"Normal_vs_Abnormal","topHits":[{"chebi_id":"27607","direction":"up","inn_name":"","iupac_name":"5-methyl-2-(propan-2-yl)phenol","metabolite_id":"MGSRCZKZVOBKFT-UHFFFAOYSA-N","pvalue":4.934652735099223e-06,"ratio":1.5305490670427704,"synonym_name":"5-methyl-2-isopropylphenol"},{"chebi_id":"17172","direction":"up","inn_name":"","iupac_name":"2'-deoxyguanosine","metabolite_id":"YKBGVTZYEHREMT-KVQBGUIXSA-N","pvalue":0.0001567846550909,"ratio":1.5298934784032112,"synonym_name":"dG"},{"chebi_id":"29073","direction":"up","inn_name":"\u00e1cido asc\u00f3rbico","iupac_name":"(5<i>R</i>)-5-[(1<i>S</i>)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5<em>H</em>)-one","metabolite_id":"CIWBSHSKHKDKBQ-JLAZNSOCSA-N","pvalue":0.034282808681107,"ratio":2.7804966416337296,"synonym_name":"Vitamin C"},{"chebi_id":"17553","direction":"up","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":0.0360703165874863,"ratio":2.1435985820750583,"synonym_name":"colamine phosphate"},{"chebi_id":"46823","direction":"down","inn_name":"","iupac_name":"1<em>H</em>-purine-2,6,8-triol","metabolite_id":"LEHOTFFKMJEONL-UHFFFAOYSA-N","pvalue":0.0322000831601616,"ratio":0.5434727265509359,"synonym_name":""},{"chebi_id":"17431","direction":"down","inn_name":"","iupac_name":"1-(4-aminobutyl)guanidine","metabolite_id":"QYPPJABKJHAVHS-UHFFFAOYSA-N","pvalue":0.0348517462718784,"ratio":0.5386388139814086,"synonym_name":"Agmatine"},{"chebi_id":"17596","direction":"up","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0183875834546238,"ratio":1.5815284850828697,"synonym_name":"hypoxanthine <small>D</small>-riboside"},{"chebi_id":"187909","direction":"up","inn_name":"","iupac_name":"8-methoxy-2,3-dihydrouro[2,3-b]quinoline","metabolite_id":"BBQSWPCXIWMWGH-UHFFFAOYSA-N","pvalue":0.0467683623206471,"ratio":1.7596400388277815,"synonym_name":""}],"totalFeatures":306},{"comparisonGroups":["Normal","Abnormal"],"dateCreated":"2025-09-26 00:00:00","display_title":"CRS patients: with vs without olfactory dysfunction","group_a_title":"Samples from CRS patients without olfactory dysfunction. Serves as the baseline for evaluating changes in olfactory function","group_b_title":"Samples from CRS patients with olfactory dysfunction. Key group for understanding the impact of olfactory dysfunction","id":"MTBLS7584_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":19,"studyId":"MTBLS7584","studyUrl":"http://integmet.org/study/MTBLS7584","title":"Normal_vs_Abnormal","topHits":[{"chebi_id":"168043","direction":"down","inn_name":"","iupac_name":"(E)-1-(4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one","metabolite_id":"UPRXEFYRIACHQZ-AATRIKPKSA-N","pvalue":0.0010979396305472,"ratio":0.3114263906689249,"synonym_name":""},{"chebi_id":"183568","direction":"down","inn_name":"","iupac_name":"(E)-9,10-dihydroxydec-2-enoic acid","metabolite_id":"LJVFDEUMLMNPKS-FNORWQNLSA-N","pvalue":1.1990531658204232e-05,"ratio":0.5725778317813518,"synonym_name":""},{"chebi_id":"174013","direction":"down","inn_name":"","iupac_name":"(2S,5S)-2-[(2R)-butan-2-yl]-5-hydroxy-4-oxohexanoic acid","metabolite_id":"DYYQDDUCQLULFE-CSMHCCOUSA-N","pvalue":0.0096182302196854,"ratio":0.2840785164596638,"synonym_name":""},{"chebi_id":"169020","direction":"down","inn_name":"","iupac_name":"4-(1,2-dihydroxypropan-2-yl)-1-methylcyclohexane-1,2-diol","metabolite_id":"QEFNQQRVZDFDIJ-UHFFFAOYSA-N","pvalue":0.0022458656883519,"ratio":0.4483306405234363,"synonym_name":""},{"chebi_id":"51922","direction":"down","inn_name":"","iupac_name":"(3<i>E</i>,5<i>E</i>)-7-hydroxy-6-methylhepta-3,5-dienal","metabolite_id":"ARBHCEGTLUXZRX-YNRRLODASA-N","pvalue":0.0008494322435612,"ratio":0.5031501889958541,"synonym_name":"7-hydroxy-6-methylhepta-3,5-dienal"},{"chebi_id":"168229","direction":"down","inn_name":"","iupac_name":"2-[3-oxo-2-[(E)-pent-2-enyl]cyclopenten-1-yl]acetic acid","metabolite_id":"QAAHGFINENUHAR-ONEGZZNKSA-N","pvalue":0.0098813139471484,"ratio":0.403110520836656,"synonym_name":""},{"chebi_id":"16750","direction":"up","inn_name":"","iupac_name":"guanosine","metabolite_id":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","pvalue":0.0011343145720103,"ratio":1.807439815526615,"synonym_name":"G"},{"chebi_id":"78668","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-10-hydroxydec-2-enoic acid","metabolite_id":"QHBZHVUGQROELI-SOFGYWHQSA-N","pvalue":0.0106796480146347,"ratio":0.4361820946911085,"synonym_name":"<i>trans</i>-10-hydroxydec-2-enoic acid"},{"chebi_id":"68465","direction":"down","inn_name":"","iupac_name":"2,6-dihydroxybenzoic acid","metabolite_id":"AKEUNCKRJATALU-UHFFFAOYSA-N","pvalue":0.0198230714735751,"ratio":0.4184314243410992,"synonym_name":"6-Hydroxysalicylic acid"},{"chebi_id":"78700","direction":"down","inn_name":"","iupac_name":"9-oxononanoic acid","metabolite_id":"WLGDDELKYAWBBL-UHFFFAOYSA-N","pvalue":0.0003323920545588,"ratio":0.6590108166356927,"synonym_name":"8-formyloctanoic acid"}],"totalFeatures":385},{"comparisonGroups":["Normal","Abnormal"],"dateCreated":"2025-09-26 00:00:00","display_title":"CRS patients: with vs without olfactory dysfunction","group_a_title":"Samples from CRS patients without olfactory dysfunction. Serves as the baseline for evaluating changes in olfactory function","group_b_title":"Samples from CRS patients with olfactory dysfunction. Key group for understanding the impact of olfactory dysfunction","id":"MTBLS7584_0003_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":26,"studyId":"MTBLS7584","studyUrl":"http://integmet.org/study/MTBLS7584","title":"Normal_vs_Abnormal","topHits":[{"chebi_id":"174500","direction":"down","inn_name":"","iupac_name":"2-(hydroxymethyl)-6-[2-[4-(hydroxymethyl)cyclohex-3-en-1-yl]propan-2-yloxy]oxane-3,4,5-triol","metabolite_id":"JLDWWSSQBYGULG-UHFFFAOYSA-N","pvalue":0.0003557757010894,"ratio":0.4389485078422225,"synonym_name":""},{"chebi_id":"141419","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arginyl-<small>L</small>-proline","metabolite_id":"LQJAALCCPOTJGB-YUMQZZPRSA-N","pvalue":0.0005010237202483,"ratio":0.5572399389466585,"synonym_name":"arginylproline"},{"chebi_id":"137846","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"BYBHBTCYJMUUDZ-PMACEKPBSA-N","pvalue":0.0027514112306761,"ratio":0.4916643855691783,"synonym_name":"2S-dimethylaminooctadecane-1,3R-diol"},{"chebi_id":"28647","direction":"down","inn_name":"","iupac_name":"3,4-dihydroxy-5-methoxybenzoic acid","metabolite_id":"KWCCUYSXAYTNKA-UHFFFAOYSA-N","pvalue":0.015369490096021,"ratio":0.3675508340801827,"synonym_name":"gallic acid 3-methyl ether"},{"chebi_id":"83706","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-2-aminotetradec-4-ene-1,3-diol","metabolite_id":"VDRZDTXJMRRVMF-NXFSIWHZSA-N","pvalue":0.0160683271180843,"ratio":0.377060784599364,"synonym_name":"C<small><sub>14</sub></small>-sphingosine"},{"chebi_id":"73965","direction":"down","inn_name":"","iupac_name":"11\u03b1-hydroxy-2,3,4,5-tetranor-9,15-dioxoprostan-1,20-dioic acid","metabolite_id":"ZJAZCYLYLVCSNH-JHJVBQTASA-N","pvalue":0.0307673117205962,"ratio":0.3158173996861223,"synonym_name":"PGEM"},{"chebi_id":"76235","direction":"down","inn_name":"","iupac_name":"(8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-heptadeca-8,11,14-trienoic acid","metabolite_id":"FAFSAZIEJFMBBY-PDBXOOCHSA-N","pvalue":0.0043705337314421,"ratio":0.4897835906812992,"synonym_name":"<i>all</i>-<i>cis</i>-8,11,14-heptadecatrienoic acid"},{"chebi_id":"168530","direction":"down","inn_name":"","iupac_name":"butyl 3-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoate","metabolite_id":"YUPCLHHTUNDMAN-JZSHJRBHSA-N","pvalue":0.000869055035382,"ratio":0.5812007522908039,"synonym_name":""},{"chebi_id":"3927","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MIKUYHXYGGJMLM-UUOKFMHZSA-N","pvalue":0.0018388744039729,"ratio":1.7999704648044317,"synonym_name":"Crotonoside"},{"chebi_id":"168268","direction":"down","inn_name":"","iupac_name":"(1R,2R,3S,7R,9R,10R,12S)-3-hydroxy-2-(hydroxymethyl)-1,5-dimethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one","metabolite_id":"PUMXWMGECQIOGB-SMSDQXDJSA-N","pvalue":0.0313366184761374,"ratio":0.3865225013452679,"synonym_name":""}],"totalFeatures":591},{"comparisonGroups":["Control","Head_and_Neck_Carcinoma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Head and neck carcinoma vs healthy controls","group_a_title":"Control group with no head and neck carcinoma. Provides baseline data for comparison with disease-affected samples.","group_b_title":"Samples from patients with head and neck carcinoma. Represents the disease state for comparison with healthy controls.","id":"MTBLS760_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":32,"studyId":"MTBLS760","studyUrl":"http://integmet.org/study/MTBLS760","title":"Control_vs_Head_and_Neck_Carcinoma","topHits":[{"chebi_id":"15366","direction":"down","inn_name":"","iupac_name":"acetic acid","metabolite_id":"QTBSBXVTEAMEQO-UHFFFAOYSA-N","pvalue":4.196317913145933e-09,"ratio":0.0121850489535692,"synonym_name":"Ethanoic acid"},{"chebi_id":"143858","direction":"up","inn_name":"","iupac_name":"decane-1,2-diol","metabolite_id":"YSRSBDQINUMTIF-UHFFFAOYSA-N","pvalue":2.8206748666855617e-14,"ratio":7.307942723323186,"synonym_name":"decylene glycol"},{"chebi_id":"41330","direction":"down","inn_name":"","iupac_name":"ethyl propanoate","metabolite_id":"FKRCODPIKNYEAC-UHFFFAOYSA-N","pvalue":1.144123403089186e-07,"ratio":0.054270231113229,"synonym_name":"Ethyl n-propionate"},{"chebi_id":"16135","direction":"down","inn_name":"","iupac_name":"2-methylpropanoic acid","metabolite_id":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","pvalue":6.589457548996186e-06,"ratio":0.0219401520922253,"synonym_name":"2-METHYL-PROPIONIC ACID"},{"chebi_id":"74903","direction":"down","inn_name":"","iupac_name":"4-methylpentanoic acid","metabolite_id":"FGKJLKRYENPLQH-UHFFFAOYSA-N","pvalue":3.684631238832103e-05,"ratio":0.0202172496405439,"synonym_name":"4-Methylvaleric acid"},{"chebi_id":"28618","direction":"up","inn_name":"","iupac_name":"1,4-dichlorobenzene","metabolite_id":"OCJBOOLMMGQPQU-UHFFFAOYSA-N","pvalue":1.9680742364377485e-11,"ratio":4.595288957374539,"synonym_name":"1,4-Dichlorobenzene"},{"chebi_id":"15882","direction":"down","inn_name":"","iupac_name":"phenol","metabolite_id":"ISWSIDIOOBJBQZ-UHFFFAOYSA-N","pvalue":3.549711591348529e-07,"ratio":0.1136955608777382,"synonym_name":"PhOH"},{"chebi_id":"27750","direction":"down","inn_name":"","iupac_name":"ethyl acetate","metabolite_id":"XEKOWRVHYACXOJ-UHFFFAOYSA-N","pvalue":2.0367602209083126e-06,"ratio":0.0908703541487639,"synonym_name":"Ethyl acetate"},{"chebi_id":"17847","direction":"down","inn_name":"","iupac_name":"4-methylphenol","metabolite_id":"IWDCLRJOBJJRNH-UHFFFAOYSA-N","pvalue":0.000405125440682,"ratio":0.0388406201582335,"synonym_name":"<em>p</em>-Kresol"},{"chebi_id":"40116","direction":"down","inn_name":"","iupac_name":"propyl acetate","metabolite_id":"YKYONYBAUNKHLG-UHFFFAOYSA-N","pvalue":4.08241064664299e-05,"ratio":0.1248601567658765,"synonym_name":"n-Propyl acetate"}],"totalFeatures":48},{"comparisonGroups":["HL_to_HL_0","HL_to_HL_21"],"dateCreated":"2025-09-26 00:00:00","display_title":"High light exposure: baseline vs 21-day treatment","group_a_title":"High light to high light at 0 days. Provides baseline data for high light conditions.","group_b_title":"High light to high light at 21 days. Shows the effect of prolonged high light exposure over time.","id":"MTBLS768_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS768","studyUrl":"http://integmet.org/study/MTBLS768","title":"G1_HL_to_HL_0_vs_G8_HL_to_HL_21","topHits":[],"totalFeatures":4},{"comparisonGroups":["SAR-S","SAR-R"],"dateCreated":"2025-09-26 00:00:00","display_title":"Salmonella Typhimurium: sarafloxacin-resistant vs susceptible","group_a_title":"Sarafloxacin-susceptible Salmonella Typhimurium samples. Baseline group for comparison with resistant samples.","group_b_title":"Sarafloxacin-resistant Salmonella Typhimurium samples. Key group for understanding metabolic changes due to drug resistance.","id":"MTBLS7711_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":75,"studyId":"MTBLS7711","studyUrl":"http://integmet.org/study/MTBLS7711","title":"SAR-S_vs_SAR-R","topHits":[{"chebi_id":"74823","direction":"down","inn_name":"","iupac_name":"<small>L</small>-seryl-<small>L</small>-valine","metabolite_id":"ILVGMCVCQBJPSH-WDSKDSINSA-N","pvalue":3.655331556313115e-12,"ratio":0.2452361917498555,"synonym_name":"<small>L</small>-Ser-<small>L</small>-Val"},{"chebi_id":"73579","direction":"up","inn_name":"","iupac_name":"<small>L</small>-leucyl-<small>L</small>-valine","metabolite_id":"MDSUKZSLOATHMH-IUCAKERBSA-N","pvalue":1.5522385351776335e-05,"ratio":27.381034841995337,"synonym_name":"<small>L</small>-Leu-<small>L</small>-Val"},{"chebi_id":"74754","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-asparagine","metabolite_id":"JQOHKCDMINQZRV-WDSKDSINSA-N","pvalue":7.163770413764161e-12,"ratio":0.2451336871031331,"synonym_name":"<small>L</small>-Pro-<small>L</small>-Asn"},{"chebi_id":"4828","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":7.917265943587367e-09,"ratio":0.2635072545926828,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"73928","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"VHOLZZKNEBBHTH-YUMQZZPRSA-N","pvalue":6.893614544975836e-08,"ratio":3.7709731962685984,"synonym_name":"histidylglutamic acid"},{"chebi_id":"74072","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"JWBXCSQZLLIOCI-GUBZILKMSA-N","pvalue":0.0002534548864659,"ratio":12.97527083077045,"synonym_name":"<small>L</small>-Ile-<small>L</small>-Leu"},{"chebi_id":"73704","direction":"up","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-valine","metabolite_id":"KRNYOVHEKOBTEF-YUMQZZPRSA-N","pvalue":4.193062832260954e-05,"ratio":8.113399165809435,"synonym_name":"valylvaline"},{"chebi_id":"92809","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-[[(2<i>S</i>)-2-amino-3-methyl-1-oxobutyl]amino]-3-(1<em>H</em>-indol-3-yl)propanoic acid","metabolite_id":"LZDNBBYBDGBADK-KBPBESRZSA-N","pvalue":0.0001945429663447,"ratio":7.88720852459672,"synonym_name":"V-W"},{"chebi_id":"141437","direction":"up","inn_name":"","iupac_name":"<small>L</small>-histidyl-<small>L</small>-isoleucine","metabolite_id":"IDXZDKMBEXLFMB-HGNGGELXSA-N","pvalue":9.616250794962662e-05,"ratio":6.325281233188061,"synonym_name":"H-I dipeptide"},{"chebi_id":"137259","direction":"up","inn_name":"","iupac_name":"<small>L</small>-isoleucyl-<small>L</small>-glutamic acid","metabolite_id":"KTGFOCFYOZQVRJ-ZKWXMUAHSA-N","pvalue":3.7128780680603944e-05,"ratio":4.9794209910999205,"synonym_name":"I-E"}],"totalFeatures":247},{"comparisonGroups":["SAR-R Group","SAR-S Group"],"dateCreated":"2025-09-26 00:00:00","display_title":"Salmonella Typhimurium: sarafloxacin-resistant vs susceptible","group_a_title":"Sarafloxacin-resistant Salmonella Typhimurium samples. Key group for studying the effects of drug resistance on metabolism.","group_b_title":"Sarafloxacin-susceptible Salmonella Typhimurium samples. Serves as a comparison group to understand the metabolic differences due to drug resistance.","id":"MTBLS7713_0001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":55,"studyId":"MTBLS7713","studyUrl":"http://integmet.org/study/MTBLS7713","title":"SAR-R_vs_SAR-S","topHits":[{"chebi_id":"15676","direction":"up","inn_name":"","iupac_name":"<em>N</em>-(2,5-dioxoimidazolidin-4-yl)urea","metabolite_id":"POJWUDADGALRAB-UHFFFAOYSA-N","pvalue":1.5098249802453263e-08,"ratio":3.484991995163011,"synonym_name":"(2,5-Dioxo-4-imidazolidinyl)urea"},{"chebi_id":"28729","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-mannopyranose","metabolite_id":"WQZGKKKJIJFFOK-PQMKYFCFSA-N","pvalue":7.856888908564182e-06,"ratio":0.373203092983949,"synonym_name":"ALPHA-D-MANNOSE"},{"chebi_id":"1148","direction":"down","inn_name":"","iupac_name":"2-hydroxybutanoic acid","metabolite_id":"AFENDNXGAFYKQO-UHFFFAOYSA-N","pvalue":7.204970847587638e-05,"ratio":0.3030612760782054,"synonym_name":"2-Hydroxybutanoic acid"},{"chebi_id":"73705","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamic acid","metabolite_id":"OWQDWQKWSLFFFR-WDSKDSINSA-N","pvalue":7.773417061843772e-06,"ratio":2.36289970107725,"synonym_name":"(5-L-Glutamyl)-L-glutamate"},{"chebi_id":"15784","direction":"down","inn_name":"","iupac_name":"2-acetamido-2-deoxy-<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"BRGMHAYQAZFZDJ-RTRLPJTCSA-N","pvalue":2.248667955423214e-05,"ratio":0.4229234236306933,"synonym_name":"2-acetamido-2-deoxy-6-<em>O</em>-phosphono-<small>D</small>-glucopyranose"},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0023492509417392,"ratio":0.2219429220762359,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"21547","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-acetamidobutanedioic acid","metabolite_id":"OTCCIMWXFLJLIA-BYPYZUCNSA-N","pvalue":2.5745014356334208e-05,"ratio":0.4368035707105202,"synonym_name":"<em>N</em>-acetylaspartic acid"},{"chebi_id":"18300","direction":"down","inn_name":"","iupac_name":"(2<i>Z</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UPHRSURJSA-N","pvalue":1.863113753516201e-05,"ratio":0.4757555465342908,"synonym_name":"Maleic acid"},{"chebi_id":"74956","direction":"down","inn_name":"","iupac_name":"<em>O</em>-phosphonotyrosine","metabolite_id":"DCWXELXMIBXGTH-UHFFFAOYSA-N","pvalue":0.0021916318361978,"ratio":0.3012776563280422,"synonym_name":"phosphotyrosine"},{"chebi_id":"73514","direction":"up","inn_name":"","iupac_name":"glycyl-<small>L</small>-leucine","metabolite_id":"DKEXFJVMVGETOO-LURJTMIESA-N","pvalue":0.0002877356188162,"ratio":2.354467973913904,"synonym_name":"Glycyl-L-leucine"}],"totalFeatures":184},{"comparisonGroups":["Healthy","Infected"],"dateCreated":"2025-09-26 00:00:00","display_title":"Diatom cells: healthy vs L. coscinodisci infected","group_a_title":"Healthy control group. Serves as the reference point for all other conditions.","group_b_title":"Diatom cells infected with Lagenisma coscinodisci. Crucial for understanding the direct effects of infection.","id":"MTBLS775_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":105,"studyId":"MTBLS775","studyUrl":"http://integmet.org/study/MTBLS775","title":"Healthy_vs_Infected","topHits":[{"chebi_id":"176711","direction":"down","inn_name":"","iupac_name":"(4S)-4-[(E)-oct-2-enoyl]oxy-4-(trimethylazaniumyl)butanoate","metabolite_id":"YMIVWYONPRZBEJ-LXKVQUBZSA-N","pvalue":0.0001526907409345,"ratio":0.0054140212891829,"synonym_name":""},{"chebi_id":"37024","direction":"up","inn_name":"","iupac_name":"2-aminohexanedioic acid","metabolite_id":"OYIFNHCXNCRBQI-UHFFFAOYSA-N","pvalue":1.0570950096507037e-07,"ratio":11.521828199613262,"synonym_name":"2-aminoadipic acid"},{"chebi_id":"17786","direction":"up","inn_name":"","iupac_name":"<em>N</em>-acetylleucine","metabolite_id":"WXNXCEHXYPACJF-ZETCQYMHSA-N","pvalue":3.276831582576643e-06,"ratio":19.376340670075088,"synonym_name":"N-Acetyl-L-leucine"},{"chebi_id":"17537","direction":"down","inn_name":"","iupac_name":"<small>L</small>-tyrosyl-<small>L</small>-arginine","metabolite_id":"JXNRXNCCROJZFB-RYUDHWBXSA-N","pvalue":0.0043463190611632,"ratio":0.0018968868942053,"synonym_name":"<em>N</em><small><sup>2</small></sup>-<small>L</small>-tyrosyl-<small>L</small>-arginine"},{"chebi_id":"31572","direction":"down","inn_name":"","iupac_name":"ethyl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"FMMOOAYVCKXGMF-MURFETPASA-N","pvalue":8.953243589645559e-05,"ratio":0.0267012379181027,"synonym_name":"9,12-Octadecadienoic acid ethyl ester"},{"chebi_id":"166588","direction":"up","inn_name":"","iupac_name":"2-methylsulanylpyrazine","metabolite_id":"KBPBOWBQRUXMFV-UHFFFAOYSA-N","pvalue":9.66313516848742e-06,"ratio":17.42370266749441,"synonym_name":""},{"chebi_id":"73823","direction":"down","inn_name":"","iupac_name":"<small>L</small>-arginyl-<small>L</small>-valine","metabolite_id":"DAQIJMOLTMGJLO-YUMQZZPRSA-N","pvalue":0.0026168046252217,"ratio":0.005794892708234,"synonym_name":"Arginyl-Valine"},{"chebi_id":"84883","direction":"down","inn_name":"icosapent","iupac_name":"ethyl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"SSQPWTVBQMWLSZ-AAQCHOMXSA-N","pvalue":0.0025898533061092,"ratio":0.0098030029618176,"synonym_name":"EPA ethyl ester"},{"chebi_id":"45240","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"CITHEXJVPOWHKC-UUWRZZSWSA-N","pvalue":0.0003319864950967,"ratio":0.0344116951725444,"synonym_name":"1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE"},{"chebi_id":"4746","direction":"up","inn_name":"","iupac_name":"\u03b2,\u03b2-caroten-4-one","metabolite_id":"QXNWZXMBUKUYMD-QQGJMDNJSA-N","pvalue":5.313676171342275e-05,"ratio":14.256838925184551,"synonym_name":"Echinenone"}],"totalFeatures":178},{"comparisonGroups":["PPC","PPY"],"dateCreated":"2025-09-26 00:00:00","display_title":"Paris polyphylla: chinensis vs yunnanensis varieties","group_a_title":"Samples from Paris polyphylla var. chinensis. This group is crucial for understanding the specific traits of Paris polyphylla var. chinensis.","group_b_title":"Samples from Paris polyphylla var. yunnanensis. This group is crucial for understanding the specific traits of Paris polyphylla var. yunnanensis.","id":"MTBLS779_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS779","studyUrl":"http://integmet.org/study/MTBLS779","title":"PPC_vs_PPY","topHits":[{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":2.2154920054264056e-05,"ratio":7.957822271928299,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"28044","direction":"up","inn_name":"","iupac_name":"2-amino-3-phenylpropanoic acid","metabolite_id":"COLNVLDHVKWLRT-UHFFFAOYSA-N","pvalue":0.0008495108754251,"ratio":6.693381011160507,"synonym_name":"alpha-Amino-beta-phenylpropionic acid"},{"chebi_id":"35243","direction":"up","inn_name":"","iupac_name":"2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-UHFFFAOYSA-N","pvalue":0.0118456807597131,"ratio":13.076493587531711,"synonym_name":"serine zwitterion"},{"chebi_id":"26271","direction":"down","inn_name":"","iupac_name":"proline","metabolite_id":"ONIBWKKTOPOVIA-UHFFFAOYSA-N","pvalue":0.0118788365424071,"ratio":0.0943632602942268,"synonym_name":"DL-Proline"},{"chebi_id":"32816","direction":"up","inn_name":"","iupac_name":"2-oxopropanoic acid","metabolite_id":"LCTONWCANYUPML-UHFFFAOYSA-N","pvalue":0.0024655474165387,"ratio":5.389216466553308,"synonym_name":"Acetylformic acid"},{"chebi_id":"58045","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,3<i>S</i>)-2-azaniumyl-3-methylpentanoate","metabolite_id":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","pvalue":0.0055532719106903,"ratio":0.2424316483670343,"synonym_name":"(2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate"},{"chebi_id":"17992","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranosyl \u03b1-<small>D</small>-glucopyranoside","metabolite_id":"CZMRCDWAGMRECN-UGDNZRGBSA-N","pvalue":0.0191223199705228,"ratio":0.1641438068455213,"synonym_name":"1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside"},{"chebi_id":"22958","direction":"down","inn_name":"","iupac_name":"but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-UHFFFAOYSA-N","pvalue":0.0040371110383612,"ratio":0.284399843110052,"synonym_name":"2-butenedioic acid"},{"chebi_id":"22660","direction":"down","inn_name":"","iupac_name":"aspartic acid","metabolite_id":"CKLJMWTZIZZHCS-UHFFFAOYSA-N","pvalue":0.0179117186288002,"ratio":0.1985588589201019,"synonym_name":"Aspartic acid"},{"chebi_id":"27266","direction":"down","inn_name":"","iupac_name":"valine","metabolite_id":"KZSNJWFQEVHDMF-UHFFFAOYSA-N","pvalue":0.0044834004255043,"ratio":0.3013777800066641,"synonym_name":"2-amino-3-methylbutanoic acid"}],"totalFeatures":31},{"comparisonGroups":["JURKAT_Control","JURKAT_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"JURKAT cells: hydrazinosuccinic acid treatment","group_a_title":"Control group of JURKAT E-6.1 cells. Provides baseline data for comparison with treated JURKAT E-6.1 cells","group_b_title":"Treated group of JURKAT E-6.1 cells with hydrazinosuccinic acid. Allows assessment of the effects of hydrazinosuccinic acid on JURKAT E-6.1 cells","id":"MTBLS789_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS789","studyUrl":"http://integmet.org/study/MTBLS789","title":"JURKAT_Control_vs_JURKAT_Treatment","topHits":[],"totalFeatures":77},{"comparisonGroups":["WT","ErbB2 KI"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cardiac tissue: ErbB2 knock-in vs wild-type","group_a_title":"Wild-type control group. Serves as the reference point for all other genetically modified groups.","group_b_title":"ErbB2 knock-in group. Used to study the effects of ErbB2 knock-in on cardiac function.","id":"MTBLS795_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS795","studyUrl":"http://integmet.org/study/MTBLS795","title":"WT_vs_ErbB2_KI","topHits":[{"chebi_id":"15351","direction":"down","inn_name":"","iupac_name":"3'-phosphoadenosine 5'-(3-{(3<i>R</i>)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} dihydrogen diphosphate)","metabolite_id":"ZSLZBFCDCINBPY-ZSJPKINUSA-N","pvalue":8.442119059746871e-05,"ratio":0.4626109824696574,"synonym_name":"Acetyl-CoA"},{"chebi_id":"74534","direction":"down","inn_name":"","iupac_name":"<small>L</small>-leucylglycine","metabolite_id":"LESXFEZIFXFIQR-LURJTMIESA-N","pvalue":0.0015032743324492,"ratio":0.4020368712228115,"synonym_name":"Leucyl-Glycine"},{"chebi_id":"28645","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose","metabolite_id":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","pvalue":0.0108653929779951,"ratio":0.2854521794184659,"synonym_name":"beta-D-arabino-Hexulose"},{"chebi_id":"73922","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"STKYPAFSDFAEPH-LURJTMIESA-N","pvalue":0.0002663757569571,"ratio":0.5115093018668408,"synonym_name":"Gly-<small>L</small>-Val"},{"chebi_id":"75013","direction":"down","inn_name":"","iupac_name":"<small>L</small>-valyl-<small>L</small>-leucine","metabolite_id":"XCTHZFGSVQBHBW-IUCAKERBSA-N","pvalue":0.0053765699116766,"ratio":0.3656524519021106,"synonym_name":"VL"},{"chebi_id":"4828","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.0017333223707664,"ratio":0.446420006553656,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"82931","direction":"down","inn_name":"","iupac_name":"4-ethenylphenyl hydrogen sulfate","metabolite_id":"IETVQHUKTKKBFF-UHFFFAOYSA-N","pvalue":0.0008396944201916,"ratio":0.509590189424156,"synonym_name":""},{"chebi_id":"17306","direction":"down","inn_name":"","iupac_name":"\u03b1-<small>D</small>-glucopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-PICCSMPSSA-N","pvalue":0.0207318180656115,"ratio":0.2933530535245564,"synonym_name":"Malzzucker"},{"chebi_id":"73017","direction":"up","inn_name":"","iupac_name":"3-[(2-methylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate","metabolite_id":"LRCNOZRCYBNMEP-UHFFFAOYSA-N","pvalue":0.0029135158619331,"ratio":2.2221519787951443,"synonym_name":"isobutyrylcarnitine"},{"chebi_id":"16610","direction":"down","inn_name":"","iupac_name":"<em>N</em>-(3-aminopropyl)butane-1,4-diamine","metabolite_id":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","pvalue":0.0003012363866397,"ratio":0.5856835029761661,"synonym_name":"N-(3-Aminopropyl)-1,4-butane-diamine"}],"totalFeatures":388},{"comparisonGroups":["After_Calving","21_Days_Before_Due_Date"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cattle: after calving vs 21 days before due date","group_a_title":"Samples collected immediately after calving.. Represents the metabolic state after calving, crucial for understanding postpartum changes.","group_b_title":"Samples collected 21 days before the due date.. Represents the metabolic state before calving, crucial for understanding prepartum changes.","id":"MTBLS809_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":20,"studyId":"MTBLS809","studyUrl":"http://integmet.org/study/MTBLS809","title":"After_Calving_vs_21_Days_Before_Due_Date","topHits":[{"chebi_id":"17716","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-galactopyranosyl-(1\u21924)-<small>D</small>-glucopyranose","metabolite_id":"GUBGYTABKSRVRQ-QKKXKWKRSA-N","pvalue":5.3550213939980145e-14,"ratio":10.819323978935756,"synonym_name":"milk sugar"},{"chebi_id":"16196","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-octadec-9-enoic acid","metabolite_id":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","pvalue":2.1172415613054718e-20,"ratio":3.5658831245572973,"synonym_name":"Oleate"},{"chebi_id":"28716","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-hexadec-9-enoic acid","metabolite_id":"SECPZKHBENQXJG-FPLPWBNLSA-N","pvalue":4.780070352108432e-09,"ratio":16.86241125450001,"synonym_name":"16:1\u03949"},{"chebi_id":"57912","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>)-2-azaniumyl-3-(1<em>H</em>-indol-3-yl)propanoate","metabolite_id":"QIVBCDIJIAJPQS-VIFPVBQESA-N","pvalue":6.891505554981129e-18,"ratio":0.3132602168617733,"synonym_name":"(2<i>S</i>)-2-ammonio-3-(1<em>H</em>-indol-3-yl)propanoate"},{"chebi_id":"28875","direction":"up","inn_name":"","iupac_name":"myristic acid","metabolite_id":"TUNFSRHWOTWDNC-UHFFFAOYSA-N","pvalue":3.6554536682159557e-09,"ratio":6.184836355199595,"synonym_name":"n-Tetradecan-1-oic acid"},{"chebi_id":"55328","direction":"up","inn_name":"","iupac_name":"16-hydroxyhexadecanoic acid","metabolite_id":"UGAGPNKCDRTDHP-UHFFFAOYSA-N","pvalue":4.769298480902441e-09,"ratio":4.208959617813508,"synonym_name":"16-OH 16:0"},{"chebi_id":"28661","direction":"up","inn_name":"","iupac_name":"(6<i>Z</i>,9<i>Z</i>,12<i>Z</i>)-octadeca-6,9,12-trienoic acid","metabolite_id":"VZCCETWTMQHEPK-QNEBEIHSSA-N","pvalue":4.5257935550592115e-14,"ratio":2.077640506266874,"synonym_name":"(6Z,9Z,12Z)-Octadecatrienoic acid"},{"chebi_id":"17351","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoic acid","metabolite_id":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","pvalue":9.735710311361303e-15,"ratio":1.9785155902608564,"synonym_name":"Linoleic acid"},{"chebi_id":"28631","direction":"down","inn_name":"","iupac_name":"3-phenylpropanoic acid","metabolite_id":"XMIIGOLPHOKFCH-UHFFFAOYSA-N","pvalue":4.354427935442487e-09,"ratio":0.4084195747112264,"synonym_name":"3-phenylpropionic acid"},{"chebi_id":"15756","direction":"up","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":2.957740218902768e-11,"ratio":1.9685878112812405,"synonym_name":"<em>n</em>-hexadecoic acid"}],"totalFeatures":30},{"comparisonGroups":["After_Calving","21_Days_Before_Due_Date"],"dateCreated":"2025-09-26 00:00:00","display_title":"Cattle: postpartum vs 21 days before calving","group_a_title":"Samples collected immediately after calving.. Represents the metabolic state after calving, crucial for understanding postpartum changes.","group_b_title":"Samples collected 21 days before the due date.. Represents the metabolic state before calving, crucial for understanding prepartum changes.","id":"MTBLS809_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS809","studyUrl":"http://integmet.org/study/MTBLS809","title":"After_Calving_vs_21_Days_Before_Due_Date","topHits":[{"chebi_id":"16990","direction":"up","inn_name":"","iupac_name":"bilirubin","metabolite_id":"BPYKTIZUTYGOLE-IFADSCNNSA-N","pvalue":1.5225908467020706e-07,"ratio":25.66861271146182,"synonym_name":"bilirubin-IX\u03b1"},{"chebi_id":"18257","direction":"down","inn_name":"","iupac_name":"ornithine","metabolite_id":"AHLPHDHHMVZTML-UHFFFAOYSA-N","pvalue":2.0916110867443966e-13,"ratio":0.3254494364790655,"synonym_name":"2,5-Diaminopentanoic acid"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"VONCWAQXCVELFQ-SNVBAGLBSA-N","pvalue":2.9158784929636136e-10,"ratio":0.2285293284759968,"synonym_name":""},{"chebi_id":"135063","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SUHOQUVVVLNYQR-UHFFFAOYSA-N","pvalue":4.696266725934942e-15,"ratio":0.383567207219521,"synonym_name":"glycerophosphoric acid choline ester"},{"chebi_id":"17490","direction":"up","inn_name":"","iupac_name":"(3<i>R</i>)-3-hexadecanoyloxy-4-(trimethylammonio)butanoate","metabolite_id":"XOMRRQXKHMYMOC-OAQYLSRUSA-N","pvalue":8.855060616071425e-07,"ratio":3.9094568204989337,"synonym_name":"Hexadecenoyl carnitine"},{"chebi_id":"73074","direction":"up","inn_name":"","iupac_name":"3-(octadecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"FNPHNLNTJNMAEE-UHFFFAOYSA-N","pvalue":6.884212637502719e-06,"ratio":3.5727235839997267,"synonym_name":"3-(octadecanoyloxy)-4-(trimethylammonio)butanoate"},{"chebi_id":"71466","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-<em>N</em>-(2-hydroxyethyl)octadec-9-enamide","metabolite_id":"BOWVQLFMWHZBEF-KTKRTIGZSA-N","pvalue":5.876386262178951e-09,"ratio":2.181669218768341,"synonym_name":"oleoylethanolamide"},{"chebi_id":"28610","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"YAMUFBLWGFFICM-PTGWMXDISA-N","pvalue":7.337718099978431e-08,"ratio":0.4715278474210128,"synonym_name":"1-Oleoylglycerophosphocholine"},{"chebi_id":"89516","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LOVKBDFNFACEND-HSEDGGQWSA-N","pvalue":2.1904588812542703e-08,"ratio":1.8998462883145493,"synonym_name":"PC(14:0/22:1)"},{"chebi_id":"18132","direction":"down","inn_name":"","iupac_name":"<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-(phosphonooxy)ethanaminium","metabolite_id":"YHHSONZFOIEMCP-UHFFFAOYSA-O","pvalue":1.4805102298247031e-08,"ratio":0.5948698214269307,"synonym_name":"Phosphorylcholine"}],"totalFeatures":37},{"comparisonGroups":["Untreated Control","2DG"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 2DG treatment for radiosensitivity","group_a_title":"Baseline control group with no treatment applied.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with 2-deoxy-D-glucose (2DG).. Evaluates the effect of 2DG on radiosensitivity.","id":"MTBLS858_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS858","studyUrl":"http://integmet.org/study/MTBLS858","title":"G1_Untreated_Control_vs_G2_2DG","topHits":[{"chebi_id":"16027","direction":"up","inn_name":"adenosine phosphate","iupac_name":"5'-adenylic acid","metabolite_id":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","pvalue":6.846740585969598e-05,"ratio":4.476418951608229,"synonym_name":"Adenosine-5'-monophosphoric acid"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":1.5736223635552095e-06,"ratio":2.374648508439782,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"16761","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":7.234115275613515e-05,"ratio":3.071871744544628,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"16708","direction":"up","inn_name":"","iupac_name":"9<em>H</em>-purin-6-amine","metabolite_id":"GFFGJBXGBJISGV-UHFFFAOYSA-N","pvalue":0.0001226544374468,"ratio":1.9062522148892271,"synonym_name":"Adenin"},{"chebi_id":"16856","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0012733343929672,"ratio":1.5251758693343511,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"}],"totalFeatures":7},{"comparisonGroups":["Untreated Control","2DG"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 2DG treatment effect on radiosensitivity","group_a_title":"Baseline control group with no treatment applied.. Provides a reference point for evaluating the effects of treatments.","group_b_title":"Group treated with 2-deoxy-D-glucose (2DG).. Evaluates the effect of 2DG on radiosensitivity.","id":"MTBLS858_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":8,"studyId":"MTBLS858","studyUrl":"http://integmet.org/study/MTBLS858","title":"G1_Untreated_Control_vs_G2_2DG","topHits":[{"chebi_id":"17138","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-oxopropyl dihydrogen phosphate","metabolite_id":"LXJXRIRHZLFYRP-UHFFFAOYSA-N","pvalue":2.104847958499195e-07,"ratio":1000000.0,"synonym_name":"Glyceraldehyde 3-phosphate"},{"chebi_id":"84756","direction":"down","inn_name":"","iupac_name":"2-deoxy-6-<em>O</em>-phosphono-<small>D</small>-<i>arabino</i>-hexopyranose","metabolite_id":"UQJFZAAGZAYVKZ-CERMHHMHSA-N","pvalue":4.299795682448572e-06,"ratio":0.0029388891856221,"synonym_name":"2-Deoxy-D-glucose 6-phosphate"},{"chebi_id":"4170","direction":"down","inn_name":"","iupac_name":"<small>D</small>-glucopyranose 6-(dihydrogen phosphate)","metabolite_id":"NBSCHQHZLSJFNQ-GASJEMHNSA-N","pvalue":2.322361230790836e-05,"ratio":0.0090581396280849,"synonym_name":"Glc6P"},{"chebi_id":"15903","direction":"down","inn_name":"","iupac_name":"\u03b2-<small>D</small>-glucopyranose","metabolite_id":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","pvalue":5.1938658389583165e-06,"ratio":0.0190459772485339,"synonym_name":"beta-D-Glucose"},{"chebi_id":"6650","direction":"up","inn_name":"","iupac_name":"2-hydroxybutanedioic acid","metabolite_id":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","pvalue":6.908989063312122e-06,"ratio":3.72246017555842,"synonym_name":"2-Hydroxysuccinic acid"},{"chebi_id":"44897","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoic acid","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","pvalue":0.0028664094659081,"ratio":3.1299998136934826,"synonym_name":"PEP"},{"chebi_id":"30769","direction":"up","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0005091087721887,"ratio":1.7849279725137268,"synonym_name":"Citronens\u00e4ure"},{"chebi_id":"30887","direction":"up","inn_name":"","iupac_name":"1-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"ODBLHEXUDAPZAU-UHFFFAOYSA-N","pvalue":0.0005091087721887,"ratio":1.7849279725137268,"synonym_name":"Isocitric acid"}],"totalFeatures":13},{"comparisonGroups":["Untreated","HD871-1_treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Leishmania mexicana: HD871-1 treatment vs untreated","group_a_title":"Untreated samples with dimethyl sulfoxide. Serves as the baseline for treatment comparisons","group_b_title":"Samples treated with HD871-1. Evaluates the effect of HD871-1 treatment on Leishmania mexicana","id":"MTBLS868_0001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS868","studyUrl":"http://integmet.org/study/MTBLS868","title":"Untreated_vs_HD871-1_treatment","topHits":[{"chebi_id":"35491","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":0.0011468275036736,"ratio":1000000.0,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"17025","direction":"down","inn_name":"","iupac_name":"(4<i>S</i>)-2,6-dioxohexahydropyrimidine-4-carboxylic acid","metabolite_id":"UFIVEPVSAGBUSI-REOHCLBHSA-N","pvalue":0.0055362476737459,"ratio":0.0634542297462929,"synonym_name":"L-Dihydroorotic acid"},{"chebi_id":"17713","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-adenylic acid","metabolite_id":"KHWCHTKSEGGWEX-RRKCRQDMSA-N","pvalue":2.1202403273134204e-05,"ratio":3.199284309307925,"synonym_name":"2'-deoxyadenosine monophosphate"},{"chebi_id":"17842","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,7<i>R</i>,26<i>R</i>,31<i>S</i>)-2,31-diamino-5,8,11,22,25,28-hexaoxo-7,26-bis(sulfanylmethyl)-6,9,12,16,21,24,27-heptaazadotriacontane-1,32-dioic acid","metabolite_id":"PHDOXVGRXXAYEB-VJANTYMQSA-N","pvalue":0.0003317991077918,"ratio":0.2100655007136508,"synonym_name":"N1,N8-Bis(glutathionyl)spermidine"},{"chebi_id":"16742","direction":"down","inn_name":"","iupac_name":"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid","metabolite_id":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","pvalue":0.004568065976273,"ratio":0.1304393329691776,"synonym_name":"OROTIC ACID"},{"chebi_id":"17013","direction":"up","inn_name":"","iupac_name":"5'-thymidylic acid","metabolite_id":"GYOZYWVXFNDGLU-XLPZGREQSA-N","pvalue":0.0004637897702268,"ratio":3.995583774068899,"synonym_name":"Thymidylic acid"},{"chebi_id":"16192","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-guanylic acid","metabolite_id":"LTFMZDNNPPEQNG-KVQBGUIXSA-N","pvalue":0.0010254955874018,"ratio":4.599977327564249,"synonym_name":"2'-deoxyguanosine 5'-monophosphate"},{"chebi_id":"18075","direction":"down","inn_name":"","iupac_name":"thymidine 5'-(trihydrogen diphosphate)","metabolite_id":"UJLXYODCHAELLY-XLPZGREQSA-N","pvalue":2.9135420044827593e-05,"ratio":0.3745777341382231,"synonym_name":"thymidine 5'-diphosphate"},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0001006831412067,"ratio":0.3658979081473641,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"15918","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-cytidylic acid","metabolite_id":"NCMVOABPESMRCP-SHYZEUOFSA-N","pvalue":0.0009673068592092,"ratio":3.074010741590055,"synonym_name":"Deoxycytidylate"}],"totalFeatures":12},{"comparisonGroups":["Untreated","HD871-1_treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"L. mexicana: HD871-1 treatment vs untreated control","group_a_title":"Untreated samples with dimethyl sulfoxide. Serves as the baseline for treatment comparisons","group_b_title":"Samples treated with HD871-1. Evaluates the effect of HD871-1 treatment on Leishmania mexicana","id":"MTBLS868_0002_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":12,"studyId":"MTBLS868","studyUrl":"http://integmet.org/study/MTBLS868","title":"Untreated_vs_HD871-1_treatment","topHits":[{"chebi_id":"35491","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-disulfanediylbis(2-ammoniopropanoate)","metabolite_id":"LEVWYRKDKASIDU-IMJSIDKUSA-N","pvalue":0.0011468275036736,"ratio":1000000.0,"synonym_name":"(2<i>R</i>,2'<i>R</i>)-3,3'-dithiobis(2-ammoniopropanoate)"},{"chebi_id":"17025","direction":"down","inn_name":"","iupac_name":"(4<i>S</i>)-2,6-dioxohexahydropyrimidine-4-carboxylic acid","metabolite_id":"UFIVEPVSAGBUSI-REOHCLBHSA-N","pvalue":0.0055362476737459,"ratio":0.0634542297462929,"synonym_name":"L-Dihydroorotic acid"},{"chebi_id":"17713","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-adenylic acid","metabolite_id":"KHWCHTKSEGGWEX-RRKCRQDMSA-N","pvalue":2.1202403273134204e-05,"ratio":3.199284309307925,"synonym_name":"2'-deoxyadenosine monophosphate"},{"chebi_id":"17842","direction":"down","inn_name":"","iupac_name":"(2<i>S</i>,7<i>R</i>,26<i>R</i>,31<i>S</i>)-2,31-diamino-5,8,11,22,25,28-hexaoxo-7,26-bis(sulfanylmethyl)-6,9,12,16,21,24,27-heptaazadotriacontane-1,32-dioic acid","metabolite_id":"PHDOXVGRXXAYEB-VJANTYMQSA-N","pvalue":0.0003317991077918,"ratio":0.2100655007136508,"synonym_name":"N1,N8-Bis(glutathionyl)spermidine"},{"chebi_id":"16742","direction":"down","inn_name":"","iupac_name":"2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid","metabolite_id":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","pvalue":0.004568065976273,"ratio":0.1304393329691776,"synonym_name":"OROTIC ACID"},{"chebi_id":"17013","direction":"up","inn_name":"","iupac_name":"5'-thymidylic acid","metabolite_id":"GYOZYWVXFNDGLU-XLPZGREQSA-N","pvalue":0.0004637897702268,"ratio":3.995583774068899,"synonym_name":"Thymidylic acid"},{"chebi_id":"16192","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-guanylic acid","metabolite_id":"LTFMZDNNPPEQNG-KVQBGUIXSA-N","pvalue":0.0010254955874018,"ratio":4.599977327564249,"synonym_name":"2'-deoxyguanosine 5'-monophosphate"},{"chebi_id":"18075","direction":"down","inn_name":"","iupac_name":"thymidine 5'-(trihydrogen diphosphate)","metabolite_id":"UJLXYODCHAELLY-XLPZGREQSA-N","pvalue":2.9135420044827593e-05,"ratio":0.3745777341382231,"synonym_name":"thymidine 5'-diphosphate"},{"chebi_id":"16856","direction":"down","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-cysteinylglycine","metabolite_id":"RWSXRVCMGQZWBV-WDSKDSINSA-N","pvalue":0.0001006831412067,"ratio":0.3658979081473641,"synonym_name":"5-L-Glutamyl-L-cysteinylglycine"},{"chebi_id":"15918","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-cytidylic acid","metabolite_id":"NCMVOABPESMRCP-SHYZEUOFSA-N","pvalue":0.0009673068592092,"ratio":3.074010741590055,"synonym_name":"Deoxycytidylate"}],"totalFeatures":12},{"comparisonGroups":["Human_Blood","Human_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Human blood: whole blood vs plasma comparison","group_a_title":"Samples from human blood.. Provides baseline metabolomic data for human blood.","group_b_title":"Samples from human blood plasma.. Provides metabolomic data specific to the plasma component of human blood.","id":"MTBLS87_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":27,"studyId":"MTBLS87","studyUrl":"http://integmet.org/study/MTBLS87","title":"Human_Blood_vs_Human_Plasma","topHits":[{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0248961634602227,"ratio":1000000.0,"synonym_name":"L-Saccharopine"},{"chebi_id":"17720","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UWTATZPHSA-N","pvalue":7.774589272765189e-05,"ratio":72.67612237721252,"synonym_name":"2,3-Disphospho-D-glycerate"},{"chebi_id":"76620","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-[2-(methylsulfanyl)-1<em>H</em>-imidazol-4-yl]-2-(trimethylammonio)propanoate","metabolite_id":"GVQNHIYBRMFCMS-QMMMGPOBSA-N","pvalue":0.0001956661575835,"ratio":24.166666666666664,"synonym_name":"(+)-<small>L</small>-<em>S</em>-methylergothioneine"},{"chebi_id":"28013","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":0.002395363062659,"ratio":85.06113769271664,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.0002578604169838,"ratio":12.560975609756095,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":0.0002991496686055,"ratio":11.244979919678716,"synonym_name":"UDP-glucose"},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0083549194178991,"ratio":27.38589211618257,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"18021","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoate","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-M","pvalue":0.0226898373054529,"ratio":38.19784524975514,"synonym_name":"2-hydroxy-2-propenoate (dihydrogen phosphate) (ester)"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0047758602681371,"ratio":8.803418803418804,"synonym_name":""},{"chebi_id":"48928","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0350723856529333,"ratio":26.382978723404257,"synonym_name":"6-Phospho-D-gluconate"}],"totalFeatures":148},{"comparisonGroups":["Human_Blood","Human_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Human blood: whole blood vs plasma comparison","group_a_title":"Samples from human blood.. Provides baseline metabolomic data for human blood.","group_b_title":"Samples from human blood plasma.. Provides metabolomic data specific to the plasma component of human blood.","id":"MTBLS87_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS87","studyUrl":"http://integmet.org/study/MTBLS87","title":"Human_Blood_vs_Human_Plasma","topHits":[{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0248961634602227,"ratio":1000000.0,"synonym_name":"L-Saccharopine"},{"chebi_id":"17720","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UWTATZPHSA-N","pvalue":7.774589272765189e-05,"ratio":72.67612237721252,"synonym_name":"2,3-Disphospho-D-glycerate"},{"chebi_id":"28013","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":0.002395363062659,"ratio":85.06113769271664,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":0.0002991496686055,"ratio":11.244979919678716,"synonym_name":"UDP-glucose"},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0083549194178991,"ratio":27.38589211618257,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"18021","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoate","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-M","pvalue":0.0226898373054529,"ratio":38.19784524975514,"synonym_name":"2-hydroxy-2-propenoate (dihydrogen phosphate) (ester)"},{"chebi_id":"48928","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":0.0350723856529333,"ratio":26.382978723404257,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":0.049074346864362,"ratio":33.74870197300104,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"17552","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(trihydrogen diphosphate)","metabolite_id":"QGWNDRXFNXRZMB-UUOKFMHZSA-N","pvalue":0.0311724637212264,"ratio":18.041237113402065,"synonym_name":"Guanosine diphosphate"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":0.00501751379729,"ratio":6.377952755905512,"synonym_name":"UDP-alpha-D-glucuronate"}],"totalFeatures":59},{"comparisonGroups":["Human_Blood","Human_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Human blood: whole blood vs plasma comparison","group_a_title":"Samples from human blood.. Provides baseline metabolomic data for human blood.","group_b_title":"Samples from human blood plasma.. Provides metabolomic data specific to the plasma component of human blood.","id":"MTBLS87_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS87","studyUrl":"http://integmet.org/study/MTBLS87","title":"Human_Blood_vs_Human_Plasma","topHits":[{"chebi_id":"76620","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-[2-(methylsulfanyl)-1<em>H</em>-imidazol-4-yl]-2-(trimethylammonio)propanoate","metabolite_id":"GVQNHIYBRMFCMS-QMMMGPOBSA-N","pvalue":0.0001956661575835,"ratio":24.166666666666664,"synonym_name":"(+)-<small>L</small>-<em>S</em>-methylergothioneine"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.0002578604169838,"ratio":12.560975609756095,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0047758602681371,"ratio":8.803418803418804,"synonym_name":""},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0163019170973082,"ratio":0.0912903225806451,"synonym_name":"Adenosin"},{"chebi_id":"15781","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(1<em>H</em>-imidazol-4-yl)-2-(trimethylammonio)propanoate","metabolite_id":"GPPYTCRVKHULJH-QMMMGPOBSA-N","pvalue":0.0095973604264072,"ratio":5.296052631578947,"synonym_name":"Hercynine"},{"chebi_id":"17154","direction":"up","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0405665091383709,"ratio":8.805970149253731,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"57947","direction":"up","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.0048128886712075,"ratio":3.5545023696682465,"synonym_name":""},{"chebi_id":"1941","direction":"up","inn_name":"","iupac_name":"3-carboxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylpropan-1-aminium","metabolite_id":"JHPNVNIEXXLNTR-UHFFFAOYSA-O","pvalue":0.0199821784988199,"ratio":3.777777777777778,"synonym_name":"4-Trimethylammoniobutanoate"},{"chebi_id":"73061","direction":"up","inn_name":"","iupac_name":"3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-UHFFFAOYSA-N","pvalue":0.0470943532662136,"ratio":2.4342105263157894,"synonym_name":"myristoylcarnitine"}],"totalFeatures":89},{"comparisonGroups":["Human_Blood","Human_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Human blood: whole blood vs plasma comparison","group_a_title":"Samples from human blood.. Provides baseline metabolomic data for human blood.","group_b_title":"Samples from human blood plasma.. Provides metabolomic data specific to the plasma component of human blood.","id":"MTBLS87_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":18,"studyId":"MTBLS87","studyUrl":"http://integmet.org/study/MTBLS87","title":"Human_Blood_vs_Human_Plasma","topHits":[{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0248961634602227,"ratio":1000000.0,"synonym_name":"L-Saccharopine"},{"chebi_id":"19324","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonatooxy)propanoate","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-I","pvalue":7.774589272765189e-05,"ratio":72.67612237721252,"synonym_name":"2,3-diphosphoglycerate"},{"chebi_id":"28013","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":0.002395363062659,"ratio":85.06113769271664,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":0.0002991496686055,"ratio":11.244979919678716,"synonym_name":"UDP-glucose"},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":0.0083549194178991,"ratio":27.38589211618257,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"18021","direction":"up","inn_name":"","iupac_name":"2-(phosphonooxy)prop-2-enoate","metabolite_id":"DTBNBXWJWCWCIK-UHFFFAOYSA-M","pvalue":0.0226898373054529,"ratio":38.19784524975514,"synonym_name":"2-hydroxy-2-propenoate (dihydrogen phosphate) (ester)"},{"chebi_id":"16863","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconate","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-M","pvalue":0.0350723856529333,"ratio":26.382978723404257,"synonym_name":""},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":0.049074346864362,"ratio":33.74870197300104,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"17552","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(trihydrogen diphosphate)","metabolite_id":"QGWNDRXFNXRZMB-UUOKFMHZSA-N","pvalue":0.0311724637212264,"ratio":18.041237113402065,"synonym_name":"Guanosine diphosphate"},{"chebi_id":"58052","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-K","pvalue":0.00501751379729,"ratio":6.377952755905512,"synonym_name":"UDP-\u03b1-<small>D</small>-glucuronate trianion"}],"totalFeatures":59},{"comparisonGroups":["Human_Blood","Human_Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Human blood: whole blood vs plasma comparison","group_a_title":"Samples from human blood.. Provides baseline metabolomic data for human blood.","group_b_title":"Samples from human blood plasma.. Provides metabolomic data specific to the plasma component of human blood.","id":"MTBLS87_0005_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":9,"studyId":"MTBLS87","studyUrl":"http://integmet.org/study/MTBLS87","title":"Human_Blood_vs_Human_Plasma","topHits":[{"chebi_id":"76620","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-[2-(methylsulfanyl)-1<em>H</em>-imidazol-4-yl]-2-(trimethylammonio)propanoate","metabolite_id":"GVQNHIYBRMFCMS-QMMMGPOBSA-N","pvalue":0.0001956661575835,"ratio":24.166666666666664,"synonym_name":"(+)-<small>L</small>-<em>S</em>-methylergothioneine"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":0.0002578604169838,"ratio":12.560975609756095,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"57856","direction":"up","inn_name":"","iupac_name":"5'-<em>S</em>-[(3<i>S</i>)-3-azaniumyl-3-carboxylatopropyl]-5'-thioadenosine","metabolite_id":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","pvalue":0.0047758602681371,"ratio":8.803418803418804,"synonym_name":""},{"chebi_id":"16335","direction":"down","inn_name":"","iupac_name":"adenosine","metabolite_id":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","pvalue":0.0163019170973082,"ratio":0.0912903225806451,"synonym_name":"Adenosin"},{"chebi_id":"15781","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(1<em>H</em>-imidazol-4-yl)-2-(trimethylammonio)propanoate","metabolite_id":"GPPYTCRVKHULJH-QMMMGPOBSA-N","pvalue":0.0095973604264072,"ratio":5.296052631578947,"synonym_name":"Hercynine"},{"chebi_id":"17154","direction":"up","inn_name":"nicotinamide","iupac_name":"pyridine-3-carboxamide","metabolite_id":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","pvalue":0.0405665091383709,"ratio":8.805970149253731,"synonym_name":"\u03b2-pyridinecarboxamide"},{"chebi_id":"57947","direction":"up","inn_name":"","iupac_name":"{[amino(iminio)methyl](methyl)amino}acetate","metabolite_id":"CVSVTCORWBXHQV-UHFFFAOYSA-N","pvalue":0.0048128886712075,"ratio":3.5545023696682465,"synonym_name":""},{"chebi_id":"1941","direction":"up","inn_name":"","iupac_name":"3-carboxy-<em>N</em>,<em>N</em>,<em>N</em>-trimethylpropan-1-aminium","metabolite_id":"JHPNVNIEXXLNTR-UHFFFAOYSA-O","pvalue":0.0199821784988199,"ratio":3.777777777777778,"synonym_name":"4-Trimethylammoniobutanoate"},{"chebi_id":"73061","direction":"up","inn_name":"","iupac_name":"3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"PSHXNVGSVNEJBD-UHFFFAOYSA-N","pvalue":0.0470943532662136,"ratio":2.4342105263157894,"synonym_name":"myristoylcarnitine"}],"totalFeatures":86},{"comparisonGroups":["A549_0uM","A549_1uM"],"dateCreated":"2025-09-26 00:00:00","display_title":"A549 cells: 1\u03bcM vs 0\u03bcM indomethacin treatment","group_a_title":"A549 cell line with 0 micromolar indomethacin dose. Provides baseline for comparison with treated A549 samples.","group_b_title":"A549 cell line with 1 micromolar indomethacin dose. Allows assessment of high-dose indomethacin effects on A549 cells.","id":"MTBLS873_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS873","studyUrl":"http://integmet.org/study/MTBLS873","title":"A549_0uM_vs_A549_1uM","topHits":[{"chebi_id":"17553","direction":"down","inn_name":"","iupac_name":"2-aminoethyl dihydrogen phosphate","metabolite_id":"SUHOOTKUPISOBE-UHFFFAOYSA-N","pvalue":7.910734144660452e-06,"ratio":0.0354938017943365,"synonym_name":"colamine phosphate"},{"chebi_id":"16643","direction":"down","inn_name":"","iupac_name":"<small>L</small>-methionine","metabolite_id":"FFEARJCKVFRZRR-BYPYZUCNSA-N","pvalue":0.0010793592197543,"ratio":0.0957408822459599,"synonym_name":"L-Methionine"},{"chebi_id":"15603","direction":"down","inn_name":"","iupac_name":"<small>L</small>-leucine","metabolite_id":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","pvalue":0.0078735036672876,"ratio":0.0642338136217061,"synonym_name":"<small>L</small>-Leuzin"},{"chebi_id":"17385","direction":"down","inn_name":"","iupac_name":"2-hydroxy-3-(4-hydroxyphenyl)propanoic acid","metabolite_id":"JVGVDSSUAVXRDY-UHFFFAOYSA-N","pvalue":0.0035747029062845,"ratio":0.1786198864327529,"synonym_name":"2-Hydroxy-3-(4-hydroxyphenyl)propanoate"},{"chebi_id":"62064","direction":"down","inn_name":"","iupac_name":"butane-2,3-diol","metabolite_id":"OWBTYPJTUOEWEK-UHFFFAOYSA-N","pvalue":0.0141409971494183,"ratio":0.172627527769218,"synonym_name":"2,3-Dihydroxybutane"},{"chebi_id":"18012","direction":"down","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":0.0058524794032695,"ratio":0.243956254215999,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"18202","direction":"down","inn_name":"","iupac_name":"<small>L</small>-iditol","metabolite_id":"FBPFZTCFMRRESA-UNTFVMJOSA-N","pvalue":0.0040525887072257,"ratio":0.269226525126553,"synonym_name":"<small>L</small>-Idit"},{"chebi_id":"17016","direction":"down","inn_name":"","iupac_name":"<small>L</small>-methionine <em>S</em>-oxide","metabolite_id":"QEFRNWWLZKMPFJ-YGVKFDHGSA-N","pvalue":0.0130546548359711,"ratio":0.2132247571584408,"synonym_name":"<small>L</small>-methionine sulfoxide"},{"chebi_id":"72816","direction":"down","inn_name":"","iupac_name":"<small>L</small>-alanyl-<small>L</small>-alanine","metabolite_id":"DEFJQIDDEAULHB-IMJSIDKUSA-N","pvalue":0.0152930242771247,"ratio":0.2126470174137552,"synonym_name":"<small>L</small>-Ala-<small>L</small>-Ala"},{"chebi_id":"17482","direction":"down","inn_name":"","iupac_name":"<small>L</small>-cystathionine","metabolite_id":"ILRYLPWNYFXEMH-WHFBIAKZSA-N","pvalue":0.0150034501239703,"ratio":0.2433491573982888,"synonym_name":"S-(beta-amino-beta-carboxyethyl)homocysteine"}],"totalFeatures":112},{"comparisonGroups":["Blood","Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: whole blood vs plasma fraction","group_a_title":"Whole blood samples collected from the volunteer.. Provides baseline data for comparison with plasma and RBC fractions.","group_b_title":"Plasma fraction of blood samples collected from the volunteer.. Allows for the analysis of metabolites present in the plasma fraction, distinct from cellular components.","id":"MTBLS88_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS88","studyUrl":"http://integmet.org/study/MTBLS88","title":"Blood_vs_Plasma","topHits":[{"chebi_id":"28013","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":9.162493714317028e-07,"ratio":1053.231939163498,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"17720","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2,3-bis(phosphonooxy)propanoic acid","metabolite_id":"XOHUEYCVLUUEJJ-UWTATZPHSA-N","pvalue":1.74670101672234e-06,"ratio":1150.877192982456,"synonym_name":"2,3-Disphospho-D-glycerate"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":2.9680755376358756e-11,"ratio":27.945205479452056,"synonym_name":"UDP-glucose"},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":2.164482845867764e-06,"ratio":104.44444444444444,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"17200","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(\u03b1-<small>D</small>-glucopyranuronosyl) dihydrogen diphosphate]","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-N","pvalue":6.071105286936097e-08,"ratio":34.929577464788736,"synonym_name":"UDP-alpha-D-glucuronate"},{"chebi_id":"48928","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconic acid","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","pvalue":6.845532386487473e-06,"ratio":107.25388601036268,"synonym_name":"6-Phospho-D-gluconate"},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":2.1306294724284112e-06,"ratio":67.46987951807229,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":3.5916747564886294e-09,"ratio":9.135802469135802,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"29052","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-oxopropyl dihydrogen phosphate","metabolite_id":"LXJXRIRHZLFYRP-VKHMYHEASA-N","pvalue":0.0002936589759183,"ratio":136.17021276595744,"synonym_name":"D-Glyceraldehyde 3-phosphate"},{"chebi_id":"33198","direction":"up","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":3.929797251801595e-07,"ratio":11.35483870967742,"synonym_name":"Hexonic acid"}],"totalFeatures":52},{"comparisonGroups":["Blood","Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: whole blood vs plasma fraction","group_a_title":"Whole blood samples collected from the volunteer.. Provides baseline data for comparison with plasma and RBC fractions.","group_b_title":"Plasma fraction of blood samples collected from the volunteer.. Allows for the analysis of metabolites present in the plasma fraction, distinct from cellular components.","id":"MTBLS88_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":35,"studyId":"MTBLS88","studyUrl":"http://integmet.org/study/MTBLS88","title":"Blood_vs_Plasma","topHits":[{"chebi_id":"17858","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":1.8661415082513553e-08,"ratio":1234.9726775956285,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":5.7187343726361115e-11,"ratio":69.55555555555556,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"18009","direction":"up","inn_name":"","iupac_name":"2'-<em>O</em>-phosphonoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"XJLXINKUBYWONI-NNYOXOHSSA-O","pvalue":1.498656995033836e-05,"ratio":3265.625,"synonym_name":"Nicotinamide adenine dinucleotide phosphate"},{"chebi_id":"84058","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":2.340604765601126e-07,"ratio":139.186295503212,"synonym_name":""},{"chebi_id":"15846","direction":"up","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BAWFJGJZGIEFAR-NNYOXOHSSA-O","pvalue":5.579735652852752e-08,"ratio":71.51898734177215,"synonym_name":"NAD+"},{"chebi_id":"76620","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-[2-(methylsulfanyl)-1<em>H</em>-imidazol-4-yl]-2-(trimethylammonio)propanoate","metabolite_id":"GVQNHIYBRMFCMS-QMMMGPOBSA-N","pvalue":2.1439750674443844e-06,"ratio":183.33333333333337,"synonym_name":"(+)-<small>L</small>-<em>S</em>-methylergothioneine"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":6.732012254766583e-08,"ratio":59.09090909090909,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"17202","direction":"up","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":1.777520762577342e-06,"ratio":98.1132075471698,"synonym_name":"Inosine 5'-phosphate"},{"chebi_id":"16761","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":1.151158126731083e-07,"ratio":40.65934065934066,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"17596","direction":"down","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0140660008298689,"ratio":1e-06,"synonym_name":"hypoxanthine <small>D</small>-riboside"}],"totalFeatures":76},{"comparisonGroups":["Blood","Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: whole blood vs plasma fraction","group_a_title":"Whole blood samples collected from the volunteer.. Provides baseline data for comparison with plasma and RBC fractions.","group_b_title":"Plasma fraction of blood samples collected from the volunteer.. Allows for the analysis of metabolites present in the plasma fraction, distinct from cellular components.","id":"MTBLS88_0003_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":31,"studyId":"MTBLS88","studyUrl":"http://integmet.org/study/MTBLS88","title":"Blood_vs_Plasma","topHits":[{"chebi_id":"28013","direction":"up","inn_name":"","iupac_name":"\u03b2-<small>D</small>-fructofuranose 1,6-bis(dihydrogen phosphate)","metabolite_id":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","pvalue":9.162493714317028e-07,"ratio":1053.231939163498,"synonym_name":"BETA FRUCTOSE 1,6-DIPHOSPHATE"},{"chebi_id":"19324","direction":"up","inn_name":"","iupac_name":"2,3-bis(phosphonatooxy)propanoate","metabolite_id":"XOHUEYCVLUUEJJ-UHFFFAOYSA-I","pvalue":1.74670101672234e-06,"ratio":1150.877192982456,"synonym_name":"2,3-diphosphoglycerate"},{"chebi_id":"18066","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-<small>D</small>-glucopyranosyl dihydrogen diphosphate]","metabolite_id":"HSCJRCZFDFQWRP-RDKQLNKOSA-N","pvalue":2.9680755376358756e-11,"ratio":27.945205479452056,"synonym_name":"UDP-glucose"},{"chebi_id":"24344","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"GXIURPTVHJPJLF-UHFFFAOYSA-N","pvalue":2.164482845867764e-06,"ratio":104.44444444444444,"synonym_name":"3-hydroxy-2-(phosphonooxy)propanoic acid"},{"chebi_id":"58052","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"HDYANYHVCAPMJV-LXQIFKJMSA-K","pvalue":6.071105286936097e-08,"ratio":34.929577464788736,"synonym_name":"UDP-\u03b1-<small>D</small>-glucuronate trianion"},{"chebi_id":"16863","direction":"up","inn_name":"","iupac_name":"6-<em>O</em>-phosphono-<small>D</small>-gluconate","metabolite_id":"BIRSGZKFKXLSJQ-SQOUGZDYSA-M","pvalue":6.845532386487473e-06,"ratio":107.25388601036268,"synonym_name":""},{"chebi_id":"15996","direction":"up","inn_name":"","iupac_name":"guanosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"XKMLYUALXHKNFT-UUOKFMHZSA-N","pvalue":2.1306294724284112e-06,"ratio":67.46987951807229,"synonym_name":"GUANOSINE-5'-TRIPHOSPHATE"},{"chebi_id":"16264","direction":"up","inn_name":"","iupac_name":"uridine 5'-[3-(2-acetamido-2-deoxy-\u03b1-<small>D</small>-glucopyranosyl) dihydrogen diphosphate]","metabolite_id":"LFTYTUAZOPRMMI-CFRASDGPSA-N","pvalue":3.5916747564886294e-09,"ratio":9.135802469135802,"synonym_name":"(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)"},{"chebi_id":"17138","direction":"up","inn_name":"","iupac_name":"2-hydroxy-3-oxopropyl dihydrogen phosphate","metabolite_id":"LXJXRIRHZLFYRP-UHFFFAOYSA-N","pvalue":0.0002936589759183,"ratio":136.17021276595744,"synonym_name":"Glyceraldehyde 3-phosphate"},{"chebi_id":"33198","direction":"up","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":3.929797251801595e-07,"ratio":11.35483870967742,"synonym_name":"Hexonic acid"}],"totalFeatures":52},{"comparisonGroups":["Blood","Plasma"],"dateCreated":"2025-09-26 00:00:00","display_title":"Blood: whole blood vs plasma fraction","group_a_title":"Whole blood samples collected from the volunteer.. Provides baseline data for comparison with plasma and RBC fractions.","group_b_title":"Plasma fraction of blood samples collected from the volunteer.. Allows for the analysis of metabolites present in the plasma fraction, distinct from cellular components.","id":"MTBLS88_0004_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":34,"studyId":"MTBLS88","studyUrl":"http://integmet.org/study/MTBLS88","title":"Blood_vs_Plasma","topHits":[{"chebi_id":"17858","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,2'<i>S</i>)-5,5'-[disulfanediylbis({(2<i>R</i>)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid)","metabolite_id":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","pvalue":1.8661415082513553e-08,"ratio":1234.9726775956285,"synonym_name":"OXIDIZED GLUTATHIONE DISULFIDE"},{"chebi_id":"4828","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-(2-mercapto-1<em>H</em>-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate","metabolite_id":"SSISHJJTAXXQAX-ZETCQYMHSA-N","pvalue":5.7187343726361115e-11,"ratio":69.55555555555556,"synonym_name":"(\u03b1<i>S</i>)-\u03b1-carboxy-2,3-dihydro-<em>N</em>,<em>N</em>,<em>N</em>-trimethyl-2-thioxo-1<em>H</em>-imidazole-4-ethanaminium inner salt"},{"chebi_id":"18009","direction":"up","inn_name":"","iupac_name":"2'-<em>O</em>-phosphonoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"XJLXINKUBYWONI-NNYOXOHSSA-O","pvalue":1.498656995033836e-05,"ratio":3265.625,"synonym_name":"Nicotinamide adenine dinucleotide phosphate"},{"chebi_id":"84058","direction":"up","inn_name":"","iupac_name":"<em>N</em>-{(2<i>S</i>)-1-[(carboxymethyl)amino]-1-oxobutan-2-yl}-<small>L</small>-glutamine","metabolite_id":"JCMUOFQHZLPHQP-BQBZGAKWSA-N","pvalue":2.340604765601126e-07,"ratio":139.186295503212,"synonym_name":""},{"chebi_id":"15846","direction":"up","inn_name":"","iupac_name":"adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-<small>D</small>-ribitol-5-yl] dihydrogen diphosphate}","metabolite_id":"BAWFJGJZGIEFAR-NNYOXOHSSA-O","pvalue":5.579735652852752e-08,"ratio":71.51898734177215,"synonym_name":"NAD+"},{"chebi_id":"76620","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-3-[2-(methylsulfanyl)-1<em>H</em>-imidazol-4-yl]-2-(trimethylammonio)propanoate","metabolite_id":"GVQNHIYBRMFCMS-QMMMGPOBSA-N","pvalue":2.1439750674443844e-06,"ratio":183.33333333333337,"synonym_name":"(+)-<small>L</small>-<em>S</em>-methylergothioneine"},{"chebi_id":"15422","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(tetrahydrogen triphosphate)","metabolite_id":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","pvalue":6.732012254766583e-08,"ratio":59.09090909090909,"synonym_name":"Adenosine 5'-triphosphate"},{"chebi_id":"17202","direction":"up","inn_name":"","iupac_name":"5'-inosinic acid","metabolite_id":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","pvalue":1.777520762577342e-06,"ratio":98.1132075471698,"synonym_name":"Inosine 5'-phosphate"},{"chebi_id":"16761","direction":"up","inn_name":"","iupac_name":"adenosine 5'-(trihydrogen diphosphate)","metabolite_id":"XTWYTFMLZFPYCI-KQYNXXCUSA-N","pvalue":1.151158126731083e-07,"ratio":40.65934065934066,"synonym_name":"5'-adenylphosphoric acid"},{"chebi_id":"17596","direction":"down","inn_name":"inosina","iupac_name":"inosine","metabolite_id":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","pvalue":0.0140660008298689,"ratio":1e-06,"synonym_name":"hypoxanthine <small>D</small>-riboside"}],"totalFeatures":73},{"comparisonGroups":["MGB234_Treatment","DMSO_Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"MGB234 compound treatment vs DMSO control","group_a_title":"Samples treated with MGB234 compound.. Key group for assessing the efficacy of the MGB234 compound.","group_b_title":"Samples treated with DMSO as a control.. Provides baseline for comparison with MGB234 treatment.","id":"MTBLS882_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS882","studyUrl":"http://integmet.org/study/MTBLS882","title":"MGB234_Treatment_vs_DMSO_Control","topHits":[{"chebi_id":"16450","direction":"up","inn_name":"","iupac_name":"1-(2-deoxy-\u03b2-<small>D</small>-<i>erythro</i>-pentofuranosyl)uracil","metabolite_id":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","pvalue":0.0001435580132068,"ratio":7.321328243380848,"synonym_name":"Deoxyuridine"},{"chebi_id":"17752","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-acetyl-<small>L</small>-lysine","metabolite_id":"DTERQYGMUDWYAZ-ZETCQYMHSA-N","pvalue":4.925363714022465e-06,"ratio":3.550058374625052,"synonym_name":"N(6)-ACETYLLYSINE"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":3.832354196037159e-05,"ratio":4.56376906258786,"synonym_name":"Purine-6-ol"},{"chebi_id":"16709","direction":"up","inn_name":"pyridoxine","iupac_name":"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol","metabolite_id":"LXNHXLLTXMVWPM-UHFFFAOYSA-N","pvalue":0.0003824966885592,"ratio":6.713037183687157,"synonym_name":"vitamin B<small><sub>6</sub></small>"},{"chebi_id":"16040","direction":"up","inn_name":"","iupac_name":"4-aminopyrimidin-2(1<em>H</em>)-one","metabolite_id":"OPTASPLRGRRNAP-UHFFFAOYSA-N","pvalue":1.617208254358791e-05,"ratio":3.668455494758784,"synonym_name":"Zytosin"},{"chebi_id":"17562","direction":"up","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":7.342717759837924e-05,"ratio":3.074442231439692,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"16691","direction":"up","inn_name":"","iupac_name":"6-(5-methyl-2-oxoimidazolidin-4-yl)hexanoic acid","metabolite_id":"AUTOLBMXDDTRRT-UHFFFAOYSA-N","pvalue":1.6915857650850038e-05,"ratio":2.3269322008933755,"synonym_name":"Dethiobiotin"},{"chebi_id":"16704","direction":"up","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":8.195816206788521e-05,"ratio":2.315168647020341,"synonym_name":"u"},{"chebi_id":"17929","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(dimethylamino)(imino)methyl]amino}pentanoic acid","metabolite_id":"YDGMGEXADBMOMJ-LURJTMIESA-N","pvalue":5.489566436293241e-05,"ratio":2.2269785592512066,"synonym_name":"NG,NG-Dimethyl-L-arginine"},{"chebi_id":"17622","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-uridylic acid","metabolite_id":"JSRLJPSBLDHEIO-SHYZEUOFSA-N","pvalue":0.0003382631138477,"ratio":2.255506905534984,"synonym_name":"dUMP"}],"totalFeatures":16},{"comparisonGroups":["MGB234_Treatment","DMSO_Control"],"dateCreated":"2025-09-26 00:00:00","display_title":"MGB234 compound treatment vs DMSO control","group_a_title":"Samples treated with MGB234 compound.. Key group for assessing the efficacy of the MGB234 compound.","group_b_title":"Samples treated with DMSO as a control.. Provides baseline for comparison with MGB234 treatment.","id":"MTBLS882_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS882","studyUrl":"http://integmet.org/study/MTBLS882","title":"MGB234_Treatment_vs_DMSO_Control","topHits":[{"chebi_id":"16450","direction":"up","inn_name":"","iupac_name":"1-(2-deoxy-\u03b2-<small>D</small>-<i>erythro</i>-pentofuranosyl)uracil","metabolite_id":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","pvalue":0.0001435580132068,"ratio":7.321328243380848,"synonym_name":"Deoxyuridine"},{"chebi_id":"17752","direction":"up","inn_name":"","iupac_name":"<em>N</em><small><sup>6</small></sup>-acetyl-<small>L</small>-lysine","metabolite_id":"DTERQYGMUDWYAZ-ZETCQYMHSA-N","pvalue":4.925363714022465e-06,"ratio":3.550058374625052,"synonym_name":"N(6)-ACETYLLYSINE"},{"chebi_id":"17368","direction":"up","inn_name":"","iupac_name":"1,7-dihydro-6<em>H</em>-purin-6-one","metabolite_id":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","pvalue":3.832354196037159e-05,"ratio":4.56376906258786,"synonym_name":"Purine-6-ol"},{"chebi_id":"16709","direction":"up","inn_name":"pyridoxine","iupac_name":"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol","metabolite_id":"LXNHXLLTXMVWPM-UHFFFAOYSA-N","pvalue":0.0003824966885592,"ratio":6.713037183687157,"synonym_name":"vitamin B<small><sub>6</sub></small>"},{"chebi_id":"16040","direction":"up","inn_name":"","iupac_name":"4-aminopyrimidin-2(1<em>H</em>)-one","metabolite_id":"OPTASPLRGRRNAP-UHFFFAOYSA-N","pvalue":1.617208254358791e-05,"ratio":3.668455494758784,"synonym_name":"Zytosin"},{"chebi_id":"17562","direction":"up","inn_name":"","iupac_name":"cytidine","metabolite_id":"UHDGCWIWMRVCDJ-XVFCMESISA-N","pvalue":7.342717759837924e-05,"ratio":3.074442231439692,"synonym_name":"4-amino-1-\u03b2-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one"},{"chebi_id":"16691","direction":"up","inn_name":"","iupac_name":"6-(5-methyl-2-oxoimidazolidin-4-yl)hexanoic acid","metabolite_id":"AUTOLBMXDDTRRT-UHFFFAOYSA-N","pvalue":1.6915857650850038e-05,"ratio":2.3269322008933755,"synonym_name":"Dethiobiotin"},{"chebi_id":"16704","direction":"up","inn_name":"","iupac_name":"uridine","metabolite_id":"DRTQHJPVMGBUCF-XVFCMESISA-N","pvalue":8.195816206788521e-05,"ratio":2.315168647020341,"synonym_name":"u"},{"chebi_id":"17929","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-amino-5-{[(dimethylamino)(imino)methyl]amino}pentanoic acid","metabolite_id":"YDGMGEXADBMOMJ-LURJTMIESA-N","pvalue":5.489566436293241e-05,"ratio":2.2269785592512066,"synonym_name":"NG,NG-Dimethyl-L-arginine"},{"chebi_id":"17622","direction":"up","inn_name":"","iupac_name":"2'-deoxy-5'-uridylic acid","metabolite_id":"JSRLJPSBLDHEIO-SHYZEUOFSA-N","pvalue":0.0003382631138477,"ratio":2.255506905534984,"synonym_name":"dUMP"}],"totalFeatures":16},{"comparisonGroups":["Inbreeding_Growth_Chamber_0_day","Inbreeding_Growth_Chamber_92_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"Inbreeding: 0 vs 92 days in growth chamber","group_a_title":"Inbreeding group in growth chamber at 0 day. Baseline group for comparison with other time points and breeding conditions.","group_b_title":"Inbreeding group in growth chamber at 92 day. Represents long-term response to growth conditions.","id":"MTBLS883_0001_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1,"studyId":"MTBLS883","studyUrl":"http://integmet.org/study/MTBLS883","title":"Inbreeding_Growth_Chamber_0_day_vs_Inbreeding_Growth_Chamber_92_day","topHits":[{"chebi_id":"17750","direction":"down","inn_name":"","iupac_name":"(trimethylammonio)acetate","metabolite_id":"KWIUHFFTVRNATP-UHFFFAOYSA-N","pvalue":0.0218197267835431,"ratio":0.6181059314002397,"synonym_name":"Bet"}],"totalFeatures":93},{"comparisonGroups":["Control_27_days","Water_deficit_27_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs water deficit at 27 days after anthesis","group_a_title":"Control group at 27 days after anthesis. Provides baseline data for comparison with water deficit treatment at the same time point.","group_b_title":"Water deficit group at 27 days after anthesis. Allows assessment of water deficit effects at 27 days.","id":"MTBLS889_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS889","studyUrl":"http://integmet.org/study/MTBLS889","title":"Control_27_days_vs_Water_deficit_27_days","topHits":[],"totalFeatures":12},{"comparisonGroups":["21d_Control","21d_AM"],"dateCreated":"2025-09-26 00:00:00","display_title":"Pea plants: 21d mycorrhiza vs control","group_a_title":"Control group of pea plants at 21 days post inoculation. Provides baseline for comparison with AM treated plants at the same time point","group_b_title":"Pea plants at 21 days post inoculation with Arbuscular Mycorrhiza. Represents the effect of mycorrhization at an early developmental stage","id":"MTBLS893_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS893","studyUrl":"http://integmet.org/study/MTBLS893","title":"21d_Control_vs_21d_AM","topHits":[{"chebi_id":"16995","direction":"up","inn_name":"","iupac_name":"oxalic acid","metabolite_id":"MUBZPKHOEPUJKR-UHFFFAOYSA-N","pvalue":0.0022966062582072,"ratio":1000000.0,"synonym_name":"OXALIC ACID"},{"chebi_id":"16199","direction":"up","inn_name":"carbamide","iupac_name":"urea","metabolite_id":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","pvalue":0.0218293197240255,"ratio":3.7121171073009736,"synonym_name":"H<small><sub>2</sub></small>NC(O)NH<small><sub>2</sub></small>"},{"chebi_id":"18237","direction":"up","inn_name":"","iupac_name":"2-aminopentanedioic acid","metabolite_id":"WHUUTDBJXJRKMK-UHFFFAOYSA-N","pvalue":0.0062514253671377,"ratio":2.136380575823959,"synonym_name":"Glutaminic acid"},{"chebi_id":"22211","direction":"down","inn_name":"","iupac_name":"prop-1-ene-1,2,3-tricarboxylic acid","metabolite_id":"GTZCVFVGUGFEME-UHFFFAOYSA-N","pvalue":0.034302662116723,"ratio":0.4503243247661594,"synonym_name":"equisetic acid"},{"chebi_id":"30769","direction":"down","inn_name":"","iupac_name":"2-hydroxypropane-1,2,3-tricarboxylic acid","metabolite_id":"KRKNYBCHXYNGOX-UHFFFAOYSA-N","pvalue":0.0423020213544771,"ratio":0.6383504498521206,"synonym_name":"Citronens\u00e4ure"}],"totalFeatures":88},{"comparisonGroups":["Espeletia_argentea_Leaf_Guerrero","Espeletia_argentea_Leaf_Rabanal"],"dateCreated":"2025-09-26 00:00:00","display_title":"E. argentea leaves: Guerrero vs Rabanal locations","group_a_title":"Samples of Espeletia argentea leaves from Paramo of Guerrero.. Provides insight into the metabolic profile of Espeletia argentea from Guerrero.","group_b_title":"Samples of Espeletia argentea leaves from Paramo of Rabanal.. Provides insight into the metabolic profile of Espeletia argentea from Rabanal.","id":"MTBLS943_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS943","studyUrl":"http://integmet.org/study/MTBLS943","title":"G1_Espeletia_argentea_Leaf_Guerrero_vs_G2_Espeletia_argentea_Leaf_Rabanal","topHits":[{"chebi_id":"33198","direction":"down","inn_name":"","iupac_name":"<small>D</small>-gluconic acid","metabolite_id":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","pvalue":1.948728143651045e-05,"ratio":0.0391011768778664,"synonym_name":"Hexonic acid"},{"chebi_id":"16513","direction":"down","inn_name":"","iupac_name":"hydroxypropanedioic acid","metabolite_id":"ROBFUDYVXSDBQM-UHFFFAOYSA-N","pvalue":0.0119997498056741,"ratio":0.0515622726977419,"synonym_name":"2-tartronic acid"},{"chebi_id":"16112","direction":"down","inn_name":"","iupac_name":"edit(1<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3-{[(2<i>E</i>)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4,5-trihydroxycyclohexane-1-carboxylic acid","metabolite_id":"CWVRJTMFETXNAD-JUHZACGLSA-N","pvalue":0.0190277784749963,"ratio":0.2404995836939708,"synonym_name":"5-O-(3,4-Dihydroxycinnamoyl)-L-quinic acid"},{"chebi_id":"6006","direction":"up","inn_name":"","iupac_name":"5,7-dihydroxy-2-(2,4,5-trihydroxyphenyl)-4<em>H</em>-1-benzopyran-4-one","metabolite_id":"DSNIERNBMAVNJI-UHFFFAOYSA-N","pvalue":0.0157343740192301,"ratio":3.4173447082200763,"synonym_name":"5,7,2',4',5'-Pentahydroxyflavone"},{"chebi_id":"17521","direction":"up","inn_name":"","iupac_name":"(1<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-1,3,4,5-tetrahydroxycyclohexanecarboxylic acid","metabolite_id":"AAWZDTNXLSGCEK-WYWMIBKRSA-N","pvalue":0.0336661223354286,"ratio":1.556152090616097,"synonym_name":"(\u2212)-Quinic acid"}],"totalFeatures":11},{"comparisonGroups":["WT","MPK1 Mutant"],"dateCreated":"2025-09-26 00:00:00","display_title":"Arabidopsis exudates: MPK1 mutant vs wild-type","group_a_title":"Wild type Arabidopsis thaliana exudates. Serves as the reference group for comparing mutant genotypes.","group_b_title":"Arabidopsis thaliana exudates from MPK1 mutant. Allows for the assessment of the impact of the MPK1 mutation on metabolite levels and T3SS induction.","id":"MTBLS95_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":23,"studyId":"MTBLS95","studyUrl":"http://integmet.org/study/MTBLS95","title":"WT_vs_MPK1_Mutant","topHits":[{"chebi_id":"33384","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-2-ammonio-3-hydroxypropanoate","metabolite_id":"MTCFGRXMJLQNBG-REOHCLBHSA-N","pvalue":0.0001766437050889,"ratio":2.893118563300189,"synonym_name":"<small>L</small>-serine zwitterion"},{"chebi_id":"17765","direction":"up","inn_name":"","iupac_name":"1,3-dihydroxypropan-2-yl \u03b2-<small>D</small>-glucopyranoside","metabolite_id":"AQTKXCPRNZDOJU-SYHAXYEDSA-N","pvalue":4.010470289465775e-05,"ratio":2.17306485352199,"synonym_name":"\u03b2,\u03b2'-dihydroxyisopropyl \u03b2-<small>D</small>-glucopyranoside"},{"chebi_id":"36632","direction":"down","inn_name":"","iupac_name":"2-methylbenzoic acid","metabolite_id":"ZWLPBLYKEWSWPD-UHFFFAOYSA-N","pvalue":0.0039460087778364,"ratio":0.2875530596253603,"synonym_name":"2-toluic acid"},{"chebi_id":"16857","direction":"up","inn_name":"","iupac_name":"<small>L</small>-threonine","metabolite_id":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","pvalue":0.0002294718903843,"ratio":2.212143389411736,"synonym_name":"L-2-Amino-3-hydroxybutyric acid"},{"chebi_id":"15428","direction":"up","inn_name":"","iupac_name":"glycine","metabolite_id":"DHMQDGOQFOQNFH-UHFFFAOYSA-N","pvalue":0.0012817907752113,"ratio":2.3095793816352463,"synonym_name":"aminoethanoic acid"},{"chebi_id":"15756","direction":"down","inn_name":"","iupac_name":"hexadecanoic acid","metabolite_id":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","pvalue":0.0053525114757788,"ratio":0.3460477916882269,"synonym_name":"<em>n</em>-hexadecoic acid"},{"chebi_id":"33508","direction":"up","inn_name":"","iupac_name":"2,3-dihydroxypropanoic acid","metabolite_id":"RBNPOMFGQQGHHO-UHFFFAOYSA-N","pvalue":4.163856481716287e-05,"ratio":1.7232781790084402,"synonym_name":"glyceric acid"},{"chebi_id":"30746","direction":"down","inn_name":"","iupac_name":"benzoic acid","metabolite_id":"WPYMKLBDIGXBTP-UHFFFAOYSA-N","pvalue":0.0001324287115988,"ratio":0.5465045921228491,"synonym_name":"Aromatic carboxylic acid"},{"chebi_id":"18012","direction":"up","inn_name":"","iupac_name":"(2<i>E</i>)-but-2-enedioic acid","metabolite_id":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","pvalue":0.0004893094694946,"ratio":2.019581508786405,"synonym_name":"(2<i>E</i>)-2-butenedioic acid"},{"chebi_id":"77131","direction":"up","inn_name":"","iupac_name":"3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid","metabolite_id":"PCMORTLOPMLEFB-UHFFFAOYSA-N","pvalue":0.0073962363283055,"ratio":2.940518460786357,"synonym_name":"3,5-dimethoxy-4-hydroxycinnamic acid"}],"totalFeatures":48},{"comparisonGroups":["Xiangfei_EL35","Xiangfei_EL38"],"dateCreated":"2025-09-26 00:00:00","display_title":"Xiangfei cultivar: EL35 vs EL38 development stages","group_a_title":"Xiangfei cultivar at stage EL35. Provides insights into terpene profiles at an early stage of Xiangfei cultivar development.","group_b_title":"Xiangfei cultivar at stage EL38. Provides insights into terpene profiles at a late stage of Xiangfei cultivar development.","id":"MTBLS968_0001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":17,"studyId":"MTBLS968","studyUrl":"http://integmet.org/study/MTBLS968","title":"Xiangfei_EL35_vs_Xiangfei_EL38","topHits":[{"chebi_id":"64280","direction":"down","inn_name":"","iupac_name":"(3<i>E</i>)-3,7-dimethylocta-1,3,6-triene","metabolite_id":"IHPKGUQCSIINRJ-CSKARUKUSA-N","pvalue":0.0077183481958815,"ratio":1e-06,"synonym_name":"(<i>E</i>)-3,7-dimethylocta-1,3,6-triene"},{"chebi_id":"144710","direction":"down","inn_name":"","iupac_name":"(3<i>E</i>)-3,7-dimethylocta-3,6-dien-1-ol","metabolite_id":"DTHIOPUFUOMHAY-UXBLZVDNSA-N","pvalue":0.0080952760964536,"ratio":1e-06,"synonym_name":"(3<i>E</i>)-3,7-dimethyl-3,6-octadiene-1-ol"},{"chebi_id":"10577","direction":"down","inn_name":"","iupac_name":"1-methyl-4-(propan-2-yl)cyclohexa-1,4-diene","metabolite_id":"YKFLAYDHMOASIY-UHFFFAOYSA-N","pvalue":0.0119478691483612,"ratio":1e-06,"synonym_name":"1-Isopropyl-4-methyl-1,4-cyclohexadiene"},{"chebi_id":"17221","direction":"down","inn_name":"","iupac_name":"7-methyl-3-methylideneocta-1,6-diene","metabolite_id":"UAHWPYUMFXYFJY-UHFFFAOYSA-N","pvalue":1.2539783997818077e-06,"ratio":0.0903062403634363,"synonym_name":"7-methyl-3-methylene-1,6-octadiene"},{"chebi_id":"141222","direction":"down","inn_name":"","iupac_name":"(4<i>E</i>,6<i>E</i>)-2,6-dimethylocta-2,4,6-triene","metabolite_id":"GQVMHMFBVWSSPF-SOYUKNQTSA-N","pvalue":4.728223752255447e-05,"ratio":0.0479209811552048,"synonym_name":"(4<i>E</i>,6<i>E</i>)-alloocimene"},{"chebi_id":"144704","direction":"down","inn_name":"","iupac_name":"(4E,6Z)-2,6-dimethylocta-2,4,6-triene","metabolite_id":"GQVMHMFBVWSSPF-DAIHKBMKSA-N","pvalue":0.0003279540626508,"ratio":0.0335093998055166,"synonym_name":""},{"chebi_id":"15384","direction":"down","inn_name":"","iupac_name":"1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene","metabolite_id":"XMGQYMWWDOXHJM-UHFFFAOYSA-N","pvalue":9.357835436409235e-05,"ratio":0.1237103929208813,"synonym_name":"Dipentene"},{"chebi_id":"301","direction":"down","inn_name":"","iupac_name":"(5<i>R</i>)-2-methyl-5-(propan-2-yl)cyclohexa-1,3-diene","metabolite_id":"OGLDWXZKYODSOB-SNVBAGLBSA-N","pvalue":0.0002363234604619,"ratio":0.1197973162217812,"synonym_name":"(<i>R</i>)-5-isopropyl-2-methylcyclohexa-1,3-diene"},{"chebi_id":"17580","direction":"down","inn_name":"","iupac_name":"3,7-dimethylocta-1,6-dien-3-ol","metabolite_id":"CDOSHBSSFJOMGT-UHFFFAOYSA-N","pvalue":0.0018671859134147,"ratio":0.0598594432681815,"synonym_name":"2,6-dimethylocta-2,7-dien-6-ol"},{"chebi_id":"22469","direction":"down","inn_name":"","iupac_name":"<em>p</em>-menth-1-en-8-ol","metabolite_id":"WUOACPNHFRMFPN-UHFFFAOYSA-N","pvalue":0.0054664962185324,"ratio":0.0675033432846488,"synonym_name":"1-methyl-4-isopropyl-1-cyclohexen-8-ol"}],"totalFeatures":27},{"comparisonGroups":["Control_30_days","Water_deficit_30_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Grape berries: water deficit vs control at 30 days","group_a_title":"Control group at 30 days after anthesis. Provides baseline data for comparison with water deficit treatment at the same time point.","group_b_title":"Water deficit treatment group at 30 days after anthesis. Allows assessment of the impact of water deficit on grape berries at 30 days after anthesis.","id":"MTBLS984_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"MTBLS984","studyUrl":"http://integmet.org/study/MTBLS984","title":"Control_30_days_vs_Water_deficit_30_days","topHits":[],"totalFeatures":10},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000001_AN000001_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000001","studyUrl":"http://integmet.org/study/ST000001","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000002_AN000002_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000002","studyUrl":"http://integmet.org/study/ST000002","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000003_AN000003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000003","studyUrl":"http://integmet.org/study/ST000003","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000005_AN000012_00000062","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000005","studyUrl":"http://integmet.org/study/ST000005","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000006_AN000020_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000006","studyUrl":"http://integmet.org/study/ST000006","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000007_AN000021_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000007","studyUrl":"http://integmet.org/study/ST000007","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000009_AN000023_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000009","studyUrl":"http://integmet.org/study/ST000009","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000009_AN000024_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000009","studyUrl":"http://integmet.org/study/ST000009","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000010_AN000025_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000010","studyUrl":"http://integmet.org/study/ST000010","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000010_AN000026_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000010","studyUrl":"http://integmet.org/study/ST000010","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000012_AN000029_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000012","studyUrl":"http://integmet.org/study/ST000012","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000013_AN000030_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000013","studyUrl":"http://integmet.org/study/ST000013","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000014_AN000031_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000014","studyUrl":"http://integmet.org/study/ST000014","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000015_AN000032_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000015","studyUrl":"http://integmet.org/study/ST000015","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000016_AN000033_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000016","studyUrl":"http://integmet.org/study/ST000016","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000017_AN000034_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000017","studyUrl":"http://integmet.org/study/ST000017","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000017_AN000035_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000017","studyUrl":"http://integmet.org/study/ST000017","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000025_AN000045_00000018","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000025","studyUrl":"http://integmet.org/study/ST000025","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000040_AN000060_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000040","studyUrl":"http://integmet.org/study/ST000040","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000040_AN000061_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000040","studyUrl":"http://integmet.org/study/ST000040","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000042_AN000064_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000042","studyUrl":"http://integmet.org/study/ST000042","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000042_AN000065_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000042","studyUrl":"http://integmet.org/study/ST000042","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000043_AN000070_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000043","studyUrl":"http://integmet.org/study/ST000043","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000044_AN000068_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000044","studyUrl":"http://integmet.org/study/ST000044","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000044_AN000069_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000044","studyUrl":"http://integmet.org/study/ST000044","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000045_AN000072_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000045","studyUrl":"http://integmet.org/study/ST000045","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000045_AN000073_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000045","studyUrl":"http://integmet.org/study/ST000045","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000045_AN000075_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000045","studyUrl":"http://integmet.org/study/ST000045","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000046_AN000076_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000046","studyUrl":"http://integmet.org/study/ST000046","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000046_AN000077_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000046","studyUrl":"http://integmet.org/study/ST000046","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000046_AN000078_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000046","studyUrl":"http://integmet.org/study/ST000046","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000046_AN000079_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000046","studyUrl":"http://integmet.org/study/ST000046","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000047_AN000080_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000047","studyUrl":"http://integmet.org/study/ST000047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000047_AN000081_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000047","studyUrl":"http://integmet.org/study/ST000047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000047_AN000082_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000047","studyUrl":"http://integmet.org/study/ST000047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000047_AN000083_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000047","studyUrl":"http://integmet.org/study/ST000047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000057_AN000095_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000057","studyUrl":"http://integmet.org/study/ST000057","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000058_AN000096_00000022","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000058","studyUrl":"http://integmet.org/study/ST000058","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000061_AN000099_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000061","studyUrl":"http://integmet.org/study/ST000061","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000062_AN000100_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000062","studyUrl":"http://integmet.org/study/ST000062","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000063_AN000101_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000063","studyUrl":"http://integmet.org/study/ST000063","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000075_AN000119_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000075","studyUrl":"http://integmet.org/study/ST000075","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000075_AN000120_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000075","studyUrl":"http://integmet.org/study/ST000075","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000077_AN000123_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000077","studyUrl":"http://integmet.org/study/ST000077","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000077_AN000124_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000077","studyUrl":"http://integmet.org/study/ST000077","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000081_AN000131_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000081","studyUrl":"http://integmet.org/study/ST000081","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000082_AN000133_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000082","studyUrl":"http://integmet.org/study/ST000082","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000082_AN000134_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000082","studyUrl":"http://integmet.org/study/ST000082","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000084_AN000136_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000084","studyUrl":"http://integmet.org/study/ST000084","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000085_AN000137_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000085","studyUrl":"http://integmet.org/study/ST000085","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000089_AN000141_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000089","studyUrl":"http://integmet.org/study/ST000089","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000089_AN000142_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000089","studyUrl":"http://integmet.org/study/ST000089","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000090_AN000143_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000090","studyUrl":"http://integmet.org/study/ST000090","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000090_AN000144_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000090","studyUrl":"http://integmet.org/study/ST000090","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000093_AN000147_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000093","studyUrl":"http://integmet.org/study/ST000093","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000093_AN000148_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000093","studyUrl":"http://integmet.org/study/ST000093","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000093_AN000149_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000093","studyUrl":"http://integmet.org/study/ST000093","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000095_AN000151_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000095","studyUrl":"http://integmet.org/study/ST000095","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000096_AN000152_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000096","studyUrl":"http://integmet.org/study/ST000096","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000096_AN000153_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000096","studyUrl":"http://integmet.org/study/ST000096","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000096_AN000154_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000096","studyUrl":"http://integmet.org/study/ST000096","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000105_AN000173_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000105","studyUrl":"http://integmet.org/study/ST000105","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000105_AN000174_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000105","studyUrl":"http://integmet.org/study/ST000105","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000114_AN000194_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000114","studyUrl":"http://integmet.org/study/ST000114","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000115_AN000195_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000115","studyUrl":"http://integmet.org/study/ST000115","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000117_AN000198_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000117","studyUrl":"http://integmet.org/study/ST000117","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000118_AN000199_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000118","studyUrl":"http://integmet.org/study/ST000118","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000119_AN000200_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000119","studyUrl":"http://integmet.org/study/ST000119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000119_AN000201_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000119","studyUrl":"http://integmet.org/study/ST000119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000121_AN000203_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000121","studyUrl":"http://integmet.org/study/ST000121","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000136_AN000218_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000136","studyUrl":"http://integmet.org/study/ST000136","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000140_AN000222_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000140","studyUrl":"http://integmet.org/study/ST000140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000142_AN000225_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000142","studyUrl":"http://integmet.org/study/ST000142","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000143_AN000226_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000143","studyUrl":"http://integmet.org/study/ST000143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000143_AN000227_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000143","studyUrl":"http://integmet.org/study/ST000143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000144_AN000228_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000144","studyUrl":"http://integmet.org/study/ST000144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000144_AN000229_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000144","studyUrl":"http://integmet.org/study/ST000144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000145_AN000230_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000145","studyUrl":"http://integmet.org/study/ST000145","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000145_AN000231_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000145","studyUrl":"http://integmet.org/study/ST000145","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000146_AN000232_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000146","studyUrl":"http://integmet.org/study/ST000146","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000148_AN000235_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000148","studyUrl":"http://integmet.org/study/ST000148","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000149_AN000236_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000149","studyUrl":"http://integmet.org/study/ST000149","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000153_AN000244_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000153","studyUrl":"http://integmet.org/study/ST000153","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000154_AN000245_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000154","studyUrl":"http://integmet.org/study/ST000154","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000154_AN000246_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000154","studyUrl":"http://integmet.org/study/ST000154","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000155_AN000247_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000155","studyUrl":"http://integmet.org/study/ST000155","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000158_AN000250_00000022","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000158","studyUrl":"http://integmet.org/study/ST000158","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000159_AN000251_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000159","studyUrl":"http://integmet.org/study/ST000159","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000161_AN000253_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000161","studyUrl":"http://integmet.org/study/ST000161","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000164_AN000256_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000164","studyUrl":"http://integmet.org/study/ST000164","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000164_AN000257_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000164","studyUrl":"http://integmet.org/study/ST000164","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000169_AN000263_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000169","studyUrl":"http://integmet.org/study/ST000169","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000172_AN000266_00000053","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000172","studyUrl":"http://integmet.org/study/ST000172","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000173_AN000267_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000173","studyUrl":"http://integmet.org/study/ST000173","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000174_AN000268_00000046","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000174","studyUrl":"http://integmet.org/study/ST000174","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000176_AN000270_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000176","studyUrl":"http://integmet.org/study/ST000176","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000176_AN000271_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000176","studyUrl":"http://integmet.org/study/ST000176","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000178_AN000274_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000178","studyUrl":"http://integmet.org/study/ST000178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000178_AN000275_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000178","studyUrl":"http://integmet.org/study/ST000178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000180_AN000278_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000180","studyUrl":"http://integmet.org/study/ST000180","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000181_AN000279_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000181","studyUrl":"http://integmet.org/study/ST000181","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000182_AN000280_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000182","studyUrl":"http://integmet.org/study/ST000182","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000183_AN000281_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000183","studyUrl":"http://integmet.org/study/ST000183","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000185_AN000284_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000185","studyUrl":"http://integmet.org/study/ST000185","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000185_AN000285_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000185","studyUrl":"http://integmet.org/study/ST000185","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000188_AN000289_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000188","studyUrl":"http://integmet.org/study/ST000188","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000190_AN000291_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000190","studyUrl":"http://integmet.org/study/ST000190","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000191_AN000292_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000191","studyUrl":"http://integmet.org/study/ST000191","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000191_AN000293_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000191","studyUrl":"http://integmet.org/study/ST000191","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000192_AN000294_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000192","studyUrl":"http://integmet.org/study/ST000192","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000193_AN000295_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000193","studyUrl":"http://integmet.org/study/ST000193","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000195_AN000297_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000195","studyUrl":"http://integmet.org/study/ST000195","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000196_AN000298_00000097","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000196","studyUrl":"http://integmet.org/study/ST000196","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000198_AN000300_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000198","studyUrl":"http://integmet.org/study/ST000198","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000199_AN000301_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000199","studyUrl":"http://integmet.org/study/ST000199","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000201_AN000303_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000201","studyUrl":"http://integmet.org/study/ST000201","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000202_AN000304_00000053","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000202","studyUrl":"http://integmet.org/study/ST000202","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000203_AN000305_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000203","studyUrl":"http://integmet.org/study/ST000203","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000206_AN000308_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000206","studyUrl":"http://integmet.org/study/ST000206","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000207_AN000309_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000207","studyUrl":"http://integmet.org/study/ST000207","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000209_AN000311_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000209","studyUrl":"http://integmet.org/study/ST000209","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000211_AN000313_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000211","studyUrl":"http://integmet.org/study/ST000211","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000212_AN000314_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000212","studyUrl":"http://integmet.org/study/ST000212","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000213_AN000315_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000213","studyUrl":"http://integmet.org/study/ST000213","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000218_AN000322_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000218","studyUrl":"http://integmet.org/study/ST000218","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000221_AN000327_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000221","studyUrl":"http://integmet.org/study/ST000221","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000221_AN000328_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000221","studyUrl":"http://integmet.org/study/ST000221","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000221_AN000329_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000221","studyUrl":"http://integmet.org/study/ST000221","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000221_AN000330_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000221","studyUrl":"http://integmet.org/study/ST000221","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000222_AN000331_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000222","studyUrl":"http://integmet.org/study/ST000222","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000224_AN000333_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000224","studyUrl":"http://integmet.org/study/ST000224","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000224_AN000334_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000224","studyUrl":"http://integmet.org/study/ST000224","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000228_AN000341_00000048","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000228","studyUrl":"http://integmet.org/study/ST000228","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000229_AN000342_00000055","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000229","studyUrl":"http://integmet.org/study/ST000229","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000231_AN000345_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000231","studyUrl":"http://integmet.org/study/ST000231","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000231_AN000346_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000231","studyUrl":"http://integmet.org/study/ST000231","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000235_AN000353_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000235","studyUrl":"http://integmet.org/study/ST000235","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000235_AN000354_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000235","studyUrl":"http://integmet.org/study/ST000235","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000239_AN000369_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000239","studyUrl":"http://integmet.org/study/ST000239","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000239_AN000370_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000239","studyUrl":"http://integmet.org/study/ST000239","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000241_AN000373_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000241","studyUrl":"http://integmet.org/study/ST000241","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000241_AN000374_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000241","studyUrl":"http://integmet.org/study/ST000241","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000242_AN000375_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000242","studyUrl":"http://integmet.org/study/ST000242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000242_AN000376_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000242","studyUrl":"http://integmet.org/study/ST000242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000242_AN000377_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000242","studyUrl":"http://integmet.org/study/ST000242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000242_AN000378_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000242","studyUrl":"http://integmet.org/study/ST000242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000245_AN000383_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000245","studyUrl":"http://integmet.org/study/ST000245","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000247_AN000387_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000247","studyUrl":"http://integmet.org/study/ST000247","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000247_AN000388_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000247","studyUrl":"http://integmet.org/study/ST000247","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000247_AN000389_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000247","studyUrl":"http://integmet.org/study/ST000247","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000247_AN000390_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000247","studyUrl":"http://integmet.org/study/ST000247","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000248_AN000391_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000248","studyUrl":"http://integmet.org/study/ST000248","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000248_AN000392_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000248","studyUrl":"http://integmet.org/study/ST000248","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000249_AN000393_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000249","studyUrl":"http://integmet.org/study/ST000249","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000251_AN000397_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000251","studyUrl":"http://integmet.org/study/ST000251","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000252_AN000398_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000252","studyUrl":"http://integmet.org/study/ST000252","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000252_AN000399_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000252","studyUrl":"http://integmet.org/study/ST000252","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000255_AN000403_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000255","studyUrl":"http://integmet.org/study/ST000255","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000257_AN000406_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000257","studyUrl":"http://integmet.org/study/ST000257","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000257_AN000407_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000257","studyUrl":"http://integmet.org/study/ST000257","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000257_AN000408_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000257","studyUrl":"http://integmet.org/study/ST000257","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000259_AN000411_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000259","studyUrl":"http://integmet.org/study/ST000259","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000259_AN000412_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000259","studyUrl":"http://integmet.org/study/ST000259","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000260_AN000413_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000260","studyUrl":"http://integmet.org/study/ST000260","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000260_AN000414_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000260","studyUrl":"http://integmet.org/study/ST000260","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000260_AN000415_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000260","studyUrl":"http://integmet.org/study/ST000260","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000269_AN000431_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000269","studyUrl":"http://integmet.org/study/ST000269","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000270_AN000432_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000270","studyUrl":"http://integmet.org/study/ST000270","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000270_AN000433_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000270","studyUrl":"http://integmet.org/study/ST000270","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000271_AN000434_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000271","studyUrl":"http://integmet.org/study/ST000271","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000272_AN000435_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000272","studyUrl":"http://integmet.org/study/ST000272","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000274_AN000437_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000274","studyUrl":"http://integmet.org/study/ST000274","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000275_AN000438_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000275","studyUrl":"http://integmet.org/study/ST000275","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000276_AN000440_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000276","studyUrl":"http://integmet.org/study/ST000276","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000276_AN000441_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000276","studyUrl":"http://integmet.org/study/ST000276","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000278_AN000443_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000278","studyUrl":"http://integmet.org/study/ST000278","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000278_AN000444_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000278","studyUrl":"http://integmet.org/study/ST000278","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000283_AN000451_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000283","studyUrl":"http://integmet.org/study/ST000283","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000284_AN000452_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000284","studyUrl":"http://integmet.org/study/ST000284","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000286_AN000454_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000286","studyUrl":"http://integmet.org/study/ST000286","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000286_AN000455_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000286","studyUrl":"http://integmet.org/study/ST000286","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000287_AN000456_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000287","studyUrl":"http://integmet.org/study/ST000287","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000287_AN000457_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000287","studyUrl":"http://integmet.org/study/ST000287","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000288_AN000458_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000288","studyUrl":"http://integmet.org/study/ST000288","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000288_AN000459_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000288","studyUrl":"http://integmet.org/study/ST000288","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000289_AN000460_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000289","studyUrl":"http://integmet.org/study/ST000289","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000289_AN000461_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000289","studyUrl":"http://integmet.org/study/ST000289","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000290_AN000462_00000061","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000290","studyUrl":"http://integmet.org/study/ST000290","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000290_AN000463_00000061","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000290","studyUrl":"http://integmet.org/study/ST000290","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000291_AN000464_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000291","studyUrl":"http://integmet.org/study/ST000291","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000291_AN000465_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000291","studyUrl":"http://integmet.org/study/ST000291","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000292_AN000466_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000292","studyUrl":"http://integmet.org/study/ST000292","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000292_AN000467_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000292","studyUrl":"http://integmet.org/study/ST000292","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000293_AN000468_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000293","studyUrl":"http://integmet.org/study/ST000293","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000293_AN000469_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000293","studyUrl":"http://integmet.org/study/ST000293","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000294_AN000470_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000294","studyUrl":"http://integmet.org/study/ST000294","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000294_AN000471_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000294","studyUrl":"http://integmet.org/study/ST000294","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000295_AN000473_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000295","studyUrl":"http://integmet.org/study/ST000295","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000296_AN000474_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000296","studyUrl":"http://integmet.org/study/ST000296","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000297_AN000475_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000297","studyUrl":"http://integmet.org/study/ST000297","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000298_AN000476_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000298","studyUrl":"http://integmet.org/study/ST000298","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000299_AN000477_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000299","studyUrl":"http://integmet.org/study/ST000299","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000300_AN000478_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000300","studyUrl":"http://integmet.org/study/ST000300","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000301_AN000479_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000301","studyUrl":"http://integmet.org/study/ST000301","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000302_AN000480_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000302","studyUrl":"http://integmet.org/study/ST000302","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000302_AN000481_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000302","studyUrl":"http://integmet.org/study/ST000302","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000303_AN000482_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000303","studyUrl":"http://integmet.org/study/ST000303","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000307_AN000487_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000307","studyUrl":"http://integmet.org/study/ST000307","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000309_AN000489_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000309","studyUrl":"http://integmet.org/study/ST000309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000310_AN000490_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000310","studyUrl":"http://integmet.org/study/ST000310","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000310_AN000491_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000310","studyUrl":"http://integmet.org/study/ST000310","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000310_AN000492_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000310","studyUrl":"http://integmet.org/study/ST000310","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000310_AN000493_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000310","studyUrl":"http://integmet.org/study/ST000310","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000311_AN000494_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000311","studyUrl":"http://integmet.org/study/ST000311","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000311_AN000495_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000311","studyUrl":"http://integmet.org/study/ST000311","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000311_AN000496_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000311","studyUrl":"http://integmet.org/study/ST000311","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000311_AN000497_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000311","studyUrl":"http://integmet.org/study/ST000311","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000312_AN000498_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000312","studyUrl":"http://integmet.org/study/ST000312","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000313_AN000499_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000313","studyUrl":"http://integmet.org/study/ST000313","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000316_AN000502_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000316","studyUrl":"http://integmet.org/study/ST000316","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000317_AN000503_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000317","studyUrl":"http://integmet.org/study/ST000317","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000321_AN000510_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000321","studyUrl":"http://integmet.org/study/ST000321","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000321_AN000511_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000321","studyUrl":"http://integmet.org/study/ST000321","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000325_AN000518_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000325","studyUrl":"http://integmet.org/study/ST000325","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000327_AN000521_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000327","studyUrl":"http://integmet.org/study/ST000327","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000328_AN000523_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000328","studyUrl":"http://integmet.org/study/ST000328","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000328_AN000524_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000328","studyUrl":"http://integmet.org/study/ST000328","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000330_AN000527_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000330","studyUrl":"http://integmet.org/study/ST000330","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000330_AN000528_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000330","studyUrl":"http://integmet.org/study/ST000330","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000331_AN000529_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000331","studyUrl":"http://integmet.org/study/ST000331","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000331_AN000530_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000331","studyUrl":"http://integmet.org/study/ST000331","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000332_AN000531_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000332","studyUrl":"http://integmet.org/study/ST000332","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000332_AN000532_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000332","studyUrl":"http://integmet.org/study/ST000332","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000336_AN004436_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000336","studyUrl":"http://integmet.org/study/ST000336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000336_AN004437_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000336","studyUrl":"http://integmet.org/study/ST000336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000339_AN000550_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000339","studyUrl":"http://integmet.org/study/ST000339","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000339_AN000551_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000339","studyUrl":"http://integmet.org/study/ST000339","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000340_AN000552_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000340","studyUrl":"http://integmet.org/study/ST000340","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000341_AN000553_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000341","studyUrl":"http://integmet.org/study/ST000341","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000342_AN000554_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000342","studyUrl":"http://integmet.org/study/ST000342","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000343_AN000556_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000343","studyUrl":"http://integmet.org/study/ST000343","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000346_AN000561_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000346","studyUrl":"http://integmet.org/study/ST000346","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000347_AN000563_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000347","studyUrl":"http://integmet.org/study/ST000347","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000348_AN000579_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000348","studyUrl":"http://integmet.org/study/ST000348","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000349_AN000565_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000349","studyUrl":"http://integmet.org/study/ST000349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000350_AN000566_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000350","studyUrl":"http://integmet.org/study/ST000350","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000351_AN000567_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000351","studyUrl":"http://integmet.org/study/ST000351","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000351_AN000568_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000351","studyUrl":"http://integmet.org/study/ST000351","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000351_AN000569_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000351","studyUrl":"http://integmet.org/study/ST000351","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000351_AN000570_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000351","studyUrl":"http://integmet.org/study/ST000351","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000351_AN000571_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000351","studyUrl":"http://integmet.org/study/ST000351","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000352_AN000572_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000352","studyUrl":"http://integmet.org/study/ST000352","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000352_AN000573_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000352","studyUrl":"http://integmet.org/study/ST000352","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000352_AN000574_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000352","studyUrl":"http://integmet.org/study/ST000352","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000353_AN000575_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000353","studyUrl":"http://integmet.org/study/ST000353","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000353_AN000576_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000353","studyUrl":"http://integmet.org/study/ST000353","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000354_AN000577_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000354","studyUrl":"http://integmet.org/study/ST000354","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000354_AN000578_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000354","studyUrl":"http://integmet.org/study/ST000354","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000355_AN000580_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000355","studyUrl":"http://integmet.org/study/ST000355","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000355_AN000581_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000355","studyUrl":"http://integmet.org/study/ST000355","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000356_AN000582_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000356","studyUrl":"http://integmet.org/study/ST000356","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000356_AN000583_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000356","studyUrl":"http://integmet.org/study/ST000356","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000370_AN000604_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000370","studyUrl":"http://integmet.org/study/ST000370","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000372_AN000606_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000372","studyUrl":"http://integmet.org/study/ST000372","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000373_AN000607_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000373","studyUrl":"http://integmet.org/study/ST000373","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000374_AN000608_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000374","studyUrl":"http://integmet.org/study/ST000374","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000378_AN000612_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000378","studyUrl":"http://integmet.org/study/ST000378","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000379_AN000613_00000048","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000379","studyUrl":"http://integmet.org/study/ST000379","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000380_AN000614_00000070","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000380","studyUrl":"http://integmet.org/study/ST000380","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000383_AN000618_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000383","studyUrl":"http://integmet.org/study/ST000383","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000384_AN000619_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000384","studyUrl":"http://integmet.org/study/ST000384","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000399_AN000636_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000399","studyUrl":"http://integmet.org/study/ST000399","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000401_AN000640_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000401","studyUrl":"http://integmet.org/study/ST000401","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000403_AN000642_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000403","studyUrl":"http://integmet.org/study/ST000403","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000403_AN000643_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000403","studyUrl":"http://integmet.org/study/ST000403","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000404_AN000644_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000404","studyUrl":"http://integmet.org/study/ST000404","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000418_AN000660_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000418","studyUrl":"http://integmet.org/study/ST000418","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000421_AN000664_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000421","studyUrl":"http://integmet.org/study/ST000421","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000421_AN000666_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000421","studyUrl":"http://integmet.org/study/ST000421","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000422_AN000668_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000422","studyUrl":"http://integmet.org/study/ST000422","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000422_AN000669_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000422","studyUrl":"http://integmet.org/study/ST000422","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000422_AN000670_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000422","studyUrl":"http://integmet.org/study/ST000422","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000423_AN000671_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000423","studyUrl":"http://integmet.org/study/ST000423","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000423_AN000672_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000423","studyUrl":"http://integmet.org/study/ST000423","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000425_AN000675_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000425","studyUrl":"http://integmet.org/study/ST000425","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000426_AN000676_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000426","studyUrl":"http://integmet.org/study/ST000426","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000427_AN000677_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000427","studyUrl":"http://integmet.org/study/ST000427","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000428_AN000678_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000428","studyUrl":"http://integmet.org/study/ST000428","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000429_AN000679_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000429","studyUrl":"http://integmet.org/study/ST000429","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000430_AN000680_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000430","studyUrl":"http://integmet.org/study/ST000430","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000431_AN000681_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000431","studyUrl":"http://integmet.org/study/ST000431","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000433_AN000683_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000433","studyUrl":"http://integmet.org/study/ST000433","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000434_AN000684_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000434","studyUrl":"http://integmet.org/study/ST000434","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000443_AN000694_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000443","studyUrl":"http://integmet.org/study/ST000443","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000444_AN000695_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000444","studyUrl":"http://integmet.org/study/ST000444","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000445_AN000696_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000445","studyUrl":"http://integmet.org/study/ST000445","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000446_AN000697_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000446","studyUrl":"http://integmet.org/study/ST000446","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000446_AN000698_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000446","studyUrl":"http://integmet.org/study/ST000446","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000451_AN000707_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000451","studyUrl":"http://integmet.org/study/ST000451","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000452_AN000708_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000452","studyUrl":"http://integmet.org/study/ST000452","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000457_AN000716_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000457","studyUrl":"http://integmet.org/study/ST000457","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000457_AN000717_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000457","studyUrl":"http://integmet.org/study/ST000457","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000457_AN000718_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000457","studyUrl":"http://integmet.org/study/ST000457","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000458_AN000719_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000458","studyUrl":"http://integmet.org/study/ST000458","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000460_AN000721_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000460","studyUrl":"http://integmet.org/study/ST000460","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000461_AN000722_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000461","studyUrl":"http://integmet.org/study/ST000461","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000466_AN000728_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000466","studyUrl":"http://integmet.org/study/ST000466","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000466_AN000729_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000466","studyUrl":"http://integmet.org/study/ST000466","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000468_AN000731_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000468","studyUrl":"http://integmet.org/study/ST000468","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000469_AN000732_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000469","studyUrl":"http://integmet.org/study/ST000469","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000469_AN000733_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000469","studyUrl":"http://integmet.org/study/ST000469","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000474_AN000738_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000474","studyUrl":"http://integmet.org/study/ST000474","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000475_AN000739_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000475","studyUrl":"http://integmet.org/study/ST000475","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000475_AN000740_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000475","studyUrl":"http://integmet.org/study/ST000475","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000481_AN001449_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000481","studyUrl":"http://integmet.org/study/ST000481","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000488_AN000754_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000488","studyUrl":"http://integmet.org/study/ST000488","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000489_AN000755_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000489","studyUrl":"http://integmet.org/study/ST000489","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000490_AN000756_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000490","studyUrl":"http://integmet.org/study/ST000490","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000491_AN000757_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000491","studyUrl":"http://integmet.org/study/ST000491","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000492_AN000758_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000492","studyUrl":"http://integmet.org/study/ST000492","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000495_AN000761_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000495","studyUrl":"http://integmet.org/study/ST000495","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000496_AN000762_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000496","studyUrl":"http://integmet.org/study/ST000496","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000497_AN000765_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000497","studyUrl":"http://integmet.org/study/ST000497","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000498_AN000766_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000498","studyUrl":"http://integmet.org/study/ST000498","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000505_AN000774_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000505","studyUrl":"http://integmet.org/study/ST000505","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000506_AN000775_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000506","studyUrl":"http://integmet.org/study/ST000506","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000509_AN000780_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000509","studyUrl":"http://integmet.org/study/ST000509","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000509_AN000781_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000509","studyUrl":"http://integmet.org/study/ST000509","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000510_AN000782_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000510","studyUrl":"http://integmet.org/study/ST000510","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000510_AN000783_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000510","studyUrl":"http://integmet.org/study/ST000510","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000511_AN000784_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000511","studyUrl":"http://integmet.org/study/ST000511","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000512_AN000785_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000512","studyUrl":"http://integmet.org/study/ST000512","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000516_AN000790_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000516","studyUrl":"http://integmet.org/study/ST000516","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000517_AN000791_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000517","studyUrl":"http://integmet.org/study/ST000517","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000518_AN000792_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000518","studyUrl":"http://integmet.org/study/ST000518","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000519_AN000793_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000519","studyUrl":"http://integmet.org/study/ST000519","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000520_AN000794_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000520","studyUrl":"http://integmet.org/study/ST000520","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000521_AN000795_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000521","studyUrl":"http://integmet.org/study/ST000521","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000522_AN000796_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000522","studyUrl":"http://integmet.org/study/ST000522","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000522_AN000797_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000522","studyUrl":"http://integmet.org/study/ST000522","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000526_AN000804_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000526","studyUrl":"http://integmet.org/study/ST000526","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000527_AN000805_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000527","studyUrl":"http://integmet.org/study/ST000527","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000539_AN000818_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000539","studyUrl":"http://integmet.org/study/ST000539","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000539_AN000819_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000539","studyUrl":"http://integmet.org/study/ST000539","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000546_AN000832_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000546","studyUrl":"http://integmet.org/study/ST000546","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000546_AN000833_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000546","studyUrl":"http://integmet.org/study/ST000546","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000554_AN000849_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000554","studyUrl":"http://integmet.org/study/ST000554","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000554_AN000850_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000554","studyUrl":"http://integmet.org/study/ST000554","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000555_AN000851_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000555","studyUrl":"http://integmet.org/study/ST000555","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000555_AN000852_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000555","studyUrl":"http://integmet.org/study/ST000555","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000556_AN000853_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000556","studyUrl":"http://integmet.org/study/ST000556","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000556_AN000854_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000556","studyUrl":"http://integmet.org/study/ST000556","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000561_AN000862_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000561","studyUrl":"http://integmet.org/study/ST000561","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000561_AN000863_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000561","studyUrl":"http://integmet.org/study/ST000561","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000562_AN000864_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000562","studyUrl":"http://integmet.org/study/ST000562","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000568_AN000873_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000568","studyUrl":"http://integmet.org/study/ST000568","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000568_AN000874_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000568","studyUrl":"http://integmet.org/study/ST000568","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000568_AN000875_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000568","studyUrl":"http://integmet.org/study/ST000568","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000569_AN000876_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000569","studyUrl":"http://integmet.org/study/ST000569","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000570_AN000877_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000570","studyUrl":"http://integmet.org/study/ST000570","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000570_AN000878_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000570","studyUrl":"http://integmet.org/study/ST000570","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000571_AN000879_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000571","studyUrl":"http://integmet.org/study/ST000571","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000571_AN000880_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000571","studyUrl":"http://integmet.org/study/ST000571","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000572_AN000881_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000572","studyUrl":"http://integmet.org/study/ST000572","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000572_AN000882_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000572","studyUrl":"http://integmet.org/study/ST000572","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000574_AN000884_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000574","studyUrl":"http://integmet.org/study/ST000574","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000575_AN000885_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000575","studyUrl":"http://integmet.org/study/ST000575","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000576_AN000886_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000576","studyUrl":"http://integmet.org/study/ST000576","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000577_AN000887_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000577","studyUrl":"http://integmet.org/study/ST000577","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000579_AN000890_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000579","studyUrl":"http://integmet.org/study/ST000579","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000580_AN000891_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000580","studyUrl":"http://integmet.org/study/ST000580","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000586_AN000901_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000586","studyUrl":"http://integmet.org/study/ST000586","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000589_AN000904_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000589","studyUrl":"http://integmet.org/study/ST000589","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000591_AN000906_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000591","studyUrl":"http://integmet.org/study/ST000591","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000593_AN000909_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000593","studyUrl":"http://integmet.org/study/ST000593","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000594_AN000910_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000594","studyUrl":"http://integmet.org/study/ST000594","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000597_AN000915_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000597","studyUrl":"http://integmet.org/study/ST000597","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000598_AN000916_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000598","studyUrl":"http://integmet.org/study/ST000598","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000600_AN000919_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000600","studyUrl":"http://integmet.org/study/ST000600","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000603_AN000923_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000603","studyUrl":"http://integmet.org/study/ST000603","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000608_AN000929_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000608","studyUrl":"http://integmet.org/study/ST000608","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000608_AN000930_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000608","studyUrl":"http://integmet.org/study/ST000608","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000608_AN000931_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000608","studyUrl":"http://integmet.org/study/ST000608","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000612_AN000937_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000612","studyUrl":"http://integmet.org/study/ST000612","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000613_AN000938_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000613","studyUrl":"http://integmet.org/study/ST000613","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000614_AN000939_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000614","studyUrl":"http://integmet.org/study/ST000614","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000615_AN000944_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000615","studyUrl":"http://integmet.org/study/ST000615","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000616_AN000945_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000616","studyUrl":"http://integmet.org/study/ST000616","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000623_AN001820_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000623","studyUrl":"http://integmet.org/study/ST000623","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000624_AN000956_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000624","studyUrl":"http://integmet.org/study/ST000624","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000628_AN000960_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000628","studyUrl":"http://integmet.org/study/ST000628","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000630_AN000962_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000630","studyUrl":"http://integmet.org/study/ST000630","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000631_AN000963_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000631","studyUrl":"http://integmet.org/study/ST000631","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000632_AN000964_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000632","studyUrl":"http://integmet.org/study/ST000632","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000633_AN000965_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000633","studyUrl":"http://integmet.org/study/ST000633","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000645_AN000977_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000645","studyUrl":"http://integmet.org/study/ST000645","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000646_AN000978_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000646","studyUrl":"http://integmet.org/study/ST000646","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000647_AN000979_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000647","studyUrl":"http://integmet.org/study/ST000647","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000648_AN000980_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000648","studyUrl":"http://integmet.org/study/ST000648","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000649_AN000981_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000649","studyUrl":"http://integmet.org/study/ST000649","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000650_AN000982_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000650","studyUrl":"http://integmet.org/study/ST000650","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000658_AN001287_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000658","studyUrl":"http://integmet.org/study/ST000658","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000662_AN001010_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000662","studyUrl":"http://integmet.org/study/ST000662","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000662_AN001011_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000662","studyUrl":"http://integmet.org/study/ST000662","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000663_AN001012_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000663","studyUrl":"http://integmet.org/study/ST000663","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000663_AN001013_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000663","studyUrl":"http://integmet.org/study/ST000663","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000665_AN001016_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000665","studyUrl":"http://integmet.org/study/ST000665","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000665_AN001017_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000665","studyUrl":"http://integmet.org/study/ST000665","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000667_AN001020_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000667","studyUrl":"http://integmet.org/study/ST000667","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000667_AN001021_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000667","studyUrl":"http://integmet.org/study/ST000667","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000669_AN001024_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000669","studyUrl":"http://integmet.org/study/ST000669","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000669_AN001025_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000669","studyUrl":"http://integmet.org/study/ST000669","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000671_AN001028_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000671","studyUrl":"http://integmet.org/study/ST000671","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000671_AN001029_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000671","studyUrl":"http://integmet.org/study/ST000671","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000672_AN001030_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000672","studyUrl":"http://integmet.org/study/ST000672","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000672_AN001031_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000672","studyUrl":"http://integmet.org/study/ST000672","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000673_AN001032_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000673","studyUrl":"http://integmet.org/study/ST000673","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000673_AN001033_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000673","studyUrl":"http://integmet.org/study/ST000673","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000674_AN001034_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000674","studyUrl":"http://integmet.org/study/ST000674","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000674_AN001035_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000674","studyUrl":"http://integmet.org/study/ST000674","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000675_AN001036_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000675","studyUrl":"http://integmet.org/study/ST000675","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000675_AN001037_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000675","studyUrl":"http://integmet.org/study/ST000675","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000676_AN001038_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000676","studyUrl":"http://integmet.org/study/ST000676","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000676_AN001039_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000676","studyUrl":"http://integmet.org/study/ST000676","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000678_AN001042_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000678","studyUrl":"http://integmet.org/study/ST000678","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000678_AN001043_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000678","studyUrl":"http://integmet.org/study/ST000678","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000679_AN001044_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000679","studyUrl":"http://integmet.org/study/ST000679","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000679_AN001045_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000679","studyUrl":"http://integmet.org/study/ST000679","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000680_AN001046_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000680","studyUrl":"http://integmet.org/study/ST000680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000680_AN001047_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000680","studyUrl":"http://integmet.org/study/ST000680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000683_AN001052_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000683","studyUrl":"http://integmet.org/study/ST000683","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000683_AN001053_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000683","studyUrl":"http://integmet.org/study/ST000683","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000684_AN001054_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000684","studyUrl":"http://integmet.org/study/ST000684","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000684_AN001055_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000684","studyUrl":"http://integmet.org/study/ST000684","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000685_AN001056_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000685","studyUrl":"http://integmet.org/study/ST000685","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000685_AN001057_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000685","studyUrl":"http://integmet.org/study/ST000685","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000686_AN001058_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000686","studyUrl":"http://integmet.org/study/ST000686","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000686_AN001059_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000686","studyUrl":"http://integmet.org/study/ST000686","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000687_AN001060_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000687","studyUrl":"http://integmet.org/study/ST000687","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000688_AN001061_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000688","studyUrl":"http://integmet.org/study/ST000688","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000688_AN001062_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000688","studyUrl":"http://integmet.org/study/ST000688","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000689_AN001063_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000689","studyUrl":"http://integmet.org/study/ST000689","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000689_AN001064_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000689","studyUrl":"http://integmet.org/study/ST000689","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000690_AN001065_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000690","studyUrl":"http://integmet.org/study/ST000690","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000690_AN001066_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000690","studyUrl":"http://integmet.org/study/ST000690","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000691_AN001067_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000691","studyUrl":"http://integmet.org/study/ST000691","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000691_AN001068_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000691","studyUrl":"http://integmet.org/study/ST000691","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000693_AN001071_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000693","studyUrl":"http://integmet.org/study/ST000693","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000693_AN001072_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000693","studyUrl":"http://integmet.org/study/ST000693","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000694_AN001073_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000694","studyUrl":"http://integmet.org/study/ST000694","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000694_AN001074_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000694","studyUrl":"http://integmet.org/study/ST000694","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000696_AN001079_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000696","studyUrl":"http://integmet.org/study/ST000696","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000696_AN001080_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000696","studyUrl":"http://integmet.org/study/ST000696","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000697_AN001081_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000697","studyUrl":"http://integmet.org/study/ST000697","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000697_AN001082_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000697","studyUrl":"http://integmet.org/study/ST000697","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000698_AN001083_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000698","studyUrl":"http://integmet.org/study/ST000698","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000698_AN001084_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000698","studyUrl":"http://integmet.org/study/ST000698","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000699_AN001085_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000699","studyUrl":"http://integmet.org/study/ST000699","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000699_AN001086_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000699","studyUrl":"http://integmet.org/study/ST000699","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000699_AN001087_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000699","studyUrl":"http://integmet.org/study/ST000699","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000701_AN001089_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000701","studyUrl":"http://integmet.org/study/ST000701","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000701_AN001090_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000701","studyUrl":"http://integmet.org/study/ST000701","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000702_AN001091_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000702","studyUrl":"http://integmet.org/study/ST000702","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000702_AN001092_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000702","studyUrl":"http://integmet.org/study/ST000702","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000704_AN001094_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000704","studyUrl":"http://integmet.org/study/ST000704","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000706_AN001097_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000706","studyUrl":"http://integmet.org/study/ST000706","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000707_AN001098_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000707","studyUrl":"http://integmet.org/study/ST000707","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000710_AN001109_00000012","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000710","studyUrl":"http://integmet.org/study/ST000710","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000712_AN001112_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000712","studyUrl":"http://integmet.org/study/ST000712","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000714_AN001117_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000714","studyUrl":"http://integmet.org/study/ST000714","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000714_AN001118_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000714","studyUrl":"http://integmet.org/study/ST000714","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000715_AN001119_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000715","studyUrl":"http://integmet.org/study/ST000715","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000717_AN001121_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000717","studyUrl":"http://integmet.org/study/ST000717","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000720_AN001126_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000720","studyUrl":"http://integmet.org/study/ST000720","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000722_AN001129_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000722","studyUrl":"http://integmet.org/study/ST000722","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000722_AN001130_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000722","studyUrl":"http://integmet.org/study/ST000722","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000722_AN001131_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000722","studyUrl":"http://integmet.org/study/ST000722","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000722_AN001132_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000722","studyUrl":"http://integmet.org/study/ST000722","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000723_AN001133_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000723","studyUrl":"http://integmet.org/study/ST000723","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000725_AN001136_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000725","studyUrl":"http://integmet.org/study/ST000725","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000725_AN001137_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000725","studyUrl":"http://integmet.org/study/ST000725","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000727_AN001140_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000727","studyUrl":"http://integmet.org/study/ST000727","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000728_AN001141_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000728","studyUrl":"http://integmet.org/study/ST000728","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000729_AN001142_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000729","studyUrl":"http://integmet.org/study/ST000729","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000732_AN001146_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000732","studyUrl":"http://integmet.org/study/ST000732","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000734_AN001148_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000734","studyUrl":"http://integmet.org/study/ST000734","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000736_AN001150_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000736","studyUrl":"http://integmet.org/study/ST000736","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000737_AN001151_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000737","studyUrl":"http://integmet.org/study/ST000737","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000740_AN001154_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000740","studyUrl":"http://integmet.org/study/ST000740","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000741_AN001155_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000741","studyUrl":"http://integmet.org/study/ST000741","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000741_AN001156_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000741","studyUrl":"http://integmet.org/study/ST000741","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000742_AN001157_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000742","studyUrl":"http://integmet.org/study/ST000742","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000742_AN001158_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000742","studyUrl":"http://integmet.org/study/ST000742","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000746_AN001169_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000746","studyUrl":"http://integmet.org/study/ST000746","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000746_AN001170_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000746","studyUrl":"http://integmet.org/study/ST000746","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000748_AN001172_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000748","studyUrl":"http://integmet.org/study/ST000748","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000748_AN001173_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000748","studyUrl":"http://integmet.org/study/ST000748","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000749_AN001174_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000749","studyUrl":"http://integmet.org/study/ST000749","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000749_AN001175_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000749","studyUrl":"http://integmet.org/study/ST000749","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000750_AN001176_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000750","studyUrl":"http://integmet.org/study/ST000750","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000750_AN001177_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000750","studyUrl":"http://integmet.org/study/ST000750","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000751_AN001178_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000751","studyUrl":"http://integmet.org/study/ST000751","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000751_AN001179_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000751","studyUrl":"http://integmet.org/study/ST000751","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000752_AN001180_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000752","studyUrl":"http://integmet.org/study/ST000752","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000753_AN001181_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000753","studyUrl":"http://integmet.org/study/ST000753","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000753_AN001182_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000753","studyUrl":"http://integmet.org/study/ST000753","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000753_AN001183_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000753","studyUrl":"http://integmet.org/study/ST000753","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000755_AN001329_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000755","studyUrl":"http://integmet.org/study/ST000755","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000755_AN001330_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000755","studyUrl":"http://integmet.org/study/ST000755","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000756_AN001186_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000756","studyUrl":"http://integmet.org/study/ST000756","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000756_AN001187_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000756","studyUrl":"http://integmet.org/study/ST000756","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000758_AN001190_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000758","studyUrl":"http://integmet.org/study/ST000758","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000758_AN001191_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000758","studyUrl":"http://integmet.org/study/ST000758","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000758_AN001192_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000758","studyUrl":"http://integmet.org/study/ST000758","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000758_AN001193_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000758","studyUrl":"http://integmet.org/study/ST000758","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000760_AN001198_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000760","studyUrl":"http://integmet.org/study/ST000760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000761_AN001199_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000761","studyUrl":"http://integmet.org/study/ST000761","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000767_AN001213_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000767","studyUrl":"http://integmet.org/study/ST000767","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000769_AN001216_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000769","studyUrl":"http://integmet.org/study/ST000769","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000771_AN001218_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000771","studyUrl":"http://integmet.org/study/ST000771","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000774_AN001221_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000774","studyUrl":"http://integmet.org/study/ST000774","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000776_AN001226_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000776","studyUrl":"http://integmet.org/study/ST000776","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000776_AN001227_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000776","studyUrl":"http://integmet.org/study/ST000776","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000777_AN001228_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000777","studyUrl":"http://integmet.org/study/ST000777","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000777_AN001229_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000777","studyUrl":"http://integmet.org/study/ST000777","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000778_AN001230_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000778","studyUrl":"http://integmet.org/study/ST000778","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000778_AN001231_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000778","studyUrl":"http://integmet.org/study/ST000778","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000780_AN001234_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000780","studyUrl":"http://integmet.org/study/ST000780","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000780_AN001235_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000780","studyUrl":"http://integmet.org/study/ST000780","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000781_AN001236_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000781","studyUrl":"http://integmet.org/study/ST000781","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000781_AN001237_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000781","studyUrl":"http://integmet.org/study/ST000781","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000790_AN001258_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000790","studyUrl":"http://integmet.org/study/ST000790","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000791_AN001259_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000791","studyUrl":"http://integmet.org/study/ST000791","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000793_AN001264_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000793","studyUrl":"http://integmet.org/study/ST000793","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000794_AN001265_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000794","studyUrl":"http://integmet.org/study/ST000794","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000796_AN001267_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000796","studyUrl":"http://integmet.org/study/ST000796","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000799_AN001270_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000799","studyUrl":"http://integmet.org/study/ST000799","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000815_AN001290_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000815","studyUrl":"http://integmet.org/study/ST000815","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000815_AN001291_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000815","studyUrl":"http://integmet.org/study/ST000815","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000815_AN001292_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000815","studyUrl":"http://integmet.org/study/ST000815","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000819_AN001300_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000819","studyUrl":"http://integmet.org/study/ST000819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000819_AN001301_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000819","studyUrl":"http://integmet.org/study/ST000819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000819_AN001302_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000819","studyUrl":"http://integmet.org/study/ST000819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000820_AN001303_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000820","studyUrl":"http://integmet.org/study/ST000820","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000821_AN001304_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000821","studyUrl":"http://integmet.org/study/ST000821","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000822_AN001305_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000822","studyUrl":"http://integmet.org/study/ST000822","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000823_AN001306_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000823","studyUrl":"http://integmet.org/study/ST000823","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000823_AN001307_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000823","studyUrl":"http://integmet.org/study/ST000823","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000823_AN001308_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000823","studyUrl":"http://integmet.org/study/ST000823","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000823_AN001309_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000823","studyUrl":"http://integmet.org/study/ST000823","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000824_AN001310_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000824","studyUrl":"http://integmet.org/study/ST000824","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000828_AN001834_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000828","studyUrl":"http://integmet.org/study/ST000828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000828_AN001835_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000828","studyUrl":"http://integmet.org/study/ST000828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000828_AN001836_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000828","studyUrl":"http://integmet.org/study/ST000828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000828_AN001837_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000828","studyUrl":"http://integmet.org/study/ST000828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000829_AN001321_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000829","studyUrl":"http://integmet.org/study/ST000829","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000829_AN001322_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000829","studyUrl":"http://integmet.org/study/ST000829","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000830_AN001323_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000830","studyUrl":"http://integmet.org/study/ST000830","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000830_AN001324_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000830","studyUrl":"http://integmet.org/study/ST000830","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000831_AN001325_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000831","studyUrl":"http://integmet.org/study/ST000831","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000832_AN001838_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000832","studyUrl":"http://integmet.org/study/ST000832","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000832_AN001839_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000832","studyUrl":"http://integmet.org/study/ST000832","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000832_AN001840_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000832","studyUrl":"http://integmet.org/study/ST000832","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000833_AN001841_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000833","studyUrl":"http://integmet.org/study/ST000833","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000833_AN001842_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000833","studyUrl":"http://integmet.org/study/ST000833","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000833_AN001843_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000833","studyUrl":"http://integmet.org/study/ST000833","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000834_AN001424_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000834","studyUrl":"http://integmet.org/study/ST000834","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000834_AN001425_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000834","studyUrl":"http://integmet.org/study/ST000834","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000835_AN001336_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000835","studyUrl":"http://integmet.org/study/ST000835","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000835_AN001337_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000835","studyUrl":"http://integmet.org/study/ST000835","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000836_AN001338_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000836","studyUrl":"http://integmet.org/study/ST000836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000836_AN001339_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000836","studyUrl":"http://integmet.org/study/ST000836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000837_AN001340_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000837","studyUrl":"http://integmet.org/study/ST000837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000837_AN001341_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000837","studyUrl":"http://integmet.org/study/ST000837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000838_AN001342_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000838","studyUrl":"http://integmet.org/study/ST000838","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000838_AN001343_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000838","studyUrl":"http://integmet.org/study/ST000838","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000838_AN001344_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000838","studyUrl":"http://integmet.org/study/ST000838","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000839_AN001345_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000839","studyUrl":"http://integmet.org/study/ST000839","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000839_AN001346_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000839","studyUrl":"http://integmet.org/study/ST000839","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000840_AN001844_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000840","studyUrl":"http://integmet.org/study/ST000840","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000840_AN001845_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000840","studyUrl":"http://integmet.org/study/ST000840","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000844_AN001366_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000844","studyUrl":"http://integmet.org/study/ST000844","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000844_AN001367_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000844","studyUrl":"http://integmet.org/study/ST000844","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000845_AN001368_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000845","studyUrl":"http://integmet.org/study/ST000845","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000846_AN001369_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000846","studyUrl":"http://integmet.org/study/ST000846","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000846_AN001370_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000846","studyUrl":"http://integmet.org/study/ST000846","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000847_AN001371_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000847","studyUrl":"http://integmet.org/study/ST000847","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000848_AN001372_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000848","studyUrl":"http://integmet.org/study/ST000848","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000851_AN001375_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000851","studyUrl":"http://integmet.org/study/ST000851","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000854_AN001378_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000854","studyUrl":"http://integmet.org/study/ST000854","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000856_AN001381_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000856","studyUrl":"http://integmet.org/study/ST000856","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000858_AN001383_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000858","studyUrl":"http://integmet.org/study/ST000858","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000861_AN001386_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000861","studyUrl":"http://integmet.org/study/ST000861","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000862_AN001387_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000862","studyUrl":"http://integmet.org/study/ST000862","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000864_AN001389_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000864","studyUrl":"http://integmet.org/study/ST000864","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000873_AN001478_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000873","studyUrl":"http://integmet.org/study/ST000873","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000873_AN001479_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000873","studyUrl":"http://integmet.org/study/ST000873","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000876_AN001413_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000876","studyUrl":"http://integmet.org/study/ST000876","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000878_AN001428_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000878","studyUrl":"http://integmet.org/study/ST000878","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000879_AN001429_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000879","studyUrl":"http://integmet.org/study/ST000879","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000879_AN001430_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000879","studyUrl":"http://integmet.org/study/ST000879","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000879_AN001431_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000879","studyUrl":"http://integmet.org/study/ST000879","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000879_AN001432_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000879","studyUrl":"http://integmet.org/study/ST000879","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000880_AN001433_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000880","studyUrl":"http://integmet.org/study/ST000880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000880_AN001434_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000880","studyUrl":"http://integmet.org/study/ST000880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000880_AN001435_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000880","studyUrl":"http://integmet.org/study/ST000880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000880_AN001436_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000880","studyUrl":"http://integmet.org/study/ST000880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000881_AN001437_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000881","studyUrl":"http://integmet.org/study/ST000881","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000885_AN001442_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000885","studyUrl":"http://integmet.org/study/ST000885","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000886_AN001443_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000886","studyUrl":"http://integmet.org/study/ST000886","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000886_AN001444_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000886","studyUrl":"http://integmet.org/study/ST000886","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000889_AN001451_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000889","studyUrl":"http://integmet.org/study/ST000889","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000893_AN001455_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000893","studyUrl":"http://integmet.org/study/ST000893","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000894_AN001456_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000894","studyUrl":"http://integmet.org/study/ST000894","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000895_AN001457_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000895","studyUrl":"http://integmet.org/study/ST000895","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000896_AN001458_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000896","studyUrl":"http://integmet.org/study/ST000896","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000897_AN001459_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000897","studyUrl":"http://integmet.org/study/ST000897","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000900_AN001466_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000900","studyUrl":"http://integmet.org/study/ST000900","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000901_AN001467_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000901","studyUrl":"http://integmet.org/study/ST000901","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000902_AN001468_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000902","studyUrl":"http://integmet.org/study/ST000902","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000903_AN001469_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000903","studyUrl":"http://integmet.org/study/ST000903","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000903_AN001470_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000903","studyUrl":"http://integmet.org/study/ST000903","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001485_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001486_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001487_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001488_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001489_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000915_AN001490_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000915","studyUrl":"http://integmet.org/study/ST000915","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001491_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001492_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001493_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001494_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001495_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000916_AN001496_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000916","studyUrl":"http://integmet.org/study/ST000916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000917_AN001497_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000917","studyUrl":"http://integmet.org/study/ST000917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000917_AN001499_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000917","studyUrl":"http://integmet.org/study/ST000917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000917_AN001500_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000917","studyUrl":"http://integmet.org/study/ST000917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000917_AN001501_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000917","studyUrl":"http://integmet.org/study/ST000917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000918_AN001503_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000918","studyUrl":"http://integmet.org/study/ST000918","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000922_AN001511_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000922","studyUrl":"http://integmet.org/study/ST000922","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000922_AN001512_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000922","studyUrl":"http://integmet.org/study/ST000922","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000924_AN001517_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000924","studyUrl":"http://integmet.org/study/ST000924","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000924_AN001517_00000029","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000924","studyUrl":"http://integmet.org/study/ST000924","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000930_AN001524_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000930","studyUrl":"http://integmet.org/study/ST000930","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000953_AN001562_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000953","studyUrl":"http://integmet.org/study/ST000953","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000953_AN001563_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000953","studyUrl":"http://integmet.org/study/ST000953","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000955_AN001566_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000955","studyUrl":"http://integmet.org/study/ST000955","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000955_AN001567_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000955","studyUrl":"http://integmet.org/study/ST000955","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000956_AN001568_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000956","studyUrl":"http://integmet.org/study/ST000956","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000956_AN001569_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000956","studyUrl":"http://integmet.org/study/ST000956","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000957_AN001570_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000957","studyUrl":"http://integmet.org/study/ST000957","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000957_AN001571_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000957","studyUrl":"http://integmet.org/study/ST000957","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000958_AN001572_00000028","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000958","studyUrl":"http://integmet.org/study/ST000958","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000960_AN001574_00000028","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000960","studyUrl":"http://integmet.org/study/ST000960","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000961_AN001575_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000961","studyUrl":"http://integmet.org/study/ST000961","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000962_AN001576_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000962","studyUrl":"http://integmet.org/study/ST000962","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000964_AN001578_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000964","studyUrl":"http://integmet.org/study/ST000964","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000965_AN001579_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000965","studyUrl":"http://integmet.org/study/ST000965","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000967_AN001581_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000967","studyUrl":"http://integmet.org/study/ST000967","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000968_AN001582_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000968","studyUrl":"http://integmet.org/study/ST000968","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000969_AN001583_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000969","studyUrl":"http://integmet.org/study/ST000969","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000972_AN001592_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000972","studyUrl":"http://integmet.org/study/ST000972","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000972_AN001593_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000972","studyUrl":"http://integmet.org/study/ST000972","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000980_AN001606_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000980","studyUrl":"http://integmet.org/study/ST000980","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000992_AN001619_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000992","studyUrl":"http://integmet.org/study/ST000992","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000992_AN001620_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000992","studyUrl":"http://integmet.org/study/ST000992","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000992_AN001621_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000992","studyUrl":"http://integmet.org/study/ST000992","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000995_AN001624_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000995","studyUrl":"http://integmet.org/study/ST000995","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000996_AN001625_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000996","studyUrl":"http://integmet.org/study/ST000996","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST000998_AN001627_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST000998","studyUrl":"http://integmet.org/study/ST000998","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001005_AN001647_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001005","studyUrl":"http://integmet.org/study/ST001005","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001006_AN001648_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001006","studyUrl":"http://integmet.org/study/ST001006","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001008_AN001650_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001008","studyUrl":"http://integmet.org/study/ST001008","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001019_AN001667_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001019","studyUrl":"http://integmet.org/study/ST001019","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001026_AN001683_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001026","studyUrl":"http://integmet.org/study/ST001026","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001031_AN001691_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001031","studyUrl":"http://integmet.org/study/ST001031","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001033_AN001694_00000036","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001033","studyUrl":"http://integmet.org/study/ST001033","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001034_AN001695_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001034","studyUrl":"http://integmet.org/study/ST001034","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001037_AN001698_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001037","studyUrl":"http://integmet.org/study/ST001037","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001048_AN001716_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001048","studyUrl":"http://integmet.org/study/ST001048","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001048_AN001717_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001048","studyUrl":"http://integmet.org/study/ST001048","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001051_AN001720_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001051","studyUrl":"http://integmet.org/study/ST001051","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001052_AN001721_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001052","studyUrl":"http://integmet.org/study/ST001052","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001055_AN001724_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001055","studyUrl":"http://integmet.org/study/ST001055","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001056_AN002145_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001056","studyUrl":"http://integmet.org/study/ST001056","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001058_AN001735_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001058","studyUrl":"http://integmet.org/study/ST001058","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001061_AN001731_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001061","studyUrl":"http://integmet.org/study/ST001061","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001061_AN001732_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001061","studyUrl":"http://integmet.org/study/ST001061","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001062_AN001736_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001062","studyUrl":"http://integmet.org/study/ST001062","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001062_AN001737_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001062","studyUrl":"http://integmet.org/study/ST001062","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001062_AN001738_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001062","studyUrl":"http://integmet.org/study/ST001062","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001073_AN001755_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001073","studyUrl":"http://integmet.org/study/ST001073","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001074_AN001756_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001074","studyUrl":"http://integmet.org/study/ST001074","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001076_AN001758_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001076","studyUrl":"http://integmet.org/study/ST001076","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001077_AN001759_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001077","studyUrl":"http://integmet.org/study/ST001077","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001084_AN001769_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001084","studyUrl":"http://integmet.org/study/ST001084","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001085_AN001770_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001085","studyUrl":"http://integmet.org/study/ST001085","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001086_AN001771_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001086","studyUrl":"http://integmet.org/study/ST001086","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001098_AN001786_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001098","studyUrl":"http://integmet.org/study/ST001098","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001101_AN001790_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001101","studyUrl":"http://integmet.org/study/ST001101","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001104_AN001796_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001104","studyUrl":"http://integmet.org/study/ST001104","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001105_AN001798_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001105","studyUrl":"http://integmet.org/study/ST001105","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001112_AN001807_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001112","studyUrl":"http://integmet.org/study/ST001112","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001112_AN001808_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001112","studyUrl":"http://integmet.org/study/ST001112","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001113_AN001809_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001113","studyUrl":"http://integmet.org/study/ST001113","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001114_AN001810_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001114","studyUrl":"http://integmet.org/study/ST001114","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001115_AN001811_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001115","studyUrl":"http://integmet.org/study/ST001115","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001117_AN001813_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001117","studyUrl":"http://integmet.org/study/ST001117","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001118_AN001817_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001118","studyUrl":"http://integmet.org/study/ST001118","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001119_AN001830_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001119","studyUrl":"http://integmet.org/study/ST001119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001119_AN001831_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001119","studyUrl":"http://integmet.org/study/ST001119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001125_AN001850_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001125","studyUrl":"http://integmet.org/study/ST001125","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001126_AN001851_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001126","studyUrl":"http://integmet.org/study/ST001126","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001127_AN001852_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001127","studyUrl":"http://integmet.org/study/ST001127","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001128_AN001853_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001128","studyUrl":"http://integmet.org/study/ST001128","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001131_AN001856_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001131","studyUrl":"http://integmet.org/study/ST001131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001133_AN001858_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001133","studyUrl":"http://integmet.org/study/ST001133","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001134_AN001859_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001134","studyUrl":"http://integmet.org/study/ST001134","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001135_AN001860_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001135","studyUrl":"http://integmet.org/study/ST001135","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001135_AN001861_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001135","studyUrl":"http://integmet.org/study/ST001135","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001136_AN001862_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001136","studyUrl":"http://integmet.org/study/ST001136","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001136_AN001863_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001136","studyUrl":"http://integmet.org/study/ST001136","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001140_AN001870_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001140","studyUrl":"http://integmet.org/study/ST001140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001140_AN001871_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001140","studyUrl":"http://integmet.org/study/ST001140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001140_AN001872_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001140","studyUrl":"http://integmet.org/study/ST001140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001140_AN001873_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001140","studyUrl":"http://integmet.org/study/ST001140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001141_AN001874_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001141","studyUrl":"http://integmet.org/study/ST001141","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001143_AN001882_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001143","studyUrl":"http://integmet.org/study/ST001143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001143_AN001883_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001143","studyUrl":"http://integmet.org/study/ST001143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001143_AN001884_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001143","studyUrl":"http://integmet.org/study/ST001143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001143_AN001885_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001143","studyUrl":"http://integmet.org/study/ST001143","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001144_AN001886_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001144","studyUrl":"http://integmet.org/study/ST001144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001144_AN001887_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001144","studyUrl":"http://integmet.org/study/ST001144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001144_AN001888_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001144","studyUrl":"http://integmet.org/study/ST001144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001144_AN001889_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001144","studyUrl":"http://integmet.org/study/ST001144","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001148_AN001893_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001148","studyUrl":"http://integmet.org/study/ST001148","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001148_AN001894_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001148","studyUrl":"http://integmet.org/study/ST001148","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001148_AN001895_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001148","studyUrl":"http://integmet.org/study/ST001148","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001151_AN001899_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001151","studyUrl":"http://integmet.org/study/ST001151","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001153_AN001903_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001153","studyUrl":"http://integmet.org/study/ST001153","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001157_AN001915_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001157","studyUrl":"http://integmet.org/study/ST001157","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001159_AN001917_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001159","studyUrl":"http://integmet.org/study/ST001159","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001160_AN001918_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001160","studyUrl":"http://integmet.org/study/ST001160","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001163_AN001923_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001163","studyUrl":"http://integmet.org/study/ST001163","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001163_AN001924_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001163","studyUrl":"http://integmet.org/study/ST001163","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001165_AN001926_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001165","studyUrl":"http://integmet.org/study/ST001165","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001165_AN001927_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001165","studyUrl":"http://integmet.org/study/ST001165","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001167_AN001929_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001167","studyUrl":"http://integmet.org/study/ST001167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001167_AN001929_00000057","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001167","studyUrl":"http://integmet.org/study/ST001167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001167_AN001930_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001167","studyUrl":"http://integmet.org/study/ST001167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001167_AN001930_00000057","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001167","studyUrl":"http://integmet.org/study/ST001167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001175_AN001950_00000047","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001175","studyUrl":"http://integmet.org/study/ST001175","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001175_AN001951_00000047","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001175","studyUrl":"http://integmet.org/study/ST001175","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001176_AN001952_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001176","studyUrl":"http://integmet.org/study/ST001176","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001178_AN001954_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001178","studyUrl":"http://integmet.org/study/ST001178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001178_AN001955_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001178","studyUrl":"http://integmet.org/study/ST001178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001180_AN001958_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001180","studyUrl":"http://integmet.org/study/ST001180","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001185_AN001969_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001185","studyUrl":"http://integmet.org/study/ST001185","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001188_AN001980_00000017","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001188","studyUrl":"http://integmet.org/study/ST001188","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001190_AN001982_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001190","studyUrl":"http://integmet.org/study/ST001190","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001191_AN001983_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001191","studyUrl":"http://integmet.org/study/ST001191","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001192_AN001984_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001192","studyUrl":"http://integmet.org/study/ST001192","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001192_AN001985_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001192","studyUrl":"http://integmet.org/study/ST001192","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001192_AN001986_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001192","studyUrl":"http://integmet.org/study/ST001192","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001192_AN001987_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001192","studyUrl":"http://integmet.org/study/ST001192","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001193_AN001988_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001193","studyUrl":"http://integmet.org/study/ST001193","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001193_AN001989_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001193","studyUrl":"http://integmet.org/study/ST001193","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001197_AN001993_00000024","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001197","studyUrl":"http://integmet.org/study/ST001197","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001198_AN001994_00000024","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001198","studyUrl":"http://integmet.org/study/ST001198","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001202_AN002000_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001202","studyUrl":"http://integmet.org/study/ST001202","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001202_AN002001_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001202","studyUrl":"http://integmet.org/study/ST001202","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001204_AN002004_00000052","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001204","studyUrl":"http://integmet.org/study/ST001204","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001204_AN002005_00000052","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001204","studyUrl":"http://integmet.org/study/ST001204","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001205_AN002006_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001205","studyUrl":"http://integmet.org/study/ST001205","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001205_AN002007_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001205","studyUrl":"http://integmet.org/study/ST001205","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001206_AN002008_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001206","studyUrl":"http://integmet.org/study/ST001206","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001210_AN002014_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001210","studyUrl":"http://integmet.org/study/ST001210","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001210_AN002015_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001210","studyUrl":"http://integmet.org/study/ST001210","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001213_AN002024_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001213","studyUrl":"http://integmet.org/study/ST001213","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001215_AN002026_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001215","studyUrl":"http://integmet.org/study/ST001215","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001222_AN002035_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001222","studyUrl":"http://integmet.org/study/ST001222","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001225_AN002038_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001225","studyUrl":"http://integmet.org/study/ST001225","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001226_AN002039_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001226","studyUrl":"http://integmet.org/study/ST001226","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001227_AN002040_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001227","studyUrl":"http://integmet.org/study/ST001227","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001228_AN002041_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001228","studyUrl":"http://integmet.org/study/ST001228","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001229_AN002042_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001229","studyUrl":"http://integmet.org/study/ST001229","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001230_AN002043_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001230","studyUrl":"http://integmet.org/study/ST001230","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001238_AN002056_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001238","studyUrl":"http://integmet.org/study/ST001238","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001238_AN002057_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001238","studyUrl":"http://integmet.org/study/ST001238","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001240_AN002059_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001240","studyUrl":"http://integmet.org/study/ST001240","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001240_AN002060_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001240","studyUrl":"http://integmet.org/study/ST001240","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001241_AN002061_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001241","studyUrl":"http://integmet.org/study/ST001241","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001241_AN002062_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001241","studyUrl":"http://integmet.org/study/ST001241","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001242_AN002063_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001242","studyUrl":"http://integmet.org/study/ST001242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001242_AN002064_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001242","studyUrl":"http://integmet.org/study/ST001242","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001243_AN002065_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001243","studyUrl":"http://integmet.org/study/ST001243","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001243_AN002066_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001243","studyUrl":"http://integmet.org/study/ST001243","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001245_AN002068_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001245","studyUrl":"http://integmet.org/study/ST001245","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001245_AN002069_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001245","studyUrl":"http://integmet.org/study/ST001245","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001246_AN002070_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001246","studyUrl":"http://integmet.org/study/ST001246","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001250_AN002075_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001250","studyUrl":"http://integmet.org/study/ST001250","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001250_AN002076_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001250","studyUrl":"http://integmet.org/study/ST001250","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001251_AN002077_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001251","studyUrl":"http://integmet.org/study/ST001251","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001253_AN002079_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001253","studyUrl":"http://integmet.org/study/ST001253","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001253_AN002080_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001253","studyUrl":"http://integmet.org/study/ST001253","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001253_AN002081_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001253","studyUrl":"http://integmet.org/study/ST001253","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001253_AN002082_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001253","studyUrl":"http://integmet.org/study/ST001253","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001256_AN002085_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001256","studyUrl":"http://integmet.org/study/ST001256","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001260_AN002090_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001260","studyUrl":"http://integmet.org/study/ST001260","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001260_AN002091_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001260","studyUrl":"http://integmet.org/study/ST001260","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001261_AN002092_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001261","studyUrl":"http://integmet.org/study/ST001261","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001261_AN002093_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001261","studyUrl":"http://integmet.org/study/ST001261","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001265_AN002102_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001265","studyUrl":"http://integmet.org/study/ST001265","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001267_AN002104_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001267","studyUrl":"http://integmet.org/study/ST001267","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001272_AN002112_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001272","studyUrl":"http://integmet.org/study/ST001272","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001273_AN002113_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001273","studyUrl":"http://integmet.org/study/ST001273","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001273_AN002114_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001273","studyUrl":"http://integmet.org/study/ST001273","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001274_AN002115_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001274","studyUrl":"http://integmet.org/study/ST001274","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001275_AN002116_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001275","studyUrl":"http://integmet.org/study/ST001275","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001276_AN002117_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001276","studyUrl":"http://integmet.org/study/ST001276","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001279_AN002120_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001279","studyUrl":"http://integmet.org/study/ST001279","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001288_AN002141_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001288","studyUrl":"http://integmet.org/study/ST001288","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001289_AN002142_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001289","studyUrl":"http://integmet.org/study/ST001289","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001299_AN002163_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001299","studyUrl":"http://integmet.org/study/ST001299","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001300_AN002164_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001300","studyUrl":"http://integmet.org/study/ST001300","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001300_AN002165_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001300","studyUrl":"http://integmet.org/study/ST001300","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001301_AN002166_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001301","studyUrl":"http://integmet.org/study/ST001301","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001301_AN002167_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001301","studyUrl":"http://integmet.org/study/ST001301","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001302_AN002168_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001302","studyUrl":"http://integmet.org/study/ST001302","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001306_AN002175_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001306","studyUrl":"http://integmet.org/study/ST001306","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001307_AN002176_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001307","studyUrl":"http://integmet.org/study/ST001307","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001309_AN002178_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001309","studyUrl":"http://integmet.org/study/ST001309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001309_AN002179_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001309","studyUrl":"http://integmet.org/study/ST001309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001309_AN002180_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001309","studyUrl":"http://integmet.org/study/ST001309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001318_AN002194_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001318","studyUrl":"http://integmet.org/study/ST001318","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001320_AN002196_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001320","studyUrl":"http://integmet.org/study/ST001320","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001323_AN002199_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001323","studyUrl":"http://integmet.org/study/ST001323","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001323_AN002200_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001323","studyUrl":"http://integmet.org/study/ST001323","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001323_AN002201_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001323","studyUrl":"http://integmet.org/study/ST001323","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001327_AN002209_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001327","studyUrl":"http://integmet.org/study/ST001327","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001327_AN002210_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001327","studyUrl":"http://integmet.org/study/ST001327","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001332_AN002221_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001332","studyUrl":"http://integmet.org/study/ST001332","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001336_AN002226_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001336","studyUrl":"http://integmet.org/study/ST001336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001336_AN002227_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001336","studyUrl":"http://integmet.org/study/ST001336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001336_AN002228_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001336","studyUrl":"http://integmet.org/study/ST001336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001336_AN002229_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001336","studyUrl":"http://integmet.org/study/ST001336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001336_AN002230_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001336","studyUrl":"http://integmet.org/study/ST001336","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001339_AN002233_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001339","studyUrl":"http://integmet.org/study/ST001339","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001341_AN002235_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001341","studyUrl":"http://integmet.org/study/ST001341","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001342_AN002236_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001342","studyUrl":"http://integmet.org/study/ST001342","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001343_AN002237_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001343","studyUrl":"http://integmet.org/study/ST001343","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001344_AN002238_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001344","studyUrl":"http://integmet.org/study/ST001344","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001345_AN002239_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001345","studyUrl":"http://integmet.org/study/ST001345","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001349_AN002243_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001349","studyUrl":"http://integmet.org/study/ST001349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001349_AN002244_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001349","studyUrl":"http://integmet.org/study/ST001349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001349_AN002245_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001349","studyUrl":"http://integmet.org/study/ST001349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001359_AN002263_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001359","studyUrl":"http://integmet.org/study/ST001359","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001360_AN002264_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001360","studyUrl":"http://integmet.org/study/ST001360","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001361_AN002265_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001361","studyUrl":"http://integmet.org/study/ST001361","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001363_AN002269_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001363","studyUrl":"http://integmet.org/study/ST001363","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001365_AN002272_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001365","studyUrl":"http://integmet.org/study/ST001365","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001373_AN002293_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001373","studyUrl":"http://integmet.org/study/ST001373","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001378_AN002298_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001378","studyUrl":"http://integmet.org/study/ST001378","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001384_AN002309_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001384","studyUrl":"http://integmet.org/study/ST001384","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001388_AN002317_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001388","studyUrl":"http://integmet.org/study/ST001388","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001389_AN002318_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001389","studyUrl":"http://integmet.org/study/ST001389","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002323_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002324_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002325_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002326_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002327_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002328_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002329_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002330_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001393_AN002331_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001393","studyUrl":"http://integmet.org/study/ST001393","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001394_AN002332_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001394","studyUrl":"http://integmet.org/study/ST001394","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001394_AN002333_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001394","studyUrl":"http://integmet.org/study/ST001394","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001395_AN002334_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001395","studyUrl":"http://integmet.org/study/ST001395","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001398_AN002337_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001398","studyUrl":"http://integmet.org/study/ST001398","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001398_AN002338_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001398","studyUrl":"http://integmet.org/study/ST001398","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001399_AN002339_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001399","studyUrl":"http://integmet.org/study/ST001399","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001402_AN002344_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001402","studyUrl":"http://integmet.org/study/ST001402","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001403_AN002345_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001403","studyUrl":"http://integmet.org/study/ST001403","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001404_AN002346_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001404","studyUrl":"http://integmet.org/study/ST001404","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001406_AN002349_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001406","studyUrl":"http://integmet.org/study/ST001406","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001411_AN002361_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001411","studyUrl":"http://integmet.org/study/ST001411","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001412_AN002362_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001412","studyUrl":"http://integmet.org/study/ST001412","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001413_AN002363_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001413","studyUrl":"http://integmet.org/study/ST001413","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001431_AN002393_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001431","studyUrl":"http://integmet.org/study/ST001431","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001432_AN002394_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001432","studyUrl":"http://integmet.org/study/ST001432","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001435_AN002398_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001435","studyUrl":"http://integmet.org/study/ST001435","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001439_AN002403_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001439","studyUrl":"http://integmet.org/study/ST001439","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001439_AN002404_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001439","studyUrl":"http://integmet.org/study/ST001439","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001442_AN002410_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001442","studyUrl":"http://integmet.org/study/ST001442","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001452_AN002427_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001452","studyUrl":"http://integmet.org/study/ST001452","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001474_AN004409_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001474","studyUrl":"http://integmet.org/study/ST001474","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001479_AN002455_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001479","studyUrl":"http://integmet.org/study/ST001479","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001480_AN002456_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001480","studyUrl":"http://integmet.org/study/ST001480","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001480_AN002457_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001480","studyUrl":"http://integmet.org/study/ST001480","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001483_AN002460_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001483","studyUrl":"http://integmet.org/study/ST001483","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001485_AN002462_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001485","studyUrl":"http://integmet.org/study/ST001485","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001487_AN002464_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001487","studyUrl":"http://integmet.org/study/ST001487","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001489_AN002466_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001489","studyUrl":"http://integmet.org/study/ST001489","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001489_AN002467_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001489","studyUrl":"http://integmet.org/study/ST001489","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001493_AN002475_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001493","studyUrl":"http://integmet.org/study/ST001493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001495_AN002478_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001495","studyUrl":"http://integmet.org/study/ST001495","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001496_AN002479_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001496","studyUrl":"http://integmet.org/study/ST001496","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001497_AN002480_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001497","studyUrl":"http://integmet.org/study/ST001497","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001498_AN002481_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001498","studyUrl":"http://integmet.org/study/ST001498","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001518_AN002521_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001518","studyUrl":"http://integmet.org/study/ST001518","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001523_AN002541_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001523","studyUrl":"http://integmet.org/study/ST001523","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001547_AN002576_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001547","studyUrl":"http://integmet.org/study/ST001547","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001547_AN002577_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001547","studyUrl":"http://integmet.org/study/ST001547","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001548_AN002578_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001548","studyUrl":"http://integmet.org/study/ST001548","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001548_AN002579_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001548","studyUrl":"http://integmet.org/study/ST001548","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001549_AN002580_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001549","studyUrl":"http://integmet.org/study/ST001549","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001549_AN002581_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001549","studyUrl":"http://integmet.org/study/ST001549","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001606_AN002639_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001606","studyUrl":"http://integmet.org/study/ST001606","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001607_AN002640_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001607","studyUrl":"http://integmet.org/study/ST001607","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001610_AN002644_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001610","studyUrl":"http://integmet.org/study/ST001610","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001611_AN002645_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001611","studyUrl":"http://integmet.org/study/ST001611","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001611_AN002646_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001611","studyUrl":"http://integmet.org/study/ST001611","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001620_AN002655_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001620","studyUrl":"http://integmet.org/study/ST001620","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001621_AN002656_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001621","studyUrl":"http://integmet.org/study/ST001621","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001623_AN002658_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001623","studyUrl":"http://integmet.org/study/ST001623","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001638_AN002680_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001638","studyUrl":"http://integmet.org/study/ST001638","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001642_AN002687_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001642","studyUrl":"http://integmet.org/study/ST001642","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001650_AN002696_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001650","studyUrl":"http://integmet.org/study/ST001650","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001652_AN002699_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001652","studyUrl":"http://integmet.org/study/ST001652","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001658_AN002706_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001658","studyUrl":"http://integmet.org/study/ST001658","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001658_AN002707_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001658","studyUrl":"http://integmet.org/study/ST001658","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001658_AN002708_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001658","studyUrl":"http://integmet.org/study/ST001658","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001658_AN002709_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001658","studyUrl":"http://integmet.org/study/ST001658","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001660_AN002711_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001660","studyUrl":"http://integmet.org/study/ST001660","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001666_AN002718_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001666","studyUrl":"http://integmet.org/study/ST001666","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001668_AN002720_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001668","studyUrl":"http://integmet.org/study/ST001668","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001668_AN002721_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001668","studyUrl":"http://integmet.org/study/ST001668","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001668_AN002722_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001668","studyUrl":"http://integmet.org/study/ST001668","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001668_AN002723_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001668","studyUrl":"http://integmet.org/study/ST001668","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001672_AN002730_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001672","studyUrl":"http://integmet.org/study/ST001672","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001673_AN002731_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001673","studyUrl":"http://integmet.org/study/ST001673","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001674_AN002732_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001674","studyUrl":"http://integmet.org/study/ST001674","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001675_AN002733_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001675","studyUrl":"http://integmet.org/study/ST001675","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001678_AN002736_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001678","studyUrl":"http://integmet.org/study/ST001678","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001679_AN002737_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001679","studyUrl":"http://integmet.org/study/ST001679","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001680_AN002738_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001680","studyUrl":"http://integmet.org/study/ST001680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001680_AN002739_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001680","studyUrl":"http://integmet.org/study/ST001680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001680_AN002740_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001680","studyUrl":"http://integmet.org/study/ST001680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001680_AN002741_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001680","studyUrl":"http://integmet.org/study/ST001680","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001684_AN002750_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001684","studyUrl":"http://integmet.org/study/ST001684","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001684_AN002751_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001684","studyUrl":"http://integmet.org/study/ST001684","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001689_AN002759_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001689","studyUrl":"http://integmet.org/study/ST001689","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001690_AN002760_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001690","studyUrl":"http://integmet.org/study/ST001690","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001699_AN002770_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001699","studyUrl":"http://integmet.org/study/ST001699","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001700_AN002771_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001700","studyUrl":"http://integmet.org/study/ST001700","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001701_AN002772_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001701","studyUrl":"http://integmet.org/study/ST001701","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001702_AN002773_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001702","studyUrl":"http://integmet.org/study/ST001702","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001703_AN002774_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001703","studyUrl":"http://integmet.org/study/ST001703","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001708_AN002782_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001708","studyUrl":"http://integmet.org/study/ST001708","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001709_AN002783_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001709","studyUrl":"http://integmet.org/study/ST001709","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001709_AN002784_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001709","studyUrl":"http://integmet.org/study/ST001709","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001727_AN002812_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001727","studyUrl":"http://integmet.org/study/ST001727","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001728_AN002813_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001728","studyUrl":"http://integmet.org/study/ST001728","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001729_AN002814_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001729","studyUrl":"http://integmet.org/study/ST001729","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001730_AN002815_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001730","studyUrl":"http://integmet.org/study/ST001730","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001730_AN002816_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001730","studyUrl":"http://integmet.org/study/ST001730","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001731_AN002817_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001731","studyUrl":"http://integmet.org/study/ST001731","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001731_AN002818_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001731","studyUrl":"http://integmet.org/study/ST001731","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001732_AN002819_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001732","studyUrl":"http://integmet.org/study/ST001732","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001732_AN002820_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001732","studyUrl":"http://integmet.org/study/ST001732","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001734_AN002823_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001734","studyUrl":"http://integmet.org/study/ST001734","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001738_AN002829_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001738","studyUrl":"http://integmet.org/study/ST001738","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001738_AN002830_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001738","studyUrl":"http://integmet.org/study/ST001738","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001738_AN002831_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001738","studyUrl":"http://integmet.org/study/ST001738","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001741_AN002834_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001741","studyUrl":"http://integmet.org/study/ST001741","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001752_AN002855_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001752","studyUrl":"http://integmet.org/study/ST001752","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001755_AN002859_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001755","studyUrl":"http://integmet.org/study/ST001755","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001759_AN002866_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001759","studyUrl":"http://integmet.org/study/ST001759","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001760_AN002867_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001760","studyUrl":"http://integmet.org/study/ST001760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001761_AN002868_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001761","studyUrl":"http://integmet.org/study/ST001761","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001762_AN002869_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001762","studyUrl":"http://integmet.org/study/ST001762","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001763_AN002870_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001763","studyUrl":"http://integmet.org/study/ST001763","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001765_AN002872_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001765","studyUrl":"http://integmet.org/study/ST001765","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001772_AN002879_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001772","studyUrl":"http://integmet.org/study/ST001772","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001773_AN002880_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001773","studyUrl":"http://integmet.org/study/ST001773","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001779_AN002888_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001779","studyUrl":"http://integmet.org/study/ST001779","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001779_AN002889_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001779","studyUrl":"http://integmet.org/study/ST001779","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001788_AN002899_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001788","studyUrl":"http://integmet.org/study/ST001788","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001788_AN002900_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001788","studyUrl":"http://integmet.org/study/ST001788","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001789_AN002901_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001789","studyUrl":"http://integmet.org/study/ST001789","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001789_AN002902_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001789","studyUrl":"http://integmet.org/study/ST001789","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001794_AN002911_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001794","studyUrl":"http://integmet.org/study/ST001794","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001794_AN002912_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001794","studyUrl":"http://integmet.org/study/ST001794","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001794_AN002913_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001794","studyUrl":"http://integmet.org/study/ST001794","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001794_AN002914_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001794","studyUrl":"http://integmet.org/study/ST001794","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001795_AN002915_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001795","studyUrl":"http://integmet.org/study/ST001795","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001795_AN002916_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001795","studyUrl":"http://integmet.org/study/ST001795","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001796_AN002917_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001796","studyUrl":"http://integmet.org/study/ST001796","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001796_AN002918_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001796","studyUrl":"http://integmet.org/study/ST001796","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001799_AN002921_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001799","studyUrl":"http://integmet.org/study/ST001799","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001809_AN002932_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001809","studyUrl":"http://integmet.org/study/ST001809","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001814_AN002942_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001814","studyUrl":"http://integmet.org/study/ST001814","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001819_AN002951_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001819","studyUrl":"http://integmet.org/study/ST001819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001819_AN002952_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001819","studyUrl":"http://integmet.org/study/ST001819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001819_AN002953_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001819","studyUrl":"http://integmet.org/study/ST001819","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001822_AN002958_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001822","studyUrl":"http://integmet.org/study/ST001822","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001823_AN002959_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001823","studyUrl":"http://integmet.org/study/ST001823","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001828_AN002965_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001828","studyUrl":"http://integmet.org/study/ST001828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001828_AN002967_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001828","studyUrl":"http://integmet.org/study/ST001828","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001831_AN002972_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001831","studyUrl":"http://integmet.org/study/ST001831","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001831_AN002973_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001831","studyUrl":"http://integmet.org/study/ST001831","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001834_AN002976_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001834","studyUrl":"http://integmet.org/study/ST001834","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001835_AN002977_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001835","studyUrl":"http://integmet.org/study/ST001835","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001839_AN002981_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001839","studyUrl":"http://integmet.org/study/ST001839","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001839_AN002982_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001839","studyUrl":"http://integmet.org/study/ST001839","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001842_AN002985_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001842","studyUrl":"http://integmet.org/study/ST001842","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001843_AN002986_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001843","studyUrl":"http://integmet.org/study/ST001843","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001845_AN002988_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001845","studyUrl":"http://integmet.org/study/ST001845","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001850_AN002997_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001850","studyUrl":"http://integmet.org/study/ST001850","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001850_AN002998_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001850","studyUrl":"http://integmet.org/study/ST001850","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001851_AN002999_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001851","studyUrl":"http://integmet.org/study/ST001851","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001855_AN003006_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001855","studyUrl":"http://integmet.org/study/ST001855","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001855_AN003007_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001855","studyUrl":"http://integmet.org/study/ST001855","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001856_AN003008_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001856","studyUrl":"http://integmet.org/study/ST001856","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001856_AN003009_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001856","studyUrl":"http://integmet.org/study/ST001856","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001859_AN003013_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001859","studyUrl":"http://integmet.org/study/ST001859","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001859_AN003014_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001859","studyUrl":"http://integmet.org/study/ST001859","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001860_AN003015_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001860","studyUrl":"http://integmet.org/study/ST001860","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001860_AN003016_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001860","studyUrl":"http://integmet.org/study/ST001860","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001866_AN003026_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001866","studyUrl":"http://integmet.org/study/ST001866","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001866_AN003027_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001866","studyUrl":"http://integmet.org/study/ST001866","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001866_AN003028_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001866","studyUrl":"http://integmet.org/study/ST001866","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001869_AN003031_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001869","studyUrl":"http://integmet.org/study/ST001869","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001870_AN003032_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001870","studyUrl":"http://integmet.org/study/ST001870","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001875_AN003037_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001875","studyUrl":"http://integmet.org/study/ST001875","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001877_AN003080_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001877","studyUrl":"http://integmet.org/study/ST001877","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001879_AN003039_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001879","studyUrl":"http://integmet.org/study/ST001879","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001884_AN003048_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001884","studyUrl":"http://integmet.org/study/ST001884","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001897_AN003078_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001897","studyUrl":"http://integmet.org/study/ST001897","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001897_AN003079_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001897","studyUrl":"http://integmet.org/study/ST001897","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001901_AN003089_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001901","studyUrl":"http://integmet.org/study/ST001901","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001901_AN003090_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001901","studyUrl":"http://integmet.org/study/ST001901","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001901_AN003092_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001901","studyUrl":"http://integmet.org/study/ST001901","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001902_AN003093_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001902","studyUrl":"http://integmet.org/study/ST001902","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001902_AN003094_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001902","studyUrl":"http://integmet.org/study/ST001902","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001903_AN003815_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001903","studyUrl":"http://integmet.org/study/ST001903","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001903_AN003816_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001903","studyUrl":"http://integmet.org/study/ST001903","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001903_AN003817_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001903","studyUrl":"http://integmet.org/study/ST001903","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001905_AN003102_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001905","studyUrl":"http://integmet.org/study/ST001905","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001906_AN003103_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001906","studyUrl":"http://integmet.org/study/ST001906","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001907_AN003104_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001907","studyUrl":"http://integmet.org/study/ST001907","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001909_AN003106_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001909","studyUrl":"http://integmet.org/study/ST001909","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001916_AN003114_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001916","studyUrl":"http://integmet.org/study/ST001916","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001917_AN003115_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001917","studyUrl":"http://integmet.org/study/ST001917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001920_AN003119_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001920","studyUrl":"http://integmet.org/study/ST001920","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001920_AN003120_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001920","studyUrl":"http://integmet.org/study/ST001920","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001921_AN003122_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001921","studyUrl":"http://integmet.org/study/ST001921","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001927_AN003133_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001927","studyUrl":"http://integmet.org/study/ST001927","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001933_AN003143_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001933","studyUrl":"http://integmet.org/study/ST001933","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001936_AN004932_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001936","studyUrl":"http://integmet.org/study/ST001936","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001938_AN003151_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001938","studyUrl":"http://integmet.org/study/ST001938","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001938_AN003152_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001938","studyUrl":"http://integmet.org/study/ST001938","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001939_AN003153_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001939","studyUrl":"http://integmet.org/study/ST001939","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001939_AN003154_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001939","studyUrl":"http://integmet.org/study/ST001939","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001942_AN003184_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001942","studyUrl":"http://integmet.org/study/ST001942","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001942_AN003185_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001942","studyUrl":"http://integmet.org/study/ST001942","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001942_AN003186_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001942","studyUrl":"http://integmet.org/study/ST001942","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001946_AN003168_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001946","studyUrl":"http://integmet.org/study/ST001946","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001949_AN003173_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001949","studyUrl":"http://integmet.org/study/ST001949","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001951_AN003176_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001951","studyUrl":"http://integmet.org/study/ST001951","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001952_AN003177_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001952","studyUrl":"http://integmet.org/study/ST001952","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001953_AN003178_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001953","studyUrl":"http://integmet.org/study/ST001953","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001954_AN003179_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001954","studyUrl":"http://integmet.org/study/ST001954","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001955_AN003180_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001955","studyUrl":"http://integmet.org/study/ST001955","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001955_AN003181_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001955","studyUrl":"http://integmet.org/study/ST001955","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001956_AN003188_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001956","studyUrl":"http://integmet.org/study/ST001956","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001960_AN003195_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001960","studyUrl":"http://integmet.org/study/ST001960","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001961_AN003196_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001961","studyUrl":"http://integmet.org/study/ST001961","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001961_AN003197_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001961","studyUrl":"http://integmet.org/study/ST001961","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001963_AN003200_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001963","studyUrl":"http://integmet.org/study/ST001963","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001963_AN003201_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001963","studyUrl":"http://integmet.org/study/ST001963","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001964_AN003202_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001964","studyUrl":"http://integmet.org/study/ST001964","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001970_AN003211_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001970","studyUrl":"http://integmet.org/study/ST001970","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001970_AN003212_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001970","studyUrl":"http://integmet.org/study/ST001970","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001970_AN003213_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001970","studyUrl":"http://integmet.org/study/ST001970","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001970_AN003214_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001970","studyUrl":"http://integmet.org/study/ST001970","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001973_AN003218_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001973","studyUrl":"http://integmet.org/study/ST001973","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001973_AN003219_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001973","studyUrl":"http://integmet.org/study/ST001973","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001973_AN003220_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001973","studyUrl":"http://integmet.org/study/ST001973","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001973_AN003221_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001973","studyUrl":"http://integmet.org/study/ST001973","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001974_AN003222_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001974","studyUrl":"http://integmet.org/study/ST001974","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001975_AN003223_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001975","studyUrl":"http://integmet.org/study/ST001975","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001986_AN003237_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001986","studyUrl":"http://integmet.org/study/ST001986","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001990_AN003242_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001990","studyUrl":"http://integmet.org/study/ST001990","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001990_AN003243_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001990","studyUrl":"http://integmet.org/study/ST001990","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001996_AN003255_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001996","studyUrl":"http://integmet.org/study/ST001996","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001996_AN003256_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001996","studyUrl":"http://integmet.org/study/ST001996","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001997_AN003257_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001997","studyUrl":"http://integmet.org/study/ST001997","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001997_AN003258_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001997","studyUrl":"http://integmet.org/study/ST001997","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001998_AN003259_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001998","studyUrl":"http://integmet.org/study/ST001998","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001998_AN003260_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001998","studyUrl":"http://integmet.org/study/ST001998","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001999_AN003261_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001999","studyUrl":"http://integmet.org/study/ST001999","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST001999_AN003262_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST001999","studyUrl":"http://integmet.org/study/ST001999","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002000_AN003263_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002000","studyUrl":"http://integmet.org/study/ST002000","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002009_AN003275_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002009","studyUrl":"http://integmet.org/study/ST002009","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002011_AN003277_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002011","studyUrl":"http://integmet.org/study/ST002011","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002011_AN003278_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002011","studyUrl":"http://integmet.org/study/ST002011","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002011_AN003279_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002011","studyUrl":"http://integmet.org/study/ST002011","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002012_AN003286_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002012","studyUrl":"http://integmet.org/study/ST002012","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002016_AN003284_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002016","studyUrl":"http://integmet.org/study/ST002016","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002016_AN003285_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002016","studyUrl":"http://integmet.org/study/ST002016","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002026_AN003296_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002026","studyUrl":"http://integmet.org/study/ST002026","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002028_AN003298_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002028","studyUrl":"http://integmet.org/study/ST002028","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002030_AN003300_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002030","studyUrl":"http://integmet.org/study/ST002030","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002047_AN003334_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002047","studyUrl":"http://integmet.org/study/ST002047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002051_AN003338_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002051","studyUrl":"http://integmet.org/study/ST002051","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002053_AN003343_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002053","studyUrl":"http://integmet.org/study/ST002053","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002054_AN003344_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002054","studyUrl":"http://integmet.org/study/ST002054","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002054_AN003345_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002054","studyUrl":"http://integmet.org/study/ST002054","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002056_AN003348_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002056","studyUrl":"http://integmet.org/study/ST002056","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002057_AN003349_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002057","studyUrl":"http://integmet.org/study/ST002057","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002058_AN003350_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002058","studyUrl":"http://integmet.org/study/ST002058","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002058_AN003351_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002058","studyUrl":"http://integmet.org/study/ST002058","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002059_AN003352_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002059","studyUrl":"http://integmet.org/study/ST002059","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002059_AN003353_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002059","studyUrl":"http://integmet.org/study/ST002059","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002069_AN003378_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002069","studyUrl":"http://integmet.org/study/ST002069","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002069_AN003379_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002069","studyUrl":"http://integmet.org/study/ST002069","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002071_AN003376_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002071","studyUrl":"http://integmet.org/study/ST002071","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002075_AN003382_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002075","studyUrl":"http://integmet.org/study/ST002075","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002076_AN003383_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002076","studyUrl":"http://integmet.org/study/ST002076","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002076_AN003384_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002076","studyUrl":"http://integmet.org/study/ST002076","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002077_AN003385_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002077","studyUrl":"http://integmet.org/study/ST002077","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002077_AN003386_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002077","studyUrl":"http://integmet.org/study/ST002077","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002078_AN003387_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002078","studyUrl":"http://integmet.org/study/ST002078","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002078_AN003388_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002078","studyUrl":"http://integmet.org/study/ST002078","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002078_AN003389_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002078","studyUrl":"http://integmet.org/study/ST002078","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002078_AN003390_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002078","studyUrl":"http://integmet.org/study/ST002078","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002084_AN003401_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002084","studyUrl":"http://integmet.org/study/ST002084","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002085_AN003402_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002085","studyUrl":"http://integmet.org/study/ST002085","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002085_AN003403_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002085","studyUrl":"http://integmet.org/study/ST002085","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002091_AN003415_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002091","studyUrl":"http://integmet.org/study/ST002091","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002094_AN003420_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002094","studyUrl":"http://integmet.org/study/ST002094","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002094_AN003421_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002094","studyUrl":"http://integmet.org/study/ST002094","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002094_AN003422_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002094","studyUrl":"http://integmet.org/study/ST002094","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002097_AN003425_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002097","studyUrl":"http://integmet.org/study/ST002097","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002099_AN003430_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002099","studyUrl":"http://integmet.org/study/ST002099","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002099_AN003431_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002099","studyUrl":"http://integmet.org/study/ST002099","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002100_AN003432_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002100","studyUrl":"http://integmet.org/study/ST002100","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002100_AN003433_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002100","studyUrl":"http://integmet.org/study/ST002100","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002101_AN003434_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002101","studyUrl":"http://integmet.org/study/ST002101","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002101_AN003435_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002101","studyUrl":"http://integmet.org/study/ST002101","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002104_AN003439_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002104","studyUrl":"http://integmet.org/study/ST002104","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002104_AN003440_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002104","studyUrl":"http://integmet.org/study/ST002104","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002107_AN003446_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002107","studyUrl":"http://integmet.org/study/ST002107","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002107_AN003447_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002107","studyUrl":"http://integmet.org/study/ST002107","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002108_AN003448_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002108","studyUrl":"http://integmet.org/study/ST002108","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002108_AN003449_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002108","studyUrl":"http://integmet.org/study/ST002108","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002109_AN003450_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002109","studyUrl":"http://integmet.org/study/ST002109","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002109_AN003451_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002109","studyUrl":"http://integmet.org/study/ST002109","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002111_AN003454_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002111","studyUrl":"http://integmet.org/study/ST002111","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002111_AN003455_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002111","studyUrl":"http://integmet.org/study/ST002111","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002115_AN003513_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002115","studyUrl":"http://integmet.org/study/ST002115","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002115_AN003514_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002115","studyUrl":"http://integmet.org/study/ST002115","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002119_AN003467_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002119","studyUrl":"http://integmet.org/study/ST002119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002119_AN003468_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002119","studyUrl":"http://integmet.org/study/ST002119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002119_AN003469_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002119","studyUrl":"http://integmet.org/study/ST002119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002119_AN003470_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002119","studyUrl":"http://integmet.org/study/ST002119","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002121_AN003472_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002121","studyUrl":"http://integmet.org/study/ST002121","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002121_AN003473_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002121","studyUrl":"http://integmet.org/study/ST002121","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002125_AN003478_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002125","studyUrl":"http://integmet.org/study/ST002125","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002128_AN003481_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002128","studyUrl":"http://integmet.org/study/ST002128","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002131_AN003485_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002131","studyUrl":"http://integmet.org/study/ST002131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002131_AN003486_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002131","studyUrl":"http://integmet.org/study/ST002131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002132_AN003487_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002132","studyUrl":"http://integmet.org/study/ST002132","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002137_AN003498_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002137","studyUrl":"http://integmet.org/study/ST002137","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002138_AN003499_00000091","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002138","studyUrl":"http://integmet.org/study/ST002138","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002140_AN003501_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002140","studyUrl":"http://integmet.org/study/ST002140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002140_AN003502_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002140","studyUrl":"http://integmet.org/study/ST002140","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002152_AN003523_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002152","studyUrl":"http://integmet.org/study/ST002152","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002152_AN003524_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002152","studyUrl":"http://integmet.org/study/ST002152","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002152_AN003525_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002152","studyUrl":"http://integmet.org/study/ST002152","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002153_AN003526_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002153","studyUrl":"http://integmet.org/study/ST002153","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002153_AN003527_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002153","studyUrl":"http://integmet.org/study/ST002153","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002160_AN003539_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002160","studyUrl":"http://integmet.org/study/ST002160","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002162_AN003542_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002162","studyUrl":"http://integmet.org/study/ST002162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002162_AN003543_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002162","studyUrl":"http://integmet.org/study/ST002162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002167_AN003550_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002167","studyUrl":"http://integmet.org/study/ST002167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002167_AN003551_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002167","studyUrl":"http://integmet.org/study/ST002167","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002170_AN003555_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002170","studyUrl":"http://integmet.org/study/ST002170","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002170_AN003556_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002170","studyUrl":"http://integmet.org/study/ST002170","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002171_AN003557_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002171","studyUrl":"http://integmet.org/study/ST002171","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002171_AN003558_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002171","studyUrl":"http://integmet.org/study/ST002171","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002172_AN003559_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002172","studyUrl":"http://integmet.org/study/ST002172","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002172_AN003560_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002172","studyUrl":"http://integmet.org/study/ST002172","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002173_AN003561_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002173","studyUrl":"http://integmet.org/study/ST002173","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002178_AN003566_00000052","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002178","studyUrl":"http://integmet.org/study/ST002178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002178_AN003567_00000052","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002178","studyUrl":"http://integmet.org/study/ST002178","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002182_AN003574_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002182","studyUrl":"http://integmet.org/study/ST002182","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002191_AN003586_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002191","studyUrl":"http://integmet.org/study/ST002191","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002195_AN003593_00000022","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002195","studyUrl":"http://integmet.org/study/ST002195","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002195_AN003594_00000022","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002195","studyUrl":"http://integmet.org/study/ST002195","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002196_AN003595_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002196","studyUrl":"http://integmet.org/study/ST002196","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002197_AN003596_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002197","studyUrl":"http://integmet.org/study/ST002197","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002200_AN003600_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002200","studyUrl":"http://integmet.org/study/ST002200","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002200_AN003601_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002200","studyUrl":"http://integmet.org/study/ST002200","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002200_AN003602_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002200","studyUrl":"http://integmet.org/study/ST002200","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002200_AN003603_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002200","studyUrl":"http://integmet.org/study/ST002200","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002204_AN003607_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002204","studyUrl":"http://integmet.org/study/ST002204","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002205_AN003608_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002205","studyUrl":"http://integmet.org/study/ST002205","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002206_AN003609_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002206","studyUrl":"http://integmet.org/study/ST002206","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002211_AN003615_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002211","studyUrl":"http://integmet.org/study/ST002211","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002214_AN003622_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002214","studyUrl":"http://integmet.org/study/ST002214","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002214_AN003623_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002214","studyUrl":"http://integmet.org/study/ST002214","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002216_AN003625_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002216","studyUrl":"http://integmet.org/study/ST002216","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002217_AN003626_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002217","studyUrl":"http://integmet.org/study/ST002217","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002218_AN003627_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002218","studyUrl":"http://integmet.org/study/ST002218","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002220_AN003629_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002220","studyUrl":"http://integmet.org/study/ST002220","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002223_AN003632_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002223","studyUrl":"http://integmet.org/study/ST002223","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002224_AN003633_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002224","studyUrl":"http://integmet.org/study/ST002224","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002225_AN003634_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002225","studyUrl":"http://integmet.org/study/ST002225","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002226_AN003635_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002226","studyUrl":"http://integmet.org/study/ST002226","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002227_AN003636_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002227","studyUrl":"http://integmet.org/study/ST002227","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002235_AN003645_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002235","studyUrl":"http://integmet.org/study/ST002235","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002236_AN003646_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002236","studyUrl":"http://integmet.org/study/ST002236","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002236_AN003647_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002236","studyUrl":"http://integmet.org/study/ST002236","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002236_AN003648_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002236","studyUrl":"http://integmet.org/study/ST002236","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002236_AN003649_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002236","studyUrl":"http://integmet.org/study/ST002236","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002243_AN003661_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002243","studyUrl":"http://integmet.org/study/ST002243","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002243_AN003662_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002243","studyUrl":"http://integmet.org/study/ST002243","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002244_AN003663_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002244","studyUrl":"http://integmet.org/study/ST002244","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002244_AN003664_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002244","studyUrl":"http://integmet.org/study/ST002244","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002245_AN003665_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002245","studyUrl":"http://integmet.org/study/ST002245","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002246_AN003666_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002246","studyUrl":"http://integmet.org/study/ST002246","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002246_AN003667_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002246","studyUrl":"http://integmet.org/study/ST002246","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002246_AN003668_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002246","studyUrl":"http://integmet.org/study/ST002246","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002246_AN003669_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002246","studyUrl":"http://integmet.org/study/ST002246","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002248_AN003674_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002248","studyUrl":"http://integmet.org/study/ST002248","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002250_AN003676_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002250","studyUrl":"http://integmet.org/study/ST002250","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002252_AN003679_00000015","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002252","studyUrl":"http://integmet.org/study/ST002252","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002254_AN003682_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002254","studyUrl":"http://integmet.org/study/ST002254","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002263_AN003696_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002263","studyUrl":"http://integmet.org/study/ST002263","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002263_AN003697_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002263","studyUrl":"http://integmet.org/study/ST002263","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002270_AN003710_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002270","studyUrl":"http://integmet.org/study/ST002270","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002270_AN003711_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002270","studyUrl":"http://integmet.org/study/ST002270","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002271_AN003712_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002271","studyUrl":"http://integmet.org/study/ST002271","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002271_AN003713_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002271","studyUrl":"http://integmet.org/study/ST002271","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002273_AN003715_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002273","studyUrl":"http://integmet.org/study/ST002273","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002274_AN003716_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002274","studyUrl":"http://integmet.org/study/ST002274","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002280_AN003724_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002280","studyUrl":"http://integmet.org/study/ST002280","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002282_AN003727_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002282","studyUrl":"http://integmet.org/study/ST002282","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002284_AN003732_00000130","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002284","studyUrl":"http://integmet.org/study/ST002284","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002284_AN003733_00000130","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002284","studyUrl":"http://integmet.org/study/ST002284","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002292_AN003744_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002292","studyUrl":"http://integmet.org/study/ST002292","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002292_AN003745_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002292","studyUrl":"http://integmet.org/study/ST002292","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002292_AN003746_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002292","studyUrl":"http://integmet.org/study/ST002292","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002297_AN003752_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002297","studyUrl":"http://integmet.org/study/ST002297","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002297_AN003753_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002297","studyUrl":"http://integmet.org/study/ST002297","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002303_AN003764_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002303","studyUrl":"http://integmet.org/study/ST002303","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002304_AN003765_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002304","studyUrl":"http://integmet.org/study/ST002304","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002309_AN003771_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002309","studyUrl":"http://integmet.org/study/ST002309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002309_AN003772_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002309","studyUrl":"http://integmet.org/study/ST002309","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002317_AN003784_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002317","studyUrl":"http://integmet.org/study/ST002317","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002318_AN003785_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002318","studyUrl":"http://integmet.org/study/ST002318","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002319_AN003786_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002319","studyUrl":"http://integmet.org/study/ST002319","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002322_AN003789_00000011","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002322","studyUrl":"http://integmet.org/study/ST002322","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002325_AN003794_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002325","studyUrl":"http://integmet.org/study/ST002325","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002326_AN003795_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002326","studyUrl":"http://integmet.org/study/ST002326","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002327_AN003796_00000027","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002327","studyUrl":"http://integmet.org/study/ST002327","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002328_AN003797_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002328","studyUrl":"http://integmet.org/study/ST002328","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002330_AN003801_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002330","studyUrl":"http://integmet.org/study/ST002330","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002330_AN003802_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002330","studyUrl":"http://integmet.org/study/ST002330","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002330_AN003803_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002330","studyUrl":"http://integmet.org/study/ST002330","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002335_AN003814_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002335","studyUrl":"http://integmet.org/study/ST002335","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002344_AN003828_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002344","studyUrl":"http://integmet.org/study/ST002344","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002345_AN003829_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002345","studyUrl":"http://integmet.org/study/ST002345","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002346_AN003831_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002346","studyUrl":"http://integmet.org/study/ST002346","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002348_AN003833_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002348","studyUrl":"http://integmet.org/study/ST002348","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002349_AN004095_00000094","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002349","studyUrl":"http://integmet.org/study/ST002349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002349_AN004096_00000094","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002349","studyUrl":"http://integmet.org/study/ST002349","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002352_AN004097_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002352","studyUrl":"http://integmet.org/study/ST002352","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002352_AN004098_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002352","studyUrl":"http://integmet.org/study/ST002352","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002361_AN003855_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002361","studyUrl":"http://integmet.org/study/ST002361","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002361_AN003856_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002361","studyUrl":"http://integmet.org/study/ST002361","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002363_AN003858_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002363","studyUrl":"http://integmet.org/study/ST002363","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002364_AN003859_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002364","studyUrl":"http://integmet.org/study/ST002364","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002365_AN003860_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002365","studyUrl":"http://integmet.org/study/ST002365","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002371_AN003866_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002371","studyUrl":"http://integmet.org/study/ST002371","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002372_AN003867_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002372","studyUrl":"http://integmet.org/study/ST002372","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002373_AN003868_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002373","studyUrl":"http://integmet.org/study/ST002373","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002374_AN003869_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002374","studyUrl":"http://integmet.org/study/ST002374","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002375_AN003870_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002375","studyUrl":"http://integmet.org/study/ST002375","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002376_AN003871_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002376","studyUrl":"http://integmet.org/study/ST002376","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002376_AN003872_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002376","studyUrl":"http://integmet.org/study/ST002376","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002377_AN003873_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002377","studyUrl":"http://integmet.org/study/ST002377","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002377_AN003874_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002377","studyUrl":"http://integmet.org/study/ST002377","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002378_AN003875_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002378","studyUrl":"http://integmet.org/study/ST002378","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002378_AN003876_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002378","studyUrl":"http://integmet.org/study/ST002378","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002379_AN003877_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002379","studyUrl":"http://integmet.org/study/ST002379","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002379_AN003878_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002379","studyUrl":"http://integmet.org/study/ST002379","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002383_AN003882_00000014","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002383","studyUrl":"http://integmet.org/study/ST002383","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002389_AN003893_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002389","studyUrl":"http://integmet.org/study/ST002389","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002391_AN003896_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002391","studyUrl":"http://integmet.org/study/ST002391","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002395_AN004119_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002395","studyUrl":"http://integmet.org/study/ST002395","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002397_AN003904_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002397","studyUrl":"http://integmet.org/study/ST002397","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002399_AN003906_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002399","studyUrl":"http://integmet.org/study/ST002399","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002400_AN003907_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002400","studyUrl":"http://integmet.org/study/ST002400","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002400_AN003908_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002400","studyUrl":"http://integmet.org/study/ST002400","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002400_AN003909_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002400","studyUrl":"http://integmet.org/study/ST002400","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002400_AN003910_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002400","studyUrl":"http://integmet.org/study/ST002400","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002405_AN003919_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002405","studyUrl":"http://integmet.org/study/ST002405","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002406_AN003920_00000036","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002406","studyUrl":"http://integmet.org/study/ST002406","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002406_AN003921_00000036","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002406","studyUrl":"http://integmet.org/study/ST002406","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002406_AN003922_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002406","studyUrl":"http://integmet.org/study/ST002406","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002406_AN003923_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002406","studyUrl":"http://integmet.org/study/ST002406","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002407_AN003924_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002407","studyUrl":"http://integmet.org/study/ST002407","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002409_AN003926_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002409","studyUrl":"http://integmet.org/study/ST002409","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002412_AN003931_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002412","studyUrl":"http://integmet.org/study/ST002412","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002412_AN003932_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002412","studyUrl":"http://integmet.org/study/ST002412","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002413_AN003933_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002413","studyUrl":"http://integmet.org/study/ST002413","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002413_AN003934_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002413","studyUrl":"http://integmet.org/study/ST002413","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002414_AN003935_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002414","studyUrl":"http://integmet.org/study/ST002414","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002415_AN003936_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002415","studyUrl":"http://integmet.org/study/ST002415","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002416_AN003937_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002416","studyUrl":"http://integmet.org/study/ST002416","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002421_AN003942_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002421","studyUrl":"http://integmet.org/study/ST002421","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002421_AN003943_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002421","studyUrl":"http://integmet.org/study/ST002421","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002427_AN003950_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002427","studyUrl":"http://integmet.org/study/ST002427","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002428_AN003951_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002428","studyUrl":"http://integmet.org/study/ST002428","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002428_AN003952_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002428","studyUrl":"http://integmet.org/study/ST002428","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002431_AN003957_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002431","studyUrl":"http://integmet.org/study/ST002431","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002431_AN003958_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002431","studyUrl":"http://integmet.org/study/ST002431","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002434_AN003964_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002434","studyUrl":"http://integmet.org/study/ST002434","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002434_AN003965_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002434","studyUrl":"http://integmet.org/study/ST002434","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002434_AN003966_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002434","studyUrl":"http://integmet.org/study/ST002434","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002435_AN003967_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002435","studyUrl":"http://integmet.org/study/ST002435","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002435_AN003968_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002435","studyUrl":"http://integmet.org/study/ST002435","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002438_AN003972_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002438","studyUrl":"http://integmet.org/study/ST002438","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002438_AN003973_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002438","studyUrl":"http://integmet.org/study/ST002438","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002438_AN003974_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002438","studyUrl":"http://integmet.org/study/ST002438","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002438_AN003975_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002438","studyUrl":"http://integmet.org/study/ST002438","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002444_AN003981_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002444","studyUrl":"http://integmet.org/study/ST002444","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002444_AN003982_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002444","studyUrl":"http://integmet.org/study/ST002444","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002445_AN003983_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002445","studyUrl":"http://integmet.org/study/ST002445","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002447_AN003988_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002447","studyUrl":"http://integmet.org/study/ST002447","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002450_AN003998_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002450","studyUrl":"http://integmet.org/study/ST002450","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002451_AN003999_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002451","studyUrl":"http://integmet.org/study/ST002451","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002455_AN004005_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002455","studyUrl":"http://integmet.org/study/ST002455","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002457_AN004009_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002457","studyUrl":"http://integmet.org/study/ST002457","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002458_AN004010_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002458","studyUrl":"http://integmet.org/study/ST002458","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002460_AN004014_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002460","studyUrl":"http://integmet.org/study/ST002460","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002461_AN004015_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002461","studyUrl":"http://integmet.org/study/ST002461","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002461_AN004016_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002461","studyUrl":"http://integmet.org/study/ST002461","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002462_AN004017_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002462","studyUrl":"http://integmet.org/study/ST002462","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002467_AN004023_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002467","studyUrl":"http://integmet.org/study/ST002467","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002473_AN004039_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002473","studyUrl":"http://integmet.org/study/ST002473","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002473_AN004040_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002473","studyUrl":"http://integmet.org/study/ST002473","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002475_AN004042_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002475","studyUrl":"http://integmet.org/study/ST002475","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002475_AN004043_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002475","studyUrl":"http://integmet.org/study/ST002475","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002477_AN004046_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002477","studyUrl":"http://integmet.org/study/ST002477","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002485_AN004056_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002485","studyUrl":"http://integmet.org/study/ST002485","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002485_AN004057_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002485","studyUrl":"http://integmet.org/study/ST002485","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002486_AN004058_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002486","studyUrl":"http://integmet.org/study/ST002486","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002486_AN004059_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002486","studyUrl":"http://integmet.org/study/ST002486","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002487_AN004060_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002487","studyUrl":"http://integmet.org/study/ST002487","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002487_AN004061_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002487","studyUrl":"http://integmet.org/study/ST002487","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002488_AN004062_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002488","studyUrl":"http://integmet.org/study/ST002488","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002489_AN004063_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002489","studyUrl":"http://integmet.org/study/ST002489","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002491_AN004065_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002491","studyUrl":"http://integmet.org/study/ST002491","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004085_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004086_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004087_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004088_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004089_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004090_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002493_AN004091_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002493","studyUrl":"http://integmet.org/study/ST002493","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002494_AN004092_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002494","studyUrl":"http://integmet.org/study/ST002494","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002497_AN004101_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002497","studyUrl":"http://integmet.org/study/ST002497","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002499_AN004106_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002499","studyUrl":"http://integmet.org/study/ST002499","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002500_AN004107_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002500","studyUrl":"http://integmet.org/study/ST002500","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002500_AN004108_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002500","studyUrl":"http://integmet.org/study/ST002500","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002500_AN004109_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002500","studyUrl":"http://integmet.org/study/ST002500","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002503_AN004112_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002503","studyUrl":"http://integmet.org/study/ST002503","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002507_AN004129_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002507","studyUrl":"http://integmet.org/study/ST002507","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002508_AN004130_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002508","studyUrl":"http://integmet.org/study/ST002508","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002512_AN004136_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002512","studyUrl":"http://integmet.org/study/ST002512","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002512_AN004137_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002512","studyUrl":"http://integmet.org/study/ST002512","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002522_AN004155_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002522","studyUrl":"http://integmet.org/study/ST002522","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002522_AN004156_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002522","studyUrl":"http://integmet.org/study/ST002522","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002524_AN004158_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002524","studyUrl":"http://integmet.org/study/ST002524","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002525_AN004159_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002525","studyUrl":"http://integmet.org/study/ST002525","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002527_AN004161_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002527","studyUrl":"http://integmet.org/study/ST002527","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002528_AN004162_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002528","studyUrl":"http://integmet.org/study/ST002528","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002530_AN004164_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002530","studyUrl":"http://integmet.org/study/ST002530","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002531_AN004165_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002531","studyUrl":"http://integmet.org/study/ST002531","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002536_AN004171_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002536","studyUrl":"http://integmet.org/study/ST002536","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002536_AN004172_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002536","studyUrl":"http://integmet.org/study/ST002536","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002536_AN004173_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002536","studyUrl":"http://integmet.org/study/ST002536","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002536_AN004174_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002536","studyUrl":"http://integmet.org/study/ST002536","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002540_AN004185_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002540","studyUrl":"http://integmet.org/study/ST002540","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002541_AN004186_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002541","studyUrl":"http://integmet.org/study/ST002541","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002541_AN004187_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002541","studyUrl":"http://integmet.org/study/ST002541","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002542_AN004188_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002542","studyUrl":"http://integmet.org/study/ST002542","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002542_AN004189_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002542","studyUrl":"http://integmet.org/study/ST002542","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002543_AN004190_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002543","studyUrl":"http://integmet.org/study/ST002543","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002544_AN004191_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002544","studyUrl":"http://integmet.org/study/ST002544","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002545_AN004192_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002545","studyUrl":"http://integmet.org/study/ST002545","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002546_AN004193_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002546","studyUrl":"http://integmet.org/study/ST002546","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002547_AN004194_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002547","studyUrl":"http://integmet.org/study/ST002547","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002549_AN004197_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002549","studyUrl":"http://integmet.org/study/ST002549","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002550_AN004198_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002550","studyUrl":"http://integmet.org/study/ST002550","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002550_AN004199_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002550","studyUrl":"http://integmet.org/study/ST002550","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002553_AN004204_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002553","studyUrl":"http://integmet.org/study/ST002553","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002555_AN004207_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002555","studyUrl":"http://integmet.org/study/ST002555","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002562_AN004223_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002562","studyUrl":"http://integmet.org/study/ST002562","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002564_AN004225_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002564","studyUrl":"http://integmet.org/study/ST002564","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002565_AN004226_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002565","studyUrl":"http://integmet.org/study/ST002565","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002566_AN004227_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002566","studyUrl":"http://integmet.org/study/ST002566","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002567_AN004228_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002567","studyUrl":"http://integmet.org/study/ST002567","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002571_AN004236_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002571","studyUrl":"http://integmet.org/study/ST002571","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002572_AN004237_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002572","studyUrl":"http://integmet.org/study/ST002572","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002573_AN004238_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002573","studyUrl":"http://integmet.org/study/ST002573","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002578_AN004249_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002578","studyUrl":"http://integmet.org/study/ST002578","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002584_AN004255_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002584","studyUrl":"http://integmet.org/study/ST002584","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002584_AN004256_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002584","studyUrl":"http://integmet.org/study/ST002584","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002585_AN004257_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002585","studyUrl":"http://integmet.org/study/ST002585","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002586_AN004258_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002586","studyUrl":"http://integmet.org/study/ST002586","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002587_AN004259_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002587","studyUrl":"http://integmet.org/study/ST002587","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002618_AN004290_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002618","studyUrl":"http://integmet.org/study/ST002618","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002641_AN004313_00000035","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002641","studyUrl":"http://integmet.org/study/ST002641","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002643_AN004315_00000062","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002643","studyUrl":"http://integmet.org/study/ST002643","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002666_AN004338_00000020","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002666","studyUrl":"http://integmet.org/study/ST002666","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002667_AN004339_00000013","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002667","studyUrl":"http://integmet.org/study/ST002667","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002669_AN004341_00000062","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002669","studyUrl":"http://integmet.org/study/ST002669","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002681_AN004353_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002681","studyUrl":"http://integmet.org/study/ST002681","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002681_AN004354_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002681","studyUrl":"http://integmet.org/study/ST002681","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002698_AN004372_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002698","studyUrl":"http://integmet.org/study/ST002698","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002698_AN004373_00000016","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002698","studyUrl":"http://integmet.org/study/ST002698","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002701_AN004378_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002701","studyUrl":"http://integmet.org/study/ST002701","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002703_AN004383_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002703","studyUrl":"http://integmet.org/study/ST002703","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002707_AN004389_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002707","studyUrl":"http://integmet.org/study/ST002707","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002708_AN004390_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002708","studyUrl":"http://integmet.org/study/ST002708","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002709_AN004391_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002709","studyUrl":"http://integmet.org/study/ST002709","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002712_AN004395_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002712","studyUrl":"http://integmet.org/study/ST002712","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002712_AN004396_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002712","studyUrl":"http://integmet.org/study/ST002712","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002713_AN004398_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002713","studyUrl":"http://integmet.org/study/ST002713","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002714_AN004399_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002714","studyUrl":"http://integmet.org/study/ST002714","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002714_AN004400_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002714","studyUrl":"http://integmet.org/study/ST002714","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002727_AN004420_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002727","studyUrl":"http://integmet.org/study/ST002727","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002727_AN004421_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002727","studyUrl":"http://integmet.org/study/ST002727","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002730_AN004427_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002730","studyUrl":"http://integmet.org/study/ST002730","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002731_AN004428_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002731","studyUrl":"http://integmet.org/study/ST002731","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002736_AN004438_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002736","studyUrl":"http://integmet.org/study/ST002736","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002741_AN004571_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002741","studyUrl":"http://integmet.org/study/ST002741","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002744_AN004449_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002744","studyUrl":"http://integmet.org/study/ST002744","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002744_AN004450_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002744","studyUrl":"http://integmet.org/study/ST002744","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002747_AN004454_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002747","studyUrl":"http://integmet.org/study/ST002747","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002747_AN004455_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002747","studyUrl":"http://integmet.org/study/ST002747","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002747_AN004456_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002747","studyUrl":"http://integmet.org/study/ST002747","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002747_AN004457_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002747","studyUrl":"http://integmet.org/study/ST002747","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002752_AN004465_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002752","studyUrl":"http://integmet.org/study/ST002752","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002752_AN004466_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002752","studyUrl":"http://integmet.org/study/ST002752","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002754_AN004468_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002754","studyUrl":"http://integmet.org/study/ST002754","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002754_AN004469_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002754","studyUrl":"http://integmet.org/study/ST002754","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002754_AN004470_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002754","studyUrl":"http://integmet.org/study/ST002754","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002754_AN004471_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002754","studyUrl":"http://integmet.org/study/ST002754","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002755_AN004472_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002755","studyUrl":"http://integmet.org/study/ST002755","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002756_AN004473_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002756","studyUrl":"http://integmet.org/study/ST002756","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002760_AN004483_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002760","studyUrl":"http://integmet.org/study/ST002760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002760_AN004484_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002760","studyUrl":"http://integmet.org/study/ST002760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002760_AN004485_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002760","studyUrl":"http://integmet.org/study/ST002760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002760_AN004486_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002760","studyUrl":"http://integmet.org/study/ST002760","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002763_AN004492_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002763","studyUrl":"http://integmet.org/study/ST002763","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002764_AN004498_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002764","studyUrl":"http://integmet.org/study/ST002764","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002764_AN004499_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002764","studyUrl":"http://integmet.org/study/ST002764","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002774_AN004515_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002774","studyUrl":"http://integmet.org/study/ST002774","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002774_AN004516_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002774","studyUrl":"http://integmet.org/study/ST002774","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002775_AN004517_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002775","studyUrl":"http://integmet.org/study/ST002775","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002775_AN004518_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002775","studyUrl":"http://integmet.org/study/ST002775","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002776_AN004519_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002776","studyUrl":"http://integmet.org/study/ST002776","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002776_AN004520_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002776","studyUrl":"http://integmet.org/study/ST002776","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002778_AN004522_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002778","studyUrl":"http://integmet.org/study/ST002778","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002778_AN004523_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002778","studyUrl":"http://integmet.org/study/ST002778","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002778_AN004524_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002778","studyUrl":"http://integmet.org/study/ST002778","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002782_AN004529_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002782","studyUrl":"http://integmet.org/study/ST002782","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002791_AN004541_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002791","studyUrl":"http://integmet.org/study/ST002791","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002792_AN004542_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002792","studyUrl":"http://integmet.org/study/ST002792","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002792_AN004543_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002792","studyUrl":"http://integmet.org/study/ST002792","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002797_AN004550_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002797","studyUrl":"http://integmet.org/study/ST002797","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002797_AN004551_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002797","studyUrl":"http://integmet.org/study/ST002797","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002801_AN004557_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002801","studyUrl":"http://integmet.org/study/ST002801","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002810_AN004570_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002810","studyUrl":"http://integmet.org/study/ST002810","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002815_AN004582_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002815","studyUrl":"http://integmet.org/study/ST002815","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002817_AN004584_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002817","studyUrl":"http://integmet.org/study/ST002817","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002824_AN004605_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002824","studyUrl":"http://integmet.org/study/ST002824","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002824_AN004606_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002824","studyUrl":"http://integmet.org/study/ST002824","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002824_AN004607_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002824","studyUrl":"http://integmet.org/study/ST002824","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002824_AN004608_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002824","studyUrl":"http://integmet.org/study/ST002824","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002825_AN004609_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002825","studyUrl":"http://integmet.org/study/ST002825","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002830_AN004623_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002830","studyUrl":"http://integmet.org/study/ST002830","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002831_AN004624_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002831","studyUrl":"http://integmet.org/study/ST002831","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002832_AN004625_00000067","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002832","studyUrl":"http://integmet.org/study/ST002832","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002832_AN004626_00000067","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002832","studyUrl":"http://integmet.org/study/ST002832","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002835_AN004631_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002835","studyUrl":"http://integmet.org/study/ST002835","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002835_AN004632_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002835","studyUrl":"http://integmet.org/study/ST002835","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002836_AN004633_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002836","studyUrl":"http://integmet.org/study/ST002836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002836_AN004634_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002836","studyUrl":"http://integmet.org/study/ST002836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002836_AN004635_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002836","studyUrl":"http://integmet.org/study/ST002836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002836_AN004636_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002836","studyUrl":"http://integmet.org/study/ST002836","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002837_AN004637_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002837","studyUrl":"http://integmet.org/study/ST002837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002837_AN004638_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002837","studyUrl":"http://integmet.org/study/ST002837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002837_AN004639_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002837","studyUrl":"http://integmet.org/study/ST002837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002837_AN004640_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002837","studyUrl":"http://integmet.org/study/ST002837","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002840_AN004647_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002840","studyUrl":"http://integmet.org/study/ST002840","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002840_AN004648_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002840","studyUrl":"http://integmet.org/study/ST002840","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002841_AN004649_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002841","studyUrl":"http://integmet.org/study/ST002841","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002841_AN004650_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002841","studyUrl":"http://integmet.org/study/ST002841","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002842_AN004651_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002842","studyUrl":"http://integmet.org/study/ST002842","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002843_AN004652_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002843","studyUrl":"http://integmet.org/study/ST002843","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002843_AN004653_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002843","studyUrl":"http://integmet.org/study/ST002843","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002844_AN004658_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002844","studyUrl":"http://integmet.org/study/ST002844","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002857_AN004679_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002857","studyUrl":"http://integmet.org/study/ST002857","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002857_AN004680_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002857","studyUrl":"http://integmet.org/study/ST002857","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002857_AN004681_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002857","studyUrl":"http://integmet.org/study/ST002857","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002857_AN004682_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002857","studyUrl":"http://integmet.org/study/ST002857","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002857_AN004683_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002857","studyUrl":"http://integmet.org/study/ST002857","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002861_AN004691_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002861","studyUrl":"http://integmet.org/study/ST002861","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002861_AN004692_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002861","studyUrl":"http://integmet.org/study/ST002861","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002862_AN004693_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002862","studyUrl":"http://integmet.org/study/ST002862","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002862_AN004694_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002862","studyUrl":"http://integmet.org/study/ST002862","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002867_AN004700_00000012","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002867","studyUrl":"http://integmet.org/study/ST002867","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002869_AN004702_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002869","studyUrl":"http://integmet.org/study/ST002869","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002869_AN004703_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002869","studyUrl":"http://integmet.org/study/ST002869","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002873_AN004709_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002873","studyUrl":"http://integmet.org/study/ST002873","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002874_AN004711_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002874","studyUrl":"http://integmet.org/study/ST002874","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002880_AN004719_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002880","studyUrl":"http://integmet.org/study/ST002880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002880_AN004720_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002880","studyUrl":"http://integmet.org/study/ST002880","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002890_AN004749_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002890","studyUrl":"http://integmet.org/study/ST002890","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002892_AN004751_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002892","studyUrl":"http://integmet.org/study/ST002892","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002893_AN004752_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002893","studyUrl":"http://integmet.org/study/ST002893","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002894_AN004753_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002894","studyUrl":"http://integmet.org/study/ST002894","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002895_AN004754_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002895","studyUrl":"http://integmet.org/study/ST002895","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002896_AN004755_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002896","studyUrl":"http://integmet.org/study/ST002896","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002897_AN004756_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002897","studyUrl":"http://integmet.org/study/ST002897","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002898_AN004757_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002898","studyUrl":"http://integmet.org/study/ST002898","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002899_AN004758_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002899","studyUrl":"http://integmet.org/study/ST002899","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002900_AN004759_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002900","studyUrl":"http://integmet.org/study/ST002900","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002902_AN004761_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002902","studyUrl":"http://integmet.org/study/ST002902","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002906_AN004769_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002906","studyUrl":"http://integmet.org/study/ST002906","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002907_AN004770_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002907","studyUrl":"http://integmet.org/study/ST002907","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002910_AN004779_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002910","studyUrl":"http://integmet.org/study/ST002910","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002911_AN004780_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002911","studyUrl":"http://integmet.org/study/ST002911","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002911_AN004781_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002911","studyUrl":"http://integmet.org/study/ST002911","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002912_AN004782_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002912","studyUrl":"http://integmet.org/study/ST002912","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002913_AN004783_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002913","studyUrl":"http://integmet.org/study/ST002913","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002917_AN004787_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002917","studyUrl":"http://integmet.org/study/ST002917","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002923_AN004793_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002923","studyUrl":"http://integmet.org/study/ST002923","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002925_AN004796_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002925","studyUrl":"http://integmet.org/study/ST002925","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002925_AN004797_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002925","studyUrl":"http://integmet.org/study/ST002925","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002927_AN004800_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002927","studyUrl":"http://integmet.org/study/ST002927","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002927_AN004801_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002927","studyUrl":"http://integmet.org/study/ST002927","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002931_AN004809_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002931","studyUrl":"http://integmet.org/study/ST002931","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002933_AN004811_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002933","studyUrl":"http://integmet.org/study/ST002933","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002935_AN004814_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002935","studyUrl":"http://integmet.org/study/ST002935","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002936_AN004815_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002936","studyUrl":"http://integmet.org/study/ST002936","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002936_AN004816_00000008","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002936","studyUrl":"http://integmet.org/study/ST002936","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002949_AN004836_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002949","studyUrl":"http://integmet.org/study/ST002949","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002949_AN004837_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002949","studyUrl":"http://integmet.org/study/ST002949","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002952_AN004848_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002952","studyUrl":"http://integmet.org/study/ST002952","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002952_AN004849_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002952","studyUrl":"http://integmet.org/study/ST002952","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002959_AN004859_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002959","studyUrl":"http://integmet.org/study/ST002959","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002959_AN004860_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002959","studyUrl":"http://integmet.org/study/ST002959","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002962_AN004863_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002962","studyUrl":"http://integmet.org/study/ST002962","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002966_AN004873_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002966","studyUrl":"http://integmet.org/study/ST002966","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002966_AN004874_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002966","studyUrl":"http://integmet.org/study/ST002966","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002968_AN004876_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002968","studyUrl":"http://integmet.org/study/ST002968","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002968_AN004877_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002968","studyUrl":"http://integmet.org/study/ST002968","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002969_AN004878_00000004","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002969","studyUrl":"http://integmet.org/study/ST002969","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002970_AN004879_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002970","studyUrl":"http://integmet.org/study/ST002970","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002971_AN004880_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002971","studyUrl":"http://integmet.org/study/ST002971","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002972_AN004881_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002972","studyUrl":"http://integmet.org/study/ST002972","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002989_AN004909_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002989","studyUrl":"http://integmet.org/study/ST002989","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002990_AN004910_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002990","studyUrl":"http://integmet.org/study/ST002990","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002993_AN004915_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002993","studyUrl":"http://integmet.org/study/ST002993","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST002999_AN004926_00000031","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST002999","studyUrl":"http://integmet.org/study/ST002999","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003012_AN004944_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003012","studyUrl":"http://integmet.org/study/ST003012","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003012_AN004945_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003012","studyUrl":"http://integmet.org/study/ST003012","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003018_AN004952_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003018","studyUrl":"http://integmet.org/study/ST003018","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003020_AN004954_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003020","studyUrl":"http://integmet.org/study/ST003020","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003021_AN004955_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003021","studyUrl":"http://integmet.org/study/ST003021","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003022_AN004956_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003022","studyUrl":"http://integmet.org/study/ST003022","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003023_AN004957_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003023","studyUrl":"http://integmet.org/study/ST003023","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003028_AN004964_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003028","studyUrl":"http://integmet.org/study/ST003028","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003028_AN004965_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003028","studyUrl":"http://integmet.org/study/ST003028","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003036_AN004977_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003036","studyUrl":"http://integmet.org/study/ST003036","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003036_AN004978_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003036","studyUrl":"http://integmet.org/study/ST003036","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003038_AN004984_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003038","studyUrl":"http://integmet.org/study/ST003038","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003038_AN004985_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003038","studyUrl":"http://integmet.org/study/ST003038","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003039_AN004986_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003039","studyUrl":"http://integmet.org/study/ST003039","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003044_AN004993_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003044","studyUrl":"http://integmet.org/study/ST003044","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003044_AN004994_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003044","studyUrl":"http://integmet.org/study/ST003044","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003045_AN004995_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003045","studyUrl":"http://integmet.org/study/ST003045","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003047_AN004998_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003047","studyUrl":"http://integmet.org/study/ST003047","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003049_AN005000_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003049","studyUrl":"http://integmet.org/study/ST003049","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003050_AN005001_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003050","studyUrl":"http://integmet.org/study/ST003050","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003053_AN005006_00000017","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003053","studyUrl":"http://integmet.org/study/ST003053","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003053_AN005007_00000017","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003053","studyUrl":"http://integmet.org/study/ST003053","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003063_AN005018_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003063","studyUrl":"http://integmet.org/study/ST003063","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003064_AN005019_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003064","studyUrl":"http://integmet.org/study/ST003064","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003064_AN005020_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003064","studyUrl":"http://integmet.org/study/ST003064","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003066_AN005022_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003066","studyUrl":"http://integmet.org/study/ST003066","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003072_AN005030_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003072","studyUrl":"http://integmet.org/study/ST003072","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003095_AN005066_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003095","studyUrl":"http://integmet.org/study/ST003095","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003096_AN005067_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003096","studyUrl":"http://integmet.org/study/ST003096","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003097_AN005068_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003097","studyUrl":"http://integmet.org/study/ST003097","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003098_AN005069_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003098","studyUrl":"http://integmet.org/study/ST003098","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003099_AN005070_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003099","studyUrl":"http://integmet.org/study/ST003099","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003100_AN005071_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003100","studyUrl":"http://integmet.org/study/ST003100","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003102_AN005076_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003102","studyUrl":"http://integmet.org/study/ST003102","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003103_AN005077_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003103","studyUrl":"http://integmet.org/study/ST003103","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003103_AN005078_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003103","studyUrl":"http://integmet.org/study/ST003103","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003103_AN005079_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003103","studyUrl":"http://integmet.org/study/ST003103","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003106_AN005085_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003106","studyUrl":"http://integmet.org/study/ST003106","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003107_AN005086_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003107","studyUrl":"http://integmet.org/study/ST003107","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003112_AN005111_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003112","studyUrl":"http://integmet.org/study/ST003112","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003114_AN005102_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003114","studyUrl":"http://integmet.org/study/ST003114","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003118_AN005112_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003118","studyUrl":"http://integmet.org/study/ST003118","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003126_AN005125_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003126","studyUrl":"http://integmet.org/study/ST003126","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003128_AN005128_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003128","studyUrl":"http://integmet.org/study/ST003128","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003128_AN005129_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003128","studyUrl":"http://integmet.org/study/ST003128","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003128_AN005130_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003128","studyUrl":"http://integmet.org/study/ST003128","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003131_AN005135_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003131","studyUrl":"http://integmet.org/study/ST003131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003131_AN005136_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003131","studyUrl":"http://integmet.org/study/ST003131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003131_AN005137_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003131","studyUrl":"http://integmet.org/study/ST003131","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003132_AN005139_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003132","studyUrl":"http://integmet.org/study/ST003132","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003132_AN005140_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003132","studyUrl":"http://integmet.org/study/ST003132","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003132_AN005141_00000010","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003132","studyUrl":"http://integmet.org/study/ST003132","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003162_AN005187_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003162","studyUrl":"http://integmet.org/study/ST003162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003162_AN005188_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003162","studyUrl":"http://integmet.org/study/ST003162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003162_AN005189_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003162","studyUrl":"http://integmet.org/study/ST003162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003162_AN005190_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003162","studyUrl":"http://integmet.org/study/ST003162","title":"","topHits":[],"totalFeatures":0},{"comparisonGroups":[],"dateCreated":"2025-09-26 00:00:00","group_a_title":"","group_b_title":"","id":"ST003172_AN005206_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":0,"studyId":"ST003172","studyUrl":"http://integmet.org/study/ST003172","title":"","topHits":[],"totalFeatures":0}]